Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.5984375177718313,-2.62790976641918,0.0,0.0,0.0,59/87,21.25%,RPL13;RPS8;RPS23;RPS29;RPL37A;RPS21;RPL38;RPS11;RPL21;RPL35A;RPL23;RPL17;RPL3;RPS15;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;RPS14;RPSA;RPL10;RPL18;RPL32;RPS28;RPS5;SRP68;RPS24;RPL15;RPS19;RPL39;RPL12;RPL27;RPL24;RPS12;RPS4X;RPS27;RPL27A;RPS9;RPL30;RPL19;RPL28;RPL31;RPL13A;RPL36A;SEC61B;RPLP2;RPL29;RPLP0;RPL10A;RPS10;RPL35;RPS26
prerank,protein targeting to ER (GO:0045047),-0.5684045195096475,-2.576095264329718,0.0,0.0,0.0,69/99,24.74%,RPL13;RPS8;RPS23;RPS29;RPL37A;RPS21;RPL38;RPS11;RPL21;RPL35A;RPL23;RPL17;RPL3;RPS15;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;EDEM1;RPS14;RPSA;SPCS2;RPL10;RPL18;RPL32;RPS28;RPS5;SRP68;RPS24;RPL15;RPS19;RPL39;RPL12;RPL27;RPL24;RPS12;SGTA;RPS4X;RPS27;RPL27A;RPS9;RPL30;SGTB;RPL19;RPL28;RPL31;RPL13A;RPL36A;SEC62;RPLP2;RPL29;RPLP0;RPL10A;RPS10;RPL35;RPS26;ZFAND2A;RPS27A;RPS3;RPL4;SEC63;SPCS1
prerank,cytoplasmic translation (GO:0002181),-0.5583440222390577,-2.510835494205502,0.0,0.0,0.0,61/91,23.10%,RPL13;RPS8;EIF3M;RPS23;RPS29;RPL37A;RPS21;RPL38;RPS11;RPL21;RPL35A;RPL23;RPL17;RPL3;RPS15;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;RPS14;RPSA;RPL10;RPL18;RPL32;RPS28;RPS5;RPS24;RPL15;RPS19;RPL39;RWDD1;RPL12;RPL27;RPL24;RPS12;RPS4X;RPS27;RPL27A;RPS9;RPL30;RPL19;RPL28;RPL31;RPL13A;RPL36A;RPL29;RPLP0;RPL10A;RPS10;RPL35;RPS26;TMA7;RPS27A;RPS3
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.568809757150111,-2.4178888636351004,0.0,0.0,0.0,61/91,21.25%,RPL13;RPS8;RPS23;RPS29;RPL37A;RPS21;SIL1;RPL38;RPS11;RPL21;RPL35A;RPL23;RPL17;RPL3;RPS15;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;RPS14;RPSA;RPL10;RPL18;RPL32;RPS28;RPS5;SRP68;RPS24;RPL15;RPS19;RPL39;RPL12;RPL27;RPL24;RPS12;RPS4X;RPS27;RPL27A;RPS9;RPL30;RPL19;RPL28;RPL31;RPL13A;RPL36A;SEC62;RPLP2;RPL29;RPLP0;RPL10A;SSR2;RPS10;RPL35;RPS26
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.49409268919443083,-2.2504912134767316,0.0,0.0006831576212550081,0.002,72/110,26.41%,RPL13;RPS8;RPS23;RPS29;RPL37A;RPS21;RPL38;RPS11;RPL21;RPL35A;RPL23;RPL17;RPL3;RPS15;EIF4G1;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;RPS14;RPSA;RPL10;RPL18;RPL32;RPS28;RPS5;RPS24;RPL15;RPS19;RPL39;RPL12;RPL27;RPL24;RPS12;RPS4X;RPS27;RPL27A;RPS9;RPL30;RPL19;RPL28;EIF4A3;RPL31;RBM8A;SMG1;RPL13A;RPL36A;RPLP2;RPL29;RPLP0;DCP1A;RPL10A;RPS10;NCBP1;RPL35;RPS26;RPS27A;CASC3;RPS3;RPL4;MAGOH;EIF3E;UPF1;GSPT1;RPS25
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.9081866168971852,2.159418650753005,0.0,0.0,0.0,50/125,2.95%,KNL1;KIF11;CENPF;KIF4A;CENPE;NUF2;CDCA8;SPC25;NSL1;CENPM;KIF2C;NUSAP1;CENPH;CENPP;ZWILCH;CCNB1;KNTC1;NDC80;STIL;CENPK;CENPA;DLGAP5;INCENP;TTK;BUB1B;SGO1;SKA1;PLK1;BIRC5;BUB1;ESPL1;CENPI;SPDL1;KIF18A;CDC20;WDR62;CENPN;AURKB;CENPQ;CKAP5;CENPU;SKA2;STMN1;XPO1;DSN1;ITGB3BP;PMF1;GPSM2;AURKA;NUP160
prerank,mitotic sister chromatid segregation (GO:0000070),0.9084020935034068,2.1571159583456314,0.0,0.0,0.0,41/98,2.82%,PRC1;KIF18B;CENPE;KIF14;CDCA8;NSL1;KIF23;CEP55;KIF2C;NUSAP1;NCAPG;CCNB1;NDC80;CDK1;CENPK;DLGAP5;KIFC1;SGO1;NCAPG2;PLK1;CDCA5;SPAG5;ESPL1;KNSTRN;SPDL1;NCAPH;SMC2;KIF18A;SMC4;KIF22;NCAPD3;NCAPD2;NCAPH2;HASPIN;PDS5A;DSN1;PSRC1;KMT5A;SMC1A;RB1;PDS5B
prerank,mitotic spindle organization (GO:0007052),0.9007635080422143,2.1413159529195003,0.0,0.0,0.0,56/153,3.26%,KNL1;KIF11;PRC1;CENPF;TPX2;KIF4A;CENPE;NUF2;CDCA8;SPC25;NSL1;CENPM;KIF23;KIF2C;CENPH;CENPP;ZWILCH;CCNB1;KNTC1;NDC80;STIL;CENPK;CENPA;DLGAP5;KIFC1;INCENP;TTK;BUB1B;SGO1;SKA1;PLK1;BIRC5;BUB1;CENPI;SPDL1;KIF18A;CDC20;WDR62;CENPN;AURKB;CEP192;CENPQ;CKAP5;CENPU;SKA2;STMN1;XPO1;DSN1;ITGB3BP;SMC1A;PMF1;GPSM2;CCDC61;AURKA;NUP160;RHOA
prerank,centromere complex assembly (GO:0034508),0.9366928890527524,2.111420941845797,0.0,0.0,0.0,18/36,2.05%,KNL1;CENPF;MIS18BP1;CENPE;CENPM;CENPH;CENPP;CENPK;CENPA;DLGAP5;CENPI;HJURP;CENPN;CENPQ;CENPU;HELLS;OIP5;ITGB3BP
prerank,sister chromatid segregation (GO:0000819),0.95018752172819,2.101766539679898,0.0,0.0,0.0,19/31,2.56%,TOP2A;KIF18B;CDCA8;NSL1;NUSAP1;NDC80;CENPK;KIFC1;SGO1;NCAPG2;PLK1;SPAG5;ESPL1;KNSTRN;KIF18A;SMC4;DSN1;SMC1A;RB1
prerank,mitotic nuclear division (GO:0140014),0.8926655749785573,2.0917066026291486,0.0,0.0,0.0,23/71,2.40%,KIF11;KIF18B;TPX2;CDCA8;NSL1;NUSAP1;NDC80;CENPK;KIFC1;SGO1;NCAPG2;PLK1;SPAG5;ESPL1;KNSTRN;KIF18A;SMC4;UBE2C;CEP192;DSN1;UBE2S;SMC1A;CCDC61
prerank,chromosome condensation (GO:0030261),0.9243649683002819,2.07477100374696,0.0,0.0,0.0,17/36,2.56%,TOP2A;NUSAP1;NCAPG;CCNB1;CDK1;INCENP;NCAPG2;PLK1;CDCA5;NCAPH;SMC2;SMC4;NCAPD3;NCAPD2;NCAPH2;KMT5A;RB1
prerank,chromatin remodeling at centromere (GO:0031055),0.9298560570969265,2.0533602227080325,0.0,0.0,0.0,15/31,2.05%,KNL1;MIS18BP1;CENPM;CENPH;CENPP;CENPK;CENPA;CENPI;HJURP;CENPN;CENPQ;CENPU;HELLS;OIP5;ITGB3BP
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.914111619619161,2.05140598497802,0.0,0.0,0.0,16/38,2.05%,KNL1;MIS18BP1;CENPM;CENPH;CENPP;CENPK;CENPA;ASF1B;CENPI;HJURP;CENPN;ATRX;CENPQ;CENPU;OIP5;ITGB3BP
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.8804473036072589,2.046960047104239,0.0,0.0,0.0,18/56,3.26%,KIF4A;KIF23;CEP55;ECT2;NUSAP1;CKAP2;CENPA;INCENP;PLK1;RACGAP1;ESPL1;KIF20A;AURKB;ANLN;CIT;STMN1;ROCK2;RHOA
prerank,CENP-A containing chromatin organization (GO:0061641),0.9329418238831623,2.0437349325697687,0.0,0.0,0.0,14/29,2.05%,KNL1;MIS18BP1;CENPM;CENPH;CENPP;CENPK;CENPA;CENPI;HJURP;CENPN;CENPQ;CENPU;OIP5;ITGB3BP
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.9329418238831623,2.0437349325697687,0.0,0.0,0.0,14/29,2.05%,KNL1;MIS18BP1;CENPM;CENPH;CENPP;CENPK;CENPA;CENPI;HJURP;CENPN;CENPQ;CENPU;OIP5;ITGB3BP
prerank,mitotic metaphase plate congression (GO:0007080),0.8946961498236973,2.038233878599349,0.0,0.0,0.0,14/51,2.10%,CENPE;KIF14;NUF2;CDCA8;CEP55;KIF2C;CCNB1;NDC80;KIFC1;CDCA5;SPDL1;KIF18A;KIF22;PSRC1
prerank,mitotic cytokinesis (GO:0000281),0.8868914008702345,2.035526679236045,0.0,0.0,0.0,15/47,1.85%,KIF4A;KIF23;CEP55;ECT2;NUSAP1;CKAP2;CENPA;INCENP;PLK1;RACGAP1;ESPL1;KIF20A;ANLN;CIT;STMN1
prerank,histone exchange (GO:0043486),0.9103746513348089,2.0243849499253055,0.0,5.527518216935286e-05,0.001,14/37,2.05%,KNL1;MIS18BP1;CENPM;CENPH;CENPP;CENPK;CENPA;CENPI;HJURP;CENPN;CENPQ;CENPU;OIP5;ITGB3BP
prerank,mitotic spindle assembly (GO:0090307),0.8989133927732579,2.004032034005579,0.0,5.1820483283768306e-05,0.001,14/42,4.72%,KIF11;PRC1;TPX2;KIF4A;KIF23;KIFC1;RACGAP1;AURKB;CEP192;SMC1A;CCDC61;RHOA;CHEK2;SMC3
prerank,regulation of cation channel activity (GO:2001257),-0.46864958590461453,-2.001361153791166,0.0,0.07287014626720087,0.217,36/89,18.60%,CAMK2D;AHNAK;FGF14;LRRC7;MEF2C;GRIN2A;KCNAB1;CALM1;FKBP1A;GRIN2B;HOMER1;FGF13;SHISA6;CACNG7;NETO1;NEFL;CACNG4;MINK1;RELN;OPRM1;GRIA1;APP;SELENON;SHANK1;CACNG2;CACNB2;DLG4;PRRT1;GRIN1;CACNG3;CACNG8;CACNB1;GRIA2;STAC;NLGN1;PDE4D
prerank,positive regulation of cytokinesis (GO:0032467),0.8889880720352875,2.0005745372448076,0.0,9.75444391223874e-05,0.002,10/32,3.48%,KIF20B;KIF14;KIF23;ECT2;RACGAP1;AURKB;CIT;CSPP1;RHOA;CDC6
prerank,positive regulation of cell cycle process (GO:0090068),0.8544788681002637,1.9990638232314528,0.0,9.21253036155881e-05,0.002,26/91,3.48%,KIF20B;KIF14;KIF23;ECT2;NUSAP1;E2F7;CCNB1;NDC80;E2F8;SPAG5;RACGAP1;CEP295;ATRX;AURKB;DBF4;GEN1;CIT;DDX11;PLK4;GPSM2;AURKA;PHIP;CSPP1;RHOA;RAD21;CDC6
prerank,mitotic chromosome condensation (GO:0007076),0.920654021292698,1.9963295619701575,0.0,8.7276603425294e-05,0.002,15/26,2.56%,NUSAP1;NCAPG;CCNB1;CDK1;NCAPG2;PLK1;CDCA5;NCAPH;SMC2;SMC4;NCAPD3;NCAPD2;NCAPH2;KMT5A;RB1
prerank,positive regulation of cell division (GO:0051781),0.8720190370692366,1.989081914877568,0.0,0.00012436915988104394,0.003,11/38,3.53%,KIF20B;KIF14;KIF23;ECT2;RACGAP1;AURKB;CIT;CSPP1;RHOA;CDC6;FGFR2
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.8373528431249431,1.9806779721635073,0.0,0.00019741136489054593,0.005,21/82,3.30%,CENPF;TPX2;HMMR;KIF14;NEK2;CDK1;PLK1;ATAD5;GTSE1;CEP192;CEP152;CDK5RAP2;CKAP5;HAUS8;PLK4;CEP57;HAUS4;HAUS6;AURKA;ACTR1A;CEP43
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.8593602303494313,1.9690186478878122,0.0,0.0006030019873020313,0.016,20/40,7.38%,EME1;POLE;RAD51;ATRX;GEN1;DDX11;ZRANB3;TIPIN;MMS22L;RFWD3;TIMELESS;FAM111A;RTEL1;MSH3;PRIMPOL;TONSL;BLM;POLD1;ETAA1;NUCKS1
prerank,replication fork processing (GO:0031297),0.8590916703410459,1.9595717560349462,0.0,0.0011535690191864945,0.03,19/38,7.38%,EME1;RAD51;ATRX;ZGRF1;GEN1;DDX11;BRCA2;ZRANB3;MMS22L;RFWD3;FAM111A;RTEL1;PRIMPOL;DNA2;TONSL;BLM;MRE11;ETAA1;NUCKS1
prerank,DNA replication (GO:0006260),0.832102756143286,1.959477982717292,0.0,0.0011055036433870573,0.03,49/105,7.96%,BRCA1;EXO1;TICRR;CDK1;BRIP1;POLE;CLSPN;PIF1;BARD1;RMI2;DBF4;MCM5;POLA1;WDHD1;ORC1;PCLAF;TIPIN;POLA2;MCM8;CDC45;RFC4;NAP1L1;TIMELESS;FAM111A;MCM10;MCM6;MCM7;MCM2;RPAIN;TOPBP1;RBBP8;CDC6;RPA1;RAD1;DNA2;RFC2;BLM;MRE11;MCM3;POLD1;RPA2;MCM4;RFC1;RFC3;ORC2;CHEK1;RNASEH2A;ORC3;CDK2
prerank,dendrite morphogenesis (GO:0048813),-0.5340028761750577,-1.9583665110179542,0.0,0.12028453831382822,0.359,17/35,15.34%,CTNND2;DOCK10;SHANK3;PAK3;KLF7;TAOK2;DIP2A;EPHB2;BTBD3;TMEM106B;MINK1;CTNNA2;CHRNA7;MEF2A;SHANK1;DLG4;DVL1
prerank,cellular response to cadmium ion (GO:0071276),-0.6176057061785661,-1.9561551377331334,0.0,0.10845127237423255,0.37,15/24,20.87%,MAPK8;MAPK9;JUN;MAPK3;MAPK1;CHUK;MT2A;MT1X;MT1E;MT1M;MT1H;MT1F;MT1B;MT1A;MT1G
prerank,regulation of cytokinesis (GO:0032465),0.8299791316899776,1.9486018402696006,0.0,0.0019567414487950915,0.053,17/78,3.48%,PRC1;KIF20B;KIF14;KIF23;ECT2;E2F7;E2F8;PLK1;RACGAP1;KIF20A;AURKB;CIT;PLK4;AURKA;CSPP1;RHOA;CDC6
prerank,dendritic spine morphogenesis (GO:0060997),-0.686114111152505,-1.9432647706437702,0.0,0.1129107735129805,0.419,8/15,13.64%,CTNND2;DOCK10;SHANK3;PAK3;DIP2A;EPHB2;SHANK1;DLG4
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.8283915398414023,1.9428594186690107,0.0,0.0025511622539701323,0.069,21/57,8.19%,DTL;BRCA1;EME1;TICRR;CDK1;CLSPN;PLK1;FANCD2;TIPIN;RFWD3;TOPBP1;CHEK2;PRKDC;BLM;MRE11;RPA2;MDC1;CHEK1;CDK2;UIMC1;MRNIP
prerank,regulation of cell cycle process (GO:0010564),0.8185756404448311,1.9364769223533382,0.0,0.0033472193646997012,0.089,20/104,2.76%,KIF11;PRC1;KIF20B;MKI67;NEK2;ECT2;PLK1;SPAG5;RACGAP1;BUB1;KNSTRN;BORA;RMI2;KIF20A;AURKB;DBF4;TIPIN;PLK4;FBXO5;AURKA
prerank,kinetochore organization (GO:0051383),0.968621217816492,1.9339920472173155,0.0,0.003819909910632064,0.103,7/13,0.52%,CENPF;CENPE;NUF2;CENPH;NDC80;CENPA;DLGAP5
prerank,response to cadmium ion (GO:0046686),-0.6041865353483293,-1.9310168925667832,0.0,0.11972337312494019,0.47,15/26,20.87%,MAPK8;MAPK9;JUN;MAPK3;MAPK1;CHUK;MT2A;MT1X;MT1E;MT1M;MT1H;MT1F;MT1B;MT1A;MT1G
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.9020973275251171,1.9282927937945429,0.0,0.0044398452774738265,0.133,8/20,0.93%,CENPF;KNTC1;TTK;BUB1B;PLK1;BUB1;TRIP13;CDC20
prerank,spindle assembly checkpoint signaling (GO:0071173),0.9020973275251171,1.9282927937945429,0.0,0.0044398452774738265,0.133,8/20,0.93%,CENPF;KNTC1;TTK;BUB1B;PLK1;BUB1;TRIP13;CDC20
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.9020973275251171,1.9282927937945429,0.0,0.0044398452774738265,0.133,8/20,0.93%,CENPF;KNTC1;TTK;BUB1B;PLK1;BUB1;TRIP13;CDC20
prerank,negative regulation of protein transport (GO:0051224),-0.5958235708222838,-1.9256598601057306,0.0,0.11536048013465251,0.487,12/25,23.23%,APOE;SNX3;SERGEF;CYP51A1;PPM1F;RHBDF1;PKDCC;WWP2;RHBDF2;DRD2;DPH3;NDFIP1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.9287851185153606,1.9252788550546622,0.0,0.004871125428674221,0.146,11/17,3.49%,KNL1;ZWILCH;CDK1;CENPA;TTK;SPDL1;AURKB;HASPIN;MTBP;RB1;CTCF
prerank,protein depolymerization (GO:0051261),0.8862785405395156,1.9167697624405085,0.0,0.006457146280692584,0.189,7/27,1.85%,KIF18B;KIF14;KIF2C;KIF24;KIF18A;CKAP5;STMN1
prerank,regulation of nuclear division (GO:0051783),0.8938847326172751,1.9138377461381997,0.0,0.007145130165714877,0.206,6/20,3.98%,KIF20B;MKI67;NEK2;BORA;FBXO5;OBSL1
prerank,negative regulation of cell cycle process (GO:0010948),0.8290157204867913,1.913217505686528,0.0,0.007035741044699056,0.208,22/61,7.14%,BRCA1;NEK2;E2F7;E2F8;RRM2;EZH2;ESPL1;RAD51;AURKB;E2F1;CBX5;TERF1;FBXO5;SUZ12;RBBP8;TFDP1;EED;WAPL;YAF2;RBBP4;RBBP7;CHEK1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.8920578626098635,1.912396599258838,0.0,0.0070936483784002835,0.214,9/21,2.18%,CENPF;KNTC1;TTK;BUB1B;PLK1;BUB1;TRIP13;CDC20;FBXO5
prerank,DNA replication initiation (GO:0006270),0.869850475146365,1.9120379402596446,0.0,0.006991563582501929,0.217,23/37,7.96%,POLE;DBF4;MCM5;POLA1;ORC1;PRIM2;POLA2;MCM8;CDC45;PRIM1;MCM10;MCM6;MCM7;MCM2;TOPBP1;CDC6;RPA1;MCM3;RPA2;MCM4;ORC2;ORC3;CDK2
prerank,establishment of mitotic spindle localization (GO:0040001),0.8687949301566228,1.9059159462448856,0.0024154589371980675,0.008509468833966163,0.263,12/28,6.66%,NUSAP1;NDC80;CENPA;PLK1;ESPL1;SPDL1;SAPCD2;CDK5RAP2;GPSM2;NUMA1;ZW10;NDE1
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.8474761043365066,1.904403455128551,0.0,0.0086952113489482,0.271,17/42,6.49%,DTL;POLK;POLE;POLA1;PCLAF;USP43;RFC4;CDKN2D;POLH;RPA1;PRIMPOL;POLD3;RFC2;POLD1;RPA2;RFC1;RFC3
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.8198723428497452,1.8968736731569134,0.0,0.011089583422726418,0.333,11/79,2.92%,KIF11;KIF15;KIF4A;CENPE;KIF23;KIF2C;RACGAP1;KIF18A;KIF22;CTSE;ACTR1A
prerank,interstrand cross-link repair (GO:0036297),0.8208677067929094,1.896729062766004,0.0,0.010879773661138478,0.333,18/53,7.38%,NEIL3;EME1;RAD51AP1;FANCA;UBE2T;FANCD2;RAD51;RAD51AP2;MCM8;RFWD3;RNF168;FANCI;USP1;RPA1;ERCC4;RPA2;FANCL;NUCKS1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.8204940947092662,1.8957513495758913,0.0,0.010797942563315443,0.34,11/78,2.92%,KIF11;KIF15;KIF4A;CENPE;KIF23;KIF2C;RACGAP1;KIF18A;KIF22;CTSE;ACTR1A
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.8204940947092662,1.8957513495758913,0.0,0.010797942563315443,0.34,11/78,2.92%,KIF11;KIF15;KIF4A;CENPE;KIF23;KIF2C;RACGAP1;KIF18A;KIF22;CTSE;ACTR1A
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.9533307778374239,1.8929469678748634,0.0,0.01136281869822265,0.358,4/12,0.39%,CENPE;NUF2;KIF2C;NDC80
prerank,regulation of mitotic nuclear division (GO:0007088),0.8245386525745645,1.892799431522377,0.0010976948408342481,0.011239287041101748,0.361,11/55,3.98%,KIF20B;MKI67;NEK2;NUSAP1;CCNB1;BORA;CDK5RAP2;FBXO5;AURKA;PHIP;OBSL1
prerank,microtubule depolymerization (GO:0007019),0.9289191883721915,1.8884800706527602,0.0,0.012599136631427496,0.397,7/17,1.85%,KIF18B;KIF14;KIF2C;KIF24;KIF18A;CKAP5;STMN1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.7953045113061856,1.8873605406593814,0.0,0.012683890206307885,0.402,39/95,8.72%,BRCA1;RAD51AP1;POLQ;RAD51B;RAD54B;RAD51;RAD54L;MCM5;GEN1;RAD51AP2;BRCA2;MMS22L;MCM8;CDC45;AUNIP;RFWD3;XRCC2;SMC6;MCM6;MCM7;MCM2;RAD21;RBBP8;RPA1;SMC5;ERCC4;TONSL;BLM;MRE11;RECQL;MCM3;RPA2;MCM4;SPIDR;UBE2N;NUCKS1;NIPBL;RAD51C;PSMD14
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.8883312233088653,1.8865062109996584,0.0,0.012834206359946617,0.408,12/26,3.65%,CENPE;CCNB1;DLGAP5;PLK1;ESPL1;UBE2C;CDK5RAP2;FBXO5;ANAPC7;RB1;CDC6;CDC27
prerank,monoacylglycerol metabolic process (GO:0046462),-0.7108149226382335,-1.8861524563954513,0.0,0.1732089218890302,0.657,4/13,4.62%,PLA2G4A;ABHD6;ABHD12;ABHD16A
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.9120187239483944,1.884856950086054,0.0,0.013249122746511213,0.428,4/16,4.48%,TOP2A;EME1;HFM1;ERCC4
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.837536446836915,1.8840847574826909,0.0011904761904761906,0.013282626275295494,0.438,12/32,8.19%,DTL;BRCA1;TICRR;CDK1;CLSPN;PLK1;TOPBP1;BLM;MRE11;CHEK1;UIMC1;MRNIP
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.9713033755175007,1.8838191241206177,0.0,0.013135984468481505,0.44,6/10,0.77%,NEK2;ECT2;CCNB1;SPAG5;RACGAP1;KNSTRN
prerank,regulation of DNA recombination (GO:0000018),0.8327948897419197,1.8829188586053833,0.0035545023696682463,0.013409546597430507,0.453,14/32,7.50%,RAD51AP1;FIGNL1;KPNA2;RAD51;ZRANB3;RTEL1;MSH3;SMARCAD1;BLM;MRE11;RPA2;SPIDR;CHEK1;SETD2
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.8316222072388076,1.8774316287871524,0.001152073732718894,0.015487480287073396,0.5,18/42,8.39%,RAD51AP1;POLQ;PARPBP;FIGNL1;RMI2;RAD51;TIMELESS;RTEL1;ARID2;KLHL15;RPA2;SPIDR;CHEK1;RIF1;SETD2;FUS;MRNIP;SMCHD1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.8878566125120186,1.8756876262338273,0.0,0.016137282349997183,0.522,7/24,1.85%,KIF18B;KIF14;KIF2C;KIF24;KIF18A;CKAP5;STMN1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.8046262708136862,1.8741142212795325,0.0,0.016507179402393105,0.537,9/80,1.09%,KIF11;KIF15;KIF4A;CENPE;KIF23;KIF2C;RACGAP1;KIF18A;KIF22
prerank,postreplication repair (GO:0006301),0.8210158616083476,1.8733715942843998,0.0,0.016523331241338694,0.544,17/45,6.79%,DTL;BRCA1;POLK;RAD18;PCLAF;USP43;RFC4;POLH;RPA1;PRIMPOL;POLD3;RFC2;POLD1;RPA2;RFC1;RFC3;UBE2N
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.6995662986954289,-1.8723097033769227,0.006734006734006734,0.1890507340357609,0.713,8/13,13.93%,SHANK3;SQSTM1;EPHB2;LGMN;RELN;CHRNA7;APP;ADCY8
prerank,spindle assembly (GO:0051225),0.8056792619499422,1.8716382234473583,0.0,0.017251675277066447,0.559,19/67,8.32%,KIF11;TPX2;NEK2;KIFC1;CEP192;HAUS8;SMC1A;CCDC61;HAUS4;HAUS6;RHOA;CHEK2;TUBGCP5;SMC3;NUMA1;HAUS7;STAG1;HAUS1;GOLGA8B
prerank,DNA metabolic process (GO:0006259),0.7854810734722216,1.8704479409268917,0.0,0.01756893074641414,0.575,88/270,7.66%,TOP2A;NEIL3;BRCA1;EXO1;TICRR;RAD51AP1;POLK;POLQ;UHRF1;CDK1;FANCA;POLE;RAD51B;BARD1;UBE2T;KPNA2;RMI2;RAD51;RAD54L;DBF4;MCM5;GEN1;POLA1;WDHD1;ORC1;RAD18;HELLS;HMGB2;PRIM2;TYMS;ZRANB3;POLA2;MCM8;TERF1;CDC45;RFC4;PRIM1;PDS5A;DMC1;SMC1A;TIMELESS;XRCC2;MCM10;MCM6;MCM7;MCM2;PDS5B;RPAIN;TOPBP1;RTEL1;EID3;POLH;RAD21;RBBP8;CDC6;RPA1;STN1;CHD1L;MSH3;PRIMPOL;UHRF2;SMARCAD1;ERCC4;RAD1;POLD3;DNA2;RFC2;PRKDC;BLM;MRE11;RECQL;MCM3;NSMCE4A;POLD1;RPA2;MCM4;ERCC3;RFC1;TCF7L2;FANCL;RFC3;ORC2;UBE2N;DNASE2;CHEK1;RIF1;RNASEH2A;ORC3
prerank,protein localization to kinetochore (GO:0034501),0.9248328839732105,1.8666394908537345,0.0014285714285714286,0.019350998096745477,0.615,7/14,2.47%,KNL1;ZWILCH;CDK1;TTK;SPDL1;AURKB;MTBP
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.7779249163450569,1.8644457870336335,0.0,0.02029981065169484,0.634,44/145,10.33%,CENPF;TPX2;HMMR;DTL;KIF14;NEK2;CCNB1;CDK1;PLK1;RAD51B;CEP192;CEP152;CDK5RAP2;CKAP5;HAUS8;PLK4;CEP57;FBXO5;HAUS4;HAUS6;AURKA;ACTR1A;CEP43;PSMC2;PSMD5;PCM1;FBXL7;HAUS7;NDE1;CDC25B;CNTRL;HAUS1;CDK2;CEP76;PSMB1;RAD51C;PSMD14;ALMS1;CDC25C;ODF2;PSMD1;SDCCAG8;CDC25A;NINL
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.689630504548653,-1.8638464510172708,0.003484320557491289,0.19604183881371395,0.746,6/14,6.74%,PTK2;STAT3;STAT6;SOCS2;PIK3R1;LYN
prerank,embryonic heart tube development (GO:0035050),-0.6988569695788719,-1.8625990433456263,0.0,0.18468027694593722,0.753,7/14,17.86%,ACVR1;RYR2;MEGF8;SOX17;NDRG4;CITED2;TBX2
prerank,recombinational repair (GO:0000725),0.7864754465498747,1.8597779631412528,0.0,0.022821401031723795,0.676,29/77,8.72%,BRCA1;RAD51AP1;POLQ;RAD51B;RAD54B;RAD51;GEN1;RAD51AP2;BRCA2;MMS22L;MCM8;AUNIP;RFWD3;XRCC2;SMC6;RBBP8;RPA1;SMC5;ERCC4;TONSL;BLM;MRE11;RECQL;RPA2;SPIDR;UBE2N;NUCKS1;RAD51C;PSMD14
prerank,regulation of chromosome segregation (GO:0051983),0.9047912384463307,1.8579590494087208,0.0027662517289073307,0.023737124600951932,0.692,10/16,4.92%,MKI67;KIF2C;BUB1;RMI2;AURKB;RAD18;SMC6;CDC6;SMC5;NUMA1
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.808931010642279,1.8553007939878767,0.0,0.02524233319067114,0.71,14/43,8.19%,DTL;BRCA1;TICRR;CDK1;CLSPN;PLK1;ORC1;TOPBP1;CDC6;BLM;MRE11;CHEK1;UIMC1;MRNIP
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.5903445746660181,-1.855003166052295,0.014285714285714285,0.1871211421968796,0.777,13/23,28.01%,ELOVL7;HACD2;ACSL4;HACD1;ACSL5;ACSL6;ELOVL6;ACOT7;ACSL1;ELOVL1;ACSBG1;TECR;FAR2
prerank,DNA recombination (GO:0006310),0.8404801527558005,1.8523572833833204,0.0,0.026804144978529156,0.731,16/37,5.39%,EXO1;RAD51B;RAD54B;RAD51;RAD54L;GEN1;DMC1;XRCC2;RPAIN;RTEL1;RAD21;RPA1;MSH3;BLM;MRE11;RECQL
prerank,glycerolipid catabolic process (GO:0046503),-0.6070083130343882,-1.8503810649235746,0.01171875,0.18626091614805662,0.785,9/19,14.75%,GPCPD1;PLA2G4A;ABHD6;ABHD12;PNPLA6;ENPP6;ABHD2;GDPD3;GDPD1
prerank,regulation of DNA replication (GO:0006275),0.8025648753780014,1.8481160540429427,0.0,0.029465924033355025,0.764,19/49,7.66%,ESCO2;ATAD5;GLI2;DSCC1;TERF1;PDS5A;FBXO5;CDC6;STN1;WAPL;CCNA2;DNA2;SMC3;DHX9;BLM;FAF1;USP37;NUCKS1;ORC3
prerank,regulation of spindle organization (GO:0090224),0.881361869294677,1.847123835774342,0.002758620689655172,0.02981091074724417,0.775,6/18,4.92%,TPX2;BORA;PSRC1;GPSM2;TACC3;NUMA1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.8560189381918831,1.8458124531563225,0.0037593984962406013,0.03030647488046533,0.786,10/23,6.66%,NDC80;CENPA;PLK1;SPDL1;SAPCD2;CDK5RAP2;GPSM2;NUMA1;ZW10;NDE1
prerank,protein localization to condensed chromosome (GO:1903083),0.9341466803066353,1.8447052246026858,0.0029585798816568047,0.030726498323552027,0.794,7/12,2.47%,KNL1;ZWILCH;CDK1;TTK;SPDL1;AURKB;MTBP
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.6384196767925142,-1.844588531305412,0.00398406374501992,0.18644510080084595,0.804,11/18,27.90%,ELOVL7;HACD2;ACSL4;HACD1;ACSL5;ACSL6;ELOVL6;ACSL1;ELOVL1;ACSBG1;TECR
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.46220037570494654,-1.841388474051601,0.0,0.18247499620364035,0.813,25/57,18.42%,DLGAP1;DLGAP4;LRRC7;MEF2C;GRIN2A;GRIN2B;SHISA6;CACNG7;NETO1;NEFL;CACNG4;MINK1;RELN;OPRM1;GRIA1;APP;SHANK1;CACNG2;DLG4;PRRT1;GRIN1;CACNG3;CACNG8;GRIA2;NLGN1
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.41671631609569976,-1.8412550346983527,0.0,0.17403440401471332,0.814,36/107,16.25%,NRG3;GRM7;GRIK1;DLGAP1;DLGAP4;MCTP1;SYN3;RIMS1;IQSEC2;MEF2C;CDH2;SLC8A3;GRM3;OPHN1;TMEM108;GRID2;CNTNAP4;SYT1;LGI1;HOMER1;BCR;GRIK4;CACNA1B;DGKI;RELN;CHRNA7;APP;GRM5;PSMC5;ATP1A2;DLG4;GRM1;LRP8;CPLX1;SLC4A8;SLC12A2
prerank,apoptotic nuclear changes (GO:0030262),0.8590549017527669,1.84041969456358,0.0025220680958385876,0.0340543187539013,0.825,2/24,1.44%,TOP2A;HMGB2
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.7683719371155404,1.8321159593373266,0.0,0.04190648453896509,0.89,51/184,9.82%,CENPF;TPX2;HMMR;CENPE;KIF14;NEK2;CCNB1;KNTC1;CDK1;BUB1B;PLK1;CDC20;UBE2C;CEP192;CEP152;CDK5RAP2;CKAP5;ANLN;E2F1;HAUS8;PLK4;CEP57;UBE2S;FBXO5;ANAPC7;HAUS4;HAUS6;AURKA;ACTR1A;CEP43;CDC6;PSMC2;CDC27;PSMD5;PCM1;ZW10;HAUS7;ERCC3;BUB3;NDE1;CNTRL;HAUS1;CDK2;CEP76;PSMB1;CUL3;PSMD14;ALMS1;ODF2;PSMD1;SDCCAG8
prerank,double-strand break repair (GO:0006302),0.7673291483036194,1.8283653145508811,0.0,0.04550860244661298,0.902,50/158,7.38%,BRCA1;EME1;RAD51AP1;POLQ;BRIP1;CDCA5;RAD51B;RAD54B;BARD1;TRIP13;KPNA2;RAD51;GEN1;POLA1;NSD2;RAD51AP2;HMGB2;BRCA2;MMS22L;MCM8;AUNIP;RFWD3;RNF168;XRCC2;SMC6;PAXIP1;BAZ1B;SETX;RAD21;RBBP8;RPA1;SMC5;CHEK2;SMARCAD1;ERCC4;DNA2;TDP2;TONSL;PRKDC;BLM;MRE11;RECQL;RPA2;SPIDR;MDC1;UBE2N;TENT4A;PRPF19;RIF1;NUCKS1
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.7155108672532983,-1.828121477287428,0.0,0.19185343196911478,0.857,7/12,17.83%,PARP8;PARP12;TIPARP;PARP6;PARP1;PARP16;PARP10
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.7772195691909095,1.827817734059342,0.0010940919037199124,0.045463837334292725,0.905,14/56,3.72%,DTL;CCNB1;CDK1;DLGAP5;CDCA5;RAD51B;ESPL1;UBE2C;FBXO5;ANAPC7;RB1;HYAL1;CDC27;TFDP1
prerank,negative regulation of centrosome duplication (GO:0010826),0.9338135532635817,1.8264083163937916,0.00291970802919708,0.04645386885054518,0.911,4/11,2.31%,BRCA1;CCNF;CDK5RAP2;TRIM37
prerank,translesion synthesis (GO:0019985),0.7978594332984362,1.8207740586559518,0.0,0.05257118001458182,0.943,14/42,6.49%,DTL;POLK;PCLAF;USP43;RFC4;POLH;RPA1;PRIMPOL;POLD3;RFC2;POLD1;RPA2;RFC1;RFC3
prerank,regulation of exit from mitosis (GO:0007096),0.8212637215805416,1.8207208896900837,0.0011574074074074073,0.051969726275625565,0.943,12/38,6.47%,NEK2;KNTC1;BUB1B;CDCA5;CDC20;UBE2C;ANLN;UBE2S;ANAPC7;CDC27;ZW10;BUB3
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.758330792790173,1.8193648171410965,0.0,0.05290053125115632,0.951,46/128,10.33%,NEK2;MELK;CCNB1;CDK1;PLK1;MASTL;BORA;CEP192;CCNB2;CEP152;CDK5RAP2;CKAP5;WEE1;HAUS8;PLK4;CEP57;HAUS4;HAUS6;CDK14;AURKA;ACTR1A;CEP43;AJUBA;CHEK2;PCM1;KHDRBS1;FBXL7;CCNA2;HAUS7;NDE1;CDC25B;CNTRL;FBXL8;HAUS1;CCDC57;CDK2;CEP76;DNM2;ALMS1;CDC25C;ODF2;SKP2;SDCCAG8;FBXL17;CDC25A;NINL
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.8157935374002162,1.8191430915585352,0.0024242424242424242,0.05250424446579829,0.951,17/36,10.08%,BRCA1;RRM2;EZH2;RAD51;E2F1;CBX5;SUZ12;RBBP8;TFDP1;EED;YAF2;RBBP4;RBBP7;CHEK1;UXT;EPC1;APAF1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.8871076845425854,1.818982938200984,0.0028011204481792717,0.05197993092464144,0.952,9/16,3.40%,SGO1;CDCA5;DSCC1;HASPIN;PDS5A;SMC1A;RB1;PDS5B;RAD21
prerank,DNA replication checkpoint signaling (GO:0000076),0.9111293949011063,1.817584985915498,0.001358695652173913,0.052990707868303025,0.958,9/16,4.70%,TICRR;CLSPN;ORC1;TIPIN;CDC45;TIMELESS;TOPBP1;CDC6;DNA2
prerank,regulation of centriole replication (GO:0046599),0.8706868516024779,1.8131945850824023,0.0026954177897574125,0.05786275163465569,0.967,6/17,2.31%,BRCA1;STIL;CEP295;CDK5RAP2;PLK4;TRIM37
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.830531994674065,1.8125299037414695,0.00468384074941452,0.05809012200205139,0.967,14/32,6.38%,E2F7;RRM2;POLA1;ORC1;E2F1;TYMS;CDC45;FBXO5;RB1;CDK14;CDC6;TFDP1;CCNA1;CCNE1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.7653553475799214,1.8121376820929103,0.0,0.05783671500159116,0.969,33/94,11.83%,NEK2;CDK1;KIF24;PLK1;CEP192;CEP152;CDK5RAP2;CKAP5;HAUS8;PLK4;CEP57;CEP89;HAUS4;HAUS6;SCLT1;ACTR1A;CEP43;CEP97;PCM1;C2CD3;HAUS7;NDE1;CEP83;CNTRL;HAUS1;CEP76;ALMS1;ODF2;SDCCAG8;NINL;NPHP1;AKAP9;CC2D2A
prerank,regulation of G0 to G1 transition (GO:0070316),0.8128102561923796,1.808868632215087,0.0024271844660194173,0.06182495827339606,0.97,17/38,10.08%,BRCA1;RRM2;EZH2;RAD51;E2F1;CBX5;SUZ12;RBBP8;TFDP1;EED;YAF2;RBBP4;RBBP7;CHEK1;UXT;EPC1;APAF1
prerank,cell cycle G2/M phase transition (GO:0044839),0.7527081826499533,1.8034557671186027,0.0,0.06873863725488809,0.98,46/129,10.33%,NEK2;MELK;CCNB1;CDK1;PLK1;MASTL;BORA;CEP192;CCNB2;CEP152;CDK5RAP2;CKAP5;WEE1;HAUS8;PLK4;CEP57;HAUS4;HAUS6;CDK14;AURKA;ACTR1A;CEP43;AJUBA;CHEK2;PCM1;KHDRBS1;FBXL7;CCNA2;HAUS7;NDE1;CDC25B;CNTRL;FBXL8;HAUS1;CCDC57;CDK2;CEP76;DNM2;ALMS1;CDC25C;ODF2;SKP2;SDCCAG8;FBXL17;CDC25A;NINL
prerank,base-excision repair (GO:0006284),0.766240171057413,1.8010326045570766,0.0,0.07157810942800787,0.983,13/48,6.49%,NEIL3;POLQ;POLE;RFC4;RPA1;APEX2;POLD3;DNA2;RFC2;POLD1;RPA2;RFC1;RFC3
prerank,DNA repair (GO:0006281),0.756965391841627,1.79872825772375,0.0,0.07422621410264785,0.986,81/284,7.58%,NEIL3;BRCA1;EME1;EXO1;TICRR;RAD51AP1;POLK;POLQ;CDK1;FANCA;BRIP1;POLE;CDCA5;RAD51B;BARD1;TRIP13;UBE2T;FANCD2;KPNA2;RMI2;RAD51;RAD54L;POLA1;NSD2;WDHD1;RAD18;RAD51AP2;BRCA2;ZRANB3;RFC4;PDS5A;CDKN2D;SMC1A;RFWD3;RNF168;TIMELESS;XRCC2;FAM111A;BAZ1B;SETX;PDS5B;FANCI;USP1;RPAIN;MGME1;TOPBP1;EID3;POLH;RAD21;RBBP8;RPA1;FTO;CHD1L;APEX2;MSH3;PRIMPOL;CHEK2;ERCC4;RAD1;POLD3;DNA2;TDP2;RFC2;PRKDC;BLM;MRE11;RECQL;NSMCE4A;POLD1;RPA2;ERCC3;FANCL;RFC3;MDC1;UBE2N;TENT4A;CHEK1;MLH1;NUCKS1;SETD2;RNASEH2A
prerank,protein localization to centrosome (GO:0071539),0.8439518720001655,1.7976820498085975,0.01078167115902965,0.07500270408151845,0.987,8/17,7.18%,STIL;SPAG5;CEP192;PCM1;CCDC14;C2CD3;CEP83;NUDCD3
prerank,establishment of spindle orientation (GO:0051294),0.8213224282251812,1.7974875308739335,0.0048367593712212815,0.07447074543180086,0.987,12/28,9.50%,NDC80;CENPA;PLK1;SPDL1;SAPCD2;CDK5RAP2;GPSM2;NUMA1;ZW10;NDE1;LLGL2;MAP4
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.49216691102288296,-1.7971425351757164,0.0,0.2519920043856541,0.941,22/46,18.42%,GRM7;GRIK1;MEF2C;CDH2;GRM3;SHANK3;OPHN1;SYT1;HOMER1;CACNG7;NRXN1;TSHZ3;CACNG4;DGKI;RELN;GRM5;CACNG2;ATP1A2;GRM1;CACNG3;CACNG8;NLGN1
prerank,mitotic cell cycle phase transition (GO:0044772),0.7509732079720972,1.7964120861857737,0.0,0.07541335949341203,0.987,69/203,10.33%,CCNF;NEK2;MELK;CCNB1;CDKN3;CDK1;POLE;PLK1;CCNE2;MASTL;BORA;UBE2C;CEP192;CCNB2;CEP152;DBF4;CDK5RAP2;CKAP5;WEE1;E2F1;HAUS8;PLK4;SPDYA;CEP57;UBE2S;CDKN2D;ANAPC7;CDKN2C;HAUS4;HAUS6;RB1;CDK14;AURKA;ACTR1A;CEP43;E2F3;CDC27;TACC3;AJUBA;CHEK2;PCM1;KHDRBS1;FBXL7;CCNA2;EIF4E;HAUS7;CCNA1;CCNE1;USP37;NDE1;CDC25B;CUL5;CNTRL;FBXL8;HAUS1;CCDC57;CDK2;CEP76;CUL3;DNM2;ALMS1;CDC25C;CUL4B;ODF2;SKP2;SDCCAG8;FBXL17;CDC25A;NINL
prerank,keratan sulfate catabolic process (GO:0042340),-0.7100415438524571,-1.7940760850096948,0.0031446540880503146,0.24764463770494044,0.946,8/11,16.97%,GNS;FMOD;HEXB;PRELP;HEXA;OGN;LUM;GALNS
prerank,negative regulation of secretion by cell (GO:1903531),-0.4847186128980743,-1.7912537715636132,0.007246376811594203,0.24422884959866545,0.954,19/38,30.80%,GRM7;APOE;STXBP6;IL1RAPL1;SERGEF;CYP51A1;TNFRSF1B;SYT11;RHBDF1;SLC30A1;VAMP8;VAMP3;RHBDF2;DRD2;DPH3;TNFRSF1A;RSAD2;CHGA;HTR1B
prerank,ganglion development (GO:0061548),-0.6978403070990404,-1.7904606329057333,0.012232415902140673,0.2360309581436053,0.955,6/11,19.33%,NRP2;SEMA3A;CTNNB1;UNC5C;TUBB3;NRP1
prerank,DNA biosynthetic process (GO:0071897),0.8785301426082672,1.7878182959885804,0.0067842605156037995,0.08840344134951834,0.994,8/16,6.49%,POLE;POLA1;TYMS;CDKN2D;POLH;POLD3;POLD1;RFC3
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.9166104846743481,1.7834880917705551,0.00425531914893617,0.09524946501072772,0.994,6/12,4.20%,TICRR;CLSPN;ORC1;TOPBP1;CDC6;CHEK2
prerank,positive regulation of synaptic transmission (GO:0050806),-0.42864966285582795,-1.7794012434660849,0.0,0.25289969632997894,0.967,30/72,18.62%,RIMS1;SLC8A3;GRIN2A;SHANK3;SYT1;GRIN2B;STX4;LGI1;SLC24A2;SQSTM1;EPHB2;CACNG7;NRXN1;LGMN;TSHZ3;CACNG4;RELN;CHRNA7;DTNBP1;APP;NFATC4;CACNG2;ADRA1A;DLG4;ADCY8;CACNG3;CACNG8;PRKCZ;NLGN1;STX1B
prerank,cellular response to radiation (GO:0071478),0.7853319113933812,1.778835585661016,0.002317497103128621,0.10307319431590577,0.995,9/40,6.30%,ECT2;RAD51AP1;FIGNL1;RAD51;INTS7;RAD1;BLM;NET1;SPIDR
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.8446056867095573,1.7782634994099242,0.0026041666666666665,0.10299906122621509,0.995,6/21,2.18%,DTL;CCNB1;CDK1;RAD51B;ATAD5;FBXO5
prerank,regulation of NMDA receptor activity (GO:2000310),-0.5075619344143922,-1.7762974104453095,0.006369426751592357,0.2516929791642294,0.97,14/32,18.42%,LRRC7;MEF2C;GRIN2A;GRIN2B;EPHB2;NEFL;RELN;OPRM1;GRIA1;APP;DLG4;GRIN1;GRIA2;NLGN1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.8194557485576738,1.7756074097456385,0.004889975550122249,0.10701040054445568,0.997,10/24,6.49%,POLK;POLE;RFC4;RPA1;POLD3;RFC2;POLD1;RPA2;RFC1;RFC3
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.7423064367632425,-1.7733575309955603,0.003048780487804878,0.2496575128389954,0.97,5/10,12.77%,LYN;FAS;MAPK3;MAPK1;MAP2K1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.8965485656134007,1.7695012534486203,0.002849002849002849,0.11846926148949406,0.997,4/12,1.03%,CCNB1;CDK1;PLK1;CCNB2
prerank,protein localization to microtubule organizing center (GO:1905508),0.8509714178890496,1.7689849015137387,0.008438818565400843,0.11817661212863363,0.997,7/15,6.86%,STIL;SPAG5;CEP192;PCM1;CCDC14;C2CD3;CEP83
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.8763424477490247,1.7660742210882825,0.00819672131147541,0.1226767135816318,0.998,8/15,6.59%,CENPE;PLK1;UBE2C;ANAPC7;CDC6;CDC27;TACC3;TPR
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.7529723276121248,1.7637295732452432,0.0010799136069114472,0.12718650207426757,0.998,20/63,9.34%,E2F7;CCNB1;E2F8;CDK1;GTSE1;E2F1;RFWD3;AURKA;TFDP1;CNOT1;CHEK2;MDM4;PRKDC;CNOT6L;RPA2;PML;CDK2;CNOT6;CDC25C;PLAGL1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.7871004295781567,1.762461319202147,0.008383233532934131,0.12866554904057093,0.999,6/33,4.06%,KIF14;EZH2;FAM83D;E2F1;ATP2B4;DDRGK1
prerank,intracellular pH reduction (GO:0051452),-0.4925087139420757,-1.761539260867039,0.01282051282051282,0.27020061778603255,0.978,18/33,32.33%,ATP6V0A1;DMXL2;ATP6V0D1;ATP6V1E1;ATP6V0B;ATP6V0A4;GPR89B;GPR89A;ATP6V0C;ATP6V1H;TMEM9;RAB38;ATP6V1G2;ATP6V1B2;RAB39A;ATP6V1F;ATP6V0D2;ATP6V0E1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.8514433156330752,1.7598727609606508,0.004021447721179625,0.13344810855236014,0.999,5/18,2.18%,DTL;CCNB1;CDK1;RAD51B;FBXO5
prerank,chloride transmembrane transport (GO:1902476),-0.46630619561756337,-1.7596443595634503,0.010416666666666666,0.2661468232805969,0.98,20/48,16.25%,GABRB1;ANO3;GABRB3;GABRA2;SLC6A1;GLRB;GLRA1;ANO6;ANO1;GABRA3;GLRA3;GABRA5;GABRB2;ANO4;GABRG2;SLC12A9;GABRG1;SLC4A8;SLC1A1;SLC12A2
prerank,DNA double-strand break processing (GO:0000729),0.8413009392793906,1.7593942977492778,0.00938337801608579,0.1331611975201593,0.999,8/18,6.79%,BRCA1;BARD1;RBBP8;SMARCAD1;DNA2;BLM;MRE11;UBE2N
prerank,response to ionizing radiation (GO:0010212),0.7404328263395145,1.7589965495300162,0.001053740779768177,0.13274985294230907,0.999,16/70,6.30%,BRCA1;ECT2;TICRR;RAD51AP1;FIGNL1;FANCD2;RAD51;RFWD3;RNF168;PAXIP1;TOPBP1;INTS7;RAD1;BLM;NET1;SPIDR
prerank,sodium ion export across plasma membrane (GO:0036376),-0.6444499001555672,-1.757462719197597,0.0,0.26257493733075554,0.98,5/13,13.14%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;ATP1A2
prerank,regulation of mitotic spindle organization (GO:0060236),0.7700835065414197,1.7567255731857685,0.009269988412514484,0.1367899763015262,0.999,12/35,10.91%,TPX2;PLK1;BORA;PSRC1;GPSM2;CEP97;TACC3;NUMA1;TPR;CCSAP;HNRNPU;DRG1
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.687002006859216,-1.7565027088770768,0.010714285714285714,0.2566110814839125,0.98,6/12,18.03%,PTK2;LYN;MAPK3;MAPK1;BST2;IL34
prerank,regulation of sister chromatid cohesion (GO:0007063),0.8901392876475994,1.7539657108512627,0.015580736543909348,0.1422591851870095,0.999,8/12,4.40%,CDCA5;BUB1;ESPL1;DDX11;RB1;RAD21;CTCF;WAPL
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.8955086684846055,1.7537663843851576,0.00723589001447178,0.14147288053516086,1.0,4/13,1.20%,CCNB1;NDC80;GEN1;CDK5RAP2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.7540958984709922,1.7528311046615606,0.0011049723756906078,0.14225015984884684,1.0,16/54,9.34%,E2F7;CCNB1;E2F8;CDK1;GTSE1;E2F1;AURKA;TFDP1;CNOT1;CHEK2;MDM4;CNOT6L;PML;CNOT6;CDC25C;PLAGL1
prerank,chromosome organization (GO:0051276),0.7485396297586382,1.7525093329832744,0.0,0.14170335369125547,1.0,10/99,2.16%,TOP2A;NUF2;CDCA8;CENPH;NDC80;PHF19;EZH2;HMGB2;NUP155;RFWD3
prerank,DNA integrity checkpoint signaling (GO:0031570),0.7902712564254507,1.7516792831963086,0.0023228803716608595,0.1423489483033529,1.0,14/36,7.17%,BRIP1;CLSPN;E2F1;TIPIN;CDC45;TIMELESS;CDC6;CHEK2;INTS7;RAD1;DNA2;MAP3K20;CHEK1;PRPF19
prerank,cellular potassium ion homeostasis (GO:0030007),-0.6641218115200097,-1.7491544480282577,0.0,0.26881217309079636,0.985,6/13,16.25%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;ATP1A2;SLC12A2
prerank,intracellular protein transmembrane transport (GO:0065002),-0.4685880862695518,-1.7475572572502178,0.01680672268907563,0.26472357823631565,0.985,32/42,38.86%,PEX1;DNAJC19;AKT2;HSPD1;AIFM1;HSPA5;PEX5;TIMM44;PEX6;TOMM70;SEC61B;SEC62;DNAJC15;PAM16;TIMM17A;PEX26;TIMM17B;SEC63;CHCHD4;SEC61A2;C2CD5;PEX10;ROMO1;GRPEL1;ZFAND2B;SEC61A1;PEX16;DNLZ;TOMM40L;PEX2;PEX14;TIMM50
prerank,meiosis I (GO:0007127),0.8382417005967437,1.7466418612959094,0.006361323155216285,0.15302351005057865,1.0,3/23,1.03%,SGO1;MEIOC;MYBL1
prerank,regulation of double-strand break repair (GO:2000779),0.773085916372819,1.7419393815037578,0.005787037037037037,0.1630366623167867,1.0,16/39,9.21%,RAD51AP1;FIGNL1;RAD51;DDX11;TIMELESS;DEK;RTEL1;RPA2;SLF1;SPIDR;PML;CHEK1;SETD2;UBR5;MRNIP;MGMT
prerank,double-strand break repair via break-induced replication (GO:0000727),0.8753013928179091,1.7408316842063716,0.009708737864077669,0.16454824162279383,1.0,7/12,6.02%,MCM5;CDC45;MCM6;MCM7;MCM2;MCM3;MCM4
prerank,nuclear membrane disassembly (GO:0051081),0.8702289011941129,1.739254969552837,0.007052186177715092,0.16699520884503508,1.0,4/14,1.03%,CCNB1;CDK1;PLK1;CCNB2
prerank,regulation of cell division (GO:0051302),0.7377035763614307,1.7375160734163702,0.0031779661016949155,0.17022065723187838,1.0,15/72,7.87%,PRC1;KIF18B;PLK1;KIF20A;AURKB;PLK4;AURKA;CSPP1;FGFR2;BLM;AHCTF1;PRPF40A;SFRP2;SETD2;SH3GLB1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.6201343297134665,-1.7328072317910688,0.006711409395973154,0.29492890449037634,0.994,8/14,28.44%,ECE1;NOS3;ACE;ENPEP;AGTR1;EDN1;EDN3;ACE2
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.5569705954883643,-1.7319541636580902,0.021834061135371178,0.28901362699204924,0.994,12/23,29.46%,GPX4;PTGS2;ASAH2;GSTM1;EPHX2;ELOVL6;ACOT7;HPGD;FADS1;GSTM2;ACSBG1;ALOX12
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.6988239610911078,-1.7310365055316794,0.011799410029498525,0.2836488907170287,0.995,7/10,25.25%,WDFY1;IFI35;LBP;PTPN22;NR1H3;TIRAP;NINJ1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.8016332625093554,1.729981210959566,0.02122347066167291,0.1890193038683305,1.0,5/23,1.42%,ZWILCH;BUB1B;BUB1;AURKB;WEE1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.6367502349118921,-1.728844149088562,0.010869565217391304,0.28175757418734515,0.996,6/14,18.03%,PTK2;MAPK3;MAPK1;THBS1;CMKLR1;IL34
prerank,proton transmembrane transport (GO:1902600),-0.48523410922704285,-1.7283521164351725,0.008695652173913044,0.27567161703847926,0.996,10/36,15.03%,ATP6V0D1;ATP6V0A4;ATP1A1;ATP1A3;ATP5PO;ATP5MF;ATP6V0C;ATP1A2;ATP6V1H;ATP5F1B
prerank,homologous chromosome segregation (GO:0045143),0.8204973744172509,1.7275982920286412,0.013089005235602094,0.19416729534819677,1.0,2/20,0.88%,SGO1;FANCD2
prerank,negative regulation of cell division (GO:0051782),0.8776719567000955,1.727530408903451,0.013412816691505217,0.19272931189841774,1.0,4/11,5.21%,E2F7;E2F8;AURKB;BLM
prerank,protein localization to chromosome (GO:0034502),0.7722053474804761,1.7265642378027688,0.011547344110854504,0.19352691664908428,1.0,12/34,6.04%,CENPA;PLK1;ATRX;MCM8;HASPIN;RB1;RAD21;CTCF;RPA1;WAPL;RPA2;SLF1
prerank,neuron maturation (GO:0042551),-0.5788645518436196,-1.7244153982146428,0.02531645569620253,0.2796249538499405,0.997,13/18,22.35%,B4GALT5;B4GALT6;APP;SCARF1;CX3CL1;FARP2;ADGRB3;EPHA8;MTCH1;PICK1;LGI4;CLN5;ANKS1A
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.742264741992168,1.7220545015700341,0.0010718113612004287,0.20487886801194796,1.0,20/58,10.41%,BRCA1;POLQ;BARD1;POLA1;NSD2;HMGB2;RNF168;PAXIP1;SMC5;ERCC4;PRKDC;MRE11;MDC1;UBE2N;PRPF19;RIF1;UIMC1;PSMD14;HMGB1;HERC2
prerank,mitotic recombination (GO:0006312),0.8447807111383148,1.7219384538755265,0.018413597733711047,0.2035334396887986,1.0,7/15,4.06%,RAD54B;RAD51;GEN1;DMC1;SMC6;SMC5;MSH3
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.7508634269881278,1.7218827086994597,0.0033333333333333335,0.20201006263567117,1.0,12/50,6.38%,CCNF;CCNB1;CDKN3;CCNE2;CCNB2;CDKN2D;CDKN2C;CDC6;CCNA2;BLM;CCNA1;CCNE1
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.5390917539586387,-1.7209719735322646,0.009569377990430622,0.28184417472020634,0.997,14/22,20.99%,AEBP1;APOE;CAMSAP2;MAP1B;PRUNE1;MAP1A;CHRNA7;ABL1;CAMSAP1;GPX1;PIK3CA;ARL2;PARK7;GBA2
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.7400616874893614,1.720406123691528,0.0,0.20439026451414755,1.0,37/83,14.15%,CDKN3;RRM2;POLE;CCNE2;DBF4;POLA1;ORC1;E2F1;TYMS;SPDYA;CDC45;CDKN2D;FBXO5;CDKN2C;RB1;CDK14;CDC6;E2F3;TFDP1;KHDRBS1;EIF4E;CCNA1;CCNE1;USP37;CUL5;CDK2;CUL3;KLF11;CUL4B;CDC25A;CRLF3;PCNA;NASP;BRD4;DHFR;PLK2;CDKN1B
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.8260855973358916,1.7169447954849881,0.031506849315068496,0.213160584681363,1.0,5/15,5.21%,EZH2;FAM83D;ATAD5;DDRGK1;DYRK3
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.8339980865547469,1.7163948221460532,0.010362694300518135,0.21317345864922133,1.0,11/18,11.30%,POLE;POLA1;RFC4;MCM7;GINS3;POLD3;MCM3;MCM4;RFC3;GINS1;PCNA
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.9033117354051416,1.7131424293538837,0.00933125972006221,0.22134367201839772,1.0,2/10,0.99%,BRCA1;ATRX
prerank,cellular response to nitrogen compound (GO:1901699),0.8153386949864461,1.7126072845264098,0.021333333333333333,0.22117811393244852,1.0,9/20,8.99%,ATRX;DDX11;ATP2B4;TIMELESS;ROCK2;BLM;SPIDR;FMR1;RIOK3
prerank,negative regulation of DNA recombination (GO:0045910),0.7546138893782024,1.7124602094741816,0.0056753688989784334,0.21984387632094163,1.0,13/43,8.39%,POLQ;PARPBP;RMI2;ATRX;ZRANB3;TERF1;RTEL1;MSH3;BLM;KLHL15;RIF1;POLR2A;SMCHD1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.7819276665944113,1.7111821705466117,0.029792746113989636,0.22152726157919067,1.0,10/24,9.70%,PHF19;EZH2;PPM1D;SUZ12;MPHOSPH8;EED;RBBP4;RBBP7;PHF1;EPC1
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.8434541136206182,1.711002140471834,0.017173051519154558,0.22026296419765717,1.0,8/16,6.02%,RAD51;MCM6;MCM7;MCM2;RPA1;BLM;RECQL;MCM4
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.8905822781598787,1.709034205059098,0.016541353383458645,0.22410229961614256,1.0,6/10,7.38%,E2F7;E2F8;ATRX;DBF4;WIZ;STOML2
prerank,dopamine metabolic process (GO:0042417),-0.5797716237736743,-1.7088542525676205,0.021739130434782608,0.3044931111879465,0.998,9/18,23.84%,PRKN;TGFB2;MAOA;MAOB;MOXD1;GCH1;ATP7A;DRD2;COMT
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.8340574051918364,1.7086771424104394,0.02194787379972565,0.2235647262210376,1.0,6/16,8.39%,POLQ;PARPBP;RMI2;KLHL15;RIF1;SMCHD1
prerank,establishment of spindle localization (GO:0051293),0.8497491829721614,1.706168276616198,0.02592087312414734,0.22921900734106296,1.0,2/14,0.75%,NUSAP1;ESPL1
prerank,regulation of DNA repair (GO:0006282),0.741112825027598,1.7044561606881712,0.007927519818799546,0.23260801660175853,1.0,17/44,12.38%,BRCA1;RNF168;DEK;EYA4;USP1;POLH;DHX9;PML;UBE2N;UIMC1;UBR5;TRIM28;SMCHD1;AXIN2;EYA2;PCNA;TRIP12
prerank,negative regulation of protein secretion (GO:0050709),-0.4584653366156957,-1.7039994371943437,0.0,0.31020122220939617,0.998,15/38,23.06%,PRKN;APOE;KCNB1;SERGEF;NR1H3;OPRM1;IRS1;CYP51A1;RHBDF1;RAB11FIP1;MIDN;ADRA2A;RHBDF2;DRD2;DPH3
prerank,placenta development (GO:0001890),0.8580220213410594,1.6994535387314755,0.02710413694721826,0.24600157484039473,1.0,2/12,0.44%,E2F7;E2F8
prerank,regulation of chromosome organization (GO:0033044),0.8006174947059611,1.6993044403424995,0.020050125313283207,0.24468549390526778,1.0,11/22,12.01%,PIF1;BUB1;RMI2;RB1;HNRNPD;WAPL;MAPT;YLPM1;HDAC8;TERF2;CENPV
prerank,cellular response to DNA damage stimulus (GO:0006974),0.7112264787274163,1.699130708454614,0.0,0.24347489408218392,1.0,94/336,11.16%,TOP2A;DTL;BRCA1;EXO1;TICRR;RAD51AP1;POLK;POLQ;CDK1;FANCA;RAD51B;BARD1;UBE2T;MASTL;RMI2;RAD51;RAD54L;POLA1;WDHD1;RAD18;WDR76;PCLAF;DDX11;E2F1;CBX5;ZRANB3;MCM8;SPDYA;RFC4;PDS5A;SMC1A;RFWD3;RNF168;TIMELESS;XRCC2;SMC6;FAM111A;MCM10;BAZ1B;SETX;MCM7;PDS5B;RPAIN;TOPBP1;RTEL1;EID3;POLH;RBBP8;RPA1;SMC5;CHD1L;MSH3;CHEK2;ERCC4;RAD1;RFC2;PRKDC;BLM;MRE11;RECQL;NSMCE4A;POLD1;SLF1;ERCC3;NRDE2;SPIDR;FANCL;RFC3;PML;FMR1;ETAA1;CHEK1;RIF1;NIPBL;PHF1;UBR5;TRIM28;MRNIP;HTRA2;RAD51C;USP16;YAP1;MGMT;CUL4B;IKBKG;CBX1;MBD4;SUSD6;HERC2;MMS19;FBXO45;BOK;USP28;XPA
prerank,positive regulation of viral genome replication (GO:0045070),0.776942172082922,1.697681787529266,0.011194029850746268,0.24578760047863565,1.0,1/29,0.01%,TOP2A
prerank,cellular response to ionizing radiation (GO:0071479),0.7381683901497351,1.6973814297581291,0.0044994375703037125,0.2451131554424409,1.0,12/47,7.60%,ECT2;RAD51AP1;FIGNL1;RAD51;INTS7;RAD1;BLM;NET1;SPIDR;MAP3K20;NUCKS1;NIPBL
prerank,hyaluronan metabolic process (GO:0030212),0.7771876461777396,1.6967083860015586,0.017902813299232736,0.24541580065995175,1.0,4/23,3.29%,HMMR;HAS3;SPAM1;HYAL1
prerank,regulation of centrosome duplication (GO:0010824),0.7766742817816437,1.696595844658222,0.013530135301353014,0.24402601106635527,1.0,4/29,1.11%,CCNF;STIL;CEP295;GEN1
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.7731096344186797,1.6952334838260474,0.011723329425556858,0.24630423763298745,1.0,8/34,3.65%,NUSAP1;DLGAP5;ESPL1;ANAPC7;RB1;AURKA;PHIP;CDC27
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.8542453034467757,1.6943695645164298,0.023121387283236993,0.2473505598693254,1.0,6/15,6.75%,EME1;FANCD2;TIPIN;CHEK2;MRE11;MDC1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.8642850066039377,1.6929584094216152,0.01908957415565345,0.2496842260485071,1.0,6/11,5.21%,ZRANB3;TIPIN;FBXO5;TIMELESS;MSH3;BLM
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.5672045513966169,-1.6890367018478394,0.00823045267489712,0.3449169671859092,0.999,12/19,28.28%,MAPK8;SLCO1C1;MAP2K5;KLF4;CHRNA7;APP;KLF2;WFS1;PAX8;MAPK7;TMEM106A;EGF
prerank,regulation of DNA metabolic process (GO:0051052),0.7316166886519179,1.6869471567022567,0.01762114537444934,0.2669559374938473,1.0,17/44,13.91%,TICRR;PIF1;KPNA2;USP1;POLH;HNRNPD;MPHOSPH8;SMARCAD1;YLPM1;GRHL2;UBE2N;NUCKS1;HDAC8;TERF2;STOX1;WDR70;SMG6
prerank,phosphatidylserine metabolic process (GO:0006658),-0.4771395583248683,-1.6868919585964839,0.011111111111111112,0.34366623669244994,1.0,8/32,10.44%,PLA2G4A;PLAAT3;ABHD12;ABHD16A;PLA1A;OSBPL10;SLC27A1;SERINC1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.4978210583660476,-1.6867942755574001,0.0,0.33641800033650154,1.0,17/29,30.35%,ELOVL7;ACLY;HACD2;ACSL4;HACD1;ACSL5;ACSL6;ELOVL6;PPT1;CBR4;ACSL1;SCD;ELOVL1;FASN;ACSBG1;TECR;HSD17B8
prerank,DNA conformation change (GO:0071103),0.8389324045996276,1.6864185284370796,0.018995929443690638,0.26681791059664706,1.0,4/17,6.10%,TOP2A;HMGB2;HAT1;ERCC3
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.8583545182162452,1.6861746431534566,0.03453689167974882,0.26210024900282225,1.0,4/10,5.21%,EXO1;TERF1;DNA2;BLM
prerank,t-circle formation (GO:0090656),0.8583545182162452,1.6861746431534566,0.03453689167974882,0.26210024900282225,1.0,4/10,5.21%,EXO1;TERF1;DNA2;BLM
prerank,telomere maintenance via telomere trimming (GO:0090737),0.8583545182162452,1.6861746431534566,0.03453689167974882,0.26210024900282225,1.0,4/10,5.21%,EXO1;TERF1;DNA2;BLM
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.7152531854460918,1.684861740148585,0.0010570824524312897,0.2643236802480817,1.0,15/78,6.38%,CCNF;CCNB1;CDKN3;PLK1;CCNE2;CCNB2;SPDYA;PSRC1;CDKN2D;CDKN2C;CDC6;CCNA2;BLM;CCNA1;CCNE1
prerank,response to hydroxyurea (GO:0072710),0.8519437696918276,1.6830552803769783,0.03463855421686747,0.2681254407028287,1.0,6/11,6.94%,ATRX;DDX11;TIMELESS;BLM;SPIDR;FMR1
prerank,error-prone translesion synthesis (GO:0042276),0.7978627756730243,1.682508614282447,0.026054590570719603,0.2681233261488799,1.0,9/21,6.49%,POLK;RFC4;POLH;RPA1;PRIMPOL;RFC2;RPA2;RFC1;RFC3
prerank,regulation of catecholamine secretion (GO:0050433),-0.49096737830173437,-1.682369364836381,0.00641025641025641,0.34172416331287747,1.0,12/29,22.19%,PRKN;KCNB1;SYT1;SYT7;DTNBP1;KCNA2;SYT11;SYT12;SYT10;SYT6;SYT2;DRD2
prerank,positive regulation of histone methylation (GO:0031062),0.7796890506235651,1.6817414664857264,0.0149812734082397,0.2688295672678159,1.0,7/24,9.85%,BRCA1;PHF19;PAXIP1;AUTS2;RIF1;PHF1;KMT2A
prerank,phagosome acidification (GO:0090383),-0.4987020071607404,-1.6800576404832241,0.010752688172043012,0.3408316069792564,1.0,14/26,32.33%,ATP6V0A1;ATP6V0D1;ATP6V1E1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP6V1H;RAB38;ATP6V1G2;ATP6V1B2;RAB39A;ATP6V1F;ATP6V0D2;ATP6V0E1
prerank,hyaluronan catabolic process (GO:0030214),0.7992962902107206,1.6796147200827862,0.013908205841446454,0.27353032992258547,1.0,3/18,3.29%,HMMR;SPAM1;HYAL1
prerank,positive regulation of macrophage migration (GO:1905523),-0.5541864413377164,-1.6790772378945455,0.008298755186721992,0.33690824321688306,1.0,8/19,22.05%,PTK2;MAPK3;MAPK1;THBS1;CX3CL1;CMKLR1;IL34;P2RX4
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.6120612655112463,-1.6774829794025767,0.022058823529411766,0.3342348661990127,1.0,3/15,6.91%,PLTP;APOE;ABCA5
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.7070101192891636,1.6751227213938145,0.005376344086021506,0.28592984674525146,1.0,19/72,9.34%,E2F7;CCNB1;E2F8;CDK1;GTSE1;ATRX;E2F1;PAXIP1;AURKA;TFDP1;CNOT1;CHEK2;MDM4;CNOT6L;PML;CNOT6;ING4;CDC25C;PLAGL1
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.5511303276485484,-1.674909092527201,0.0,0.33474723441495396,1.0,7/21,18.03%,PTK2;MTUS1;MAPK3;MAPK1;THBS1;CMKLR1;IL34
prerank,signal transduction in response to DNA damage (GO:0042770),0.7238405099375624,1.6743948802013742,0.008869179600886918,0.28639902423688884,1.0,13/49,7.17%,E2F7;BRIP1;CLSPN;ATRX;E2F1;PAXIP1;CHEK2;MDM4;INTS7;RAD1;MAP3K20;CHEK1;PRPF19
prerank,cell cycle checkpoint signaling (GO:0000075),0.8529271726393379,1.6733620126714828,0.0226628895184136,0.2879587361168326,1.0,4/12,1.42%,ZWILCH;BUB1B;BUB1;WEE1
prerank,phagosome maturation (GO:0090382),-0.45608407534611206,-1.673158000006137,0.028169014084507043,0.332940808012597,1.0,19/35,32.33%,ATP6V0A1;ATP6V0D1;ATP6V1E1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP6V1H;MCOLN1;RAB38;ATP6V1G2;MREG;ATP6V1B2;RAB14;RAB32;RAB39A;ATP6V1F;ATP6V0D2;RAB31;ATP6V0E1
prerank,positive regulation of DNA replication (GO:0045740),0.8058117664301084,1.673095220065645,0.03818953323903819,0.28702701325708957,1.0,6/16,5.71%,ATAD5;GLI2;STN1;DNA2;DHX9;FAF1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.7621762094173856,1.6686883638156762,0.027194066749072928,0.29906162016575955,1.0,3/29,3.40%,TRIP13;FANCD2;RAD21
prerank,mitotic nuclear membrane organization (GO:0101024),0.7147885808793241,1.6679925976020715,0.006615214994487321,0.29756820710490106,1.0,10/51,6.18%,CCNB1;CDK1;CCNB2;NDC1;NUP155;LBR;NUP205;NUP160;NUP85;AHCTF1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.7147885808793241,1.6679925976020715,0.006615214994487321,0.29756820710490106,1.0,10/51,6.18%,CCNB1;CDK1;CCNB2;NDC1;NUP155;LBR;NUP205;NUP160;NUP85;AHCTF1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.703156550602304,1.6649698197395215,0.002072538860103627,0.30530555931464937,1.0,22/84,9.62%,CCNB1;CDK1;BUB1B;PLK1;CDC20;UBE2C;AURKB;UBE2S;FBXO5;ANAPC7;RB1;AURKA;PSMC2;CDC27;PSMD5;BUB3;CDK2;PSMB1;CUL3;PSMD14;PSMD1;SKP2
prerank,cellular response to hydroxyurea (GO:0072711),0.8675690249107212,1.6629866013592123,0.0327613104524181,0.30998047501282805,1.0,6/10,6.94%,ATRX;DDX11;TIMELESS;BLM;SPIDR;FMR1
prerank,negative regulation of histone methylation (GO:0031061),0.8612160005064888,1.6625965157128375,0.0249609984399376,0.3095103117138375,1.0,3/10,7.92%,BRCA1;BCOR;PHF1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.8371369911489537,1.6625089553282937,0.037481259370314844,0.30787598245235437,1.0,3/12,5.21%,TICRR;TIPIN;BLM
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.8167336089483951,1.6621425208978169,0.0424597364568082,0.30723732581833013,1.0,4/12,5.46%,EZH2;CYP26B1;CNOT1;ASXL1
prerank,negative regulation of double-strand break repair (GO:2000780),0.7591057870159542,1.659712228521538,0.02038369304556355,0.31358113346329963,1.0,8/30,8.39%,POLQ;PARPBP;RMI2;AUNIP;KLHL15;RIF1;UBR5;SMCHD1
prerank,glycerophospholipid catabolic process (GO:0046475),-0.5059867010920558,-1.657926503929759,0.009852216748768473,0.3690662375581891,1.0,10/27,16.10%,GPCPD1;PLA2G4A;ABHD12;ABHD16A;PNPLA6;PNPLA8;ENPP6;GDPD3;GDPD1;PLA2G7
prerank,DNA-dependent DNA replication (GO:0006261),0.7023262736162398,1.6560742174118328,0.0,0.32408904851571957,1.0,42/128,8.72%,POLE;RAD51;DBF4;MCM5;POLA1;WDHD1;ORC1;PRIM2;POLA2;MCM8;CDC45;RFC4;PRIM1;MCM10;MCM6;MCM7;MCM2;RPAIN;MGME1;TOPBP1;GINS3;CDC6;PSMC2;RPA1;PSMD5;PRIMPOL;POLD3;DNA2;RFC2;BLM;RECQL;MCM3;POLD1;RPA2;MCM4;RFC1;RFC3;ORC2;ORC3;CDK2;PSMB1;PSMD14
prerank,DNA damage checkpoint signaling (GO:0000077),0.7633208088540224,1.655264822531984,0.019583843329253364,0.32502800082923844,1.0,9/28,7.17%,BRIP1;CLSPN;E2F1;CHEK2;INTS7;RAD1;MAP3K20;CHEK1;PRPF19
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.7871775367233467,1.654197393083724,0.02069857697283312,0.32670593832560896,1.0,5/21,2.18%,PLK1;CDC20;UBE2C;UBE2S;FBXO5
prerank,cell cycle G1/S phase transition (GO:0044843),0.7144476880318748,1.652398154680194,0.010752688172043012,0.33074837406471236,1.0,21/61,10.74%,CDKN3;POLE;CCNE2;DBF4;E2F1;SPDYA;CDKN2D;CDKN2C;RB1;E2F3;KHDRBS1;CCNA2;EIF4E;CCNE1;USP37;CUL5;CDK2;CUL3;CUL4B;CDC25A;CRLF3
prerank,response to ethanol (GO:0045471),-0.6215546635507139,-1.651253923552912,0.018867924528301886,0.3841496512853393,1.0,5/14,4.69%,GRIN3A;GRIN2A;GLRA1;GRIN2B;GOT2
prerank,insulin receptor signaling pathway (GO:0008286),-0.3873081549405598,-1.6510881080296818,0.0,0.37763090145827977,1.0,26/69,14.76%,FOXO1;ATP6V0A1;GRB14;GRB10;ATP6V0D1;ATP6V1E1;INSR;ATP6V0B;PIK3R3;AKT2;PIK3R1;ATP6V0A4;FOXC2;IRS2;IGF2;NAMPT;GPLD1;BCAR3;IRS1;CAV2;GRB2;ATP6V0C;ATP6V1H;SHC1;GSK3A;APC
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.8074374177382033,1.6500426764304528,0.03099730458221024,0.33674778996026195,1.0,4/16,4.18%,BRCA1;PAXIP1;AUTS2;BCOR
prerank,male meiosis I (GO:0007141),0.8320217841683963,1.6499864162654838,0.01780821917808219,0.3350597292498939,1.0,3/16,6.03%,MEIOC;MYBL1;CCNA1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.6044683646922037,-1.648887990680038,0.015151515151515152,0.3709426031200439,1.0,3/14,8.13%,SLCO2B1;HMOX2;ABCG2
prerank,heme catabolic process (GO:0042167),-0.6044683646922037,-1.648887990680038,0.015151515151515152,0.3709426031200439,1.0,3/14,8.13%,SLCO2B1;HMOX2;ABCG2
prerank,positive regulation of DNA repair (GO:0045739),0.7261987231981681,1.6486658036455104,0.02254791431792559,0.3374453461237534,1.0,16/46,11.30%,BRCA1;DDX11;RNF168;TIMELESS;EYA4;DHX9;SLF1;SPIDR;UBE2N;UIMC1;TRIM28;SMCHD1;MGMT;HMGB1;EYA2;PCNA
prerank,DNA geometric change (GO:0032392),0.7740228615869816,1.647025171564386,0.02445302445302445,0.34113094651302295,1.0,13/24,11.48%,PIF1;DDX11;HMGB2;ZRANB3;RTEL1;DNA2;DHX9;BLM;MRE11;RECQL;HMGB3;HMGB1;ANXA1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.8446936848060742,1.646429548531378,0.024531024531024532,0.34116223643077476,1.0,4/12,2.03%,PLK1;CDC20;UBE2C;UBE2S
prerank,catecholamine metabolic process (GO:0006584),-0.5950976853099622,-1.6448761160723204,0.02247191011235955,0.3758250310378306,1.0,6/14,23.84%,PRKN;RNF180;DDC;ATP7A;DRD2;COMT
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.7360531196693321,1.6441170945306047,0.020954598370197905,0.34701127649552077,1.0,14/40,8.71%,ANKLE1;WDR76;KMT5A;RFWD3;FBXO5;USP1;POLH;MAPT;NSMCE4A;RPA2;UBE2N;FMR1;ETAA1;BCLAF1
prerank,rRNA metabolic process (GO:0016072),-0.3255823552297106,-1.6416900053290018,0.0,0.37906563772603097,1.0,80/160,27.93%,RPL13;RPL37A;RPL38;RPL21;RPL35A;RPL23;RPL17;RPL3;RPS15;RPS7;NVL;RPL18A;RPS6;RPL14;RPLP1;RPL9;RPL37;RPL8;RPS14;NOL8;RPL10;RPL18;RPL32;RPS28;SENP3;RPS24;RPL15;RPS19;HEATR1;UTP20;RPL39;KRR1;RPL12;RPL27;RPL24;WDR75;EXOSC1;RPS27;RPL27A;RPS9;RPL30;EXOSC9;RRP1B;RRP1;RPL19;RPL28;RPL31;MPHOSPH10;LAS1L;SNU13;DKC1;DDX49;RPL13A;RPL36A;RPLP2;RPL29;MDN1;RPLP0;RPL10A;RPL35;NOB1;NOLC1;EMG1;EXOSC2;PIH1D1;EBNA1BP2;DDX54;RPL4;BYSL;DEDD2;IMP3;DDX47;BOP1;EXOSC3;NIFK;RPS25;EXOSC5;POP5;WDR18;PDCD11
prerank,protein monoubiquitination (GO:0006513),0.741193619021269,1.6402700437397095,0.018561484918793503,0.35848468145105755,1.0,11/36,9.72%,DTL;UHRF1;UBE2T;RAD18;FANCL;RNF40;CUL3;UBE2R2;KLHL22;LEO1;OBI1
prerank,DNA strand elongation (GO:0022616),0.7966670722773663,1.6390118845354011,0.040973111395646605,0.3608813588412665,1.0,9/18,6.49%,POLA1;RFC4;MCM7;GINS3;POLD3;MRE11;MCM3;MCM4;RFC3
prerank,mitotic DNA replication (GO:1902969),0.8635404690059395,1.6389231344783624,0.033823529411764704,0.3591660228819346,1.0,8/10,10.54%,POLA1;CDC45;MCM6;MCM2;GINS3;MCM3;MCM4;GINS1
prerank,nuclear membrane reassembly (GO:0031468),0.7017781802671565,1.6387259907904732,0.008743169398907104,0.3578172525754474,1.0,10/54,6.18%,CCNB1;CDK1;CCNB2;NDC1;NUP155;LBR;NUP205;NUP160;NUP85;AHCTF1
prerank,negative regulation of histone acetylation (GO:0035067),0.8466865296173328,1.6386858138305231,0.04341317365269461,0.35599059823135554,1.0,2/11,5.16%,BRCA1;CTBP1
prerank,smooth muscle tissue development (GO:0048745),-0.6758112153368532,-1.6383687941252778,0.023529411764705882,0.3827105924072327,1.0,6/10,15.54%,PROX1;MYLK;NF1;PTCH1;ENG;STRA6
prerank,nucleosome assembly (GO:0006334),0.747676765260698,1.6370641079774217,0.027218934911242602,0.35963988000960445,1.0,13/31,13.56%,ASF1B;CHAF1B;ATRX;HMGB2;NAP1L1;ANP32B;HAT1;RBBP4;UBN1;NASP;SPTY2D1;SOX9;CHAF1A
prerank,negative regulation of histone modification (GO:0031057),0.8039545964271093,1.6366302738827871,0.04721030042918455,0.35931298088416475,1.0,2/14,5.16%,BRCA1;CTBP1
prerank,maintenance of blood-brain barrier (GO:0035633),-0.48558214456136933,-1.6359465462962917,0.005780346820809248,0.38464013937710256,1.0,16/30,23.34%,OCLN;JAM2;PECAM1;ACTB;CLDN5;ESAM;F11R;CDH5;TJP1;CLDN12;SLC1A1;SLC12A2;GJB6;LAMA2;CLDN1;MFSD2A
prerank,negative regulation of JNK cascade (GO:0046329),-0.48217724622600405,-1.6346389514666115,0.006172839506172839,0.38256826790280457,1.0,12/31,14.06%,MECOM;PRKN;ZMYND11;PDCD4;DUSP3;CYLD;DNAJA1;DACT1;PTPN22;HDAC3;PINK1;SH3RF2
prerank,chloride transport (GO:0006821),-0.39016671681569526,-1.6317727756332272,0.0,0.3853063202737076,1.0,26/74,19.08%,GABRB1;ANO3;GABRB3;GABRA2;SLC6A1;GLRB;GLRA1;ANO6;ANO1;GABRA3;GLRA3;ANO10;GABRA5;CLIC5;GABRB2;ANO4;GABRG2;SLC12A9;GABRG1;SLC4A8;TTYH3;SLC1A1;SLC12A2;CLCN2;FXYD1;LRRC8A
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.8295667239784328,1.6309880873553995,0.033873343151693665,0.3732374510174219,1.0,5/12,3.65%,DLGAP5;ESPL1;ANAPC7;RB1;CDC27
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.8295667239784328,1.6309880873553995,0.033873343151693665,0.3732374510174219,1.0,5/12,3.65%,DLGAP5;ESPL1;ANAPC7;RB1;CDC27
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.8295667239784328,1.6309880873553995,0.033873343151693665,0.3732374510174219,1.0,5/12,3.65%,DLGAP5;ESPL1;ANAPC7;RB1;CDC27
prerank,negative regulation of chemokine production (GO:0032682),-0.5865348966091681,-1.6302761823573797,0.02867383512544803,0.3837691309089169,1.0,5/14,17.26%,APOD;MAP2K5;KLF4;C1QTNF3;LGALS9
prerank,regulation of mitotic cell cycle (GO:0007346),0.6797937373977329,1.6302306933284136,0.0,0.3738964882918395,1.0,38/171,10.89%,KIF20B;MKI67;NEK2;CCNB1;CDK1;DLGAP5;BUB1B;PLK1;CKS2;BORA;CDC20;UBE2C;UBE2S;FBXO5;ANAPC7;RB1;TTC28;PSMC2;CDC27;PSMD5;GBF1;OBSL1;EIF4E;ERCC3;BUB3;CDC25B;SCRIB;CCDC57;RNF40;PSMB1;BTG3;PSMD14;CDC25C;PSMD1;GAS1;HNRNPU;TAL1;PSMB9
prerank,regulation of mitochondrial fusion (GO:0010635),-0.6420321739925957,-1.6275779045522576,0.02127659574468085,0.3861942583540811,1.0,5/11,18.02%,PRKN;ADCK1;OMA1;BNIP3;VAT1
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.5745919629413874,-1.6270996457573506,0.014035087719298246,0.3821024786155853,1.0,8/16,29.54%,BMPR2;PLCB3;ACE;PRCP;GSK3A;DRD2;ADM;GPR37L1
prerank,regulation of cell cycle phase transition (GO:1901987),0.6897175941779443,1.6240119507838617,0.0031185031185031187,0.39468253604174713,1.0,18/91,6.72%,CCNB1;CDK1;BUB1B;PLK1;GTSE1;CDC20;UBE2C;DBF4;UBE2S;ATP2B4;FBXO5;ANAPC7;PSMC2;CDC27;PSMD5;ERCC3;BUB3;FBXW7
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.80948310928786,1.6237463405681798,0.04809052333804809,0.3935622372150567,1.0,6/14,10.63%,RAD51AP1;TIMELESS;ARID2;FUS;MRNIP;MMS19
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.8274872647495062,1.6233511504943938,0.03741007194244604,0.39287055072828536,1.0,7/12,11.08%,BRCA1;RBM15;PCGF5;LRIF1;SMCHD1;HNRNPU;RBM15B
prerank,microtubule nucleation (GO:0007020),0.7901925731326733,1.6196872253676482,0.03708609271523179,0.40429577387716065,1.0,6/19,11.56%,TPX2;TUBGCP5;NDE1;CCDC57;TPPP;AKAP9
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5439588101056805,-1.6183622278752732,0.022727272727272728,0.4015845210914701,1.0,8/20,12.68%,ANO6;PDCD4;PLCG1;SFRP4;GSN;THBS1;PIAS4;RGCC
prerank,"base-excision repair, AP site formation (GO:0006285)",0.770376728563407,1.615464294473416,0.06548431105047749,0.4180149476699869,1.0,2/17,1.68%,NEIL3;TERF1
prerank,positive regulation of double-strand break repair (GO:2000781),0.7091210534974564,1.6152329817233364,0.030577576443941108,0.41671873470002985,1.0,17/39,15.25%,RAD51AP1;DDX11;TIMELESS;ARID2;PRKDC;SLF1;SPIDR;RIF1;FUS;MRNIP;SMCHD1;MGMT;PARP9;MMS19;KMT5C;FOXM1;SHLD2
prerank,inorganic anion transmembrane transport (GO:0098661),-0.39866659691582573,-1.6115782198978283,0.0,0.4173038190129397,1.0,26/63,19.27%,GABRB1;ANO3;GABRB3;GABRA2;SLC6A1;GLRB;GLRA1;ANO6;ANO1;GABRA3;GLRA3;SLC25A3;GABRA5;GABRB2;SLC5A6;SLC5A5;ANO4;GABRG2;SLC12A9;GABRG1;SLC4A8;SLC1A1;SLC12A2;SLC25A11;LRRC8A;SLC26A2
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.7204957588324888,1.611135228299595,0.030857142857142857,0.42962134141291186,1.0,15/37,11.30%,POLK;RFC4;RPA1;CHD1L;ERCC4;POLD3;RFC2;POLD1;RPA2;ERCC3;RFC1;RFC3;CUL4B;XPA;PCNA
prerank,RNA biosynthetic process (GO:0032774),0.7229362852324411,1.609521327271482,0.039663461538461536,0.43325343108663467,1.0,11/31,11.89%,POLA1;PRIM2;TTF2;POLA2;PRIM1;NAT14;SETX;TAF12;POLR2A;TTF1;TAF4
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.6029427487654127,-1.6081676242803888,0.03785488958990536,0.4219735915636007,1.0,10/13,27.32%,EDEM2;EDEM1;SAR1A;CD81;BCAP31;SAR1B;SORL1;SEC16B;TMEM30A;SEC16A
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.3969674979570541,-1.607903889750195,0.01098901098901099,0.41675054745202833,1.0,16/51,19.54%,PTK2;VEGFC;ANO6;GAS6;LGMN;MAPK3;MAPK1;THBS1;VEGFA;PLA2G7;CMKLR1;LGALS9;IL34;VEGFB;CREB3;VEGFD
prerank,actin filament polymerization (GO:0030041),0.726906511945331,1.606797069308578,0.033128834355828224,0.4411172133968856,1.0,1/29,0.03%,DIAPH3
prerank,regulation of dendritic spine development (GO:0060998),-0.5260844564754948,-1.6064635259465665,0.03614457831325301,0.41533096790806234,1.0,8/19,8.17%,GRIN3A;CPEB3;PSEN1;MEF2C;SHANK3;APOE;KIF1A;CAMK1
prerank,microtubule polymerization (GO:0046785),0.7496967089199587,1.6046769582315574,0.03519417475728155,0.4470309853887523,1.0,11/28,15.29%,TPX2;CKAP5;TUBGCP5;MAPT;NDE1;CCDC57;TPPP;AKAP9;TUBGCP3;PIN1;HDGFL3
prerank,tRNA modification (GO:0006400),-0.3934473075894512,-1.6038367193753562,0.0,0.41843404301869247,1.0,27/62,25.84%,TRMT9B;ANKRD16;DTWD2;MTO1;PUS10;AARS1;NSUN2;THUMPD3;TRMT61B;OSGEP;CDKAL1;QTRT2;TRMT1;TPRKB;TRUB1;METTL1;PUS3;THUMPD1;QTRT1;TRMT10A;LCMT2;TRMO;WDR6;DTWD1;WDR4;GTPBP3;ALKBH1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.6702582580485108,1.6028321209433765,0.009155645981688708,0.4519714159494263,1.0,18/104,7.14%,CCNF;CCNB1;CDKN3;EZH2;INCENP;CCNE2;CCNB2;CDKN2D;CDKN2C;KSR1;RB1;RHOA;CDC6;CCNA2;BLM;CCNA1;CCNE1;ETAA1
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.6013612180521267,-1.60270300281807,0.025889967637540454,0.416211441168719,1.0,7/13,25.58%,GLUL;GLS;NOS3;PRODH;GLUD1;NOS1;GLS2
prerank,regulation of integrin activation (GO:0033623),0.7961333974692827,1.6024134163806103,0.04397163120567376,0.4513427999817697,1.0,1/15,0.13%,KIF14
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.7740277372155306,1.6020846472585972,0.05695364238410596,0.4504788464434999,1.0,1/16,0.19%,BRCA1
prerank,midbody abscission (GO:0061952),0.7808455519252775,1.6007382475273544,0.04429530201342282,0.4533919179850084,1.0,2/17,1.01%,CEP55;KIF20A
prerank,transport across blood-brain barrier (GO:0150104),-0.35975374771286567,-1.5991281589948154,0.0,0.4213651584882664,1.0,29/83,16.25%,SLC6A6;SLC16A12;SLC1A2;ATP8A1;SLC6A1;SLC13A3;SLC2A1;SLC44A1;SLC7A2;INSR;SLCO1C1;SLC22A8;SLCO2B1;LRP1;SLC7A5;SLC27A1;ABCC4;ABCG2;SLC5A6;SLC15A2;SLC5A5;SLC22A5;SLC16A1;ATP1A2;ABCC5;SLC2A3;SLC4A8;SLC1A1;SLC12A2
prerank,vascular transport (GO:0010232),-0.365474104913091,-1.5978179670119157,0.0,0.419458779450575,1.0,29/81,16.25%,SLC6A6;SLC16A12;SLC1A2;ATP8A1;SLC6A1;SLC13A3;SLC2A1;SLC44A1;SLC7A2;INSR;SLCO1C1;SLC22A8;SLCO2B1;LRP1;SLC7A5;SLC27A1;ABCC4;ABCG2;SLC5A6;SLC15A2;SLC5A5;SLC22A5;SLC16A1;ATP1A2;ABCC5;SLC2A3;SLC4A8;SLC1A1;SLC12A2
prerank,rRNA processing (GO:0006364),-0.29811643990469777,-1.596331300181284,0.0,0.41859134904990253,1.0,82/172,27.09%,RPL13;RPL37A;RPL38;RPL21;RPL35A;RPL23;RPL17;RPL3;RPS15;RPS7;NVL;RPL18A;RPS6;RPL14;RPLP1;RPL9;RPL37;RPL8;RPS14;NOL8;RPL10;RPL18;RPL32;RPS28;SENP3;RPS24;RPL15;RPS19;HEATR1;UTP20;RSL1D1;RPL39;KRR1;RPL12;RPL27;RPL24;NSA2;WDR75;EXOSC1;RPS27;RPL27A;RPS9;RPL30;EXOSC9;RRP1B;RRP1;RPL19;RPL28;RPL31;MPHOSPH10;LAS1L;SNU13;DKC1;DDX49;RPL13A;RPL36A;RPLP2;RPL29;MDN1;RIOK2;RPLP0;RPL10A;RPL35;NOB1;NOLC1;EMG1;THUMPD1;NOP2;EXOSC2;PIH1D1;RRP15;EBNA1BP2;DDX54;RPL4;BYSL;IMP3;DDX47;BOP1;EXOSC3;RPS25;EXOSC5;POP5
prerank,mitotic cytokinetic process (GO:1902410),0.7603519513882514,1.5948430250177874,0.04330708661417323,0.47359281081070165,1.0,3/20,3.26%,CEP55;KIF20A;RHOA
prerank,positive regulation of DNA metabolic process (GO:0051054),0.6861914064229456,1.5937501102544596,0.01847826086956522,0.4753528846806502,1.0,17/61,11.30%,BRCA1;RAD51;ATRX;RNF168;EYA4;RTEL1;FGFR4;DHX9;MRE11;PML;UBE2N;UIMC1;TRIM28;SMCHD1;HMGB1;EYA2;PCNA
prerank,determination of bilateral symmetry (GO:0009855),0.7348930491973509,1.5935625287449018,0.05610972568578554,0.47377093824504346,1.0,5/24,9.04%,STIL;DNAH11;CFAP53;MKKS;NPHP3
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.737469520204437,1.59342283307502,0.044063647490820076,0.47201347656160253,1.0,13/29,15.39%,MEIOC;E2F1;THRAP3;EIF4ENIF1;FMR1;FUS;LARP1;AXIN2;HNRNPU;TENT5D;TAF15;PABPC1;GDNF
prerank,glutamate receptor signaling pathway (GO:0007215),-0.4448306463839462,-1.5927500209549292,0.0,0.42409005579207004,1.0,15/37,14.10%,GRM7;GRIK1;GRIN3A;GRIN2A;GRM3;GRID2;KCNB1;CPEB4;GRIN2B;HOMER1;GRIK4;APP;GRM5;GRM1;GRIN1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.843134385475072,1.5920477844172654,0.05069124423963134,0.47509019074558784,1.0,2/10,5.16%,BRCA1;CTBP1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.7134411889242253,1.5915643480464894,0.03424657534246575,0.47467562687931775,1.0,15/39,11.30%,POLK;RFC4;RPA1;CHD1L;ERCC4;POLD3;RFC2;POLD1;RPA2;ERCC3;RFC1;RFC3;CUL4B;XPA;PCNA
prerank,positive regulation of intracellular transport (GO:0032388),0.6989312182029874,1.5897287113291074,0.04252873563218391,0.47946413994333664,1.0,7/38,7.69%,KIF20B;SPAG5;NEDD4;PCM1;NUMA1;TPR;RAB29
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.8153097451082908,1.5876054601860432,0.0649546827794562,0.48531875690759935,1.0,5/11,7.09%,ASF1B;ATRX;HAT1;RBBP4;UBN1
prerank,positive regulation of telomere capping (GO:1904355),0.7910392877598779,1.5873577157360188,0.04532967032967033,0.4838733907448425,1.0,4/17,3.73%,NEK2;AURKB;RTEL1;HNRNPD
prerank,gas transport (GO:0015669),0.8232329991826304,1.5863646562224891,0.042105263157894736,0.48552535549370207,1.0,2/10,1.82%,RHAG;AQP1
prerank,ERAD pathway (GO:0036503),-0.3803519862659762,-1.5858341281099038,0.0,0.4410088990287538,1.0,39/83,24.46%,PRKN;UBE4A;ATXN3;HSP90B1;ERLEC1;OS9;TRIM25;ECPAS;RNF103;EDEM1;UFD1;DERL1;SELENOS;HSPA5;UBXN4;RHBDD2;SGTA;STUB1;YOD1;RCN3;SGTB;DNAJC18;POMT2;UBXN6;DNAJB9;ERLIN2;SEC61B;AUP1;DNAJB12;SYVN1;UBE2G2;UBXN8;GET4;SEL1L;UBE4B;TOR1A;FAM8A1;WFS1;RNF103-CHMP3
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.8077789148858684,1.58335365608461,0.05785123966942149,0.49489494795887257,1.0,1/12,0.19%,BRCA1
prerank,positive regulation of cellular respiration (GO:1901857),-0.6213287400626987,-1.582803587441117,0.03254437869822485,0.4451117805069419,1.0,7/11,24.97%,IFNAR1;PINK1;NUPR1;IL10RB;PARK7;ISCU;PRELID1
prerank,cellular response to zinc ion (GO:0071294),-0.5816707155882992,-1.5825162883902972,0.020202020202020204,0.44059396835815184,1.0,11/15,22.05%,GLRA1;MT2A;MT1X;MT1E;MT1M;MT1H;MT1F;MT1B;MT1A;MT1G;P2RX4
prerank,protein prenylation (GO:0018342),0.8229100631715294,1.5824599966854431,0.0549777117384844,0.4959787342337846,1.0,1/10,0.45%,AIPL1
prerank,regulation of DNA damage checkpoint (GO:2000001),0.8221694600115474,1.5816294249908223,0.057488653555219364,0.49681100176706594,1.0,5/10,7.14%,WDR76;RFWD3;RPA2;DDX39B;ETAA1
prerank,positive regulation of B cell proliferation (GO:0030890),0.714706696577019,1.5813861488833278,0.05514705882352941,0.4954386900507356,1.0,1/29,0.09%,TNFSF13B
prerank,protein export from nucleus (GO:0006611),0.7305048377022156,1.58091079312542,0.046341463414634146,0.49489670253315504,1.0,10/27,12.91%,ANKLE1;CCHCR1;RANBP17;XPO1;XPO4;CSE1L;TPR;SMURF1;NUP214;STRADA
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.6622373625188303,1.5808947205863266,0.0030303030303030303,0.4926822851818479,1.0,30/148,7.34%,TPX2;BRCA1;EXO1;CDK1;BRIP1;BARD1;RMI2;AURKB;RFC4;KMT5A;AURKA;TOPBP1;RBBP8;RPA1;CHEK2;MDM4;TAF3;RAD1;DNA2;RFC2;BLM;MRE11;RPA2;RFC3;RBBP4;RBBP7;PML;RRS1;CHEK1;TAF12
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.7371174971831785,1.5793764141075264,0.044848484848484846,0.49632655912097473,1.0,5/28,5.54%,SKA3;SKA1;SKA2;STMN1;MAPT
prerank,positive regulation of neuron migration (GO:2001224),0.8035834466701137,1.5779385645482473,0.059334298118668596,0.4994809987675186,1.0,1/11,0.10%,KIF20B
prerank,regulation of cell cycle (GO:0051726),0.6565521643887183,1.577718245782439,0.0,0.49799153163205473,1.0,54/271,10.74%,CENPF;DTL;KIF20B;BRCA1;PRR11;CCNB1;CDKN3;DLGAP5;PLK1;BIRC5;BARD1;MASTL;CKS2;FIGNL1;CCNB2;TGM1;PCLAF;DDIAS;CDKN2D;FBXO5;CDKN2C;RB1;TTC28;RASSF1;FGFR2;LIN54;GBF1;UHRF2;CTBP1;LIN52;TCF7L2;RBBP4;PML;MAP3K20;MYBL2;CHEK1;FBXL8;LIN9;HTRA2;RNF40;LIN37;MFN2;IRF1;ING4;GRK5;PLAGL1;SKP2;CSNK2A2;FBXL17;CDC25A;CDC123;TGFBR1;HNRNPU;CRLF3
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.5044404153915228,-1.57710797470237,0.030303030303030304,0.4522334771814017,1.0,10/22,14.11%,CYRIB;TMSB4X;KANK3;KANK4;PFN1;SSH1;SLIT2;GSN;ARFGEF1;TMSB10
prerank,regulation of muscle contraction (GO:0006937),-0.48548931338351703,-1.5764778623723041,0.03286384976525822,0.44882206037878564,1.0,9/26,16.92%,CHRM2;CAV1;ANXA6;TPM1;ATP1A2;ENO1;MYL9;PLCE1;SRI
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.5849332988005331,-1.5759064993623146,0.02962962962962963,0.44524592194927304,1.0,6/15,8.46%,ACVR1;SMAD7;ACVR2A;FKBP1A;ACVR2B;DACT1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.607708263021182,-1.5756461577469245,0.03214285714285714,0.44069766192566373,1.0,4/12,8.32%,UNC13B;RIMS1;SYT1;SYT7
prerank,DNA modification (GO:0006304),0.7325327225717188,1.5737170939624736,0.05974025974025974,0.5114210604805353,1.0,2/22,1.68%,NEIL3;TERF1
prerank,histone monoubiquitination (GO:0010390),0.7313353991171273,1.5731860056455484,0.05791505791505792,0.5111666263840832,1.0,8/24,9.31%,UHRF1;RNF168;TRIM37;BCOR;RNF40;KDM2B;LEO1;CUL4B
prerank,dendritic spine organization (GO:0097061),-0.4776720603460084,-1.570835216110897,0.0223463687150838,0.4517480234904809,1.0,11/26,13.64%,CTNND2;DOCK10;SHANK3;PAK3;INSR;DIP2A;EPHB2;LGMN;CHRNA7;SHANK1;DLG4
prerank,regulation of multicellular organismal development (GO:2000026),0.7304594055987003,1.5699526621063433,0.06288532675709001,0.5215512222446925,1.0,5/25,8.96%,CDK1;RACGAP1;HPSE;NIPBL;CCSAP
prerank,neuron remodeling (GO:0016322),-0.6323336952820486,-1.569523192336682,0.03821656050955414,0.4507648746292493,1.0,8/10,26.80%,APP;SCARF1;CX3CL1;FARP2;ADGRB3;EPHA8;ANKS1A;C1QA
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.53111801047538,-1.568478577678589,0.023255813953488372,0.4489013024493756,1.0,7/17,16.70%,PCSK5;PCSK6;FURIN;LMF1;NR1H3;HDAC9;NR1H2
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.5943152935094861,-1.5683785543797133,0.04216867469879518,0.44401363804182037,1.0,6/12,21.65%,PODXL;JAG1;PROM1;PTPRO;KLF15;BASP1
prerank,regulation of spindle assembly (GO:0090169),0.7200500747261603,1.566575129629203,0.059850374064837904,0.5322702597982208,1.0,9/25,10.91%,PLK1;SPAG5;GPSM2;CEP97;NUMA1;TPR;CCSAP;HNRNPU;DRG1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.7478977624679136,1.5651695297747172,0.07235142118863049,0.5354314420664443,1.0,8/19,9.15%,TYMS;ADK;ADA;POLD3;DCK;HPRT1;POLD1;CDA
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.5073490469880734,-1.5631825702639561,0.03153153153153153,0.45451090616361983,1.0,4/21,6.12%,PLA2G4A;PLAAT3;PLA1A;OSBPL10
prerank,positive regulation of chromosome organization (GO:2001252),0.7794190056026229,1.5630647855877158,0.05758426966292135,0.5412693238508818,1.0,6/15,6.70%,ATRX;DDX11;RTEL1;RAD21;MRE11;PML
prerank,glucose import (GO:0046323),-0.5702357038673864,-1.5606294469301278,0.03908794788273615,0.4579053722467596,1.0,6/13,21.40%,SLC2A1;SLC27A1;SLC2A3;ZDHHC7;SLC2A10;SLC27A4
prerank,synaptonemal complex assembly (GO:0007130),0.7743420177422302,1.5603588433264826,0.06779661016949153,0.5472206509315161,1.0,2/15,3.40%,TRIP13;RAD21
prerank,synaptonemal complex organization (GO:0070193),0.7743420177422302,1.5603588433264826,0.06779661016949153,0.5472206509315161,1.0,2/15,3.40%,TRIP13;RAD21
prerank,lymphocyte mediated immunity (GO:0002449),-0.6059123362912469,-1.5596144994645595,0.05573770491803279,0.4564393777176319,1.0,3/12,12.98%,JAG1;MSH2;GNL1
prerank,response to steroid hormone (GO:0048545),-0.4485770318922093,-1.5582660694674146,0.006578947368421052,0.45556217460863857,1.0,18/31,25.79%,CAV1;PAQR8;TGFB2;AR;ATP1A1;ABHD2;NR1H3;ATP1A3;CATSPER2;THBS1;ATP1A2;TGFB3;WBP2;ABCA2;PAQR7;URI1;UBE3A;CATSPER3
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.596120851814717,-1.5571168415024546,0.02976190476190476,0.4541529025171062,1.0,5/12,17.57%,APOD;IFT20;CBLB;NDRG4;CBL
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.7406430336955008,1.5568862621363826,0.07392996108949416,0.5590211910395789,1.0,4/22,8.58%,FANCA;CBFB;LAG3;IRF1
prerank,regulation of chromatin organization (GO:1902275),0.7743260899611153,1.5556463138611465,0.07313642756680731,0.5616670568613236,1.0,1/14,0.23%,MKI67
prerank,cell proliferation in forebrain (GO:0021846),0.8054644660986416,1.554454444272494,0.06973058637083994,0.5640916454790109,1.0,3/10,6.67%,KIF14;PCM1;AKNA
prerank,microtubule bundle formation (GO:0001578),0.6779119279766057,1.5536135720972315,0.04377880184331797,0.5650918266479594,1.0,7/42,4.92%,PLK1;KIF20A;CDK5RAP2;PSRC1;SPAG16;SPEF1;NUMA1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.7782410910530045,1.5532265938779293,0.07366984993178717,0.5640820427627682,1.0,3/14,4.14%,BRCA1;PAXIP1;AUTS2
prerank,positive regulation of protein binding (GO:0032092),-0.3867333906870602,-1.552829914920096,0.013157894736842105,0.46314816285668653,1.0,20/56,11.05%,PRKN;MARK3;PSEN1;EPB41;TIAM1;CAV1;APOE;CLDN5;VTN;HIPK2;FKBP1A;RALB;LRP1;NVL;PPP2CB;DACT1;B2M;DERL1;ABL1;APP
prerank,positive regulation of cellular protein localization (GO:1903829),0.661887359985145,1.551354154207997,0.023206751054852322,0.5692335525141973,1.0,16/69,11.15%,NDC80;CDK1;PLK1;GTSE1;CENPQ;RANGRF;GSK3B;DDRGK1;NUMA1;PDZK1;MAPT;WWTR1;YAP1;SNX33;PARP9;EIF2AK3
prerank,protein oxidation (GO:0018158),0.8010664056022258,1.5509117575536215,0.06550218340611354,0.5685725709490518,1.0,3/11,2.55%,LOXL3;LOXL2;LOX
prerank,protein autoubiquitination (GO:0051865),0.6672229744099067,1.550560968899531,0.0183585313174946,0.5674479637443421,1.0,7/61,4.25%,BRCA1;UHRF1;UBE2T;RAD18;TRIM37;RNF220;UHRF2
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.7429015639299159,1.550358095067292,0.06030150753768844,0.5658375184215021,1.0,2/21,4.77%,TPX2;SPEF1
prerank,telomere maintenance (GO:0000723),0.6688587599192294,1.5500953361544727,0.04524886877828054,0.5645415282701564,1.0,27/50,19.63%,RAD51;TERF1;SMC6;RTEL1;RPA1;SMC5;STN1;ERCC4;POLD3;DNA2;PRKDC;BLM;MRE11;POLD1;RPA2;RIF1;PCNA;NSMCE2;TERF2;TEP1;TINF2;ATR;ACD;TERF2IP;RAD50;SP100;TERT
prerank,neuromuscular process controlling balance (GO:0050885),-0.5800583287986689,-1.5499989452644465,0.03773584905660377,0.4677112809097445,1.0,4/12,12.24%,PCDH15;NRXN1;TPP1;SHANK1
prerank,regulation of protein export from nucleus (GO:0046825),0.7264265197946335,1.549984206386176,0.06875,0.5626398085878992,1.0,9/23,9.94%,BARD1;GTSE1;GSK3B;XPO4;ANP32B;TCF7L2;TPR;EMD;RANGAP1
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.7284315111322703,1.549746921935087,0.07417218543046358,0.5612119311653065,1.0,5/22,8.30%,SHCBP1;NAP1L1;SLC16A2;KDM2B;LRRK2
prerank,response to light stimulus (GO:0009416),0.6766297796746511,1.5497221359534128,0.02717391304347826,0.5589840984831231,1.0,9/55,6.10%,DTL;PCLAF;ZRANB3;CDKN2D;USP1;PRIMPOL;ERCC4;POLD1;ERCC3
prerank,positive regulation of endocytosis (GO:0045807),-0.40772565969894053,-1.5496646176304534,0.008928571428571428,0.46378218824210443,1.0,18/45,19.71%,SGIP1;APOE;VTN;ANO6;LRP1;BICD1;CLIP3;DAB2;B2M;HNRNPK;LDLRAP1;HIP1;CBLL1;CBL;PPT1;NLGN1;NCKAP1L;CD151
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5288215261186334,-1.549444238064545,0.030534351145038167,0.4597404290873586,1.0,9/18,21.39%,CDH8;UNC13B;GRIK1;GRID2;GRIK4;SLC17A6;GRIA2;GRIK2;GRID1
prerank,cellular response to inorganic substance (GO:0071241),0.7307530875776295,1.5492494707807063,0.07227332457293036,0.5584674131444011,1.0,8/21,7.96%,ATRX;DDX11;AQP1;TIMELESS;BLM;SPIDR;FMR1;CDK2
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.7247636373237106,1.5487515812716641,0.06382978723404255,0.5579858332613414,1.0,7/24,14.44%,BRCA1;HPSE;SULF2;SULF1;EIF2AK3;RORA;ARNT
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.7402952688983675,1.5486741469825431,0.06675224646983312,0.5560000916580485,1.0,2/21,1.19%,BRCA1;SLC18A2
prerank,regulation of protein localization to nucleus (GO:1900180),0.6858775092742352,1.5479955854417673,0.039125431530494824,0.5561748053106553,1.0,11/43,11.70%,CDK1;PLK1;GTSE1;GSK3B;CTNNA1;TPR;WWTR1;YAP1;PARP9;EIF2AK3;ILRUN
prerank,positive regulation of protein kinase activity (GO:0045860),0.6463605446349541,1.5474208891618,0.0020161290322580645,0.5561551936242416,1.0,23/148,9.99%,TPX2;CENPE;KIF14;ECT2;EZH2;INCENP;CLSPN;BORA;SPDYA;MAP4K4;RHOA;PRNP;STK3;NRK;EFNA1;ETAA1;CCN1;EPHA4;MRNIP;NOX4;AGT;MARK2;DDR2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.661926571275507,1.5472980072001232,0.03571428571428571,0.5543595205895518,1.0,24/60,16.15%,CCNB1;CDK1;MED26;PPM1D;CBFB;PAXIP1;MOV10;MED14;SRF;TCF7L2;MED30;ATF7IP;TRIM28;MED24;MED15;SOX9;HEY2;MED1;CDK8;MED27;TNRC6C;NFKB1;TP53;PTEN
prerank,response to muramyl dipeptide (GO:0032495),-0.602756242464598,-1.546294511710247,0.06153846153846154,0.4646691748857725,1.0,6/12,16.26%,TRIM41;NOD1;PTPN22;ARHGEF2;CHMP5;ERBIN
prerank,peroxisomal membrane transport (GO:0015919),-0.4534707559437403,-1.5461502275912027,0.03048780487804878,0.4603723303235138,1.0,12/27,22.31%,PEX1;FIS1;ABCD4;ALDH3A2;PEX3;PEX5;PEX6;ABCD2;GDAP1;PXMP4;PEX26;PXMP2
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.5272320376549312,-1.5461313128696013,0.03731343283582089,0.45583692278240423,1.0,7/17,16.43%,PRKG1;MEF2C;PDCD4;SOD2;TPM1;TAFA5;TGFB3
prerank,zinc ion homeostasis (GO:0055069),-0.45177443077526186,-1.545715559023595,0.014018691588785047,0.45269338313410457,1.0,14/28,20.87%,PRKN;SLC39A10;SLC39A13;SLC39A7;SLC30A1;MT2A;MT1X;MT1E;MT1M;MT1H;MT1F;MT1B;MT1A;MT1G
prerank,peptidyl-arginine modification (GO:0018195),-0.5607179001909396,-1.544512272462405,0.02040816326530612,0.45237425130996456,1.0,6/15,20.20%,ART3;KRTCAP2;PRMT8;PRMT1;PARK7;PADI2
prerank,regulation of platelet activation (GO:0010543),-0.5079955909962889,-1.544091168043859,0.023255813953488372,0.44907664700119865,1.0,8/21,8.02%,PLA2G4A;APOE;NOS3;TLR4;PLEK;THBD;LYN;PRKCQ
prerank,positive regulation of DNA recombination (GO:0045911),0.714022939571162,1.5427358714916386,0.06854345165238677,0.569849084518381,1.0,9/27,12.73%,RAD51AP1;TIMELESS;PAXIP1;ARID2;RIF1;FUS;MRNIP;MMS19;KMT5C
prerank,DNA duplex unwinding (GO:0032508),0.6791810761062007,1.5420528327982486,0.03888888888888889,0.5703863878759448,1.0,15/50,6.10%,PIF1;RAD51;DDX11;MCM6;MCM7;MCM2;RTEL1;RPA1;CHD1L;DHX9;BLM;MRE11;RECQL;MCM4;ERCC3
prerank,regulation of telomere maintenance (GO:0032204),0.7131373709781434,1.5418961749569546,0.07568238213399504,0.5686883892756083,1.0,15/26,18.77%,PIF1;ATRX;RTEL1;HNRNPD;ERCC4;MRE11;YLPM1;PML;HDAC8;TERF2;SMG6;GNL3;TINF2;TERF2IP;RAD50
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.44590386065751075,-1.5412779107820644,0.024844720496894408,0.4532652284677759,1.0,23/31,38.86%,PEX1;DNAJC19;HSPD1;AIFM1;PEX5;TIMM44;PEX6;TOMM70;DNAJC15;PAM16;TIMM17A;PEX26;TIMM17B;CHCHD4;PEX10;ROMO1;GRPEL1;PEX16;DNLZ;TOMM40L;PEX2;PEX14;TIMM50
prerank,potassium ion homeostasis (GO:0055075),-0.49209463240518936,-1.538812042858811,0.0297029702970297,0.4568535263854622,1.0,7/23,16.25%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;SLC12A9;ATP1A2;SLC12A2
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.6191751788470867,-1.5383750480712926,0.03170028818443804,0.4537520030609325,1.0,8/10,33.47%,MAP2K5;KLF4;TLE5;MAPK7;IRAK3;PTPRC;SH2B3;SIGIRR
prerank,regulation of secretion (GO:0051046),-0.5832542584498364,-1.5376934303516396,0.05090909090909091,0.4519215357615198,1.0,9/13,30.37%,MYO6;SGK1;GPLD1;KCNQ1;FGF10;POFUT2;EGF;ERBB3;OPRK1
prerank,nuclear migration (GO:0007097),0.7512690454597737,1.537651265974622,0.08124076809453472,0.5831819149814007,1.0,8/13,15.63%,SYNE3;SYNE2;PCM1;CLMN;CEP120;FBXW11;DOCK7;SUN2
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.6715697301242662,1.5372891997142566,0.042483660130718956,0.5823218419556395,1.0,19/53,16.10%,BRCA1;ANKLE1;RNF168;EYA4;DHX9;NSMCE4A;UBE2N;FMR1;UIMC1;TRIM28;SMCHD1;BCLAF1;EYA2;PCNA;SPRED1;BRCC3;NSMCE1;FXR1;SPRED2
prerank,regulation of dopamine secretion (GO:0014059),-0.46885962675196646,-1.536113092464528,0.026881720430107527,0.4521491367343331,1.0,11/25,22.19%,PRKN;SYT1;SYT7;DTNBP1;KCNA2;SYT11;SYT12;SYT10;SYT6;SYT2;DRD2
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.6723655561612945,1.5358411344935023,0.05116796440489433,0.5857030686831756,1.0,14/46,9.69%,ECT2;GTSE1;GSK3B;XPO4;ANP32B;NEDD4;KHDRBS1;DHX9;NRDE2;TCF7L2;TPR;UBR5;TRIM28;EMD
prerank,protein heterotetramerization (GO:0051290),-0.5784443094177683,-1.5350367815395178,0.04180064308681672,0.4512600800950512,1.0,7/13,20.26%,FARSB;CPSF6;GRIN2B;FARSA;CPSF7;GRIN1;CBR4
prerank,nucleosome organization (GO:0034728),0.6605778880124604,1.5326117879571528,0.04694323144104803,0.5958544474416739,1.0,20/55,13.56%,CHAF1B;ATRX;HMGB2;NAP1L1;SMARCC1;CTCF;LIN54;NFE2;ARID2;ANP32B;ARID1A;SETD2;SRCAP;SMARCA4;ANP32E;NASP;SPTY2D1;SOX9;MCM3AP;CHAF1A
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.7770544409972096,1.5322323849695003,0.08849557522123894,0.5926540002571932,1.0,5/12,12.27%,ATP2B4;GSK3B;FHL2;PRNP;HOMER2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.7770544409972096,1.5322323849695003,0.08849557522123894,0.5926540002571932,1.0,5/12,12.27%,ATP2B4;GSK3B;FHL2;PRNP;HOMER2
prerank,mismatch repair (GO:0006298),0.7067410178506464,1.531951274135178,0.06985294117647059,0.5913980266958005,1.0,14/27,17.30%,EXO1;RPA1;MSH3;POLD3;POLD1;RPA2;MLH1;SETD2;RNASEH2A;PCNA;MSH6;PMS1;MSH5;MCM9
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.41661961792316227,-1.5309398153435383,0.009174311926605505,0.45920613195995724,1.0,22/43,34.34%,IGF1;GAS6;TLR4;CD34;LBP;PTPN22;SELENOS;CHRNA7;CX3CL1;SYT11;TRIM27;DICER1;LGALS9;ZC3H12A;CD274;NLRC3;IRAK3;CACTIN;TNFAIP3;NR1H4;RARA;PTPN6
prerank,protein heterooligomerization (GO:0051291),-0.5434776868165129,-1.5298471089193917,0.054474708171206226,0.45843876858767946,1.0,7/17,14.10%,FARSB;KCNC2;CPSF6;GRIN2B;FARSA;CPSF7;GRIN1
prerank,acylglycerol metabolic process (GO:0006639),-0.4258745073622824,-1.529478746129799,0.0,0.45555024056634186,1.0,10/37,9.48%,CAV1;APOE;PLAAT3;DGKB;ABHD6;ABHD12;DGKG;LMF1;DGKI;ABHD2
prerank,Golgi inheritance (GO:0048313),0.7888650978770521,1.5286049844901952,0.08238636363636363,0.6018725317314572,1.0,2/11,3.74%,CDK1;GBF1
prerank,positive regulation of chromatin organization (GO:1905269),0.7749755848889959,1.5284764045892156,0.08504398826979472,0.6000121024483253,1.0,9/12,18.31%,ATRX;TERF1;MIER1;UBE2N;TAL1;TERF2;TINF2;ACD;TERF2IP
prerank,retinoic acid metabolic process (GO:0042573),0.7615493585715571,1.5273555329493718,0.08177905308464849,0.6021324072160956,1.0,4/14,9.16%,ALDH8A1;CYP26B1;ALDH1A2;SCPEP1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.6957668880689565,1.526861592898425,0.048894062863795114,0.6017458297967525,1.0,10/37,9.82%,SKA3;SKA1;SKA2;STMN1;GSK3B;MAPT;BICD2;TPPP;ROCK1;MARK2
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.6097741822183386,-1.525921376648463,0.03651685393258427,0.4625370062669693,1.0,9/11,33.90%,UQCRC2;UQCRB;UQCR10;UQCRQ;UQCRC1;CYC1;UQCRFS1;CYCS;UQCC3
prerank,negative regulation of viral life cycle (GO:1903901),-0.5594447959920803,-1.5253826236418475,0.04844290657439446,0.4602025396866522,1.0,7/15,16.82%,MID2;LY6E;SNX3;IFITM3;GSN;BST2;IFITM2
prerank,ceramide catabolic process (GO:0046514),-0.5686901449181821,-1.5247532328853761,0.046511627906976744,0.4580868875567549,1.0,6/14,13.79%,HEXB;ACER2;ASAH1;ACER3;HEXA;ASAH2
prerank,epithelial cell-cell adhesion (GO:0090136),0.7855698037710418,1.5240625889359936,0.06956521739130435,0.6100759976846764,1.0,3/11,4.54%,SERPINB8;PLEKHA7;KIT
prerank,long-term synaptic potentiation (GO:0060291),-0.48403780455163126,-1.5236417625113625,0.048458149779735685,0.45714140048161095,1.0,7/21,11.23%,SLC8A3;GRIN2A;GRIN2B;STX4;SLC24A2;TSHZ3;NFATC4
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.6961439376291008,1.5219449043335143,0.05985915492957746,0.6162665925637367,1.0,4/32,4.77%,TPX2;STMN1;DYRK1A;SPEF1
prerank,error-free translesion synthesis (GO:0070987),0.708175210423522,1.5213142029593671,0.09021601016518424,0.6164139093551554,1.0,8/22,6.49%,RFC4;POLH;RPA1;RFC2;POLD1;RPA2;RFC1;RFC3
prerank,positive regulation of protein export from nucleus (GO:0046827),0.7490418872154201,1.5193984908992715,0.0958904109589041,0.6214406574450011,1.0,7/15,9.69%,GTSE1;GSK3B;XPO4;ANP32B;TCF7L2;TPR;EMD
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.5374445991048316,-1.5182515488351866,0.05970149253731343,0.469057774439897,1.0,4/15,9.46%,ATP1B1;KCNJ3;ATP1A1;KCNN2
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.41617713532394635,-1.5178875950973214,0.008849557522123894,0.4661537607576281,1.0,14/41,19.48%,IGF1;GAS6;TLR4;CD34;LBP;PTPN22;SELENOS;CHRNA7;CX3CL1;SYT11;TRIM27;DICER1;LGALS9;ZC3H12A
prerank,response to UV (GO:0009411),0.6378813749475417,1.5165137275476293,0.022587268993839837,0.6306689699930069,1.0,26/95,14.31%,DTL;POLK;AURKB;PCLAF;ZRANB3;AQP1;CDKN2D;USP1;POLH;BMF;PRIMPOL;NEDD4;ERCC4;POLD1;ERCC3;FMR1;MAP3K4;CDC25A;USP28;XPA;PCNA;MSH6;USP47;YY1;SMPD1;RUVBL2
prerank,mRNA stabilization (GO:0048255),0.6715846832644878,1.5164807789094739,0.07542857142857143,0.6284382999853803,1.0,13/40,10.95%,MEIOC;E2F1;SYNCRIP;DHX9;THRAP3;EIF4ENIF1;YBX3;FUS;LARP1;AXIN2;HNRNPU;TENT5D;TAF15
prerank,smoothened signaling pathway (GO:0007224),0.6882873382445103,1.5161983058327633,0.0729665071770335,0.6271714700468175,1.0,3/32,1.27%,STIL;GLI2;GLI3
prerank,negative regulation of protein depolymerization (GO:1901880),0.7195690942483375,1.5157946651312515,0.06956521739130435,0.6264678771381123,1.0,2/24,4.77%,TPX2;SPEF1
prerank,vacuolar acidification (GO:0007035),-0.4897113623986436,-1.5138190639833058,0.04608294930875576,0.4732158211768934,1.0,15/21,33.43%,ATP6V0A1;DMXL2;ATP6V0D1;ATP6V0A4;GRN;ATP6V1H;PPT1;ATP6AP2;TMEM9;CLN5;TMEM199;CLN3;ATP6V0D2;ATP6V0E1;CLN6
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.42769021185526795,-1.5137208066188919,0.023076923076923078,0.46954277255883275,1.0,6/38,4.31%,CAMK2D;CTNNA3;CACNA2D1;CAV1;KCNJ3;BIN1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.7586489769204281,1.512598063734756,0.10212765957446808,0.6362276209666807,1.0,1/15,0.19%,BRCA1
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.685622026579622,1.511997126740753,0.08492822966507177,0.6361927800216206,1.0,9/33,7.96%,PIF1;RAD51;TERF1;RTEL1;RPA1;STN1;MRE11;RFC1;CDK2
prerank,negative regulation of T cell differentiation (GO:0045581),0.7729362424748667,1.5118116358927636,0.0867579908675799,0.6345733690265024,1.0,3/10,8.58%,GLI3;LAG3;IRF1
prerank,histone H4-K5 acetylation (GO:0043981),0.7579270866434082,1.5103135824451146,0.08539944903581267,0.6357557078851996,1.0,2/15,2.62%,KANSL1;KANSL2
prerank,histone H4-K8 acetylation (GO:0043982),0.7579270866434082,1.5103135824451146,0.08539944903581267,0.6357557078851996,1.0,2/15,2.62%,KANSL1;KANSL2
prerank,cellular response to fluid shear stress (GO:0071498),-0.5864057293138872,-1.5085629726825938,0.046052631578947366,0.4812591374857595,1.0,9/12,25.43%,MEF2C;MAP2K5;KLF4;HDAC3;SREBF2;KLF2;MTSS1;ASS1;MAPK7
prerank,positive regulation of telomere maintenance (GO:0032206),0.701268001433128,1.5083485352074841,0.07710843373493977,0.6410488818530324,1.0,7/31,6.70%,NEK2;ATRX;AURKB;RTEL1;HNRNPD;MRE11;PML
prerank,pore complex assembly (GO:0046931),0.7203000214507412,1.508022453505628,0.08781127129750983,0.6399810841733282,1.0,7/19,6.59%,PLEKHA7;NDC1;NUP205;TSPAN33;AFDN;AHCTF1;TPR
prerank,negative regulation of DNA replication (GO:0008156),0.7620493093067489,1.507668888159272,0.08263305322128851,0.6390832448012927,1.0,4/13,4.40%,TERF1;PDS5A;CDC6;WAPL
prerank,piRNA metabolic process (GO:0034587),0.7346779516049674,1.5074824947972325,0.06640625,0.6375603141916332,1.0,3/19,6.25%,MYBL1;MAEL;EXD1
prerank,embryonic organ development (GO:0048568),0.629843703450775,1.506507011288632,0.05150214592274678,0.6388966024517407,1.0,22/61,16.87%,STIL;PBX4;GLI2;GLI3;FOXE1;PBX3;BMPR1A;TEAD1;FGFR2;KIT;ERCC3;KMT2A;TAL1;TEAD3;RBPJ;NES;HEY2;RARB;GDNF;SALL1;COBL;TEAD4
prerank,negative regulation of mRNA processing (GO:0050686),0.745876620303283,1.505879719236967,0.08516483516483517,0.639085118317285,1.0,5/15,8.16%,BARD1;SRSF4;SRSF10;SRSF7;SAP18
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.7035825709170619,1.5054034056737973,0.0865265760197775,0.638730393444308,1.0,7/26,14.44%,BRCA1;HPSE;SULF2;SULF1;EIF2AK3;RORA;ARNT
prerank,protein polymerization (GO:0051258),0.6517487050879861,1.5048057903629304,0.05125408942202835,0.6388325907085451,1.0,7/55,5.54%,DIAPH3;UBE2C;CKAP5;UBE2S;UBE2K;DIAPH1;MAPT
prerank,regulation of interleukin-4 production (GO:0032673),-0.48810210374439483,-1.504427393310593,0.05627705627705628,0.49013759498730214,1.0,10/21,28.18%,LEF1;SLC7A5;PRKCQ;CEBPB;DDIT3;LGALS9;PRKCZ;CD86;SYK;FCER1G
prerank,chromatin assembly (GO:0031497),0.67936238583337,1.504401369105546,0.06036446469248292,0.638154918314443,1.0,8/38,6.49%,CHAF1B;ATRX;HMGB2;NAP1L1;CTCF;LIN54;ANP32B;RBBP4
prerank,hemidesmosome assembly (GO:0031581),-0.5932703575643429,-1.5015989526128084,0.05750798722044728,0.49458112421711653,1.0,6/11,27.04%,ITGA6;LAMA3;ITGB4;CD151;PLEC;LAMC2
prerank,protein acetylation (GO:0006473),0.6813672334088192,1.5013554536350981,0.0773955773955774,0.6475985653735207,1.0,4/30,5.54%,ESCO2;DSCC1;HAT1;MAPT
prerank,liver development (GO:0001889),0.6791040833831217,1.5008732120649049,0.06602641056422569,0.6472480543377306,1.0,11/32,16.77%,E2F7;E2F8;AURKA;TGFBR3;PHF2;NPHP3;ANXA1;GFER;PKD2;PCK2;COBL
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.6441869932503329,1.499100330784175,0.028291621327529923,0.6517176715375836,1.0,10/66,3.72%,KIF14;E2F7;RBL1;WEE1;E2F1;CDKN2D;CDKN2C;RB1;HYAL1;TFDP1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.6632891926016535,1.4986900743327496,0.07540603248259861,0.6508884624282569,1.0,11/35,11.30%,POLE;RFC4;RPA1;POLD3;RFC2;POLD1;RPA2;RFC1;RFC3;MBD4;PCNA
prerank,positive regulation of nuclear division (GO:0051785),0.705670360660059,1.4977631808961474,0.09405940594059406,0.6519890703506044,1.0,3/25,2.78%,NUSAP1;AURKA;PHIP
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.38353177387225423,-1.4975688643177574,0.02912621359223301,0.502658011848821,1.0,26/46,31.27%,FIS1;DNAJC19;HSPD1;AIFM1;TIMM44;PINK1;TOMM70;HK1;BCAP31;GDAP1;AIP;FBXO7;TOMM34;DNAJC15;PAM16;TIMM17A;TOMM7;TIMM17B;CHCHD4;TIMM9;TIMM13;TOMM22;TIMM8B;ROMO1;GRPEL1;TOMM5
prerank,positive regulation of histone modification (GO:0031058),0.6735838588151757,1.4975214423138685,0.07904191616766468,0.6506896561841127,1.0,8/33,7.81%,BRCA1;PAXIP1;CTBP1;ARRB1;UBE2N;FMR1;NIPBL;ZBTB7B
prerank,protein neddylation (GO:0045116),-0.5495888610690776,-1.4952183642406667,0.07773851590106007,0.5062334605023862,1.0,5/13,15.14%,DCUN1D3;RBX1;DCUN1D5;DCUN1D4;DCUN1D2
prerank,histone H4-K16 acetylation (GO:0043984),0.7244917387940801,1.4938092393905786,0.08985879332477535,0.6626968367188572,1.0,5/19,9.85%,KANSL1;KANSL2;ING4;MSL3;KMT2A
prerank,indolalkylamine catabolic process (GO:0046218),0.7646440721714507,1.4937126141303703,0.11044776119402985,0.6607862122231466,1.0,3/10,13.22%,ACMSD;KMO;IL4I1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.6888870606446893,1.493701074040662,0.09570552147239264,0.6585553585325363,1.0,9/27,14.74%,RRM2;TYMS;RRM1;AK1;CTPS1;GUK1;DTYMK;DUT;AK7
prerank,axonogenesis (GO:0007409),-0.2727180354392723,-1.493544347684245,0.0,0.5071903149230138,1.0,90/237,19.34%,PTK2;ENAH;SH3KBP1;EPHA5;TNR;UNC5D;NRP2;NRXN3;RPS6KA5;HSP90AB1;SHANK3;SPG11;OPHN1;DCC;SEMA6A;PAK3;BSG;GRB10;ACTB;B4GALT5;CNTN6;FEZ1;S100A6;KLF7;NRCAM;LGI1;SEMA6D;MAP1B;TAOK2;SEMA7A;BRSK1;EPHB2;PIK3R1;IRS2;PLCG1;ULK1;B4GALT6;SEMA4D;NRXN1;MAP1A;PRKCQ;KIF5B;SEMA3A;PTPRO;SPTBN1;DAB1;LAMA3;RELN;KIF5C;MAPK3;CTNNA2;SIAH1;NOTCH3;GFRA1;FEZ2;GFRA2;VLDLR;APP;MAPK1;PDLIM7;SLIT2;GRB2;UNC5C;SLITRK1;PTPN11;CNTN2;EPHA8;NTNG1;SEMA3B;SHC1;DOK5;SCN1B;UNC5B;ROBO2;USP33;SEMA3C;SHTN1;APBB1;PIK3CD;PIK3CA;NEXN;TUBB3;BAIAP2;SLITRK4;SHC3;ROBO4;EFNB3;SEMA5B;NRP1;CYFIP1
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.4998284279036017,-1.4930569527600959,0.06870229007633588,0.5046894166944724,1.0,5/17,12.98%,STAT3;JAG1;TLR4;MSH2;GNL1
prerank,DNA methylation or demethylation (GO:0044728),0.6975515715632165,1.4926490420485403,0.09686221009549795,0.6580585898261007,1.0,5/19,8.12%,ATRX;HELLS;PPM1D;GATAD2A;ATF7IP
prerank,DNA alkylation (GO:0006305),0.6975515715632165,1.4926490420485403,0.09686221009549795,0.6580585898261007,1.0,5/19,8.12%,ATRX;HELLS;PPM1D;GATAD2A;ATF7IP
prerank,regulation of neuron migration (GO:2001222),0.6765008250559419,1.4925826777665183,0.08404384896467722,0.6560741099148847,1.0,6/26,10.73%,KIF20B;ULK4;PHACTR1;NIPBL;SRGAP2;PLXNB2
prerank,nuclear pore complex assembly (GO:0051292),0.7721096857382292,1.4925314680612467,0.10869565217391304,0.654105894707245,1.0,4/10,6.59%,NDC1;NUP205;AHCTF1;TPR
prerank,regulation of telomere capping (GO:1904353),0.7123729403162937,1.4922844124735757,0.09743589743589744,0.6528400506233222,1.0,4/23,3.73%,NEK2;AURKB;RTEL1;HNRNPD
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.43814418536427324,-1.4911666656401659,0.03550295857988166,0.5068309031908493,1.0,12/29,15.20%,CYRIB;PRKN;SHANK3;KANK3;KANK4;PFN1;SSH1;TJP1;SLIT2;SHANK1;ARFGEF1;FKBP4
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.7079942511052552,1.4910927810429015,0.1117092866756393,0.655264951210741,1.0,10/19,18.37%,PIF1;TERF1;STN1;HNRNPA1;HNRNPU;TERF2;SRC;TINF2;ACD;EXOSC10
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.4955031410114692,-1.4909045926671436,0.05859375,0.5036963507877283,1.0,9/18,18.34%,EPHA5;RPS6KA5;CRTC1;RELN;CRTC3;ADCY8;LRP8;VEGFA;CRTC2
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.6317840643239855,1.4901638853013854,0.04940923737916219,0.6564910964709637,1.0,12/66,11.15%,ECT2;CDK1;PLK1;GTSE1;TPR;NMD3;WWTR1;UBR5;TRIM28;YAP1;PARP9;EIF2AK3
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.6361218640380617,1.4895455728823679,0.06545064377682404,0.6567329432282613,1.0,23/59,16.15%,CCNB1;CDK1;MED26;PPM1D;CBFB;SETX;MOV10;MED14;TCF7L2;MED30;TRIM28;BCLAF1;MED24;MED15;SOX9;TWIST1;MED1;CDK8;MED27;TNRC6C;NFKB1;TP53;PTEN
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.6766853940481515,1.4887772308246703,0.09857482185273159,0.6574015603356559,1.0,6/31,2.56%,E2F7;RBL1;WEE1;CDKN2D;CDKN2C;RB1
prerank,chordate embryonic development (GO:0043009),0.6441338848279545,1.4868598670362938,0.07362637362637363,0.6624758128768785,1.0,9/55,8.22%,BRCA1;STIL;FGFR2;ALDH1A2;SULF2;ZNF568;GRHL2;SULF1;LMX1B
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.6405140964687343,1.4868482750970502,0.04113924050632911,0.6603206207423709,1.0,21/72,11.80%,POLK;ANKLE1;RFC4;RPA1;CHD1L;ERCC4;RNASE6;POLD3;DNA2;RFC2;MRE11;POLD1;RPA2;ERCC3;RFC1;RFC3;CUL4B;XPA;PCNA;RNASE1;ENPP1
prerank,acidic amino acid transport (GO:0015800),-0.5034067806828482,-1.4862877646041208,0.06299212598425197,0.5140235594081433,1.0,8/17,15.85%,SLC6A6;SLC1A2;SLC6A1;SLC25A13;SLC25A12;GIPC1;LRRC8D;SLC1A1
prerank,protein targeting to peroxisome (GO:0006625),-0.4288606844049068,-1.4857698218993292,0.05128205128205128,0.5118467215738859,1.0,17/29,34.35%,PEX1;FIS1;ALDH3A2;PEX3;LONP2;PEX5;PEX6;ABCD2;GDAP1;PXMP4;PEX26;PXMP2;HACL1;PEX11B;PEX10;ACBD5;PEX16
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.5513861155162014,-1.485623139021211,0.08064516129032258,0.5084219455912035,1.0,6/13,21.78%,TMSB4X;NOS3;PINK1;ENO1;PPARGC1A;NOS1
prerank,regulation of microtubule depolymerization (GO:0031114),0.7011811483539184,1.4836629725208228,0.0812807881773399,0.6699352078925567,1.0,1/25,0.06%,TPX2
prerank,glycerolipid metabolic process (GO:0046486),-0.5950154577094908,-1.4821897327943185,0.06769230769230769,0.515527177874127,1.0,8/11,30.25%,DGKB;DGKG;PIP5K1A;DGKQ;GAL3ST1;PLA2G15;PGP;PNPLA3
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.7071872133644226,1.480163644206129,0.11506849315068493,0.6811475240388499,1.0,5/17,6.81%,DHDDS;ALG14;ALG13;SRD5A3;MPDU1
prerank,membrane repolarization (GO:0086009),-0.5248312665996215,-1.4800418975476375,0.07865168539325842,0.5181546629571101,1.0,8/15,31.94%,ATP1B1;ATP1A1;ATP1B3;ATP1A2;KCNQ1;ATP1B2;KCNIP2;KCNE4
prerank,determination of left/right symmetry (GO:0007368),0.658165841591123,1.4800235982361558,0.09122401847575058,0.6794389146235759,1.0,5/36,9.04%,STIL;DNAH11;CFAP53;MKKS;NPHP3
prerank,positive regulation of organelle assembly (GO:1902117),0.6512210039332406,1.4796915344706103,0.06070640176600441,0.6785272472385869,1.0,15/44,11.31%,SPAG5;PLK4;GPSM2;ASAP1;CNOT1;CNOT6L;NUMA1;G3BP1;SH3GLB1;CNOT6;TAPT1;SDC1;ARHGAP35;CEP120;STX18
prerank,telomere maintenance via recombination (GO:0000722),0.7470817322167634,1.4790780561138148,0.12518628912071536,0.6785775816519343,1.0,4/11,4.48%,RAD51;SMC6;SMC5;ERCC4
prerank,telomere capping (GO:0016233),0.7256660831257113,1.4789245837136182,0.10437235543018336,0.67693703007547,1.0,11/16,18.77%,TERF1;STN1;PRKDC;MRE11;TERF2;TINF2;ACD;DCLRE1A;TERF2IP;DCLRE1C;RAD50
prerank,protein localization to chromatin (GO:0071168),0.7172618597545258,1.4787883463563496,0.09152086137281291,0.6752131828113487,1.0,7/18,8.19%,PLK1;MCM8;SGF29;RAD21;WAPL;NIPBL;MRNIP
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.4147249280135646,-1.478370472079325,0.041379310344827586,0.519642579500916,1.0,13/36,14.73%,MECOM;PRKN;FOXO1;ZMYND11;IGBP1;DUSP3;CYLD;DACT1;PTPN22;HDAC3;PINK1;SH3RF2;DUSP1
prerank,negative regulation of organelle assembly (GO:1902116),0.6652017751313885,1.4781722859033182,0.06697459584295612,0.6751453395796163,1.0,11/35,12.61%,BRCA1;CDK5RAP2;TRIM37;CEP97;EVI5L;LRRK2;YAP1;TBC1D7;TMEM39A;SCFD1;SMAD4
prerank,dopaminergic neuron differentiation (GO:0071542),0.7095455463848469,1.4773770523435903,0.10846560846560846,0.6759843745328588,1.0,3/19,10.20%,EN1;LMX1B;NR4A2
prerank,regulation of multicellular organism growth (GO:0040014),-0.521904194126202,-1.476750419284526,0.07196969696969698,0.5207318735838266,1.0,5/15,16.36%,MBD5;IGF1;APP;PTCH1;PPIB
prerank,cilium assembly (GO:0060271),0.6182568552250498,1.47638760063043,0.0,0.6775461752835676,1.0,66/296,10.84%,NEK2;CDK1;KIF24;PLK1;CEP192;CEP152;CDK5RAP2;CKAP5;HAUS8;PLK4;IFT80;CEP57;HYLS1;CEP89;BBS9;HAUS4;HAUS6;DZIP1L;SCLT1;ACTR1A;DNAAF3;ACTR3;CEP43;WDR35;PARVA;ASAP1;GBF1;CEP97;SPAG16;WDR90;IFT140;POC1B;FAM161A;EXOC4;KIF27;PCM1;TNPO1;C2CD3;OCRL;HAUS7;TXNDC15;MKKS;WDR11;NDE1;CEP83;RILPL1;NUDCD3;RFX2;CNTRL;SSX2IP;HAUS1;CCDC57;CFAP52;SPATA6;CEP76;WDPCP;NPHP3;ALMS1;ODF2;SDCCAG8;RAB1A;NINL;RSPH9;NPHP1;TRAPPC14;TTC39C
prerank,regulation of myelination (GO:0031641),0.6735979203573773,1.4761281774827357,0.08856088560885608,0.6763907487366484,1.0,1/25,0.13%,KIF14
prerank,protein-DNA complex assembly (GO:0065004),0.6204880850028927,1.4738670675087058,0.025252525252525252,0.6824170129617222,1.0,36/116,13.56%,CHAF1B;RAD51;ATRX;MCM5;ORC1;HMGB2;MCM8;DMC1;NAP1L1;MCM6;MCM7;MCM2;CDC6;PSMC2;RPA1;PSMD5;CHD1L;ANP32B;MCM3;RPA2;MCM4;ERCC3;ORC2;TCF4;ORC3;PSMB1;PSMD14;CUL4B;PSMD1;PSMB9;XPA;CENPV;SPTY2D1;SOX9;ORC6;CHAF1A
prerank,regulation of osteoblast proliferation (GO:0033688),0.7202993119084145,1.4728686895816452,0.11378848728246319,0.6840777580733153,1.0,7/17,11.42%,HPSE;RHOA;FGFR2;CCN1;NPR3;PLXNB1;BMP2
prerank,telomere organization (GO:0032200),0.6415421112200371,1.471073525607887,0.08466819221967964,0.6887191491496958,1.0,22/43,19.63%,TERF1;RTEL1;RPA1;STN1;ERCC4;POLD3;DNA2;PRKDC;BLM;MRE11;POLD1;RPA2;RIF1;PCNA;TERF2;TINF2;ATR;ACD;TERF2IP;RAD50;SP100;TERT
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.6793521870812795,1.4707147698796574,0.10411622276029056,0.6878281505370618,1.0,7/29,9.18%,BRCA1;CBFB;CNOT1;DDRGK1;VPS18;KANK2;YAP1
prerank,regulation of nervous system development (GO:0051960),0.6494374005696909,1.46938368936054,0.08064516129032258,0.6905304278904679,1.0,6/37,10.57%,KIF14;HMGB2;BHLHE41;NPHP3;YAP1;YTHDF2
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.7694263569410895,1.4692963378397883,0.11179173047473201,0.6886906490148473,1.0,4/10,12.61%,BRCA1;CHEK1;KMT2A;SMAD4
prerank,modulation by symbiont of host process (GO:0044003),-0.5994038224838032,-1.4672019711219637,0.06685236768802229,0.547835066898747,1.0,8/10,32.33%,B2M;PGK1;ENO1;UBB;UBC;RPS27A;MRC1;UBA52
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.6790570958307927,1.4668922990859086,0.11875,0.6953997933782003,1.0,11/24,18.37%,PIF1;TERF1;STN1;ERCC4;HNRNPA1;HNRNPU;TERF2;SRC;TINF2;ACD;EXOSC10
prerank,activation of protein kinase activity (GO:0032147),0.6189101078295237,1.4666980397737361,0.02968270214943705,0.6939618314691604,1.0,15/106,9.93%,TPX2;KIF14;ECT2;CLSPN;BORA;MAP4K4;STK3;NRK;IL18;TXN;TNFRSF10B;ANGPT1;OSBPL8;MARK2;MAPKAP1
prerank,tRNA methylation (GO:0030488),-0.4179474033397513,-1.4664255543634759,0.03870967741935484,0.5460558073372006,1.0,21/34,36.54%,MTO1;NSUN2;THUMPD3;TRMT61B;DALRD3;TRMT1;METTL1;TRMT10A;LCMT2;TRMO;WDR6;GTPBP3;TRMT44;TRMT1L;TRMT10C;METTL6;TYW3;TRMT12;BCDIN3D;TRMT112;HSD17B10
prerank,chromatin assembly or disassembly (GO:0006333),0.7601650707364309,1.4647445402043462,0.10709117221418235,0.6991529482066395,1.0,7/11,18.79%,CHAF1B;RBBP4;HDAC8;CHAF1A;TP53;SUV39H2;HIRIP3
prerank,nuclear transport (GO:0051169),0.7086116923821849,1.4630692153560725,0.1270949720670391,0.7034442896900209,1.0,7/16,17.34%,XPO1;NUP205;PSIP1;RBM15B;NXT1;NUP98;NXT2
prerank,organophosphate catabolic process (GO:0046434),0.7612802170667452,1.462327176798628,0.10518731988472622,0.7040522786648629,1.0,2/11,6.98%,PON1;ENPP2
prerank,RNA stabilization (GO:0043489),0.6682636610395384,1.4623239824957928,0.08254716981132075,0.7019038220970563,1.0,12/33,10.95%,MEIOC;E2F1;TENT2;PHAX;THRAP3;EIF4ENIF1;FUS;LARP1;AXIN2;HNRNPU;TENT5D;TAF15
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.5699853591221203,-1.4608417409611023,0.090625,0.5604964246185199,1.0,6/12,16.82%,MID2;LY6E;SNX3;IFITM3;GSN;IFITM2
prerank,cellular response to hydrogen peroxide (GO:0070301),0.6633298120072098,1.4602914494034411,0.10488676996424315,0.7073019092621333,1.0,5/33,5.43%,ECT2;AQP1;SETX;FXN;NET1
prerank,peroxisome organization (GO:0007031),-0.45017935757937527,-1.459456327610277,0.06770833333333333,0.5604210350506038,1.0,8/25,13.66%,PLAAT3;PEX1;FIS1;ABCD4;PEX3;LONP2;PEX6;ABCD2
prerank,renal system development (GO:0072001),0.6222023509861749,1.4594006731415792,0.08568329718004339,0.7082906060886942,1.0,12/52,15.42%,CENPF;GLI2;SULF2;SULF1;NPHP3;AGT;C1GALT1;TGFBR1;TBX18;IFT27;ITGA8;GREB1L
prerank,tryptophan metabolic process (GO:0006568),0.7372810106254755,1.4588070823156625,0.1301775147928994,0.7082950046648095,1.0,3/11,13.22%,ACMSD;KMO;IL4I1
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.47576463858715445,-1.4584112335959905,0.05726872246696035,0.5599227695059221,1.0,8/19,22.21%,MAOB;NOX1;PRDX2;PRDX1;GPX1;PRDX3;PARK7;PRDX5
prerank,regulation of glucose metabolic process (GO:0010906),-0.3956730564332188,-1.457292938253347,0.03184713375796178,0.5595999057065452,1.0,10/34,14.46%,PRKN;OGT;AKT2;IRS2;GPLD1;PDK1;SELENOS;IRS1;ZNF692;DGKQ
prerank,water transport (GO:0006833),0.7347505788483799,1.4569470627498613,0.10973724884080371,0.7130246485338148,1.0,2/12,5.72%,AQP1;PDPN
prerank,neural tube development (GO:0021915),0.7161155398001398,1.4569074405317717,0.12624113475177304,0.7110021557361055,1.0,3/15,6.60%,STIL;ALDH1A2;GRHL2
prerank,regulation of chromatin binding (GO:0035561),0.7757937903007988,1.4560191675752154,0.11937984496124031,0.7121105058767889,1.0,4/10,10.40%,DDX11;BTAF1;WAPL;PARP9
prerank,retrograde axonal transport (GO:0008090),-0.5163576630330341,-1.4557371757134576,0.0695970695970696,0.5606908686614966,1.0,6/16,10.40%,TMEM108;KIF1A;MAP1A;KIF5B;NEFL;ACTR10
prerank,response to organonitrogen compound (GO:0010243),-0.38800136346471886,-1.4553317915078452,0.03571428571428571,0.5579713592351017,1.0,14/38,23.09%,PRKN;GLRB;ERLEC1;GLRA1;GLRA3;DERL1;MTOR;RCN3;RRAGC;UBXN6;DNAJB12;SYVN1;DRD2;SEL1L
prerank,cardiac muscle cell contraction (GO:0086003),-0.473068791684363,-1.4540653019426573,0.06640625,0.5583164552604938,1.0,7/19,18.25%,CAMK2D;CACNA2D1;SCN1A;ATP1A1;GSN;SCN1B;PIK3CA
prerank,cellular response to light stimulus (GO:0071482),0.6285307185799389,1.4536753951936843,0.06510138740661686,0.7185840278620895,1.0,20/66,17.21%,POLK;AURKB;AQP1;BMF;NEDD4;ERCC4;POLD1;FMR1;CDC25A;USP28;PCNA;USP47;YY1;SMPD1;RUVBL2;INO80;TP53;METTL3;PTPRK;ATR
prerank,T cell differentiation in thymus (GO:0033077),0.7225529740570353,1.453543452819565,0.12756598240469208,0.7169564608325669,1.0,2/14,2.15%,GLI3;FADD
prerank,renal absorption (GO:0070293),-0.6074840977264386,-1.4531768572653256,0.06804733727810651,0.5571711900749321,1.0,8/10,38.36%,SGK1;SLC15A2;GSN;KLHL3;KCNQ1;MAGED2;HYAL2;HAS2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.6540970268820702,1.45210243060088,0.11778563015312132,0.7202190742109285,1.0,6/31,6.79%,PLK1;CDC20;UBE2C;UBE2S;FBXW7;UBE2N
prerank,tryptophan catabolic process (GO:0006569),0.7440997071483126,1.4512109748919546,0.12462908011869436,0.7212842021224476,1.0,3/11,13.22%,ACMSD;KMO;IL4I1
prerank,positive regulation of dephosphorylation (GO:0035306),0.66072481701547,1.4508466651161591,0.11822660098522167,0.7204231644633138,1.0,11/27,16.20%,CDCA2;PPP1R7;MTMR9;CALM2;BMP2;SMPD1;CAMTA1;PTPA;PIN1;SRC;ANKLE2
prerank,clathrin-dependent endocytosis (GO:0072583),-0.4294932331490691,-1.4496939064525565,0.05314009661835749,0.5650108550893248,1.0,13/26,21.77%,SGIP1;ITSN2;FNBP1L;AP2A2;GPR107;AP2M1;AP2S1;AP2A1;FCHO2;CLTB;LMBRD1;FCHSD2;ITSN1
prerank,myotube cell development (GO:0014904),-0.6028856310571746,-1.4486144047527905,0.0903954802259887,0.5646551615815677,1.0,4/10,11.42%,IGF1;CAV2;SELENON;SIX1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.6721610895781446,1.4483676228534568,0.12083847102342787,0.7275337519474551,1.0,6/26,11.38%,BRCA1;CNOT1;VPS18;SMARCA4;KANK2;HDAC1
prerank,odontogenesis (GO:0042476),0.6446475520840776,1.4477763128089656,0.12095808383233533,0.7276650660511462,1.0,12/35,12.63%,GLI2;AQP1;FGFR2;BCOR;LAMB1;ANKRD11;AXIN2;WNT6;EDA;HDAC1;BMP2;HDAC2
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.6079600458873627,1.446762644972628,0.0,0.7292117262578857,1.0,56/306,7.96%,BRCA1;EXO1;TICRR;CDK1;MRPL36;BRIP1;POLE;CLSPN;PIF1;BARD1;RMI2;DBF4;MCM5;POLA1;ORC1;PCLAF;E2F1;TYMS;TIPIN;POLA2;MCM8;CDC45;RFC4;NAP1L1;TIMELESS;FAM111A;MCM10;MCM6;MCM7;MCM2;PABPC4;TOPBP1;RBBP8;CDC6;AGO2;RPA1;LARGE1;RAD1;POLD3;DNA2;RFC2;SRBD1;BLM;MRE11;MRPL18;MCM3;POLD1;RPA2;MCM4;RFC3;ORC2;CHEK1;POLR2A;RNASEH2A;ORC3;CDK2
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.48565851351566836,-1.4452652090478462,0.0703125,0.571869410772376,1.0,11/18,18.62%,RIMS1;SHANK3;NRXN1;RELN;CHRNA7;SHANK1;DLG4;GRIN1;PRKCZ;NLGN1;STX1B
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.5954676061152095,-1.4450696502049911,0.07449856733524356,0.5687287196947943,1.0,8/10,34.91%,HSP90AB1;LAPTM4B;FURIN;GATA6;CD24;TSKU;TYROBP;CDH3
prerank,diol metabolic process (GO:0034311),-0.47563066952592714,-1.4448748161073464,0.06578947368421052,0.5656748694011047,1.0,8/19,16.50%,CALM1;NOS3;PLPP3;DEGS2;ASAH2;GCH1;PRKG2;PTS
prerank,regulation of transposition (GO:0010528),0.7225014908498425,1.4445380750749823,0.12352941176470589,0.7353119296033588,1.0,1/13,1.03%,MYBL1
prerank,fatty acid biosynthetic process (GO:0006633),-0.35278420075040134,-1.4443240277310117,0.025974025974025976,0.563481439939431,1.0,27/63,31.52%,ELOVL7;HACD3;ACLY;HACD2;GPX4;LIAS;HACD1;ABHD2;PTGS2;ASAH2;DEGS1;EPHX2;XBP1;ELOVL6;DECR2;ACOT7;CBR4;HPGD;SCD;ELOVL1;FADS1;ACSBG1;TECR;ALOX12;HSD17B8;OXSM;TECRL
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.5733132539463117,-1.4434174587971698,0.07575757575757576,0.5624217906750382,1.0,6/11,16.50%,CALM1;NOS3;QDPR;GCH1;PRKG2;PTS
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.42885714242125267,-1.4427711013309028,0.04878048780487805,0.5608657529176871,1.0,16/29,30.55%,MCTP1;APOE;EPHB2;SHISA6;NETO1;RAB5A;APP;NSMF;DLG4;GRIK2;DRD2;SHISA9;SHISA7;CAMK2B;RAB3GAP1;CLN3
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.7471323019154317,1.4420009376199725,0.11897590361445783,0.7426674596916117,1.0,7/10,18.46%,RTEL1;RIF1;TERF2;ACD;DCLRE1A;TERF2IP;DCLRE1C
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.6146941220020997,1.4404741601276254,0.06540084388185655,0.7463264793906405,1.0,18/73,10.07%,PHF19;EZH2;PPM1D;BAZ1B;DEK;SUZ12;CTCF;POLR1A;MPHOSPH8;EED;MYO1C;POLR1B;RBBP4;RBBP7;PHF2;PHF1;EPC1;TAF1D
prerank,striated muscle tissue development (GO:0014706),-0.4385275715495983,-1.4398963783285386,0.05699481865284974,0.5661834066220538,1.0,7/29,11.42%,MEF2C;PGM5;CAV1;IGSF8;BMPR2;MYL6;SIX1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.6714202659213381,1.4395886880318718,0.118562874251497,0.7473776719374352,1.0,1/26,0.19%,BRCA1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.6420050310339769,1.4395122353149024,0.09001097694840834,0.7455135750706554,1.0,13/45,14.35%,ZWILCH;BUB1B;BUB1;WEE1;ZW10;CHEK1;SCRIB;BTG3;GAS1;TOM1L2;PLK2;CDKN1B;SMAD3
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.44466133208116054,-1.4382372113993271,0.04918032786885246,0.5681156295218731,1.0,11/26,25.97%,HSP90AB1;INSR;TLR4;KLF4;KLF2;PTGS2;DDAH2;P2RX4;ASS1;EDN1;TMEM106A
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.6547215803345132,1.4376477725969385,0.13023255813953488,0.7503029194980056,1.0,6/33,2.56%,E2F7;RBL1;WEE1;CDKN2D;CDKN2C;RB1
prerank,negative regulation of calcium ion transport (GO:0051926),-0.5190990615620569,-1.43712641100435,0.0967741935483871,0.5681521694730344,1.0,7/15,21.78%,INPP5K;ATP1A2;TRIM27;SLC30A1;ADRA2A;PACSIN3;NOS1
prerank,vasoconstriction (GO:0042310),0.7344315664009088,1.4370719966411039,0.1343065693430657,0.7502479707714236,1.0,1/11,0.68%,KEL
prerank,potassium ion import across plasma membrane (GO:1990573),-0.38563478500356174,-1.4364467412034758,0.03225806451612903,0.5667938270649739,1.0,11/41,17.53%,ATP1B1;KCNJ3;KCNJ6;ATP1A1;ATP1B3;ATP1A3;SLC12A9;KCNJ10;ATP1A2;SLC12A2;KCNK9
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.40263695982417247,-1.4355431102756198,0.04487179487179487,0.5661829908231364,1.0,9/34,6.83%,PTK2;FLT1;TEK;PIK3R3;PDGFRB;PIK3R1;FGF2;PIK3R4;PIK3IP1
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.48707100127113445,-1.4353607004426499,0.08333333333333333,0.5633595277652432,1.0,6/19,18.03%,PTK2;MAPK3;MAPK1;THBS1;CMKLR1;IL34
prerank,positive regulation of chemotaxis (GO:0050921),-0.3745271020293804,-1.435196805506222,0.03418803418803419,0.5602104655043009,1.0,16/43,22.30%,TMSB4X;STX4;PDGFRB;NTRK3;STX3;FGF2;LGMN;MEGF8;MET;THBS1;PPM1F;VEGFA;SMOC2;NRP1;P2RX4;HSPB1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.441148387252292,-1.4351938360660477,0.07106598984771574,0.55334719533893,1.0,12/23,21.79%,EP300;HSP90AB1;HIPK2;DAB2;GIPC1;THBS1;SDCBP;CITED2;SLC2A10;TGFB1I1;SNW1;CDKN1C
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.441148387252292,-1.4351938360660477,0.07106598984771574,0.55334719533893,1.0,12/23,21.79%,EP300;HSP90AB1;HIPK2;DAB2;GIPC1;THBS1;SDCBP;CITED2;SLC2A10;TGFB1I1;SNW1;CDKN1C
prerank,regulation of establishment of cell polarity (GO:2000114),0.6887832210068415,1.4349660336435937,0.12064343163538874,0.7559876752115944,1.0,2/16,3.09%,KIF20B;ROCK2
prerank,female gamete generation (GO:0007292),0.6536434516014065,1.4347110178952236,0.11366384522370013,0.7547778474206022,1.0,10/29,19.57%,TRIP13;MCM8;DMC1;KMT2D;TOB2;USP9X;METTL3;MCM9;MARF1;FMN2
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.5934395066182545,-1.4341389441697439,0.09855072463768116,0.5529619416676588,1.0,5/10,16.43%,CCT5;TCP1;CCT7;CCT2;DKC1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.7185963289753017,1.4333209313566109,0.11849710982658959,0.7577681058861014,1.0,4/12,7.61%,GLI2;MYCBP2;NFIB;EPHA4
prerank,sympathetic nervous system development (GO:0048485),-0.5040607445739554,-1.4322338916305313,0.05925925925925926,0.5556348652874066,1.0,6/15,19.33%,NRP2;SEMA3A;NF1;CTNNB1;SOX4;NRP1
prerank,ribosome biogenesis (GO:0042254),-0.23395841219626418,-1.4320496221330419,0.0,0.5529152669256836,1.0,81/187,23.97%,GLUL;RPL13;HEATR3;RPL37A;RPL38;RPL21;RPL35A;RPL23;RPL17;RPL3;RPS15;RPS7;NVL;RPL18A;RPS6;RPL14;RPLP1;RPL9;RPL37;RPL8;RPS14;NAF1;NOL8;RPL10;RPL18;RPL32;RPS28;SENP3;RPS24;RPL15;RPS19;HEATR1;UTP20;RPL39;KRR1;RPL12;RPL27;RPL24;WDR75;EXOSC1;RPS27;RPL27A;RPS9;RPL30;DHX29;EXOSC9;RRP1B;RRP1;RPL19;METTL17;RPL28;RBIS;RPL31;MPHOSPH10;LAS1L;SNU13;DKC1;DDX49;RPL13A;RPL36A;RPLP2;LTO1;RPL29;MDN1;RIOK2;LSG1;RPLP0;LTV1;RPL10A;RPL35;NOB1;NOLC1;EMG1;SURF6;EXOSC2;PIH1D1;EBNA1BP2;RAN;TSC1;DDX54;RPL4
prerank,positive regulation of tissue remodeling (GO:0034105),0.7433518955588443,1.4318515816646464,0.1144578313253012,0.7612411227362724,1.0,3/10,9.40%,ROCK2;IL18;ROCK1
prerank,fluid transport (GO:0042044),0.7187564655937911,1.4317357921900975,0.12808641975308643,0.7595306089396243,1.0,2/12,5.72%,AQP1;PDPN
prerank,regulation of intracellular protein transport (GO:0033157),0.6560938555293652,1.4312809408620508,0.11004784688995216,0.7591418143890509,1.0,4/32,7.69%,KIF20B;PCM1;TPR;RAB29
prerank,transepithelial transport (GO:0070633),-0.5074672102893252,-1.4311907020842511,0.0706713780918728,0.5520179479413411,1.0,5/15,16.25%,SLC1A2;ABCG2;GPLD1;SLC1A1;SLC12A2
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.5852079834454051,-1.4307771263722142,0.09627329192546584,0.5501858699750154,1.0,8/10,36.27%,OGT;SELENOS;ZNF692;DGKQ;PDK2;SIRT7;USP7;SDHAF3
prerank,aerobic electron transport chain (GO:0019646),-0.3507620884908645,-1.4302776555979237,0.046875,0.548456320460511,1.0,33/68,25.20%,COX6C;COX4I1;COX5A;COX7B;NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;COX7C;NDUFS3;UQCRC2;NDUFB3;NDUFS4;NDUFA5;UQCRB;NDUFA6;NDUFA4;NDUFB9;UQCR10;UQCRQ;NDUFAF1;NDUFB6;NDUFA11;COX8A;NDUFB10;NDUFB11;NDUFA10;UQCRC1;COX5B;NDUFS6;NDUFA1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.4959546909193493,-1.4302402521918107,0.05928853754940711,0.5452803389887768,1.0,3/16,1.04%,MCTP1;RIMS1;MEF2C
prerank,response to nutrient levels (GO:0031667),-0.5056737322011544,-1.4298892261543374,0.09363295880149813,0.5430304074215613,1.0,5/17,10.95%,KCNB1;EIF4G1;ULK1;PRKAA1;MTOR
prerank,regulation of protein acetylation (GO:1901983),0.727444512238018,1.4292949567300381,0.14285714285714285,0.7642749115114825,1.0,3/12,4.23%,CEP295;GSK3B;FAM161A
prerank,metal ion transport (GO:0030001),-0.3412970093774393,-1.428626408974339,0.02631578947368421,0.5440337632404163,1.0,27/86,16.93%,CACNA2D1;GRIN3A;RYR3;NIPA1;PSEN1;SLC8A3;TRPM7;CALCRL;TRPC5;CAV1;RYR2;NIPA2;SLC3A2;CACNG7;TPT1;RAMP1;RAMP2;CACNA1B;TRPC3;TRPC1;CHRNA7;SLC30A1;ATP2B2;NIPAL3;PANX1;CACNG3;CACNG8
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.41466824380007966,-1.428044831230889,0.05421686746987952,0.5430017144781678,1.0,8/30,21.17%,STAT3;TLR4;PIBF1;CD34;HSPD1;LGALS9;PRKCZ;CD274
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.6546138773008328,1.4272120107813995,0.11680572109654351,0.7697560972516944,1.0,5/30,8.92%,BRCA1;FADD;GSK3B;SERPINE1;TNFRSF10B
prerank,protein sumoylation (GO:0016925),0.6151824973057605,1.4269313797886305,0.10643015521064302,0.7687205221898079,1.0,30/49,25.27%,NDC1;NUP155;SAE1;NUP205;NUP160;NUP85;TPR;TRIM28;RANGAP1;NSMCE2;SUMO2;NUP214;TRPM4;RANBP2;NUP133;NUP42;NUP98;NUP210;EGR2;NUP188;NUP35;NUP43;PIAS1;UBA2;NUP93;UBE2I;NUP107;STX1A;SEH1L;EYA1
prerank,negative regulation of viral transcription (GO:0032897),-0.5400891866904731,-1.426727684863803,0.09121621621621621,0.5439348094751081,1.0,10/13,31.63%,MID2;IFITM3;TRIM27;TRIM14;TRIM21;TRIM11;TRIM32;ZFP36;HEXIM1;TRIM13
prerank,tRNA export from nucleus (GO:0006409),0.6340803121890312,1.4258853297505394,0.12203791469194313,0.7684039966999608,1.0,15/32,20.12%,NDC1;NUP155;NUP205;NUP160;NUP85;TPR;NOL6;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;NUP188;NUP35
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.6340803121890312,1.4258853297505394,0.12203791469194313,0.7684039966999608,1.0,15/32,20.12%,NDC1;NUP155;NUP205;NUP160;NUP85;TPR;NOL6;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;NUP188;NUP35
prerank,regulation of interleukin-10 production (GO:0032653),-0.3787825544765706,-1.4257404035004002,0.028846153846153848,0.5434128501300016,1.0,7/44,8.62%,STAT3;TRIB2;TLR4;PIBF1;CD34;TNFRSF21;HSPD1
prerank,cellular response to alcohol (GO:0097306),0.6299266579056257,1.4253675651734083,0.10835214446952596,0.7682169521888692,1.0,9/42,11.57%,BRCA1;RAD51;GRAMD1C;BLM;CTNNA1;SPIDR;LARP1;AHR;KLF9
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.5806009832186605,-1.4252772087886774,0.0914826498422713,0.5418002765274271,1.0,4/10,23.40%,PFKP;HK1;PFKM;PFKL
prerank,negative regulation of transmembrane transport (GO:0034763),-0.5847362244200247,-1.4250646901833615,0.09230769230769231,0.5392506613200195,1.0,5/10,12.52%,AKT2;CTTNBP2NL;IRS2;INPP5K;THBS1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.6923241246996953,1.4246251049872443,0.15129682997118155,0.768887792017038,1.0,7/15,12.63%,GLI2;ANKRD11;WNT6;EDA;HDAC1;BMP2;HDAC2
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.3390739342160267,-1.4238617502199566,0.030303030303030304,0.5401262917599463,1.0,39/87,25.25%,IMMP2L;TTC19;COX16;UQCC1;NDUFS5;OXA1L;NDUFS1;OMA1;AIFM1;NDUFA9;COX19;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;UQCC2;NDUFA6;NDUFB9;DMAC2;ACAD9;PET100;COX20;SMIM20;COX17;NDUFAF1;NDUFB6;NDUFA11;NDUFB10;NDUFB11;COX14;TIMMDC1;NDUFA10;COA8;NDUFS6;NDUFA1;CHCHD4
prerank,response to amyloid-beta (GO:1904645),-0.3852131486143752,-1.4226421926829629,0.06722689075630252,0.5407058993927557,1.0,16/44,14.10%,CACNA2D1;PSEN1;GRIN2A;IGF1;TLR4;LRP1;CASP4;VCAM1;LGMN;CACNA1B;CHRNA7;ATP1A3;APP;GRM5;MMP2;GRIN1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.40587674299981347,-1.4221127765853132,0.07236842105263158,0.5392865238787624,1.0,10/33,17.38%,PRKG1;APOD;MEF2C;PDCD4;SOD2;TPM1;OGN;TAFA5;TGFB3;NDRG4
prerank,exit from mitosis (GO:0010458),0.7240983202956539,1.4218183573276058,0.14244186046511628,0.777007842019774,1.0,2/12,2.03%,UBE2C;UBE2S
prerank,histone methylation (GO:0016571),0.6362776812952281,1.4213123693234884,0.1267605633802817,0.776715835430682,1.0,2/26,2.23%,EZH2;SETD6
prerank,bicarbonate transport (GO:0015701),0.6530081630991277,1.4212484905367757,0.12658227848101267,0.7748107044265,1.0,7/25,14.88%,RHAG;AQP1;SLC4A2;CYB5RL;SLC39A8;CA2;CYB5R1
prerank,regulation of calcium ion transport (GO:0051924),-0.3528069982974104,-1.421173976390836,0.024691358024691357,0.5389207787342339,1.0,18/54,22.05%,CACNA2D1;EPB41;SARAF;HOMER1;MYLK;CAMK2G;INPP5K;BCL2;CTNNB1;CACNB2;CRACR2A;SRI;ADRA2A;PLPP4;PACSIN3;NOS1;CD84;P2RX4
prerank,purine-containing compound salvage (GO:0043101),0.7240645257189351,1.4210832328785592,0.150354609929078,0.7732746734664422,1.0,4/12,5.28%,ADK;ADA;DCK;HPRT1
prerank,skeletal system morphogenesis (GO:0048705),0.6242633833386879,1.4205202230462395,0.10933940774487472,0.7732276674736135,1.0,11/42,10.49%,RAB33B;CYP26B1;WWOX;FGFR2;HOXC4;PDGFRA;RFLNA;ANKRD11;DSCAML1;HOXB3;TGFBR1
prerank,spermatid development (GO:0007286),0.6485490707503083,1.4204645171170227,0.11191335740072202,0.7713136779625313,1.0,4/32,7.19%,MEIOC;CEP57;MKKS;RFX2
prerank,positive regulation of histone acetylation (GO:0035066),0.6664625260566136,1.4203590517013798,0.1251596424010217,0.7696049697739099,1.0,3/23,6.68%,BRCA1;PAXIP1;ARRB1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.39383519161170416,-1.4203169335067638,0.027777777777777776,0.538343220002161,1.0,16/31,32.75%,KCNB1;SYT1;SYT7;SYT11;SYT12;SCAMP5;ADRA2A;SYT10;SYT6;SYT2;CACNA1H;RAB3GAP1;CACNA1I;SYT13;SYT3;CBARP
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.6678844919043013,1.419089205532045,0.14915693904020752,0.7721777274125661,1.0,3/20,6.68%,BRCA1;PAXIP1;ARRB1
prerank,regulation of B cell proliferation (GO:0030888),0.619860433752546,1.4188332473361058,0.10901001112347053,0.7710482361016416,1.0,1/44,0.09%,TNFSF13B
prerank,cellular response to interleukin-4 (GO:0071353),-0.5757777416828657,-1.4186046986429606,0.0914826498422713,0.5403571463530563,1.0,4/10,21.09%,LEF1;STAT6;XBP1;SHPK
prerank,epithelial cell differentiation (GO:0030855),0.5985716015060336,1.418405489313121,0.05520833333333333,0.7704933472269082,1.0,12/88,11.48%,E2F7;E2F8;CDK1;SCUBE1;FGFR2;RAB10;GRHL2;SCRIB;FN3K;PCNA;HDAC1;ANXA1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.6235657913293885,1.4182588364381903,0.13198573127229488,0.7689465044724494,1.0,6/33,6.40%,EZH2;FAM83D;HYAL1;TFDP1;DDRGK1;LSM11
prerank,histone lysine methylation (GO:0034968),0.6399271810605499,1.4182555703891913,0.11515863689776733,0.7668872814587642,1.0,5/33,5.86%,EZH2;SETD6;PAXIP1;SETDB2;SETD3
prerank,tRNA transport (GO:0051031),0.62876771284423,1.4178171629079581,0.11592505854800937,0.7663837142641053,1.0,21/35,25.21%,NDC1;NUP155;NUP205;NUP160;NUP85;TPR;NOL6;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;NUP188;NUP35;NUP43;TOMM20;NUP93;NUP107;SSB;SEH1L
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5559657846321696,-1.416026324548341,0.0960960960960961,0.5443633833388921,1.0,6/11,21.78%,CAMK2D;CACNA2D1;BIN1;CACNB2;CACNB1;NOS1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.4417555266661233,-1.4158676504516987,0.06382978723404255,0.5418732396916751,1.0,10/25,25.13%,HSP90AB1;INSR;TLR4;KLF4;KLF2;PTGS2;DDAH2;P2RX4;ASS1;EDN1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.6256841656213941,1.4157952174232762,0.10414333706606943,0.771833450217971,1.0,7/47,6.72%,BRCA1;ACMSD;ATP2B4;ROCK2;GCK;ERFE;FBXW7
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.48594725926379523,-1.4154333236566958,0.07984790874524715,0.5404107344266431,1.0,9/17,33.38%,SLC7A5;PRKCQ;CEBPB;LGALS9;PRKCZ;CD86;SYK;FCER1G;RARA
prerank,positive regulation of rRNA processing (GO:2000234),-0.576939333585148,-1.4126263316066685,0.09826589595375723,0.5458411127580958,1.0,9/10,39.97%,HEATR1;WDR75;BUD23;RIOK2;DIMT1;RIOK1;TRMT112;SIRT7;WDR43
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.615302646094114,1.4122832506642702,0.10614525139664804,0.7828517638530039,1.0,15/46,17.21%,KIF14;RHOA;ATRNL1;PARVA;ITGB7;LAMB1;EFNA1;TMEFF2;SRGAP2;RAC1;ITGA8;ITGAV;NTN4;FERMT3;ANTXR1
prerank,actin polymerization or depolymerization (GO:0008154),0.6123064628662701,1.4113293521117605,0.1091314031180401,0.7843194588665287,1.0,10/50,14.61%,DIAPH3;DIAPH1;MICAL3;ABI1;ARHGAP6;TWF1;RAC1;SVIL;DSTN;CAPG
prerank,nuclear pore organization (GO:0006999),0.697523817329086,1.4112806131091564,0.1514705882352941,0.7824518104267812,1.0,12/14,26.69%,NDC1;NUP205;AHCTF1;TPR;NUP133;NUP98;NUP35;NUP93;NUP107;SEH1L;RTN4;NUP153
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.6774953522450402,1.4110652917701816,0.14228187919463087,0.7811702807212646,1.0,5/18,9.40%,KIF20B;ROCK2;RIPOR2;LLGL2;ROCK1
prerank,neural tube closure (GO:0001843),0.6222854252932787,1.4109872373504593,0.12630359212050984,0.7793756816686556,1.0,7/34,10.73%,STIL;MTHFD1L;MTHFR;GRHL2;SCRIB;KDM2B;PLXNB2
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.69946201792325,1.4106551159091043,0.14157973174366617,0.7785487531832175,1.0,5/13,15.77%,KPNA2;KPNA3;RANBP2;KPNA4;IPO5
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.49335711861810905,-1.4104084061519588,0.1124031007751938,0.5497147715393856,1.0,9/15,22.30%,TMSB4X;FGF2;LGMN;FGF1;MET;THBS1;SMOC2;P2RX4;HSPB1
prerank,epiboly involved in wound healing (GO:0090505),0.68615613441489,1.4091505203893602,0.14804469273743018,0.7820180039264049,1.0,9/16,15.79%,RHOA;PDPN;CCN1;TMEFF2;ARHGAP35;MRTFA;CD44;RHOC;LCP1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.5744070334659904,-1.4089048146728211,0.1,0.5514419402045716,1.0,2/10,2.43%,KCNAB1;CAV1
prerank,protein K11-linked ubiquitination (GO:0070979),0.6577468180853905,1.4084023612014147,0.13407134071340712,0.7827096366476828,1.0,5/27,3.65%,UBE2T;UBE2C;UBE2S;ANAPC7;CDC27
prerank,spinal cord development (GO:0021510),0.7219503411401993,1.4082095616348198,0.14553314121037464,0.7813183174495468,1.0,2/12,1.21%,GLI2;LOXL3
prerank,in utero embryonic development (GO:0001701),0.6594006814742154,1.408087438001418,0.1419753086419753,0.779750253554623,1.0,6/25,11.42%,STIL;FGFR2;ZNF568;LMX1B;TGFBR1;BMP2
prerank,positive regulation of leukocyte activation (GO:0002696),-0.47665739365952564,-1.4078885850157998,0.0851063829787234,0.5513801116813447,1.0,6/18,19.30%,TLR4;LBP;HSPD1;THBS1;NECTIN2;KARS1
prerank,DNA packaging (GO:0006323),0.7071467200814463,1.4074745434408322,0.15177304964539007,0.7800407797497434,1.0,6/16,15.84%,CHAF1B;HAT1;RBBP4;CHAF1A;KAT6A;TP53
prerank,regulation of AMPA receptor activity (GO:2000311),-0.43689485718079435,-1.407295397324106,0.06422018348623854,0.55026379184281,1.0,13/25,18.42%,MEF2C;SHANK3;SHISA6;CACNG7;CACNG4;MINK1;RELN;SHANK1;CACNG2;PRRT1;CACNG3;CACNG8;NLGN1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.4243742212245599,-1.4072810839668386,0.06914893617021277,0.5474334157197358,1.0,12/27,26.82%,CAMK2D;AHNAK;CALM1;FKBP1A;SELENON;CACNB2;CACNB1;ADRA2A;PDE4D;NOS1;JPH2;JPH4
prerank,sodium ion transport (GO:0006814),-0.3222869756268725,-1.4070392096716868,0.03125,0.5452695117421126,1.0,22/85,16.25%,SLC6A6;SLC8A3;ATP1B1;SLC6A1;HCN1;ANO6;SLC24A2;SGK1;SCN1A;FGF13;SCN9A;ATP1B3;NDUFA9;SLC5A6;SLC5A5;ATP1A2;SCN3A;SCN8A;SCN1B;SLC4A8;SLC6A11;SLC12A2
prerank,receptor-mediated endocytosis (GO:0006898),-0.30972458159950805,-1.4062663943905007,0.0,0.5447741850629014,1.0,45/132,19.63%,DNM3;SGIP1;CALCRL;LRP1B;MICALL1;CAV1;APOE;FNBP1L;TMEM108;INSR;HSP90B1;AP2A2;LRP1;ACKR3;RAMP1;DNM1;GPR107;DAB2;RAMP2;HSPH1;CD81;VLDLR;CAV2;SCARF1;AP2M1;PDLIM7;GRB2;ARHGAP27;IGF2R;CTSL;LDLRAP1;AP2S1;AP1S1;AP2A1;FCHO2;LRP6;CLTB;CUBN;LMBRD1;STAB1;PPT1;SORL1;GRK4;LRP3;SPARC
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.5277943697285012,-1.405663177867154,0.09246575342465753,0.543775949656903,1.0,3/13,2.53%,PSEN1;TMSB4X;PER2
prerank,transition metal ion homeostasis (GO:0055076),-0.41888218726437126,-1.4050958290957019,0.057692307692307696,0.5425613429520801,1.0,9/28,18.30%,PRKN;FBXL5;FTL;HMOX2;NEO1;B2M;IREB2;CUTC;COMMD1
prerank,negative regulation of transposition (GO:0010529),0.6915543878921583,1.4048531187994404,0.14929577464788732,0.7876627315991739,1.0,4/16,13.47%,MYBL1;MOV10;TUT7;TUT4
prerank,embryonic axis specification (GO:0000578),0.6984838479276317,1.404667187376372,0.153737658674189,0.7862214463809863,1.0,1/15,0.41%,STIL
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.5585710423378849,-1.4041596455237673,0.11146496815286625,0.5425988076330862,1.0,3/11,7.70%,ATP1B1;KCNJ3;ATP1A1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.7326152022561349,1.4038712851090303,0.13312693498452013,0.7869900471563072,1.0,5/10,7.50%,KMT5A;SETD6;SETD3;EEF1AKMT2;SETD2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.38232856306153035,-1.4038097514434051,0.06956521739130435,0.540703730913765,1.0,18/39,21.48%,PIP4K2A;PIK3R3;PIP4K2B;SOCS2;PIK3C2B;PIK3R1;EFR3A;SOCS5;ITPKB;PI4KA;SMG1;PIK3CD;TMEM150A;PIK3CA;EFR3B;ITPKC;PIP4K2C;PIK3R2
prerank,nucleoside salvage (GO:0043174),0.7303015678947566,1.4032056314305728,0.13803230543318648,0.7871841265240536,1.0,4/10,9.15%,TK1;DCK;HPRT1;CDA
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.6206509678869014,1.4029226170767588,0.1001100110011001,0.7861857365827368,1.0,6/51,5.04%,NEK2;PIF1;AURKB;TERF1;STN1;HNRNPA1
prerank,embryonic digestive tract development (GO:0048566),0.6570781760150777,1.402883369947742,0.15191545574636725,0.7842953078638578,1.0,7/18,13.82%,GLI2;GLI3;FGFR2;PDGFRA;NIPBL;RBPMS2;RARB
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.40623647641057237,-1.4025866806218965,0.06451612903225806,0.5413080086406517,1.0,15/29,23.75%,RASGRF1;IGF1;IRS2;LYN;TGM2;RELN;RASGEF1A;SHOC2;GRB2;SHC1;ERBIN;LRRC59;JAK2;MMD2;FGF10
prerank,cellular response to UV (GO:0034644),0.5984756465196464,1.4014960139701147,0.08455114822546973,0.7873193377199236,1.0,26/76,17.21%,POLK;AURKB;AQP1;HYAL1;BMF;NEDD4;ERCC4;POLD1;FMR1;CHEK1;CUL4B;CDC25A;USP28;XPA;PCNA;PPID;USP47;YY1;SMPD1;RUVBL2;STK11;INO80;TP53;METTL3;PTPRK;ATR
prerank,positive regulation of synapse assembly (GO:0051965),-0.4186450089342859,-1.4013242997917774,0.07766990291262135,0.5423417565738196,1.0,14/27,23.77%,PTPRD;SYNDIG1;GRID2;AGRN;EPHB2;IL1RAPL1;SEMA4D;NRXN1;LRRC4B;NLGN1;IL1RAP;BDNF;DLG5;SRPX2
prerank,telomere maintenance via telomerase (GO:0007004),0.6444564493328026,1.4010888030918753,0.1543134872417983,0.786848563546038,1.0,14/28,19.63%,PIF1;TERF1;RTEL1;RPA1;MRE11;RFC1;CDK2;TERF2;ANKRD28;TINF2;ACD;TERF2IP;RAD50;TERT
prerank,ncRNA export from nucleus (GO:0097064),0.6213588874621913,1.4009465687002467,0.1295215869311552,0.7853464126785215,1.0,16/36,20.12%,NDC1;NUP155;NUP205;NUP160;PHAX;NUP85;TPR;NOL6;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;NUP188;NUP35
prerank,nucleotide biosynthetic process (GO:0009165),0.6853678568005135,1.4009152130839801,0.1567357512953368,0.7834815151633094,1.0,6/18,11.45%,RRM2;RRM1;HPRT1;PRPS1L1;PRPS1;ADSL
prerank,nuclear export (GO:0051168),0.6004648259319091,1.4005081703978766,0.07135362014690451,0.7829883485175886,1.0,22/80,12.91%,ANKLE1;CCHCR1;RANBP17;NUP155;XPO1;XPO4;SRSF4;PHAX;HNRNPA1;EIF4E;UPF3B;CSE1L;WASHC4;TPR;DDX39B;SRSF7;SMURF1;SRSF3;SRRM1;ATXN1;NUP214;STRADA
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.6326371542678696,1.3996621749214295,0.14007308160779536,0.7839591149289501,1.0,8/30,7.53%,DDIAS;CDKN2D;FBXO5;DYRK1A;RTEL1;DDX39B;SFRP2;YJU2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.4580451992841353,-1.399649912144351,0.09090909090909091,0.5446142753027331,1.0,8/20,13.50%,CAMK2D;PSEN1;FIS1;PACS2;TGM2;BCL2;TMCO1;BCAP31
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.5442273052324919,-1.3994270254175134,0.11075949367088607,0.5426791079239196,1.0,6/12,21.97%,MAOA;HNMT;SMS;OAZ2;DDC;ATP7A
prerank,neuron migration (GO:0001764),-0.34777941567513165,-1.3989706986695358,0.07563025210084033,0.5413603484886053,1.0,20/48,19.33%,ASTN2;MEF2C;SPOCK1;DNER;NTRK2;CDKL5;ELP3;ADGRL3;NRCAM;MAP1B;FGF13;SEMA3A;RELN;LRP12;VEGFA;DCX;DDIT4;GPM6A;TUBB2A;NRP1
prerank,prostanoid metabolic process (GO:0006692),0.7080355513617571,1.3984654461675858,0.1402002861230329,0.786276239300339,1.0,4/13,7.46%,PTGR1;PTGR2;HPGDS;PTGS1
prerank,cellular protein catabolic process (GO:0044257),-0.3338023975336368,-1.3963327104112682,0.02666666666666667,0.5466684215084346,1.0,23/59,21.46%,PRKN;ADAMTS12;UBE2G1;CTSC;CLPX;MALT1;AP2A2;CTSB;LGMN;CTSZ;BNIP3L;BNIP3;VLDLR;AP2M1;RAB12;CTSL;AP2S1;AP2A1;UBE2G2;CTSF;FAP;YME1L1;CTSS
prerank,kidney development (GO:0001822),0.595408673960913,1.3956195366817572,0.10333692142088267,0.7947751789986109,1.0,15/65,15.42%,CENPF;GLI2;SULF2;NIPBL;SULF1;KANK2;NPHP3;AGT;C1GALT1;TGFBR1;CTSH;IFT27;ITGA8;GDNF;GREB1L
prerank,regulation of phospholipase C activity (GO:1900274),-0.49906414305595154,-1.3953848586931736,0.10526315789473684,0.5466760584330626,1.0,8/15,10.85%,FLT1;PDGFRB;NTRK3;FGF2;BICD1;PLCG1;ESR1;ABL1
prerank,catecholamine biosynthetic process (GO:0042423),-0.5741887629502216,-1.3944995492526873,0.09667673716012085,0.5467167842041141,1.0,4/11,19.19%,TGFB2;MOXD1;GCH1;DDC
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.34205904223621647,-1.3942729168897379,0.07017543859649122,0.5445954341613294,1.0,32/69,24.46%,UBE4A;HSP90B1;OS9;TRIM25;ECPAS;RNF103;EDEM2;EDEM1;UFD1;DERL1;SELENOS;HSPA5;UBXN4;RHBDD2;SGTA;STUB1;YOD1;SGTB;DNAJC18;DNAJB9;ERLIN2;SEC61B;AUP1;DNAJB12;SYVN1;UBE2G2;UBXN8;SEL1L;UBE4B;FAM8A1;WFS1;RNF103-CHMP3
prerank,tube closure (GO:0060606),0.6262287942051467,1.393947221189752,0.1380952380952381,0.7987222263184143,1.0,6/31,10.73%,STIL;MTHFD1L;MTHFR;GRHL2;SCRIB;PLXNB2
prerank,histone modification (GO:0016570),0.5870014009130929,1.393600325769098,0.07494866529774127,0.7980354425700319,1.0,20/109,10.24%,UHRF1;EZH2;INCENP;AURKB;SGF29;BAZ1B;EYA4;MIER1;CCNA2;TBL1XR1;UBE2N;MIDEAS;CDK2;RCOR1;MSL3;USP21;USP16;MIER3;MTA3;EYA2
prerank,regulation of embryonic development (GO:0045995),0.6247497050443311,1.3927491153352882,0.14733178654292342,0.7990103396420836,1.0,6/34,9.04%,CDK1;RACGAP1;NIPBL;WDPCP;CCSAP;NPHP3
prerank,mRNA methylation (GO:0080009),-0.49482556521393173,-1.3926614460291866,0.099644128113879,0.5465343080331081,1.0,8/15,16.73%,METTL16;NSUN2;TRMT61B;METTL14;PCIF1;ZC3H13;CMTR1;CBLL1
prerank,covalent chromatin modification (GO:0016569),0.6986096104511352,1.3925180949958897,0.1589310829817159,0.7978663170126481,1.0,2/14,1.39%,AURKB;HELLS
prerank,B cell homeostasis (GO:0001782),-0.5604060225710182,-1.392354209845679,0.12576687116564417,0.5450715269491814,1.0,3/10,6.74%,DOCK10;MEF2C;LYN
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.5785270370954011,-1.3918499802396194,0.12654320987654322,0.5439235917801779,1.0,6/10,32.65%,NR1H3;ABCD2;NR1H2;SLC45A3;MID1IP1;MLXIPL
prerank,sulfate transport (GO:0008272),0.6744899443116716,1.3915767088348885,0.16212338593974174,0.7992976506690728,1.0,1/14,0.73%,RACGAP1
prerank,histone H2A monoubiquitination (GO:0035518),0.6765157935487254,1.391503394260095,0.15782312925170067,0.7975716235909376,1.0,6/17,9.31%,RNF168;TRIM37;BCOR;PCGF5;KDM2B;CUL4B
prerank,skeletal muscle tissue development (GO:0007519),-0.39234099723610083,-1.3914369018871204,0.05641025641025641,0.5423818232826491,1.0,7/32,11.42%,MEF2C;CAV1;IGSF8;MYL6;CAV2;SELENON;SIX1
prerank,artery development (GO:0060840),-0.4434248868151316,-1.3914221314305324,0.0867579908675799,0.5398556428719411,1.0,13/23,19.33%,SMAD7;BMPR2;ACVRL1;ACVR2B;NF1;TBX1;VEGFA;ENG;STRA6;ROBO2;PDE2A;SLC2A10;NRP1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.4866040267636377,-1.3911037884528767,0.07905138339920949,0.5382432117603865,1.0,10/18,18.42%,SHANK3;CACNG7;NRXN1;TSHZ3;CACNG4;RELN;CACNG2;CACNG3;CACNG8;NLGN1
prerank,regulation of striated muscle contraction (GO:0006942),-0.4058359814389511,-1.3906539010502812,0.09090909090909091,0.536765562298459,1.0,9/27,22.05%,SMAD7;SLC8A3;CALM1;RYR2;ATP1A2;SRI;CALM3;NOS1;P2RX4
prerank,primary neural tube formation (GO:0014020),0.6284777493137564,1.39019138365638,0.14028776978417265,0.8003825905832602,1.0,6/30,10.73%,STIL;MTHFD1L;MTHFR;GRHL2;SCRIB;PLXNB2
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.5582287365006686,-1.3898061320633783,0.11676646706586827,0.5365408745631048,1.0,9/10,43.84%,NAF1;DKC1;RPUSD4;GAR1;NOP10;RPUSD1;NHP2;RPUSD2;RPUSD3
prerank,signal peptide processing (GO:0006465),-0.5582265179218773,-1.3897548976202927,0.10787172011661808,0.5342387481217116,1.0,7/11,26.41%,PCSK5;FURIN;SPCS2;PARL;CLN5;SPCS1;SEC11A
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.343160872270117,-1.3883920374101022,0.0,0.5352476998696929,1.0,27/64,32.10%,PLA2G4A;SCP2;ACSL4;GPX4;PNPLA8;ACSL5;ACSL6;PTGS2;ASAH2;EPHX2;ELOVL6;GPX1;ACAD9;HPGD;SLC27A4;ACSL1;ELOVL1;AIG1;FADS1;GSTM2;HACL1;ACSBG1;ALOX12;CPT1A;PNPLA3;PLA2G4C;FAAH
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.371557449671732,-1.3880783905912268,0.048,0.533599375959617,1.0,11/39,12.68%,KRIT1;TEK;ANO6;GAS6;PDCD4;CDH5;PLCG1;RAMP2;THBS1;SCG2;RGCC
prerank,tRNA wobble uridine modification (GO:0002098),-0.51247280820677,-1.3879008590280812,0.11231884057971014,0.531630765307693,1.0,7/14,25.82%,ELP3;TRMT9B;MTO1;TRMU;DPH3;ELP4;GTPBP3
prerank,response to hydrogen peroxide (GO:0042542),0.6088767262441344,1.3877487931029902,0.13370165745856355,0.8072048601047755,1.0,6/45,5.77%,ECT2;AQP1;SETX;FXN;NET1;STK24
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.3759535526807434,-1.3873606080567014,0.03968253968253968,0.5305883402263187,1.0,21/38,25.20%,NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFA4;NDUFB9;NDUFAF1;NDUFB6;NDUFA11;NDUFB10;NDUFB11;NDUFA10;NDUFS6;NDUFA1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.7311566843177943,1.3862883029191237,0.15407407407407409,0.8105650497419952,1.0,4/10,9.75%,CBFB;ZBTB7B;SH3RF1;HMGB1
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.40736259499523486,-1.3860445327995656,0.06918238993710692,0.532059229730371,1.0,13/30,27.90%,ELOVL7;HACD3;HACD2;ABCD4;HACD1;ACSL6;ABCD2;ELOVL6;SLC27A4;ACSL1;ELOVL1;ACSBG1;TECR
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.6372719964351896,1.3846095167319186,0.15552855407047386,0.8146728659678442,1.0,14/29,19.63%,PIF1;TERF1;RTEL1;RPA1;MRE11;RFC1;CDK2;TERF2;ANKRD28;TINF2;ACD;TERF2IP;RAD50;TERT
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.5169501926900844,-1.3845131137083213,0.13013698630136986,0.5337399712548418,1.0,5/13,18.96%,GOT2;DLST;ADHFE1;GOT1;GPT2
prerank,cell differentiation in hindbrain (GO:0021533),-0.5434228488948105,-1.3836156151425993,0.1347305389221557,0.5336824273757033,1.0,3/11,4.85%,OPHN1;GRID2;PROX1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.4184883777697149,-1.3835405665408391,0.07729468599033816,0.5314905297147781,1.0,12/24,26.82%,CAMK2D;CALM1;FKBP1A;AKAP6;SELENON;SRI;PDE4D;CALM3;NOS1;GSTM2;JPH2;JPH4
prerank,oogenesis (GO:0048477),0.6930361359172027,1.3835157799973246,0.16151685393258428,0.8166218915084076,1.0,5/15,19.57%,TRIP13;KMT2D;METTL3;MARF1;FMN2
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.48103228868808257,-1.3829902544387715,0.09731543624161074,0.5307375653127797,1.0,7/15,24.36%,VEGFC;NTRK3;SCG2;VEGFA;VEGFB;VEGFD;CXCL12
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.33228829836190543,-1.3828814051699205,0.030303030303030304,0.5287670216727093,1.0,33/69,25.20%,COX6C;COX4I1;COX5A;COX7B;NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;COX7C;NDUFS3;UQCRC2;NDUFB3;NDUFS4;NDUFA5;UQCRB;NDUFA6;NDUFA4;NDUFB9;UQCR10;UQCRQ;NDUFAF1;NDUFB6;NDUFA11;COX8A;NDUFB10;NDUFB11;NDUFA10;UQCRC1;COX5B;NDUFS6;NDUFA1
prerank,inhibitory synapse assembly (GO:1904862),-0.5319021133493573,-1.3825658643294645,0.12539184952978055,0.5272351703421361,1.0,5/11,11.29%,GABRB3;GABRA2;FGF13;GABRB2;GABRG2
prerank,nucleotide-excision repair (GO:0006289),0.5893997270100985,1.3814925144707197,0.06358974358974359,0.8219325216320531,1.0,18/101,7.48%,POLK;BRIP1;POLE;POLA1;BRCA2;RFC4;RPA1;CHD1L;ERCC4;POLD3;RFC2;POLD1;RPA2;ERCC3;RFC1;RFC3;PRPF19;POLR2A
prerank,histone H4 acetylation (GO:0043967),0.6141307184508313,1.3811010760639768,0.12147505422993492,0.8213307041065503,1.0,21/47,18.80%,KANSL1;BRCA2;KANSL2;HAT1;ING4;MSL3;EP400;EPC1;KMT2A;JADE1;ACTL6B;RUVBL2;PER1;TRRAP;BRD8;PHF20;ZZZ3;KANSL3;NAA60;NAA40;JADE3
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.5338785742760311,-1.380887058915519,0.11356466876971609,0.5290426552495198,1.0,6/12,30.20%,TLR4;GRIN1;RAB27A;ZNF205;SLC5A3;ADGRB1
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.4907250393911903,-1.3801430999702244,0.10726643598615918,0.5285447321039429,1.0,11/14,43.87%,UQCC2;RPUSD4;FASTKD2;RMND1;COA3;MPV17L2;TRMT10C;C1QBP;FASTKD3;RPUSD3;NGRN
prerank,cellular sodium ion homeostasis (GO:0006883),-0.48548565305207925,-1.3797433768374177,0.09665427509293681,0.5272343198298706,1.0,6/15,16.25%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;ATP1A2;SLC12A2
prerank,somite development (GO:0061053),0.7136942885779024,1.379463621544252,0.16911764705882354,0.8252678612028845,1.0,4/11,9.91%,LOXL3;PPP2R3A;SFRP2;MEOX2
prerank,regulation of coagulation (GO:0050818),-0.5553429647347496,-1.379307953915657,0.12386706948640483,0.5261792379813465,1.0,2/11,5.30%,CAV1;EPHB2
prerank,regulation of catabolic process (GO:0009894),0.6542778648494268,1.3774440364394835,0.16944444444444445,0.8305330337818866,1.0,3/18,5.71%,FAM83D;CHEK2;FAF1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.5385603373144101,-1.3774154484389893,0.1402439024390244,0.5289907365101549,1.0,2/11,8.02%,MALT1;PRKCQ
prerank,electron transport chain (GO:0022900),-0.4781062660651709,-1.376598894821499,0.1111111111111111,0.5289780353593232,1.0,9/15,30.24%,PDIA5;NDUFA5;PPARGC1A;ETFRF1;ETFDH;ETFB;NDOR1;CYB561;UQCRFS1
prerank,signal release from synapse (GO:0099643),-0.36237087389719763,-1.3763938501287798,0.031007751937984496,0.5272648474047334,1.0,13/43,17.37%,PCLO;SYN3;RIMS1;SYN2;SYT1;LIN7A;BRSK1;NRXN1;SNPH;DVL1;CPLX1;SNAP25;SYT10
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.39701997625069463,-1.3760629950403045,0.07006369426751592,0.5260095654635503,1.0,15/33,22.52%,NRG3;GRIK1;IQSEC2;GRID2;BCR;GRIK4;CACNA1B;RELN;PSMC5;LRP8;SLC4A8;NLGN1;GRIK2;GRID1;BDNF
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.648941432697252,1.3757616807408244,0.1613316261203585,0.8345170628018048,1.0,4/20,9.15%,ACMSD;GCK;ERFE;CDA
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.6512843817497574,1.3756487697586053,0.18699186991869918,0.8329557053970332,1.0,8/18,22.49%,AQP1;NR3C1;HNRNPU;ANXA1;KLF9;PCK2;UBE2L3;ZFP36L1
prerank,mesenchymal cell differentiation (GO:0048762),0.5941650763668104,1.3755464404961826,0.11589403973509933,0.8313002066471894,1.0,18/51,13.45%,FAM83D;LOXL3;LOXL2;TGFBR3L;ROCK2;GSK3B;FGFR2;TGFBR3;AKNA;TRIM28;ROCK1;FBXL17;TGFBR1;LIMS1;BMP2;RBPJ;SOX9;HEY2
prerank,positive regulation of microtubule polymerization (GO:0031116),0.6245709708385401,1.3752407575956351,0.1605231866825208,0.8303962780879205,1.0,8/28,11.75%,CDK5RAP2;CKAP5;PSRC1;NUMA1;MAPT;DRG1;AKAP9;RAC1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5180441715282046,-1.3749588562194952,0.1398176291793313,0.5268418943576758,1.0,3/12,7.98%,PRKG1;MEF2C;TPM1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.4205017893090372,-1.3748519354611766,0.08602150537634409,0.5250368984113648,1.0,14/26,18.62%,RIMS1;SLC8A3;SHANK3;TMEM108;NRXN1;RELN;CHRNA7;APP;SHANK1;DLG4;GRIN1;PRKCZ;NLGN1;STX1B
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.4913904980117515,-1.3705353721399298,0.15140845070422534,0.5343770859453434,1.0,8/14,19.13%,ETNK1;SLC27A1;CHKA;ETNK2;PCYT2;SELENOI;CHKB;LPIN1
prerank,relaxation of muscle (GO:0090075),-0.5162868570383414,-1.370036512356892,0.11194029850746269,0.5333131425929134,1.0,8/13,25.08%,CAMK2D;ATP1B1;ATP1A1;GSN;ATP1A2;PIK3CA;P2RX4;GSTM2
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.6997953783261772,1.3697189270238412,0.18208955223880596,0.8484991713823707,1.0,5/11,8.19%,MPHOSPH8;SETDB2;TPR;ATF7IP;TRIM28
prerank,histone H2A ubiquitination (GO:0033522),0.6659137816404739,1.369115408375463,0.19293478260869565,0.848779444979094,1.0,5/17,9.31%,RNF168;TRIM37;BCOR;KDM2B;CUL4B
prerank,response to muscle stretch (GO:0035994),-0.5062000483422079,-1.368970824088125,0.10839160839160839,0.5343431194249588,1.0,5/15,12.26%,PTK2;CDH2;RYR2;CTNNB1;GSN
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.5783507273071138,1.367993518347374,0.11075949367088607,0.8508291638827107,1.0,10/72,7.48%,SHCBP1;CEP57;SETX;FGFR4;FGFR2;RBFOX2;HNRNPA1;FRS2;HNRNPH1;POLR2A
prerank,regulation of anoikis (GO:2000209),-0.44674589616486265,-1.3679860684407674,0.08764940239043825,0.5347692661568897,1.0,9/19,21.74%,PTK2;CAV1;SIK1;TLE1;BCL2;PIK3CA;TLE5;MYBBP1A;PTRH2
prerank,mRNA modification (GO:0016556),-0.43586039642935864,-1.367359544491746,0.09569377990430622,0.5340979919313819,1.0,10/22,16.73%,METTL16;NSUN2;TRMT61B;METTL14;PCIF1;ZC3H13;TRUB1;CMTR1;DKC1;CBLL1
prerank,DNA methylation (GO:0006306),0.6273706966428304,1.3672574422697106,0.16339869281045752,0.8515122118943379,1.0,7/23,14.29%,ATRX;HELLS;PPM1D;GATAD2A;ATF7IP;METTL4;DNMT3A
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.6771032703259027,1.3671558417999325,0.17872968980797638,0.8498559258538003,1.0,4/13,6.81%,ALG14;ALG13;SRD5A3;MPDU1
prerank,neurotransmitter secretion (GO:0007269),-0.35871882530122357,-1.3667229599031083,0.03225806451612903,0.5336430937142902,1.0,13/44,17.37%,PCLO;SYN3;RIMS1;SYN2;SYT1;LIN7A;BRSK1;NRXN1;SNPH;DVL1;CPLX1;SNAP25;SYT10
prerank,tRNA wobble base modification (GO:0002097),-0.5027819746611089,-1.3664547576563018,0.11724137931034483,0.5321489888681685,1.0,7/14,25.84%,ELP3;TRMT9B;MTO1;DPH3;ELP4;GTPBP3;ALKBH1
prerank,regulation of protein neddylation (GO:2000434),-0.5734648675036371,-1.3661649455076765,0.10903426791277258,0.5307925587267356,1.0,7/10,30.04%,DCUN1D3;DCUN1D5;DCUN1D4;DCUN1D2;HIF1A;RPL11;COPS9
prerank,nuclear membrane organization (GO:0071763),0.6520494215681215,1.3660083262280274,0.1736842105263158,0.8519258050158866,1.0,2/19,1.13%,PLK1;NEMP1
prerank,linoleic acid metabolic process (GO:0043651),-0.4921437512739653,-1.3652689481653904,0.08812260536398467,0.5311133945732532,1.0,10/17,46.82%,PNPLA8;ACSL1;ELOVL1;FADS1;GSTM2;ALOX12;ELOVL2;ALOXE3;ALOX5;FADS2
prerank,sodium ion homeostasis (GO:0055078),-0.42887266552063563,-1.3652638428022161,0.11255411255411256,0.5290115397708189,1.0,6/21,16.25%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;ATP1A2;SLC12A2
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.47866855382637513,-1.3651990090951078,0.11594202898550725,0.5270368221234453,1.0,10/16,32.97%,PINK1;NUPR1;COX7A2;UQCC2;ATP7A;AK4;PDE12;MLXIPL;PPIF;VCP
prerank,peptide biosynthetic process (GO:0043043),-0.2898455067657202,-1.3649531712873368,0.0,0.5256129686183989,1.0,79/153,21.25%,EEF1A1;RPL13;FARSB;RPS8;PCSK5;RPS23;RPS29;RPL37A;RPS21;RPL38;RPS11;RPL21;RPL35A;RPL23;RPL17;RPL3;RPS15;EIF4G1;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;GGT5;MRRF;RPL8;FURIN;RPS14;RPSA;RPL10;RPL18;RPL32;RPS28;RPS5;RPS24;RPL15;RPS19;RPL39;SARS1;RPL12;RPL27;RPL24;MRPS5;RPS12;RPS4X;RPS27;RPL27A;RPS9;WARS1;MRPS18A;MRPS15;RPL30;MRPS21;MRPS6;RPL19;RPL28;MRPL27;RPL31;RPL13A;RPL36A;RPLP2;RPL29;HBS1L;PCSK1;MRPL23;DHPS;MRPL9;TNIP1;RPLP0;RPL10A;RPS6KB2;RPS10;RPL35;RPS26
prerank,inorganic ion transmembrane transport (GO:0098660),0.6930245954250325,1.363991998693084,0.16472303206997085,0.8572379003593182,1.0,1/12,0.91%,RHAG
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.47721796268464806,-1.3636084292824344,0.09541984732824428,0.5271517468652145,1.0,8/15,34.08%,NR1H3;NR1H2;PPARGC1A;SLC45A3;MID1IP1;MLXIPL;PPARG;NR4A3
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.44446506048059314,-1.3625098466644894,0.10548523206751055,0.5276167839614998,1.0,13/20,30.21%,CDC73;MEIS2;CDK6;MEIS1;HOXA5;PRMT1;HOXA9;PTK2B;MAFB;HSPA9;ZFP36;HOXB8;CIB1
prerank,regulation of histone acetylation (GO:0035065),0.6170540561923314,1.3622762944175382,0.16908212560386474,0.8613252010058104,1.0,6/33,9.85%,BRCA1;PAXIP1;CTBP1;ARRB1;CHEK1;KMT2A
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.625514862499374,1.3621166399772837,0.17712177121771217,0.8598190828089031,1.0,10/26,18.78%,RRM2;RRM1;LARGE1;TKT;ALG8;ST3GAL4;ST3GAL2;GK5;GK;GCNT1
prerank,negative regulation of secretion (GO:0051048),-0.5592816660634455,-1.3609717162146828,0.1355421686746988,0.5298537979138546,1.0,7/10,28.82%,NR1H3;VAMP8;VAMP3;PTGER3;CD74;EGF;ERBB3
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.6402707823351584,1.360836904221557,0.18985695708712613,0.8624598324390906,1.0,10/21,15.95%,PNLDC1;CNOT1;CNOT6L;SAMD4A;TUT7;CNOT6;PAN3;TUT4;CNOT7;CNOT4
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.4288951562306277,-1.3607307012360237,0.07179487179487179,0.5284413216350128,1.0,7/25,14.10%,PRKN;TMTC2;TRPM7;CAV1;FAM20A;SELENON;GRIN1
prerank,cellular zinc ion homeostasis (GO:0006882),-0.4114212921751653,-1.360292605392904,0.09389671361502347,0.5273089269100418,1.0,13/26,20.87%,SLC39A10;SLC39A13;SLC39A7;SLC30A1;MT2A;MT1X;MT1E;MT1M;MT1H;MT1F;MT1B;MT1A;MT1G
prerank,negative regulation of translational initiation (GO:0045947),0.6689968131028758,1.3601956091656962,0.17216642754662842,0.8628023292102648,1.0,6/13,17.59%,AGO2;TPR;FMR1;LARP1;RBM4;PAIP2B
prerank,regulation of T cell differentiation (GO:0045580),0.613766442137892,1.3601084955403688,0.17520858164481526,0.8610926359633323,1.0,2/33,2.36%,FANCA;CBFB
prerank,secretory granule organization (GO:0033363),-0.5600348784209365,-1.3598869099450355,0.11363636363636363,0.526265785197179,1.0,5/10,14.61%,LYST;SRGN;DTNBP1;BLOC1S2;VPS33B
prerank,aromatic amino acid family catabolic process (GO:0009074),0.6696171924151096,1.3598762039299934,0.16642958748221906,0.8599654995787043,1.0,3/15,13.22%,ACMSD;KMO;IL4I1
prerank,regulation of telomerase activity (GO:0051972),0.6151072171106976,1.3594708411464007,0.13245033112582782,0.8595072804574073,1.0,6/45,6.60%,NEK2;PIF1;AURKB;TERF1;ERCC4;GRHL2
prerank,protein localization to Golgi apparatus (GO:0034067),0.625201427110826,1.358686120505508,0.1763975155279503,0.8602488116679338,1.0,7/27,12.35%,RAB33B;GBF1;OBSL1;BICD2;VPS13A;GAK;ZDHHC15
prerank,regulation of B cell apoptotic process (GO:0002902),0.6863588806459724,1.358621311419798,0.15971223021582734,0.8584957049051208,1.0,2/12,2.99%,AURKB;FNIP1
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.4060048723562431,-1.3584233960928156,0.08771929824561403,0.5283196795391147,1.0,9/27,20.57%,RIMS1;SYT1;SYT7;SYT11;SYT12;ARL8B;SYT10;SYT6;SYT2
prerank,central nervous system neuron differentiation (GO:0021953),-0.3900283698006739,-1.3573659246441558,0.057692307692307696,0.5290750083521033,1.0,13/33,22.17%,SPOCK1;NTRK2;OPHN1;GRID2;PROX1;MDGA2;CTNNB1;SOX4;LRP6;TOX;GBA2;ATP7A;ZC4H2
prerank,pre-replicative complex assembly (GO:0036388),0.5882490494624603,1.3562080056722574,0.12486544671689989,0.8651680428499072,1.0,17/64,10.89%,MCM5;ORC1;MCM8;MCM6;MCM7;MCM2;CDC6;PSMC2;PSMD5;MCM3;MCM4;ORC2;ORC3;PSMB1;PSMD14;PSMD1;PSMB9
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.6043874864335026,1.3560910318164552,0.13489409141583056,0.8636289764177913,1.0,10/49,11.96%,KIF14;GSK3B;IAPP;PMEPA1;ANKRD27;SMAD6;RIOK3;HMGB1;PYDC1;AIDA
prerank,regulation of synapse maturation (GO:0090128),0.7017843569831841,1.3560152152033715,0.15522388059701492,0.8618687696300777,1.0,2/10,4.56%,CDC20;ADGRL1
prerank,lipoprotein catabolic process (GO:0042159),-0.5389047518115087,-1.3551670959650608,0.13043478260869565,0.5332137910316826,1.0,8/11,27.00%,APOE;LYPLA1;ABHD17C;CTSD;PPT1;LYPLAL1;LYPLA2;ABHD17B
prerank,anterograde axonal transport (GO:0008089),0.6022892754920618,1.3551047412450863,0.1707891637220259,0.8632718576542405,1.0,2/37,3.22%,KIF4A;TRAK1
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.48052558181534966,-1.3550021323211654,0.11971830985915492,0.5315507016577699,1.0,6/15,13.87%,AKT2;PPM1K;IRS2;GPLD1;IRS1;LDLRAP1
prerank,positive regulation of nervous system development (GO:0051962),-0.35622496617061605,-1.3538261798185127,0.08490566037735849,0.5324819528285911,1.0,23/42,27.95%,PTPRD;SYNDIG1;GRID2;EPHB2;NUMBL;IL1RAPL1;NUMB;NRXN1;TGM2;OPRM1;FAIM;LRRC4B;NLGN1;IL1RAP;SNW1;BDNF;DLG5;SRPX2;SERPINF1;TRIM32;GPER1;SOX11;EPHB3
prerank,engulfment of apoptotic cell (GO:0043652),0.6571812930437152,1.3531844448899462,0.17391304347826086,0.8682141010825122,1.0,1/15,0.66%,XKR5
prerank,regulation of mitotic spindle assembly (GO:1901673),0.6382015714742021,1.3531395977337912,0.18556701030927836,0.8664063730525486,1.0,6/19,10.91%,PLK1;CEP97;TPR;CCSAP;HNRNPU;DRG1
prerank,cellular response to amyloid-beta (GO:1904646),-0.3746785630867497,-1.3522872216051898,0.0880503144654088,0.5344923147675318,1.0,13/35,14.10%,CACNA2D1;PSEN1;GRIN2A;IGF1;TLR4;LRP1;CASP4;VCAM1;LGMN;ATP1A3;APP;GRM5;GRIN1
prerank,lipoxygenase pathway (GO:0019372),0.666279185133733,1.3521718456724146,0.19478737997256515,0.8677594317330396,1.0,1/14,0.82%,PON1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.6380444021703906,1.350600649893689,0.17834394904458598,0.8713831651680549,1.0,9/21,13.65%,PAXIP1;SETX;MED14;SRF;MED30;BCLAF1;MED24;TWIST1;MED1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.5399355993342634,-1.3503946688145787,0.12316715542521994,0.5354280326054817,1.0,5/10,15.62%,AP2A2;VLDLR;AP2M1;AP2S1;AP2A1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.5399355993342634,-1.3503946688145787,0.12316715542521994,0.5354280326054817,1.0,5/10,15.62%,AP2A2;VLDLR;AP2M1;AP2S1;AP2A1
prerank,epithelial to mesenchymal transition (GO:0001837),0.5905684762537522,1.350216691745486,0.1444321940463065,0.8707979665915374,1.0,16/47,13.45%,FAM83D;LOXL3;LOXL2;TGFBR3L;ROCK2;GSK3B;TGFBR3;AKNA;TRIM28;ROCK1;TGFBR1;LIMS1;BMP2;RBPJ;SOX9;HEY2
prerank,"wound healing, spreading of cells (GO:0044319)",0.6197183979764569,1.3500121393151148,0.16876574307304787,0.8695154240538076,1.0,12/24,15.79%,RHOA;PDPN;CCN1;ARHGAP24;TMEFF2;ARHGAP35;MRTFA;ADAM17;ITGA5;CD44;RHOC;LCP1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.4994381347095979,-1.349866396791315,0.1396103896103896,0.5346937552495046,1.0,8/13,18.75%,ERLEC1;OS9;EDEM2;EDEM1;YOD1;BCAP31;SVIP;UBE2G2
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.6168909978382661,1.3491346454449653,0.1633835457705678,0.8708119425532759,1.0,4/35,5.04%,NEK2;AURKB;RTEL1;HNRNPA1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.3101291328991956,-1.348266558149313,0.02040816326530612,0.5369683351896558,1.0,15/72,7.53%,PTK2;FLT1;TEK;NTRK2;INSR;IGF1;TGFB2;PDGFRB;BECN1;NTRK3;PIK3R1;FGF2;IRS2;LYN;SEMA4D
prerank,histone ubiquitination (GO:0016574),0.6386005450277656,1.3477976996233059,0.17609254498714652,0.873732941342573,1.0,4/21,9.11%,UHRF1;UBE2N;RNF40;LEO1
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.36937143048064613,-1.346544139598938,0.05172413793103448,0.5396367349024405,1.0,19/39,24.35%,RPS15;RPS7;RPS6;RPS14;RPSA;RPS28;RPS5;RPS24;RPS19;RPS27;METTL17;SNU13;RIOK2;ERAL1;LTV1;NOB1;EMG1;SURF6;MRPS7
prerank,acyl-CoA metabolic process (GO:0006637),-0.380451159177978,-1.3441855395198392,0.08227848101265822,0.5439738508347112,1.0,14/35,27.84%,ACOT11;SUCLG2;ACBD6;DLST;ACACB;HMGCS2;ACSL6;DBI;ACSF2;ACOT7;ACOT13;MCEE;ACOT6;HMGCS1
prerank,positive regulation of B cell activation (GO:0050871),0.5808377817375304,1.343659218017083,0.15725359911406422,0.8868971143534984,1.0,3/50,3.93%,TNFSF13B;PAXIP1;MMP14
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.5420949744004431,-1.3434788361784824,0.13569321533923304,0.5439132740122663,1.0,5/10,13.64%,SHANK3;NETO1;RAB5A;APP;DLG4
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.34037507588964366,-1.3433025367995564,0.024691358024691357,0.5422785835409991,1.0,20/56,22.47%,HSP90B1;TAB2;TLR4;CTSB;SFTPA2;SFTPA1;TAB3;LGMN;NOD1;LBP;IRAK4;CTSL;CNPY3;UNC93B1;UBB;TIFA;CTSS;S100A1;UBC;RPS27A
prerank,genitalia development (GO:0048806),-0.519474010481006,-1.3431272420066063,0.1414790996784566,0.5408014891592308,1.0,6/12,27.80%,DNAJC19;TBX3;PTPN11;STRA6;CHD7;FOXF2
prerank,positive regulation of protein processing (GO:0010954),-0.45381029785049415,-1.3431216529232701,0.11336032388663968,0.5388500270530047,1.0,6/19,18.88%,CCBE1;GSN;PLGRKT;ENO1;NKD2;CLEC3B
prerank,regulation of nervous system process (GO:0031644),-0.45299537499950293,-1.3428330111496865,0.0743801652892562,0.5375910483363054,1.0,8/18,11.05%,DLGAP1;DLGAP4;SLC8A3;TMEM108;NOS3;HTR2C;CHRNA7;APP
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.6801188068526078,1.3427680923606355,0.18577648766328012,0.8881108036075162,1.0,3/12,9.15%,TK1;DCK;CDA
prerank,relaxation of cardiac muscle (GO:0055119),-0.5007602430046472,-1.3426012059522507,0.1259259259259259,0.5362286845078,1.0,8/13,25.08%,CAMK2D;ATP1B1;ATP1A1;GSN;ATP1A2;PIK3CA;P2RX4;GSTM2
prerank,cytoskeleton organization (GO:0007010),0.5570679222377797,1.3422654894229606,0.08850457782299084,0.8878514444900776,1.0,29/114,13.67%,DIAPH3;SYNE3;MAST2;PHIP;ARHGAP10;RHOA;OBSL1;PACSIN2;AJUBA;DIAPH1;MICAL3;CNN2;FGD4;ANK1;PRPF40A;PDZD8;FGD1;WDPCP;SH3D19;LIMD1;STRIP2;EPB41L3;FGD6;RND2;RAC1;DMTN;DES;LARP4;PRKCI
prerank,translation (GO:0006412),-0.254081184080927,-1.3420803042700178,0.0,0.5356055481678863,1.0,89/208,21.68%,EEF1A1;RPL13;FARSB;RPS8;RPS23;RPS29;RPL37A;RPS21;LARS2;RPL38;RPS11;RPL21;RPL35A;RPL23;RPL17;RPL3;RPS15;EIF4G1;EEF2;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;AARS1;RPLP1;RPS13;RARS1;RPL9;RPL37;MRRF;RPL8;FARSA;RPS14;RPSA;RPL10;RPL18;RPL32;RPS28;RPS5;RPS24;RPL15;RPS19;RPL39;SARS1;RWDD1;RPL12;RPL27;RPL24;MRPS5;RPS12;RPS4X;RPS27;RPL27A;RPS9;N6AMT1;WARS1;MRPS18A;MRPS15;RPL30;EEF1B2;MRPS21;MRPS6;RPL19;RPL28;MRPL27;RPL31;RPL13A;RPL36A;TARS1;NARS1;RPLP2;RPL29;HBS1L;MRPL23;DHPS;KARS1;MRPL9;TNIP1;RPLP0;RPL10A;RPS6KB2;TSFM;RPS10;RPL35;RPS26;MRPL51;TMA7
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.6356960530503283,1.3416417246892938,0.18604651162790697,0.888182309125234,1.0,9/20,15.51%,MOV10;AGO2;CNOT1;AJUBA;NRDE2;CNOT6;LIMD1;CNOT7;TNRC6C
prerank,UV-damage excision repair (GO:0070914),0.6716042479176809,1.3396870253677406,0.19405099150141644,0.8934606745611304,1.0,5/12,15.21%,POLA1;POLD3;CUL4B;XPA;INO80
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.6022380433605986,1.3393669476359842,0.18106508875739644,0.8926653901108584,1.0,13/30,18.67%,PIF1;TERF1;STN1;ERCC4;HNRNPA1;HNRNPU;TERF2;SRC;TP53;TINF2;ACD;EXOSC10;NIBAN2
prerank,membrane depolarization (GO:0051899),-0.3881418904192178,-1.3384582123627988,0.08187134502923976,0.5432966246126192,1.0,20/32,37.85%,CAV1;SCN1A;CACNA1B;SCN9A;CACNG4;ABL1;CACNG2;SCN3A;SCN8A;SCN1B;P2RX4;P2RX7;CACNA1H;CACNB3;CACNA1I;YWHAH;SCN3B;CHRNA4;CACNA1A;KCNH2
prerank,fatty acid elongation (GO:0030497),-0.5023187699626954,-1.3379003514063745,0.13504823151125403,0.5428256598888752,1.0,7/13,27.90%,ELOVL7;HACD3;HACD2;HACD1;ELOVL6;ELOVL1;TECR
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.33652482990524746,-1.336909296897284,0.028169014084507043,0.5435542380378972,1.0,34/54,36.41%,DCUN1D3;SMAD7;OGT;PRMT3;CAV1;PER2;UFL1;SQSTM1;PINX1;DNAJA1;CTNNB1;SPRY2;SOX4;SH3RF2;PIAS3;UBXN1;PRKCG;PARK7;MINAR1;RPS3;TRIM21;RPL11;U2AF2;COPS9;ADGRB1;TNFAIP3;SPOPL;VPS28;AKT1;BAG2;HSPA1A;SIRT7;ARRB2;CHP1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.6429341515862794,1.3350824995288075,0.194125159642401,0.9063319980428501,1.0,1/20,0.19%,BRCA1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.5794033524220008,1.3347069069532,0.1400862068965517,0.9057918477835217,1.0,26/59,18.72%,CDK1;CIT;DYRK1A;ROCK2;GSK3B;NLK;PRKDC;DYRK3;WNK1;CHEK1;CDC42BPA;LRRK2;ROCK1;MARK2;CSNK2A2;CDC42BPG;TGFBR1;PRKCA;PDPK1;PRKD1;PRKD2;STK39;HIPK3;WNK3;OXSR1;HIPK1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.5356080438729833,-1.33402391734506,0.13690476190476192,0.5491247991064423,1.0,3/10,6.74%,STAT3;STAT6;LYN
prerank,V(D)J recombination (GO:0033151),0.6849226984617426,1.3337032492065186,0.1951219512195122,0.9074693456301188,1.0,4/11,15.44%,HMGB2;PRKDC;HMGB1;DCAF1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.495988985055549,-1.3333132447985112,0.12686567164179105,0.5489318402401465,1.0,8/14,29.12%,ANO6;PDCD4;PLCG1;THBS1;RGCC;ECSCR;GPER1;CD40
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.4161480669646218,-1.3329021378564085,0.11219512195121951,0.5479168107329899,1.0,6/23,19.48%,CARD16;IGF1;GAS6;CX3CL1;GIT1;ZC3H12A
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.47315871384917707,-1.3328446441649948,0.13732394366197184,0.5460702533955178,1.0,5/15,9.37%,ABHD12;ABHD16A;GOT2;GGT5;PRODH
prerank,regulation of phosphate metabolic process (GO:0019220),0.6436968825604429,1.3322633989265986,0.19307589880159787,0.9106428333308971,1.0,2/16,2.72%,BARD1;MCM7
prerank,axonal transport (GO:0098930),0.597238130026994,1.3311666742300674,0.18501170960187355,0.9126659881188701,1.0,1/36,0.11%,KIF4A
prerank,signal transduction by p53 class mediator (GO:0072331),0.6064021021887965,1.3309906055704095,0.19244823386114496,0.9113256779461364,1.0,7/30,10.90%,E2F7;ATRX;PAXIP1;MDM4;HINT1;BOK;NDRG1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.339279005243506,-1.3309774418706735,0.038461538461538464,0.5488154017986376,1.0,15/57,18.26%,GRM7;CHRM2;GABBR1;GNAI1;PSAP;GNAL;GPR37;OPRM1;HTR4;ADCY3;ADCY8;ADCY4;CHRM3;ADRA2A;PDE2A
prerank,negative regulation of transferase activity (GO:0051348),0.6182564549273157,1.3301934554381112,0.18802395209580838,0.9122740374045794,1.0,12/28,15.84%,PIF1;TERF1;FBXO5;GSK3B;ERCC4;MAPT;HNRNPU;BAG5;EIF4A2;CDKN1B;SRC;TP53
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.5577999578213484,1.3296973796880494,0.003,0.9120766333643675,1.0,101/417,15.04%,DEPDC1;CENPF;BRCA1;EZH2;BIRC5;LOXL3;GLI3;HMGB2;E2F1;CBX5;RBM15;FOXE1;ATOH8;BTAF1;ILF3;KMT5A;SFMBT1;TIMELESS;LOXL2;RB1;SP3;TWIST2;CTCF;ZEB1;MPHOSPH8;EED;RBFOX2;DAP;BCOR;SETDB2;MBD1;KHDRBS1;BHLHE41;NFIL3;CTBP1;ZNF568;MAEL;IKZF1;GZF1;SCML2;YAF2;TCF7L2;HOXA7;PML;SCMH1;GATAD2A;PSPC1;MIDEAS;SFRP2;NIPBL;POU2F1;ZHX2;UIMC1;ATF7IP;SAP18;TRIM28;RCOR1;IRF1;ING4;BCLAF1;SMARCA4;LIMD1;NONO;ARID4A;EPC1;MTA3;NR3C1;SFPQ;RUNX1T1;LIMS1;RBM15B;DKK3;SMURF2;L3MBTL2;HDAC1;BMP2;AHR;NKX2-1;ZHX3;ATXN1;FBXW11;RBPJ;SOX9;SMAD4;HDAC2;ATF5;TWIST1;HEY2;USP47;BTRC;BCL7A;EIF4A2;FOXK2;CDKN1B;KDM5C;PCGF6;FOXM1;QARS1;PER1;YEATS2;RBAK
prerank,cellular response to alkaloid (GO:0071312),0.6440863499961884,1.3289880150224591,0.17827298050139276,0.912660549142135,1.0,5/17,9.41%,RAD51;CASP7;BLM;SPIDR;SLC8A1
prerank,aggrephagy (GO:0035973),-0.3875395668726755,-1.3286733123261267,0.0962566844919786,0.5529291909629426,1.0,12/27,22.55%,PRKN;DYNC1LI2;SQSTM1;DYNC1I2;DYNC1LI1;DYNLL2;WDFY3;UBB;PARK7;UBC;RPS27A;WDR81
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5923885009001688,1.3282939920552754,0.1781609195402299,0.9132437302044512,1.0,5/38,8.92%,BRCA1;FADD;GSK3B;SERPINE1;TNFRSF10B
prerank,organelle assembly (GO:0070925),0.557691087263739,1.3280003841639647,0.01,0.9122953459199081,1.0,67/384,10.90%,CENPF;CENPE;NEK2;CENPA;DLGAP5;KIF24;ANLN;HAUS8;PLK4;IFT80;HYLS1;CEP89;BBS9;CCDC61;HAUS4;HAUS6;DZIP1L;SCLT1;VPS37B;ACTR3;WDR35;PARVA;ASAP1;GBF1;SPAG16;WDR90;IFT140;POC1B;FAM161A;PATL1;EXOC4;KIF27;PCM1;TUBGCP5;OCRL;MAPT;HAUS7;TXNDC15;LSM3;EIF4ENIF1;MKKS;G3BP1;WDR11;CEP83;ATG7;VPS37A;RILPL1;NUDCD3;RFX2;SSX2IP;STAM;HAUS1;CCDC57;CFAP52;GOLGA8B;ZFYVE1;WDPCP;ATP2A2;NPHP3;LIMD1;RAB1A;RB1CC1;YTHDF2;CENPW;TRAPPC14;TTC39C;VTA1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.6950274760482559,1.3274668371288083,0.19440353460972018,0.9121372075169079,1.0,3/11,3.25%,FADD;TICAM1;COLEC12
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.5272675465438612,-1.326854955874196,0.1355421686746988,0.5536632963629076,1.0,6/11,21.47%,CCT5;TCP1;CCT7;CCT2;DKC1;MEPCE
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.5272675465438612,-1.326854955874196,0.1355421686746988,0.5536632963629076,1.0,6/11,21.47%,CCT5;TCP1;CCT7;CCT2;DKC1;MEPCE
prerank,neurogenesis (GO:0022008),0.573286630996912,1.3262374808389832,0.18421052631578946,0.9147101541400446,1.0,7/43,6.31%,WDR62;CDK5RAP2;CIT;TRAK1;LPAR1;MAPT;CXCR4
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.3884565927238863,-1.3256556793003358,0.11666666666666667,0.5548087859959706,1.0,10/29,16.08%,PTK2;FLT1;TEK;PDGFRB;FGF2;PIK3R4;IRS1;CD81;EPHA8;TNFAIP8L3
prerank,cardiac muscle contraction (GO:0060048),-0.3791358122406532,-1.325484077396289,0.10638297872340426,0.5533695749172753,1.0,9/34,19.39%,CAMK2D;ATP1B1;RYR2;TPM1;GSN;ATP1A2;SCN1B;PIK3CA;KCNQ1
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.6491236397126025,1.3252623468102107,0.180028129395218,0.9163537530739243,1.0,6/13,16.13%,MOV10;ZC3HAV1;CNOT1;RC3H1;CNOT7;PNPT1
prerank,long-term memory (GO:0007616),-0.43292275534055713,-1.3241290787148,0.13765182186234817,0.5552849842140207,1.0,7/19,12.24%,CPEB3;APOE;RASGRF1;SGK1;CAMK4;NFATC4;SHANK1
prerank,cellular protein-containing complex assembly (GO:0034622),0.5501419457122045,1.3229444897872573,0.07049345417925479,0.9227978153886112,1.0,20/159,9.56%,CENPF;CENPE;CENPA;DLGAP5;ANLN;NDC1;NUP205;DNAAF3;DHX9;MAPT;EIF4H;MKKS;AHCTF1;TPR;TCF4;NCK1;DNAI4;ANGPT1;LONP1;PICALM
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.278737331254215,-1.3229041602663654,0.14285714285714285,0.5566079906187215,1.0,77/168,21.25%,RPL13;AGO1;RPS8;NBDY;RPS23;RPS29;RPL37A;RPS21;RPL38;PARN;RPS11;RPL21;RPL35A;RPL23;RPL17;RPL3;RPS15;EIF4G1;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;CSDE1;RPS14;RPSA;RPL10;ATM;RPL18;RPL32;RPS28;RPS5;RPS24;RPL15;RPS19;RPL39;RPL12;RPL27;RPL24;RPS12;DDX5;DCP1B;RPS4X;RPS27;RPL27A;RPS9;RPL30;EXOSC9;RPL19;RPL28;EIF4A3;RPL31;RBM8A;SMG1;MTPAP;RPL13A;RPL36A;DCPS;TENT4B;RPLP2;RPL29;TNKS1BP1;CNOT11;ZC3H12A;RPLP0;DCP1A;RPL10A;RPS10;NCBP1;RPL35;RPS26
prerank,positive regulation of cartilage development (GO:0061036),0.6533612394927308,1.321920879461859,0.20053835800807537,0.9247614912411127,1.0,6/17,12.57%,BMP1;LOXL2;SOX6;TAPT1;BMP2;SOX9
prerank,fibrinolysis (GO:0042730),0.657096796137485,1.3217981820806592,0.19054652880354506,0.9232248719813455,1.0,4/13,18.52%,PLAU;SERPINE1;PLAUR;PLAT
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.46956338674211473,-1.321727263686457,0.13310580204778158,0.5578747585226134,1.0,8/15,22.30%,TMSB4X;FGF2;LGMN;MET;VEGFA;SMOC2;P2RX4;HSPB1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.6106197466078872,1.3216146585898405,0.21526908635794745,0.921908716888224,1.0,7/26,12.19%,CCNB1;EIF4E;CDC25B;CCDC57;CUL3;TAL1;PRKCA
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.4868623688476179,-1.3213409750608225,0.1611842105263158,0.5570023543402625,1.0,9/13,20.27%,INSR;IGF1;AKT2;IRS2;IGF2;EPM2AIP1;IRS1;DYRK2;SORBS1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.6121206583072728,1.3209060681368494,0.18646080760095013,0.9223975460448416,1.0,3/32,5.04%,NEK2;AURKB;HNRNPA1
prerank,chromatin organization (GO:0006325),0.5522009605072175,1.3205293205584727,0.08316633266533066,0.9219301864767243,1.0,36/132,15.74%,PHF19;EZH2;ATRX;DDX11;HMGB2;LOXL2;SMARCC1;RB1;BAZ1B;CHD1L;SMARCAD1;SETDB2;TCF7L1;NUDT5;HMGN2;HP1BP3;RBBP4;ARID1A;NUCKS1;SETD2;PHF1;SMARCA4;HDAC8;HDAC1;SOX9;HDAC2;MCM3AP;TADA2A;ACTL6B;KDM5C;RUVBL2;BAZ1A;SOX1;INO80;DR1;CHD1
prerank,negative regulation of cilium assembly (GO:1902018),0.665546378379557,1.3202560920652728,0.19710144927536233,0.9209026867491226,1.0,7/12,18.57%,CEP97;EVI5L;YAP1;TBC1D7;MAP4;ODF2L;LIMK2
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.4135366270487847,-1.3198296231675937,0.11822660098522167,0.5590194589817523,1.0,6/22,8.62%,CYRIB;STX7;MALT1;FBXO38;B2M;HSPD1
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.5415210671652986,-1.319572956469046,0.1592920353982301,0.5578343374923572,1.0,6/10,15.05%,GABRA2;GABRA3;GABRA5;GABRB2;GABRG2;GABRG1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.6996973937291984,1.3188899527254878,0.2054380664652568,0.9238516319293254,1.0,3/10,5.68%,TYMS;MTHFD1L;MTHFR
prerank,positive regulation of protein import into nucleus (GO:0042307),0.6027325972325958,1.3184622039198695,0.19877300613496932,0.9234751218019506,1.0,4/28,8.19%,ECT2;TPR;UBR5;TRIM28
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.6704993525776685,1.317755389447574,0.19688385269121814,0.924144025157342,1.0,8/14,19.63%,ATRX;BRCA2;TERF2;TINF2;ATR;ACD;TERF2IP;TERT
prerank,regulation of mitochondrial translation (GO:0070129),-0.42339111209604896,-1.3172573974669468,0.10628019323671498,0.5619552351167046,1.0,17/21,44.16%,UQCC2;MTG2;TSFM;RPUSD4;ALKBH1;FASTKD2;RMND1;COA3;MPV17L2;TRMT10C;C1QBP;FASTKD3;MTG1;SHMT2;RPUSD3;NGRN;MALSU1
prerank,early endosome to late endosome transport (GO:0045022),-0.4170186929982507,-1.3165768404926987,0.12669683257918551,0.5617871435262793,1.0,5/20,12.93%,STX8;KIF16B;BECN1;RAB5A;HOOK1
prerank,regulation of lipid kinase activity (GO:0043550),0.6682496466028658,1.316513478614883,0.18664643399089528,0.9268045534014892,1.0,2/11,2.56%,RBL1;RB1
prerank,response to progesterone (GO:0032570),-0.4357531348378072,-1.3162649580753087,0.13688212927756654,0.5606854618904912,1.0,10/18,25.79%,CAV1;TGFB2;ABHD2;NR1H3;CATSPER2;THBS1;TGFB3;WBP2;UBE3A;CATSPER3
prerank,regulation of axon regeneration (GO:0048679),0.6600832445235704,1.3157778327264844,0.20869565217391303,0.9275332007212229,1.0,5/12,11.39%,RTN4R;STK24;EPHA4;CNTF;PTPRS
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.42597419760742145,-1.315636689422122,0.136986301369863,0.5604480212553395,1.0,3/23,7.29%,PLA2G4A;PLAAT3;PNPLA8
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.559376582699188,1.315165489110267,0.14771519659936239,0.9278043401736656,1.0,23/70,17.68%,KIF14;RB1;RHOA;ATRNL1;PARVA;ITGB7;LAMB1;GRHL2;EFNA1;RILPL1;TMEFF2;SRGAP2;YTHDF2;RAC1;ITGA8;ITGAV;NTN4;UNK;TBCD;METTL3;FERMT3;ANTXR1;ABI2
prerank,sprouting angiogenesis (GO:0002040),0.5701034739741839,1.3151542137640593,0.17666666666666667,0.9259019982414677,1.0,12/51,14.43%,E2F7;E2F8;LOXL2;PARVA;SRF;ADGRA2;ROBO1;ANGPT1;NR4A1;RSPO3;EFNB2;MIA3
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.37090233990726273,-1.3149999327119397,0.09016393442622951,0.560229367745791,1.0,8/39,4.32%,MAML3;STAT3;EP300;MAML2;JAG1;ZMIZ1;TGFB2;NOS3
prerank,positive regulation of transporter activity (GO:0032411),0.6683181651164147,1.3149387244232338,0.19519094766619519,0.9247261601021886,1.0,5/13,17.54%,PON1;PDZK1;KMT2A;STK39;WNK3
prerank,regulation of microtubule nucleation (GO:0010968),0.6740112926143493,1.3148571363501371,0.1948249619482496,0.9230760063010227,1.0,2/10,2.26%,CKAP5;RANGRF
prerank,iron ion transport (GO:0006826),-0.34261866296336113,-1.3144268921572027,0.06382978723404255,0.5600807210444592,1.0,11/47,14.97%,ATP6V0A1;FTH1;ATP6V0D1;ATP6V1E1;SCARA5;ATP6V0B;ATP6V0A4;IREB2;ATP6V0C;ATP6V1H;MCOLN1
prerank,nucleus organization (GO:0006997),0.5766093556313032,1.314234452596209,0.18201997780244172,0.9233180191024842,1.0,7/47,7.65%,CEP55;NDC1;NUP155;NUP205;NUMA1;TPR;LEMD3
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.6660857574396054,1.313784992454771,0.19605077574047955,0.9229135804483807,1.0,3/13,7.81%,GLI3;CBFB;ZBTB7B
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.3773999226270757,-1.3129546654976398,0.10493827160493827,0.5621647135505691,1.0,12/32,26.78%,CAV1;AKAP6;CEMIP;PLCG1;TRPC3;TRPC1;CX3CL1;GRIN1;P2RX4;P2RX7;GPER1;THY1
prerank,peptidyl-threonine modification (GO:0018210),0.5657163754159147,1.3123382746987846,0.14361140443505807,0.9262213309388853,1.0,24/66,16.35%,CDK1;CIT;DYRK1A;ROCK2;GSK3B;NLK;GALNT1;PRKDC;DYRK3;WNK1;CHEK1;CDC42BPA;LRRK2;ROCK1;MARK2;CSNK2A2;CDC42BPG;TGFBR1;PRKCA;PDPK1;PRKD1;PRKD2;STK39;HIPK3
prerank,positive regulation of immune effector process (GO:0002699),-0.3880597225033209,-1.312272788235665,0.11764705882352941,0.5621638246134649,1.0,7/27,17.26%,DDX60;LBP;RPS19;MYO18A;CD81;XBP1;LGALS9
prerank,positive regulation of intracellular protein transport (GO:0090316),0.5493052954872025,1.3114500558862237,0.0783132530120482,0.9274520243692722,1.0,27/144,10.36%,KIF20B;ECT2;GTSE1;E2F1;SAE1;MIEF2;GSK3B;XPO4;TFDP1;ANP32B;PCM1;PRNP;PDZK1;MYO1C;LEPROT;TCF7L2;TPR;FBXW7;RNF31;RAB29;SH3GLB1;UBR5;TRIM28;HTRA2;EMD;CSNK2A2;MIEF1
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.5158106571237705,-1.3102852781264067,0.1523809523809524,0.565267689361946,1.0,6/11,17.83%,PARP8;PARP12;TIPARP;PARP6;PARP16;PARP10
prerank,defense response to protozoan (GO:0042832),-0.5183803339478544,-1.3099110833615006,0.1882716049382716,0.5642645213776823,1.0,10/12,43.11%,LYST;GBP4;GBP6;CD40;BATF;GBP7;MYD88;SLC11A1;GBP2;BATF2
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.44980050792035486,-1.3095377950019291,0.15,0.5633746965611098,1.0,7/16,19.29%,PPP1R16B;FGF2;AGTR1;THBS1;VEGFA;GATA2;FGFBP1
prerank,negative regulation of platelet activation (GO:0010544),-0.45348790025593155,-1.3095039757011167,0.14339622641509434,0.5615667639768831,1.0,4/16,5.31%,PRKG1;APOE;NOS3;THBD
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.5463515805353083,1.308945772151321,0.14153846153846153,0.9345378461420769,1.0,22/88,16.23%,KIF14;CCNF;PSMC2;PSMD5;FBXL7;FBXW7;CUL5;FBXL8;PSMB1;PSMD14;CUL4B;PSMD1;SKP2;FBXL17;PSMB9;FBXW11;BTRC;FBXO27;PSMC6;FBXO17;FBXL14;AMN1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.5915197708309704,1.3087944410543202,0.21420118343195266,0.9331875192766281,1.0,10/33,11.28%,TTF2;SETX;CSTF3;FIP1L1;SLBP;LSM11;WDR33;PCF11;SCAF8;CPSF4
prerank,response to estrogen (GO:0043627),0.5879485304693641,1.3077977353425925,0.19759036144578312,0.934878897148434,1.0,1/31,0.19%,BRCA1
prerank,response to ATP (GO:0033198),-0.4429670936762117,-1.307150714955552,0.16216216216216217,0.5658375787813131,1.0,9/18,28.46%,RYR3;HSP90B1;TRPC3;SSH1;DGKQ;P2RX4;P2RX7;ABCC9;P2RY12
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.4319767941296842,-1.3068356279682893,0.125,0.5648344987267283,1.0,13/20,31.65%,APOE;SREBF2;ARV1;FMO5;LDLRAP1;DGKQ;EPHX2;ABCA2;RAN;MBTPS1;ACADVL;MBTPS2;NR1H4
prerank,regulation of membrane repolarization (GO:0060306),-0.48603028878538446,-1.3064852262148907,0.14878892733564014,0.563904473505737,1.0,3/13,3.47%,CACNA2D1;CAV1;AKAP6
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.5008731778228188,-1.3057628662245575,0.17981072555205047,0.564074846579125,1.0,9/12,20.27%,INSR;IGF1;AKT2;IRS2;IGF2;EPM2AIP1;IRS1;DYRK2;SORBS1
prerank,negative regulation of hemostasis (GO:1900047),-0.5051627095971745,-1.3055375396340494,0.16091954022988506,0.5628227118723316,1.0,4/12,6.10%,APOE;VTN;THBD;CD34
prerank,lipid transport (GO:0006869),-0.2944796267289272,-1.304584645693822,0.045454545454545456,0.5634073391883948,1.0,35/97,25.83%,CERT1;PLTP;ATP8A1;APOE;SLCO1C1;SLCO2B1;GOT2;SCP2;PEX3;ABCA5;SLC27A1;ABCC4;ATP8B1;CHKA;SLCO2A1;LBP;MTTP;SPNS2;GLTP;ABCD2;TNFAIP8L3;STARD5;PRELID3B;OSBP;SLC27A4;ACSL1;OSBPL2;PLEKHA8;ABCA2;MFSD2A;NPC2;PITPNC1;PRELID3A;PRELID1;ABCA3
prerank,endoderm development (GO:0007492),-0.49617446703747503,-1.30406427574626,0.1602787456445993,0.5628058307028238,1.0,3/13,15.07%,KIF16B;DUSP1;SOX17
prerank,positive regulation of viral life cycle (GO:1903902),0.6066453709480757,1.30223460864182,0.20728643216080403,0.9533103810704586,1.0,3/22,6.94%,KPNA2;VPS37B;FMR1
prerank,central nervous system myelination (GO:0022010),-0.5191531313421476,-1.3016106047294582,0.15339233038348082,0.5673154782898019,1.0,4/11,13.78%,B4GALT5;B4GALT6;PLP1;TENM4
prerank,epithelial cell morphogenesis (GO:0003382),0.6371311058315506,1.3013492575838348,0.21074380165289255,0.9545781426684659,1.0,5/17,13.51%,COL22A1;COL18A1;GRHL2;RILPL1;COL15A1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.41201629511600063,-1.301308072481886,0.13488372093023257,0.566433397113826,1.0,14/22,32.10%,RPL23;RPS15;RPS7;RPS20;RPL37;ATM;DDX5;UBB;CDK5RAP3;EEF1E1;HEXIM1;CHD5;HIC1;SPRED3
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.49314218485933276,-1.300666509059043,0.1597222222222222,0.5663756212215825,1.0,5/14,13.12%,IGF1;GRN;TNFRSF1B;CX3CL1;SYT11
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5648171764245729,1.3005783711177292,0.18604651162790697,0.9554033796108237,1.0,5/55,5.63%,HMMR;HPSE;SPAM1;HYAL1;GPC6
prerank,protein import into nucleus (GO:0006606),0.5526344091159044,1.3001882390573283,0.16666666666666666,0.9548871980704136,1.0,26/66,20.53%,KPNA2;RANBP17;NUP155;KPNA3;RPAIN;E2F3;TNPO1;NUP85;EIF4ENIF1;CSE1L;TPR;IPO7;APPL2;NUP214;RANBP2;IPO11;NXT1;NUP133;KPNA4;IPO5;NXT2;FAM53B;IPO9;NUP188;NUP35;IPO4
prerank,organelle transport along microtubule (GO:0072384),0.5871958215943708,1.2997928878755367,0.21811680572109654,0.9544538370051411,1.0,9/31,12.14%,ARHGAP21;TRAK1;MAPT;RHOT1;BICD2;NDE1;UXT;RAB1A;FBXW11
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.4254316836477304,-1.299407654457396,0.14007782101167315,0.5679450341324368,1.0,3/18,4.31%,CAMK2D;CAV1;BIN1
prerank,natural killer cell mediated immunity (GO:0002228),0.647304392935369,1.2992824043560993,0.2079343365253078,0.9542924522294828,1.0,2/15,5.54%,ULBP1;RAET1E
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.6540317638896284,1.2991475375759531,0.21030042918454936,0.9528285652187438,1.0,4/12,7.96%,RFWD3;PRKDC;RPA2;CDK2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.5441292148419631,1.2984343582592783,0.003,0.9534935491643508,1.0,123/497,15.62%,DEPDC1;CENPF;BRCA1;EZH2;BIRC5;LOXL3;GLI3;HMGB2;E2F1;CBX5;TYMS;RBM15;FOXE1;ATOH8;TERF1;BTAF1;PDS5A;ILF3;SYNCRIP;KMT5A;SFMBT1;TIMELESS;LOXL2;RB1;SP3;TWIST2;CDC6;CTCF;GSK3B;ZEB1;CNOT1;MPHOSPH8;EED;RBFOX2;DAP;BCOR;SETDB2;WAPL;MBD1;KHDRBS1;BHLHE41;NFIL3;CTBP1;ZNF568;MAEL;IKZF1;EIF4ENIF1;GZF1;SCML2;YAF2;TCF7L2;SAMD4A;HOXA7;CAPRIN1;PML;SCMH1;GATAD2A;PSPC1;MIDEAS;FMR1;SFRP2;NIPBL;POU2F1;ZHX2;UIMC1;ATF7IP;SAP18;LARP1;TRIM28;RCOR1;IRF1;ING4;BCLAF1;SMARCA4;LIMD1;NONO;ARID4A;EPC1;MTA3;NR3C1;SFPQ;RUNX1T1;LIMS1;MRPL13;RBM15B;DKK3;EIF2AK3;SMURF2;L3MBTL2;HDAC1;BMP2;AHR;NKX2-1;ENPP1;ZHX3;ATXN1;FBXW11;RBPJ;SOX9;SMAD4;HDAC2;ATF5;TWIST1;HEY2;RBM4;DHFR;USP47;BTRC;BCL7A;FOXK2;CDKN1B;KDM5C;PCGF6;FOXM1;EPRS1;QARS1;PER1;YEATS2;RBAK;CNOT7;KAT6A;FXR1;PASK
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.6642771661534965,1.298307616986251,0.20597014925373133,0.9520571796785154,1.0,1/11,0.73%,BARD1
prerank,fatty acid oxidation (GO:0019395),-0.31134803647556236,-1.2982886520058277,0.06493506493506493,0.5692028353940881,1.0,15/57,16.01%,ADIPOR2;HADHB;ACADM;CROT;SCP2;ABCD4;MECR;ALDH3A2;HADH;ACAD10;ECHS1;ABCD2;DECR1;ECHDC2;ADH5
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.6175346681778906,1.296667532632962,0.2230971128608924,0.9542977733172976,1.0,8/19,19.34%,ATRX;TERF1;POLR2A;TERF2;TINF2;ACD;TERF2IP;POLR2B
prerank,regulation of DNA recombination at telomere (GO:0072695),0.6175346681778906,1.296667532632962,0.2230971128608924,0.9542977733172976,1.0,8/19,19.34%,ATRX;TERF1;POLR2A;TERF2;TINF2;ACD;TERF2IP;POLR2B
prerank,retinal metabolic process (GO:0042574),0.6611920037317496,1.296178304607436,0.1977077363896848,0.9541784354174848,1.0,3/12,4.68%,ALDH8A1;ABCA4;RDH11
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.568158097315687,1.29616571716713,0.1824175824175824,0.952310296444827,1.0,10/51,11.06%,KIF20B;MAP4K4;SNX1;NRK;ANKRD27;LRRK2;DNM2;SRGAP2;EPB41L3;PLXNB1
prerank,natural killer cell activation (GO:0030101),0.5982948291334637,1.294834136213732,0.21391752577319587,0.9553764688349441,1.0,5/23,12.76%,ULBP1;NFIL3;ELF4;SNX27;CASP8
prerank,regulation of macrophage activation (GO:0043030),-0.39350203161912445,-1.294316701682007,0.10625,0.5776924781057582,1.0,18/30,38.82%,TLR4;LBP;HSPD1;NR1H3;MYO18A;THBS1;KARS1;ZC3H12A;SHPK;SPHK1;MFHAS1;LRFN5;CD74;MIF;PJA2;TNIP2;FCGR2B;CEBPA
prerank,neural crest cell migration (GO:0001755),-0.36382575306825793,-1.2941132636773438,0.08571428571428572,0.5765025822814891,1.0,22/36,37.45%,SEMA6A;ANXA6;SEMA6D;SEMA7A;SEMA4D;SEMA3A;ERBB4;TBX1;SEMA3B;SEMA3C;SEMA5B;NRP1;SEMA6C;SEMA3G;SEMA4C;SOX10;SOX8;SEMA4A;HTR2B;SEMA3E;SEMA4G;SEMA3F
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.6509536103513522,1.2932681190063715,0.21306818181818182,0.9589562782069699,1.0,7/11,22.34%,PDPN;ENPP2;CORO1B;CD44;SRC;RREB1;ARPIN
prerank,photoreceptor cell development (GO:0042461),-0.46805390550866693,-1.2931047046979036,0.15517241379310345,0.5772895386361462,1.0,6/14,23.34%,RORB;VEGFA;DCX;AHI1;RP1;MFSD2A
prerank,ERK1 and ERK2 cascade (GO:0070371),0.6096397678584552,1.2928264861069012,0.22023047375160051,0.9586049114878796,1.0,1/21,0.46%,CDK1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.4724398027328419,-1.2925986613483431,0.14930555555555555,0.5767627384494287,1.0,5/14,13.66%,AKT2;IRS2;LONP2;IRS1;ABCD2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.6068342024020463,1.2921327591619762,0.19029374201787994,0.9590643620075628,1.0,3/22,3.51%,MASTL;ROCK2;GSK3B
prerank,negative regulation of cell aging (GO:0090344),0.6346261834256467,1.2915713778859979,0.20943134535367544,0.9591811693070725,1.0,7/16,15.03%,RBL1;FBXO5;MAP3K3;TERF2;TWIST1;FOXM1;SLC30A10
prerank,regulation of Golgi organization (GO:1903358),0.6286771335501588,1.291337911265591,0.2110215053763441,0.9580808076763871,1.0,5/17,11.56%,RAB33B;USP6NL;ARMH3;STX18;AKAP9
prerank,myelination (GO:0042552),-0.3456064034324534,-1.2910534538756187,0.05504587155963303,0.5790450362580007,1.0,21/46,24.19%,SLC8A3;MAL;B4GALT5;TNFRSF21;B4GALT6;PLP1;ACER3;NF1;ABCD2;ARHGEF10;SCN8A;DEGS1;CMTM8;GAL3ST1;ADGRG6;LGI4;PLLP;EIF2B2;PMP22;MARVELD1;GPC1
prerank,maintenance of protein location in nucleus (GO:0051457),0.6135672469269337,1.290828471818728,0.2133676092544987,0.9580717842211605,1.0,9/20,19.18%,BARD1;TAF3;PML;RANGAP1;HNRNPU;MORC3;SUN2;SP100;SUN1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.5695019784089856,1.2904375121461857,0.17124735729386892,0.9575790026330185,1.0,9/60,6.60%,NEK2;AURKB;DSCC1;RFC4;FGFR4;RFC2;HNRNPA1;RFC3;GRHL2
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.6391828772069177,1.2903013349008048,0.20608575380359612,0.9562135050508952,1.0,5/15,8.28%,RAB10;RTN3;LNPK;ATL2;ARL6IP1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.4859790320711883,-1.289274163824151,0.16451612903225807,0.5818578247534335,1.0,4/12,4.31%,CTNNA3;CAV1;RYR2;BIN1
prerank,ribosome assembly (GO:0042255),-0.3290457835110528,-1.2890152910501798,0.0891089108910891,0.5807156057344076,1.0,29/47,34.09%,RPL3;RPS15;RPS14;RPSA;BRIX1;RPL10;RPS28;RPS5;RPS19;RPL24;TRAF7;RPS27;DHX29;MDN1;MTERF3;ERAL1;RPLP0;NOP2;MRPS7;BOP1;RPL11;MRPS11;MRPL22;DDX3X;RSL24D1;NLE1;MPV17L2;C1QBP;PWP2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.4782009049323814,-1.288906851535697,0.19205298013245034,0.5792598571793715,1.0,8/13,31.52%,ELOVL7;HACD3;HACD2;HACD1;ELOVL6;ELOVL1;TECR;TECRL
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.36759429204305794,-1.2884765168470538,0.11038961038961038,0.5786669866236344,1.0,11/31,23.45%,PRKN;ATXN3;HSPA5;PACRG;STUB1;DNAJC18;TM7SF3;HSPB8;DNAJB12;UBE2W;BAG3
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5007757610869843,-1.2874975744885282,0.15838509316770186,0.57937302575074,1.0,4/11,4.12%,ACVR1;SMAD7;TGFBR2;TGFB2
prerank,positive regulation of macrophage activation (GO:0043032),-0.45574510332105367,-1.2854106163801902,0.16981132075471697,0.5831781282236255,1.0,5/17,19.30%,TLR4;LBP;HSPD1;THBS1;KARS1
prerank,positive regulation of telomerase activity (GO:0051973),0.5967009695656817,1.2846475531215762,0.22339181286549709,0.9747183437205433,1.0,2/33,1.02%,NEK2;AURKB
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.5330080488380624,-1.2838565759267038,0.18032786885245902,0.5855688665287703,1.0,2/10,8.29%,PRKN;OXA1L
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.5940044673889314,1.2833958078576055,0.21916010498687663,0.9773472698526912,1.0,6/20,17.40%,PLK1;IPO7;CDKN1B;IPO5;PTEN;TFAP4
prerank,L-amino acid transport (GO:0015807),-0.3873634146956119,-1.2829380616457486,0.1130952380952381,0.5861440636002724,1.0,6/28,5.85%,SLC1A2;SLC7A2;SLC25A13;SLC25A12;SLC3A2;SLC7A5
prerank,modification-dependent protein catabolic process (GO:0019941),0.5319310104175047,1.2828211303579795,0.07715430861723446,0.9775076557636733,1.0,31/193,8.72%,DTL;UHRF1;BUB1B;PLK1;CDC20;UBE2C;AURKB;UBE2S;RNF168;ANAPC7;AURKA;FEM1C;PSMC2;CDC27;UBE2K;NEDD4;FBXL7;UBR4;KLHL15;SIAH2;SPSB2;RNF43;BUB3;ARRB1;ELOC;RC3H2;RNF40;SMURF1;CUL3;UBE2R2;PSMD14
prerank,positive regulation of catabolic process (GO:0009896),0.551526664659481,1.2827143362521152,0.1703940362087327,0.9760365846524369,1.0,6/65,8.40%,DTL;BARD1;GSK3B;NEDD4;ATG7;SMURF1
prerank,innate immune response in mucosa (GO:0002227),-0.5434623012153714,-1.2826913384917547,0.1907356948228883,0.5850801283183374,1.0,2/10,10.51%,DEFA6;RPL39
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.45243390327614363,-1.282422892404999,0.18661971830985916,0.5839660154339308,1.0,4/16,7.68%,KCNC2;APOE;NOS3;GUCY1A1
prerank,nucleic acid metabolic process (GO:0090304),0.5419882433864659,1.2821762823178657,0.1742826780021254,0.976058826487006,1.0,23/69,19.34%,ANKLE1;KPNA2;TOPBP1;HNRNPD;RBFOX2;DNA2;HNRNPA1;DNASE2;HNRNPH1;POLR2A;HNRNPU;MMS19;HNRNPL;ENPP1;HNRNPH2;DXO;HNRNPA2B1;DDX1;METTL3;RAD50;XRN2;HNRNPR;POLR2B
prerank,respiratory electron transport chain (GO:0022904),-0.4749711408207579,-1.2817375978755896,0.17832167832167833,0.5838997425451871,1.0,10/14,30.43%,SLC25A13;SLC25A12;GPD2;NDUFA5;PPARGC1A;ETFRF1;ETFDH;ETFB;UQCRFS1;SLC25A18
prerank,positive regulation of protein import (GO:1904591),0.5810369182831691,1.28161561520317,0.21660649819494585,0.9762079222115005,1.0,4/30,8.19%,ECT2;TPR;UBR5;TRIM28
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.49112096970514085,-1.280889935818319,0.16666666666666666,0.5843094178382375,1.0,5/13,25.13%,TLR4;NAMPT;SELENOS;JAK2;EDN1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.5380036594060534,1.2808762749842064,0.16580310880829016,0.9769658580654271,1.0,11/87,7.48%,SHCBP1;CEP57;SETX;FGFR4;HYAL1;FGFR2;RBFOX2;HNRNPA1;FRS2;HNRNPH1;POLR2A
prerank,selective autophagy (GO:0061912),-0.3221750386877882,-1.2801161964928418,0.053763440860215055,0.5846044871021681,1.0,23/56,22.55%,PRKN;DYNC1LI2;UFL1;BECN1;SQSTM1;UBA5;DYNC1I2;ULK1;DYNC1LI1;ATM;PEX5;DYNLL2;KLHL3;WDFY3;USP30;AUP1;ATG2B;TEX264;UBB;PARK7;UBC;RPS27A;WDR81
prerank,regulation of microtubule-based movement (GO:0060632),-0.5012874488779949,-1.2794376811479777,0.16944444444444445,0.5846385660826527,1.0,9/11,45.27%,LAMP1;IGBP1;TTC21B;DYNLT2B;CFAP298;DRC1;HAP1;CCDC65;HDAC6
prerank,positive regulation of protein deacetylation (GO:0090312),0.6240988509261595,1.2790076547787377,0.2105997210599721,0.9818793112503029,1.0,4/14,7.81%,DYRK1A;CTBP1;NIPBL;ZBTB7B
prerank,positive regulation of hemostasis (GO:1900048),0.6666248609484244,1.2788798914904855,0.2190332326283988,0.9785764118542719,1.0,4/10,14.14%,HPSE;SERPINE1;DMTN;ST3GAL4
prerank,positive regulation of coagulation (GO:0050820),0.6666248609484244,1.2788798914904855,0.2190332326283988,0.9785764118542719,1.0,4/10,14.14%,HPSE;SERPINE1;DMTN;ST3GAL4
prerank,negative regulation of coagulation (GO:0050819),-0.46765085279297514,-1.2781565092664748,0.1984126984126984,0.5863144537137475,1.0,4/14,6.10%,APOE;VTN;THBD;CD34
prerank,nucleosome disassembly (GO:0006337),0.6252269947897855,1.2778443809638191,0.2211267605633803,0.9785454448009544,1.0,5/14,8.79%,SMARCC1;NFE2;ARID2;ARID1A;SMARCA4
prerank,chromatin disassembly (GO:0031498),0.6252269947897855,1.2778443809638191,0.2211267605633803,0.9785454448009544,1.0,5/14,8.79%,SMARCC1;NFE2;ARID2;ARID1A;SMARCA4
prerank,negative regulation of cytokine production (GO:0001818),-0.28816141601186335,-1.2776860774312515,0.0,0.5857369190523709,1.0,47/163,19.48%,APOD;LEF1;RPS6KA5;TMSB4X;TRIB2;MAP2K5;RNF135;GAS6;TLR4;PIBF1;TRIM25;KLF4;PDCD4;IKBKE;CD34;TNFRSF21;CYLD;UFD1;PTPN22;SELENOS;SARS1;SRGN;CHID1;IRF3;THBS1;RGCC;CX3CL1;SYT11;TRIM27;RNF125;ABCD2;HDAC7;HDAC9;TBK1;C1QTNF3;IFIH1;PPP1R11;SSC5D;DDIT3;CMKLR1;LGALS9;NLRC5;UBA7;SLC2A10;NCKAP1L;INHBA;ZC3H12A
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.3994354034847047,-1.2776220196306458,0.16580310880829016,0.5841954888485765,1.0,11/24,19.33%,SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;MEGF8;SEMA3B;VEGFA;SEMA3C;SEMA5B;NRP1
prerank,negative regulation of cellular senescence (GO:2000773),0.6430267543311082,1.2773076640058973,0.21857142857142858,0.9787163263969602,1.0,6/13,15.03%,RBL1;FBXO5;MAP3K3;TERF2;TWIST1;SLC30A10
prerank,protein import into peroxisome membrane (GO:0045046),-0.3924009010012288,-1.2771535068787474,0.1457286432160804,0.5836275836995175,1.0,9/22,22.31%,FIS1;ALDH3A2;PEX3;PEX5;ABCD2;GDAP1;PXMP4;PEX26;PXMP2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.44553814621054266,-1.276736968576076,0.18907563025210083,0.5829928905550161,1.0,2/17,2.92%,PLA2G4A;PLAAT3
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.42364461376118173,-1.2758267074429566,0.1596244131455399,0.5835604312088832,1.0,15/20,37.45%,SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;SEMA3B;SEMA3C;SEMA5B;SEMA6C;SEMA3G;SEMA4C;SEMA4A;SEMA3E;SEMA4G;SEMA3F
prerank,receptor recycling (GO:0001881),-0.5202767821523201,-1.2757214081508983,0.18862275449101795,0.5821379286892531,1.0,6/10,29.67%,ARFGEF2;SORL1;NSG1;PHETA1;PLEKHJ1;REP15
prerank,thymus development (GO:0048538),0.6241521917170951,1.2747550793490001,0.2503556187766714,0.9862142094551833,1.0,3/13,10.49%,FOXE1;FADD;TGFBR1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.6019947118766779,1.2744966422412085,0.2358974358974359,0.9852580120958471,1.0,9/22,15.84%,PAXIP1;PSMC2;MED14;SRF;MED30;MED24;MED1;PSMC6;TP53
prerank,granulocyte differentiation (GO:0030851),0.6043514668254409,1.274482420746224,0.244,0.9834479495430062,1.0,6/18,10.58%,E2F1;LBR;DEK;PML;CDK2;TAL1
prerank,regulation of protein dephosphorylation (GO:0035304),0.5681318348717781,1.2733433784646702,0.22158438576349024,0.9858265808007874,1.0,11/37,17.47%,CDCA2;PPP1R7;PPP1R8;CALM2;ENSA;SMPD1;CAMTA1;PTPA;PIN1;ANKLE2;PPP6R2
prerank,regulation of adaptive immune response (GO:0002819),0.6048177479615074,1.2730043249866878,0.24670184696569922,0.9851183794481624,1.0,5/18,13.22%,FADD;IRF1;SAMSN1;AHR;IL4I1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.3582746837284432,-1.2729364144421385,0.11486486486486487,0.5875254838958951,1.0,14/36,20.05%,FHIT;HSP90AB1;OPHN1;OGT;MAP1A;GIPC1;CCAR2;SDCBP;UBXN1;PRKCG;RYBP;AQP11;GABARAPL2;PARK7
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.5690334280340008,1.272781582283745,0.21495327102803738,0.9839724304771279,1.0,9/32,16.20%,CDCA2;PPP1R7;CALM2;PPP1R15B;SMPD1;CAMTA1;PTPA;PIN1;ANKLE2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.44234120225987184,-1.2726582352303997,0.18775510204081633,0.5865601236930591,1.0,5/17,10.12%,TGFB2;TAOK2;LYN;MID1;STK25
prerank,regulation of intracellular signal transduction (GO:1902531),0.5332368217020614,1.2718527644968936,0.022,0.9852368406581481,1.0,104/420,15.84%,TPX2;BRCA1;ECT2;EXO1;CDK1;BRIP1;FAM83D;BARD1;RACGAP1;RMI2;AURKB;ARHGAP22;ARHGAP11A;ARHGAP21;RFC4;KMT5A;MAP4K4;ULK4;AURKA;DEPDC1B;ARHGAP10;TOPBP1;ARHGAP28;RHOA;RBBP8;RPA1;CHEK2;MDM4;TAF3;RAD1;DNA2;WDR54;RFC2;ARHGAP18;BLM;MRE11;OCRL;NET1;MAPT;RHOT1;VRK2;STK3;RPA2;NRK;FGD4;RFC3;RBBP4;RBBP7;PML;ARHGAP36;RRS1;VAV2;CHEK1;TAF12;GNA13;FGD1;INPP5B;CDK2;ARHGAP24;LRRK2;SYDE2;ARHGAP19;RHOQ;IKBKG;CSNK2A2;MAPKAP1;SRGAP2;SRGAP3;PPP2R5C;MYO9B;ARHGAP6;ARHGAP35;TAF15;ARHGAP23;ARHGEF18;HDAC1;EZR;FAM13B;RAC1;TAF4;RRAS;PDPK1;TRIM6;SSRP1;HDAC2;DLG1;SPRED1;XIAP;PAK1IP1;ITFG2;PIP5K1C;STK11;PTPN13;ITGAV;PIN1;SLC15A4;TAOK1;PRKAG1;KAT6A;RHOC;PRKD2;NF2;PPP2R5B;TP53
prerank,regulation of glucose import (GO:0046324),-0.3679141515060687,-1.2718499335323628,0.13953488372093023,0.586923221081687,1.0,12/30,14.61%,OCLN;GRB10;INSR;IGF1;CREBL2;AKT2;PIK3R1;IRS2;SELENOS;IRS1;PTPN11;GSK3A
prerank,endochondral bone morphogenesis (GO:0060350),-0.4997863412474824,-1.271109307324312,0.19607843137254902,0.5872645381504598,1.0,3/11,7.11%,MEF2C;BMPR2;FOXC1
prerank,negative regulation of insulin secretion (GO:0046676),-0.43612148390303596,-1.2707640451674942,0.1781818181818182,0.586489836299118,1.0,6/17,17.16%,PRKN;KCNB1;KLF7;IRS1;MIDN;ADRA2A
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.45754950616033735,-1.270062917670292,0.16494845360824742,0.5866836288092973,1.0,6/15,16.43%,NAF1;CCT5;TCP1;CCT7;CCT2;DKC1
prerank,regulation of isotype switching (GO:0045191),0.6303040249960088,1.2696212898505428,0.2247191011235955,0.9915165367897428,1.0,5/14,15.25%,PAXIP1;RIF1;KMT5C;SLC15A4;SHLD2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.5410159738748993,1.2688622499734323,0.1893939393939394,0.9923895288227333,1.0,6/63,12.31%,TNFSF13B;IL18;CD80;NCK1;ANXA1;NCK2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.5509683228042137,1.267184568992409,0.21593533487297922,0.996651979768678,1.0,17/41,20.12%,NDC1;NUP155;NUP205;NUP160;GCK;NUP85;TPR;NUP214;RANBP2;NUP133;PRKAG1;NUP42;NUP98;NUP210;LACC1;NUP188;NUP35
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.6234375839676864,1.2671097523400894,0.23450134770889489,0.9950542028360202,1.0,1/15,1.27%,GLI3
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.5044924269930848,-1.2660755020216115,0.19817073170731708,0.5951327617563004,1.0,5/11,23.69%,UFD1;DERL1;POMT2;AUP1;TOR1A
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.5087208774902205,-1.2658292209308046,0.2070063694267516,0.5941233039207906,1.0,5/11,14.68%,GIGYF1;IGF1;PIK3R1;IRS1;GIGYF2
prerank,regulation of cellular metabolic process (GO:0031323),-0.3355275933696432,-1.2656946685454797,0.10309278350515463,0.5928284633366524,1.0,11/45,13.48%,PRKN;KIF16B;TBC1D16;ACLY;RNF34;ACACB;PARL;SSH1;STUB1;PINK1;MPV17
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5914744692782435,1.2649986953241532,0.251621271076524,1.0,1.0,8/22,16.92%,TGM1;FGFR2;CASK;KLF9;NOTCH2;PRKD1;MED1;PTPRK
prerank,presynapse assembly (GO:0099054),-0.442204605867876,-1.2647389864918102,0.15770609318996415,0.5934907643518986,1.0,7/16,19.55%,PCLO;PTPRD;LRRTM3;IL1RAPL1;DVL1;NLGN1;FZD1
prerank,epithelium development (GO:0060429),0.5294561859016966,1.2641544102662357,0.1712538226299694,1.0,1.0,14/107,11.42%,STIL;CDK1;LOXL3;TIMELESS;FGFR2;ALDH1A2;PPP2R3A;GRHL2;FN3K;KANK2;MEOX2;ERRFI1;PCNA;BMP2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.559842249701738,1.2638506490237078,0.21597300337457817,1.0,1.0,9/48,12.42%,BRCA1;E2F1;CHEK2;PRKDC;PML;HTRA2;BOK;USP28;MSH6
prerank,protein homooligomerization (GO:0051260),0.5280758325200263,1.2636129790207644,0.1612576064908722,1.0,1.0,24/114,16.13%,ECT2;POLQ;TK1;UPB1;ALDH1A2;BLM;HPRT1;TRPA1;ATL2;ATL3;FUS;USP16;APIP;TRPM2;ACACA;APPL2;MICU1;TRPM4;EHD1;GSDMD;VSTM5;SLC1A5;PKD2;PNPT1
prerank,respiratory system development (GO:0060541),0.5732333817592721,1.2627545887399194,0.22652582159624413,1.0,1.0,7/32,11.53%,GLI2;LOXL3;FGFR2;PDPN;SMCHD1;NPHP3;NKX2-1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.38333444570599173,-1.2624700538207227,0.1443850267379679,0.5977677431576044,1.0,9/27,15.31%,PLAAT3;ETNK1;SLC27A1;PNPLA8;CHKA;ETNK2;PCYT2;SELENOI;CHKB
prerank,polyamine metabolic process (GO:0006595),-0.47754265414895897,-1.2621951497396087,0.1780821917808219,0.5967526150737409,1.0,8/13,38.17%,SAT1;SMS;OAZ2;DHPS;PAOX;HDAC10;ODC1;SRM
prerank,regulation of hydrolase activity (GO:0051336),-0.2962067732314259,-1.2618098068150572,0.08163265306122448,0.596102999097049,1.0,17/71,12.12%,PRKG1;PTK2;EPHA5;CHN2;NTRK2;FGD5;CAV1;VAV3;RABGAP1;TDG;ARHGEF5;NF1;ARHGAP44;PLXNC1;RASIP1;RAB3GAP2;ARHGAP27
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.41874483468541435,-1.2616935408621741,0.18061674008810572,0.5947202838143913,1.0,5/19,19.48%,CARD16;IGF1;CX3CL1;GIT1;ZC3H12A
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.42588251735509286,-1.2610670348902862,0.1623931623931624,0.594781259985811,1.0,10/17,19.76%,SMAD7;CALM1;EIF4G1;INPP5K;SPRY2;CADM4;DGKQ;PPEF2;DDIT4;CALM3
prerank,regulation of intracellular transport (GO:0032386),0.5645507359218035,1.2597706298283606,0.2224824355971897,1.0,1.0,9/38,15.79%,SPAG5;ATPSCKMT;NUMA1;LRRK2;GAS1;NUP214;SCFD1;RBM4;LCP1
prerank,heart looping (GO:0001947),0.5567698637888064,1.2597414217685388,0.23638470451911936,1.0,1.0,5/39,9.04%,STIL;SETDB2;SRF;MKKS;NPHP3
prerank,calcium ion transport (GO:0006816),-0.28146928965266643,-1.2593124967029041,0.09090909090909091,0.5975964108213638,1.0,33/113,16.93%,CACNA2D1;GRIN3A;RYR3;PSEN1;SLC8A3;TRPM7;CALCRL;TRPC5;CAV1;RYR2;FKBP1A;ANO6;GAS6;SLC24A2;TRPC4AP;SLC3A2;CACNG7;TPT1;RAMP1;RAMP2;CACNA1B;TRPC3;TRPC1;CHRNA7;TRPM3;TMCO1;CACNB2;ATP2B2;MCOLN1;PANX1;CACNG3;CRACR2A;CACNG8
prerank,protein methylation (GO:0006479),0.5507179740814415,1.2579307350290345,0.22732626619552415,1.0,1.0,4/40,7.00%,EZH2;ATPSCKMT;SETD3;EEF1AKMT2
prerank,positive regulation of ERAD pathway (GO:1904294),-0.47608818229054556,-1.2579074849744416,0.15605095541401273,0.5995846722548122,1.0,4/13,13.50%,ATXN3;CAV1;SGTA;BCAP31
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.36337152509869314,-1.257387944616103,0.15846994535519127,0.5992579172706846,1.0,10/28,13.93%,SHANK3;APOE;SQSTM1;EPHB2;LGMN;RELN;CHRNA7;ABL1;APP;ADCY8
prerank,receptor metabolic process (GO:0043112),-0.3143104192432356,-1.257164705331478,0.10309278350515463,0.5981403537479968,1.0,16/53,12.14%,DNM3;KIF16B;CALCRL;CAV1;BECN1;LRP1;ACKR3;PIK3R4;RAMP1;DNM1;RAMP2;LGMN;CD81;AP2M1;GRB2;ARFGEF2
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5272593056923913,-1.257036668276992,0.2132132132132132,0.5968360449659886,1.0,5/10,22.19%,SMARCD3;CTNNB1;CX3CL1;VEGFA;DRD2
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.3409793400411131,-1.256257372144378,0.12605042016806722,0.5970638081203369,1.0,13/37,17.02%,FHIT;HSP90AB1;OGT;HIPK2;RPL23;RPS7;MAP1A;GIPC1;SGTA;CCAR2;SDCBP;UBXN1;RYBP
prerank,positive regulation of calcium ion transport (GO:0051928),-0.3369639213779752,-1.256020997545377,0.13138686131386862,0.596003553765311,1.0,11/36,25.13%,CAV1;PDGFRB;MYLK;TRPC3;CACNB2;GRIN1;CRACR2A;P2RX4;WFS1;CXCL12;P2RX7
prerank,regulation of establishment of protein localization (GO:0070201),0.6371001069770149,1.2557290049953758,0.23741007194244604,1.0,1.0,4/13,12.16%,CEP295;SPIDR;CEP120;SCFD1
prerank,thyroid hormone generation (GO:0006590),0.6659678516823195,1.2556278399480931,0.23159509202453987,1.0,1.0,2/10,8.47%,FOXE1;CPQ
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.49655776455107115,-1.2555596276257017,0.2052980132450331,0.5955930532027525,1.0,6/12,19.76%,CAMK2D;CALM1;CAV1;SRI;PDE4D;CALM3
prerank,sodium ion transmembrane transport (GO:0035725),-0.28687720814599216,-1.2554539495987942,0.07142857142857142,0.5941842523124026,1.0,19/84,16.25%,SLC6A6;SLC8A3;ATP1B1;SLC6A1;HCN1;ANO6;SLC24A2;SCN1A;ATP1A1;SCN9A;ATP1B3;ATP1A3;ATP1A2;SCN3A;SCN8A;SCN1B;SLC4A8;SLC6A11;SLC12A2
prerank,regulation of gene silencing by RNA (GO:0060966),0.5385281634161008,1.2549458099100823,0.2230769230769231,1.0,1.0,19/50,20.12%,NDC1;NUP155;NUP205;NUP160;AGO2;NUP85;TPR;FMR1;POLR2A;PUM2;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;POLR2B;NUP188;NUP35
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.5385281634161008,1.2549458099100823,0.2230769230769231,1.0,1.0,19/50,20.12%,NDC1;NUP155;NUP205;NUP160;AGO2;NUP85;TPR;FMR1;POLR2A;PUM2;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;POLR2B;NUP188;NUP35
prerank,neural crest cell development (GO:0014032),-0.33169024006217396,-1.254577915566486,0.11016949152542373,0.5946487965610253,1.0,31/44,42.24%,CDH2;SEMA6A;ANXA6;SEMA6D;SEMA7A;SEMA4D;SEMA3A;ERBB4;TBX1;SEMA3B;SEMA3C;SEMA5B;NOLC1;KLHL12;SEMA6C;SOX11;SEMA3G;SEMA4C;SOX10;SOX8;SEMA4A;KBTBD8;HTR2B;SEMA3E;SEMA4G;SEMA3F;PDCD6;SNAI2;NRTN;SEMA4F;NRG1
prerank,amide biosynthetic process (GO:0043604),0.5424485248594156,1.254148147547968,0.22737306843267108,1.0,1.0,10/47,14.83%,RHD;SLC25A15;CERS6;CERS5;PAM;SLC25A2;ASMT;AGK;SMPD1;SPTLC2
prerank,supramolecular fiber organization (GO:0097435),0.5271984478062842,1.2528962570259494,0.042,1.0,1.0,51/333,12.12%,KIF18B;KIF14;KIF2C;KIF24;FIGNL1;KIF18A;BMP1;SPTA1;LOXL3;CKAP5;KATNAL2;COL22A1;SHROOM3;STMN1;LOXL2;LOX;TRIOBP;TSPAN33;RHOA;COL4A6;CGNL1;IAPP;COL4A4;PCM1;TUBGCP5;TPM4;SIAH2;MAPT;MYO1C;COL18A1;COL5A2;CDC42EP2;FAT1;COL23A1;ADAMTS14;FBLN5;B4GALT7;CORO1B;TPPP;ADAMTS2;DDR2;SAMD14;FIGN;TLL2;TGFBR1;RND2;RAC1;COL4A5;CALB1;COL12A1;P3H1
prerank,polarized epithelial cell differentiation (GO:0030859),0.6107372514802054,1.2523830885986933,0.23209169054441262,1.0,1.0,6/13,16.28%,RHOA;RAB10;RAP2A;SCRIB;EZR;MSN
prerank,positive regulation of cellular metabolic process (GO:0031325),0.524445624501383,1.2521273905229966,0.18386108273748722,1.0,1.0,12/98,9.89%,CCNB1;UHRF1;CDK1;ANXA2;XDH;ARRB1;FMR1;SCRIB;RAB29;ANGPT1;AGT;RAB1A
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.5752723345314583,1.2508531077383043,0.2421875,1.0,1.0,6/22,17.40%,PLK1;IPO7;CDKN1B;IPO5;PTEN;TFAP4
prerank,protein targeting to mitochondrion (GO:0006626),-0.3186020601737291,-1.2507022753140529,0.06593406593406594,0.6027292338258193,1.0,28/52,31.74%,IMMP2L;FIS1;DNAJC19;HSPD1;AIFM1;IMMP1L;TIMM44;TOMM70;BCAP31;GDAP1;AIP;FBXO7;TOMM34;DNAJC15;PAM16;TIMM17A;TOMM7;TIMM17B;CHCHD4;TIMM9;TIMM13;TOMM22;TIMM8B;NDUFA13;ROMO1;GRPEL1;TOMM5;TIMM29
prerank,protein autoprocessing (GO:0016540),0.6002410236276924,1.2500477676002995,0.2591093117408907,1.0,1.0,3/17,8.23%,FAM111A;FXN;HTRA2
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.2784479338149727,-1.249750888101044,0.07142857142857142,0.6036113017476598,1.0,42/107,24.57%,PRKN;RASGRF1;RASGRF2;HSP90B1;ERLEC1;UFL1;ATF6;OS9;PIK3R1;UBA5;MAP3K5;CASP4;ATG10;DERL1;SELENOS;AIFM1;HSPA5;JUN;BCL2;PDIA4;THBS1;TMCO1;RCN3;BCAP31;CEBPB;TMTC3;NIBAN1;CREB3L1;SCAMP5;DDIT3;UBXN6;DNAJB9;DNAJB12;SYVN1;TMEM33;PIK3R2;ATP2A3;CDK5RAP3;SEL1L;WFS1;ERP44;MBTPS1
prerank,digestive tract development (GO:0048565),0.5596552069761072,1.2493481745640949,0.24342857142857144,1.0,1.0,6/32,7.60%,GLI2;GLI3;CLMP;FGFR2;KIT;NIPBL
prerank,peptidyl-lysine modification (GO:0018205),0.527741785046441,1.2486099937523112,0.18388429752066116,1.0,1.0,46/99,25.27%,LOXL3;NDC1;NUP155;SAE1;LOXL2;LOX;NUP205;ATPSCKMT;NUP160;SENP1;NUP85;NDUFAB1;TPR;EEF1AKMT2;TRIM28;RANGAP1;VIPAS39;NSMCE2;SUMO2;NUP214;TRPM4;RANBP2;P3H4;NUP133;NUP42;PLOD2;NUP98;NUP210;EGR2;NUP188;NUP35;HDAC4;PLOD1;SIRT2;SIRT3;NUP43;PIAS1;UBA2;LOXL1;NUP93;UBE2I;NUP107;STX1A;EEF1AKMT1;SEH1L;EYA1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.2968611894089811,-1.2484151087652944,0.1,0.6053356563809118,1.0,24/71,22.47%,PRKN;CHFR;OTUD7A;ADAMTS12;CTSC;ATXN3;CLPX;MALT1;CTSB;VPS4B;LGMN;OMA1;CTSZ;STUB1;CTSL;NGLY1;CTSF;UBB;FAP;UBE2W;YME1L1;CTSS;UBC;RPS27A
prerank,negative regulation of protein processing (GO:0010955),0.6246489880274252,1.2473504847794092,0.25677603423680456,1.0,1.0,4/12,10.00%,PRNP;SERPINE1;LRRK2;GAS1
prerank,positive regulation of protein metabolic process (GO:0051247),0.5241863904906227,1.246746299221048,0.17563451776649747,1.0,1.0,14/110,9.89%,DTL;UHRF1;BARD1;ROCK2;GSK3B;NEDD4;IL18;SLC25A37;ATG7;CD80;SMURF1;ABCB10;AGT;RAB1A
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.4543243513666494,-1.2461126343876,0.1853035143769968,0.6093141590220407,1.0,6/14,36.10%,PIBF1;THBS1;CMKLR1;IRAK3;C1QBP;JAK3
prerank,cardiolipin metabolic process (GO:0032048),-0.4845546539088702,-1.2454968804918636,0.23278688524590163,0.6092877693534864,1.0,4/13,7.29%,PLA2G4A;HADHB;SLC27A1;PNPLA8
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.2942544354570733,-1.2454007240787088,0.14,0.6078869857526934,1.0,30/75,23.34%,MEF2C;OPHN1;DCC;PAK3;ACTB;S100A6;KLF7;NRCAM;MAP1B;TAOK2;BRSK1;MAP1A;BTBD3;TMEM106B;MINK1;CTNNA2;APP;MEF2A;SLITRK1;NTNG1;DVL1;SHTN1;APBB1;BAIAP2;SLITRK4;S100B;PLPPR4;DRD2;ZDHHC17;MFSD2A
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.37487282918305403,-1.2451495344500276,0.16243654822335024,0.6069308938753744,1.0,9/27,16.08%,PTK2;FLT1;TEK;PDGFRB;FGF2;PIK3R4;IRS1;EPHA8;TNFAIP8L3
prerank,phosphate ion homeostasis (GO:0055062),0.6441993675992744,1.2449666414669618,0.23937007874015748,1.0,1.0,2/10,11.80%,FGFR4;ENPP1
prerank,sphingosine biosynthetic process (GO:0046512),-0.4935602731360172,-1.244572191760735,0.2084507042253521,0.6052830886994804,1.0,6/11,23.85%,ACER2;ASAH1;ACER3;ASAH2;ABCA2;SPHK1
prerank,sphingoid biosynthetic process (GO:0046520),-0.4935602731360172,-1.244572191760735,0.2084507042253521,0.6052830886994804,1.0,6/11,23.85%,ACER2;ASAH1;ACER3;ASAH2;ABCA2;SPHK1
prerank,response to interleukin-4 (GO:0070670),-0.49720041347893373,-1.2441388619289035,0.23148148148148148,0.6047390784342282,1.0,3/10,21.09%,LEF1;XBP1;SHPK
prerank,positive regulation of response to stimulus (GO:0048584),0.5548883199518795,1.2434509184735791,0.24249422632794457,1.0,1.0,7/40,8.71%,ANKLE1;ECHDC3;DHX9;NSMCE4A;FMR1;CD80;BCLAF1
prerank,cellular response to organic substance (GO:0071310),-0.2623974581862843,-1.242561732741729,0.05555555555555555,0.6073523606695744,1.0,45/116,24.64%,STAT3;ACVR1;LEF1;ACVR2A;MAPK8;TGFBR2;BMPR2;AKAP6;ACVRL1;MAP2K5;NFAT5;SOCS2;KLF4;IL1RAPL1;RAMP1;TIPARP;RAMP2;ACVR2B;INPP5K;CTNNB1;SLIT2;PTPN14;PTPN11;ASAH2;LDLRAP1;SHC1;TBK1;SLC1A1;ROBO2;DCPS;ADRA2A;ERBB2;PTPN9;BMPR1B;CLEC3B;PTPN12;PARK7;CERS1;NOS1;RACK1;SLIT3;SPHK1;URI1;ARL6IP5;PLK5
prerank,cilium organization (GO:0044782),0.5211001737464804,1.2425405420367126,0.107,1.0,1.0,40/209,10.84%,KIF24;MNS1;PLK4;IFT80;HYLS1;CEP89;BBS9;DZIP1L;SCLT1;ACTR3;WDR35;PARVA;ASAP1;GBF1;SPAG16;WDR90;IFT140;POC1B;FAM161A;EXOC4;KIF27;PCM1;OCRL;TXNDC15;MKKS;RTTN;WDR11;CEP83;RILPL1;NUDCD3;RFX2;SSX2IP;CCDC57;CFAP52;WDPCP;NPHP3;ODF2;RAB1A;TRAPPC14;TTC39C
prerank,vitamin D metabolic process (GO:0042359),-0.46625283612326773,-1.2424810687748427,0.23049645390070922,0.6059473266790886,1.0,4/13,25.89%,LGMN;PIAS4;CUBN;CYP2R1
prerank,regulation of protein catabolic process (GO:0042176),0.5242142400666852,1.24235306329889,0.18499486125385406,1.0,1.0,9/99,6.96%,DTL;FAM83D;BARD1;GSK3B;CHEK2;MDM4;NEDD4;FAF1;ATG7
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.5387662978553953,1.242336083845477,0.23414071510957324,1.0,1.0,14/41,17.41%,NDC1;NUP155;NUP205;NUP160;GCK;NUP85;TPR;NUP214;RANBP2;NUP133;PRKAG1;NUP42;NUP98;NUP210
prerank,endocrine system development (GO:0035270),0.5789210969626283,1.2422112120303523,0.2630241423125794,1.0,1.0,5/21,11.53%,GLI2;FOXE1;TGFBR1;DKK3;NKX2-1
prerank,motile cilium assembly (GO:0044458),0.6309255108114942,1.2418103542458316,0.2507204610951009,1.0,1.0,4/12,14.76%,DNAAF3;SPATA6;RSPH9;E2F4
prerank,negative regulation of cellular metabolic process (GO:0031324),0.5552093416272859,1.241457115951193,0.22769953051643194,1.0,1.0,2/37,4.74%,BRCA1;WDR54
prerank,response to acidic pH (GO:0010447),-0.46385641719061876,-1.2410720287387744,0.23870967741935484,0.6082209680101265,1.0,7/13,36.62%,GPR4;LGMN;CTSS;SLC9A1;PKD2L1;CHP1;PKD1L3
prerank,positive regulation of programmed cell death (GO:0043068),0.5201555070030058,1.2407089391174126,0.07607607607607608,1.0,1.0,43/272,11.42%,TOP2A;ECT2;MELK;BARD1;E2F1;STPG1;ITGB3BP;FADD;STK17B;BMF;IAPP;AIFM2;FAM162A;NET1;CCAR1;FAF1;STK3;ERCC3;FGD4;MAP3K20;ATG7;VAV2;SFRP2;CALHM2;GNA13;SCRIB;FGD1;FOXO3;SAP18;HTRA2;LRRK2;ING4;BCLAF1;KLF11;TNFRSF10B;DNM2;HMGB1;APAF1;BOK;IP6K2;ARHGEF18;QRICH1;BMP2
prerank,positive regulation of protein ubiquitination (GO:0031398),0.5204743350596103,1.2405959253943428,0.20456905503634476,1.0,1.0,11/80,9.26%,BRCA1;PLK1;PAXIP1;FANCI;MYCBP2;FBXW7;UBE2N;LRRK2;CUL3;ANGPT1;TBC1D7
prerank,regulation of organelle assembly (GO:1902115),0.5282269130028295,1.2404712538028806,0.2110286320254507,1.0,1.0,18/72,14.96%,STIL;CEP295;USP6NL;IFT140;TBC1D13;TBC1D2B;STAM;CEP76;ALMS1;SPICE1;NPRL3;SDCCAG8;TBC1D19;STX18;EZR;ATG3;PLK2;MTMR3
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.6170266854816656,1.2398059424291639,0.2635135135135135,1.0,1.0,2/16,5.54%,ULBP1;RAET1E
prerank,diol biosynthetic process (GO:0034312),-0.44994753396250736,-1.239446536352656,0.2119205298013245,0.610661542533477,1.0,8/15,23.85%,ACER2;ASAH1;ACER3;QDPR;ASAH2;GCH1;ABCA2;SPHK1
prerank,calcium import into the mitochondrion (GO:0036444),0.6471455958894666,1.2392103631848184,0.2570093457943925,1.0,1.0,5/10,20.73%,MCU;MCUB;MICU1;MAIP1;MICU2
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.6014609265679984,1.2391890710728932,0.2600276625172891,1.0,1.0,6/14,14.74%,AK1;SMPDL3A;ENPP3;ITPA;ENPP1;AK7
prerank,regulation of mononuclear cell migration (GO:0071675),-0.3849246623568188,-1.2391611230167747,0.1782178217821782,0.609820739798351,1.0,8/23,18.03%,PTK2;LYN;MAPK3;MAPK1;SLIT2;THBS1;CMKLR1;IL34
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.4098001436608874,-1.238542405082228,0.17972350230414746,0.6099005302413933,1.0,7/20,15.14%,PRKN;DCUN1D3;HSP90AB1;ZMIZ1;DCUN1D5;PINK1;DCUN1D2
prerank,apoptotic DNA fragmentation (GO:0006309),0.6093928675193861,1.238541579485594,0.23392612859097128,1.0,1.0,3/16,9.75%,HMGB2;DNASE2;HMGB1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.5345190084990404,1.2384581246731923,0.2191780821917808,1.0,1.0,16/72,11.30%,POLK;RFC4;RPA1;ERCC4;POLD3;RFC2;POLD1;RPA2;ERCC3;RFC1;RFC3;PRPF19;POLR2A;CUL4B;XPA;PCNA
prerank,intestinal lipid absorption (GO:0098856),0.6200015034373997,1.2384382901653528,0.2556053811659193,1.0,1.0,3/11,20.18%,SOAT2;LDLR;UGCG
prerank,peptidyl-serine phosphorylation (GO:0018105),0.5196807934004499,1.2384212901429352,0.14300202839756593,1.0,1.0,51/153,18.84%,CDK1;TTK;CLSPN;PLK1;MASTL;MAST2;DYRK1A;AURKA;ROCK2;GSK3B;NLK;PRKDC;DYRK3;VRK2;WNK1;CDK2;LRRK2;ROCK1;MARK2;CSNK2A2;CAMK1D;TGFBR1;EIF2AK3;PRKCB;PRKCA;ULK2;PDPK1;CSNK1G2;MAPKAPK3;PRKCE;PRKD1;PRKCI;CAB39;PLK2;MORC3;VRK1;PRKD2;STK39;HIPK3;ATR;CSNK1A1;MAST4;CSNK1G1;SRPK2;PIKFYVE;MAST1;PKN2;MAPK14;HIPK1;RIPK1;CAMKV
prerank,regulated exocytosis (GO:0045055),-0.25742750718009005,-1.2372167916824965,0.0,0.6115635897651732,1.0,54/173,20.57%,CYRIB;PCLO;RIMS1;VWF;TMSB4X;PECAM1;TIMP3;CALM1;VEGFC;IGF1;SYT1;APOOL;TGFB2;RAB27B;GAS6;PLEK;PSAP;ISLR;LYN;ABCC4;IGF2;SYT7;LHFPL2;ENDOD1;SCG3;SRGN;APP;TAGLN2;CHID1;THBS1;SYT11;SYT12;RAB11FIP2;RAB11FIP1;VEGFA;TMX3;HABP4;STEAP2;CPLX1;LAMP2;SCCPDH;TGFB3;SNAP25;SYT10;ACTN1;VEGFB;SYT6;TEX264;CLEC3B;VEGFD;SPARC;LGALS3BP;ITGB3;SYT2
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.4836012370156122,-1.2365789339503026,0.24615384615384617,0.6116826975908022,1.0,7/11,45.55%,AKAP6;LRRC38;KCNIP2;LRRC55;NOS1AP;TREM2;RNF207
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.6336181655159099,1.2363477864882648,0.26222222222222225,1.0,1.0,3/11,10.11%,E2F2;ADAMTS9;PIK3CB
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.4743312461823679,-1.2351469939094002,0.21766561514195584,0.6120467232435735,1.0,6/13,28.88%,STAT3;GRB2;SHC1;IL15;JAK1;PLCB1
prerank,cellular response to interleukin-15 (GO:0071350),-0.4743312461823679,-1.2351469939094002,0.21766561514195584,0.6120467232435735,1.0,6/13,28.88%,STAT3;GRB2;SHC1;IL15;JAK1;PLCB1
prerank,peptidyl-lysine methylation (GO:0018022),0.5687394627246628,1.2345848614055355,0.2575,1.0,1.0,6/26,7.50%,KMT5A;SETD6;ATPSCKMT;SETD3;EEF1AKMT2;SETD2
prerank,lung development (GO:0030324),0.5539575561329834,1.2344869813364403,0.2589073634204275,1.0,1.0,7/33,11.53%,GLI2;LOXL3;FGFR2;PDPN;NPHP3;ERRFI1;NKX2-1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.6194479077236384,1.234429517342242,0.2554112554112554,1.0,1.0,5/12,12.83%,DPYD;CTPS1;CDA;DPYSL4;DPYSL3
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.27434710302782916,-1.2343584833666057,0.07142857142857142,0.6125236893093104,1.0,19/100,7.53%,PTK2;FLT1;TEK;NTRK2;PIP4K2A;PPP1R16B;INSR;IGF1;TGFB2;PDGFRB;BECN1;PIP4K2B;NTRK3;PIK3R1;FGF2;IRS2;LYN;PIK3IP1;SEMA4D
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.35662321808299197,-1.234046917650478,0.11875,0.611697582385526,1.0,12/30,20.05%,FHIT;HSP90AB1;OGT;MAP1A;GIPC1;SGTA;CCAR2;SDCBP;UBXN1;RYBP;SVIP;PARK7
prerank,positive regulation of glucose import (GO:0046326),-0.3981087802984139,-1.2339201351631297,0.18421052631578946,0.6104913157102619,1.0,9/21,13.59%,OCLN;INSR;IGF1;CREBL2;AKT2;PIK3R1;IRS2;IRS1;PTPN11
prerank,synapse assembly (GO:0007416),-0.2935990353491903,-1.2337216342290125,0.14754098360655737,0.6094393371246846,1.0,13/67,5.66%,DNM3;GABRB3;CDH2;DNER;GABRA2;SHANK3;SPOCK2;LRRTM3;GRID2;ADGRL3;NRCAM;SDK2;FGF13
prerank,protein import into peroxisome matrix (GO:0016558),-0.4789853422294672,-1.2336627762510488,0.20327868852459016,0.607997245557773,1.0,4/12,10.96%,PEX5L;PEX1;PEX5;PEX6
prerank,respiratory tube development (GO:0030323),0.5662580644381592,1.2330502716794915,0.25703794369645044,1.0,1.0,6/28,11.53%,GLI2;LOXL3;FGFR2;PDPN;NPHP3;NKX2-1
prerank,regulation of viral transcription (GO:0046782),-0.33053389908895214,-1.2322973008920375,0.09701492537313433,0.6100606227320183,1.0,23/39,31.63%,MID2;CCNT1;NELFB;IFITM3;TRIM27;TRIM14;POLR2K;POLR2H;POLR2F;POLR2C;TRIM21;TRIM11;TRIM32;TARBP2;POLR2E;ZFP36;NELFCD;MDFIC;HEXIM1;POLR2J;NELFE;POLR2D;TRIM13
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.5424525621314366,1.2294902770464031,0.2323008849557522,1.0,1.0,11/48,10.07%,ATAD2;BAZ1B;DEK;POLR1A;MYO1C;POLR1B;ELOF1;ARID1A;CHEK1;PHF2;TAF1D
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.4106140486079025,-1.229173314777816,0.1946564885496183,0.6163940970157765,1.0,5/18,8.00%,FLT1;MEF2C;FGF2;PLCG1;IGF2
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.4331839064282459,-1.2290984071452746,0.19776119402985073,0.6150229994078704,1.0,3/16,12.83%,CLDN5;CLDN11;CLDN12
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.48801559399018724,-1.229047401708981,0.21525885558583105,0.6135770710901561,1.0,5/10,26.48%,DIP2A;PRKAA1;KLF15;PARK7;MYOCD
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.4266732698453596,-1.2290452223932333,0.20080321285140562,0.6120440025399453,1.0,7/18,16.43%,PARN;NAF1;CCT5;TCP1;CCT7;CCT2;DKC1
prerank,proteoglycan biosynthetic process (GO:0030166),-0.3548513022246979,-1.2290383305477703,0.16556291390728478,0.6105400207249879,1.0,12/31,19.05%,IGF1;BMPR2;CSGALNACT1;CHST9;FAM20B;NDST3;HS3ST3B1;EXTL3;CANT1;BMPR1B;B3GAT2;XYLT2
prerank,establishment of protein localization to organelle (GO:0072594),0.5277383434793617,1.2289215058521519,0.2133051742344245,1.0,1.0,20/72,17.51%,NEURL1B;RANBP17;NUP155;RPAIN;E2F3;TNPO1;NUP85;EIF4ENIF1;CSE1L;TPR;IPO7;APPL2;NUP214;ZDHHC15;IPO11;NXT1;NUP133;IPO5;NXT2;FAM53B
prerank,sulfur amino acid catabolic process (GO:0000098),-0.5055906023221078,-1.228264340139818,0.2222222222222222,0.6110417948612764,1.0,7/10,41.53%,TXN2;MTRR;CBS;CTH;ADO;MPST;BLMH
prerank,synaptic vesicle localization (GO:0097479),-0.4729619385663147,-1.2280785154393061,0.24749163879598662,0.6099907585646105,1.0,7/13,18.48%,SPG11;SYNDIG1;KIF5B;KIF5C;SYNJ1;NLGN1;RAB27A
prerank,regulation of cellular component organization (GO:0051128),0.5117384153195379,1.228076572857451,0.18163471241170534,1.0,1.0,22/135,12.85%,KIF14;MKI67;HJURP;RAB33B;AURKA;ROCK2;STON1;PACSIN2;NEDD4;NET1;STON2;NCLN;ZFYVE16;ROCK1;PICALM;AGT;HNRNPU;BAG5;METTL4;SSRP1;ATF5;ITCH
prerank,positive regulation of protein transport (GO:0051222),0.5281666305963493,1.22674636157539,0.24734607218683652,1.0,1.0,12/67,13.78%,KIF20B;FRMD4A;PCM1;MYH10;BMP6;TPR;RAB29;EZR;SYTL4;ACHE;PPID;ADAM9
prerank,protein homotetramerization (GO:0051289),0.5344572298461687,1.2259661393190298,0.2638580931263858,1.0,1.0,11/49,12.53%,TK1;UPB1;ALDH1A2;HPRT1;TRPA1;USP16;APIP;TRPM2;ACACA;APPL2;TRPM4
prerank,keratan sulfate metabolic process (GO:0042339),-0.35572950031543393,-1.225145769998718,0.17222222222222222,0.6159337217455678,1.0,14/31,17.46%,GNS;FMOD;B4GALT5;HEXB;B3GNT2;ST3GAL6;B4GALT6;PRELP;HEXA;OGN;LUM;B4GALT4;GALNS;CHST2
prerank,protein O-linked mannosylation (GO:0035269),0.5925546572589186,1.2248205999761423,0.25098554533508544,1.0,1.0,6/18,12.00%,POMT1;LARGE1;CRPPA;FKRP;RXYLT1;TMTC4
prerank,positive regulation of cell population proliferation (GO:0008284),0.5106422570479084,1.2236930957898926,0.051,1.0,1.0,72/423,13.40%,PRC1;KIF20B;KIF14;EZH2;TTK;BIRC5;SAPCD2;E2F1;TIPIN;SPDYA;MATK;AQP1;HPSE;NAP1L1;FBXO5;BMPR1A;PHIP;FGFR4;HYAL1;CEP43;FGFR2;FXN;GAREM1;DDRGK1;LAMB1;DHX9;CNOT6L;CCAR1;BMP6;TCF7L2;RTKN2;IL18;TGFBR3;DERL2;CDC25B;PDGFRA;SFRP2;CCN1;SAAL1;POU3F2;WWTR1;CDK2;CNOT6;GRK5;CUL3;YAP1;MAP3K3;PIM1;AGT;DDR2;CDC123;S1PR2;TGFBR1;HNRNPU;RBPMS2;CRKL;CNTF;HDAC1;BMP2;STOX1;GLP2R;RBPJ;GJA1;ADAM17;KMT2D;TRPM4;SOX9;HDAC2;IL31RA;CTSH;LRP5;NES
prerank,regulation of gene silencing by miRNA (GO:0060964),0.5233021955017618,1.2236701788111863,0.25,1.0,1.0,23/62,20.12%,NDC1;NUP155;NUP205;NUP160;AGO2;AJUBA;DHX9;NUP85;TPR;FMR1;POLR2A;LIMD1;PUM2;NUP214;RANBP2;NUP133;FXR1;NUP42;NUP98;NUP210;POLR2B;NUP188;NUP35
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.604721638437717,1.2230321186346036,0.2619392185238784,1.0,1.0,3/13,9.94%,BARD1;TPR;RANGAP1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.6134090988850913,1.2229886922876037,0.2589928057553957,1.0,1.0,4/12,8.19%,MPHOSPH8;SETDB2;ATF7IP;TRIM28
prerank,protein complex oligomerization (GO:0051259),0.5141971776889142,1.2223009935279008,0.222684703433923,1.0,1.0,19/85,16.73%,ECT2;POLQ;UPB1;BLM;ATL2;ATL3;STOML2;FUS;MCU;WDCP;BOK;MICU1;EHD1;GSDMD;VSTM5;PKD2;PNPT1;UGDH;LRRC8C
prerank,cellular response to increased oxygen levels (GO:0036295),-0.4690488057404515,-1.2221144786064986,0.24092409240924093,0.6223684592247238,1.0,4/11,7.95%,FOXO1;ATP6V0D1;CAV1;FAS
prerank,determination of heart left/right asymmetry (GO:0061371),0.5385825282716664,1.2216292297596811,0.26187717265353416,1.0,1.0,5/42,9.04%,STIL;SETDB2;SRF;MKKS;NPHP3
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.3835851428916701,-1.2211876509117165,0.1796116504854369,0.6231149993819581,1.0,6/26,9.73%,CAV1;WDFY1;IFI35;LBP;PTPN22;NR1H3
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.43223159236242437,-1.2197246717837675,0.2037735849056604,0.6252452532754091,1.0,8/16,39.60%,TRIB2;TNFRSF21;CD274;TYROBP;JAK3;FCGR2B;DLL1;AGER
prerank,clathrin coat assembly (GO:0048268),-0.4283084430578521,-1.2196612035729892,0.18705035971223022,0.623865092489064,1.0,7/15,19.84%,SGIP1;NSG2;AP2S1;HIP1;FCHO2;CLTB;NSG1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.5406946530283677,1.2191435076390529,0.26106696935300794,1.0,1.0,3/46,6.34%,LMNB1;ANXA2;CNN2
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.5114440246146219,1.2190993724318286,0.007,1.0,1.0,176/807,15.44%,DEPDC1;CENPF;BRCA1;E2F7;NR2E3;E2F8;UHRF1;EZH2;EN1;PLK1;BIRC5;AURKB;GLI2;LOXL3;TCFL5;GLI3;HMGB2;E2F1;CBX5;RBM15;FOXE1;ATOH8;BTAF1;ILF3;KMT5A;SFMBT1;TIMELESS;LOXL2;TRIM37;ZFP69;CBFB;RB1;SP3;ETV6;TWIST2;FNIP1;MIER1;WWOX;SP2;HDGF;CTCF;FGFR2;ZEB1;JAZF1;CNOT1;MPHOSPH8;EED;RBFOX2;DAP;BCOR;MDM4;TAF3;SETDB2;MBD1;KHDRBS1;HIVEP1;CUX1;FHL2;BHLHE41;NFIL3;CTBP1;ZNF568;MAEL;TBL1XR1;IKZF1;MCPH1;BMP6;GZF1;LCOR;SCML2;YAF2;TCF7L2;ORC2;HOXA7;TPR;PML;SCMH1;GATAD2A;PSPC1;MIDEAS;EFNA1;GLIS3;RIF1;SFRP2;NIPBL;POU2F1;ZBTB2;MXD1;ZBTB7B;ZHX2;UIMC1;FOXO3;ATF7IP;SAP18;TRIM28;KDM2B;LIN37;RCOR1;IRF1;ING4;BCLAF1;SMARCA4;ZFP90;KLF11;MIER3;KANK2;LIMD1;YAP1;NONO;VHL;ARID4A;UXT;EPC1;HMGB1;HDAC8;MTA3;NR4A2;MYPOP;NR3C1;CXXC5;PARP9;SFPQ;HNRNPU;RUNX1T1;LIMS1;KCNIP3;RBM15B;DKK3;SMURF2;L3MBTL2;HDAC1;BMP2;AHR;EZR;NKX2-1;ZHX3;ATXN1;FBXW11;RBPJ;SOX9;SMAD4;HDAC2;SAP130;ATF5;ELK4;IRF2BP1;PPID;TWIST1;HEY2;USP9X;MED1;USP47;DLG1;BTRC;RARB;YY1;BCL7A;ZMYM5;FOXK2;CDKN1B;KDM5C;PCGF6;DNMT3A;FOXM1;SMAD3;FOXP4;QARS1;SOX1;PER1;YEATS2;RBAK;OTUD7B;DR1;CNOT7;KAT6A;DCAF1
prerank,negative regulation of DNA metabolic process (GO:0051053),0.5687272312535191,1.2190356631288828,0.2506112469437653,1.0,1.0,8/24,12.42%,ZRANB3;RTEL1;MSH3;ERCC4;BLM;KMT2A;TERF2;MSH6
prerank,alpha-amino acid catabolic process (GO:1901606),0.5530340500361853,1.2189968021563586,0.2577565632458234,1.0,1.0,5/29,13.22%,ACMSD;ACAT1;KMO;HOGA1;IL4I1
prerank,regulation of T cell cytokine production (GO:0002724),-0.42898367553444006,-1.2187824384400958,0.20446096654275092,0.6247535194575438,1.0,4/15,11.61%,SMAD7;MALT1;B2M;TNFRSF1B
prerank,L-serine metabolic process (GO:0006563),-0.49693052941810034,-1.2183550988890144,0.2344213649851632,0.6242771365701248,1.0,7/10,43.39%,SERINC3;PSAT1;CBS;PSPH;SHMT2;PHGDH;SHMT1
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.351400478775495,-1.2183187770258666,0.16666666666666666,0.6228468295448243,1.0,13/34,16.14%,MEF2C;GRIN2A;GABRA2;GRID2;GLRA1;GRIN2B;GABRA3;GABRA5;GABRG2;GRIN1;GSK3A;GABRG1;INSYN2A
prerank,cellular response to reactive oxygen species (GO:0034614),0.5278379889165262,1.2166605972016804,0.2647374062165059,1.0,1.0,10/59,11.48%,ECT2;AQP1;SETX;FXN;NET1;MAPT;PDGFRA;AGAP3;TRPM2;ANXA1
prerank,regulation of acrosome reaction (GO:0060046),-0.4983327624897288,-1.2160368741436545,0.23053892215568864,0.6270678811928211,1.0,3/10,28.88%,GLRA1;CACNA1H;PLCB1
prerank,cytoplasmic microtubule organization (GO:0031122),0.5261187138192377,1.216023964167639,0.26490066225165565,1.0,1.0,15/54,18.57%,FIGNL1;KATNAL2;RHOA;PCM1;TUBGCP5;NUMA1;MAPT;TPPP;FIGN;EZR;DLG1;TUBGCP3;TRPV4;CLASP1;LIMK2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.6101489700124136,1.2159741947280631,0.2607449856733524,1.0,1.0,5/12,13.48%,NEDD4;KHDRBS1;TPR;NUP214;RBM4
prerank,regulation of ERAD pathway (GO:1904292),-0.47669018968997157,-1.2153396690330793,0.2375366568914956,0.6274703020187651,1.0,6/11,27.85%,ATXN3;UBXN1;AQP11;TMEM259;USP19;RNFT1
prerank,carboxylic acid catabolic process (GO:0046395),0.6230637986700079,1.214181597865377,0.2755102040816326,1.0,1.0,1/12,0.82%,PON1
prerank,negative regulation of heart contraction (GO:0045822),-0.4756143305361218,-1.2130143952373218,0.22297297297297297,0.6318296014347441,1.0,7/11,40.75%,ATP1A2;SRI;PDE4D;ZC3H12A;PLN;SPX;PIK3CG
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.5125105638347551,1.2125651510298867,0.18604651162790697,1.0,1.0,33/140,11.75%,ECT2;RACGAP1;ARHGAP22;ARHGAP11A;ARHGAP21;DEPDC1B;ARHGAP10;ARHGAP28;RHOA;CGNL1;ARHGAP18;OCRL;NET1;RHOT1;FGD4;ARHGAP36;VAV2;GNA13;FGD1;INPP5B;ARHGAP24;SYDE2;ARHGAP19;RHOQ;SRGAP2;SRGAP3;MYO9B;ARHGAP6;ARHGAP35;ARHGAP23;ARHGEF18;FAM13B;RAC1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.5698715779262573,1.211946855691373,0.28756476683937826,1.0,1.0,7/21,11.16%,RPA1;CHD1L;ERCC4;RPA2;ERCC3;CUL4B;XPA
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.5698715779262573,1.211946855691373,0.28756476683937826,1.0,1.0,7/21,11.16%,RPA1;CHD1L;ERCC4;RPA2;ERCC3;CUL4B;XPA
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.3282084728493251,-1.2109016881744556,0.16666666666666666,0.6356384673455572,1.0,19/48,26.82%,CAMK2D;CALM1;FKBP1A;AKAP6;CEMIP;PLCG1;TRPC1;SELENON;CX3CL1;SRI;PDE4D;CALM3;NOS1;PTK2B;GSTM2;JPH2;GPER1;THY1;JPH4
prerank,cognition (GO:0050890),-0.3270852289953356,-1.208234442022188,0.16417910447761194,0.6409058075056495,1.0,18/42,27.66%,SHROOM4;PTCHD1;NF1;BBS4;SOBP;CHMP2B;CHRNA7;APP;GRM5;STRA6;CYFIP1;MFSD2A;CTNS;JAKMIP1;DOP1B;NSUN5;DGCR2;CHD7
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.5058850831118235,1.208195571998396,0.096,1.0,1.0,52/314,11.25%,KIF14;CCNF;CCNB1;CDK1;BUB1B;PLK1;CDC20;UBE2C;AURKB;UBE2S;FBXO5;ANAPC7;RB1;AURKA;FEM1C;PSMC2;CDC27;PSMD5;UBE2K;NEDD4;FBXL7;SPSB3;KLHL15;SIAH2;SPSB2;TBL1XR1;FAF1;BUB3;ARRB1;PML;FBXW7;DERL2;CUL5;FBXL8;CDK2;AGAP3;PSMB1;SMURF1;CUL3;PSMD14;KCTD2;KLHL22;CUL4B;PSMD1;SKP2;FBXL17;ARMC8;PPP2R5C;FBXO45;PSMB9;SMURF2;DCAF12
prerank,platelet degranulation (GO:0002576),-0.26236451032666064,-1.2081529142257794,0.1111111111111111,0.639587803566895,1.0,40/118,20.57%,CYRIB;VWF;TMSB4X;PECAM1;TIMP3;CALM1;VEGFC;IGF1;APOOL;TGFB2;RAB27B;GAS6;PLEK;PSAP;ISLR;LYN;ABCC4;IGF2;LHFPL2;ENDOD1;SCG3;SRGN;APP;TAGLN2;CHID1;THBS1;VEGFA;TMX3;HABP4;LAMP2;SCCPDH;TGFB3;ACTN1;VEGFB;TEX264;CLEC3B;VEGFD;SPARC;LGALS3BP;ITGB3
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5131623642139165,1.2080944629244708,0.23357664233576642,1.0,1.0,17/74,15.39%,BRCA1;FADD;PHIP;EYA4;GSK3B;SIAH2;TCF7L2;SERPINE1;SH3RF1;TNFRSF10B;EYA2;TGFBR1;CASP8;BIRC6;ITGAV;SRC;GDNF
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.5810300905528376,1.207928709137036,0.27034120734908135,1.0,1.0,6/18,11.42%,BHLHE41;FRS2;SOX6;CCN3;HDAC1;BMP2
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.596803133638545,1.2078066229017652,0.27529761904761907,1.0,1.0,4/13,14.38%,DYRK1A;YJU2;TWIST1;CD44
prerank,monocyte chemotaxis (GO:0002548),-0.3351940214227041,-1.2076315432031774,0.15853658536585366,0.6392573541631824,1.0,5/32,13.08%,FLT1;PTPRO;RPS19;TNFRSF11A;CX3CL1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.5648044697611021,1.2074192316760515,0.27037037037037037,1.0,1.0,10/26,17.87%,CDK5RAP2;PSRC1;NUMA1;MAPT;DRG1;AKAP9;RAC1;STMN2;TRPV4;CLASP1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.5958495308977606,1.207244445219537,0.2788844621513944,1.0,1.0,7/16,16.32%,TERF1;RTEL1;ERCC4;TERF2;SMG6;HNRNPA2B1;TINF2
prerank,protein-containing complex subunit organization (GO:0043933),0.5094627522659508,1.2070610250269966,0.2199383350462487,1.0,1.0,23/109,14.68%,KNTC1;FANCA;NDC1;KPNA3;NUP205;TEAD1;MDM4;ADD2;ZW10;TPR;PML;DARS1;YAP1;PICALM;IKBKG;KMT2A;CAPZA1;SOX9;DMTN;PPID;EPRS1;CAPG;NUP133
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.32226332279081793,-1.2069031104479901,0.18110236220472442,0.6394650223128713,1.0,17/40,19.78%,SGIP1;INSR;VTN;BICD1;DAB2;B2M;HNRNPK;SFRP4;LDLRAP1;HIP1;VEGFA;PICK1;CBL;PPT1;AHI1;TBC1D5;DGKD
prerank,long-chain fatty acid import into cell (GO:0044539),-0.5119015249385888,-1.206747499528206,0.25225225225225223,0.6383928192306668,1.0,4/10,21.46%,SLC2A1;SLC27A1;SLC27A4;ACSL1
prerank,dendritic cell chemotaxis (GO:0002407),0.6018483709134674,1.2066849484494595,0.2792022792022792,1.0,1.0,4/14,12.53%,CXCR4;HMGB1;TRPM2;TRPM4
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.3914225806535261,-1.2065699394390956,0.19313304721030042,0.63737057137698,1.0,13/20,37.02%,ACLY;ACSL4;PPT1;CBR4;SCD;FASN;FAR2;HSD17B8;DGAT2;FITM2;GCDH;SCD5;PPT2
prerank,negative regulation of cell development (GO:0010721),0.5520898878765208,1.2059774461937602,0.26913265306122447,1.0,1.0,6/25,11.99%,GSK3B;FBN1;PCM1;FBXW7;RFLNA;APPL2
prerank,regulation of microtubule-based process (GO:0032886),0.5462533052831454,1.2059251973361134,0.2994152046783626,1.0,1.0,15/36,17.87%,MACF1;AURKA;GSK3B;MEMO1;DIAPH1;MAPT;BICD2;TPPP;ROCK1;MARK2;ATF5;MAP6;TAOK1;EPHA3;CLASP1
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.6225965350216647,1.2054017773932948,0.2705530642750374,1.0,1.0,3/11,11.31%,ATL2;ARL6IP1;STX18
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.5656449569159262,1.204681998902576,0.2782152230971129,1.0,1.0,3/20,9.56%,SAPCD2;RHOQ;PICALM
prerank,atrial septum morphogenesis (GO:0060413),-0.4743906083431887,-1.204567692635517,0.2469879518072289,0.6411434275478252,1.0,4/10,12.73%,ACVR1;BMPR2;TGFB2;SOX4
prerank,positive regulation of protein acetylation (GO:1901985),0.6005403237646557,1.2042609151679575,0.27605633802816903,1.0,1.0,2/12,4.23%,CEP295;FAM161A
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.37574347345579523,-1.204155353089767,0.1935483870967742,0.6405900861016305,1.0,10/26,13.59%,OCLN;INSR;IGF1;CREBL2;AKT2;PIK3R1;IRS2;CLIP3;IRS1;PTPN11
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.5155650575005867,1.203437408279482,0.2697881828316611,1.0,1.0,15/48,17.41%,NDC1;NUP155;NUP205;NUP160;GCK;NUP85;TPR;NUP214;RANBP2;NUP133;PRKAG1;NUP42;PNPT1;NUP98;NUP210
prerank,cellular response to insulin stimulus (GO:0032869),-0.26097388012990846,-1.203180348385624,0.07692307692307693,0.6415327626376636,1.0,38/124,14.88%,TBC1D4;FOXO1;ATP6V0A1;GRB14;GRB10;ATP6V0D1;ATP6V1E1;INSR;ATP6V0B;PIK3R3;PKM;AKT2;PIK3R1;ATP6V0A4;FOXC2;IRS2;SLC27A1;IGF2;NAMPT;INPP5K;GPLD1;SELENOS;BCAR3;IRS1;HDAC5;CAV2;PARP1;GRB2;ATP6V0C;KAT2B;RAB12;GOT1;ATP6V1H;SHC1;GSK3A;HDAC9;APC;ZDHHC7
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.5437161751715224,1.2024759857643335,0.28622754491017965,1.0,1.0,8/28,15.25%,AUNIP;PRKDC;RIF1;MRNIP;SMCHD1;PARP9;KMT5C;SHLD2
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.3745032538052206,-1.2022452678801419,0.18536585365853658,0.6423942681569552,1.0,12/24,35.90%,TAPBP;SEC24B;B2M;ACE;BCAP31;SAR1B;TAP2;FCER1G;ABCB9;CALR;SEC13;CANX
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.36501807388422824,-1.2019540571551288,0.20103092783505155,0.6416928538422779,1.0,14/27,34.37%,GAS6;TLR4;PTPN22;SELENOS;CX3CL1;SYT11;C1QTNF3;NCKAP1L;ZC3H12A;NLRC3;IRAK3;TNFAIP3;PTPN6;CD200R1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.4526818422715635,-1.201142007952515,0.25705329153605017,0.6422766654842599,1.0,7/13,27.32%,SAR1A;CD81;SAR1B;SORL1;SEC16B;TMEM30A;SEC16A
prerank,epithelial tube morphogenesis (GO:0060562),-0.347151262015246,-1.2011229069778808,0.19718309859154928,0.640793028627064,1.0,14/32,16.18%,ACVR1;MEF2C;PODXL;RYR2;ACVRL1;RHOB;PAK1;RASIP1;CTNNB1;MEGF8;SLIT2;MET;SOX17;MTSS1
prerank,heart morphogenesis (GO:0003007),-0.30322892474808166,-1.2007876402322752,0.17142857142857143,0.640260282332526,1.0,15/50,15.07%,PTK2;ACVR1;INSR;RYR2;FKBP1A;ACVRL1;TGFB2;NOS3;TBX3;MEGF8;HEYL;TBX1;VEGFA;ENG;SOX17
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.4106468215740342,-1.2007219595100165,0.20912547528517111,0.6389399249867445,1.0,12/18,31.39%,GOT2;SLC25A13;SLC25A12;MTHFD1;SMS;GOT1;NIT2;ASS1;ASPG;ADI1;ASNS;NAT8L
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.5583201188297711,1.200262831828735,0.2857142857142857,1.0,1.0,8/26,15.73%,ATP2B4;GSK3B;FHL2;PRNP;HOMER2;CAMTA1;LMCD1;STIMATE
prerank,protein-DNA complex disassembly (GO:0032986),0.5782071280862929,1.2002004195633937,0.27906976744186046,1.0,1.0,5/16,8.79%,SMARCC1;NFE2;ARID2;ARID1A;SMARCA4
prerank,regulation of leukocyte activation (GO:0002694),-0.44980145346388145,-1.2000767936767454,0.22743682310469315,0.6389753177544948,1.0,8/14,32.52%,LYN;MYO18A;SHPK;MFHAS1;GPER1;CD74;MIF;PJA2
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.5482072805489757,1.1994469200617335,0.26590330788804073,1.0,1.0,8/23,14.78%,PLK1;UBE2K;S1PR2;CALM2;STOX1;TRIM6;CAB39;RPTOR
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.3448736497264958,-1.1994215000642112,0.184,0.6391177857638713,1.0,12/35,12.68%,FLT1;KRIT1;MEF2C;CAV1;APOE;NF1;ATP5F1A;CAV2;SYNJ2BP;THBS1;SCG2;RGCC
prerank,cellular response to interleukin-12 (GO:0071349),0.5302534900107835,1.1991192796619234,0.2818489289740699,1.0,1.0,9/48,17.31%,LMNB1;ANXA2;CNN2;CAPZA1;HNRNPA2B1;LCP1;MSN;SIRPA;CD47
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.34387918625966707,-1.1986898465450313,0.1864406779661017,0.6396043415843945,1.0,20/33,34.92%,IGF1;PIK3C2B;PIK3R1;MYO16;NYAP2;NF1;IRS1;HTR2A;ERBB2;PIK3CD;PIK3CA;PIK3R2;EDN1;PIK3R5;ERBB3;PIK3C2A;C1QBP;AKT1;TYRO3;HTR2B
prerank,endothelial cell differentiation (GO:0045446),-0.47314876956235136,-1.198634729506215,0.25,0.6382700539417595,1.0,6/12,8.29%,JAG1;BMPR2;ACVRL1;PROX1;TIE1;ACVR2B
prerank,regulation of actomyosin structure organization (GO:0110020),0.6068605150120935,1.1979961782178996,0.2692307692307692,1.0,1.0,5/13,15.86%,ROCK2;ALMS1;ROCK1;RAC1;FHOD1
prerank,regulation of viral life cycle (GO:1903900),0.5650254544522562,1.1979072638934762,0.2831168831168831,1.0,1.0,2/21,2.48%,KPNA2;TRIML2
prerank,establishment of apical/basal cell polarity (GO:0035089),0.5755477793314628,1.1969477900809027,0.266016713091922,1.0,1.0,5/14,16.28%,RHOA;RAP2A;SCRIB;EZR;MSN
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.4067488827764003,-1.196704204732296,0.20229007633587787,0.6417106219239017,1.0,2/17,3.47%,KCNAB1;AKAP6
prerank,positive regulation of protein catabolic process (GO:0045732),0.5056714699340187,1.1955010676464997,0.2453416149068323,1.0,1.0,19/84,17.04%,DTL;BARD1;GSK3B;NEDD4;FAF1;ATG7;SMURF1;SH3D19;SNX33;SMURF2;EZR;ITCH;ADAM9;PLK2;CDKN1B;NKD1;MSN;AMER1;WWP1
prerank,regulation of cell population proliferation (GO:0042127),0.5025507938759621,1.1953607875618455,0.029,1.0,1.0,106/691,12.77%,PRC1;KIF20B;KIF14;SHCBP1;E2F7;CDKN3;UHRF1;EZH2;TTK;BIRC5;RAB33B;SAPCD2;TCFL5;HMGB2;TIPIN;SPDYA;MATK;CDKN2D;NAP1L1;FBXO5;TIMELESS;PPM1D;CDKN2C;KSR1;BMPR1A;PHIP;PDS5B;FGFR4;RHOA;CEP43;CDC6;CTCF;FGFR2;FXN;GAREM1;DDRGK1;RBFOX2;ALDH1A2;MDM4;ARID2;KIT;PRKDC;CNOT6L;CTBP1;CCAR1;PDPN;NMI;COL18A1;BMP6;PTPN2;TCF7L2;RTKN2;HP1BP3;RBBP4;PML;DERL2;CDC25B;PDGFRA;SFRP2;POU3F2;WWTR1;CLMN;CDK2;BTG3;SMAD6;CNOT6;IRF1;ING4;GRK5;CDCA7;CUL3;KLF11;AXIN2;KANK2;YAP1;VHL;ABI1;ELN;NPR3;NOX4;AGT;PPP2R5C;CDC123;S1PR2;TGFBR1;LIMS1;TRAPPC14;BOK;CRKL;CNTF;HDAC1;BMP2;STOX1;P3H1;GLP2R;PLPP1;NCK2;ADAM17;KMT2D;WNT9A;TRPM4;SOX9;TES;HDAC2;ATF5;IL31RA
prerank,pseudouridine synthesis (GO:0001522),-0.447398694874795,-1.1951277246355523,0.24822695035460993,0.6442538410492075,1.0,11/13,42.87%,PUS10;TRUB1;DKC1;PUS3;GAR1;NOP10;PUS1;PUS7L;NHP2;PUSL1;RPUSD2
prerank,actin filament capping (GO:0051693),0.5766417447530496,1.1936398720843635,0.28777923784494086,1.0,1.0,8/18,15.62%,TRIOBP;ADD2;TWF1;CAPZA1;ADD3;SVIL;CAPG;ADD1
prerank,barbed-end actin filament capping (GO:0051016),0.5766417447530496,1.1936398720843635,0.28777923784494086,1.0,1.0,8/18,15.62%,TRIOBP;ADD2;TWF1;CAPZA1;ADD3;SVIL;CAPG;ADD1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.2835022732234257,-1.1935868866704016,0.1346153846153846,0.6467932195994686,1.0,18/76,17.16%,CHRM2;ANO1;HOMER1;HTR2C;GPR4;TGM2;ESR1;OPRM1;GNA14;AGTR1;GRM5;ADRA1A;GRM1;HTR2A;PTH1R;PLCE1;CMKLR1;ADRA2A
prerank,positive regulation of dendritic spine development (GO:0060999),-0.38636761314546875,-1.1932363921060134,0.21212121212121213,0.6462694600201548,1.0,8/20,14.40%,CPEB3;PSEN1;SHANK3;APOE;CAMK1;RELN;SHANK1;LRP8
prerank,positive regulation of neuron differentiation (GO:0045666),0.5274098899637806,1.193174688941168,0.2675893886966551,1.0,1.0,4/40,6.83%,ECT2;RHOA;ZEB1;TCF4
prerank,regulation of glycogen metabolic process (GO:0070873),-0.45123073607631525,-1.1930123707755131,0.25949367088607594,0.6454158984377334,1.0,9/12,48.94%,INPP5K;PPP1R3B;PPP1R3C;AKT1;RUBCNL;KHK;PPP1R3E;PPP1R3D;GCGR
prerank,regulation of epithelial cell proliferation (GO:0050678),0.49945902819676186,1.1925005856404007,0.2692307692307692,1.0,1.0,17/85,13.65%,UHRF1;RAB33B;HYAL1;FGFR2;LAMB1;PRKDC;MCC;BMP6;TCF7L2;TGFBR3;SFRP2;YAP1;ANGPT1;LIMS1;NR4A1;SOX9;PRKD1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.5895219545278151,1.1924258714641687,0.2902777777777778,1.0,1.0,4/14,13.65%,LOXL3;LIMS1;DMTN;PRKD1
prerank,histone H4 deacetylation (GO:0070933),0.627142962086095,1.1922231132393573,0.2818590704647676,1.0,1.0,5/10,12.63%,SMARCAD1;RCOR1;HDAC8;HDAC1;HDAC2
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.4515411347525037,-1.1911238966213236,0.24662162162162163,0.6485786156312102,1.0,3/13,2.43%,CAMK2D;CALM1;CAV1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5950983065200489,1.1906768071108877,0.2909090909090909,1.0,1.0,8/14,20.62%,ADK;LHPP;ADSL;PFAS;RFK;GART;PPAT;ADSS2
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.3854086071548008,-1.190328459904542,0.2217391304347826,0.6492176036705622,1.0,4/20,3.07%,CAMK2D;ATP1B1;CALM1;RYR2
prerank,positive regulation of apoptotic process (GO:0043065),0.49717752285917516,1.1895339003046979,0.12712712712712712,1.0,1.0,44/293,11.42%,TOP2A;ECT2;MELK;BARD1;E2F1;STPG1;ITGB3BP;FADD;STK17B;BMF;IAPP;AIFM2;FAM162A;PRNP;NET1;CCAR1;FAF1;STK3;ERCC3;FGD4;MAP3K20;ATG7;VAV2;SFRP2;CALHM2;GNA13;SCRIB;FGD1;FOXO3;SAP18;HTRA2;ING4;BCLAF1;KLF11;TNFRSF10B;DNM2;HMGB1;APAF1;TGFBR1;BOK;IP6K2;ARHGEF18;QRICH1;BMP2
prerank,icosanoid biosynthetic process (GO:0046456),-0.4866658376745248,-1.1884603369290212,0.2548476454293629,0.6524504624950742,1.0,1/10,0.17%,PLA2G4A
prerank,positive regulation of cell cycle (GO:0045787),0.5055081574822513,1.1881587594949288,0.2901833872707659,1.0,1.0,12/62,12.40%,CCNB1;TGM1;SPDYA;PSRC1;FGFR2;EIF4E;CDC25B;CHEK1;CCDC57;TAL1;PRKCA;ADAM17
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.5040312343680954,1.1878035603699866,0.26715176715176714,1.0,1.0,20/87,14.40%,E2F7;RBL1;WEE1;CDKN2D;FBXO5;CDKN2C;RB1;AURKA;PSMC2;PSMD5;FBXL7;PSMB1;PSMD14;KANK2;PSMD1;PSMB9;JADE1;USP47;DLG1;PSMC6
prerank,protein modification by small protein conjugation (GO:0032446),0.49801809418414983,1.1877638076768202,0.088,1.0,1.0,73/361,14.68%,BRCA1;CCNF;UHRF1;PLK1;BARD1;UBE2T;UBE2C;RAD18;NDC1;NUP155;SAE1;UBE2S;RFWD3;RNF168;ANAPC7;TRIML2;NUP205;NUP160;BRAP;PDZRN3;CDC27;RNF220;UBE2K;DDRGK1;UHRF2;NEDD4;FBXL7;MYCBP2;PRKDC;SPSB2;NUP85;RNF43;TPR;ARRB1;ELOC;FBXW7;UBE2N;ATG7;CUL5;TRIM28;VPS18;RNF40;SMURF1;CUL3;UBE2R2;LEO1;VHL;CUL4B;FBXL17;RANGAP1;HERC2;FBXO45;TRIM63;ARRDC1;SMURF2;PCNA;NSMCE2;SUMO2;NUP214;FBXW11;TRPM4;TRIM6;RANBP2;ITCH;ATG3;USP9X;CRBN;BTRC;FBXO25;HLTF;TRIM5;BIRC6;NUP133
prerank,peptidyl-serine modification (GO:0018209),0.49682719450515367,1.1877518800070082,0.2,1.0,1.0,49/166,18.84%,CDK1;TTK;CLSPN;PLK1;MASTL;MAST2;DYRK1A;AURKA;ROCK2;GSK3B;GALNT1;PRKDC;DYRK3;VRK2;WNK1;CDK2;LRRK2;ROCK1;MARK2;CSNK2A2;CAMK1D;TGFBR1;EIF2AK3;PRKCB;PRKCA;ULK2;PDPK1;CSNK1G2;MAPKAPK3;PRKCE;PRKD1;PRKCI;CAB39;PLK2;MORC3;VRK1;PRKD2;STK39;HIPK3;ATR;CSNK1A1;MAST4;CSNK1G1;SRPK2;MAST1;PKN2;MAPK14;HIPK1;CAMKV
prerank,positive regulation of phosphatase activity (GO:0010922),-0.39445652220296523,-1.1875747898506417,0.2112676056338028,0.6532249384053486,1.0,7/21,10.95%,MEF2C;HSP90AB1;CALM1;PDGFRB;PLEK;GPLD1;MTOR
prerank,regulation of protein import into nucleus (GO:0042306),0.5224034588730763,1.187496059663741,0.2921478060046189,1.0,1.0,4/36,8.19%,ECT2;TPR;UBR5;TRIM28
prerank,regulation of RNA export from nucleus (GO:0046831),0.6136662083597872,1.1873389555860374,0.2958152958152958,1.0,1.0,5/11,7.50%,KHDRBS1;DHX9;NRDE2;TPR;SETD2
prerank,response to alcohol (GO:0097305),-0.36152330185744885,-1.1865985647412471,0.23076923076923078,0.6543900392966171,1.0,6/27,4.69%,GRIN3A;GRIN2A;TGFBR2;GLRA1;GRIN2B;GOT2
prerank,gene silencing by miRNA (GO:0035195),0.5334141381993729,1.1854469328787869,0.29612220916568743,1.0,1.0,12/32,15.51%,ZC3H7A;MOV10;AGO2;CNOT1;AJUBA;CNOT6;LIMD1;PUM2;RBM4;CNOT7;ZC3H7B;TNRC6C
prerank,regulation of protein kinase activity (GO:0045859),0.5008302730963465,1.1852586216637233,0.24693877551020407,1.0,1.0,12/106,10.12%,CENPE;ECT2;SPDYA;RB1;CEP43;TAB1;CCN1;WWTR1;MRNIP;GNAQ;DDR2;CEP85
prerank,negative regulation of ossification (GO:0030279),0.5404627846870979,1.184297807669158,0.29508196721311475,1.0,1.0,8/23,16.07%,BCOR;CHSY1;SMAD6;ENPP1;RBPJ;TRPM4;SOX9;SFRP1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.3672860932606413,-1.1841219862170185,0.22631578947368422,0.6593203550460932,1.0,13/26,32.32%,EPHA5;KLF7;STX4;ANO1;GPLD1;ADCY8;ADRA2A;EFNA5;PIM3;BAIAP3;ADCY5;NR1H4;CFTR
prerank,negative regulation of vascular permeability (GO:0043116),-0.4564524723057389,-1.183138614806238,0.25263157894736843,0.6602818421243576,1.0,7/12,23.72%,PDE3A;CLDN5;RAMP2;SLIT2;VEGFA;PDE2A;SH3GL2
prerank,bile acid and bile salt transport (GO:0015721),-0.36157961889079604,-1.1830255889713612,0.18691588785046728,0.659097423908673,1.0,4/24,7.82%,SLCO1C1;SLCO2B1;ABCC4;ATP8B1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.5619665044324533,1.1820647897959797,0.29411764705882354,1.0,1.0,7/18,18.15%,RB1;PDPN;DDR2;BMP2;SMAD3;CLASP1;RUNX1
prerank,fatty acid transport (GO:0015908),-0.4078803468767805,-1.1817680156642678,0.2289156626506024,0.6609090462578578,1.0,13/17,45.96%,APOE;GOT2;SLC27A1;SLC27A4;ACSL1;MFSD2A;FABP5;PPARG;SLC27A3;FABP3;SLC27A6;CD36;CPT1B
prerank,cobalamin metabolic process (GO:0009235),-0.4106767296128307,-1.1805364654848118,0.23809523809523808,0.6627240252904009,1.0,7/17,25.37%,ABCD4;CUBN;LMBRD1;MTRR;MMAA;MTR;TCN2
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.44614465356231037,-1.180379014417372,0.24382716049382716,0.6616488305233076,1.0,5/12,14.56%,STAT3;SDK2;PROM1;RORB;VEGFA
prerank,embryonic digit morphogenesis (GO:0042733),0.5737955164514172,1.1802248483852942,0.3083989501312336,1.0,1.0,8/18,18.17%,GLI3;MAP3K20;WDPCP;HDAC1;HDAC2;TWIST1;SALL1;OSR1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.35241040740886936,-1.1801941687281101,0.2222222222222222,0.6607229684144623,1.0,8/29,19.73%,PLA2G4A;PLAAT3;PNPLA8;NR1H3;LPCAT2;DBI;NR1H2;PLA2G12A
prerank,organelle disassembly (GO:1903008),0.5434257166120644,1.1801153590710058,0.30120481927710846,1.0,1.0,12/33,17.32%,CDK1;GBF1;DDRGK1;DYRK3;RB1CC1;ULK2;VRK1;ATG2A;GFM2;MCTS1;DENR;MTIF3
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.4626623626079544,-1.179554086586751,0.2616822429906542,0.6609701798446928,1.0,6/11,14.65%,MAP3K5;GSKIP;PRODH;PDK1;STK25;DIABLO
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.4330564449424767,-1.178554821486695,0.24916943521594684,0.6620304795200764,1.0,11/15,31.96%,PKM;KLF4;FGF2;FGF1;TJP1;VEGFA;S100A1;JAK1;JMJD8;SMAD1;BMPER
prerank,RNA export from nucleus (GO:0006405),0.49528018955959213,1.1784774615579539,0.25638406537282943,1.0,1.0,31/100,17.41%,NDC1;NUP155;NUP205;NUP160;SRSF4;FIP1L1;HNRNPA1;EIF4E;UPF3B;NUP85;SLBP;TPR;DDX39B;SRSF7;WDR33;SRSF3;RBM15B;SRRM1;CPSF4;NUP214;RANBP2;MCM3AP;SMG6;NXT1;NUP133;HNRNPA2B1;NUP42;UPF2;DHX38;NUP98;NUP210
prerank,import into cell (GO:0098657),0.5252998872942292,1.1784215114485281,0.31715575620767494,1.0,1.0,4/41,8.07%,NEURL1B;TSPO2;SLC19A1;SLC16A2
prerank,response to interferon-alpha (GO:0035455),-0.4114949286399995,-1.1776725527905394,0.2952029520295203,0.6628820471639995,1.0,7/16,16.82%,IFNAR1;RO60;GAS6;IFITM3;ADAR;BST2;IFITM2
prerank,protein mannosylation (GO:0035268),0.5499065424671584,1.177619922227227,0.29463171036204744,1.0,1.0,6/22,12.00%,POMT1;LARGE1;CRPPA;FKRP;RXYLT1;TMTC4
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.46345423184391243,-1.1775471275392257,0.2733118971061093,0.6617806691991809,1.0,5/12,16.43%,CCT5;TCP1;CCT7;CCT2;DKC1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.5836891387580694,1.1773652449242649,0.2956403269754768,1.0,1.0,3/15,7.26%,IQGAP2;ACTR3;ARPC5L
prerank,cellular response to hormone stimulus (GO:0032870),-0.29245818597849643,-1.177090343569476,0.16326530612244897,0.661421471829835,1.0,22/69,17.16%,THRB;STAT3;MEF2C;CAV1;AR;SOCS2;CTSB;RAMP1;RAMP2;ATP1A1;INPP5K;ATP1A3;SLC5A5;SFR1;SLIT2;ATP1A2;NSMF;SERPINB9;CTSL;ROBO2;XBP1;ADRA2A
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.3586450724299696,-1.1768518170103417,0.21717171717171718,0.660602158913682,1.0,14/24,24.17%,PRKN;SELENOS;NR1H3;CREB3L1;UBXN1;NR1H2;XBP1;AQP11;SYVN1;CREB3;PARK7;BCL2L1;RACK1;WFS1
prerank,positive regulation of biosynthetic process (GO:0009891),-0.3085881197162258,-1.1767470039439483,0.17037037037037037,0.659453100504334,1.0,12/40,21.58%,APOE;CREBL2;TLR4;LARP6;MTOR;RGCC;GRIN1;CREB3L1;TGFB3;RAB27A;SORBS1;SUCO
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.49416097822228977,1.1764558786056138,0.26741803278688525,1.0,1.0,30/96,17.41%,NDC1;NUP155;NUP205;NUP160;SRSF4;FIP1L1;EIF4E;UPF3B;NUP85;SLBP;TPR;DDX39B;SRSF7;WDR33;SRSF3;RBM15B;SRRM1;CPSF4;NUP214;RANBP2;MCM3AP;SMG6;NXT1;NUP133;HNRNPA2B1;NUP42;UPF2;DHX38;NUP98;NUP210
prerank,L-glutamate transmembrane transport (GO:0015813),-0.4880039858713048,-1.1763449191362563,0.25846153846153846,0.6590751939499355,1.0,8/10,33.46%,SLC1A2;SLC25A13;SLC25A12;SLC1A1;ARL6IP5;SLC25A18;SLC1A6;PRAF2
prerank,mitochondrion distribution (GO:0048311),0.6020164571186459,1.1756034534733162,0.29473684210526313,1.0,1.0,3/12,8.30%,TRAK1;MAPT;LRRK2
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.33761916790054225,-1.1755447053579737,0.22727272727272727,0.6597691681954481,1.0,16/32,26.58%,PSEN1;TMSB4X;INSR;IGF1;PFKFB3;PRKAA1;APP;PINK1;NUPR1;ENO1;PPARGC1A;P2RX7;HIF1A;ENTPD5;PRXL2C;BEND3
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.3462025393311513,-1.1754883089249961,0.22777777777777777,0.658439668760471,1.0,12/29,25.64%,APOE;CREBL2;SLC27A1;GPLD1;NR1H3;MTOR;NR1H2;SORBS1;SLC45A3;MFSD2A;CTDNEP1;MID1IP1
prerank,dendritic cell differentiation (GO:0097028),-0.3669420251421067,-1.1747328233566499,0.22018348623853212,0.6589426538320453,1.0,4/22,6.74%,TGFBR2;GAS6;CAMK4;LYN
prerank,regulation of macrophage migration (GO:1905521),-0.4771832979434193,-1.174335950384005,0.2756756756756757,0.6584431717355279,1.0,8/10,45.64%,MTUS1;CD81;PTK2B;P2RY12;CD200R1;CX3CR1;EMILIN1;CSF1
prerank,C4-dicarboxylate transport (GO:0015740),-0.4379535522176369,-1.1742374711642323,0.24489795918367346,0.6572952255932114,1.0,6/14,18.11%,SLC1A2;SLC25A13;SLC25A12;LRRC8D;SLC1A1;SLC25A11
prerank,positive regulation of cell communication (GO:0010647),-0.3555637125360488,-1.1735615768454541,0.19883040935672514,0.6574728128489681,1.0,12/28,27.00%,RIMS1;SYT1;LGI1;HOMER1;DLG4;GRIK2;KCTD13;CDKN2AIP;NMU;EDN1;SOX11;EDN3
prerank,negative regulation of nuclear division (GO:0051784),0.6165772249184885,1.1735403640805742,0.3034379671150972,1.0,1.0,3/11,11.99%,FBXO5;CHEK1;TOM1L2
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.3802055660340708,-1.1731145188276069,0.23728813559322035,0.6573257237013032,1.0,5/20,10.73%,IL1R1;MALT1;B2M;DENND1B;CD81
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.3725009807858604,-1.172171368761361,0.2245762711864407,0.6583729565871114,1.0,8/20,25.61%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;ATP1A2;SLC12A2;NEDD4L;ATP6AP1
prerank,striated muscle contraction (GO:0006941),-0.29424686886581786,-1.1721290720024453,0.16,0.6570407692750554,1.0,24/53,39.74%,ATP1B1;RCSD1;RYR2;TPM1;ATP1A2;SCN1B;DTNA;STAC;PIK3CA;KCNQ1;NOS1;ALDOA;SCN4B;MYH14;STAC3;SCN3B;MYL4;CASQ2;TNNI1;GAA;KCNH2;STAC2;TTN;SCN5A
prerank,replicative senescence (GO:0090399),0.5962496620928192,1.1715636514978467,0.2922173274596182,1.0,1.0,6/12,19.63%,CHEK2;CHEK1;SERPINE1;TP53;ATR;TERT
prerank,eosinophil migration (GO:0072677),-0.4215581643543223,-1.1712063627485658,0.2591240875912409,0.6565137441568094,1.0,12/14,57.87%,SCG2;CX3CL1;CCL13;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,eosinophil chemotaxis (GO:0048245),-0.4215581643543223,-1.1712063627485658,0.2591240875912409,0.6565137441568094,1.0,12/14,57.87%,SCG2;CX3CL1;CCL13;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.46591595155419074,-1.1711128145417204,0.25396825396825395,0.6552777985027248,1.0,7/11,29.59%,ATF6;HSPA5;CEBPB;CREB3L1;DDIT3;ATF6B;MBTPS2
prerank,actin crosslink formation (GO:0051764),0.5913661582955795,1.1709541234622274,0.2935103244837758,1.0,1.0,4/12,15.79%,GAS2L3;DPYSL3;BAIAP2L1;LCP1
prerank,apical junction assembly (GO:0043297),0.5117643033599988,1.1707046382197988,0.30718954248366015,1.0,1.0,5/53,6.60%,ECT2;RHOA;AFDN;CTNNA1;GRHL2
prerank,carbohydrate transport (GO:0008643),0.5900571641208955,1.170447465701673,0.3015625,1.0,1.0,1/11,1.82%,AQP1
prerank,regulation of oxidoreductase activity (GO:0051341),-0.43876398808893696,-1.1701390373192042,0.2553846153846154,0.6565253754774658,1.0,6/13,34.28%,OXA1L;SZT2;ABL1;ATP7A;MT3;NOD2
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.358875635556524,-1.1698097421420754,0.21634615384615385,0.6560815174444394,1.0,8/24,25.83%,PLA2G4A;CDS2;SLC27A1;PNPLA8;SERAC1;PLA2G12A;PLA2G15;ABCA3
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3261418179493085,-1.1698019962688133,0.20134228187919462,0.6547168431667434,1.0,17/34,23.85%,FLT1;SEMA6A;VEGFC;FOXC1;RAMP2;SPRY2;VEGFA;ITGB1BP1;VEGFB;PIK3CA;NRP1;VEGFD;MT1G;HSPB1;NUS1;FLT4;SPHK1
prerank,ncRNA processing (GO:0034470),-0.25592700487272424,-1.1695059056927013,0.0,0.6541125900426652,1.0,91/200,27.09%,RPL13;AGO1;AGO3;SRRT;RPL37A;RPL38;RPL21;RPL35A;RPL23;RPL17;RPL3;RPS15;PUS10;RPS7;NVL;RPL18A;RPS6;RPL14;AARS1;RPLP1;RPL9;RPL37;RPL8;RPS14;INTS3;NOL8;RPL10;RPL18;RPL32;RPS28;SENP3;RPS24;RPL15;RPS19;HEATR1;UTP20;RPL39;SARS1;KRR1;RPL12;RPL27;RPL24;WDR75;EXOSC1;RPS27;RPL27A;RPS9;RPL30;ADAR;EXOSC9;RRP1B;RRP1;RPL19;DICER1;RPL28;RPL31;MPHOSPH10;LAS1L;SNU13;DKC1;DDX49;RPL13A;RPL36A;AGO4;RPLP2;RPL29;MDN1;INTS12;KARS1;RPLP0;RPL10A;RPL35;NOB1;NOLC1;EMG1;EXOSC2;PIH1D1;EBNA1BP2;DDX54;RPL4;BYSL;INTS1;IMP3;DDX47;INTS11;BOP1;EXOSC3;RPS25;EXOSC5;TARBP2;POP5
prerank,response to amino acid (GO:0043200),-0.34518820999350214,-1.1694716665425393,0.2073170731707317,0.6528046687157034,1.0,11/31,16.81%,CPEB3;GLRB;CPEB4;GLRA1;SH3BP4;GLRA3;MTOR;NSMF;GRIN1;RRAGC;XBP1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.3143706069348944,-1.1691929132744976,0.17886178861788618,0.6521746253478797,1.0,14/39,20.19%,SH3KBP1;STAM2;DUSP3;EPN1;TSG101;LGMN;TGFA;GRB2;SPRY2;ARHGEF7;ERBB2;CBL;PTPN12;HBEGF
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.4889865691812588,1.1689622826807726,0.005,1.0,1.0,345/1646,15.88%,DEPDC1;CENPF;BRCA1;E2F7;NR2E3;E2F8;RRM2;MXD3;PHF19;ATAD2;EZH2;BRIP1;EN1;BIRC5;E2F2;ATRX;MYBL1;PBX4;POLA1;NSD2;GLI2;CDK5RAP2;LOXL3;ORC1;TCFL5;GLI3;LCORL;HMGB2;E2F1;BRCA2;CBX5;TYMS;RBM15;FOXE1;ATOH8;HAS3;CDC45;BTAF1;ZBTB8A;ILF3;NAT14;MED26;ATP2B4;PSRC1;KMT5A;SFMBT1;FBXO5;TIMELESS;DYRK1A;LOXL2;ZFP69;BRD9;CBFB;SMARCC1;ZNF32;RB1;PBX3;BAZ1B;SP3;CDK14;HOXC5;DEK;PHIP;ZFP41;ETV6;TWIST2;ELF2;TRAK1;TEAD1;SP2;ZSCAN29;RAD21;RBBP8;HDGF;CDC6;CTCF;E2F3;ZEB1;LIN54;TFDP1;HNRNPD;NFE2;TFCP2L1;NLK;MPHOSPH8;MED14;EED;RBFOX2;DAP;BCOR;AJUBA;CHEK2;RFXAP;MDM4;ZNF260;SETDB2;MBD1;NFIA;KHDRBS1;HIVEP1;KIT;CUX1;PCGF5;DHX9;WIZ;ZFP62;BHLHE41;NFIL3;KLF5;SRF;TCF7L1;CTBP1;EPC2;BLM;SRSF10;TSHZ1;ELF4;NFIB;THRAP3;KLF13;ZNF568;ZNF697;MAEL;CCAR1;TBL1XR1;SP8;IKZF1;SETD3;NUP85;CCNA1;GZF1;LCOR;PCBD2;SCML2;HOXC4;YAF2;TCF7L2;PSIP1;MED30;SOX6;ELF1;CCNE1;HP1BP3;HOXA7;GMEB1;GRHL2;GON4L;ARRB1;PML;SCMH1;ELOC;GATAD2A;TCF4;PSPC1;MIDEAS;ARID1A;MYBL2;GLIS3;TASP1;RFX2;SFRP2;ELK1;NUCKS1;POLR2A;FUS;NIPBL;POU2F1;ZBTB2;PROX2;POU3F2;MXD1;MAMSTR;SIM1;ZBTB7B;MYCBP;WWTR1;SRCAP;ZFX;PHF2;PHF1;LIN9;ZHX2;UIMC1;PRRX2;OLIG2;FOXO3;ATF7IP;CD80;SAP18;TRIM28;LMX1B;KDM2B;PLAGL2;SMAD6;ZNF23;BNC2;RCOR1;IRF1;ING4;HMGB3;BCLAF1;CREB5;MED24;SMARCA4;MSL3;USP21;USP16;ZFP90;KLF11;LIMD1;DNM2;ZBTB25;HOXB3;YAP1;NONO;NFYA;VHL;ARID4A;PLAGL1;ZIC5;PICALM;ZBTB20;UXT;EPC1;ZNHIT3;HMGB1;AGT;ERC1;KMT2A;HOXB6;MEOX2;MTA3;NR4A2;CARF;MYPOP;NR3C1;HINT1;PARP9;SFPQ;TGFBR1;TAL1;TADA1;MMS19;RUNX1T1;CRLF3;SLC39A8;TEAD3;LIMS1;ZBTB24;TAF15;RBM15B;POFUT1;DKK3;NCOA2;SMURF2;PRKCB;PCNA;ZNF585B;ZNF585A;CHD2;QRICH1;L3MBTL2;HDAC1;BMP2;AHR;NKX2-1;KLF9;HTATSF1;TBX18;ZHX3;ATXN1;SPTY2D1;FBXW11;RBPJ;NR4A1;METTL4;ZIC4;KMT2D;SOX9;SMAD4;HDAC2;ZNF394;ATF5;IL31RA;ZNF496;ILF2;BRD4;TCF20;ELK4;RAI1;LRP5;RORA;NCOA7;TADA2A;IRF2BP1;TWIST1;HEY2;DHFR;ACTL6B;MED1;USP47;BTRC;FOXL1;GPBP1L1;POU2F2;YY1;BCL7A;RLF;FOXK2;CDKN1B;KDM5C;CAMTA1;PCGF6;RUVBL2;FOXM1;SMAD3;ARNT;FOXP4;QARS1;ZFP91;JMJD1C;BAZ1A;SOX1;E2F4;PER1;YEATS2;RBAK;ZNF445;MED27;PRDM8;EFEMP1;HDGFL3;CNOT7;ATF1;KAT6A;TRRAP;MLF2;HOXB7;BICRA;CHD1;ZNF112;NFKB1;ZBTB7C;TP53;PKNOX2
prerank,positive regulation of innate immune response (GO:0045089),0.5332582789717881,1.1687296757384917,0.31527093596059114,1.0,1.0,10/30,17.17%,FADD;UBE2K;DHX9;NMI;RIOK3;POLR3D;AKIRIN2;TRIM6;SLC15A4;MAVS
prerank,aortic valve morphogenesis (GO:0003180),0.5311946290037494,1.1679272653367156,0.31470230862697446,1.0,1.0,10/30,13.45%,RB1;ROCK2;EFNA1;SMAD6;ROBO1;ROCK1;ELN;SOX9;TWIST1;HEY2
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.5833188692114034,1.1673998581863843,0.3028485757121439,1.0,1.0,1/13,1.19%,GLI2
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.4893554781204004,1.1670499132064762,0.145,1.0,1.0,66/366,12.06%,ESCO2;PHF19;EZH2;ATRX;MYBL1;NSD2;TCFL5;E2F1;DSCC1;BRCA2;FBXO5;RB1;SP3;LIN54;HNRNPD;NLK;AJUBA;CHEK2;NFIA;CCNA2;SMC3;NFIL3;EIF4E;TCF7L1;SRSF10;CCAR1;GZF1;YAF2;SOX6;HP1BP3;USP37;GON4L;PML;PSPC1;MYBL2;NUCKS1;POLR2A;FUS;ORC3;MYCBP;WWTR1;PHF1;PRRX2;FOXO3;LMX1B;BNC2;MSL3;LIMD1;DNM2;NONO;NFYA;VHL;OBI1;ZNHIT3;ERC1;NR3C1;HINT1;SFPQ;TGFBR1;SLC39A8;POFUT1;NCOA2;BMP2;AHR;ATXN1;SPTY2D1
prerank,positive regulation of secretion (GO:0051047),0.597375175005082,1.1666988126625584,0.29923664122137406,1.0,1.0,1/11,1.82%,AQP1
prerank,heterochromatin assembly (GO:0031507),0.5635547678175824,1.1664499007727271,0.3123359580052493,1.0,1.0,5/20,12.01%,HELLS;NRDE2;SMCHD1;HDAC1;CENPV
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5977812492430813,1.1663717952638264,0.2932551319648094,1.0,1.0,4/11,18.74%,FADD;PRKCA;CASP8;RIPK1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.42785399012512026,-1.166362669529052,0.2491103202846975,0.6579087757677629,1.0,9/15,23.09%,HSP90B1;OS9;UFD1;DERL1;SELENOS;SEC61B;AUP1;SYVN1;SEL1L
prerank,protein autophosphorylation (GO:0046777),0.49050327013301176,1.1660312113275668,0.2515090543259557,1.0,1.0,38/157,15.62%,NEK2;MELK;AURKB;DYRK1A;STK17B;AURKA;FGFR4;GSK3B;FGFR2;STK10;CHEK2;KIT;VRK2;STK24;MUSK;PDGFRA;EPHA4;LRRK2;GRK5;MAP3K3;PIM1;MARK2;DDR2;EIF2AK3;ULK2;PDPK1;AAK1;SIK2;MAPKAPK3;MEX3B;PRKD1;VRK1;STK11;TAOK1;SRC;PRKD2;STK39;PASK
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.2966093586262474,-1.1652054368409768,0.21052631578947367,0.6581752044777329,1.0,24/56,25.20%,NDUFS5;OXA1L;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFB9;DMAC2;ACAD9;NDUFAF1;NDUFB6;NDUFA11;NDUFB10;NDUFB11;TIMMDC1;NDUFA10;NDUFS6;NDUFA1
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.2966093586262474,-1.1652054368409768,0.21052631578947367,0.6581752044777329,1.0,24/56,25.20%,NDUFS5;OXA1L;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFB9;DMAC2;ACAD9;NDUFAF1;NDUFB6;NDUFA11;NDUFB10;NDUFB11;TIMMDC1;NDUFA10;NDUFS6;NDUFA1
prerank,regulation of heart contraction (GO:0008016),-0.2643940442419108,-1.1651138326924528,0.1,0.6570721246104275,1.0,30/90,22.37%,CAMK2D;RYR3;SMAD7;SLC8A3;ATP1B1;CALM1;RYR2;TGFB2;DMPK;ATP1A1;TPM1;ATP1B3;NPR1;TRPC1;ATP1A3;ATP1A2;ATP2B2;ATP2B3;GSK3A;SRI;TBX2;PDE4D;FXYD1;KCNQ1;CALM3;KCNJ12;NOS1;ATP2A3;P2RX4;S100A1
prerank,gland development (GO:0048732),0.49933923277182574,1.1646126434887363,0.30235042735042733,1.0,1.0,21/59,19.06%,GLI2;FOXE1;FADD;FGFR2;TGFBR3;PHF2;ARHGAP35;TGFBR1;DKK3;EZR;ANXA1;NKX2-1;SOX9;GFER;PKD2;MSN;SALL1;COBL;IGSF3;ZBTB1;WNT4
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.4250185643803501,-1.1645289216619499,0.2482758620689655,0.6571940735347072,1.0,10/14,22.66%,VEGFC;FOXC1;VEGFA;PIK3CD;VEGFB;PIK3CA;NRP1;VEGFD;NUS1;FLT4
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.32821290486493054,-1.1644924923757594,0.21232876712328766,0.6558952292799772,1.0,11/37,13.87%,PRKG1;MEF2C;IGF1;PDCD4;FGF2;SOD2;TPM1;JUN;MMP2;TAFA5;LDLRAP1
prerank,mRNA export from nucleus (GO:0006406),0.4876428662177192,1.1642774814912102,0.28877551020408165,1.0,1.0,31/102,17.41%,NDC1;NUP155;NUP205;NUP160;SRSF4;FIP1L1;EIF4E;UPF3B;NUP85;SLBP;TPR;DDX39B;SRSF7;WDR33;SRSF3;RBM15B;SRRM1;CPSF4;NUP214;RANBP2;MCM3AP;SMG6;NXT1;NUP133;HNRNPA2B1;NUP42;UPF2;IWS1;DHX38;NUP98;NUP210
prerank,synaptic vesicle exocytosis (GO:0016079),-0.3226122485665154,-1.1640590687470986,0.234375,0.6556824957611733,1.0,14/40,18.62%,UNC13B;PCLO;RIMS1;SNAP47;SYT1;STX4;STX3;SYT7;SNPH;SNAP29;CPLX1;SNAP25;SYT10;STX1B
prerank,mitochondrial fusion (GO:0008053),0.5449439010572081,1.1640574281667684,0.31417624521072796,1.0,1.0,8/18,20.48%,MIEF2;STOML2;MFN2;MIEF1;CHCHD3;MFN1;MIGA2;SPG7
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.4692278538368317,-1.1634477393701947,0.2824207492795389,0.6558171723546784,1.0,3/10,19.55%,CTNNB1;LRP6;FZD1
prerank,regulation of mast cell activation (GO:0033003),-0.4812908608494111,-1.163142874159871,0.2934131736526946,0.6551538047143071,1.0,9/10,49.95%,LYN;NECTIN2;CD84;CRLF2;MILR1;CD300LF;TSLP;PLSCR1;CD226
prerank,mRNA transport (GO:0051028),0.4874447056842402,1.1629721847798693,0.28147389969293757,1.0,1.0,31/101,17.41%,NDC1;NUP155;NUP205;NUP160;SRSF4;FIP1L1;EIF4E;UPF3B;NUP85;SLBP;TPR;DDX39B;FMR1;SRSF7;WDR33;SRSF3;RBM15B;SRRM1;CPSF4;NUP214;RANBP2;MCM3AP;SMG6;NXT1;NUP133;HNRNPA2B1;NUP42;UPF2;DHX38;NUP98;NUP210
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.5793731588422409,1.1628372190451728,0.318118948824343,1.0,1.0,4/14,8.16%,SRSF4;SRSF10;SRSF7;SAP18
prerank,blood vessel diameter maintenance (GO:0097746),0.5128985088620512,1.1628335299010912,0.3231132075471698,1.0,1.0,7/34,9.78%,KEL;ROCK2;SCPEP1;ROCK1;BDKRB2;KCNMB2;AGT
prerank,negative regulation of response to wounding (GO:1903035),0.5627283805188836,1.162629742813025,0.31763122476446837,1.0,1.0,5/19,11.39%,RTN4R;CASK;EPHA4;SERPINE1;PTPRS
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.4760587879117674,-1.1625999147579205,0.3020527859237537,0.6551446373525155,1.0,6/10,21.77%,AKT2;IRS2;GPLD1;IRS1;PTH1R;SLC45A3
prerank,ribosomal small subunit assembly (GO:0000028),-0.4147682110562014,-1.1624037997046597,0.25660377358490566,0.6542780465046292,1.0,7/16,11.77%,RPS15;RPS14;RPSA;RPS28;RPS5;RPS19;RPS27
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.45413176876331207,-1.1623395448239289,0.2796352583586626,0.6530853594364162,1.0,5/11,22.21%,PRDX2;PRDX1;GPX1;PRDX3;PRDX5
prerank,inositol lipid-mediated signaling (GO:0048017),-0.28852535328891027,-1.16225646079768,0.14285714285714285,0.6519500571733948,1.0,18/50,21.48%,OGT;ADAP2;IGF1;PDGFRB;PIK3C2B;KCNH1;PLCB3;PIK3R1;IRS2;IRS1;TNFAIP8L3;PI4KA;PLCE1;PIK3CD;PIK3CA;EXOC1;PLCH1;PIK3R2
prerank,purine-containing compound catabolic process (GO:0072523),0.5783456792424193,1.162170233599201,0.3248587570621469,1.0,1.0,3/13,9.07%,DPYD;XDH;ITPA
prerank,negative regulation of wound healing (GO:0061045),-0.3546776059789858,-1.1610995486400622,0.23563218390804597,0.6533829856660565,1.0,6/28,6.10%,PHLDB2;APOE;VTN;THBD;FGF2;CD34
prerank,regulation of cellular respiration (GO:0043457),-0.413739973235152,-1.1603557792828851,0.2781954887218045,0.6538376115101248,1.0,7/17,26.30%,IFNAR1;TRAP1;CBFA2T3;IL10RB;PRDM16;PRELID1;NOA1
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6016873462297161,1.1603186556686425,0.30712166172106825,1.0,1.0,4/10,18.18%,WNK1;ADAM17;STK39;OXSR1
prerank,skeletal system development (GO:0001501),0.48833016324944317,1.160206915852621,0.25728643216080405,1.0,1.0,26/148,12.57%,EN1;RAB33B;BMP1;GLI2;MATN3;HYAL1;WWOX;FGFR2;FBN1;MMP14;DDRGK1;SULF2;BMP6;SOX6;SLC10A7;PAPSS2;RFLNA;SULF1;ANKRD11;NPR3;TGFBR1;EIF2AK3;BMP2;P3H1;GJA1;SOX9
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.39186624000695836,-1.1601919969844021,0.26153846153846155,0.6529372881925666,1.0,4/18,9.25%,OCLN;SLC2A1;CLIP3;INPP5K
prerank,regulation of filopodium assembly (GO:0051489),-0.3248551479928018,-1.1601901725867705,0.19491525423728814,0.6516240652007373,1.0,11/38,9.20%,PPP1R16B;ARAP1;FNBP1L;AGRN;GAP43;PIK3R1;PALM;MYO10;RAB5A;CAPZB;ARHGAP44
prerank,organic hydroxy compound transport (GO:0015850),-0.3228915834487508,-1.1594077725613545,0.22972972972972974,0.6522492424678014,1.0,12/36,31.65%,SLCO1C1;SLCO2B1;ABCC4;ATP8B1;SLC16A1;STRA6;STARD5;OSBP;NPC2;SLC5A3;RBP4;NR1H4
prerank,axonemal dynein complex assembly (GO:0070286),0.5326269264756528,1.1585196226151042,0.31435643564356436,1.0,1.0,8/27,19.02%,DNAAF3;DNAH1;DNAI4;DNAAF5;LRRC49;SPAG1;ODAD1;DNAH8
prerank,negative regulation of cellular protein localization (GO:1903828),0.5215109661353989,1.158518300098026,0.3212616822429907,1.0,1.0,12/34,16.80%,ROCK2;GSK3B;MAPT;LEPROT;CTNNA1;RIPOR2;PICALM;SNX33;ILRUN;OTUD7B;LZTFL1;UBXN2B
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.5084661001393972,1.158114166651814,0.32323232323232326,1.0,1.0,16/44,16.36%,MOV10;ROCK2;AGO2;ZC3HAV1;CNOT1;FTO;EIF4ENIF1;ROCK1;YTHDF2;MEX3D;RC3H1;PABPC1;CNOT7;TNRC6C;PNPT1;METTL3
prerank,nuclear envelope organization (GO:0006998),0.5537816847940622,1.1579474267165306,0.32756324900133155,1.0,1.0,6/20,15.63%,NEMP1;NUP155;LEMD3;EMD;TOR1B;SUN2
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.5917484438273694,1.1572626521786853,0.30158730158730157,1.0,1.0,5/12,18.15%,CBFB;ELF2;ELF1;RC3H1;RUNX1
prerank,organelle organization (GO:0006996),0.4840133317884896,1.1571893862542904,0.138,1.0,1.0,67/388,13.67%,DIAPH3;KIF4A;CDCA8;CEP55;MNS1;ARHGAP21;USP6NL;SYNE3;MAST2;MTFR2;MIEF2;PHIP;ARHGAP10;GBF1;OBSL1;PACSIN2;AJUBA;FAM161A;LNPK;DIAPH1;TSPO2;NUMA1;DYRK3;COG1;ZW10;RHOT1;MICAL3;TMEM11;CNN2;FGD4;ATL2;ANK1;PRPF40A;ATL3;STOML2;RAB29;PDZD8;FGD1;VPS18;LRRK2;GOLGA8B;GOLGA5;ZFYVE16;WDPCP;SH3D19;LIMD1;ODF2;LONP1;STRIP2;RAB1A;PITPNB;YTHDF2;NIPSNAP2;FGD6;CENPW;EIF2AK3;BAG5;GAK;FANCG;GORASP2;DMTN;DES;PPID;PPRC1;LARP4;PRKD1;PRKCI
prerank,endodermal cell fate commitment (GO:0001711),-0.4704224900920493,-1.1570806368978344,0.2947976878612717,0.6565366005886946,1.0,4/10,17.59%,CDC73;RTF1;SOX17;SOX2
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.39513884304532654,-1.1570305907455003,0.2777777777777778,0.6553241236253913,1.0,5/18,17.16%,PRKN;KCNB1;IRS1;MIDN;ADRA2A
prerank,intraciliary retrograde transport (GO:0035721),0.5845308888940122,1.1568856012302267,0.3,1.0,1.0,2/12,3.88%,WDR35;IFT140
prerank,cellular response to peptide (GO:1901653),-0.28549742937398825,-1.156569207211737,0.22330097087378642,0.6552252894827266,1.0,20/56,14.10%,CACNA2D1;PSEN1;GRIN2A;CAV1;IGF1;TLR4;LRP1;RPL23;CASP4;TRIM41;VCAM1;LGMN;NOD1;PTPN22;ATP1A3;APP;ARHGEF2;GRM5;CHMP5;GRIN1
prerank,regulation of proteolysis (GO:0030162),0.500668506295624,1.156333720100714,0.32065217391304346,1.0,1.0,11/48,13.90%,PLK1;FADD;FGFR4;DNAJC1;FBXW11;HDAC2;CASP8;ITCH;PLAUR;BTRC;SPOP
prerank,cellular response to tumor necrosis factor (GO:0071356),0.47903814742043355,1.156252402929417,0.24,1.0,1.0,18/175,11.49%,TNFSF13B;BRCA1;MAP3K14;HYAL1;PSMC2;PSMD5;ACTN4;DHX9;NPNT;YBX3;FOXO3;PSMB1;PSMD14;PSMD1;EDA;LIMS1;PSMB9;PYDC1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.5035673957822657,1.155054694822133,0.3088235294117647,1.0,1.0,6/72,5.71%,TPX2;STMN1;DYRK1A;IAPP;SPEF1;SSH2
prerank,regulation of cartilage development (GO:0061035),0.5581418862841272,1.1550310036279483,0.3255208333333333,1.0,1.0,5/18,12.57%,BMP1;SOX6;TAPT1;BMP2;SOX9
prerank,T cell differentiation (GO:0030217),0.5079967537341854,1.1545681936320509,0.3215962441314554,1.0,1.0,8/40,12.40%,GLI3;FADD;KIT;LEPR;PTPN2;ANXA1;LMBR1L;ADAM17
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.4793843026992415,-1.1544559442485418,0.30116959064327486,0.6592642865438106,1.0,2/10,0.92%,CPEB3;CDC73
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.35460817536426253,-1.154391347850692,0.23300970873786409,0.6581016494633962,1.0,6/25,13.08%,AKAP6;CEMIP;PLCG1;TRPC1;CACNB2;CX3CL1
prerank,mitochondrial transport (GO:0006839),-0.2907301574293106,-1.154296672710823,0.1643835616438356,0.657001857018381,1.0,28/53,31.40%,FIS1;DNAJC19;SLC25A13;MTX2;OXA1L;SLC25A24;BCL2;BNIP3;TIMM44;TOMM70;BCAP31;GDAP1;SLC25A4;AIP;FBXO7;TOMM34;BCL2L1;TIMM17A;TOMM7;TIMM17B;TIMM9;TMEM14C;TMEM14A;TIMM13;TOMM22;TIMM8B;TOMM5;BAK1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.46873851835061225,-1.1541949814829122,0.29085872576177285,0.6559850268695901,1.0,5/10,19.76%,CACNA2D1;CALM1;CACNB2;SRI;CALM3
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.3547127861470485,-1.1529379230635752,0.2182741116751269,0.6578051101308889,1.0,16/24,36.57%,ATF6;GCN1;HSPA5;KLF2;CEBPB;VEGFA;CREB3L1;DDIT3;MAPK7;HIF1A;ATF6B;MBTPS2;MT3;CHD6;NFE2L2;ATF3
prerank,leukotriene biosynthetic process (GO:0019370),-0.4296076890462036,-1.1528359132597616,0.2598684210526316,0.6567362961222074,1.0,2/14,7.68%,PLA2G4A;GGT5
prerank,glutamate metabolic process (GO:0006536),-0.38181690631621934,-1.152539124032954,0.26582278481012656,0.6561233221474914,1.0,9/19,25.58%,GLUL;GLS;GOT2;PRODH;GOT1;ALDH5A1;GLUD1;OAT;GLS2
prerank,positive regulation of T cell differentiation (GO:0045582),0.5133950885182528,1.1520722965477788,0.31139835487661577,1.0,1.0,2/36,1.27%,GLI2;GLI3
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.33230860813384244,-1.1517389016599577,0.26,0.6568038671850667,1.0,17/32,34.90%,ADIPOR2;APOE;CREBL2;ASAH1;ASXL3;MTOR;PRKAG2;SORBS1;AVIL;MID1IP1;GPER1;MLXIPL;AKT1;FITM2;STAR;C3;PDK4
prerank,embryonic organ morphogenesis (GO:0048562),0.5032454189398334,1.151624432686165,0.32662192393736017,1.0,1.0,15/42,19.71%,FOXE1;MFAP2;FGFR2;FBN1;HOXC4;PDGFRA;NIPBL;DSCAML1;HOXB3;RBPMS2;MFAP5;EFEMP1;HOXA3;DYNC2I1;ALDH1A3
prerank,negative regulation of telomere maintenance (GO:0032205),0.5693902927061283,1.1514947332235939,0.31129476584022037,1.0,1.0,7/15,18.77%,TERF1;RTEL1;ERCC4;TERF2;SMG6;TERF2IP;RAD50
prerank,pyroptosis (GO:0070269),0.5722772157930839,1.1512879560225346,0.3290414878397711,1.0,1.0,4/15,14.53%,DHX9;APIP;CASP8;GSDMD
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.37638933705069505,-1.151196057987602,0.22009569377990432,0.6567004822892758,1.0,4/21,3.47%,CAMK2D;CALM1;RYR2;AKAP6
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.4571993028318645,-1.1503182568002406,0.29295774647887324,0.6575763385895352,1.0,3/11,9.41%,MERTK;GAS6;SELENOS
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.5427096995649932,1.1501393450409945,0.3271144278606965,1.0,1.0,6/27,9.99%,E2F1;AQP1;DHX9;PDGFRA;AGT;DDR2
prerank,regulation of neuroblast proliferation (GO:1902692),-0.4106313072228948,-1.1493137398470386,0.2579505300353357,0.6587687594311114,1.0,7/15,22.19%,NF1;SMARCD3;CTNNB1;CX3CL1;VEGFA;TAFA1;DRD2
prerank,nitrogen compound transport (GO:0071705),0.48102571916526116,1.1485446869882732,0.2718052738336714,1.0,1.0,11/141,7.78%,CENPF;RHAG;SLC18A2;NDC1;AQP1;ZG16;SLC6A2;PDPN;SLC38A4;SLC25A47;SLC16A10
prerank,response to histamine (GO:0034776),-0.4730049070273118,-1.1483211207290926,0.3149847094801223,0.6600102776411266,1.0,4/10,11.29%,GABRB1;GABRB3;GABRB2;GABRG2
prerank,cartilage development (GO:0051216),0.5003142353952242,1.148189451096071,0.3232998885172798,1.0,1.0,16/49,18.17%,HYAL1;DDRGK1;SULF2;WNT2B;NFIB;SOX6;SULF1;CCN3;BMP2;SOX9;CD44;SNX19;ITGB8;TRPV4;RUNX1;OSR1
prerank,phospholipid catabolic process (GO:0009395),-0.35972864460120574,-1.1474300608211314,0.25213675213675213,0.6609784863016899,1.0,7/24,14.75%,GPCPD1;PLA2G4A;ABHD12;PNPLA6;ENPP6;GDPD3;GDPD1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.5574718234332015,1.1473780051583558,0.312,1.0,1.0,6/16,15.25%,PRKDC;RIF1;SMCHD1;PARP9;KMT5C;SHLD2
prerank,epithelial cell migration (GO:0010631),0.5083592632559831,1.1472834507994853,0.3187066974595843,1.0,1.0,7/37,9.40%,ANLN;LOXL2;RHOA;KIT;ADGRA2;KANK2;ROCK1
prerank,histone deacetylation (GO:0016575),0.5125575051340561,1.1468172689869658,0.3246899661781285,1.0,1.0,14/43,14.81%,MIER1;SMARCAD1;TBL1XR1;MIDEAS;RCOR1;MSL3;MIER3;HDAC8;MTA3;SFPQ;HDAC1;HDAC2;ELK4;PER1
prerank,P-body assembly (GO:0033962),0.5759828353048926,1.146739834048126,0.3202797202797203,1.0,1.0,7/12,17.42%,PATL1;LSM3;EIF4ENIF1;LIMD1;RC3H1;LSM4;EDC3
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.3691606955453446,-1.1465852469318971,0.2693877551020408,0.6618323872738714,1.0,5/19,10.95%,CHD8;AR;ICE1;ZNF76;MTOR
prerank,positive regulation of protein maturation (GO:1903319),-0.4578304681774726,-1.146341637326966,0.3020527859237537,0.661102057934745,1.0,3/11,15.03%,CCBE1;SOX4;NKD2
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.3732859842866145,-1.1462630668555331,0.2583732057416268,0.6600076510816206,1.0,4/22,3.47%,ATP1B1;CALM1;RYR2;AKAP6
prerank,membrane repolarization during action potential (GO:0086011),-0.42790690834755796,-1.1462424511011504,0.26223776223776224,0.6587943294794518,1.0,5/13,31.94%,ATP1B1;ATP1A1;KCNQ1;KCNIP2;KCNE4
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.5723024991376103,1.1460505416812885,0.34252539912917274,1.0,1.0,2/12,8.15%,IL18;CD80
prerank,smooth muscle contraction (GO:0006939),0.5552992610055155,1.1457427462280454,0.3149931224209078,1.0,1.0,6/14,16.39%,ROCK2;ROCK1;SLC8A1;BDKRB2;SMTN;TPCN2
prerank,negative regulation of bone mineralization (GO:0030502),0.5681268766139546,1.1457072311110368,0.32127351664254705,1.0,1.0,4/13,12.53%,BCOR;RFLNA;ENPP1;TRPM4
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.4425877230062177,-1.145583336928023,0.30340557275541796,0.6591175172191133,1.0,5/12,19.45%,AKT2;IRS2;IRS1;ABCD2;PPARGC1A
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.35362903475389623,-1.1449824875097583,0.2825112107623318,0.6594062868694335,1.0,12/24,16.83%,INSR;IGF1;AKT2;IRS2;IGF2;EPM2AIP1;INPP5K;SELENOS;IRS1;PPP1R3B;GSK3A;DYRK2
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.47995073969784724,1.1448825869636206,0.319672131147541,1.0,1.0,28/101,16.97%,UHRF1;PLK1;FADD;FGFR4;LARP4B;HNRNPD;PRKDC;UPF3B;FAF1;SAMD4A;FMR1;ATG7;AGT;PLXNB2;METTL5;EZR;EIF3C;FBXW11;HDAC2;CASP8;LARP4;BTRC;FXR1;PASK;MSN;METTL3;AMER1;PYM1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.5700061609757054,1.144558695884454,0.31484049930651875,1.0,1.0,4/14,15.25%,PAXIP1;RIF1;KMT5C;SHLD2
prerank,positive regulation of hormone secretion (GO:0046887),-0.40003047502475986,-1.1439193748213048,0.27710843373493976,0.6607795753378323,1.0,11/17,46.50%,SNX4;C1QTNF3;VAMP8;EDN1;SOX11;EDN3;SPP1;GRP;VAMP7;RASL10B;NMB
prerank,protein polyubiquitination (GO:0000209),0.47863571533613064,1.1434790366317633,0.199,1.0,1.0,57/297,15.07%,DTL;BRCA1;CCNF;BARD1;UBE2T;UBE2C;UBE2S;RNF168;ANAPC7;CBFB;TRIML2;PSMC2;CDC27;PSMD5;UBE2K;NEDD4;FBXL7;SIAH2;FBXW7;FBXO30;UBE2N;PRPF19;FBXL8;RNF31;RC3H2;UBR5;PSMB1;SMURF1;CUL3;UBE2R2;PSMD14;PSMD1;SKP2;TPP2;FBXL17;UBOX5;PSMB9;SMURF2;FBXW11;TRIP12;TRIM6;ITCH;IRF2BP1;UBE2J1;BTRC;FBXO27;ZNRF2;SPOP;RC3H1;TRIM5;PSMC6;RNF114;UBE2QL1;ZNRF1;ZFP91;FBXO17;NPEPPS
prerank,negative regulation of translation (GO:0017148),0.480869282237204,1.1425161423974344,0.3201663201663202,1.0,1.0,26/87,16.36%,TYMS;ILF3;SYNCRIP;ROCK2;AGO2;CNOT1;FTO;EIF4ENIF1;SAMD4A;CAPRIN1;TPR;FMR1;LARP1;CPEB2;ROCK1;YTHDF2;MRPL13;EIF2AK3;MEX3D;RBM4;DHFR;EPRS1;CNOT7;FXR1;UNK;METTL3
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5013307481455933,1.142285979869789,0.3333333333333333,1.0,1.0,11/40,14.35%,EZH2;LOXL2;PDPN;TCF7L2;WWTR1;AXIN2;TGFBR1;BMP2;SMAD4;TWIST1;SMAD3
prerank,artery morphogenesis (GO:0048844),-0.33540020364247747,-1.1416699573181106,0.28901734104046245,0.6649092523004014,1.0,14/30,21.14%,SMAD7;JAG1;BMPR2;TGFB2;PDGFRB;LRP1;NF1;TBX1;VEGFA;ENG;STRA6;TBX2;NRP1;HPGD
prerank,neurotransmitter transport (GO:0006836),-0.2701716556130202,-1.1414776837270544,0.21818181818181817,0.6641432872695949,1.0,21/73,16.78%,UNC13B;SYN3;RIMS1;GLUL;SLC1A2;GABRA2;GLS;APBA1;SYN2;SYT1;LIN7A;BRSK1;NRXN1;SNPH;SLC17A6;ATP1A2;DVL1;CPLX1;SLC1A1;SYNJ1;SNAP25
prerank,cortical actin cytoskeleton organization (GO:0030866),0.5530477387249964,1.1413738962936157,0.32989690721649484,1.0,1.0,11/20,21.70%,ROCK2;RHOQ;LLGL2;ROCK1;DLG1;LCP1;FHOD1;NCKAP1;RAB13;FMNL2;IKBKB
prerank,regulation of humoral immune response (GO:0002920),-0.31160394145119613,-1.1412406541371476,0.19791666666666666,0.6635250664938936,1.0,19/44,39.05%,VTN;CD81;C4B;C1QB;GATA6;C2;CR1L;C1QC;C1QA;CFHR2;PHB2;CR2;C1QBP;SERPING1;C3;C3AR1;C6;FCGR2B;C7
prerank,pulmonary valve development (GO:0003177),-0.3965783103438161,-1.1396416502209783,0.2775330396475771,0.6661542221913679,1.0,9/18,16.20%,JAG1;BMPR2;TGFB2;NOS3;TNFRSF1B;SLIT2;HEYL;STRA6;ROBO2
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3181515711965564,-1.1395894694903772,0.21666666666666667,0.6650264081880147,1.0,9/41,6.47%,CACNA2D1;RYR3;SLC8A3;GRIN2A;RYR2;GRIN2B;SLC24A2;FGF2;HTR2C
prerank,carnitine metabolic process (GO:0009437),-0.44129188946638676,-1.1392192502044203,0.3149847094801223,0.6646063582640317,1.0,4/12,11.12%,TMLHE;ACADM;CROT;BBOX1
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.2638773945485322,-1.139174522074132,0.16981132075471697,0.6634694888527785,1.0,14/75,13.14%,CACNA2D1;SLC8A3;ATP1B1;SLC39A10;SLC6A1;KCNJ3;SLC24A2;KCNJ6;ATP1A1;ATP1B3;ATP1A3;SLC12A9;KCNJ10;ATP1A2
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5227850264565614,1.1390778493275422,0.32634338138925295,1.0,1.0,7/21,13.45%,ROCK2;BCOR;ROCK1;ENPP1;TRPM4;SOX9;HEY2
prerank,tetrapyrrole metabolic process (GO:0033013),-0.38816356544978525,-1.1387652024342958,0.2777777777777778,0.6631029034898265,1.0,7/18,25.37%,ABCD4;CUBN;LMBRD1;MTRR;MMAA;MTR;TCN2
prerank,myeloid cell development (GO:0061515),0.5523145493628454,1.1382226132192066,0.3238341968911917,1.0,1.0,8/18,17.26%,ANXA2;KIT;ABCB10;DMTN;MED1;SRC;ALAS2;FOXP1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5306625100654764,1.1381600789199253,0.33375,1.0,1.0,8/24,13.65%,CBFB;ROCK2;NUMA1;HOXA7;GRHL2;ROCK1;ERRFI1;MED1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.47662349992931846,1.138146196553404,0.192,1.0,1.0,77/341,16.80%,DTL;KIF14;UHRF1;BUB1B;PLK1;CDC20;UBE2C;AURKB;UBE2S;RNF168;ANAPC7;AURKA;VPS37B;FEM1C;PSMC2;CDC27;PSMD5;UBE2K;NEDD4;FBXL7;UBR4;SPSB3;KLHL15;SIAH2;SPSB2;TBL1XR1;FAF1;RNF43;BUB3;ARRB1;PML;ELOC;FBXW7;VPS37A;RC3H2;AGAP3;RNF40;PSMB1;SMURF1;CUL3;UBE2R2;PSMD14;KCTD2;KLHL22;PSMD1;SKP2;FBXL17;ARMC8;PPP2R5C;FBXO45;PSMB9;ARRDC1;SMURF2;ADRM1;FBXW11;TRIP12;ITCH;COPS3;USP9X;CRBN;BTRC;SPOP;RC3H1;PSMC6;RNF114;ZNRF1;BIRC6;ANAPC15;OTUD7B;ASB2;NTAN1;CNOT4;FBXL14;RAD23B;ANAPC5;SIAH3;UBXN2B
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.3557074760775665,-1.13775505635996,0.2555066079295154,0.6643870523281443,1.0,11/26,23.85%,NOS3;ACER2;ASAH1;ACER3;CYB5R3;ASAH2;GCH1;DDAH2;NOS1;ABCA2;SPHK1
prerank,embryonic heart tube morphogenesis (GO:0003143),0.5010976415376273,1.1375875968958573,0.3249714937286203,1.0,1.0,5/43,9.04%,STIL;SETDB2;SRF;MKKS;NPHP3
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.3640432189719382,-1.1374150481006187,0.2897196261682243,0.664003881674289,1.0,9/23,12.93%,KIF1B;MYO10;DYNC1I2;KIF1A;KIF5B;KIF5C;TUBA1A;TUBA1B;HOOK1
prerank,cardiac conduction system development (GO:0003161),0.5381571988908004,1.1370536111790817,0.35255570117955437,1.0,1.0,7/24,13.45%,BMPR1A;TBX18;GJA1;SMAD4;NOTCH2;MAML1;HEY2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.5327225920763421,1.1370517252559305,0.332,1.0,1.0,6/18,14.28%,ITGB7;ADD2;PODXL2;ROCK1;SLC39A8;ITGB1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.5602262681622459,1.1365328101369434,0.3342579750346741,1.0,1.0,6/15,13.30%,MTHFD1L;FGFR2;PDGFRA;NIPBL;TGFBR1;TWIST1
prerank,regulation of macrophage differentiation (GO:0045649),0.5624045135872655,1.1363225288646566,0.33194444444444443,1.0,1.0,4/15,12.76%,FADD;PTPN2;PRKCA;CASP8
prerank,connective tissue development (GO:0061448),0.5078930238324957,1.1356788870064694,0.35428571428571426,1.0,1.0,12/35,17.53%,HYAL1;DDRGK1;SULF2;SOX6;SULF1;PGRMC2;SOX9;LRP5;CD44;SPTLC2;ITGB8;SH3PXD2B
prerank,axoneme assembly (GO:0035082),0.5123044914427806,1.1354994783171843,0.32800982800982803,1.0,1.0,7/30,16.51%,DNAAF3;SPAG16;SPEF1;DNAI4;RSPH9;TTLL3;SPAG1
prerank,retina homeostasis (GO:0001895),-0.35436814775765046,-1.1348313349456478,0.2683982683982684,0.6689694615498164,1.0,6/23,13.15%,ACTB;POTEF;B2M;WHRN;BBS4;PRDX1
prerank,regulation of lamellipodium organization (GO:1902743),0.5595955953004931,1.1343015412640274,0.3453757225433526,1.0,1.0,5/14,14.38%,PDPN;TWF1;RAC1;DMTN;CD44
prerank,substrate-dependent cell migration (GO:0006929),-0.4187038361586237,-1.1317351774965714,0.3037542662116041,0.6753491813984287,1.0,11/14,31.32%,OPHN1;VEGFC;SDCBP;EPHA8;ITGB1BP1;SHTN1;NRP1;ANKS1A;P2RY12;PTPRC;ITGA2
prerank,high-density lipoprotein particle assembly (GO:0034380),0.6051611675450812,1.1316828424944299,0.3490853658536585,1.0,1.0,1/10,1.05%,BMP1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.4013202276562588,-1.1316502539164424,0.29069767441860467,0.6742694694056932,1.0,8/17,18.55%,HSP90B1;OS9;UFD1;DERL1;SELENOS;SEC61B;AUP1;SYVN1
prerank,regulation of cell morphogenesis (GO:0022604),0.5154298491681613,1.131543867229963,0.3313032886723508,1.0,1.0,8/30,14.38%,MACF1;MOV10;PHIP;PDPN;PDZD8;SH3D19;LARP4;CD44
prerank,positive regulation of hydrolase activity (GO:0051345),0.4732116881993859,1.1315115550068338,0.305668016194332,1.0,1.0,24/137,13.10%,ECT2;EZH2;ARHGAP11A;HMGB2;USP6NL;MAP4K4;RHOA;GSK3B;RTN4R;EVI5L;NET1;AFDN;RSU1;TBC1D7;PICALM;MTMR9;SRGAP2;LIMS1;CALM2;PLXNB1;BMP2;DOCK11;SNX18;CTSH
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.3770783012617016,-1.1305712226733158,0.28444444444444444,0.6757427831111036,1.0,13/18,35.41%,COX16;OXA1L;COX19;PET100;COX20;SMIM20;COX17;COX14;COA8;COA5;COA3;SURF1;FASTKD3
prerank,regulation of actin filament-based process (GO:0032970),0.485092907699412,1.1299794779896652,0.3298538622129436,1.0,1.0,13/70,12.65%,IQGAP3;IQGAP2;ROCK2;RHOA;ARHGAP18;CNN2;RHOQ;ROCK1;ARHGAP35;RND2;EZR;RAC1;DMTN
prerank,regulation of protein localization to cell periphery (GO:1904375),0.5400718062554895,1.129759290630509,0.3333333333333333,1.0,1.0,2/18,3.93%,PLK1;MMP14
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.3840141738441817,-1.1296508182103808,0.24193548387096775,0.6768921266871891,1.0,9/19,19.05%,CSGALNACT1;HS6ST3;NDST3;NDST1;HS3ST3B1;NDST2;EXTL3;NDST4;XYLT2
prerank,lysine metabolic process (GO:0006553),0.5755786079655099,1.1291954225650551,0.3328550932568149,1.0,1.0,1/12,1.41%,SLC25A21
prerank,lysine catabolic process (GO:0006554),0.5755786079655099,1.1291954225650551,0.3328550932568149,1.0,1.0,1/12,1.41%,SLC25A21
prerank,protein localization to nucleus (GO:0034504),0.46944368699811423,1.12908207457644,0.31771894093686354,1.0,1.0,27/102,17.78%,PLK1;RANBP17;NUP155;RPAIN;E2F3;TAF3;TNPO1;NUP85;EIF4ENIF1;CSE1L;TPR;PML;RRS1;HNRNPU;XPA;IPO7;APPL2;NUP214;IPO11;NXT1;MORC3;NUP133;TOR1B;IPO5;NXT2;FAM53B;PIKFYVE
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.31007879768133934,-1.1288703842414898,0.2153846153846154,0.6776005449279761,1.0,10/39,14.56%,PTK2;PODXL;JAG1;MAP2K5;NEXMIF;KLF4;FXYD5;RGCC;PPM1F;VEGFA
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.3400518910640873,-1.1284838011468246,0.26875,0.677309766382633,1.0,8/30,13.05%,EP300;SAFB2;AR;PRMT2;KDM4C;DAB2;DDX5;HEYL
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.2612777296436509,-1.1284305409349278,0.18181818181818182,0.6761501383515918,1.0,26/73,19.34%,PTK2;HSP90AB1;ELMO1;ACTB;WIPF1;VAV3;PIK3R1;PLD2;PLCG1;MYO10;LYN;PAK1;MAPK3;WIPF2;ABL1;LIMK1;WIPF3;MAPK1;GRB2;ELMO2;PLPP4;PIK3CA;ARPC5;BAIAP2;NCKAP1L;CYFIP1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.40640483121073534,-1.128003048820146,0.3103448275862069,0.6759908508824964,1.0,3/14,6.59%,PUM1;DDX60;ZDHHC5
prerank,protein ubiquitination (GO:0016567),0.4739495135890376,1.1276920602188956,0.153,1.0,1.0,90/471,14.65%,DTL;BRCA1;CCNF;UHRF1;PLK1;BARD1;UBE2T;UBE2C;RAD18;UBE2S;RFWD3;RNF168;ANAPC7;TRIM37;CBFB;TRIML2;BRAP;PDZRN3;PSMC2;CDC27;RNF220;PSMD5;UBE2K;UHRF2;NEDD4;FBXL7;MYCBP2;PRKDC;SIAH2;SPSB2;RNF43;FANCL;ARRB1;ELOC;FBXW7;FBXO30;UBE2N;PRPF19;CUL5;FBXL8;RNF31;RC3H2;UBR5;VPS18;RNF40;PSMB1;SMURF1;CUL3;UBE2R2;PSMD14;SH3RF1;KLHL22;LEO1;VHL;CUL4B;PSMD1;SKP2;OBI1;TPP2;FBXL17;HERC2;FBXO45;UBOX5;PSMB9;TRIM63;ARRDC1;SMURF2;PCNA;FBXW11;TRIP12;TRIM6;ITCH;ATG3;IRF2BP1;UBE2J1;USP9X;CRBN;BTRC;FBXO27;ZNRF2;FBXO25;SPOP;RC3H1;HLTF;TRIM5;PSMC6;RNF114;UBE2QL1;ZNRF1;BIRC6
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5588397858392709,1.127589631543081,0.3472022955523673,1.0,1.0,7/15,15.51%,AGO2;CNOT1;EIF4ENIF1;TENT4A;PABPC1;CNOT7;TNRC6C
prerank,cortical cytoskeleton organization (GO:0030865),0.5053383761911426,1.127249637310591,0.34668192219679633,1.0,1.0,20/41,22.91%,ROCK2;RHOA;RHOQ;LLGL2;ROCK1;EPB41L3;RND2;EZR;RAC1;DLG1;RHOC;LCP1;FHOD1;NCKAP1;RAB13;TRPV4;FMNL2;RND3;IKBKB;RHOH
prerank,cellular senescence (GO:0090398),0.520018059006582,1.1269878511031608,0.3484276729559748,1.0,1.0,9/27,19.54%,SMC6;SMC5;SRF;PML;NSMCE2;TERF2;KAT6A;MAPK14;PRKCD
prerank,regulation of peptidase activity (GO:0052547),-0.383069317429446,-1.1268645449695434,0.26294820717131473,0.6775846609957963,1.0,6/19,13.28%,CST3;CAV1;PSMA3;FURIN;PINK1;RCN3
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.48068379645258547,1.126322806063198,0.33613445378151263,1.0,1.0,10/76,9.26%,BRCA1;SAE1;PAXIP1;FANCI;MYCBP2;FBXW7;LRRK2;CUL3;ANGPT1;TBC1D7
prerank,positive regulation of cellular process (GO:0048522),0.47305211754911447,1.1256000745257324,0.152,1.0,1.0,80/565,12.77%,PRC1;KIF20B;KIF14;EZH2;TTK;BIRC5;SPAG5;ANKLE1;SAPCD2;TGM1;RAD18;TIPIN;SPDYA;MATK;NAP1L1;FBXO5;SMC6;ECHDC3;PHIP;FGFR4;CSPP1;COLEC12;HYAL1;CEP43;CDC6;FGFR2;SMC5;FXN;MMP14;GAREM1;DDRGK1;ACTN4;CNOT6L;NUMA1;SRF;MAPT;CCAR1;NSMCE4A;FAF1;PDPN;BMP6;RTKN2;DERL2;FMR1;CDC25B;PDGFRA;CHEK1;SFRP2;PPP3CA;EPHA4;POU3F2;WWTR1;CDK2;CNOT6;GRK5;CUL3;BCLAF1;AXIN2;KLHL22;TPPP;VHL;CAMK1D;CDC123;S1PR2;TGFBR1;TAL1;CRKL;CNTF;HDAC1;ACACA;RAC1;STOX1;PRKCA;GLP2R;ADAM17;KMT2D;TRPM4;SOX9;HDAC2;IL31RA
prerank,negative regulation of immune system process (GO:0002683),0.5432892485976093,1.1250736046701937,0.3595206391478029,1.0,1.0,3/16,12.57%,FADD;HOXA7;SOX9
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.47135881320180956,1.1249374938327679,0.142,1.0,1.0,118/572,15.22%,E2F7;NR2E3;E2F8;UHRF1;EZH2;EN1;PLK1;ATRX;AURKB;GLI2;TCFL5;GLI3;E2F1;CBX5;FOXE1;KMT5A;LOXL2;TRIM37;ZFP69;CBFB;RB1;ETV6;FNIP1;MIER1;WWOX;SP2;HDGF;CTCF;FGFR2;ZEB1;JAZF1;CNOT1;EED;BCOR;MDM4;TAF3;NEDD4;HIVEP1;CUX1;FHL2;BHLHE41;NFIL3;SRF;CTBP1;NFIB;ZNF568;TBL1XR1;MCPH1;BMP6;GZF1;LCOR;TCF7L2;ORC2;HOXA7;TPR;GATAD2A;EFNA1;GLIS3;RIF1;NIPBL;ZBTB2;MXD1;ZBTB7B;ZHX2;FOXO3;KDM2B;LIN37;SMARCA4;ZFP90;KLF11;MIER3;KANK2;YAP1;VHL;UXT;EPC1;HMGB1;HDAC8;MTA3;NR4A2;MYPOP;NR3C1;CXXC5;PARP9;SFPQ;HNRNPU;KCNIP3;SMURF2;HDAC1;BMP2;EZR;NKX2-1;ATXN1;RBPJ;SOX9;SMAD4;HDAC2;SAP130;ELK4;IRF2BP1;PPID;TWIST1;HEY2;USP9X;MED1;DLG1;RARB;YY1;ZMYM5;DNMT3A;FOXM1;SMAD3;FOXP4;SOX1;PER1;YEATS2;OTUD7B;DR1
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.30775667665423345,-1.1248629638706364,0.21238938053097345,0.6812461793072695,1.0,13/41,14.92%,SMAD7;MEF2C;JAG1;TGFBR2;FKBP1A;CPE;TGFB2;PROX1;TPM1;SOX4;HEYL;GSK3A;ENG
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.3233139977940619,-1.1244143244819647,0.271523178807947,0.6811417983484239,1.0,13/32,20.66%,EP300;FHIT;PPP1R13B;CDIP1;HIPK2;MSH2;DDX5;DYRK2;DDIT4;RRP8;SNW1;BCL3;MYBBP1A
prerank,nucleoside phosphate catabolic process (GO:1901292),0.554376746177005,1.123686581448163,0.33707865168539325,1.0,1.0,4/13,11.80%,SMPDL3A;ENPP3;ITPA;ENPP1
prerank,fatty acid catabolic process (GO:0009062),-0.2697593864211244,-1.1235693768460466,0.21212121212121213,0.6819979009888701,1.0,25/67,26.46%,HADHB;ACADM;CROT;PCCB;SCP2;ABCD4;MECR;ALDH3A2;HADH;ABHD2;ACAD10;ECHS1;ABCD2;DECR1;ECHDC2;NUDT7;LPIN1;SLC27A4;PECR;MCEE;AIG1;PLA2G15;MMAA;HACL1;ILVBL
prerank,ubiquinone biosynthetic process (GO:0006744),-0.41256438325906203,-1.1231536887257527,0.3116438356164384,0.6817090740766063,1.0,6/15,12.22%,COQ8B;COQ5;NDUFA9;COQ10A;COQ3;PDSS2
prerank,protein phosphorylation (GO:0006468),0.47327019393824876,1.1228190703073893,0.172,1.0,1.0,106/478,15.62%,NEK2;MELK;CDK1;INCENP;TTK;CLSPN;PLK1;BIRC5;MASTL;AURKB;NEK3;CIT;PLK4;MATK;HUNK;HASPIN;MAST2;ILF3;MAP4K4;DYRK1A;STK17B;BAZ1B;BMPR1A;CDK14;AURKA;ROCK2;FGFR4;MAP4K2;GSK3B;FGFR2;STK10;NLK;CHEK2;MYLK3;KIT;CCNA2;PRKDC;CTBP1;DYRK3;VRK2;STK24;STK3;MUSK;NRK;MAP3K1;CCNE1;TGFBR3;WNK1;MAP3K20;CDC25B;PDGFRA;CHEK1;CDC42BPA;EPHA4;CDK2;LRRK2;GRK5;MAP3K3;ABI1;ROCK1;PIM1;ERC1;MARK2;CSNK2A2;DDR2;PXK;CDC42BPG;CAMK1D;TGFBR1;SRPK1;EIF2AK3;LMTK3;PRKCB;BMP2;PRKCA;ULK2;PDPK1;GRK3;AAK1;CSNK1G2;SIK2;MAPKAPK3;MEX3B;STRADA;BTK;CDK19;PRKCE;MAML1;PRKD1;PRKCI;CAB39;PLK2;PRDX4;NRBP1;MORC3;VRK1;CDK8;BIRC6;STK11;TAOK1;EFEMP1;PRKAG1;SRC;PRKD2;STK39;PASK
prerank,response to zinc ion (GO:0010043),-0.34582195852850883,-1.1227639936732086,0.3105022831050228,0.6814276287575602,1.0,12/25,22.05%,GLRA1;SLC30A4;MT2A;MT1X;MT1E;MT1M;MT1H;MT1F;MT1B;MT1A;MT1G;P2RX4
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.514426516945281,1.122623944987033,0.34099153567110035,1.0,1.0,12/29,21.11%,FADD;UBE2K;USP18;PTPN2;YTHDF2;TRIM6;CNOT7;IFNAR2;METTL3;MAVS;PTPN1;ISG15
prerank,dendritic cell migration (GO:0036336),0.5504038445883197,1.1213208203304144,0.34642356241234223,1.0,1.0,4/16,12.53%,CXCR4;HMGB1;TRPM2;TRPM4
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.5853797629127631,1.1208478281604697,0.3634920634920635,1.0,1.0,3/10,7.97%,PDE3B;WNK1;SERPINE1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5808885049023694,1.120260729774052,0.36596385542168675,1.0,1.0,7/11,24.90%,ACAT1;PPCDC;PANK4;PANK2;COASY;SLC25A16;DCAKD
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5808885049023694,1.120260729774052,0.36596385542168675,1.0,1.0,7/11,24.90%,ACAT1;PPCDC;PANK4;PANK2;COASY;SLC25A16;DCAKD
prerank,coenzyme A biosynthetic process (GO:0015937),0.5808885049023694,1.120260729774052,0.36596385542168675,1.0,1.0,7/11,24.90%,ACAT1;PPCDC;PANK4;PANK2;COASY;SLC25A16;DCAKD
prerank,embryonic eye morphogenesis (GO:0048048),0.5858186504905106,1.120182023130551,0.3609467455621302,1.0,1.0,5/11,15.24%,MFAP2;FBN1;KDM2B;MFAP5;EFEMP1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.5448576668887064,1.1199042957307859,0.33146853146853145,1.0,1.0,6/15,20.23%,ADGRV1;KIT;MKKS;LHFPL5;KCNA1;PIEZO2
prerank,positive regulation of ATPase activity (GO:0032781),0.48858406116170405,1.119789045754466,0.34615384615384615,1.0,1.0,3/41,4.75%,UHRF1;MSH3;DHX9
prerank,import into nucleus (GO:0051170),0.47496231492314694,1.1195621834664944,0.3432518597236982,1.0,1.0,24/73,20.53%,RANBP17;NUP155;RPAIN;E2F3;HNRNPA1;TNPO1;NUP85;EIF4ENIF1;CSE1L;TPR;IPO7;APPL2;NUP214;IPO11;NXT1;NUP133;IPO5;GEMIN7;NXT2;FAM53B;IPO9;NUP188;SNRPB;IPO4
prerank,cellular response to mechanical stimulus (GO:0071260),0.4823322042944951,1.1194868298045098,0.35379464285714285,1.0,1.0,12/46,12.76%,AQP1;FADD;MAP3K14;CASP8AP2;MAP3K1;CNN2;CHEK1;IRF1;TNFRSF10B;PIEZO1;SOX9;CASP8
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.47926198034535045,1.1193720766282798,0.3281573498964803,1.0,1.0,23/88,16.43%,HAS3;FNIP1;HYAL1;GSK3B;BMF;TRABD2B;AJUBA;FAF1;SLF1;SPIDR;TPR;CDC42EP2;STAM;SH3GLB1;TPPP;SDC1;TAL1;STX18;PRKCA;SYNPO2;SMAD3;RHOC;SMPD3
prerank,regulation of cell-cell adhesion (GO:0022407),-0.30436104553253,-1.1191456995995128,0.2605633802816901,0.6894787199092404,1.0,5/39,2.63%,PTK2;PTPRG;SMAD7;PODXL;JAG1
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.2598862167531138,-1.119140499665795,0.23214285714285715,0.6882278334348565,1.0,26/78,17.95%,STX8;PRKCH;ACTB;STX7;STX4;AR;SQSTM1;LRP1;EPHB2;PIK3R1;STX3;CLIP3;ZDHHC5;NUMB;DAB2;KIF5B;SPTBN1;AP2M1;LDLRAP1;ZDHHC7;NKD2;ZDHHC8;VAMP8;STAC;PTPN9;DPP10
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.4212698197057543,-1.1189169699922914,0.3116438356164384,0.6875843319442065,1.0,4/13,17.37%,KCNB1;SYT1;SCAMP5;SYT10
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.3086501982321846,-1.11845314180094,0.271523178807947,0.6875636745370474,1.0,15/34,28.16%,PTPRB;PTPRZ1;DUSP3;DUSP22;PTPN22;PTPRO;PTPN11;DUSP1;PTPN9;PTPN12;PTPRT;PGP;PTPRF;DUSP8;DUSP6
prerank,positive regulation of vasculature development (GO:1904018),0.47666967016223283,1.118046731705765,0.3474663908996898,1.0,1.0,20/94,14.28%,BRCA1;VASH2;AQP1;ANGPT4;HYAL1;AGO2;ADAM12;ANXA3;SFRP2;HSPB6;SERPINE1;GAB1;PRKCB;RRAS;PRKCA;PDPK1;CTSH;TWIST1;PRKD1;ITGB1
prerank,negative regulation of anoikis (GO:2000811),-0.41536290741384,-1.117936392882592,0.34210526315789475,0.6874805325763195,1.0,4/14,10.54%,PTK2;CAV1;TLE1;BCL2
prerank,inner dynein arm assembly (GO:0036159),0.5660162055389792,1.1175265953619438,0.3502235469448584,1.0,1.0,2/10,10.88%,DNAH1;DNAAF5
prerank,positive regulation of behavior (GO:0048520),-0.4560603890446083,-1.117399104141377,0.34411764705882353,0.6876037659198487,1.0,3/10,5.06%,SGIP1;MEF2C;CFAP20
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.5320134449636208,1.1172234791267022,0.34318766066838047,1.0,1.0,5/21,14.66%,MASTL;GSK3B;PPP1R8;ENSA;PTPA
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.5833111871219816,1.116925913693181,0.34231378763866877,1.0,1.0,3/11,18.15%,CBFB;HMGB1;RUNX1
prerank,response to copper ion (GO:0046688),0.5304069263194738,1.1165571090014572,0.3346613545816733,1.0,1.0,3/20,5.25%,AQP1;LOXL2;PRNP
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.5559136294230851,1.1163036710022527,0.3708513708513709,1.0,1.0,7/13,19.33%,AGO2;CNOT1;EIF4ENIF1;PABPC1;CNOT7;TNRC6C;TNRC6B
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.42307972153061874,-1.1162441992260779,0.3237410071942446,0.6892661474304635,1.0,2/13,3.89%,LAMP1;STX4
prerank,bicellular tight junction assembly (GO:0070830),0.49433814121842107,1.115584256850678,0.36824696802646084,1.0,1.0,3/46,6.60%,ECT2;AFDN;GRHL2
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.3672258852265853,-1.115552959367207,0.33064516129032256,0.6897185475902851,1.0,5/19,13.66%,ABHD5;AKT2;IRS2;IRS1;ABCD2
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.5631697949213378,1.1155293860986262,0.34097421203438394,1.0,1.0,4/12,10.33%,NIN;PCM1;BICD2;NINL
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.3420263590089092,-1.1151232829153652,0.29901960784313725,0.6894799345135318,1.0,6/25,5.66%,CAMK2D;CTNNA3;CALM1;CAV1;RYR2;FGF13
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.5652653419630271,1.1148103097765374,0.3549848942598187,1.0,1.0,3/10,13.97%,PRNP;SCRIB;RC3H1
prerank,digestive tract morphogenesis (GO:0048546),0.5561040347028255,1.1147207176509089,0.3574408901251738,1.0,1.0,4/14,10.83%,FGFR2;PDGFRA;NIPBL;RBPMS2
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.2691056920684208,-1.1144714179815434,0.21153846153846154,0.6898187180248675,1.0,26/70,19.34%,PTK2;HSP90AB1;ELMO1;ACTB;WIPF1;VAV3;PIK3R1;PLD2;PLCG1;MYO10;LYN;PAK1;MAPK3;WIPF2;ABL1;LIMK1;WIPF3;MAPK1;GRB2;ELMO2;PLPP4;PIK3CA;ARPC5;BAIAP2;NCKAP1L;CYFIP1
prerank,regulation of cell killing (GO:0031341),-0.3852965518926438,-1.1140570235072007,0.299625468164794,0.6896426682393855,1.0,3/16,10.17%,MAPK8;TGFB2;NOX1
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.372149699215273,-1.113910232628689,0.29831932773109243,0.6874982617366284,1.0,8/20,18.64%,MCCC1;BCKDHA;HIBADH;ACAD8;BCAT1;ECHS1;BCKDK;MCCC2
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.372149699215273,-1.113910232628689,0.29831932773109243,0.6874982617366284,1.0,8/20,18.64%,MCCC1;BCKDHA;HIBADH;ACAD8;BCAT1;ECHS1;BCKDK;MCCC2
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.5108196785761722,1.1138914838483134,0.37037037037037035,1.0,1.0,8/27,17.21%,KMT5A;DYRK1A;YJU2;TWIST1;SPRED1;CD44;SPRED2;ATR
prerank,regulation of mRNA stability (GO:0043488),0.4688325915373466,1.1136334679785582,0.32896064581231077,1.0,1.0,38/145,15.54%,MEIOC;E2F1;XPO1;ROCK2;PSMC2;PSMD5;HNRNPD;FTO;TNPO1;SERBP1;THRAP3;EIF4ENIF1;SAMD4A;FMR1;FUS;RC3H2;LARP1;PSMB1;PSMD14;AXIN2;PUM2;ROCK1;PSMD1;HNRNPU;YTHDF2;PSMB9;TENT5D;TAF15;EXOSC7;NUP214;PRKCA;MEX3D;RC3H1;PABPC1;PSMC6;ZC3H14;GDNF;FXR1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.4903502694171388,1.1136022661690677,0.35722543352601155,1.0,1.0,6/37,7.68%,IFT80;WDR35;IFT140;PCM1;TNPO1;SSX2IP
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.5646759864833774,1.1134610829550444,0.3567251461988304,1.0,1.0,3/11,10.13%,DDX11;SMARCA4;NOL11
prerank,regulation of synapse assembly (GO:0051963),-0.28703437060575426,-1.1131919670775796,0.24299065420560748,0.6881089753658158,1.0,18/46,23.78%,PTPRD;MEF2C;SYNDIG1;GRID2;EPHB2;IL1RAPL1;EIF4G1;NRXN1;APP;SLITRK1;LRRC4B;ROBO2;NLGN1;IL1RAP;BDNF;DLG5;SRPX2;SLIT1
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.25375469833658504,-1.1129432507909478,0.05555555555555555,0.6874550021548991,1.0,35/109,19.88%,PLA2G4A;PIP4K2A;INPP4B;PLAAT3;MTMR10;PIK3R3;PDGFRB;PIP4K2B;PLEK;PIK3C2B;PLCB3;PIK3R1;FGF2;PIK3R4;PLCG1;SLC27A1;RAB5A;MTMR4;RUFY1;INPP5K;PIP5K1A;BMX;INPP5D;SYNJ2;CDS1;PIK3R6;SYNJ1;PI4KA;IMPA1;INPP4A;PIK3CD;PIK3CA;PIP4P1;PLA2G12A;CDIPT
prerank,glycolipid metabolic process (GO:0006664),-0.29847115218860676,-1.1124283268246917,0.2222222222222222,0.6876404598648592,1.0,18/47,23.95%,HEXB;ST3GAL6;PSAP;ASAH1;ST6GALNAC3;ESYT1;B3GALNT1;HEXA;ST8SIA6;GBGT1;GLTP;CTSA;SCCPDH;GBA2;ST6GALNAC4;ABCA2;ESYT3;NEU1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.4900807659572429,1.1123852205591374,0.36101083032490977,1.0,1.0,10/33,15.84%,ATOH8;TEAD1;KLF5;SRF;FOXO3;SMARCA4;NR3C1;SMAD3;GNL3;TP53
prerank,peptidyl-lysine acetylation (GO:0018394),-0.4582876937543926,-1.112318955188718,0.35501355013550134,0.6866468671700203,1.0,5/10,32.81%,EP300;KAT2B;KAT7;CREBBP;ESCO1
prerank,regulation of stem cell proliferation (GO:0072091),0.5346199999364029,1.1120191873548224,0.37177747625508817,1.0,1.0,9/17,24.26%,HMGB2;YAP1;HNRNPU;GJA1;TERT;FBLN1;EIF2AK2;ZFP36L1;KDM1A
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.3104470521954381,-1.1120041980996698,0.27631578947368424,0.6862128878974725,1.0,12/34,22.05%,SMAD7;ATP1B1;CALM1;RYR2;ADRA1A;SRI;PDE4D;KCNQ1;ZC3H12A;CALM3;NOS1;P2RX4
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5082825552585476,1.1119951623265063,0.35572139303482586,1.0,1.0,9/26,14.78%,MTBP;HYAL1;CDC6;TFDP1;LSM11;ANXA1;ADAM17;ADAMTS1;RPTOR
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.5624979792562971,1.1119321754020046,0.36418816388467373,1.0,1.0,4/10,16.28%,RHOA;RAP2A;EZR;MSN
prerank,negative regulation of hippo signaling (GO:0035331),0.5470689827243651,1.1114362526510964,0.36585365853658536,1.0,1.0,7/12,22.85%,CIT;AJUBA;LIMD1;SHANK2;MAPK14;WWC2;VGLL4
prerank,actin nucleation (GO:0045010),0.5205540463332003,1.1109916138282052,0.351213282247765,1.0,1.0,3/21,7.26%,IQGAP2;ACTR3;ARPC5L
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.48862682020700865,1.1109290010187238,0.35667396061269147,1.0,1.0,14/52,11.10%,RBM15;TRA2B;RBFOX2;KHDRBS1;HNRNPA1;THRAP3;MBNL3;RBM25;FMR1;SAP18;CELF2;HNRNPU;RBM15B;HNRNPL
prerank,regulation of ion transport (GO:0043269),-0.25617408491132454,-1.1109173956896277,0.20408163265306123,0.6876652416309675,1.0,28/76,23.69%,PRKN;NKAIN2;SYT1;KCNJ3;KCNJ6;SIK1;ATP1A1;NKAIN4;SYT7;B2M;DTNBP1;KCNJ10;KCNA2;SYT11;SYT12;WWP2;VAMP3;SYT10;NKAIN3;SYT6;ITGB3;SYT2;KCNJ12;NOS1;P2RX4;DRD2;NEDD4L;TOR1A
prerank,cellular macromolecule catabolic process (GO:0044265),0.48939253866141946,1.1106258014370036,0.3609865470852018,1.0,1.0,16/49,18.77%,PABPC4;HNRNPD;CHEK2;RNASE6;SIAH2;RNASEH2A;ADAMTS9;HTRA2;PPP1R8;EXOSC7;STT3B;FBXO27;FBXO17;PNPT1;RIPK1;XRN2
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.34437206350282223,-1.110447495321369,0.31443298969072164,0.6875597866753946,1.0,9/25,19.33%,PSEN1;ITGA6;AR;APP;THBS1;SDCBP;PTH1R;NCKAP1L;NRP1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.5150895148432308,1.1104038124196218,0.37001209189842804,1.0,1.0,8/26,16.43%,ATPSCKMT;SETD3;SETD2;KMT2A;KMT2D;KMT5C;SETD4;SUV39H2
prerank,intracellular lipid transport (GO:0032365),-0.35613183371864354,-1.1094142656362251,0.2747747747747748,0.6889194844663049,1.0,9/21,25.64%,CERT1;ABCD4;ACACB;ARV1;ABCD2;PRKAG2;PLEKHA8;NPC2;MID1IP1
prerank,sphingolipid metabolic process (GO:0006665),-0.24212618810081665,-1.1094067036643804,0.20689655172413793,0.6877170613293699,1.0,39/108,23.95%,CERT1;ELOVL7;HEXB;SGMS2;HACD3;ACER2;PLPP3;HACD2;PSAP;ASAH1;ALDH3A2;ST6GALNAC3;ACER3;ESYT1;B3GALNT1;HACD1;HEXA;SERINC1;DEGS2;SPNS2;ARV1;GLTP;CTSA;ASAH2;DEGS1;GAL3ST1;ELOVL6;PPT1;VAPB;CERS1;GBA2;SPTSSA;SGPL1;ABCA2;ELOVL1;ESYT3;PLA2G15;SPHK1;NEU1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.46542365530510504,1.1093240997634224,0.3503575076608784,1.0,1.0,17/94,12.42%,BRCA1;E2F1;CHEK2;ITPR1;PRKDC;STK24;PML;CUL5;HTRA2;CUL3;TNFRSF10B;APAF1;HINT1;BOK;LGALS12;QRICH1;MSH6
prerank,cellular component assembly (GO:0022607),0.4614182069653445,1.1092951000378357,0.282,1.0,1.0,54/253,16.38%,KNTC1;FANCA;TRIP13;CHAF1B;HAS3;KPNA3;RHOA;TEAD1;RAD21;PARVA;SPAG16;RTN3;MDM4;SPEF1;ADD2;ZW10;NLGN3;RBBP4;GRHL2;PML;QSOX1;ARL6IP1;DARS1;CORO1B;RHOQ;YAP1;PICALM;IKBKG;KMT2A;HAS1;RSPH9;YTHDF2;LIMS1;CAPZA1;EZR;RAC1;GORASP2;SOX9;DMTN;DPYSL3;BAIAP2L1;TTLL3;PPID;CHAF1A;P3H4;EPRS1;CAPG;ADD1;LCP1;TP53;SYCP2;TINF2;NLGN2;NCKAP1
prerank,contractile actin filament bundle assembly (GO:0030038),0.553998569573106,1.1091533453880713,0.3500697350069735,1.0,1.0,6/15,15.34%,RHOA;ARRB1;PHACTR1;CUL3;ITGB1;SRC
prerank,stress fiber assembly (GO:0043149),0.553998569573106,1.1091533453880713,0.3500697350069735,1.0,1.0,6/15,15.34%,RHOA;ARRB1;PHACTR1;CUL3;ITGB1;SRC
prerank,histone H2A acetylation (GO:0043968),0.5567401008223526,1.1086517326760943,0.3900134952766532,1.0,1.0,10/16,23.75%,MSL3;EP400;EPC1;RUVBL2;TRRAP;BRD8;NAA40;MEAF6;ACTL6A;MORF4L2
prerank,neuron projection organization (GO:0106027),-0.39897887775350055,-1.1083547581742819,0.34507042253521125,0.6891776449742233,1.0,10/15,19.57%,PSEN1;INSR;LGMN;MAP1A;CHRNA7;ATP1A3;APP;ABCD2;PICK1;DCTN1
prerank,regulation of biomineral tissue development (GO:0070167),0.49897857996600414,1.1082578853700398,0.3488372093023256,1.0,1.0,9/26,15.99%,FBXO5;ROCK2;ROCK1;DDR2;ENPP1;SOX9;TWIST1;HEY2;NOTUM
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.26535855862229063,-1.108212936926909,0.21568627450980393,0.6883901249824083,1.0,26/71,19.34%,PTK2;HSP90AB1;ELMO1;ACTB;WIPF1;VAV3;PIK3R1;PLD2;PLCG1;MYO10;LYN;PAK1;MAPK3;WIPF2;ABL1;LIMK1;WIPF3;MAPK1;GRB2;ELMO2;PLPP4;PIK3CA;ARPC5;BAIAP2;NCKAP1L;CYFIP1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.45015732581777634,-1.1080676305389932,0.34169278996865204,0.6874937409623555,1.0,5/10,19.23%,TGFBR2;PRKCQ;CD81;LGALS9;NCKAP1L
prerank,ether lipid biosynthetic process (GO:0008611),-0.4522328134863818,-1.107917350341368,0.3247863247863248,0.6866908835554143,1.0,4/10,11.45%,PLA2G4A;CHPT1;DHRS7B;LPCAT2
prerank,regulation of stem cell population maintenance (GO:2000036),0.5310915595251279,1.1071978170715235,0.34782608695652173,1.0,1.0,2/18,3.91%,LOXL2;CNOT1
prerank,regulation of cell projection organization (GO:0031344),0.5506081739732629,1.1067954531160034,0.353204172876304,1.0,1.0,2/13,2.77%,MACF1;MOV10
prerank,plasma membrane invagination (GO:0099024),0.5004707532903144,1.106675328164236,0.3539928486293206,1.0,1.0,5/29,13.45%,AURKB;RHOA;SNX33;SNX18;DOCK1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.30938597977455135,-1.106508193444304,0.3422818791946309,0.689081127037897,1.0,9/37,13.78%,PTPRD;FAT4;GRID2;IL1RAPL1;VCAM1;NECTIN3;CADM3;HMCN1;TENM4
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.5218044259644548,1.106476863113314,0.34908136482939633,1.0,1.0,10/22,18.37%,ERI2;ERI1;RRS1;RPP40;EXOSC7;ERI3;WDR12;NOL9;ABT1;EXOSC10
prerank,response to growth factor (GO:0070848),-0.29430243316289567,-1.1064356614859927,0.27205882352941174,0.6880351745702076,1.0,20/41,25.43%,ACVR1;ACVR2A;TGFBR2;BMPR2;ACVRL1;MAP2K5;KLF4;ACVR2B;CTNNB1;SHC1;ERBB2;SOX2;BMPR1B;NOS1;RACK1;GATA6;SPHK1;URI1;PLK5;MAPK7
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5378491941375648,1.105788805329708,0.36786188579017265,1.0,1.0,8/18,16.43%,SETD3;EEF1AKMT2;SETD2;KMT2A;KMT2D;ASH1L;SETD4;SUV39H2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.49356560570793717,1.105658293162667,0.3690888119953864,1.0,1.0,10/35,15.64%,NLK;KIT;LEPROT;VHL;OCIAD2;CRLF3;PIGU;ADIPOR1;OCIAD1;NF2
prerank,regulation of T cell chemotaxis (GO:0010819),0.5693454957866131,1.105291118685885,0.36229749631811486,1.0,1.0,4/11,18.18%,WNK1;ADAM17;STK39;OXSR1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.5085288220156183,1.1051783920345906,0.3559322033898305,1.0,1.0,4/21,11.78%,CYP26B1;LPIN2;AGXT;HOGA1
prerank,cristae formation (GO:0042407),-0.3335962031602253,-1.1040020215010526,0.3076923076923077,0.6928237023346953,1.0,14/27,25.82%,APOOL;ATP5PF;ATP5F1A;ATP5PO;ATP5MF;ATP5MC3;DNAJC11;ATP5PD;ATP5F1B;ATP5F1D;ATP5F1E;ATP5MG;MICOS13;ATP5ME
prerank,nuclear body organization (GO:0030575),0.5726836974818538,1.1039580031347591,0.35103244837758113,1.0,1.0,3/12,6.70%,DYRK3;SERBP1;PML
prerank,negative regulation of B cell proliferation (GO:0030889),-0.4259964841526611,-1.103635477947505,0.35714285714285715,0.6925345877288893,1.0,3/11,9.05%,TNFRSF21;LYN;ATM
prerank,negative regulation of phosphatase activity (GO:0010923),0.5169486891363685,1.1036068876941763,0.37997587454764775,1.0,1.0,2/25,3.51%,MASTL;GSK3B
prerank,monocarboxylic acid transport (GO:0015718),-0.27856477059669243,-1.1035005890712644,0.27472527472527475,0.6916134883152975,1.0,13/51,17.60%,SLC16A12;SLCO1C1;SLCO2B1;SLC27A1;ABCC4;ATP8B1;SLCO2A1;ABCG2;SLC5A6;SLC16A1;SLC16A4;SLC6A11;STARD5
prerank,autonomic nervous system development (GO:0048483),-0.37713488708387854,-1.103488727738651,0.35019455252918286,0.6904422513874132,1.0,9/17,33.24%,SEMA3A;NF1;SOX4;NRP1;KIF26A;EDNRB;SOX11;SOX10;SOX8
prerank,regulation of protein kinase C signaling (GO:0090036),0.5324177133953247,1.1034718981459275,0.3653566229985444,1.0,1.0,2/14,2.62%,ADGRV1;ULK4
prerank,regulation of phosphorylation (GO:0042325),0.46185865381537894,1.1034619676464326,0.3350357507660878,1.0,1.0,29/120,16.69%,BARD1;NDC1;NUP155;CDKN2D;CDKN2C;NUP205;MCM7;PHIP;NUP160;FNIP1;GCK;NUP85;TPR;PML;ROCK1;PLXNB2;DSCAM;NUP214;KCTD20;RANBP2;CDKN1B;BTBD10;NUP133;PIN1;PRKAG1;NUP42;SESN2;ANKLE2;NUP98
prerank,tyrosine metabolic process (GO:0006570),0.562843553229513,1.10345700599503,0.353204172876304,1.0,1.0,4/11,22.12%,TYR;IL4I1;THAP4;GSTZ1
prerank,regulation of viral entry into host cell (GO:0046596),-0.33091022133685666,-1.1034342735873939,0.2676767676767677,0.6893792353057233,1.0,11/30,17.26%,MID2;LY6E;SNX3;TRIM25;IFITM3;GSN;TRIM27;TRIM14;NECTIN2;IFITM2;LGALS9
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.4017518145579672,-1.1030886662859358,0.30604982206405695,0.688982282538839,1.0,7/14,21.77%,AKT2;IRS2;GPLD1;IRS1;NNMT;PPARGC1A;SLC45A3
prerank,positive regulation of cellular component organization (GO:0051130),0.4636894746453866,1.1028915813431115,0.34994913530010174,1.0,1.0,20/107,10.58%,CDC20;HAS3;RB1;FNIP1;HYAL1;GSK3B;ASAP1;BMF;TRABD2B;AJUBA;ADGRL1;ABCB4;FAF1;SLF1;SPIDR;CDC42EP2;SH3GLB1;TPPP;TGFBR1;TAL1
prerank,regulation of activated T cell proliferation (GO:0046006),0.49245872358165477,1.1026896390867293,0.3738095238095238,1.0,1.0,6/30,13.97%,FADD;PRNP;IL18;SCRIB;HMGB1;RC3H1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.42105115421909134,-1.1021298963098185,0.3343949044585987,0.6901255917843018,1.0,7/12,26.43%,HSPA5;SGTA;SGTB;SEC61B;SEC62;SEC63;SEC61A2
prerank,defense response to Gram-negative bacterium (GO:0050829),0.4855396990803861,1.1020626808923593,0.3658256880733945,1.0,1.0,4/42,7.97%,HMGB2;AQP1;RNASE6;SERPINE1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.3808295212992619,-1.101904336315298,0.2947761194029851,0.6894948849773087,1.0,3/16,3.07%,CAMK2D;CALM1;RYR2
prerank,regulation of centrosome cycle (GO:0046605),0.5190508267838436,1.1017439570903,0.3567708333333333,1.0,1.0,2/21,2.76%,GEN1;AURKA
prerank,aortic valve development (GO:0003176),0.49135089374226704,1.1016810160313903,0.3720657276995305,1.0,1.0,11/34,13.45%,RB1;ROCK2;EFNA1;SMAD6;ROBO1;ROCK1;ELN;BMP2;SOX9;TWIST1;HEY2
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.46182234589606097,1.1007203030316424,0.296,1.0,1.0,60/259,15.43%,KIF24;PLK4;IFT80;HYLS1;CEP89;MAP4K4;BBS9;DZIP1L;SCLT1;ACTR3;WDR35;PARVA;ASAP1;GBF1;SPAG16;WDR90;IFT140;POC1B;FAM161A;EXOC4;KIF27;PCM1;KIT;SPEF1;OCRL;NTN1;TXNDC15;RAP2A;MKKS;WDR11;FGD4;CEP83;RILPL1;NUDCD3;RFX2;SSX2IP;FGD1;CCDC57;CFAP52;WDPCP;NPHP3;RAB1A;SRGAP2;S1PR2;FGD6;TRAPPC14;TTC39C;EZR;RAC1;CC2D2A;DMTN;EHD1;TTLL3;EXOC8;ARF4;ITGB1;CEP162;VSTM5;LZTFL1;EMP1
prerank,collagen fibril organization (GO:0030199),0.4689204123013266,1.1005628750284966,0.3655804480651731,1.0,1.0,21/88,14.41%,BMP1;LOXL3;COL22A1;LOXL2;LOX;COL4A6;COL4A4;COL18A1;COL5A2;COL23A1;ADAMTS14;ADAMTS2;DDR2;TLL2;TGFBR1;COL4A5;COL12A1;P3H1;COL15A1;COL20A1;P3H4
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.45735170074170095,1.1004827608101697,0.355464759959142,1.0,1.0,31/114,22.99%,TNFSF13B;MAP3K14;PSMC2;PSMD5;ACTN4;FOXO3;PSMB1;PSMD14;PSMD1;EDA;LIMS1;PSMB9;PYDC1;ADAM17;PSMC6;PLVAP;TP53;TNFRSF25;PSMB2;PSME4;PSMB7;RIPK1;PSMD11;TRAF6;PSME3;TRAF2;IKBKB;PSMD13;BIRC2;PSMB8;PSMD4
prerank,positive regulation of JNK cascade (GO:0046330),-0.255545923199977,-1.1002858070250117,0.20689655172413793,0.692314651827107,1.0,39/70,39.60%,TNFRSF19;SH3RF3;HIPK2;TPD52L1;TAOK2;ANKRD6;MAP3K5;DUSP22;SEMA3A;MINK1;APP;SDCBP;SH3RF2;TIRAP;GADD45B;FLT4;MAP3K11;WNT16;PTK2B;MAPK8IP1;MFHAS1;EDA2R;PLCB1;MBIP;GADD45G;DUSP19;TRAF1;HRAS;PJA2;CCL19;EDAR;NOD2;DUSP15;PYCARD;GADD45A;UNC5CL;FCGR2B;RASSF2;AGER
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.5174689203973436,1.0998242574802568,0.37142857142857144,1.0,1.0,7/22,16.20%,CDKN2D;CDKN2C;CDA;ROCK1;CDKN1B;TP53;ANKLE2
prerank,regulation of monooxygenase activity (GO:0032768),-0.347721450201661,-1.099415638979444,0.3033175355450237,0.6933341920379519,1.0,5/23,5.48%,CALM1;CAV1;NOS3;LYPLA1;NOSTRIN
prerank,regulation of apoptotic process (GO:0042981),0.4598228681121721,1.0986055091761044,0.183,1.0,1.0,104/676,14.01%,TOP2A;KIF14;ECT2;MELK;STIL;CDK1;PLK1;BIRC5;BARD1;FIGNL1;E2F1;STPG1;AQP1;ITGB3BP;FADD;MAP4K4;STK17B;SETX;PHIP;ARHGAP10;ANGPT4;STEAP3;GSK3B;BMF;FXN;DDRGK1;IAPP;ACTN4;ANP32B;AIFM2;FHL2;PRKDC;FAM162A;MRE11;NET1;SIAH2;CCAR1;FAF1;PDPN;STK3;ERCC3;ANXA5;RBM25;FGD4;TMEM219;MAP3K20;ATG7;VAV2;SFRP2;CALHM2;GNA13;SCRIB;FGD1;FOXO3;SAP18;HTRA2;ARL6IP1;SMAD6;ING4;GRK5;BCLAF1;KLF11;SH3RF1;TNFRSF10B;DNM2;MGMT;ANGPT1;VHL;PIM1;SKP2;HMGB1;APIP;AGT;ERC1;GAS1;APAF1;BOK;NDRG1;ANP32E;IP6K2;ARHGEF18;QRICH1;HDAC1;BMP2;ANXA1;CHM;SOX9;HDAC2;NOTCH2;ATF5;CASP8;IL31RA;ITCH;TXNDC5;PLAUR;CTSH;PPID;MED1;PRKCI;USP47;ARF4;PLK2;XIAP;SMPD1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.5148960008475263,1.0985520029056788,0.36536030341340076,1.0,1.0,3/23,9.75%,HMGB2;DNASE2;HMGB1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.43282157846121494,-1.098464241807739,0.378125,0.6944827256142614,1.0,6/11,24.59%,SLC27A1;GPLD1;NR1H3;NR1H2;MFSD2A;CTDNEP1
prerank,regulation of blood circulation (GO:1903522),-0.31592943626709835,-1.0984430455921368,0.2875816993464052,0.6933373753101119,1.0,13/34,22.37%,CAMK2D;ECE1;PER2;DMPK;TPM1;ACE;AGTR1;SRI;TBX2;FXYD1;KCNQ1;KCNJ12;S100A1
prerank,regulation of immune effector process (GO:0002697),-0.3021316178621758,-1.097812792768499,0.2636363636363636,0.6935605154446517,1.0,18/41,39.05%,VTN;CD81;C4B;C1QB;C2;CR1L;C1QC;C1QA;CFHR2;PHB2;CR2;C1QBP;SERPING1;C3;C3AR1;C6;FCGR2B;C7
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.33076930171583446,-1.0976200026695844,0.2864583333333333,0.6916853936162222,1.0,9/29,21.11%,CROT;ACOT11;ACLY;ACBD6;ACSL6;DBI;ACSF2;ACOT7;ACOT13
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.33076930171583446,-1.0976200026695844,0.2864583333333333,0.6916853936162222,1.0,9/29,21.11%,CROT;ACOT11;ACLY;ACBD6;ACSL6;DBI;ACSF2;ACOT7;ACOT13
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.3830889105280738,-1.0974775184080616,0.311787072243346,0.690847523709648,1.0,11/16,25.82%,ATP5PF;ATP5F1A;ATP5PO;ATP5MF;ATP5MC3;ATP5PD;ATP5F1B;ATP5F1D;ATP5F1E;ATP5MG;ATP5ME
prerank,cellular response to interleukin-7 (GO:0098761),-0.3736778475437642,-1.09658874358776,0.3125,0.6906583893452782,1.0,4/17,10.42%,STAT3;SOCS2;IRS2;IRS1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.3736778475437642,-1.09658874358776,0.3125,0.6906583893452782,1.0,4/17,10.42%,STAT3;SOCS2;IRS2;IRS1
prerank,ribosomal subunit export from nucleus (GO:0000054),0.5548018694957917,1.0965168096810733,0.37209302325581395,1.0,1.0,4/13,13.03%,XPO1;NMD3;RRS1;SDAD1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.5348794769067859,1.095793843832418,0.364010989010989,1.0,1.0,7/16,16.26%,GBF1;DDRGK1;LRRK2;TAPT1;MIA3;VAPA;BCAP29
prerank,regulation of aerobic respiration (GO:1903715),-0.3930608650268098,-1.0956948304031466,0.32413793103448274,0.6916912823572497,1.0,6/15,26.17%,CBFA2T3;PINK1;COX7A2;UQCC2;ATP7A;AK4
prerank,positive regulation of response to wounding (GO:1903036),-0.341233766545488,-1.0954946841862119,0.32524271844660196,0.6909895768365437,1.0,10/24,22.63%,PTK2;OCLN;VTN;MYLK;GRN;SCARF1;ARFGEF1;ADRA2A;HBEGF;CLDN1
prerank,amino acid import (GO:0043090),-0.35278339964572447,-1.0953248411949612,0.2974137931034483,0.6902555131504203,1.0,5/21,5.85%,SLC6A6;SLC6A1;SH3BP4;SFXN2;SLC7A5
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.27924870071326086,-1.0935475449905447,0.3023255813953488,0.6935639266447683,1.0,16/50,16.68%,SMAD7;OGT;PRMT3;CAV1;PER2;UFL1;SQSTM1;PINX1;DNAJA1;ABL1;LIMK1;SPRY2;SOX4;SH3RF2;UBXN1;PRKCG
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.33212026729655536,-1.0926872233591827,0.3063583815028902,0.6945156936996069,1.0,9/27,12.68%,DACH1;BMPR2;ACVRL1;PDGFRB;FGF2;PINX1;ATM;NABP2;RGCC
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.4654248489012331,1.0923119522369482,0.3700623700623701,1.0,1.0,16/87,12.65%,IQGAP3;IQGAP2;ROCK2;RHOA;ARHGAP18;PDGFRA;RHOQ;ROCK1;ARHGAP35;TRPM2;TWF1;RND2;EZR;RAC1;NOTCH2;DMTN
prerank,positive regulation of isotype switching (GO:0045830),0.5282974297915026,1.0922612528984759,0.3746518105849582,1.0,1.0,4/15,15.25%,PAXIP1;RIF1;KMT5C;SHLD2
prerank,mRNA polyadenylation (GO:0006378),0.5126663628114663,1.0915728970929688,0.38583638583638585,1.0,1.0,11/26,16.13%,TENT2;CSTF3;FIP1L1;TUT1;WDR33;LEO1;PAPOLB;PCF11;SCAF8;PABPC1;PNPT1
prerank,RNA polyadenylation (GO:0043631),0.5126663628114663,1.0915728970929688,0.38583638583638585,1.0,1.0,11/26,16.13%,TENT2;CSTF3;FIP1L1;TUT1;WDR33;LEO1;PAPOLB;PCF11;SCAF8;PABPC1;PNPT1
prerank,positive regulation of transferase activity (GO:0051347),0.4670321109790321,1.091554383999566,0.3561368209255533,1.0,1.0,18/142,7.61%,NEK2;PLK1;AURKB;DSCC1;RFC4;FGFR4;FGFR2;HNRNPD;KIT;RFC2;MRE11;MUSK;RFC3;GRHL2;FBXW7;UBE2N;PDGFRA;EPHA4
prerank,regulation of transmembrane transport (GO:0034762),-0.3124577751642085,-1.0914608055868114,0.3507853403141361,0.696518364109148,1.0,8/31,12.01%,OCLN;SLC2A1;ACTB;KCNJ3;CTTNBP2NL;KCNJ6;BCL2;KCNJ10
prerank,icosanoid metabolic process (GO:0006690),0.48598943567160113,1.091255658858015,0.38507109004739337,1.0,1.0,12/40,20.71%,PON1;PTGR1;ABCC10;PTGS1;DAGLB;PON2;DPEP1;PTGIS;DPEP2;PON3;DAGLA;MAPKAPK2
prerank,microtubule anchoring at centrosome (GO:0034454),0.5663599040031466,1.0912158191516608,0.3614088820826952,1.0,1.0,3/10,10.33%,NIN;PCM1;NINL
prerank,cellular response to interferon-beta (GO:0035458),0.5581655793353963,1.091156570922544,0.3813813813813814,1.0,1.0,5/14,16.13%,UBE2K;HTRA2;IRF1;TRIM6;PNPT1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.5120060248215548,1.0910978877863664,0.3878048780487805,1.0,1.0,7/25,11.45%,ADK;ADA;DCK;HPRT1;PRPS1L1;PRPS1;ADSL
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.39392310032868944,-1.090366042380092,0.3702290076335878,0.6969757758294687,1.0,6/16,15.61%,APOD;PHLDB2;ACVRL1;DUSP22;THBS1;ITGB1BP1
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.39392310032868944,-1.090366042380092,0.3702290076335878,0.6969757758294687,1.0,6/16,15.61%,APOD;PHLDB2;ACVRL1;DUSP22;THBS1;ITGB1BP1
prerank,purine nucleotide catabolic process (GO:0006195),0.5437907810746244,1.0900663169501537,0.3792134831460674,1.0,1.0,6/13,24.41%,XDH;ITPA;HINT1;PNP;NT5E;GDA
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.37671728578665364,-1.08981213151621,0.31153846153846154,0.6972477471933927,1.0,8/17,26.62%,KCNB1;SLC4A8;SCAMP5;SYT10;NLGN1;RAB27A;RAB3D;CACNA1H
prerank,blood vessel morphogenesis (GO:0048514),-0.2713615015893627,-1.089516750303233,0.25263157894736843,0.6968379384444614,1.0,17/54,15.85%,FLT1;SMAD7;CDH2;CAV1;TGFBR2;PROX1;RAMP2;NF1;RASIP1;CUL7;CCBE1;TBX1;VEGFA;ENG;SOX17;STRA6;SLC1A1
prerank,RNA destabilization (GO:0050779),0.5182961350856632,1.0893175351302753,0.36528497409326427,1.0,1.0,8/18,16.36%,ROCK2;FTO;ROCK1;YTHDF2;MEX3D;DXO;ZC3H18;METTL3
prerank,basement membrane organization (GO:0071711),0.5456193209931406,1.0888401530221996,0.38613861386138615,1.0,1.0,4/14,15.49%,NID2;LAMB1;NID1;NTN4
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.4231149309978422,-1.0887002865152906,0.35333333333333333,0.6976290245447202,1.0,7/12,29.59%,SREBF2;DGKQ;CLCN2;ABCA2;RAN;MBTPS1;MBTPS2
prerank,positive regulation of ruffle assembly (GO:1900029),-0.41146672433367665,-1.0884294773855927,0.3639240506329114,0.6970289143577026,1.0,9/13,32.30%,FAM98A;PFN1;PLEKHM1;EPS8L2;NLGN1;P2RY12;DEF8;EPS8;HRAS
prerank,protein import into mitochondrial matrix (GO:0030150),-0.36781219320564096,-1.0876197047430736,0.35384615384615387,0.6978939004434964,1.0,12/18,38.86%,DNAJC19;TIMM44;TOMM70;DNAJC15;PAM16;TIMM17A;TIMM17B;ROMO1;GRPEL1;DNLZ;TOMM40L;TIMM50
prerank,nucleocytoplasmic transport (GO:0006913),0.47744603753048764,1.0873721401400582,0.3759820426487093,1.0,1.0,10/40,17.34%,XPO1;NUP205;PHAX;HNRNPA1;RBM15B;ATXN1;NXT1;NUP98;GEMIN7;NXT2
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.2856136436534651,-1.0868035207681324,0.32710280373831774,0.6987560080398199,1.0,17/45,20.19%,PTK2;KIF16B;RPS6KA5;PIK3R1;PLCG1;TGFA;GRB2;PTPN11;SHC1;ERBIN;PLCE1;CBL;PIK3CA;BCAR1;SHC3;DGKD;HBEGF
prerank,autophagy of peroxisome (GO:0030242),-0.4110718119383828,-1.0861141960564795,0.38109756097560976,0.6992464371608934,1.0,5/12,17.36%,SQSTM1;PIK3R4;ATM;PEX5;USP30
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.24741101265281978,-1.0860643456809935,0.2962962962962963,0.6982284409179347,1.0,31/100,15.34%,PRKN;FHIT;COP1;SMAD7;HSP90AB1;NUB1;OGT;RNF180;TRIB2;UFL1;GNA12;RBX1;RNF144B;DAB2;CBFA2T3;MAP1A;SOCS5;ARAF;RNF19B;UBQLN4;GIPC1;STUB1;RNF217;ARIH2;CCAR2;SDCBP;SH3RF2;GSK3A;NKD2;ELOB;DVL1
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.48364101171301166,1.085853057308335,0.37252619324796277,1.0,1.0,7/37,11.82%,PABPC4;HNRNPD;RNASE6;NUDT5;RNASEH2A;PPP1R8;EXOSC7
prerank,organic substance transport (GO:0071702),0.4579773030935478,1.08544014437434,0.3532388663967611,1.0,1.0,8/121,7.11%,CENPF;SLC18A2;NDC1;ZG16;ABCA4;SLC6A2;SLC19A1;ABCA9
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5471463735481341,1.084989150029197,0.384180790960452,1.0,1.0,5/13,15.76%,EFL1;LRRK2;RHOQ;GNAI3;MFN1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.4984878909376272,1.084846950502252,0.3844282238442822,1.0,1.0,4/29,6.79%,PLK1;FBXO5;FBXW7;UBE2N
prerank,B cell receptor signaling pathway (GO:0050853),-0.31193893133592865,-1.084781670841371,0.3167701863354037,0.7002337341472226,1.0,9/32,19.23%,MEF2C;VAV3;BCL2;BMX;RFTN1;PIK3CD;BCAR1;CD38;NCKAP1L
prerank,regulation of DNA binding (GO:0051101),0.47766958699063844,1.0844355294281716,0.38478747203579416,1.0,1.0,3/44,1.44%,HJURP;HMGB2;E2F1
prerank,diacylglycerol metabolic process (GO:0046339),-0.3422760111883789,-1.0843780894343227,0.3526570048309179,0.7000502460714956,1.0,13/23,36.89%,DGKB;DGKG;DGKI;DGKQ;PLCE1;DGKD;PLA2G15;DGKK;PNPLA2;LIPE;DGAT2;ANG;DGKA
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.4700540055584734,1.0840382523788377,0.392090395480226,1.0,1.0,12/43,15.84%,ATOH8;TEAD1;KLF5;SRF;NFIB;FOXO3;SMARCA4;NR3C1;SOX9;SMAD3;GNL3;TP53
prerank,tight junction assembly (GO:0120192),0.478218768450276,1.083356690950293,0.40175631174533477,1.0,1.0,3/49,6.60%,ECT2;AFDN;GRHL2
prerank,negative regulation of chemotaxis (GO:0050922),-0.3151884648004761,-1.0832068558215135,0.28,0.701699263128922,1.0,13/31,19.19%,SEMA6A;SEMA6D;SEMA7A;DUSP3;SEMA4D;SEMA3A;SLIT2;ANGPT2;THBS1;SEMA3B;ROBO2;SEMA3C;SEMA5B
prerank,vesicle organization (GO:0016050),-0.27711534151023803,-1.0829705082565333,0.29591836734693877,0.7010750336609055,1.0,15/46,14.61%,CAV1;FNBP1L;SQSTM1;CD34;LAPTM4B;DNM1;USP8;SAR1A;VPS11;CHMP2B;SRGN;CAV2;ARFGEF2;HOOK1;VPS33B
prerank,negative regulation of gene expression (GO:0010629),0.4538092429939708,1.0829053595559344,0.306,1.0,1.0,71/302,16.36%,PHF19;EZH2;RBL1;HELLS;TYMS;ATOH8;ILF3;SYNCRIP;ATP2B4;PPM1D;RB1;BMPR1A;AURKA;MOV10;ROCK2;SUZ12;AGO2;CNOT1;DDRGK1;MPHOSPH8;EED;SETDB2;MAPT;XDH;EIF4ENIF1;SAMD4A;RBBP4;CAPRIN1;RBBP7;FBXW7;FMR1;SFRP2;PHF1;LARP1;ROBO1;YAP1;VHL;SLC24A3;PICALM;EPC1;LSM2;PARP9;YTHDF2;FLOT2;ATP2B1;MRPL13;EIF2AK3;CRKL;HDAC1;BMP2;TERF2;STOX1;CENPV;RBMS3;TRIM6;NOTCH2;DXO;PTBP2;HEY2;RBM4;DHFR;YY1;DNMT3A;EPRS1;CNOT7;TNRC6C;FXR1;NFKB1;SFRP1;PNPT1;METTL3
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.4594954404538906,1.0827415743015048,0.37846153846153846,1.0,1.0,30/113,15.84%,TERF1;FNIP1;GSK3B;PSMC2;RPA1;ASAP1;BMF;TRABD2B;CHD1L;AJUBA;ERCC4;FAF1;RPA2;SLF1;ERCC3;SPIDR;CDC42EP2;SH3GLB1;TPPP;CUL4B;TAL1;XPA;PIEZO1;ABCA1;PSMC6;CAPG;SRC;RHOC;LCP1;TP53
prerank,cyclooxygenase pathway (GO:0019371),0.5631083481149963,1.082369732684863,0.38591117917304746,1.0,1.0,3/10,7.46%,PTGES2;HPGDS;PTGS1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.4517337024362349,-1.0823597302540613,0.3843843843843844,0.7013377040048535,1.0,2/10,8.26%,TLR4;NAMPT
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.4276112487246372,-1.0818933657071705,0.34069400630914826,0.7013891799404712,1.0,2/11,4.12%,MEF2C;TGFB2
prerank,regulation of metal ion transport (GO:0010959),-0.3792941818773606,-1.081697883639629,0.35918367346938773,0.700723731565475,1.0,4/16,10.54%,CACNA2D1;EPB41;CAMK2G;BCL2
prerank,"DNA-templated transcription, termination (GO:0006353)",0.46484515199048704,1.0815831230535105,0.3915343915343915,1.0,1.0,17/68,13.17%,TTF2;SETX;POLR1A;CSTF3;FIP1L1;POLR1B;SLBP;ERCC3;LSM11;POLR2A;WDR33;PCF11;TAF1D;SCAF8;CPSF4;TTF1;POLR1G
prerank,peptide cross-linking (GO:0018149),0.5084051119144618,1.080832816992356,0.39974937343358397,1.0,1.0,1/25,1.15%,TGM1
prerank,positive regulation of RNA splicing (GO:0033120),0.4865107060565937,1.0802391073537292,0.3900709219858156,1.0,1.0,11/29,21.30%,DYRK1A;SETX;TRA2B;THRAP3;POLR2A;DAZAP1;NUP98;HNRNPLL;SLC38A2;TRA2A;RBMX
prerank,regulation of protein kinase A signaling (GO:0010738),0.5128411163776382,1.0799022188909875,0.38174807197943444,1.0,1.0,7/20,17.33%,ADGRV1;IAPP;LRRK2;ADRB2;RAMP3;PRKAR2B;PRKAR2A
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.4676108503692912,1.0796593004745518,0.3973655323819978,1.0,1.0,19/52,17.42%,PNLDC1;CNOT1;PATL1;CNOT6L;LSM3;SAMD4A;RC3H2;TUT7;CNOT6;LSM2;PAN3;EXOSC7;TUT4;LSM7;RC3H1;CNOT7;LSM4;CNOT4;EDC3
prerank,regulation of ATP metabolic process (GO:1903578),0.46269734729059664,1.0795618649391776,0.40327868852459015,1.0,1.0,15/54,17.41%,NDC1;NUP155;NUP205;NUP160;GCK;NUP85;TPR;NUP214;RANBP2;ATP5IF1;NUP133;PRKAG1;NUP42;NUP98;NUP210
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.3218146455828428,-1.0790665441432838,0.32967032967032966,0.7058941355401482,1.0,6/27,5.85%,SLC1A2;SLC7A2;SLC25A13;SLC25A12;SLC3A2;SLC7A5
prerank,lipid phosphorylation (GO:0046834),-0.4507321212289627,-1.0788165741424232,0.4036144578313253,0.705393732064485,1.0,6/10,24.52%,DGKB;DGKG;DGKI;DGKQ;DGKD;DGKK
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.555472431541219,1.0781894873932623,0.391304347826087,1.0,1.0,3/10,7.61%,ANXA2;EFNA1;EPHA4
prerank,regulation of cellular component biogenesis (GO:0044087),0.48128218977387144,1.078124679181694,0.3934240362811791,1.0,1.0,8/39,12.06%,HJURP;ROCK2;NCLN;ROCK1;AGT;BAG5;EZR;SPTY2D1
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.22261010816136856,-1.0780630817768186,0.25,0.7061236419401835,1.0,51/172,19.88%,PLA2G4A;PLD1;PIP4K2A;INPP4B;SLC44A1;CHPT1;DGKB;ETNK1;PIK3R3;ABHD5;PIP4K2B;CDS2;PIK3C2B;PIK3R1;FGF2;PIK3R4;PLD2;SLC27A1;AGPAT5;RAB5A;CHKA;ETNK2;DGKG;MTMR4;RUFY1;PCYT2;INPP5K;STARD7;LPCAT2;SELENOI;PIP5K1A;BMX;INPP5D;DGKQ;SYNJ2;CHKB;CDS1;SLC44A5;PIK3R6;SYNJ1;PI4KA;IMPA1;INPP4A;PIK3CD;PIK3CA;HDHD5;ACP6;LPIN1;PLA2G12A;DGKD;CDIPT
prerank,Golgi organization (GO:0007030),0.46269292336444967,1.078055955774499,0.3738508682328907,1.0,1.0,28/112,18.50%,CDK1;ARHGAP21;USP6NL;GBF1;OBSL1;COG1;ZW10;ATL2;ATL3;RAB29;LRRK2;GOLGA8B;GOLGA5;RAB1A;BAG5;GAK;GORASP2;VTI1A;PRKD1;VRK1;BET1;TMED3;UBXN2B;CSNK1A1;COG4;CLASP1;TMED10;PI4K2B
prerank,regulation of cation transmembrane transport (GO:1904062),0.4891466561561259,1.0778996917043173,0.3785103785103785,1.0,1.0,9/29,17.54%,ATP2B4;RANGRF;PDZK1;WNK1;SNTA1;KCNIP3;DLG1;DPP6;WNK3
prerank,secretion (GO:0046903),-0.39421789207476576,-1.0777023731727309,0.375886524822695,0.7059137796405424,1.0,4/14,10.61%,RIMS1;SLC22A6;NPR1;TPD52
prerank,neurotransmitter uptake (GO:0001504),-0.411181757568727,-1.0770684756623181,0.35333333333333333,0.7063266620441567,1.0,9/12,46.55%,GLUL;ATP1A2;SNAP25;SLC22A2;SLC1A6;SLC22A3;SLC29A2;SLC29A4;SLC38A1
prerank,regulation of microtubule polymerization (GO:0031113),0.48264497262384537,1.0770553335595763,0.4126436781609195,1.0,1.0,9/40,11.75%,CDK5RAP2;STMN1;PSRC1;DYRK1A;NUMA1;MAPT;DRG1;AKAP9;RAC1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.4297309966278887,-1.0769864349443279,0.364741641337386,0.7053546988352338,1.0,6/11,25.76%,PRKN;PINK1;FBXO7;PARK7;RACK1;HIF1A
prerank,positive regulation of organelle organization (GO:0010638),0.4951373978932823,1.0762248458678243,0.38823529411764707,1.0,1.0,10/32,15.22%,GSK3B;ANXA2;LNPK;ATL3;SORBS3;HTRA2;STX18;ANXA1;ADRB2;UVRAG
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.534414372409513,1.0756400888226094,0.3832599118942731,1.0,1.0,4/13,10.27%,SRSF10;PRPF19;PRPF3;LSM2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.5314741161220713,1.0746087654571639,0.3778409090909091,1.0,1.0,5/15,16.36%,USP18;PTPN2;YTHDF2;CNOT7;METTL3
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.25945254008239516,-1.074193337219262,0.2923076923076923,0.7111593331537749,1.0,17/66,25.97%,STAT3;CARD16;IGF1;MALT1;TLR4;APP;CX3CL1;PANX1;LGALS9;TRIM16;GIT1;EGR1;ZC3H12A;HSPB1;JAK2;P2RX7;TMEM106A
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.517856375181319,1.0737762599909328,0.38114209827357237,1.0,1.0,4/18,10.44%,STMN1;CUL3;RIPOR2;ARHGAP35
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.45006549574805066,1.0736360563580731,0.297,1.0,1.0,93/476,14.35%,BRCA1;ATAD2;MYBL1;PBX4;GLI2;CDK5RAP2;GLI3;HMGB2;E2F1;BRCA2;FOXE1;ATOH8;HAS3;ILF3;NAT14;PSRC1;DYRK1A;SMARCC1;SP3;PHIP;ELF2;TEAD1;CTCF;HNRNPD;NFE2;MED14;CHEK2;NFIL3;BLM;ELF4;NFIB;THRAP3;TBL1XR1;SETD3;NUP85;PCBD2;YAF2;MED30;ELF1;PML;TCF4;ARID1A;TASP1;ELK1;FOXO3;ATF7IP;CD80;TRIM28;IRF1;CREB5;MED24;SMARCA4;USP21;USP16;ZFP90;DNM2;YAP1;NFYA;VHL;PICALM;EPC1;AGT;KMT2A;PARP9;TGFBR1;TAL1;MMS19;CRLF3;TAF15;QRICH1;HDAC1;BMP2;AHR;NKX2-1;FBXW11;SOX9;SMAD4;HDAC2;ATF5;IL31RA;ZNF496;ILF2;BRD4;RAI1;LRP5;RORA;HEY2;MED1;BTRC;RLF;FOXK2;FOXM1;SMAD3
prerank,regulation of feeding behavior (GO:0060259),-0.4192533148781267,-1.0735331880794041,0.3898305084745763,0.711605940644972,1.0,3/11,5.06%,SGIP1;STAT3;CFAP20
prerank,response to estradiol (GO:0032355),-0.3073698488712932,-1.071909304858166,0.32558139534883723,0.714490165467334,1.0,7/31,11.74%,STAT3;SOCS2;CCDC62;STRN3;GGT5;ESR1;CTNNB1
prerank,purine nucleotide biosynthetic process (GO:0006164),0.5568104554199877,1.071719943122909,0.4094151212553495,1.0,1.0,7/12,19.11%,ADA;HPRT1;PRPS1L1;PRPS1;ADSL;GART;PPAT
prerank,mitochondrion disassembly (GO:0061726),-0.30334285108910114,-1.0716035882232287,0.3115942028985507,0.7141448796481434,1.0,14/34,19.95%,PRKN;FIS1;WDR45B;BECN1;SQSTM1;ULK1;BNIP3;PINK1;ATG9A;USP30;ATG2B;FBXO7;FUNDC1;GABARAPL2
prerank,transition metal ion transport (GO:0000041),-0.30299501186323397,-1.0713841607831398,0.3381294964028777,0.7134651775602827,1.0,11/35,21.97%,FTH1;TRPC5;TRPC3;TRPC1;IREB2;SLC31A2;SLC30A1;ATOX1;CUTC;COX17;ATP7A
prerank,positive regulation of heart contraction (GO:0045823),-0.3637404322533561,-1.0713719302953493,0.35874439461883406,0.7123565687808351,1.0,11/19,32.54%,RYR2;TGFB2;ATP1A2;ADRA1A;GSK3A;KCNQ1;EDN1;ADM;EDN3;CHGA;SCN3B
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.41879664574947734,-1.071319135139328,0.3709677419354839,0.7113365024302899,1.0,2/12,8.37%,STAT3;ESR1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.4608371050633055,1.0712108816444983,0.41201264488935724,1.0,1.0,22/74,17.87%,EZH2;LOXL2;USF3;PDPN;EFNA1;SFRP2;WWTR1;AXIN2;TGFBR1;BMP2;NKX2-1;SMAD4;ADIPOR1;TWIST1;SPRED1;SMAD3;SFRP1;SPRED2;PTEN;EPHA3;SMAD2;CLASP1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.4467383855018111,1.0710232229451377,0.156,1.0,1.0,336/1668,15.88%,BRCA1;CKAP2;E2F7;CCNB1;NR2E3;E2F8;UHRF1;CDK1;MXD3;ATAD2;EZH2;BRIP1;EN1;PLK1;E2F2;ATRX;AURKB;MYBL1;PBX4;GLI2;TCFL5;GLI3;RBL1;LCORL;HMGB2;E2F1;CBX5;FOXE1;ATOH8;ZBTB8A;MED26;ATP2B4;KMT5A;FADD;PPM1D;LOXL2;TRIM37;ZFP69;BRD9;CBFB;SMARCC1;ZNF32;RB1;PBX3;BAZ1B;SP3;SETX;BMPR1A;HOXC5;DEK;MOV10;PHIP;ZFP41;ETV6;TWIST2;FNIP1;ELF2;MIER1;ACTR3;TRAK1;TEAD1;WWOX;SP2;ZSCAN29;RAD21;RBBP8;HDGF;AGO2;CTCF;E2F3;FGFR2;SENP1;ZEB1;JAZF1;TFDP1;BCL2L12;NFE2;TFCP2L1;CNOT1;GALR1;DDRGK1;MED14;EED;AUTS2;BCOR;RFXAP;MDM4;TAF3;ZNF260;RGMA;NFIA;HIVEP1;KIT;CUX1;PCGF5;SSBP3;DHX9;WIZ;FHL2;PRKDC;ZFP62;BHLHE41;NFIL3;KLF5;SRF;TCF7L1;CTBP1;EPC2;TSHZ1;ELF4;ASXL1;NFIB;THRAP3;KLF13;ZNF568;ZNF697;TBL1XR1;SP8;LPIN2;IKZF1;MCPH1;MLLT10;SETD3;BMP6;GZF1;LCOR;HOXC4;TCF7L2;PSIP1;MED30;SOX6;ELF1;IL18;ORC2;HOXA7;GMEB1;TPR;GRHL2;AKNA;ARRB1;ELOC;GATAD2A;TCF4;MIDEAS;ARID1A;EFNA1;MYBL2;GLIS3;RFX2;RIF1;SFRP2;ELK1;NUCKS1;CCN1;PPP3CA;FUS;NIPBL;POU2F1;ZBTB2;PROX2;POU3F2;MXD1;MAMSTR;FHL5;SIM1;ZBTB7B;WWTR1;SRCAP;ZFX;PHF2;LIN9;SERPINE1;ZHX2;PRRX2;OLIG2;FOXO3;SAP18;TRIM28;LMX1B;KDM2B;LIN37;PLAGL2;SMAD6;ZNF23;RCOR1;PELP1;IRF1;ZFP64;HMGB3;BCLAF1;CREB5;MED24;RHOQ;SMARCA4;USP16;ZFP90;KLF11;NCK1;MIER3;KANK2;ZBTB25;HOXB3;YAP1;NFYA;VHL;ARID4A;PLAGL1;ZIC5;MED15;ZBTB20;UXT;EPC1;HMGB1;IKBKG;KMT2A;HOXB6;HDAC8;MEOX2;MTA3;NR4A2;CARF;MYPOP;NR3C1;CXXC5;PARP9;SFPQ;HNRNPU;TAL1;TADA1;CRLF3;TEAD3;ZBTB24;KCNIP3;NCOA2;SMURF2;PRKCB;ZNF585B;ZNF585A;CHD2;HDAC1;BMP2;AHR;EZR;NKX2-1;KLF9;HTATSF1;TBX18;MRTFA;NFATC2IP;ZHX3;ATXN1;AKIRIN2;NCK2;SLC30A9;RBPJ;NR4A1;ZIC4;KMT2D;SOX9;SMAD4;HDAC2;ZNF394;RPRD1A;SAP130;ATF5;ZNF496;BRD4;TCF20;ELK4;RAI1;LRP5;RORA;IL4I1;NCOA7;TADA2A;IRF2BP1;PPID;TWIST1;MAML1;HEY2;USP9X;PPRC1;ACTL6B;PRKD1;MED1;DLG1;ARF4;FOXL1;RARB;POU2F2;YY1;ZMYM5;RLF;FOXK2;CAMTA1;PCGF6;DNMT3A;RUVBL2;FOXM1;SMAD3;ARNT;FOXP4;ZFP91;CDK8;JMJD1C;BAZ1A;SOX1;E2F4;PER1;YEATS2;RBAK;ZNF445;PIN1;MED27;OTUD7B;INO80;DR1;HDGFL3;GDNF;ATF1;KAT6A;DCAF1;TNRC6C;ZNF507;HOXB7;PRKD2;PKD2;CSRP3;CHD1;ZNF112;NFKB1;ZBTB7C;PPIL4;TP53;FHOD1;PKNOX2
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.28084826241684263,-1.0709597149457757,0.3627450980392157,0.7110012209386106,1.0,12/45,13.70%,CAMK2D;TRIM25;MID1;VCAM1;TRIM8;B2M;IRF2;CAMK2G;IFNGR2;IRF3;IRF9;IFNGR1
prerank,embryonic limb morphogenesis (GO:0030326),0.4822691663481324,1.0698154696960427,0.39044289044289043,1.0,1.0,14/34,20.40%,GLI3;CYP26B1;AFF3;MAP3K20;NIPBL;WDPCP;CACNA1C;HDAC1;HDAC2;TWIST1;SALL1;OSR1;SKI;FBXW4
prerank,positive regulation of mitochondrial fission (GO:0090141),0.5022647282683882,1.0696586091734828,0.3678474114441417,1.0,1.0,5/18,10.36%,MIEF2;AURKA;MCU;DDHD1;MIEF1
prerank,lymphocyte proliferation (GO:0046651),0.4991315493398113,1.0692313606141355,0.4064935064935065,1.0,1.0,5/22,16.28%,HELLS;ELF4;CTPS1;LMBR1L;MSN
prerank,positive regulation of dendrite extension (GO:1903861),-0.3638446635862796,-1.0687260267448133,0.3467741935483871,0.7154491156964898,1.0,3/17,3.34%,RIMS1;ITSN2;SYT1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.440193361557341,-1.068674221409058,0.3753943217665615,0.7144208128762588,1.0,2/10,0.68%,DLGAP1;DLGAP4
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.3015307504606648,-1.0686160429572846,0.3496932515337423,0.7134230292684228,1.0,10/33,13.35%,EP300;SAFB2;UFL1;AR;UBA5;PRMT2;KDM4C;ESR1;DDX5;KCTD6
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.5417835786386769,1.0679608611377758,0.39854014598540144,1.0,1.0,5/12,10.72%,ROCK2;PRNP;ROCK1;PICALM;FLOT2
prerank,histone H3 deacetylation (GO:0070932),0.5347749651590601,1.0679237955792387,0.4096551724137931,1.0,1.0,7/15,14.81%,SMARCAD1;HDAC8;SFPQ;HDAC1;HDAC2;ELK4;PER1
prerank,negative regulation of microtubule polymerization (GO:0031115),0.5334842516502337,1.0669744396522802,0.41414141414141414,1.0,1.0,2/12,2.25%,STMN1;DYRK1A
prerank,negative regulation of programmed cell death (GO:0043069),0.44617173955800676,1.0669091237245771,0.342,1.0,1.0,61/355,16.35%,KIF14;STIL;CDK1;PLK1;BIRC5;BARD1;FIGNL1;AQP1;MAP4K4;SETX;PHIP;ARHGAP10;ANGPT4;GSK3B;FXN;DDRGK1;AIFM2;FHL2;PRKDC;MRE11;SIAH2;PDPN;ANXA5;ARL6IP1;SMAD6;GRK5;SH3RF1;KANK2;MGMT;ANGPT1;VHL;PIM1;APIP;ERC1;HDAC1;ANXA1;SOX9;HDAC2;NOTCH2;ATF5;IL31RA;ITCH;TXNDC5;PLAUR;CTSH;MED1;PRKCI;USP47;ARF4;PLK2;XIAP;CD44;BIRC6;SRC;GDNF;TNFAIP8;NFKB1;TP53;SFRP1;ANKLE2;HIPK3
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.36254064025951205,-1.0668086950043731,0.3680297397769517,0.716714475907339,1.0,6/17,19.33%,VTN;IGF1;PDGFRB;S100A11;CCN4;NRP1
prerank,RNA transport (GO:0050658),0.46291352894400195,1.0663122532297729,0.4093816631130064,1.0,1.0,18/71,16.56%,CKAP5;NUP155;SRSF4;HNRNPA1;EIF4E;UPF3B;SLBP;TPR;DDX39B;FMR1;SRSF7;SRSF3;SRRM1;NUP214;SIDT1;HNRNPA2B1;PNPT1;DHX38
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.4471228591256454,1.0662330774898834,0.343,1.0,1.0,72/327,16.25%,PHF19;EZH2;ATRX;MYBL1;NSD2;TCFL5;E2F1;BRCA2;RB1;SP3;LIN54;HNRNPD;NLK;AJUBA;CHEK2;ACTN4;NFIA;NFIL3;TCF7L1;SRSF10;CCAR1;GZF1;YAF2;SOX6;HP1BP3;GON4L;PML;PSPC1;MYBL2;POLR2A;FUS;MYCBP;WWTR1;PHF1;PRRX2;LMX1B;BNC2;MSL3;LIMD1;DNM2;NONO;NFYA;VHL;ZNHIT3;ERC1;NR3C1;HINT1;SFPQ;TGFBR1;SLC39A8;POFUT1;NCOA2;BMP2;AHR;ATXN1;SPTY2D1;KMT2D;ATF5;RORA;GPBP1L1;FOXK2;JMJD1C;SOX1;RBAK;PRDM8;EFEMP1;TRRAP;MLF2;HOXB7;TP53;DRAP1;RALY
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.5408009708373167,1.0658180719483064,0.3944954128440367,1.0,1.0,4/11,14.30%,FRS2;SOX6;BMP2;EFNB2
prerank,anterior/posterior axis specification (GO:0009948),-0.3894681492709193,-1.0655727381590636,0.4014084507042254,0.7185455118663615,1.0,3/15,16.63%,TASOR;TBX3;DDIT3
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.5552992360003037,1.0654731005317017,0.42441860465116277,1.0,1.0,5/11,9.38%,AJUBA;DHX9;FMR1;LIMD1;PUM2
prerank,cilium movement (GO:0003341),0.46577661072615156,1.0648090950596105,0.40451977401129946,1.0,1.0,7/47,10.88%,DNAH11;CFAP53;SPEF1;DNAH1;DNAI4;RSPH9;DNAAF5
prerank,cellular response to organic cyclic compound (GO:0071407),0.4492411090376506,1.0645377283925566,0.39959636730575177,1.0,1.0,30/141,16.28%,BRCA1;RAD51;AQP1;ROCK2;CASP7;ABCB4;DIAPH1;BLM;LCOR;CTNNA1;SPIDR;IL18;LARP1;LRRK2;RIOK3;P2RY1;NR3C1;TRPM2;AHR;EZR;AKAP9;DMTN;RORA;MED1;RUVBL2;RAMP3;ADCY6;PKD2;SFRP1;MSN
prerank,reverse cholesterol transport (GO:0043691),-0.40619190665556915,-1.0644538556634329,0.3885135135135135,0.7202785629528051,1.0,2/13,6.91%,APOE;ABCA5
prerank,positive regulation of cellular component movement (GO:0051272),0.504116391624038,1.0644281762324226,0.4107365792759051,1.0,1.0,8/24,14.70%,CCDC25;ACTN4;NTN1;PDPN;TGFBR1;ADAM17;TWIST1;STK11
prerank,regulation of kinase activity (GO:0043549),0.45774952295388627,1.0641740515564289,0.4020618556701031,1.0,1.0,11/89,7.61%,ECT2;RBL1;RB1;FGFR4;FGFR2;KIT;MRE11;MAPT;MUSK;PDGFRA;EPHA4
prerank,chondrocyte differentiation (GO:0002062),0.4839454550980267,1.064145220749903,0.40588235294117647,1.0,1.0,13/32,20.06%,SULF2;WNT2B;NFIB;SOX6;SULF1;EIF2AK3;CCN3;BMP2;SOX9;SNX19;RUNX1;OSR1;CREB3L2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.5107367217816322,1.0636029293893887,0.3962516733601071,1.0,1.0,6/20,15.58%,PPIL1;FKBP5;PPIG;PPID;PIN1;PPWD1
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.3637581200734021,-1.0632996800837171,0.35271317829457366,0.7221035602892328,1.0,11/17,25.82%,ATP5PF;ATP5F1A;ATP5PO;ATP5MF;ATP5MC3;ATP5PD;ATP5F1B;ATP5F1D;ATP5F1E;ATP5MG;ATP5ME
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.5288964118386814,1.0628155486576878,0.3979739507959479,1.0,1.0,5/13,12.34%,BMPR1A;FGFR2;TGFBR3;PIM1;RBPJ
prerank,regulation of transport (GO:0051049),-0.3107687705010153,-1.0626132725813011,0.35135135135135137,0.7226823972379027,1.0,14/36,25.72%,PRKN;MYO6;EPB41;ACTB;ICA1;DNAJA1;WWC1;PINK1;RAB11A;NRP1;GAPVD1;MBTPS1;ARL6IP5;POFUT2
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.4309283951383056,-1.062377332215019,0.3580645161290323,0.7221100169029487,1.0,1/10,0.01%,PRKG1
prerank,dorsal/ventral pattern formation (GO:0009953),0.5112186646429295,1.0619387683388504,0.3868421052631579,1.0,1.0,5/20,11.96%,GLI2;BMPR1A;LMX1B;DSCAML1;AIDA
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.4461221871699117,1.0618471817924298,0.39036885245901637,1.0,1.0,17/101,15.61%,EZH2;INCENP;SPDYA;ATP2B4;PSRC1;RHOA;KIT;ETAA1;LRRK2;ROBO1;CALM2;ADAM17;ADRB2;CAB39;RPTOR;SRC;PKD2
prerank,protein K63-linked ubiquitination (GO:0070534),0.46817292259295684,1.0617279517489262,0.40935005701254273,1.0,1.0,6/41,7.17%,UBE2T;UBE2S;RNF168;NEDD4;UBE2N;PRPF19
prerank,regulation of complement activation (GO:0030449),-0.29695404189221336,-1.0614766069070396,0.3482142857142857,0.7230641551716948,1.0,17/40,39.05%,VTN;CD81;C4B;C1QB;C2;CR1L;C1QC;C1QA;CFHR2;PHB2;CR2;C1QBP;SERPING1;C3;C3AR1;C6;C7
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.3532005542869938,-1.0611034019513157,0.37549407114624506,0.7229260015222386,1.0,7/20,17.19%,OGT;ASAH1;CYLD;STUB1;NUPR1;SDCBP;BIRC3
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.41173787092086517,-1.061049734733005,0.40559440559440557,0.7219343352916524,1.0,8/13,29.59%,NR1H3;NUPR1;NR1H2;AQP11;MANF;WFS1;USP19;MBTPS2
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.48707196597785013,1.0607965221355045,0.41075794621026895,1.0,1.0,8/29,13.81%,RAB33B;COG1;GOLGA5;COPB2;COPZ1;VTI1A;GOSR1;TRAPPC10
prerank,negative regulation of MAPK cascade (GO:0043409),-0.23257846785387742,-1.0605771083706022,0.25925925925925924,0.7219324466811853,1.0,35/87,29.74%,FOXO1;SEMA6A;TIMP3;CAV1;APOE;TLR4;WNK2;EPHB2;IGBP1;DUSP3;LYN;STK38;NF1;INPP5K;LMO3;SYNJ2BP;SPRY2;DUSP1;ITGB1BP1;SORL1;PPEF2;TNIP1;UCHL1;PIK3R2;RPS6KA6;CDK5RAP3;BMP7;CD300A;P2RX7;GPER1;DAG1;IRAK3;DUSP6;PTPRC;SPRY4
prerank,response to laminar fluid shear stress (GO:0034616),-0.4468629840503542,-1.0596005125835615,0.40683229813664595,0.723186053506678,1.0,5/10,11.66%,SMAD7;MAP2K5;KLF4;SREBF2;KLF2
prerank,histone mRNA catabolic process (GO:0071044),0.5287669524375136,1.0594404465753544,0.40860215053763443,1.0,1.0,5/15,13.47%,TENT2;ERI1;TUT1;TUT7;TUT4
prerank,cell-substrate junction assembly (GO:0007044),-0.2971036634965305,-1.059116006774181,0.3741496598639456,0.723318522729882,1.0,12/33,20.27%,ITGA6;THSD1;TAOK2;BCR;LAMA3;ITGB4;PIP5K1A;ARHGEF7;ACTN1;CD151;PLEC;SORBS1
prerank,protein deubiquitination (GO:0016579),0.4442439652872384,1.0588025257692504,0.3777555110220441,1.0,1.0,60/242,19.03%,BRCA1;CDK1;CLSPN;BARD1;CDC20;USP1;RHOA;PSMC2;PSMD5;MDM4;USP18;CCNA2;TAB1;ASXL1;SIAH2;RHOT1;CCNA1;USP37;STAM;UIMC1;PSMB1;PSMD14;USP21;USP16;PSMD1;SKP2;IKBKG;CDC25A;TGFBR1;PSMB9;USP28;SMURF2;ADRM1;SMAD4;ADRB2;USP9X;USP47;YY1;FOXK2;BRCC3;SMAD3;OTUD1;PSMC6;OTUD7B;INO80;TRRAP;TP53;TAF10;PTEN;RAD23B;USP48;PSMB2;WDR20;SMAD2;USP14;PSME4;PSMB7;RIPK1;USP46;USP20
prerank,heart development (GO:0007507),-0.2281133324324118,-1.0582892275922122,0.2,0.7241177241012704,1.0,43/150,18.28%,PTK2;ACVR1;TEK;ECE1;TCF25;MEF2C;ADAP2;TGFBR2;PCSK5;INSR;TAB2;FKBP1A;BMPR2;ACVRL1;TGFB2;RBM20;NTRK3;POU6F1;FOXC2;MTHFD1;FOXC1;RAMP2;ERBB4;NF1;PDLIM2;MEF2A;MEGF8;PDLIM7;SOX4;KAT2B;CACYBP;TBX1;PTPN11;VEGFA;HDAC9;SOX17;STRA6;PLCE1;CRELD1;NDRG4;CITED2;TBX2;PDLIM1
prerank,ion homeostasis (GO:0050801),0.4788187784671907,1.0578360905781692,0.42574257425742573,1.0,1.0,4/30,8.21%,RHAG;RANGRF;WNK1;SLC4A2
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.45942527802580113,1.0572600634910934,0.41721132897603486,1.0,1.0,1/55,0.19%,BRCA1
prerank,regulation of amyloid fibril formation (GO:1905906),-0.3724177037785635,-1.0571035990061892,0.36996336996337,0.7259029321668417,1.0,6/15,13.22%,PSEN1;APOE;CHRNA7;APP;CRYAB;PFDN5
prerank,positive regulation of proteolysis (GO:0045862),0.4523565551326718,1.0570883356057135,0.4067982456140351,1.0,1.0,12/55,13.78%,PLK1;FADD;FGFR4;SH3D19;SNX33;FBXW11;HDAC2;CASP8;ATP5IF1;CTSH;BTRC;ADAM9
prerank,leukocyte tethering or rolling (GO:0050901),0.5030702896855971,1.0569531750581072,0.40902872777017785,1.0,1.0,6/17,18.78%,ITGB7;ADD2;PODXL2;ROCK1;ITGB1;GCNT1
prerank,actomyosin structure organization (GO:0031032),0.4505592962192314,1.0568898839324343,0.42275574112734865,1.0,1.0,20/75,16.50%,CIT;ROCK2;RHOA;MYLK3;CSRP2;MYH10;ARRB1;EPB41L2;CDC42BPA;PHACTR1;CUL3;ROCK1;CDC42BPG;EPB41L3;TMOD3;ITGB1;FRMD6;SRC;CSRP3;TNNT3
prerank,positive regulation of establishment of protein localization (GO:1904951),0.5086110483821707,1.0567584555989604,0.39572192513368987,1.0,1.0,1/18,0.97%,CEP295
prerank,apoptotic cell clearance (GO:0043277),0.47768058113890177,1.0558753864652994,0.401219512195122,1.0,1.0,6/30,15.02%,XKR5;HMGB1;ANXA1;RAC1;TXNDC5;ITGAV
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.3902924668136624,-1.0555546377177383,0.38661710037174724,0.7284700190853686,1.0,2/15,4.12%,SMAD7;TGFB2
prerank,post-translational protein modification (GO:0043687),0.4424233512375926,1.055342713321151,0.36936936936936937,1.0,1.0,45/332,12.63%,DTL;ESCO2;CCNF;MATN3;DSCC1;F5;FEM1C;ASB15;PSMC2;PSMD5;FBN1;OBSL1;LAMB1;FBXL7;SPSB3;SPSB2;RBBP7;ELOC;FBXW7;FBXO30;CUL5;CCN1;FBXL8;QSOX1;KLHL5;PSMB1;FN3K;SUMF2;CUL3;PSMD14;KLHL22;VHL;CUL4B;PSMD1;SKP2;DCAF10;RAB1A;WSB2;PSMB9;STT3A;APLP2;CHM;FBXW11;STT3B;DCAF7
prerank,stress granule assembly (GO:0034063),-0.34393395468675436,-1.0553058724447395,0.38967136150234744,0.7278975394992513,1.0,5/20,8.25%,DDX6;RPS23;UBAP2L;BICD1;CSDE1
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.34301320015440817,-1.0553021556183824,0.37073170731707317,0.7267725678355976,1.0,5/22,17.16%,APOD;PRKAA1;ASXL3;CCDC3;ADRA2A
prerank,regulation of cytoskeleton organization (GO:0051493),0.4491123438807839,1.0552287418175181,0.42594484167517876,1.0,1.0,22/108,12.68%,IQGAP3;IQGAP2;ROCK2;RHOA;GSK3B;SPEF1;DIAPH1;ARHGAP18;MAPT;BICD2;SORBS3;RHOQ;TPPP;ROCK1;MARK2;ARHGAP35;PLXNB1;RND2;EZR;RAC1;DMTN;CLIC4
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5343063873858915,1.0551543694736547,0.4115983026874116,1.0,1.0,4/13,19.14%,SRF;NFIB;SOX9;NFATC3
prerank,establishment of endothelial barrier (GO:0061028),-0.29500126746847455,-1.054989157404778,0.37333333333333335,0.7264401579876995,1.0,11/29,20.76%,PPP1R16B;PECAM1;RAP1A;F11R;TJP1;RAP2C;PDE2A;PDE4D;RAB1B;ROBO4;RAPGEF3
prerank,regulation of cellular senescence (GO:2000772),0.480391453414651,1.0544693788560404,0.42117930204572807,1.0,1.0,9/28,19.63%,RBL1;FBXO5;MAP3K3;TERF2;TWIST1;SLC30A10;PNPT1;YPEL3;TERT
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.46127838499508006,1.054423108934066,0.4247191011235955,1.0,1.0,16/44,20.67%,AQP1;CDKN2D;FNIP1;SIAH2;ARL6IP1;SH3RF1;CAST;USP47;XIAP;CD44;SRC;NGF;LAMTOR5;DPEP1;DNAJB6;SNCA
prerank,activin receptor signaling pathway (GO:0032924),-0.37848870676994406,-1.0542212209709259,0.37209302325581395,0.7272482545741636,1.0,3/15,8.29%,ACVR1;ACVR2A;ACVR2B
prerank,mitochondrial fission (GO:0000266),-0.3638519701498443,-1.0540149949771345,0.4122137404580153,0.7266046509622577,1.0,4/16,7.00%,DNM3;PRKN;FIS1;DNM1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.5082137365704817,1.053970585029289,0.41701534170153415,1.0,1.0,1/17,0.52%,DLGAP5
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.46985142528080337,1.0538052636355681,0.4052757793764988,1.0,1.0,10/31,16.28%,RHOA;PARD3B;RAP2A;ANK1;SCRIB;MARK2;EZR;PRKCI;DLG1;MSN
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.361461216386006,-1.0535961099070823,0.37453183520599254,0.7264453557129259,1.0,5/17,16.67%,CAV1;KLF7;MAFG;CEBPB;AJAP1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4774811124048327,1.0535121795174247,0.4107981220657277,1.0,1.0,9/34,14.35%,E2F1;ASXL1;ANKRD26;WWTR1;YAP1;RUNX1T1;ENPP1;RORA;SMAD3
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.4608041141477808,1.0534217603848715,0.4232081911262799,1.0,1.0,22/42,23.92%,SMARCC1;SMARCAD1;RBBP4;ARID1A;SRCAP;SMARCA4;ANP32E;HDAC1;NASP;SPTY2D1;HDAC2;ACTL6B;INO80;MBD3;MBD2;ZNHIT1;ARID1B;CHD4;ACTL6A;SMARCC2;CECR2;SMARCB1
prerank,sphingosine metabolic process (GO:0006670),-0.35627838784461824,-1.0527453698800662,0.35507246376811596,0.7274339193197829,1.0,7/17,23.85%,ACER2;PLPP3;ASAH1;ACER3;ASAH2;ABCA2;SPHK1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.4235087282301415,-1.052407958694333,0.39344262295081966,0.7270977939482678,1.0,1/11,0.28%,STAT3
prerank,regulation of dendrite extension (GO:1903859),-0.3612463553874645,-1.0522983607939482,0.3662551440329218,0.7262983429290379,1.0,3/18,3.34%,RIMS1;ITSN2;SYT1
prerank,synapse organization (GO:0050808),-0.2280855812895876,-1.0520808965951345,0.37037037037037035,0.7257082822966736,1.0,17/125,4.75%,DNM3;UNC13B;CTNND2;PTPRD;PSEN1;CDH2;SLC8A3;DNER;SLC6A1;SHANK3;ARHGAP39;PAK3;SPOCK2;ADGRL3;NRCAM;AGRN;SDK2
prerank,protein modification by small protein removal (GO:0070646),0.4429138248446635,1.0520173762486658,0.3913913913913914,1.0,1.0,62/252,19.03%,BRCA1;CDK1;CLSPN;BARD1;CDC20;USP1;RHOA;PSMC2;SENP1;PSMD5;MDM4;USP18;CCNA2;TAB1;ASXL1;SIAH2;RHOT1;CCNA1;USP37;STAM;UIMC1;PSMB1;PSMD14;USP21;USP16;PSMD1;SKP2;IKBKG;CDC25A;TGFBR1;PSMB9;USP28;SMURF2;ADRM1;SMAD4;COPS3;ADRB2;USP9X;USP47;YY1;FOXK2;BRCC3;SMAD3;OTUD1;PSMC6;OTUD7B;INO80;TRRAP;TP53;TAF10;PTEN;RAD23B;USP48;PSMB2;WDR20;SMAD2;USP14;PSME4;PSMB7;RIPK1;USP46;USP20
prerank,macromolecule catabolic process (GO:0009057),-0.3153913619594356,-1.0518941383018787,0.4052631578947368,0.7250703351930308,1.0,8/26,10.95%,KIF16B;CLPX;BECN1;PIK3R4;LGMN;TPP1;SIAH1;MTOR
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.5424113255745066,1.051848112095896,0.42428571428571427,1.0,1.0,5/11,18.44%,DCK;ENPP3;ERH;SLC19A2;SLC25A19
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.38634313613892896,-1.051427541025345,0.3883495145631068,0.7251185412027356,1.0,5/15,13.87%,GRM7;GRM3;HOMER1;GRM5;GRM1
prerank,regulation of protein localization to membrane (GO:1905475),-0.31680590531301406,-1.051086380916386,0.3672316384180791,0.7249241051376902,1.0,10/28,16.13%,PRKN;STX8;ACTB;STX7;AR;SPTBN1;GSN;LDLRAP1;ZDHHC7;VAMP8
prerank,heme biosynthetic process (GO:0006783),0.49526491001919787,1.050747511155379,0.4102244389027431,1.0,1.0,7/22,16.88%,HMBS;FXN;COX10;ABCB10;CPOX;ATP5IF1;ALAS2
prerank,lipid modification (GO:0030258),-0.28417153668861855,-1.0506113334728586,0.34328358208955223,0.7250166465390707,1.0,11/37,21.13%,PLPPR1;DGKB;PLPP3;DGKG;DGKI;DGKQ;PLA2G7;EPHX2;PLPP4;DGKD;PLPPR4
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5025011953554844,1.0497244341426555,0.42207792207792205,1.0,1.0,6/19,13.69%,PARD3B;SCRIB;MARK2;CLIC4;PRKCI;DLG1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.3261037679894526,-1.049037199674829,0.3669724770642202,0.7278878084275154,1.0,10/22,23.09%,OS9;RNF103;EDEM2;EDEM1;MAN1A2;SYVN1;UBB;UBC;RPS27A;SEL1L
prerank,cellular response to arsenic-containing substance (GO:0071243),0.5226021503982724,1.048238261756343,0.42916093535075656,1.0,1.0,3/15,9.15%,GSTO2;HNRNPA1;CPEB2
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.38132173456071267,-1.047590875334904,0.3543046357615894,0.7304361777563758,1.0,4/14,26.61%,PTGS2;OSMR;PARK7;PTGER3
prerank,positive regulation of DNA binding (GO:0043388),0.47451293494603736,1.0471042239692807,0.4226190476190476,1.0,1.0,11/31,20.28%,HMGB2;RB1;TXN;HMGB1;TRIM6;PLAUR;TWIST1;NGF;NIBAN2;SKI;TRAF6
prerank,response to organophosphorus (GO:0046683),0.5137073551457656,1.0466320192111358,0.42,1.0,1.0,2/16,6.49%,TYMS;RFC3
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.4067562305037714,-1.0463432784332591,0.4115755627009646,0.7324973587112026,1.0,4/12,24.76%,SCP2;ACSL1;ELOVL1;FADS1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.49705831278452045,1.0461626256948506,0.41578947368421054,1.0,1.0,6/19,12.34%,BMPR1A;FGFR2;TGFBR3;PIM1;TGFBR1;RBPJ
prerank,receptor internalization (GO:0031623),-0.28221014682858986,-1.0460068495729042,0.34513274336283184,0.7322466366914002,1.0,13/44,13.87%,DNM3;CALCRL;CAV1;LRP1;ACKR3;RAMP1;DNM1;RAMP2;RAB5A;CD81;AP2M1;GRB2;LDLRAP1
prerank,regulation of neuron differentiation (GO:0045664),0.4477767058012874,1.0459328056893789,0.4309799789251844,1.0,1.0,7/76,9.40%,ECT2;CDK5RAP2;RHOA;ZEB1;TCF4;LRRK2;ROCK1
prerank,sterol transport (GO:0015918),-0.3499371017371509,-1.0459229963307255,0.3938053097345133,0.7313791442712042,1.0,6/19,23.35%,CAV1;ARV1;LDLRAP1;OSBP;OSBPL2;NPC2
prerank,response to X-ray (GO:0010165),0.5261970003431292,1.0458327194898787,0.42510699001426533,1.0,1.0,5/14,14.16%,BLM;NUCKS1;NIPBL;ANXA1;BRCC3
prerank,positive regulation of angiogenesis (GO:0045766),0.4421926571527449,1.0456882166106287,0.434560327198364,1.0,1.0,21/108,14.28%,BRCA1;VASH2;AQP1;ANGPT4;HYAL1;AGO2;ADAM12;ANXA3;SFRP2;HSPB6;SERPINE1;GAB1;PRKCB;RRAS;PRKCA;PDPK1;CTSH;TWIST1;PRKD1;ITGA5;ITGB1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.3629531975578456,-1.0456449223211566,0.38461538461538464,0.7309760748424763,1.0,11/17,39.20%,TEK;NTRK3;ABL1;BAIAP2;NRP1;FES;BCAS3;HRAS;NTF3;HCK;HCLS1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.33805629936397485,-1.0456283337055232,0.35269709543568467,0.7299147629722014,1.0,6/22,9.73%,WDFY1;IFI35;LYN;LBP;PTPN22;NR1H3
prerank,response to prostaglandin E (GO:0034695),0.5429104452137535,1.0453469585807895,0.4227405247813411,1.0,1.0,4/10,22.05%,TGFBR3;ADCY6;SFRP1;GNB1
prerank,phosphorylation (GO:0016310),0.4408261776566423,1.0451090210185614,0.38,1.0,1.0,85/384,15.62%,NEK2;MELK;CDK1;PLK1;BIRC5;AURKB;NEK3;PLK4;MATK;HUNK;HASPIN;MAST2;ILF3;MAP4K4;DYRK1A;STK17B;BMPR1A;CDK14;AURKA;ROCK2;MAP4K2;GSK3B;STK10;NLK;CHEK2;MYLK3;PRKDC;CTBP1;DYRK3;VRK2;STK24;STK3;NRK;MAP3K1;CCNE1;WNK1;MAP3K20;CDC25B;CHEK1;CDC42BPA;CDK2;LRRK2;GRK5;LIMD1;ROCK1;PIM1;MARK2;PXK;PIK3CB;CDC42BPG;TGFBR1;SRPK1;EIF2AK3;LMTK3;PRKCB;BMP2;DGKE;PRKCA;PDPK1;GRK3;AAK1;CSNK1G2;SIK2;MEX3B;STRADA;BTK;CDK19;AGK;PRKCE;MAML1;PRKD1;PANK2;PRKCI;PLK2;NRBP1;MORC3;VRK1;CDK8;BIRC6;STK11;TAOK1;PRKAG1;PRKD2;STK39;PASK
prerank,glycerophospholipid metabolic process (GO:0006650),-0.24626812610223156,-1.0445922031822197,0.43902439024390244,0.731300170942621,1.0,26/75,19.47%,GPCPD1;PLA2G4A;PDGFRB;ABHD6;ABHD12;PNPLA6;PLA1A;PLEK;PLCB3;PLCG1;ENPP6;GPLD1;PIGV;SERINC1;GDPD3;PIGX;PIP5K1A;PIGQ;GDPD1;PIGB;PIGP;PLA2G7;SYNJ1;HDHD5;ACP6;PIGF
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.4360015384425342,1.0439143643838367,0.326,1.0,1.0,163/834,15.86%,BRCA1;CKAP2;E2F7;NR2E3;E2F8;UHRF1;ATAD2;DLGAP5;E2F2;ATRX;MYBL1;GLI2;GLI3;RBL1;HMGB2;E2F1;ATOH8;FADD;PAXIP1;SP3;SETX;BMPR1A;PHIP;ACTR3;TEAD1;WWOX;AGO2;E2F3;FGFR2;SENP1;TFDP1;BCL2L12;GALR1;DDRGK1;MED14;AUTS2;RFXAP;RGMA;NFIA;HIVEP1;PCGF5;SSBP3;DHX9;PRKDC;KLF5;SRF;ELF4;ASXL1;NFIB;THRAP3;TBL1XR1;LPIN2;MLLT10;SETD3;BMP6;HOXC4;TCF7L2;MED30;ELF1;IL18;HOXA7;GRHL2;AKNA;ARRB1;TCF4;MYBL2;GLIS3;SFRP2;ELK1;CCN1;PPP3CA;POU2F1;POU3F2;FHL5;WWTR1;SERPINE1;FOXO3;LMX1B;PELP1;IRF1;ZFP64;BCLAF1;MED24;RHOQ;SMARCA4;USP16;NCK1;LEO1;HOXB3;YAP1;PLAGL1;EPC1;HMGB1;IKBKG;KMT2A;HDAC8;MEOX2;NR4A2;NR3C1;SFPQ;HNRNPU;TAL1;CRLF3;NCOA2;HDAC1;BMP2;AHR;NKX2-1;MRTFA;NFATC2IP;AKIRIN2;NCK2;SLC30A9;RBPJ;NR4A1;KMT2D;SOX9;SMAD4;HDAC2;ATF5;BRD4;TCF20;ELK4;LRP5;RORA;IL4I1;NCOA7;TWIST1;PLXND1;MAML1;HEY2;PPRC1;PRKD1;MED1;ARF4;RARB;POU2F2;YY1;RLF;FOXK2;RUVBL2;FOXM1;SMAD3;ARNT;CDK8;SOX1;E2F4;PER1;PIN1;INO80;DR1;GDNF;ATF1;KAT6A;ZNF507;HOXB7;PRKD2;PKD2;GNL3;CSRP3;NFKB1;TP53;FHOD1
prerank,cellular response to ATP (GO:0071318),-0.384203932153128,-1.0431024425334476,0.4031620553359684,0.7338165839589745,1.0,6/14,28.46%,RYR3;HSP90B1;SSH1;P2RX4;P2RX7;P2RY12
prerank,brain development (GO:0007420),0.43021714392806887,1.0429841854299844,0.44523326572008115,1.0,1.0,19/136,13.40%,CENPF;PBX4;CDK5RAP2;PBX3;NFIB;MKKS;CXCR4;SOX6;GRHL2;NIPBL;DSCAML1;UTP3;PLXNB2;DHX37;NKX2-1;ATXN1;FBXW11;TMX2;NES
prerank,regulation of cilium movement (GO:0003352),0.5505253499753443,1.0427521298490399,0.46236559139784944,1.0,1.0,1/10,3.42%,DNAH11
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.33007000883640325,-1.0422471463188645,0.42045454545454547,0.7348509070254979,1.0,18/25,34.93%,LYST;VPS4B;LAPTM4B;CHMP2B;CHMP5;CHMP1A;LEPROTL1;UBXN6;CHMP2A;CHMP3;MVB12A;TMEM50B;CHMP7;DENND10;TMEM50A;VCP;CHMP4C;CHMP1B
prerank,synaptic vesicle cycle (GO:0099504),-0.2979474874416401,-1.0422062650481752,0.36507936507936506,0.7338516039596809,1.0,12/30,18.42%,PCLO;RIMS1;SYNDIG1;BRSK1;PLD2;RAB5A;SYT7;SLC17A6;CPLX1;SNAP25;SYT10;NLGN1
prerank,negative regulation of binding (GO:0051100),0.44060003195787906,1.0420661096333284,0.453416149068323,1.0,1.0,22/81,19.70%,AURKB;DDX11;E2F1;BTAF1;AURKA;ARHGAP28;GSK3B;WAPL;LRRK2;ROCK1;PSME3IP1;ILRUN;MITD1;NES;PIN1;TFAP4;DNAJB2;SP100;STYX;ZFPM1;PRKCD;IFIT2
prerank,regulation of neuron death (GO:1901214),0.4454949853567081,1.0419255486305132,0.44008264462809915,1.0,1.0,10/82,9.79%,KIF14;GSK3B;PRNP;MAPT;RILPL1;RAB29;HTRA2;LRRK2;PICALM;IKBKG
prerank,protein ADP-ribosylation (GO:0006471),-0.3174239908835386,-1.0417108627785414,0.38125,0.7339291184214826,1.0,8/28,13.03%,PARP8;PARP12;TIPARP;ART3;PARP6;PARP1;SIRT5;PARP16
prerank,myoblast differentiation (GO:0045445),-0.38674072391439485,-1.0417104747474577,0.39552238805970147,0.7328320644328106,1.0,7/14,11.68%,DDX17;JAG1;IGF1;PLEKHM3;HINFP;MBNL1;DDX5
prerank,amide transport (GO:0042886),-0.3107224825718172,-1.041493753143222,0.3681592039800995,0.7322073188228769,1.0,10/26,20.05%,CERT1;PLTP;SLC27A1;ABCG2;SLC5A6;GLTP;AQP11;SLC38A5;TAP2;DISP1
prerank,eye morphogenesis (GO:0048592),0.5014978097503238,1.0410990329136687,0.41318977119784656,1.0,1.0,11/19,19.71%,MFAP2;FBN1;COL5A2;NIPBL;MFAP5;NKD1;EFEMP1;AGTPBP1;SHROOM2;SKI;ALDH1A3
prerank,maturation of 5.8S rRNA (GO:0000460),0.5050119616793182,1.0410477242225553,0.4367509986684421,1.0,1.0,7/17,21.18%,PRKDC;MPHOSPH6;MAK16;WDR12;NOL9;EXOSC10;URB1
prerank,regulation of wound healing (GO:0061041),-0.2745929265432701,-1.040394438459737,0.3816793893129771,0.733737756313054,1.0,7/42,5.67%,PTK2;OCLN;CAV1;VTN;EPHB2;MYLK;FGF2
prerank,filopodium assembly (GO:0046847),0.5094229357234423,1.040370318015403,0.4310099573257468,1.0,1.0,8/16,15.15%,SPEF1;FGD4;FGD1;SRGAP2;S1PR2;FGD6;EZR;VSTM5
prerank,calcium ion import (GO:0070509),0.47478205201670837,1.0401843847373917,0.4360248447204969,1.0,1.0,10/28,20.73%,MCU;ATP2A2;SLC8A1;MCUB;CACNA1C;MICU1;MAIP1;TRPV4;CACNA1G;MICU2
prerank,protein modification process (GO:0036211),0.4486671384259236,1.0400391040847807,0.4397463002114165,1.0,1.0,33/76,25.32%,TGM1;UBE2S;LOXL2;LOX;GGCX;PRKDC;ST8SIA2;PHKA2;B4GALT7;DUSP12;RPN2;SEPHS1;NAGPA;ATG3;ST3GAL1;UBL5;PLOD2;NTAQ1;PLAT;YES1;UBE2D3;ICMT;UBE2L3;NEDD8;PIGH;FBXO22;PARP4;USP25;UBE2I;FBXW2;RABGGTB;UBL4A;ADPRH
prerank,negative regulation by host of viral process (GO:0044793),-0.4283063431443331,-1.039453243953132,0.41569767441860467,0.7349459503037927,1.0,1/10,0.22%,PRKN
prerank,organophosphate ester transport (GO:0015748),-0.309641854428531,-1.0390558504898855,0.37948717948717947,0.7348943761752379,1.0,11/24,25.83%,PLTP;SCP2;MTTP;TNFAIP8L3;PRELID3B;OSBPL2;NPC2;PITPNC1;PRELID3A;PRELID1;ABCA3
prerank,fatty acid transmembrane transport (GO:1902001),-0.3474013476523662,-1.0388939517039173,0.3974358974358974,0.7342373368679846,1.0,6/19,19.09%,SLC2A1;ABCD4;SLC27A1;ACACB;ABCD2;PRKAG2
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.49466937728720417,1.0387145580515005,0.4232258064516129,1.0,1.0,2/22,2.26%,PPM1G;PPM1D
prerank,RNA processing (GO:0006396),0.4369078801727842,1.0382744156001706,0.4543630892678034,1.0,1.0,55/176,17.97%,SYNCRIP;SETX;PABPC4;SNRNP25;TENT2;SRSF4;HNRNPD;CSTF3;LSM3;NRDE2;DDX39B;TENT4A;HNRNPH1;SRSF7;YJU2;RBMS2;FUS;DHX8;PPIG;CELF2;TUT1;TUT7;HNRNPUL1;TSEN34;PRPF3;NONO;SF3A2;SFPQ;HNRNPU;FASTKD5;SNRNP48;IVNS1ABP;HNRNPL;SRPK1;SRRM1;SNRNP35;ATXN1;RNGTT;SF3B3;TUT4;RBM4;WBP4;RBMS1;TSEN2;LUC7L3;KIN;HNRNPA2B1;LSM4;ZCCHC8;METTL3;NOL9;PRPF4;PRPF18;SRPK2;PDCD7
prerank,positive regulation of protein sumoylation (GO:0033235),0.5564034704971267,1.0381200880681292,0.4417910447761194,1.0,1.0,5/10,22.98%,SAE1;GNL3;HDAC4;PIAS1;UBA2
prerank,negative regulation of metabolic process (GO:0009892),-0.26007301451870984,-1.0373511197269787,0.34146341463414637,0.73704863671838,1.0,15/54,16.70%,LNPEP;MAP2K6;FIS1;NOVA2;ZNF423;ABHD6;TLR4;ACOT11;FOXC2;ACVR2B;NR1H3;ZDHHC7;CCDC3;DDIT3;NR1H2
prerank,mitochondrion localization (GO:0051646),0.4829758387863109,1.0373441655274216,0.4191852825229961,1.0,1.0,5/19,15.76%,TRAK1;LRRK2;MFN2;MARK2;MFN1
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.5016206204181705,1.03666135146063,0.42181340341655715,1.0,1.0,3/18,9.75%,FADD;IL18;HMGB1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.3324488718093983,-1.0363175661758677,0.3744292237442922,0.7384595338720601,1.0,5/24,7.11%,KRIT1;TEK;GAS6;CDH5;RAMP2
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.4701428002076281,1.0363133779371387,0.43141852286049237,1.0,1.0,6/30,11.75%,RTN4R;LPAR1;NET1;ARRB1;ROBO1;RAC1
prerank,mRNA destabilization (GO:0061157),0.4605822974677313,1.0361161968127295,0.4279176201372998,1.0,1.0,11/38,13.97%,MOV10;ROCK2;CNOT1;FTO;RC3H2;TUT7;ROCK1;YTHDF2;MEX3D;TUT4;RC3H1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.48618197989181544,1.0358351168659414,0.42292490118577075,1.0,1.0,6/19,19.04%,MTHFD1L;MTHFR;SLC19A1;DHFR;GGH;MTHFS
prerank,cellular response to amino acid starvation (GO:0034198),-0.24955548490926188,-1.0351867826798333,0.44642857142857145,0.7401639460980636,1.0,21/71,15.14%,ATP6V0D1;MAPK8;ATP6V1E1;ATP6V0B;MIOS;SESN3;WDR59;MAP3K5;FAS;RNF152;GCN1;SZT2;MAPK3;MTOR;MAPK1;ATP6V0C;KPTN;CEBPB;ATP6V1H;RRAGC;DAPL1
prerank,cellular response to ketone (GO:1901655),0.46575092517087896,1.0351620297998019,0.43676814988290397,1.0,1.0,12/35,17.76%,AQP1;ROCK2;LARP1;NR3C1;AHR;KLF9;ADCY6;SRC;SFRP1;PCK2;MSN;ADCY2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.5478712164554589,1.0350047284825192,0.4379905808477237,1.0,1.0,3/10,12.57%,LOXL2;SOX6;SOX9
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.3628253322927433,-1.0349798036608822,0.40225563909774437,0.739568505364096,1.0,8/17,24.09%,COX6C;COX4I1;COX5A;COX7B;COX7C;NDUFA4;COX8A;COX5B
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.3978983825783109,-1.0348729150462683,0.40939597315436244,0.7387207724093643,1.0,6/13,16.50%,CALM1;NOS3;QDPR;GCH1;PRKG2;PTS
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.4416245829859838,1.0345456614155908,0.4407684098185699,1.0,1.0,13/76,13.40%,SPAG5;PLK4;GPSM2;MYLK3;NUMA1;CDC42EP2;SORBS3;NCK1;NCK2;SYNPO2;BAIAP2L1;PRKCE;NES
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.41592351958739693,-1.0342568705927806,0.4403409090909091,0.7391162675842787,1.0,8/11,46.13%,LYN;TIRAP;MFHAS1;TNFAIP3;PJA2;TREM2;TLR6;TLR1
prerank,oligosaccharide biosynthetic process (GO:0009312),0.4880736806717698,1.0336713156338158,0.425997425997426,1.0,1.0,6/20,16.85%,B4GALT1;MPDU1;ST3GAL3;ST3GAL4;ST3GAL2;B3GALT2
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5397668420647767,1.0335057040638007,0.42920353982300885,1.0,1.0,1/11,1.19%,SLC18A2
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.4674705354548819,1.033424589131845,0.43139678615574784,1.0,1.0,7/25,14.44%,HMGB2;PRKDC;FOXO3;ABCB10;TAL1;MED1;ARNT
prerank,negative regulation of proteolysis (GO:0045861),0.4666284936163725,1.0331299606203983,0.426056338028169,1.0,1.0,7/34,10.00%,DNAJC1;PRNP;EFNA1;EPHA4;LRRK2;ROCK1;GAS1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.5067349500930631,1.032957735522594,0.4368421052631579,1.0,1.0,3/16,7.30%,DDIAS;CDKN2D;SFRP2
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.5438919412156125,1.032719588744334,0.4611872146118721,1.0,1.0,5/10,20.59%,ADA;WNK1;PIEZO1;FERMT3;DPP4
prerank,positive regulation of lipid localization (GO:1905954),-0.4046343798840285,-1.0322039398633802,0.40625,0.7428988022238611,1.0,3/11,8.09%,LRP1;IKBKE;VSTM2A
prerank,regulation of hemopoiesis (GO:1903706),0.5373981985560622,1.031590751863637,0.4613050075872534,1.0,1.0,4/10,22.62%,CBFB;PRKCB;RUNX1;MYSM1
prerank,transferrin transport (GO:0033572),-0.2966331389790856,-1.0315785108254332,0.3828125,0.7433446090454877,1.0,16/33,32.33%,ATP6V0A1;ATP6V0D1;ATP6V1E1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP6V1H;MCOLN1;ARHGAP1;ATP6V1G2;ATP6V1B2;ATP6AP1;REP15;ATP6V1F;ATP6V0D2;ATP6V0E1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.43664014297666615,1.031512037473745,0.4371700105596621,1.0,1.0,19/66,16.92%,BRCA2;ATOH8;FGFR2;CASK;NFIB;MCC;XDH;TGFBR3;FBXW7;SFRP2;SULF1;ROBO1;KLF9;SOX9;ATP5IF1;MED1;SFRP1;TINF2;PTPRK
prerank,negative regulation of intracellular protein transport (GO:0090317),0.488539141129424,1.0313974786860907,0.4305732484076433,1.0,1.0,4/22,12.65%,BARD1;LRRK2;RANGAP1;DMTN
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.4767573378537028,1.0311172505088926,0.44776119402985076,1.0,1.0,8/23,16.15%,OCRL;INPP5B;MTMR1;MTMR2;MTMR9;PIP4P2;MTMR3;PTEN
prerank,response to tumor necrosis factor (GO:0034612),0.4378772389126581,1.0309316664899522,0.46680497925311204,1.0,1.0,6/91,7.41%,BRCA1;HYAL1;DHX9;AFF3;NPNT;YBX3
prerank,vesicle transport along microtubule (GO:0047496),0.4820195310534859,1.0307887703782013,0.4197689345314506,1.0,1.0,13/23,25.92%,TRAK1;NDE1;RAB1A;FBXW11;KIFAP3;FYCO1;DYNC1I1;DYNC1H1;KIF5A;KIF13A;HTT;PAFAH1B1;KIF1C
prerank,cardiac muscle cell development (GO:0055013),0.4836134269103535,1.0307169713527098,0.43523316062176165,1.0,1.0,7/20,15.72%,OBSL1;MYLK3;PDGFRA;SLC8A1;PDLIM5;HEY2;CSRP3
prerank,ribosomal large subunit assembly (GO:0000027),-0.3254278298771947,-1.0305885704319062,0.4074074074074074,0.7445792927443446,1.0,14/24,31.64%,DHX30;RPL3;BRIX1;RPL10;RPL24;TRAF7;MDN1;RPLP0;NOP2;BOP1;RPL11;FASTKD2;RSL24D1;NLE1
prerank,receptor signaling pathway via STAT (GO:0097696),-0.3167699513898757,-1.0303667098383078,0.4,0.744062521465725,1.0,4/25,5.24%,STAT3;IFNAR1;STAT6;SOCS2
prerank,rRNA 3'-end processing (GO:0031125),0.5317719898426058,1.0303277314912247,0.44461305007587254,1.0,1.0,5/10,18.37%,ERI2;ERI1;EXOSC7;ERI3;EXOSC10
prerank,regulation of lipid storage (GO:0010883),0.48710840687236373,1.0299178216378493,0.4304461942257218,1.0,1.0,6/22,15.78%,FTO;PTPN2;FBXW7;ITGAV;NFKB1;LPL
prerank,"phototransduction, visible light (GO:0007603)",0.5061239468363596,1.0295423596066764,0.42917251051893407,1.0,1.0,2/14,8.67%,ABCA4;GNAQ
prerank,positive regulation of kinase activity (GO:0033674),0.4385732196117651,1.0294844600701651,0.4713114754098361,1.0,1.0,12/107,8.19%,CENPE;SPDYA;FGFR4;FGFR2;KIT;MRE11;MAPT;MUSK;PDGFRA;CCN1;EPHA4;MRNIP
prerank,glucose metabolic process (GO:0006006),-0.25686323670478206,-1.0293117962568699,0.4230769230769231,0.7454770546246028,1.0,22/58,25.05%,APOD;PER2;GOT2;SLC25A13;SLC25A12;IRS2;MDH1;OMA1;MDH2;PGK1;GOT1;ENO1;PGAM1;SLC25A11;CRTC2;PPARGC1A;GAPDH;ALDOC;TPI1;GALM;BRAT1;ALDOA
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.3443115960235987,-1.0290932588595447,0.4072727272727273,0.744943053786661,1.0,9/18,19.29%,RHOJ;FGF2;FOXC2;PTGS2;HDAC7;VEGFA;HDAC9;GATA2;FGFBP1
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.4245765344197757,-1.0283704567699916,0.4140845070422535,0.7455914658699946,1.0,2/10,1.79%,APOD;LRCH1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.5069083757566517,1.0283572893603172,0.40373563218390807,1.0,1.0,4/14,15.60%,KCNN4;RAB29;IKBKG;PRKD2
prerank,"phagocytosis, engulfment (GO:0006911)",0.45918322660519734,1.028341718216904,0.43157894736842106,1.0,1.0,1/36,0.66%,XKR5
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.5184727319568327,1.0282886149332313,0.4447592067988669,1.0,1.0,2/13,6.96%,SAE1;ATG7
prerank,membrane lipid biosynthetic process (GO:0046467),-0.2545846886715243,-1.0282264680328468,0.43478260869565216,0.7448776355619241,1.0,25/58,25.77%,CERT1;ELOVL7;SGMS2;HACD3;ACER2;PLPP3;HACD2;ALDH3A2;ACER3;HACD1;ST8SIA6;DEGS2;SPNS2;GBGT1;DEGS1;SCCPDH;ELOVL6;VAPB;CERS1;SPTSSA;SGPL1;ELOVL1;SPHK1;SPTSSB;KDSR
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.44823044573109305,1.0279345940037385,0.46644664466446645,1.0,1.0,16/52,18.35%,E2F1;SAE1;TFDP1;LEPROT;FBXW7;RNF31;SH3GLB1;HTRA2;CSNK2A2;CASP8;NPEPPS;UBL5;TP53;PPP3R1;YWHAQ;BAD
prerank,positive regulation of cholesterol efflux (GO:0010875),0.4967365913649463,1.027753025612634,0.4280104712041885,1.0,1.0,1/21,0.82%,PON1
prerank,external encapsulating structure organization (GO:0045229),0.43174858522436926,1.0273748944737626,0.4498997995991984,1.0,1.0,46/205,15.02%,TGM1;MATN3;COL22A1;NID2;MMP24;MMP28;MMP25;MFAP2;LOX;COL4A6;FBN1;MMP14;ADAM12;COL4A4;ITGB7;LAMB1;COL18A1;COL5A2;NPNT;ADAMTS10;ADAMTS5;COL23A1;ADAMTS14;FBLN5;SERPINE1;ADAMTS9;ADAMTSL2;ELN;ADAMTS2;ADAMTS16;DDR2;SLC39A8;NID1;COL4A5;POSTN;ADAMTSL3;COL15A1;BGN;ADAM19;ADAMTS1;ITGA5;ITGB1;CD44;MFAP5;ITGA8;ITGAV
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.36532253306987894,-1.0272002389176298,0.4074074074074074,0.7463026039975701,1.0,8/16,27.65%,ABHD5;SLC27A1;GPLD1;NR1H3;NR1H2;MFSD2A;CTDNEP1;PNPLA2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.4607209182160571,1.0271210561933375,0.44205495818399043,1.0,1.0,8/33,15.60%,KCNN4;PRNP;PTPN2;RAB29;IKBKG;EZR;RC3H1;PRKD2
prerank,autophagy of mitochondrion (GO:0000422),-0.27775034686043626,-1.0259855073239654,0.4214876033057851,0.7482704632286828,1.0,14/38,19.95%,PRKN;FIS1;WDR45B;BECN1;SQSTM1;ULK1;BNIP3;PINK1;ATG9A;USP30;ATG2B;FBXO7;FUNDC1;GABARAPL2
prerank,cellular response to acid chemical (GO:0071229),-0.3183159513750886,-1.02580132262822,0.4101123595505618,0.7476448336145031,1.0,10/27,16.81%,CPEB3;CPEB4;GLRA1;SH3BP4;MTOR;KLF2;NSMF;VEGFA;RRAGC;XBP1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.47074085047866554,1.0255731506865722,0.4408866995073892,1.0,1.0,12/29,18.93%,ZC3H7A;DGCR8;AGO2;TUT7;PUM2;TUT4;SMAD3;HNRNPA2B1;ZC3H7B;METTL3;SMAD2;SPOUT1
prerank,toxin transport (GO:1901998),0.5158222221447174,1.025157780826796,0.4336283185840708,1.0,1.0,3/10,17.21%,ANTXR2;RAB29;ANTXR1
prerank,regulation of protein-containing complex assembly (GO:0043254),0.434059175288828,1.0250212202398135,0.46963562753036436,1.0,1.0,20/110,11.96%,HJURP;RB1;FNIP1;GSK3B;BMF;TRABD2B;IAPP;AJUBA;FAF1;SLF1;SPIDR;CDC42EP2;SH3GLB1;NCLN;ATF7IP;RIOK3;TPPP;TAL1;ABCA1;AIDA
prerank,cellular response to misfolded protein (GO:0071218),-0.33716302121066644,-1.024967551148434,0.42105263157894735,0.7485018451724489,1.0,10/20,23.69%,ATXN3;UFD1;DERL1;STUB1;DNAJC18;POMT2;AUP1;DNAJB12;UBE2W;TOR1A
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.48975551402435996,1.0240847891040405,0.439374185136897,1.0,1.0,4/18,14.43%,FGL1;WNK1;IL4I1;MIA3
prerank,protein N-linked glycosylation (GO:0006487),0.43738033199591253,1.023852504930074,0.46531483457844186,1.0,1.0,15/66,14.57%,ALG14;B4GALT1;ALG13;SRD5A3;MPDU1;B4GALT7;MAGT1;RPN2;SLC39A8;STT3A;STT3B;MAN1C1;ALG8;UBE2J1;ST3GAL1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5070366459961748,1.0232439919634988,0.4434782608695652,1.0,1.0,2/14,8.15%,IL18;CD80
prerank,regulation of steroid metabolic process (GO:0019218),-0.32499067689653477,-1.0231525648299205,0.3875598086124402,0.7517444776746578,1.0,7/23,16.41%,APOE;ASAH1;STUB1;ARV1;FMO5;DGKQ;EPHX2
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.4849792517244143,1.0230173576889463,0.43612903225806454,1.0,1.0,7/21,16.86%,BMPR1A;BMP6;WWTR1;TGFBR1;CCN3;SMAD4;VEPH1
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.48879641365952964,1.0228649834104615,0.44329896907216493,1.0,1.0,2/22,4.11%,VKORC1L1;ALDH1A2
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.2120670650876068,-1.0226875993133002,0.4,0.7518449856889006,1.0,20/112,13.70%,STAT3;PSEN1;IGF1;GAS6;TLR4;EPHB2;CD34;LBP;PTPN22;SELENOS;CHRNA7;APP;ARHGEF2;ARFGEF2;THBS1;CX3CL1;SYT11;TRIM27;PTPN11;IFNGR1
prerank,transcription by RNA polymerase II (GO:0006366),0.4322661647342887,1.0224794114021196,0.458,1.0,1.0,62/305,13.82%,NR2E3;E2F2;TRIP13;TCFL5;TTF2;MED26;PMF1;CBFB;SETX;DEK;TEAD1;E2F3;TFDP1;CSTF3;FIP1L1;TAF3;MBD1;INTS7;PHAX;KLF13;TBL1XR1;SLBP;ERCC3;ELOF1;LSM11;ELOC;GLIS3;TAF12;POLR2A;SETD2;POU2F1;ZBTB7B;WWTR1;NR2C2AP;WDR33;LEO1;YAP1;NFYA;PCF11;NR4A2;NR3C1;SCAF8;INTS8;TEAD3;TAF15;GTF2A1;CPSF4;HDAC1;ADRM1;TAF4;RBPJ;NR4A1;RNGTT;SSRP1;NOTCH2;RPRD1A;RORA;MAML1;DDX21;MED1;RARB;POU2F2
prerank,macrophage chemotaxis (GO:0048246),0.5422641908627176,1.0220368015392822,0.4752623688155922,1.0,1.0,1/10,4.99%,CKLF
prerank,cellular glucose homeostasis (GO:0001678),-0.27861566859218456,-1.021832145222587,0.3939393939393939,0.75292816507757,1.0,15/41,21.90%,UNC13B;FOXO1;KCNB1;GAS6;PIK3R1;PRKAA1;SOX4;HK1;ADCY8;LRRC8D;XBP1;LRRC8A;PPARGC1A;PIK3R2;RACK1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.4683938531655176,1.0218104372988066,0.44336175395858707,1.0,1.0,9/30,15.11%,SAE1;LEPROT;FBXW7;RNF31;SH3GLB1;HTRA2;CSNK2A2;NPEPPS;UBL5
prerank,regulation of cellular component movement (GO:0051270),0.4482853639100429,1.021547750330041,0.45957918050941304,1.0,1.0,12/49,12.40%,ROCK2;RHOA;ACTN4;MEMO1;MYCBP2;DIAPH1;ARHGAP18;PDPN;TGFBR3;ROCK1;TGFBR1;ADAM17
prerank,hemopoiesis (GO:0030097),0.4355658815287238,1.021441315518294,0.45764462809917356,1.0,1.0,18/87,16.07%,MELK;ETV6;FGFR2;FUT10;KIT;WNT2B;RTKN2;TGFBR3;SFRP2;KMT2A;YTHDF2;TAL1;RRAS;NOTCH2;MFAP5;KAT6A;TP53;SFRP1
prerank,regulation of cellular catabolic process (GO:0031329),-0.2523009079238459,-1.0210605182061996,0.3275862068965517,0.753777568029785,1.0,30/62,28.52%,PRKN;EP300;PIP4K2A;DRAM2;ACER2;PIP4K2B;PSAP;LONP2;MTMR4;ATM;DAPK2;ABL1;OSBPL7;NUPR1;RRAGC;FBXL2;USP33;DDIT3;USP10;RMC1;PIP4K2C;PIK3R2;HSPB1;SCARB2;RAB39B;SMCR8;RRAGD;GPR137;KEAP1;RRAGA
prerank,detection of visible light (GO:0009584),0.49900552265983805,1.0206894304024945,0.42701227830832195,1.0,1.0,3/16,18.09%,ABCA4;GNAQ;CEP250
prerank,retinoid metabolic process (GO:0001523),0.4421024852527809,1.020654923309478,0.47463002114164904,1.0,1.0,10/71,10.42%,ALDH8A1;CYP26B1;ABCA4;ALDH1A2;RDH11;GPC6;RDH12;ALDH1A1;SCPEP1;SDC1
prerank,protein-containing complex assembly (GO:0065003),0.42801345905692806,1.0206085538538603,0.4624624624624625,1.0,1.0,69/259,18.74%,KNTC1;FANCA;PLEKHA7;F5;KPNA3;FADD;TSPAN33;TEAD1;GSK3B;MDM4;FBXL7;DHX9;ADD2;TCF7L1;BLM;ZW10;AFDN;TCF7L2;PML;STOML2;LRRK2;MCU;DARS1;CUL3;SMARCA4;AXIN2;TRAPPC6B;LEO1;YAP1;PICALM;IKBKG;KMT2A;RAB1A;WDCP;RSPH9;CDC123;BOK;CAPZA1;HDAC1;F8;SCFD1;KMT2D;SOX9;DMTN;CASP8;SEC24D;PPID;TRAPPC10;TLE4;GSDMD;EPRS1;CAPG;ANKRD28;TLE3;TRRAP;TP53;BET1;AMER1;FERMT3;TRAPPC9;TFAP4;SH3PXD2B;CSNK1A1;USO1;FANCC;BAD;TMED10;KIFAP3;RIPK1
prerank,positive regulation of locomotion (GO:0040017),-0.2975519227927825,-1.020178535450726,0.4567901234567901,0.7548989728873758,1.0,6/27,5.46%,SPOCK2;STX4;PDGFRB;AKT2;CFAP20;STX3
prerank,regulation of presynapse assembly (GO:1905606),-0.3509191845742688,-1.0201234120956575,0.42907801418439717,0.7528685300247744,1.0,6/18,15.67%,PTPRD;IL1RAPL1;EIF4G1;APP;SLITRK1;LRRC4B
prerank,regulation of presynapse organization (GO:0099174),-0.3509191845742688,-1.0201234120956575,0.42907801418439717,0.7528685300247744,1.0,6/18,15.67%,PTPRD;IL1RAPL1;EIF4G1;APP;SLITRK1;LRRC4B
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.38782371798752113,-1.0201200097073762,0.4065934065934066,0.7518003230992525,1.0,4/14,21.07%,CROT;SCP2;DECR2;AMACR
prerank,protein localization to vacuole (GO:0072665),-0.38973747850326423,-1.0199495775681344,0.432258064516129,0.7511737101015705,1.0,7/13,23.17%,SH3BP4;SZT2;CD81;KPTN;MFSD1;LMBRD1;GLMP
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.337244007745368,-1.0190687719382048,0.42677824267782427,0.7521691920688242,1.0,8/19,20.39%,EP300;CDIP1;HIPK2;MSH2;DYRK2;DDIT4;SNW1;BCL3
prerank,RNA splicing (GO:0008380),0.43367798175381506,1.0187572923836683,0.465979381443299,1.0,1.0,28/95,17.97%,SYNCRIP;SNRNP25;SRSF4;TRA2B;SRSF10;NRDE2;DDX39B;SRSF7;YJU2;FUS;DHX8;PPIG;PRPF3;NONO;SFPQ;SNRNP48;IVNS1ABP;SRPK1;SRRM1;SNRNP35;SF3B3;WBP4;LUC7L3;LSM4;PRPF4;PRPF18;SRPK2;PDCD7
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.5103359006806312,1.0185694489997887,0.434971098265896,1.0,1.0,4/13,12.83%,ECHDC3;ERFE;ZBTB7B;GKAP1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.38336432785944446,-1.0174546987544013,0.4844290657439446,0.7551078207965739,1.0,4/13,15.20%,UPP2;NT5M;TDG;SMUG1
prerank,anion transport (GO:0006820),-0.2935012488829944,-1.0171533048305617,0.36419753086419754,0.7547533162780117,1.0,8/33,14.41%,SLC13A3;SLCO2B1;SLC13A4;SLC22A6;ABCG2;SLC17A6;LRRC8B;LRRC8D
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.30779357072889246,-1.0171081633114616,0.39204545454545453,0.7537917587122147,1.0,11/27,21.40%,GRB14;PIP4K2A;GRB10;PIP4K2B;PRKCQ;INPP5K;IRS1;GSK3A;PRKCZ;PIP4K2C;SLC27A4
prerank,stabilization of membrane potential (GO:0030322),0.4940169577678868,1.017064167164909,0.4233378561736771,1.0,1.0,4/16,12.54%,KCNN4;KCNK2;KCNK12;KCNK6
prerank,positive regulation of heart rate (GO:0010460),-0.35138539427354737,-1.0166619318231807,0.44609665427509293,0.7537521881936188,1.0,9/17,27.00%,RYR2;TPM1;ADRA1A;PDE4D;KCNQ1;ADRA1B;EDN1;ADM;EDN3
prerank,histone mRNA metabolic process (GO:0008334),0.47344501329933125,1.01647149694218,0.4482338611449452,1.0,1.0,6/27,8.24%,TENT2;SLBP;LSM11;ERI1;TUT1;TUT7
prerank,RNA catabolic process (GO:0006401),0.45152958665907733,1.01642886331495,0.45952109464082097,1.0,1.0,12/46,16.36%,PABPC4;HNRNPD;RNASE6;DNA2;RNASEH2A;PPP1R8;LSM2;YTHDF2;EXOSC7;DXO;PNPT1;METTL3
prerank,negative regulation of stress fiber assembly (GO:0051497),0.4816402512265091,1.0161904942667748,0.455,1.0,1.0,7/24,12.75%,STMN1;ARHGAP28;CGNL1;TMEFF2;ARHGAP6;ARHGEF18;WASF2
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.26379380405624536,-1.0161859534855588,0.45871559633027525,0.7539132320278483,1.0,8/46,8.37%,PLA2G4A;PLD1;DGKB;ABHD5;PLD2;SLC27A1;AGPAT5;DGKG
prerank,regulation of cellular protein metabolic process (GO:0032268),0.4452384806930252,1.0161803489633765,0.46223224351747466,1.0,1.0,4/47,9.78%,UHRF1;EIF4E;FOXO3;AGT
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.3411316206958503,-1.0159922515966637,0.4132231404958678,0.7533887334909486,1.0,8/18,23.09%,OS9;RNF103;EDEM2;SYVN1;UBB;UBC;RPS27A;SEL1L
prerank,neuropeptide signaling pathway (GO:0007218),-0.26073917642027133,-1.0157370981573355,0.44565217391304346,0.7528825766401498,1.0,9/58,10.55%,SORCS3;SORCS1;GLRB;GLRA1;CPE;GLRA3;GPR37;OPRM1;HCRTR2
prerank,mesenchyme development (GO:0060485),0.5018630727711243,1.0155260346662582,0.44551724137931037,1.0,1.0,5/15,15.61%,FGFR2;SFRP2;TGFBR1;BMP2;PKD2
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.42513914908212447,1.0152703920187818,0.451,1.0,1.0,214/1082,16.12%,BRCA1;CKAP2;E2F7;NR2E3;E2F8;UHRF1;ATAD2;E2F2;ATRX;MYBL1;PBX4;GLI2;CDK5RAP2;GLI3;RBL1;HMGB2;E2F1;BRCA2;FOXE1;ATOH8;HAS3;ILF3;NAT14;PSRC1;FADD;DYRK1A;SMARCC1;SP3;SETX;BMPR1A;PHIP;ELF2;ACTR3;TEAD1;WWOX;AGO2;CTCF;E2F3;FGFR2;SENP1;TFDP1;HNRNPD;BCL2L12;NFE2;GALR1;DDRGK1;MED14;AUTS2;CHEK2;RFXAP;RGMA;NFIA;HIVEP1;PCGF5;SSBP3;DHX9;PRKDC;NFIL3;KLF5;SRF;BLM;ELF4;ASXL1;NFIB;THRAP3;TBL1XR1;LPIN2;MLLT10;SETD3;NUP85;BMP6;PCBD2;HOXC4;YAF2;TCF7L2;MED30;ELF1;ELOF1;IL18;HOXA7;GRHL2;AKNA;ARRB1;PML;DDX39B;TCF4;ARID1A;MYBL2;GLIS3;TASP1;CHEK1;SFRP2;ELK1;CCN1;PPP3CA;POU2F1;POU3F2;FHL5;WWTR1;SERPINE1;FOXO3;ATF7IP;CD80;TRIM28;LMX1B;PELP1;IRF1;ZFP64;BCLAF1;CREB5;MED24;RHOQ;SMARCA4;USP21;USP16;ZFP90;NCK1;DNM2;HOXB3;YAP1;NFYA;VHL;PLAGL1;PICALM;EPC1;HMGB1;AGT;IKBKG;KMT2A;HDAC8;MEOX2;NR4A2;NR3C1;SCAF8;PARP9;SFPQ;TGFBR1;HNRNPU;TAL1;MMS19;CRLF3;TAF15;EIF2AK3;NCOA2;QRICH1;HDAC1;BMP2;AHR;NKX2-1;MRTFA;NFATC2IP;FBXW11;AKIRIN2;NCK2;SLC30A9;RBPJ;NR4A1;KMT2D;SOX9;SMAD4;HDAC2;ATF5;IL31RA;ZNF496;ILF2;BRD4;TCF20;ELK4;RAI1;LRP5;RORA;IL4I1;NCOA7;TWIST1;MAML1;HEY2;PPRC1;PRKD1;MED1;ARF4;BTRC;RARB;POU2F2;YY1;RLF;FOXK2;RUVBL2;FOXM1;SMAD3;ARNT;CDK8;SOX1;E2F4;RPTOR;PER1;PIN1;INO80;DR1;GDNF;ATF1;KAT6A;ZNF507;HOXB7;PRKD2;PKD2;BICRA;CSRP3;NFKB1;TP53;FHOD1;CDCA4;BRD8;SFRP1;DRAP1
prerank,lipid oxidation (GO:0034440),-0.3941822248983037,-1.0150876262124522,0.4360655737704918,0.7534122039535073,1.0,3/12,19.45%,ADIPOR2;PLA2G7;PPARGC1A
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.5026915176049127,1.014486492167136,0.453125,1.0,1.0,5/14,17.33%,ATP2B4;PKIG;ADRB2;PRKAR2B;PRKAR2A
prerank,regulation of potassium ion transport (GO:0043266),-0.28871527122826424,-1.0144366048961666,0.42857142857142855,0.7539835792813931,1.0,13/31,34.05%,KCNIP4;KCNAB1;KIF5B;KCNN2;ADRA2A;DPP10;NOS1;DRD2;PTK2B;KCNIP1;KCNIP2;CASQ2;CACNA1D
prerank,regulation of insulin secretion (GO:0050796),-0.22804455701288123,-1.0142960459011579,0.3548387096774194,0.7532556379893308,1.0,27/101,21.39%,PRKN;EPHA5;MYRIP;SLC2A1;KCNC2;PER2;RAP1A;KCNB1;IRS2;ACSL4;SYT7;HADH;KCNS3;IRS1;SOX4;MIDN;SNAP25;UQCC2;ADRA2A;PICK1;TM7SF3;LRRC8A;CACNA2D2;EFNA5;RAPGEF3;NNAT;GLUD1
prerank,histone acetylation (GO:0016573),0.44219129300414617,1.0142323873276906,0.47412882787750793,1.0,1.0,25/69,18.80%,BRCA2;SGF29;HAT1;TAF12;ING4;MSL3;EP400;EPC1;TADA1;TADA2A;JADE1;ACTL6B;RUVBL2;PER1;YEATS2;DR1;KAT6A;TRRAP;BRD8;TAF10;PHF20;ZZZ3;NAA60;NAA40;JADE3
prerank,inositol phosphate metabolic process (GO:0043647),-0.26031801598000115,-1.014217745763972,0.4174757281553398,0.7523812260819664,1.0,17/46,20.67%,INPP4B;CALM1;IPPK;PPIP5K2;PLCB3;FGF2;PLCG1;NUDT3;INPP1;ITPKB;INPP5D;SYNJ1;PLCE1;IMPA1;INPP4A;ITPKC;PLCH1
prerank,heart contraction (GO:0060047),-0.2788702345961951,-1.014109778380948,0.3983739837398374,0.7515905917959204,1.0,9/41,19.39%,ATP1B1;RYR2;TPM1;ACE;ATP1A2;SCN1B;GPX1;PIK3CA;KCNQ1
prerank,extracellular matrix organization (GO:0030198),0.4278624564117888,1.0140922181025902,0.487,1.0,1.0,60/276,15.02%,BMP1;LOXL3;MATN3;COL22A1;HAS3;NID2;LOXL2;MMP24;MMP28;MMP25;MFAP2;LOX;SCUBE1;COL4A6;FBN1;MMP14;ADAM12;COL4A4;ITGB7;LAMB1;COL18A1;COL5A2;NPNT;ADAMTS10;ADAMTS5;COL23A1;QSOX1;ADAMTS14;FBLN5;SERPINE1;ADAMTS9;ADAMTSL2;ELN;ADAMTS2;ADAMTS16;DDR2;HAS1;TLL2;TGFBR1;SLC39A8;NID1;COL4A5;COL12A1;P3H1;POSTN;ADAMTSL3;EXOC8;COL15A1;COL20A1;BGN;ADAM19;ADAMTS1;ITGA5;ITGB1;CD44;P3H4;MFAP5;CAPG;ITGA8;ITGAV
prerank,cellular response to hexose stimulus (GO:0071331),-0.3120531623187747,-1.013765046245826,0.415929203539823,0.7513587275559628,1.0,7/23,16.81%,UNC13B;KCNB1;GAS6;PRKAA1;SOX4;ADCY8;XBP1
prerank,response to unfolded protein (GO:0006986),-0.2515049273650177,-1.0135727291672376,0.44,0.7507339320446533,1.0,12/48,18.18%,PRKN;HSP90AB1;DNAJA1;HSPH1;HSPD1;DERL1;HSPA4L;HSPA5;PACRG;DDIT3;TM7SF3;HSPB8
prerank,regulation of response to oxidative stress (GO:1902882),-0.4070653671721955,-1.0134800246570088,0.4426751592356688,0.7499369933327074,1.0,4/11,12.39%,PRKN;MCTP1;SELENON;PINK1
prerank,activation of GTPase activity (GO:0090630),0.4248011543162813,1.0134399295976495,0.4845360824742268,1.0,1.0,12/89,9.94%,ECT2;ARHGAP22;USP6NL;EVI5L;TBC1D25;TBC1D13;TBC1D2B;SCRIB;ARHGAP24;SYDE2;TBC1D7;RANGAP1
prerank,ceramide transport (GO:0035627),-0.38996733483083024,-1.0134337275035947,0.428125,0.7490066896018132,1.0,6/12,23.08%,CERT1;PLTP;PSAP;GLTP;PLEKHA8;ABCA2
prerank,positive regulation of histone deacetylation (GO:0031065),0.5181016628912148,1.0133607700228,0.44395924308588064,1.0,1.0,5/12,15.60%,CTBP1;NIPBL;ZBTB7B;PRKD1;PRKD2
prerank,serine family amino acid metabolic process (GO:0009069),-0.35741358853666716,-1.0132055513360874,0.43846153846153846,0.7485065409989112,1.0,12/16,49.33%,MTHFD1;SARS1;CBS;THNSL2;SEPHS2;CTH;SEPSECS;PSPH;SHMT2;SHMT1;GLYAT;DAO
prerank,myelination in peripheral nervous system (GO:0022011),-0.3751547038592721,-1.0131720298122662,0.4230769230769231,0.7475475991333664,1.0,6/13,25.69%,NF1;ARHGEF10;DICER1;ADGRG6;LGI4;PRX
prerank,regulation of mitochondrial fission (GO:0090140),0.46953004119037617,1.012947880943437,0.4573643410852713,1.0,1.0,7/24,10.36%,MIEF2;AURKA;MAPT;LRRK2;MCU;DDHD1;MIEF1
prerank,heterochromatin organization (GO:0070828),0.5065122191021589,1.0129391470693658,0.46442953020134226,1.0,1.0,4/14,8.39%,LOXL2;SETDB2;HP1BP3;SMCHD1
prerank,ephrin receptor signaling pathway (GO:0048013),-0.23162745252656144,-1.0128990054999785,0.46875,0.7471764072190784,1.0,27/82,19.18%,PTK2;EPHA5;PSEN1;PAK3;TIAM1;ACTB;VAV3;GRIN2B;AP2A2;EPHB2;NCSTN;LYN;DNM1;PAK1;AP2M1;MMP2;PTPN11;SDCBP;AP2S1;EPHA8;GRIN1;AP2A1;ARHGEF7;PSEN2;ARPC5;GIT1;EFNB3
prerank,negative regulation of establishment of protein localization (GO:1904950),0.5380382500865487,1.0128886283884713,0.4421052631578947,1.0,1.0,2/10,5.54%,TERF1;MAPT
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.2591816279706547,-1.011871510107534,0.39325842696629215,0.7487388604921059,1.0,21/54,23.02%,HEATR3;RPL35A;RPL3;NVL;RPL14;BRIX1;RPL10;RSL1D1;RPL24;TRAF7;NSA2;LAS1L;SNU13;LTO1;MDN1;RPLP0;RPL10A;NOP2;SURF6;RRP15;EBNA1BP2
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.21712414868728377,-1.0118119277139066,0.5,0.7478497188196335,1.0,43/119,21.48%,PIP4K2A;INPP4B;PIK3R3;PIP4K2B;SOCS2;PIK3C2B;PIK3R1;FGF2;PIK3R4;SLC27A1;EFR3A;RAB5A;DPM1;SOCS5;MTMR4;RUFY1;INPP5K;PIGV;PIP5K1A;ITPKB;PIGQ;BMX;INPP5D;SYNJ2;PIGB;PIGP;CDS1;PIK3R6;SYNJ1;PGAP2;PI4KA;SMG1;IMPA1;INPP4A;PIK3CD;TMEM150A;PIK3CA;PIGF;CDIPT;EFR3B;ITPKC;PIP4K2C;PIK3R2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.43940458217496575,1.0117774945717988,0.464,1.0,1.0,6/45,12.61%,TTK;BMPR1A;BMP6;TGFBR1;BMP2;SMAD4
prerank,nucleotide metabolic process (GO:0009117),0.4639727463094608,1.0115706707973664,0.4488778054862843,1.0,1.0,9/23,21.52%,AK1;DCK;NUDT5;ENPP3;GUK1;AK7;NMNAT1;NMNAT2;PNP
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.44495919786387544,1.011506796043247,0.4635603345280765,1.0,1.0,8/33,14.44%,HMGB2;RAB7B;PRKDC;FOXO3;ABCB10;TAL1;MED1;ARNT
prerank,regulation of cell adhesion (GO:0030155),0.429231024525834,1.0113339807657094,0.48484848484848486,1.0,1.0,24/129,15.60%,KIF14;ROCK2;HYAL1;PDE3B;CXCR4;IL18;EFNA1;PLAU;PPP3CA;EPHA4;RIPOR2;RSU1;ANGPT1;ROCK1;YTHDF2;PLXNB2;PLXNB1;DSCAM;PRKCA;PLXND1;MIA3;ITGAV;SRC;PRKD2
prerank,positive regulation of phagocytosis (GO:0050766),-0.26794778050706036,-1.010914847924033,0.44565217391304346,0.7489422089067291,1.0,28/47,44.89%,MERTK;ANO6;GAS6;MYO18A;C4B;GATA2;RAB27A;NCKAP1L;C2;IL15;TUB;FCER1G;PTPRC;ABCA7;CALR;RAB31;LYAR;C3;PYCARD;SLC11A1;LMAN2;FCGR2B;CD300LF;CCL2;TREM2;IL2RG;AHSG;PLA2G5
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.40295615255318684,-1.0107692225324032,0.4253968253968254,0.7483002340155762,1.0,7/11,30.22%,PARN;DKC1;TENT4B;EXOSC2;EXOSC3;EXOSC5;FBL
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.47228097288839116,1.0106963954915882,0.45745992601726265,1.0,1.0,7/24,16.88%,HMBS;FXN;COX10;ABCB10;CPOX;ATP5IF1;ALAS2
prerank,gluconeogenesis (GO:0006094),-0.28734840124043143,-1.0096538358946692,0.42657342657342656,0.7500289660958995,1.0,16/39,22.24%,PER2;GOT2;SLC25A13;SLC25A12;MDH1;MDH2;PGK1;GOT1;ENO1;PGAM1;SLC25A11;CRTC2;PPARGC1A;GAPDH;ALDOC;TPI1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.42669737652414874,1.0096483314393117,0.5065590312815338,1.0,1.0,33/138,16.94%,NR2E3;E2F2;MED26;TEAD1;E2F3;TAF3;TBL1XR1;ERCC3;TAF12;POLR2A;WWTR1;NR2C2AP;YAP1;NR4A2;NR3C1;TEAD3;TAF15;GTF2A1;HDAC1;TAF4;RBPJ;NR4A1;NOTCH2;RORA;MAML1;MED1;RARB;NRBP1;MED27;DR1;TAF10;TEAD4;CCN2
prerank,cardiac muscle cell differentiation (GO:0055007),-0.34220637495560036,-1.0095326953861175,0.4375,0.7493661193287011,1.0,8/21,26.48%,ACVR1;MEF2C;SIK1;VEGFA;MYH11;KDM6B;CBY1;MYOCD
prerank,inorganic anion transport (GO:0015698),0.42913559292927045,1.009385489227576,0.46799116997792495,1.0,1.0,8/53,13.31%,RACGAP1;ANO9;ENPP3;CLCN1;ENPP1;CLIC4;SLC25A30;CLIC1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.5082224548372646,1.0093055553627202,0.45611510791366905,1.0,1.0,5/10,18.96%,ING4;FOXM1;TP53;TFAP4;SP100
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.43609407273352013,1.0089512407717347,0.45673603504928806,1.0,1.0,16/50,19.37%,AQP1;CDKN2D;FNIP1;BCL2L12;SIAH2;ARL6IP1;SH3RF1;PLAUR;USP47;XIAP;CD44;SRC;NGF;LAMTOR5;DPEP1;DNAJB6
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.3535840293236968,-1.008508163646167,0.421875,0.7507906949609169,1.0,4/17,9.01%,CPEB3;CPSF6;CCNT1;CPSF7
prerank,motor neuron axon guidance (GO:0008045),0.502434964543586,1.0084161459600771,0.45670391061452514,1.0,1.0,4/15,11.75%,NTN1;NTN3;EPHA4;RAC1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.33196596227871,-1.0080623312018389,0.42379182156133827,0.7507846030627826,1.0,4/17,8.57%,TMSB4X;MAP2K5;KLF4;PTPN22
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.3574304782937664,-1.0067021533944758,0.4280155642023346,0.7529894318002802,1.0,4/18,18.82%,LYN;GPLD1;CMKLR1;BCAR1
prerank,response to gamma radiation (GO:0010332),0.4709587007889147,1.0066764327380362,0.45714285714285713,1.0,1.0,3/24,9.18%,FANCD2;MAP3K20;YAP1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.3131019593604003,-1.0065360818223767,0.48148148148148145,0.7523752262047374,1.0,5/25,3.74%,MEF2C;GRIN2A;GRID2;GLRA1;GRIN2B
prerank,positive regulation of developmental growth (GO:0048639),-0.2664751056121918,-1.0060765802757663,0.42696629213483145,0.7523763273676185,1.0,8/49,4.79%,RUFY3;RIMS1;ITSN2;CDKL5;INSR;SYT1;AGRN;SEMA7A
prerank,negative regulation of blood pressure (GO:0045776),-0.38332279854469503,-1.0059834267631276,0.43537414965986393,0.7516061936956916,1.0,5/13,22.19%,BMPR2;NOS3;PRCP;NOS1;DRD2
prerank,cellular response to oxygen levels (GO:0071453),-0.4090168197620646,-1.0057861045248284,0.459375,0.7510894562432233,1.0,5/10,27.82%,ATP6V0D1;CPEB4;PICK1;ATP6AP1;TMEM199
prerank,regulation of defense response to virus (GO:0050688),0.5059402792989485,1.0054303867076393,0.4594222833562586,1.0,1.0,6/14,23.20%,DHX9;ILRUN;ITCH;RNF216;ELMOD2;PCBP2
prerank,negative regulation of cation channel activity (GO:2001258),-0.30236862841035794,-1.0052826816306357,0.4031413612565445,0.7512410168426672,1.0,5/26,7.79%,KCNAB1;CALM1;FKBP1A;EPHB2;GNB5
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.2869882949816822,-1.0051905044564913,0.4444444444444444,0.7504523597617854,1.0,13/35,19.33%,NRP2;SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;MET;FARP2;SEMA3B;SEMA3C;PLXNA4;SEMA5B;NRP1
prerank,cell-matrix adhesion (GO:0007160),0.42951559302490444,1.004637173358011,0.4772256728778468,1.0,1.0,21/95,16.92%,OTOA;NID2;HPSE;TRIP6;ITGB7;NPNT;SGCE;FBLN5;ADAMTS9;RAC1;MKLN1;ADAM9;ITGB1;CD44;ITGA8;ITGAV;SRC;RCC2;ITGB8;FERMT3;PTPRK
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5294583038754763,1.0041106242952158,0.46515151515151515,1.0,1.0,5/10,15.84%,PSMC2;ATF7IP;HMGB1;PSMC6;TP53
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.47509873331892394,1.004030719229631,0.45503355704697984,1.0,1.0,4/18,9.56%,ROCK2;EFNA1;EPHA4;PICALM
prerank,secondary palate development (GO:0062009),-0.37023578680280117,-1.0037797629129155,0.4491803278688525,0.7529263678734767,1.0,3/14,4.12%,LEF1;TGFBR2;TGFB2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.43151023144467243,1.0036631359951984,0.5037037037037037,1.0,1.0,23/73,21.09%,FADD;SENP1;DAP;ANP32B;CASP8AP2;FAM162A;MAPT;XDH;ROBO1;TNFRSF10B;APAF1;BOK;EIF2AK3;CASP8;SMAD3;BCL2L13;NGF;TNFSF10;BAD;RIPK1;COL4A3;SNCA;TRAF2
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.3003291966855015,-1.0035911305584804,0.4350282485875706,0.752355101042088,1.0,5/27,5.66%,CAMK2D;CTNNA3;CAV1;RYR2;FGF13
prerank,regulation of Rho protein signal transduction (GO:0035023),0.43191055648595944,1.0035812448358585,0.48214285714285715,1.0,1.0,15/72,11.79%,STMN1;RTN4R;LPAR1;NET1;ARRB1;CUL3;RIPOR2;ROBO1;KANK2;EPS8L1;MYO9B;ARHGAP35;ARHGEF18;RAC1;ABCA1
prerank,glycosphingolipid metabolic process (GO:0006687),-0.26493421516171756,-1.0034007598057797,0.4186046511627907,0.7517391585037984,1.0,12/42,13.32%,HEXB;PSAP;ASAH1;B4GALT6;ST6GALNAC3;ST8SIA1;ESYT1;B3GALNT1;ST6GALNAC5;HEXA;GLTP;CTSA
prerank,ganglioside metabolic process (GO:0001573),-0.3377860779253814,-1.0033466708068606,0.4396887159533074,0.7508410009878608,1.0,6/20,10.93%,ST8SIA4;HEXB;ST6GALNAC3;ST6GALNAC5;HEXA;ST8SIA6
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.29701039219783365,-1.0033012872570284,0.453416149068323,0.7499498773493026,1.0,14/32,19.29%,RHOJ;MAP2K5;KLF4;FGF2;FOXC2;HDAC5;PTGS2;THBS1;HDAC7;VEGFA;HDAC9;ITGB1BP1;GATA2;FGFBP1
prerank,positive regulation of cell junction assembly (GO:1901890),-0.24870828077782978,-1.003276319555671,0.4444444444444444,0.7489805946210104,1.0,26/56,28.44%,PTPRD;TEK;SYNDIG1;CAV1;GRID2;CLDN5;EPHB2;IL1RAPL1;CNTNAP2;NRXN1;ABL1;PPM1F;VEGFA;LRRC4B;NLGN1;NRP1;IL1RAP;BDNF;DLG5;SRPX2;TSC1;THY1;EPHA2;EPHB3;COL16A1;ACE2
prerank,actin cytoskeleton reorganization (GO:0031532),0.4300483864069216,1.0030729142155737,0.47783783783783784,1.0,1.0,27/63,22.89%,RHOA;PARVA;AUTS2;KIT;PDLIM4;RAP2A;NRK;CDC42BPA;PHACTR1;MCU;CDC42BPG;S1PR2;GAB1;EZR;ANXA1;DMTN;MKLN1;SIPA1L1;ANTXR1;TRPV4;PTPN1;SYDE1;WHAMM;FER;FLNA;CXADR;MYH9
prerank,cardiac muscle cell action potential (GO:0086001),-0.29167170302802264,-1.0029908750338792,0.46153846153846156,0.748657541906628,1.0,6/30,14.98%,CACNA2D1;ATP1B1;SCN1A;ATP1A1;ATP1A2;SCN1B
prerank,response to exogenous dsRNA (GO:0043330),0.48889794591260727,1.00231741308466,0.45098039215686275,1.0,1.0,3/18,4.75%,TICAM1;COLEC12;DHX9
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.3107604820531321,-1.0017832104251965,0.45685279187817257,0.750408245153821,1.0,8/24,19.54%,NBL1;ANO6;LYN;LGMN;SLIT2;DUSP1;PLA2G7;CREB3
prerank,cellular component disassembly (GO:0022411),0.433925025312291,1.0016027954453464,0.48415300546448087,1.0,1.0,11/53,17.53%,BMP1;SCUBE1;MMP14;DYRK3;ADAMTS5;TLL2;EXOC8;CD44;CAPG;LCP1;SH3PXD2B
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.404900300680253,-1.0005241604390427,0.45786516853932585,0.7524751950600004,1.0,4/10,24.36%,GAS6;LYN;LGALS9;CXCL12
prerank,excitatory postsynaptic potential (GO:0060079),-0.3353198530881043,-1.000336038787778,0.4497816593886463,0.7518900545838214,1.0,4/19,3.74%,MEF2C;GRIN2A;GRID2;GRIN2B
prerank,chemical synaptic transmission (GO:0007268),-0.31148447529757045,-1.0,1.0,0.7506605354086949,1.0,82/284,17.59%,CDH8;GRM7;UNC13B;GRIK1;DLGAP1;GABRB1;SYN3;RIMS1;GABRB3;SLC1A2;CHRM2;GRIN2A;GABRA2;SLC6A1;GRM3;SPG11;KIF1B;ATXN3;CALM1;AMPH;APOE;APBA1;GLRB;GRID2;SYN2;SYT1;GLRA1;LIN7A;GRIN2B;PTCHD1;KCNQ3;BRSK1;HOMER1;SHISA6;GRIK4;RPS6KA2;CAMK4;GABRA3;HTR2C;RIC3;PLP1;GLRA3;NRXN1;CACNA1B;CAMK1;PRKACB;MINK1;GABRA5;SNPH;GIPC1;CHRNA7;CHRFAM7A;GABRB2;HCRTR2;GRIA1;PRKAR1B;SLC17A6;GABRG2;MAPK1;SYNJ2BP;HTR4;CAMKK2;GRM5;CACNB2;DLG4;SDCBP;GRM1;GRIN1;TBC1D24;GABRG1;DVL1;CPLX1;DTNA;CHRM3;SLC1A1;LRP6;HTR2A;SNAP25;CACNB1;GRIA2;SYT10;SYPL1
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.3399712747799534,-1.0,1.0,0.7506605354086949,1.0,68/224,17.59%,GRM7;UNC13B;GRIK1;DLGAP1;GABRB1;GABRB3;SLC1A2;CHRM2;GRIN2A;GABRA2;SLC6A1;GRM3;SPG11;ATXN3;CALM1;AMPH;APBA1;GLRB;SYN2;SYT1;GLRA1;GRIN2B;PTCHD1;KCNQ3;HOMER1;GRIK4;RPS6KA2;CAMK4;GABRA3;HTR2C;PLP1;GLRA3;NRXN1;CACNA1B;CAMK1;PRKACB;MINK1;GABRA5;GIPC1;CHRNA7;CHRFAM7A;GABRB2;HCRTR2;GRIA1;PRKAR1B;GABRG2;MAPK1;SYNJ2BP;HTR4;CAMKK2;GRM5;CACNB2;DLG4;SDCBP;GRM1;GRIN1;GABRG1;CPLX1;DTNA;CHRM3;SLC1A1;LRP6;HTR2A;SNAP25;CACNB1;GRIA2;SYT10;SYPL1
prerank,regulation of cell motility (GO:2000145),0.4185013509793985,0.9999627023611316,0.49696969696969695,1.0,1.0,17/121,13.37%,KIF14;CCDC25;MACF1;ROCK2;RHOA;MEMO1;DIAPH1;ARHGAP18;NTN1;ENPP2;ROCK1;PLXNB2;PLXNB1;TBCCD1;RAC1;TWIST1;PLXND1
prerank,establishment of epithelial cell polarity (GO:0090162),0.4785358606375363,0.9998615927571329,0.4576719576719577,1.0,1.0,10/19,26.20%,RHOA;RAP2A;CYTH3;EZR;MSN;CLASP1;SIPA1L3;GOLPH3;CYTH1;CDC42
prerank,positive regulation of cell migration (GO:0030335),0.4207182979656235,0.9996646288981054,0.5125125125125125,1.0,1.0,49/253,15.63%,KIF20B;ARHGEF39;GTSE1;FBXO5;MAP4K4;SYNE2;TWIST2;TRIP6;ROCK2;HYAL1;CEP43;AGO2;MMP14;DDRGK1;ACTN4;LAMB1;KIT;SPAG9;CCAR1;PDPN;MYO1C;ENPP2;PDGFRA;PLAU;CCN1;PPP3CA;NIPBL;DDR2;TGFBR1;GAB1;SMURF2;CRKL;BMP2;PRKCA;ADAM17;SOX9;DMTN;CTSH;PRKCE;DOCK1;ADAM9;INSL3;ITGB1;MIA3;SEMA3D;SRC;ELP6;RHOC;SUN2
prerank,fatty acid beta-oxidation (GO:0006635),-0.2559455866758161,-0.9989509860103153,0.4270833333333333,0.752084485658534,1.0,12/51,15.94%,HADHB;ACADM;CROT;SCP2;ABCD4;MECR;HADH;ACAD10;ECHS1;ABCD2;DECR1;ECHDC2
prerank,axonal transport of mitochondrion (GO:0019896),0.5170576810034233,0.9985552534249698,0.463452566096423,1.0,1.0,2/11,5.54%,TRAK1;MAPT
prerank,cardiac myofibril assembly (GO:0055003),0.479085101399374,0.9984374928455646,0.4653179190751445,1.0,1.0,3/15,7.03%,OBSL1;MYLK3;PDGFRA
prerank,cellular response to glucose stimulus (GO:0071333),-0.2907566337249677,-0.9982810152339304,0.4438202247191011,0.7526210881842172,1.0,8/30,16.81%,UNC13B;KCNB1;GAS6;PRKAA1;SOX4;RAB11FIP2;ADCY8;XBP1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5357723009208718,0.9977052054113548,0.4618973561430793,1.0,1.0,3/10,8.30%,TXN;PYCR1;LRRK2
prerank,phosphatidic acid metabolic process (GO:0046473),-0.25857081739547394,-0.997075605718745,0.5252525252525253,0.7545298542292663,1.0,8/48,8.37%,PLA2G4A;PLD1;DGKB;ABHD5;PLD2;SLC27A1;AGPAT5;DGKG
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.3808676698498234,-0.9969640725443509,0.46254071661237783,0.7537922129393566,1.0,4/12,6.94%,HSP90AB1;B4GALT5;EPHB2;B4GALT6
prerank,positive regulation of cyclase activity (GO:0031281),-0.37174887473221513,-0.9968298992421097,0.46048109965635736,0.7530814801715773,1.0,4/14,9.92%,MAPK8;NOS3;NF1;MAPK3
prerank,regulation of translational initiation (GO:0006446),0.420475989697742,0.996269846043222,0.4594309799789252,1.0,1.0,18/63,17.59%,AGO2;CTIF;KHDRBS1;EIF4H;TPR;FMR1;LARP1;NCK1;CDC123;YTHDF2;EIF2AK3;NCK2;RBM4;PPP1R15B;EIF4A2;DDX1;EIF3H;PAIP2B
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.4605358367772607,0.9961761575047641,0.44416562107904645,1.0,1.0,9/25,19.68%,CEP97;EVI5L;ARHGAP24;YAP1;TBC1D7;ODF2L;LIMK2;PRKCD;PLXNB3
prerank,phospholipid transport (GO:0015914),-0.2530032408829593,-0.9961644967345404,0.4594594594594595,0.7537158437420556,1.0,21/52,25.83%,PLTP;ATP8A1;APOE;SCP2;ATP8B1;ATP8A2;ATP9B;MTTP;ATP9A;TNFAIP8L3;PRELID3B;OSBPL2;MFSD2A;NPC2;SCARB2;PITPNC1;TMEM30A;PRELID3A;ATP10B;PRELID1;ABCA3
prerank,morphogenesis of an epithelium (GO:0002009),0.4604331194573759,0.9961333652983494,0.4548919949174079,1.0,1.0,5/25,12.57%,TIMELESS;FGFR2;KDM2B;TBX18;SOX9
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.23209682454915556,-0.996104584730491,0.42857142857142855,0.7529030377402215,1.0,21/69,21.48%,OGT;IGF1;PDGFRB;PIK3C2B;KCNH1;PLCB3;PIK3R1;IRS2;MYO16;NYAP2;NF1;IRS1;HTR2A;PI4KA;PLCE1;ERBB2;PIK3CD;PIK3CA;EXOC1;PLCH1;PIK3R2
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4680203292852077,0.9960564540209532,0.4741275571600481,1.0,1.0,9/29,16.15%,USF3;EFNA1;SFRP2;NKX2-1;ADIPOR1;SPRED1;SFRP1;SPRED2;PTEN
prerank,mRNA splice site selection (GO:0006376),0.4599823767899686,0.9959019612328488,0.45207100591715976,1.0,1.0,10/30,19.70%,SETX;SRSF10;PSIP1;CELF2;SF3A2;LUC7L3;PRPF39;SFSWAP;LUC7L2;SF3A3
prerank,RNA 3'-end processing (GO:0031123),0.4270335741800391,0.9958024935673268,0.4869927159209157,1.0,1.0,17/69,13.47%,TENT2;SRSF4;CSTF3;FIP1L1;UPF3B;DDX39B;TENT4A;SRSF7;TUT1;TUT7;WDR33;PCF11;SRSF3;SRRM1;CPSF4;RPRD1A;TUT4
prerank,primary miRNA processing (GO:0031053),0.5182604894805867,0.9957556633633502,0.48493975903614456,1.0,1.0,5/10,17.84%,DGCR8;SMAD3;HNRNPA2B1;METTL3;SMAD2
prerank,anion transmembrane transport (GO:0098656),-0.2461849127579767,-0.9954931937964114,0.3835616438356164,0.753407189345437,1.0,22/67,19.08%,SLC16A12;SLC1A2;SLC13A3;SLC7A2;SLC13A4;SLC25A13;SFXN2;SLC25A12;SLC3A2;SLC7A5;SLC27A1;SLC5A6;LRRC8B;ABCC5;LRRC8D;SLC25A4;SLC35A2;SLC1A1;SLC38A5;SLC25A11;SLC25A38;LRRC8A
prerank,regulation of stem cell differentiation (GO:2000736),0.4165795493465379,0.9948938888701042,0.5015641293013556,1.0,1.0,32/89,22.99%,CBFB;BMPR1A;PSMC2;PSMD5;PRKDC;PDGFRA;PSMB1;PSMD14;YAP1;PSMD1;KMT2A;HNRNPU;YTHDF2;TAL1;PSMB9;ITCH;PSMC6;GDNF;OCIAD1;METTL3;PSMB2;RUNX1;PSME4;PUS7;PSMB7;PSMD11;PSME3;EIF2AK2;LDB1;PSMD13;PSMB8;PSMD4
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.3786015986087522,-0.9945429251241974,0.45396825396825397,0.7546748386795871,1.0,6/13,19.33%,TGFBR2;CTNNB1;VEGFA;ENG;NOTCH4;NRP1
prerank,positive regulation by host of viral transcription (GO:0043923),-0.35294551242188954,-0.9944528163430971,0.44680851063829785,0.7538955286405654,1.0,7/15,20.33%,LEF1;EP300;CCNT1;JUN;RRP1B;TAF11;SNW1
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.26998319041461644,-0.9944388987815337,0.47474747474747475,0.7529472576951401,1.0,16/44,24.49%,APOE;PDCD4;LYN;DNAJA1;PTPN22;STK38;NF1;INPP5K;SPRY2;DUSP1;SORL1;UCHL1;CDK5RAP3;BMP7;CD300A;MAPK8IP1
prerank,regulation of rRNA processing (GO:2000232),-0.3530654224736945,-0.9942460089242556,0.42366412213740456,0.752462164148115,1.0,10/16,35.74%,USP36;HEATR1;WDR75;KAT2B;BUD23;RIOK2;DIMT1;RIOK1;TRMT112;SIRT7
prerank,positive regulation of protein polymerization (GO:0032273),0.4261254603583155,0.9937225586829421,0.4951974386339381,1.0,1.0,13/65,13.20%,CDK5RAP2;PSRC1;NUMA1;MAPT;CDC42EP2;NCK1;TPPP;DRG1;AKAP9;RAC1;NCK2;BAIAP2L1;PRKCE
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.4523405498237685,0.9935862208691625,0.4853658536585366,1.0,1.0,9/31,13.30%,TWIST2;CRIM1;SMAD6;TMEM64;LIMD1;TRPM4;SOX9;LRP5;TWIST1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.4329648778604832,0.9931427290980083,0.48484848484848486,1.0,1.0,6/49,4.46%,HMGB2;RBM15;CBFB;MOV10;NFE2;RAB7B
prerank,extracellular structure organization (GO:0043062),0.41704758163157973,0.9926784491429469,0.5285285285285285,1.0,1.0,46/204,15.02%,MATN3;COL22A1;NID2;MMP24;MMP28;MMP25;MFAP2;LOX;COL4A6;FBN1;MMP14;ADAM12;COL4A4;ITGB7;LAMB1;COL18A1;COL5A2;NPNT;ADAMTS10;ADAMTS5;COL23A1;ADAMTS14;FBLN5;SERPINE1;ADAMTS9;ADAMTSL2;ELN;ADAMTS2;ADAMTS16;DDR2;TGFBR1;SLC39A8;NID1;COL4A5;POSTN;ADAMTSL3;COL15A1;BGN;ADAM19;ADAMTS1;ITGA5;ITGB1;CD44;MFAP5;ITGA8;ITGAV
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.5062827807024606,0.9925612628373616,0.47988505747126436,1.0,1.0,3/11,13.49%,ARRB1;GRK3;ADRB2
prerank,GTP metabolic process (GO:0046039),0.4864176693011191,0.992544609612071,0.4519621109607578,1.0,1.0,5/15,15.76%,EFL1;LRRK2;RHOQ;GNAI3;MFN1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.46878806377038185,0.9924027196466858,0.4892268694550063,1.0,1.0,5/26,13.65%,KNSTRN;GAREM1;PDPK1;SOX9;MED1
prerank,central nervous system neuron development (GO:0021954),-0.3604590995022261,-0.9923972824391465,0.4555160142348754,0.755791370447837,1.0,4/15,6.94%,HSP90AB1;NTRK2;B4GALT5;B4GALT6
prerank,neuron cell-cell adhesion (GO:0007158),-0.3660617188429917,-0.9923543696791193,0.4533762057877814,0.7548869301560057,1.0,4/14,7.61%,ASTN2;NRXN3;NCAM2;NRXN1
prerank,regulation of establishment of planar polarity (GO:0090175),0.41942981835665977,0.9921868353571999,0.4979166666666667,1.0,1.0,15/88,11.75%,SAPCD2;VANGL1;RHOA;PSMC2;PSMD5;SPEF1;DAAM1;PSMB1;SMURF1;PSMD14;NPHP3;PSMD1;PSMB9;SMURF2;RAC1
prerank,megakaryocyte differentiation (GO:0030219),0.5186626931779724,0.9918627312696902,0.46396396396396394,1.0,1.0,4/11,19.43%,KIT;TAL1;MED1;ZFPM1
prerank,estrogen metabolic process (GO:0008210),-0.3508255464981217,-0.9911779145396165,0.44313725490196076,0.7566172110792114,1.0,8/15,49.16%,HSD17B11;HSD17B7;HSD17B8;HSD17B10;HSD17B2;SULT1A1;HSD17B14;HSD17B1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.45147072278228423,0.9910303394688232,0.4802395209580838,1.0,1.0,9/31,18.35%,E2F1;GSK3B;TFDP1;BOK;CASP8;TP53;PPP3R1;YWHAQ;BAD
prerank,retinol metabolic process (GO:0042572),0.4968939503314586,0.9909822787197223,0.4739010989010989,1.0,1.0,2/14,5.89%,RDH11;RDH12
prerank,actin filament bundle organization (GO:0061572),0.4455750836505894,0.9905043669073398,0.4630715123094959,1.0,1.0,13/33,22.67%,ADD2;RFLNA;CORO1B;EZR;DMTN;DPYSL3;BAIAP2L1;ADD1;LCP1;SHROOM2;SHROOM1;PLS1;MYO1B
prerank,hematopoietic stem cell proliferation (GO:0071425),0.509040371373755,0.9902706928552054,0.4665718349928876,1.0,1.0,4/11,10.57%,ETV6;WNT2B;SFRP2;YTHDF2
prerank,regulation of stress fiber assembly (GO:0051492),0.4205936114318886,0.9902622843440058,0.5020833333333333,1.0,1.0,23/74,17.87%,STMN1;ARHGAP28;ROCK2;RHOA;CGNL1;LPAR1;SORBS3;TMEFF2;ALMS1;ROCK1;ARHGAP6;TGFBR1;ARHGEF18;RAC1;WASF2;ARHGEF10L;RHOC;NF2;FHOD1;SFRP1;CCN2;CD47;CLASP1
prerank,sulfur compound catabolic process (GO:0044273),-0.276139809755491,-0.989897145271889,0.4393939393939394,0.7588302934968383,1.0,12/38,16.97%,GNS;FMOD;HEXB;GGT5;PRELP;TXN2;HEXA;OGN;LUM;IDS;NUDT7;GALNS
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.40721477971556697,-0.9892863946736178,0.49019607843137253,0.7593096031537281,1.0,4/10,24.41%,CST3;TNFRSF1B;FAP;TNFRSF1A
prerank,regulation of organelle organization (GO:0033043),0.4177939307136514,0.9892255264465755,0.5093360995850622,1.0,1.0,18/80,12.68%,RAB33B;USP6NL;MIEF2;TBC1D25;SPEF1;DIAPH1;MAPT;RHOT1;ARMH3;ARL6IP1;MARK2;PLXNB1;STX18;EZR;AKAP9;STOX1;CENPV;CLIC4
prerank,cellular component maintenance (GO:0043954),0.49868347512261635,0.9891656933521996,0.473463687150838,1.0,1.0,3/12,9.31%,LNPK;PRNP;MTMR2
prerank,extracellular matrix assembly (GO:0085029),0.4581871830669749,0.9890671087265597,0.46115288220551376,1.0,1.0,5/23,10.19%,HAS3;LAMB1;QSOX1;FBLN5;HAS1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4246393459647372,0.9888901109143428,0.509375,1.0,1.0,11/85,12.64%,KIF14;DENND4C;MFN2;KANK2;EPS8L1;MAPKAP1;MYO9B;CRKL;ARHGEF18;DENND1A;NOTCH2
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.2865824937630189,-0.9886459279842184,0.4682080924855491,0.7597898909760742,1.0,9/29,11.84%,RPS8;RPS21;NOL10;RPS14;KRI1;RPS19;HEATR1;UTP20;NGDN
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.3063837754082487,-0.9883341956847507,0.4585635359116022,0.7594984813824746,1.0,7/24,18.60%,PDE3A;PEX5L;GNAI1;PRKAR1B;UBE2B;PDE2A;PDE4D
prerank,positive regulation of binding (GO:0051099),0.4198640459581016,0.9877397163194361,0.4947916666666667,1.0,1.0,15/84,11.42%,PON1;DDX11;HMGB2;STMN1;GSK3B;DHX9;ADD2;STK3;TCF7L2;NMD3;TXN;LRRK2;HMGB1;PARP9;BMP2
prerank,positive regulation of transport (GO:0051050),0.42107663233192644,0.9872193266989094,0.5098855359001041,1.0,1.0,10/85,11.48%,SPAG5;PON1;GSK3B;ANXA2;NUMA1;FMR1;KMT2A;CAMK1D;BOK;ANXA1
prerank,prostanoid biosynthetic process (GO:0046457),-0.3545547024366183,-0.9871303259542588,0.4750830564784053,0.761349369695592,1.0,4/15,12.36%,PLA2G4A;PTGDS;PNPLA8;PTGS2
prerank,regulation of neuron projection arborization (GO:0150011),0.48170896100292254,0.9869139140075367,0.47124824684431976,1.0,1.0,3/15,11.18%,MACF1;MOV10;GRIP1
prerank,synaptic vesicle transport (GO:0048489),-0.3977088105812936,-0.9868211447302861,0.4855305466237942,0.761067794706327,1.0,6/11,23.69%,SPG11;KIF5B;KIF5C;SYNJ1;RAB27A;TOR1A
prerank,quinone biosynthetic process (GO:1901663),-0.36907971519021493,-0.9864684385628012,0.4868421052631579,0.7608823269823393,1.0,5/14,12.22%,COQ8B;COQ5;COQ10A;COQ3;PDSS2
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.4937535190813921,0.9863342195197985,0.47412587412587415,1.0,1.0,4/14,18.18%,WNK1;ADAM17;STK39;OXSR1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.44229629547938776,0.9861552320357464,0.4717208182912154,1.0,1.0,10/31,19.65%,FGFR2;HOXC4;PDGFRA;DSCAML1;HOXB3;TGFBR1;TWIST1;OSR1;HOXA3;DYNC2I1
prerank,sensory perception of chemical stimulus (GO:0007606),-0.35178333930721,-0.9861260916589175,0.483271375464684,0.7606486066854319,1.0,6/15,22.19%,GNAL;BBS4;ADCY3;SYT10;SLC24A4;DRD2
prerank,B cell proliferation (GO:0042100),-0.3414282394649762,-0.9859282029665055,0.48175182481751827,0.7601610776119481,1.0,7/17,32.87%,MEF2C;HSPD1;BCL2;CD180;CD40;PTPRC;CR2
prerank,positive regulation of cholesterol transport (GO:0032376),0.45759221365584696,0.9858710760022427,0.47815533980582525,1.0,1.0,2/27,4.58%,PON1;ABCB4
prerank,negative regulation of biosynthetic process (GO:0009890),0.49383240723751864,0.9853758431004105,0.4641873278236915,1.0,1.0,1/16,1.19%,SLC18A2
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.39833964338380545,-0.9850310830000296,0.48517520215633425,0.7613274680855456,1.0,4/10,18.94%,APOD;LRP1;NDRG4;PTPN12
prerank,cellular calcium ion homeostasis (GO:0006874),-0.20859383821240385,-0.9846671866868751,0.6,0.7611889615665096,1.0,29/133,16.64%,CAMK2D;PSEN1;SLC8A3;ATP1B1;TRPC5;CAV1;RYR2;ANXA6;PACS2;SLC24A2;DMPK;CDH5;TPT1;HTR2C;TRPC3;TRPC1;CHRNA7;BCL2;HCRTR2;CAV2;TMCO1;SLC30A1;ADCY8;ATP2B2;ATP2B3;SMDT1;HTR2A;PTH1R;RMDN3
prerank,response to amino acid starvation (GO:1990928),-0.23642377667611442,-0.9845323844191937,0.48148148148148145,0.7604866565125509,1.0,21/72,15.14%,ATP6V0D1;MAPK8;ATP6V1E1;ATP6V0B;MIOS;SESN3;WDR59;MAP3K5;FAS;RNF152;GCN1;SZT2;MAPK3;MTOR;MAPK1;ATP6V0C;KPTN;CEBPB;ATP6V1H;RRAGC;DAPL1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.28854032938544816,-0.9844878216291945,0.43125,0.7596210944432861,1.0,4/29,5.24%,STAT3;IFNAR1;STAT6;SOCS2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.33573338387995,-0.9843192710436254,0.453125,0.759047904496483,1.0,10/17,39.74%,RYR2;KCNQ1;NEDD4L;KCNJ8;PKP2;GPD1L;KCNE4;SCN3B;KCNH2;SCN5A
prerank,regulation of cilium assembly (GO:1902017),0.42128640436896947,0.9843189624381777,0.5150214592274678,1.0,1.0,14/62,12.89%,USP6NL;CEP97;IFT140;EVI5L;TBC1D13;TBC1D2B;YAP1;TBC1D7;SDCCAG8;TAPT1;ARHGAP35;CEP120;TBC1D19;ATG3
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.27993176214814586,-0.9840782530107833,0.44654088050314467,0.7585925355840115,1.0,14/32,32.74%,CALM1;AKAP6;CEMIP;PLCG1;TRPC1;CX3CL1;CALM3;GSTM2;JPH2;GPER1;THY1;P2RY6;GSTO1;APLNR
prerank,negative regulation of cellular component organization (GO:0051129),0.4207767407085879,0.9839285717566875,0.5179324894514767,1.0,1.0,13/74,13.65%,PON1;RTEL1;GSK3B;IAPP;BMP6;TMEFF2;RIOK3;DNM2;MTMR2;SNX33;TERF2;AIDA;PRKD1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.4193731532173308,0.9834787526511051,0.5063694267515924,1.0,1.0,30/70,24.78%,CBFB;PSMC2;PSMD5;PRKDC;PSMB1;PSMD14;YAP1;PSMD1;KMT2A;YTHDF2;TAL1;PSMB9;ITCH;PSMC6;METTL3;PSMB2;RUNX1;PSME4;PUS7;PSMB7;PSMD11;PSME3;EIF2AK2;LDB1;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,regulation of fat cell differentiation (GO:0045598),0.42080774240548036,0.9834465480416635,0.511482254697286,1.0,1.0,24/74,19.43%,E2F1;FTO;ASXL1;ANKRD26;SFRP2;WWTR1;TMEM64;YAP1;RUNX1T1;BMP2;ENPP1;TRPM4;LRP5;RORA;SMAD3;MEDAG;WDFY2;LPL;SFRP1;AAMDC;FRZB;SYAP1;ZFPM2;ZFPM1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.5190341512783089,0.9829190838215903,0.488,1.0,1.0,1/10,2.44%,ADGRV1
prerank,protein targeting to lysosome (GO:0006622),0.46032474106214627,0.9829056575451052,0.4705128205128205,1.0,1.0,4/20,12.21%,AP4M1;NEDD4;ZFYVE16;NAGPA
prerank,aorta morphogenesis (GO:0035909),-0.33203627778557143,-0.982733988040672,0.4280155642023346,0.7607955470697781,1.0,6/17,5.49%,JAG1;ACVRL1;PDGFRB;PROX1;LRP1;MYLK
prerank,ESCRT complex disassembly (GO:1904896),-0.4119066388722397,-0.9821280186824496,0.5144694533762058,0.760209666021078,1.0,6/10,27.22%,VPS4B;CHMP2B;CHMP5;CHMP1A;CHMP2A;CHMP7
prerank,ESCRT III complex disassembly (GO:1904903),-0.4119066388722397,-0.9821280186824496,0.5144694533762058,0.760209666021078,1.0,6/10,27.22%,VPS4B;CHMP2B;CHMP5;CHMP1A;CHMP2A;CHMP7
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.4970418293635093,0.9819998769822421,0.4726507713884993,1.0,1.0,5/14,18.17%,ZEB1;XDH;SPRED1;SPRED2;OSR1
prerank,B cell mediated immunity (GO:0019724),-0.4011576828834792,-0.9819613888673814,0.4732142857142857,0.7595760520980795,1.0,4/10,38.40%,MSH2;CD74;FCER1G;FCGR2B
prerank,regulation of autophagosome maturation (GO:1901096),0.4978353371018711,0.9818743573934826,0.47531734837799716,1.0,1.0,6/13,20.08%,TBC1D25;TMEM39A;ADRB2;UVRAG;CLEC16A;FYCO1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.43416389089225155,0.9815762720446911,0.4965675057208238,1.0,1.0,16/38,22.31%,SAE1;LEPROT;FBXW7;RNF31;SH3GLB1;HTRA2;LRRK2;CSNK2A2;ATP5IF1;NPEPPS;UBL5;SIAH3;SREBF1;UBE2D3;UBE2L3;ATG13
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.4146911042770085,0.9815679454306367,0.5562248995983936,1.0,1.0,35/166,15.17%,NR2E3;E2F2;NAT14;MED26;TEAD1;E2F3;POLR1A;TAF3;TBL1XR1;POLR1B;ERCC3;TAF12;POLR2A;WWTR1;NR2C2AP;YAP1;TAF1D;NR4A2;NR3C1;TEAD3;TAF15;GTF2A1;HDAC1;TAF4;RBPJ;NR4A1;NOTCH2;POLR1G;RORA;MAML1;MED1;RARB;NRBP1;TFB1M;MED27
prerank,regulation of developmental growth (GO:0048638),-0.28718799398040956,-0.9813898050084573,0.47619047619047616,0.7600172160831139,1.0,8/29,11.42%,MBD5;APOE;INSR;IGF1;NRCAM;ABL1;APP;SIX1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.27267156555342775,-0.9813499507693823,0.4666666666666667,0.7591523713107509,1.0,11/35,18.01%,SGIP1;VTN;BICD1;B2M;HNRNPK;SMAP1;LDLRAP1;BMP2K;HIP1;CBL;PPT1
prerank,actin filament-based transport (GO:0099515),0.4642983750397396,0.9798843084172502,0.4881889763779528,1.0,1.0,3/21,5.75%,SYNE2;ACTN4;MYO1C
prerank,ncRNA metabolic process (GO:0034660),0.45022654392065375,0.9798700152043827,0.5011494252873563,1.0,1.0,6/37,8.24%,DGCR8;AGO2;MAPT;MAEL;EXD1;TUT7
prerank,long-chain fatty acid transport (GO:0015909),-0.2911210258234184,-0.9798011332435768,0.4838709677419355,0.7617272746829766,1.0,12/30,30.25%,APOE;ABCD4;SLC27A1;ACACB;ABCD2;PRKAG2;SLC27A4;ACSL1;MFSD2A;MID1IP1;FABP5;CPT1A
prerank,establishment of skin barrier (GO:0061436),0.48907996774524126,0.9796795251223475,0.49182561307901906,1.0,1.0,1/15,1.85%,STMN1
prerank,regulation of water loss via skin (GO:0033561),0.48907996774524126,0.9796795251223475,0.49182561307901906,1.0,1.0,1/15,1.85%,STMN1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.4931867505985752,0.979333827374697,0.47819767441860467,1.0,1.0,4/13,12.61%,BMPR1A;BMP6;TGFBR1;SMAD4
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.2725017543164417,-0.9790853122252602,0.5272727272727272,0.7624378024544681,1.0,13/33,25.58%,GLUL;GLS;GOT2;PRODH;KYAT1;GOT1;ALDH5A1;DDAH2;GLUD1;NIT2;RIMKLA;OAT;GLS2
prerank,RNA metabolic process (GO:0016070),0.4092770228348737,0.978244431054282,0.5447154471544715,1.0,1.0,34/127,16.60%,SYNCRIP;SETX;PABPC4;TENT2;AGO2;HNRNPD;FTO;RBFOX2;RNASE6;DHX9;HNRNPA1;DDX39B;HNRNPH1;POLR2A;RBMS2;RNASEH2A;DHX8;CELF2;HNRNPUL1;PPP1R8;HNRNPU;HNRNPL;RNASE1;EXOSC7;ATXN1;HNRNPH2;RNGTT;RBM4;RBMS1;HNRNPA2B1;PNPT1;METTL3;NOL9;PRPF4
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4182107693781716,0.9781608100333978,0.5038503850385039,1.0,1.0,8/56,12.61%,TTK;BMPR1A;BMP6;PMEPA1;SMAD6;TGFBR1;BMP2;SMAD4
prerank,negative regulation of cell adhesion (GO:0007162),-0.2313313831656219,-0.9781103994783219,0.5166666666666667,0.7637758629068578,1.0,19/72,17.76%,PTK2;SPOCK1;PODXL;SEMA6A;JAG1;ACVRL1;ACER2;NEXMIF;EPHB2;SEMA4D;PTPRO;PLXNC1;FZD4;CX3CL1;DUSP1;ITGB1BP1;CORO2B;CBLL1;PLXNA4
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.479964523505526,0.978052987213461,0.4751066856330014,1.0,1.0,5/15,22.49%,NR3C1;HNRNPU;ANXA1;UBE2L3;ZFP36L1
prerank,negative regulation of RNA splicing (GO:0033119),0.4659066350402974,0.9779825249810802,0.4888304862023653,1.0,1.0,6/19,17.75%,SRSF4;SRSF10;SRSF7;SAP18;PTBP2;SFSWAP
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.25590868723053545,-0.977478141277095,0.4857142857142857,0.7643671165304013,1.0,13/43,17.57%,SH3KBP1;STAM2;DUSP3;EPN1;TSG101;SOCS5;ZGPAT;TGFA;GRB2;SPRY2;CBLB;ARHGEF7;CBL
prerank,regulation of trophoblast cell migration (GO:1901163),0.49765447489591474,0.9772627627324109,0.49642346208869814,1.0,1.0,3/14,12.36%,AGO2;SMURF2;GJA1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.5000512782986873,0.9771213590892944,0.4821173104434907,1.0,1.0,6/12,20.62%,LHPP;ADSL;PFAS;GART;PPAT;ADSS2
prerank,organic acid transport (GO:0015849),-0.22481139547790122,-0.9770808245433291,0.4857142857142857,0.7644308660193952,1.0,26/94,23.58%,SLC6A6;SLC13A3;SLC7A2;SLCO1C1;SFXN5;SLCO2B1;GOT2;SLC3A2;SLC27A1;ABCC4;ATP8B1;SLC22A6;ABCG2;SLC5A6;SLC7A6;SLC16A1;LRRC8D;SLC38A5;STARD5;SLC25A11;SLC6A15;SLC27A4;ACSL1;SLC36A1;MFSD2A;SLC7A14
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.39965855988052823,-0.9770640991365921,0.48104956268221577,0.7634870128150472,1.0,5/10,18.16%,NEXMIF;RGCC;PPM1F;VEGFA;NOTCH4
prerank,protein tetramerization (GO:0051262),0.41408086169600267,0.9768811359424076,0.523093447905478,1.0,1.0,11/67,12.53%,TK1;UPB1;ALDH1A2;HPRT1;TRPA1;USP16;APIP;TRPM2;ACACA;APPL2;TRPM4
prerank,protein localization to cilium (GO:0061512),0.4389108833448496,0.9767309545325843,0.5017751479289941,1.0,1.0,4/32,7.69%,BBS9;WDR35;IFT140;RAB29
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.3100105944554342,-0.9764072387290496,0.4410480349344978,0.764028887702879,1.0,2/23,0.29%,CAMK2D;CACNA2D1
prerank,axon development (GO:0061564),-0.23835193176315106,-0.9762481143086162,0.5333333333333333,0.7634113902973894,1.0,21/78,14.13%,GRM7;DCC;PAK3;ACTB;S100A6;CAMSAP2;KLF7;NRCAM;MAP1B;TAOK2;BRSK1;EPHB2;GAP43;PLP1;MAP1A;CTNNA2;APP;RTN4RL1;SLITRK1;NREP;NTNG1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.3688826160788324,-0.9759931461363452,0.5,0.7630215900802862,1.0,4/13,16.62%,BPNT2;TPST1;ABHD14B;TPST2
prerank,folic acid metabolic process (GO:0046655),0.46589145129129755,0.9759757569735003,0.4777327935222672,1.0,1.0,4/18,13.55%,MTHFD1L;MTHFR;SLC19A1;DHFR
prerank,steroid catabolic process (GO:0006706),-0.4145958674314211,-0.9758299375768239,0.5093167701863354,0.7624692957226236,1.0,4/10,34.53%,HSD17B11;SPP1;YWHAH;HSD11B1
prerank,immunoglobulin mediated immune response (GO:0016064),-0.40311090930460974,-0.9756653940453224,0.4879518072289157,0.7618625351301606,1.0,4/10,38.40%,CD81;CD74;FCER1G;FCGR2B
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.5001555300941398,0.9756303638054007,0.48372781065088755,1.0,1.0,3/11,6.26%,AGO2;NECAB1;SOAT1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.3367618052768413,-0.9754963776758782,0.44813278008298757,0.7613559964568297,1.0,6/16,11.73%,CAMK2D;IGF1;AKAP6;TRPC3;PARP1;MEF2A
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.49443972083886534,0.9744864073191963,0.4977645305514158,1.0,1.0,5/12,19.93%,GSS;GCLM;BDH2;GCLC;HAGH
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.39927324809363707,-0.9737570208805629,0.481994459833795,0.7644765215416613,1.0,4/10,23.39%,PLA2G4A;PNPLA8;PLA2G7;PLA2G15
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.294350821908724,-0.9736709714571444,0.553763440860215,0.7637282722881097,1.0,9/27,14.61%,PSEN1;BRSK1;HOMER1;IL1RAPL1;CAMK2G;CTNNA2;NCS1;NTNG1;GSK3A
prerank,ether lipid metabolic process (GO:0046485),0.4846332032409889,0.9736256733620208,0.4811715481171548,1.0,1.0,4/14,11.77%,AGMO;AGPS;PEDS1;TMEM86B
prerank,ganglioside biosynthetic process (GO:0001574),-0.36177443207596094,-0.9734610997467682,0.4769736842105263,0.7633046644620061,1.0,6/15,10.93%,ST8SIA4;B4GALT5;B4GALT6;ST6GALNAC3;ST6GALNAC5;ST8SIA6
prerank,organelle fusion (GO:0048284),0.4509700038596549,0.9733663181769444,0.47924528301886793,1.0,1.0,9/22,21.25%,MIEF2;VPS18;MFN2;MIEF1;CHCHD3;MFN1;MIGA2;SPG7;EEA1
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.2913171684931015,-0.9732605405902869,0.4973821989528796,0.7628479577744048,1.0,7/29,19.54%,JAM2;ANO6;GAS6;LGMN;PLA2G7;LGALS9;CREB3
prerank,limb morphogenesis (GO:0035108),0.46535507939978704,0.973082432773941,0.4993288590604027,1.0,1.0,3/20,7.60%,GLI3;CYP26B1;NIPBL
prerank,sulfur compound transport (GO:0072348),0.4514387795145588,0.9728380848038481,0.47642679900744417,1.0,1.0,1/27,0.73%,RACGAP1
prerank,tRNA 5'-leader removal (GO:0001682),0.48456907335019556,0.9725884880121703,0.48354792560801146,1.0,1.0,5/13,19.62%,RPP40;RPP30;POP1;PRORP;RPP21
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.49488524126728406,0.9725586638276027,0.5007153075822603,1.0,1.0,5/13,17.17%,DHX9;AGPAT2;AGPAT1;AXL;MAVS
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.41463446338561627,0.9716970140890995,0.5176848874598071,1.0,1.0,1/69,0.13%,KIF14
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.37079472841984196,-0.9715869155026322,0.511864406779661,0.7659019964361664,1.0,4/12,12.33%,OS9;RER1;HSPA5;KDELR3
prerank,positive regulation of T cell migration (GO:2000406),0.46507413927059105,0.9714192279347834,0.47979139504563234,1.0,1.0,5/20,18.18%,RHOA;WNK1;ADAM17;STK39;OXSR1
prerank,bone development (GO:0060348),0.43838751816996135,0.9714125751563645,0.5022935779816514,1.0,1.0,13/39,20.39%,CYP26B1;FGFR2;SULF2;SLC10A7;SULF1;P3H1;GJA1;LRP5;TP53;NOTUM;SH3PXD2B;SKI;RANBP3L
prerank,regulation of glycolytic process (GO:0006110),0.4123669366121726,0.9713798174024044,0.5196182396606575,1.0,1.0,17/68,17.41%,NDC1;NUP155;NUP205;NUP160;PFKFB1;GCK;NUP85;TPR;ZBTB20;NUP214;RANBP2;ARNT;NUP133;PRKAG1;NUP42;NUP98;NUP210
prerank,carboxylic acid transport (GO:0046942),-0.24565576205925707,-0.9709739263535297,0.5168539325842697,0.7663525052623941,1.0,16/55,24.51%,SLC6A6;SLC16A12;SLC13A3;SLC3A2;SLC7A5;PSAP;SLC7A6;SLC16A1;SLC16A4;SLC6A11;SLC1A1;SLC38A5;SLC6A15;SLC36A1;SLC6A7;SLC16A13
prerank,response to reactive oxygen species (GO:0000302),-0.2440265241414171,-0.9699626666321469,0.47474747474747475,0.7678270538345243,1.0,22/54,23.88%,APOD;APOE;MAPK8;MAPK9;SOD2;TPM1;JUN;MAPK3;STK25;MAPK1;CAMKK2;MPV17;TXNRD2;CHUK;GLRX2;GPX1;PRDX3;PRDX5;ERCC6L2;RPS3;COA8;PDK2
prerank,metallo-sulfur cluster assembly (GO:0031163),0.4571125197502108,0.9696687554097533,0.4847715736040609,1.0,1.0,10/22,24.56%,FXN;NUBP2;CIAO3;MMS19;ISCA2;NUBP1;LYRM4;CIAO2A;NFS1;CIAPIN1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.3794453265480737,-0.9694467637032126,0.5227272727272727,0.7680446290378793,1.0,4/12,13.93%,STX4;ANO1;GPLD1;ADCY8
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.29270676541674184,-0.9693615497104262,0.49246231155778897,0.7673175483355785,1.0,9/26,12.71%,FMOD;B4GALT5;B3GNT2;ST3GAL6;B4GALT6;PRELP;OGN;LUM;B4GALT4
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.2621113225848682,-0.9693448148860282,0.49242424242424243,0.766403683006324,1.0,10/40,11.25%,PTK2;NUB1;HIPK2;UFL1;GNA12;RPL23;RPS7;ARAF;UBQLN4;SGTA
prerank,myeloid dendritic cell activation (GO:0001773),-0.3689308552170336,-0.9690437964533963,0.45741324921135645,0.7661735470646394,1.0,2/12,6.22%,TGFBR2;CAMK4
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.4616487216364378,0.9688398178382458,0.4876783398184176,1.0,1.0,7/16,23.34%,TRA2B;THRAP3;DAZAP1;NUP98;TRA2A;RBMX;NCL
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.4117684084713269,0.9687457017983336,0.5285565939771547,1.0,1.0,29/84,19.98%,RBM15;SRSF4;TRA2B;RBFOX2;KHDRBS1;HNRNPA1;SRSF10;THRAP3;MBNL3;RBM25;FMR1;SRSF7;SAP18;CELF2;SRSF3;HNRNPU;RBM15B;HNRNPL;SRPK1;RBM4;DAZAP1;FXR1;NUP98;SFSWAP;SRPK2;CWC22;LARP7;KHDRBS3;TRA2A
prerank,T cell activation (GO:0042110),0.4126258351682175,0.9686957593619753,0.5207667731629393,1.0,1.0,15/69,16.28%,ADA;KIT;LEPR;PTPN2;PPP3CA;SCRIB;RAB29;CTPS1;NCK1;NCK2;LMBR1L;CASP8;CD44;LCP1;MSN
prerank,response to cholesterol (GO:0070723),0.465199045762397,0.9682276817442174,0.5034293552812071,1.0,1.0,3/17,10.49%,GRAMD1C;PMVK;TGFBR1
prerank,regulation of blood coagulation (GO:0030193),-0.28824751641751745,-0.9680279916182818,0.5053763440860215,0.7675483020365867,1.0,6/27,6.10%,CAV1;APOE;VTN;EPHB2;THBD;CD34
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.423010506108614,0.9674278523531266,0.5226019845644984,1.0,1.0,14/45,18.93%,ZC3H7A;EIF4E;MATR3;FOXO3;LARP1;PUM2;PARP9;MEX3D;LARP4;RC3H1;PER1;ZC3H7B;METAP1;SPOUT1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.40472602180055994,0.9670516586938963,0.5731462925851704,1.0,1.0,40/199,16.15%,PON1;BRCA2;ATP2B4;SFMBT1;LOXL2;RB1;ROCK2;USF3;GSK3B;SRF;NFIB;MCC;CHSY1;HOXA7;GRHL2;EFNA1;SFRP2;ADAMTS5;SMAD6;ALDH1A1;ROBO1;ROCK1;NPR3;ATP2B1;BMP2;NKX2-1;TBX18;RBPJ;GJA1;ADAM17;SOX9;ADIPOR1;HEY2;SPRED1;DOCK7;STK11;TLE3;SFRP1;SPRED2;PTEN
prerank,response to ketone (GO:1901654),-0.2998663124975034,-0.9666447672212706,0.5422222222222223,0.769823216643638,1.0,12/24,25.79%,CAV1;TGFB2;ABHD2;NR1H3;CATSPER2;SLIT2;THBS1;TGFB3;WBP2;SLIT3;UBE3A;CATSPER3
prerank,cardiocyte differentiation (GO:0035051),-0.4027746857954294,-0.9666355372112786,0.4804804804804805,0.7688960112336883,1.0,6/10,26.48%,TGFB2;SIK1;KDM6B;GATA6;CBY1;MYOCD
prerank,organonitrogen compound catabolic process (GO:1901565),-0.24965423173729018,-0.9665668602039621,0.5287356321839081,0.7680848116063397,1.0,20/57,23.67%,PLA2G4A;LNPEP;CLPX;RENBP;PNPLA8;TPP1;TXN2;SIAH1;ACE;MTOR;ENPEP;RIDA;PLA2G7;PPT1;BCKDK;NAGK;CLN5;SGPL1;PLA2G15;USE1
prerank,response to nitric oxide (GO:0071731),0.4825339758709005,0.9663812853805425,0.4992636229749632,1.0,1.0,3/13,7.96%,AQP1;TXN;CDK2
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.2879700035415473,-0.9660802296198713,0.4919786096256685,0.7681884499325827,1.0,5/28,8.92%,CYRIB;SH3KBP1;PRKCQ;HSPD1;XRCC6
prerank,pulmonary valve morphogenesis (GO:0003184),-0.3303891060373979,-0.9660429516555907,0.4895397489539749,0.7673191949952891,1.0,7/17,16.20%,JAG1;TGFB2;NOS3;SLIT2;HEYL;STRA6;ROBO2
prerank,response to iron ion (GO:0010039),0.4786131477990666,0.9659561111688194,0.48104956268221577,1.0,1.0,5/12,23.21%,FXN;BMP6;ACO1;SNCA;SLC11A2
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.40095625358655895,0.9658288472607984,0.5655241935483871,1.0,1.0,63/152,24.87%,MACF1;DEPDC1B;FGFR2;PSMC2;RNF220;PSMD5;SULF2;TBL1XR1;ADGRA2;WNK1;SFRP2;SULF1;UBR5;LRRK2;PSMB1;PSMD14;SMARCA4;AXIN2;PSMD1;LRRK1;PSMB9;SMURF2;BMP2;RSPO3;CSNK1G2;TRPM4;USP47;XIAP;PSMC6;PIN1;NFKB1;SFRP1;SALL1;AMER1;FAM53B;PSMB2;CSNK1G1;PSME4;PSMB7;CAPRIN2;SKI;PPM1A;TERT;PSMD11;SEMA5A;LGR4;ZEB2;PSME3;CSNK1E;PSMD13;COL1A1;ZRANB1;GPRC5B;PSMB8;PSMD4;DISC1;PSMF1;GPC3;WLS;AXIN1;PSMA5;PSMC3;TGFB1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.4955886311465226,0.9654560406646361,0.5083969465648855,1.0,1.0,2/11,11.75%,STMN1;RAC1
prerank,cellular protein modification process (GO:0006464),0.4060549231682483,0.9654130757176219,0.636,1.0,1.0,240/982,19.99%,DTL;CCNF;NEK2;MELK;CDK1;PLK1;BIRC5;AURKB;TGM1;MATN3;NEK3;F5;PLK4;MATK;HUNK;HASPIN;MAST2;ILF3;UBE2S;PPM1G;MAP4K4;DYRK1A;PPM1D;LOXL2;STK17B;LOX;TRIOBP;BMPR1A;CDK14;AURKA;ROCK2;FEM1C;ASB15;MAP4K2;GSK3B;PSMC2;ZC3HAV1;GGCX;LARGE1;PSMD5;FBN1;STK10;OBSL1;NLK;CHEK2;MYLK3;FUT10;LAMB1;FBXL7;PRKDC;ST8SIA2;LHPP;SPSB3;B3GNT8;CTBP1;DYRK3;TAB1;PPP2R3A;SPSB2;VRK2;SSH2;STK24;STK3;SETD3;NRK;MAP3K1;CCNE1;RBBP7;ELOC;FBXW7;FBXO30;WNK1;MAP3K20;ATG7;CDC25B;CHEK1;CUL5;CCN1;PPP3CA;CDC42BPA;FBXL8;ST3GAL3;PHKA2;QSOX1;KLHL5;CDK2;B4GALT7;PORCN;LRRK2;PSMB1;FN3K;SUMF2;GRK5;CUL3;PSMD14;KLHL22;DUSP12;VHL;MTMR2;CUL4B;ROCK1;PIM1;PSMD1;RPN2;SKP2;DCAF10;ST3GAL5;MARK2;RAB1A;PXK;UST;CDC42BPG;PPP2R5C;PARP9;TGFBR1;WSB2;PTPN21;PSMB9;PIGU;SRPK1;EIF2AK3;LMTK3;PRKCB;PTPRS;BMP2;ANXA1;STT3A;APLP2;CHM;P3H1;FBXW11;SEPHS1;PRKCA;NAGPA;PDPK1;GRK3;STT3B;AAK1;CSNK1G2;DCAF7;SIK2;PPP1CC;MEX3B;ATG3;STRADA;BTK;CDK19;PRKCE;COPS3;MAML1;PRKD1;PRKCI;ARF4;BTRC;FBXO27;PLK2;ST3GAL4;MACROD2;NRBP1;MORC3;PSMC6;MIA3;PIGT;VRK1;ST3GAL1;CDK8;BIRC6;PTPRA;STK11;PTPN13;FBXO17;PTPRU;MTMR3;UBL5;TAOK1;PRKAG1;ST3GAL2;CKAP4;PRKD2;STK39;PASK;ASB2;PRSS23;PPP2R5B;NOTUM;DAPP1;FBXL14;PPP2R1B;PTEN;PLOD2;FBXW10;HIPK3;UBLCP1;NTAQ1;GLRX;B3GALT2;PTPRK;GOLM1;RAB13;PTPRE;WNK3;CDKL4;CSNK1A1;PSMB2;SRPK2;MAST1;PKN2;METAP1;OXSR1;FNTB;PLAT;IGFBP3;LIMK2;PSME4;LTBP1;FBXO4;PSMB7;HIPK1;BRAF;OGFOD1;DUSP7;CLK3;STRADB;ASB3;PPM1A;CAND1;PRKCD;RAB3A;TESK2;DCAF8;PARP14;YES1;TYK2;UBE2D3;DAPK1;PTPN1;TRIB1;PRKAB1;PTPN5;PSMD11
prerank,histone H3 acetylation (GO:0043966),0.4324125853857569,0.9651963862987544,0.4948921679909194,1.0,1.0,14/40,18.80%,BRCA2;SGF29;TAF12;ING4;TADA1;TADA2A;JADE1;PER1;YEATS2;DR1;KAT6A;TAF10;NAA60;JADE3
prerank,nerve growth factor signaling pathway (GO:0038180),-0.39302740190799873,-0.9647916445957802,0.48985507246376814,0.7692635967423678,1.0,2/10,9.82%,RAP1A;KIDINS220
prerank,regulation of epidermal cell differentiation (GO:0045604),0.4548197043504691,0.9646856584479113,0.4851228978007762,1.0,1.0,4/21,10.56%,CBFB;ROCK2;ROCK1;ERRFI1
prerank,positive regulation of vasoconstriction (GO:0045907),-0.3525781490838769,-0.9644806178039091,0.4884488448844885,0.7690280195561323,1.0,4/13,24.73%,CAV1;ADRA1A;TBXA2R;ADRA1B
prerank,neurotrophin signaling pathway (GO:0038179),-0.30907627574324364,-0.9643416491876927,0.5040983606557377,0.7684141854222921,1.0,9/21,29.25%,NTRK2;RAP1A;KIDINS220;GRB2;DDIT4;BCAR1;BDNF;ZFYVE27;SOS1
prerank,regulation of sensory perception of pain (GO:0051930),0.49275810324161295,0.9640449732477422,0.4911242603550296,1.0,1.0,2/11,11.22%,ATPSCKMT;CCN3
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.40373657849072825,0.9640193376375772,0.5311203319502075,1.0,1.0,20/84,15.54%,TYMS;ILF3;SYNCRIP;CNOT1;RTN3;PRNP;EIF4ENIF1;SAMD4A;CAPRIN1;FMR1;LARP1;ROCK1;MRPL13;EIF2AK3;RBM4;DHFR;EPRS1;PIN1;CNOT7;FXR1
prerank,muscle tissue development (GO:0060537),-0.35694799106275704,-0.9640004845786073,0.5,0.7683161035593694,1.0,5/13,15.54%,PGM5;NF1;PTCH1;ENG;STRA6
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.4299457694871544,0.9637429704756607,0.4935521688159437,1.0,1.0,12/37,17.54%,PLK1;UBE2K;S1PR2;CALM2;STOX1;TRIM6;DMTN;CAB39;SPRED1;RPTOR;SPRED2;WNK3
prerank,primary alcohol metabolic process (GO:0034308),-0.2860652281356051,-0.9636916377022834,0.53125,0.7679906814909868,1.0,7/25,14.75%,IGF1;RDH10;GPD2;ALDH3A2;GDPD3;DHRS3;GDPD1
prerank,regulation of extracellular matrix organization (GO:1903053),0.47730788900143123,0.963550856465213,0.48010973936899864,1.0,1.0,6/15,18.15%,RB1;FGFR4;AGT;DDR2;RIC1;RUNX1
prerank,RNA modification (GO:0009451),-0.24565565043816068,-0.9634639928818173,0.5301204819277109,0.7675847258158452,1.0,24/54,25.87%,TRMT9B;ANKRD16;DTWD2;PARN;AARS1;NSUN2;CDKAL1;QTRT2;ADAR;TRMT1;TRUB1;METTL1;ADARB1;MEPCE;PUS3;THUMPD1;QTRT1;NOP2;JMJD6;LCMT2;DTWD1;WDR4;ALKBH1;NSUN5
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.40093613098651487,0.963030699919423,0.5841683366733467,1.0,1.0,72/241,19.98%,RBM15;PPIL1;SYNCRIP;SNRNP25;SRSF4;HNRNPD;TRA2B;CSTF3;FIP1L1;DHX9;HNRNPA1;SRSF10;UPF3B;CCAR1;LSM3;RAVER2;DDX39B;PSPC1;PRPF40A;HNRNPH1;PRPF19;SRSF7;POLR2A;FUS;DHX8;HNRNPUL1;WDR33;PRPF3;NONO;SF3A2;PCF11;LSM2;SRSF3;SFPQ;HNRNPU;SNRNP48;RBM15B;HNRNPL;SRRM1;CPSF4;SNRNP35;HNRNPH2;SF3B3;SNRNP27;RBM4;LSM7;WBP4;PABPC1;AQR;UBL5;RBM19;HNRNPA2B1;PPWD1;LSM4;ZCCHC8;RALY;METTL3;DHX38;PRPF4;RBM10;GEMIN7;CWC25;CWC22;PDCD7;BUD13;CDC5L;DNAJC8;HNRNPR;POLR2B;SF3A3;SNRPB;TRA2A
prerank,T cell homeostasis (GO:0043029),0.5120773982009059,0.9626911839351954,0.511520737327189,1.0,1.0,1/10,2.15%,FADD
prerank,regulation of small molecule metabolic process (GO:0062012),-0.28613597278817926,-0.9625326006215285,0.5031055900621118,0.7688647435557509,1.0,8/28,18.33%,PRKN;APOE;PDK1;ARV1;FMO5;DGKQ;EPHX2;BCKDK
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.25906769517914685,-0.9623503609759838,0.5491803278688525,0.7683276557538589,1.0,7/39,7.76%,CAMK2D;FGF14;HECW1;WNK2;FGF13;NETO1;FXYD5
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.3202000042066849,-0.9618416313246552,0.5121951219512195,0.7685481684519009,1.0,10/18,31.10%,PSEN1;APOE;NCSTN;LDLRAP1;PSEN2;NSG1;BACE1;PSENEN;CLN3;ADAM10
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.3609895788235241,-0.9615505337132055,0.4859154929577465,0.7683199009058678,1.0,7/13,36.52%,PIK3R4;IRAK4;UNC93B1;PIK3AP1;EPG5;TNIP2;MYD88
prerank,cellular defense response (GO:0006968),-0.26188358033014475,-0.9615273145925806,0.5555555555555556,0.7674434363895193,1.0,8/40,23.70%,BECN1;LSP1;RAB23;LBP;CCR9;LGALS3BP;NCF2;PTK2B
prerank,purine nucleotide metabolic process (GO:0006163),0.44743392837977203,0.9608792357217145,0.5218476903870163,1.0,1.0,7/24,11.45%,HPRT1;XDH;GUK1;ITPA;PRPS1L1;PRPS1;ADSL
prerank,calcium ion homeostasis (GO:0055074),-0.22191003112282862,-0.9608170391886887,0.5833333333333334,0.7681631310852297,1.0,21/95,16.64%,TMTC2;SLC8A3;ATP1B1;CAV1;RYR2;SLC24A2;DMPK;CDH5;TPT1;HTR2C;FAM20A;CHRNA7;SELENON;TMCO1;SLC30A1;GRIN1;ATP2B2;ATP2B3;HTR2A;PTH1R;RMDN3
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.42761531522154017,0.9602720314495927,0.5126436781609195,1.0,1.0,12/36,19.68%,FADD;UBE2K;CXCR4;AGPAT2;PARP9;ADAM17;TRIM6;AGPAT1;AXL;MAVS;RIPK1;PARP14
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.45025136767681734,0.9602003305702493,0.4912718204488778,1.0,1.0,7/23,18.35%,E2F1;TFDP1;CASP8;TP53;PPP3R1;YWHAQ;BAD
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.45025136767681734,0.9602003305702493,0.4912718204488778,1.0,1.0,7/23,18.35%,E2F1;TFDP1;CASP8;TP53;PPP3R1;YWHAQ;BAD
prerank,regulation of interleukin-13 production (GO:0032656),-0.3570927980273154,-0.9597124928327294,0.5032467532467533,0.7698363459542551,1.0,4/13,18.30%,LEF1;TNFRSF21;LGALS9;PRKCZ
prerank,embryonic skeletal system development (GO:0048706),0.42215455620116976,0.9591859269738947,0.5070422535211268,1.0,1.0,11/35,19.65%,SULF2;HOXC4;PDGFRA;SULF1;DSCAML1;HOXB3;WNT9A;OSR1;HOXA3;XYLT1;DYNC2I1
prerank,glycogen catabolic process (GO:0005980),0.46017885483262405,0.9585935014518843,0.505586592178771,1.0,1.0,4/15,10.16%,AGL;PYGB;PHKA2;RB1CC1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.4515209174607481,0.9582818614863354,0.4897172236503856,1.0,1.0,8/20,20.28%,RB1;DDRGK1;TRIM6;TWIST1;LAMTOR5;NIBAN2;GTF2B;TRAF6
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.33898087504392876,-0.9579482186518321,0.48638132295719844,0.7729883050801302,1.0,5/16,19.48%,APOD;PDCD4;CHID1;ABCD2;ZC3H12A
prerank,potassium ion transmembrane transport (GO:0071805),-0.20180536582697794,-0.9577379517170438,0.4666666666666667,0.7725477234057578,1.0,23/135,13.14%,ATP1B1;KCNAB1;KCNC2;HCN1;KCNB1;KCNJ3;SLC24A2;KCNQ3;KCNK13;KCNH1;KCNK10;KCNJ6;ATP1A1;ATP1B3;KCNN2;KCNS3;KCNH7;ATP1A3;SLC12A9;KCNJ10;KCNA6;KCNA2;ATP1A2
prerank,negative regulation of apoptotic process (GO:0043066),0.4007303651071495,0.9573253299538628,0.622,1.0,1.0,73/444,16.35%,KIF14;STIL;CDK1;PLK1;BIRC5;BARD1;FIGNL1;AQP1;CDKN2D;MAP4K4;RB1;SETX;PHIP;ARHGAP10;FNIP1;ANGPT4;GSK3B;FXN;DDRGK1;FHL2;PRKDC;MRE11;SIAH2;PDPN;ANXA5;KDM2B;ARL6IP1;SMAD6;GRK5;SH3RF1;YAP1;MGMT;ANGPT1;VHL;PIM1;APIP;ERC1;CSNK2A2;NR4A2;SFPQ;CNTF;HDAC1;ANXA1;PRKCA;SOX9;HDAC2;NOTCH2;ATF5;IL31RA;ITCH;TXNDC5;PLAUR;CTSH;MED1;PRKCI;USP47;ARF4;PLK2;XIAP;ITGA5;ITGB1;CD44;QARS1;BIRC6;SLC30A10;SRC;GDNF;TNFAIP8;NFKB1;TP53;SFRP1;ANKLE2;HIPK3
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.464645597035357,0.9570418532171485,0.5132127955493742,1.0,1.0,2/17,2.10%,SPDYA;PSRC1
prerank,carbohydrate biosynthetic process (GO:0016051),0.4521449347967135,0.9570145786644026,0.5038363171355499,1.0,1.0,6/21,16.85%,B4GALT1;MPDU1;ST3GAL3;ST3GAL4;ST3GAL2;B3GALT2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.4148004685880084,0.9570028773647471,0.5370569280343717,1.0,1.0,8/59,15.78%,ACMSD;CYP39A1;ALDH1A2;NDUFAB1;ACACA;HOGA1;ELOVL4;LPL
prerank,mitochondrion organization (GO:0007005),-0.2015014817562552,-0.9567271469123542,0.6,0.7739232283709064,1.0,61/165,23.13%,DNM3;PRKN;IMMP2L;SLC25A36;FIS1;DNAJC19;NOS3;ADCK1;MTX2;ESRRA;ALAS1;DNM1;OXA1L;HSPD1;NDUFS1;OMA1;AIFM1;CHCHD2;TFB2M;BNIP3L;BNIP3;TIMM44;CAV2;PARP1;MEF2A;SIRT5;PINK1;SUPV3L1;TOMM70;MPV17;BCAP31;GDAP1;COX7A2;SSBP1;ATP5F1B;SLC25A4;TFAM;MTX3;HIGD1A;USP30;PRDX3;ATP5F1D;AIP;FBXO7;PPARGC1A;PARK7;TOMM34;BCL2L1;GABPA;ATCAY;VPS13D;YME1L1;POLG2;TIMM17A;TOMM7;ATP7A;TIMM17B;WDR81;FMC1;SLIRP;RAB38
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.33502620251823456,-0.9562205964344641,0.5364806866952789,0.7741369316952759,1.0,4/17,10.95%,HSP90AB1;CALM1;PDGFRB;MTOR
prerank,positive regulation of biomineral tissue development (GO:0070169),0.4197220840869775,0.9559078422181556,0.4976958525345622,1.0,1.0,9/40,11.42%,FBXO5;ADGRV1;BMPR1A;BMP6;CCN1;SLC8A1;WNT6;ATP2B1;BMP2
prerank,regulation of cytoplasmic translation (GO:2000765),0.4783269108350525,0.9558439737420811,0.5153733528550513,1.0,1.0,4/14,9.15%,DHX9;FMR1;YBX3;CPEB2
prerank,regulation of muscle cell differentiation (GO:0051147),0.432904331436739,0.9553352587336726,0.5237515225334958,1.0,1.0,5/31,6.13%,CDH15;FGFR2;SPAG9;SRF;CTNNA1
prerank,alanine transport (GO:0032328),-0.39714583301743855,-0.9553290925632794,0.5093333333333333,0.7751783773743575,1.0,1/10,0.34%,SLC6A6
prerank,cellular response to osmotic stress (GO:0071470),0.45546895742333976,0.9552833613889304,0.5196335078534031,1.0,1.0,8/21,18.18%,AQP1;YBX3;CAB39;PKD2;STK39;WNK3;TRPV4;OXSR1
prerank,regulation of synapse organization (GO:0050807),0.4321426661738226,0.9551874963707756,0.5115151515151515,1.0,1.0,3/26,7.61%,ARHGAP22;NEDD4;EPHA4
prerank,sensory perception of taste (GO:0050909),-0.3950186710933838,-0.9551431274560244,0.4932249322493225,0.7746531185343898,1.0,8/10,56.22%,PKD2L1;PKD1L3;ASIC1;CD36;ASIC3;TAS1R1;TAS1R2;GNAT3
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.36857236233981877,-0.9547298656140409,0.524390243902439,0.7746006882057086,1.0,2/11,4.31%,CAV1;BIN1
prerank,regulation of hippo signaling (GO:0035330),0.4530248830021146,0.9542836905875648,0.5032765399737876,1.0,1.0,6/17,18.35%,CIT;AJUBA;LIMD1;NF2;SHANK2;MAPK14
prerank,regulation of JUN kinase activity (GO:0043506),-0.2778791545826579,-0.9539682742749511,0.5123456790123457,0.775379804455242,1.0,13/33,27.32%,PDCD4;MAP3K5;DNAJA1;PAK1;PTPN22;ARHGEF5;TNFRSF11A;PPEF2;RPS3;MAP3K11;MAPK8IP1;EDN1;DVL2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.24773679953245886,-0.9538545713052782,0.5612244897959183,0.7746966517389802,1.0,10/44,12.01%,ATP1B1;GABBR1;ANO6;AKAP6;KCNJ3;WNK2;KCNJ6;ATP1B3;KCNN2;KCNJ10
prerank,histone deubiquitination (GO:0016578),0.46498987427374844,0.9537760998814554,0.5124183006535947,1.0,1.0,6/18,16.11%,UIMC1;USP21;USP16;BRCC3;TRRAP;TAF10
prerank,negative regulation of angiogenesis (GO:0016525),0.4055903793125956,0.9535903665154013,0.54932502596054,1.0,1.0,12/84,10.11%,E2F2;ATP2B4;THBS2;ANGPT4;ROCK2;PDE3B;PML;SULF1;SERPINE1;ADAMTS9;ROCK1;PIK3CB
prerank,organic anion transport (GO:0015711),0.40486926925498656,0.953514115104285,0.5572033898305084,1.0,1.0,15/76,18.44%,RHAG;AQP1;SLCO4A1;SLC19A1;SLC16A2;SLC4A2;CYB5RL;SLC39A8;SLCO3A1;CA2;CYB5R1;SLC25A42;LRRC8C;SLC25A17;SLC25A19
prerank,outer dynein arm assembly (GO:0036158),0.47744348761445266,0.9528872213614931,0.5131195335276968,1.0,1.0,4/14,19.02%,DNAAF5;LRRC49;ODAD1;DNAH8
prerank,inner mitochondrial membrane organization (GO:0007007),-0.24816639588923478,-0.9523485719252845,0.5638297872340425,0.7771796404027931,1.0,25/47,31.74%,APOOL;MTX2;ATP5PF;ATP5F1A;ATP5PO;GHITM;ATP5MF;ATP5MC3;DNAJC11;TOMM70;ATP5PD;ATP5F1B;MTX3;ATP5F1D;ATP5F1E;ATP5MG;MICOS13;TIMM9;ATP5ME;TIMM13;HSPA9;TIMM8B;NDUFA13;ROMO1;TIMM29
prerank,protein destabilization (GO:0031648),0.4203954760383362,0.9517117018911969,0.5122235157159488,1.0,1.0,6/32,13.73%,PLK1;PRNP;CUL3;FBXW11;CTSH;BTRC
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.3181425860863338,-0.9513182092089723,0.550185873605948,0.7786140032141793,1.0,7/18,28.88%,CHRM2;AGRN;OPRM1;CHRM3;RGS10;CDK5R1;PLCB1
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.42711763793752733,0.9512000033596387,0.5423162583518931,1.0,1.0,12/43,13.65%,FBXO5;BMPR1A;BMP6;NPNT;CCN1;WWTR1;YAP1;DDR2;BMP2;ZHX3;LRP5;PRKD1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.38099422545819733,-0.9506393243165779,0.5148809523809523,0.7793173554019466,1.0,10/11,61.93%,PKD2L1;PKD1L3;LPO;RTP4;RTP3;TAS1R2;GNAT3;GNAT2;PIGR;TAS1R3
prerank,response to axon injury (GO:0048678),-0.32083026069783427,-0.9506293003601227,0.49800796812749004,0.7784088471601462,1.0,11/18,32.76%,APOD;GAP43;RTN4RL1;NREP;P2RX4;MTR;FLRT3;MORN4;P2RY12;SARM1;TYROBP
prerank,neuron differentiation (GO:0030182),0.4006817910356484,0.9503651854762003,0.593939393939394,1.0,1.0,17/165,10.49%,EN1;PBX4;GLI2;ATOH8;PBX3;MYEF2;TDP2;SRF;WNT2B;ERCC3;WNK1;POU3F2;OLIG2;LMX1B;WNT6;NR4A2;TGFBR1
prerank,neutrophil activation (GO:0042119),-0.3619756871966471,-0.9502219629949816,0.5086705202312138,0.7784357441408144,1.0,5/12,32.76%,KMT2E;IL15;SYK;FCER1G;TYROBP
prerank,positive regulation of lamellipodium organization (GO:1902745),0.4307298138790301,0.9498444541441718,0.5235294117647059,1.0,1.0,10/32,20.03%,ACTR3;AUTS2;ENPP2;CORO1B;RAC1;WASF2;SRC;NCKAP1;ABI2;RREB1
prerank,isotype switching (GO:0045190),0.4959752658240343,0.949115992105852,0.5279503105590062,1.0,1.0,2/10,12.42%,RNF168;MSH6
prerank,activation of protein kinase B activity (GO:0032148),-0.2745314008107119,-0.9489464955580241,0.5483870967741935,0.7805014899150484,1.0,10/29,17.16%,INSR;IGF1;GAS6;RICTOR;NTRK3;MTOR;FGF1;PINK1;ITGB1BP1;ADRA2A
prerank,stem cell differentiation (GO:0048863),0.4115027202943799,0.9486026110406807,0.5196304849884527,1.0,1.0,13/39,20.58%,SETD6;FGFR2;KIT;SETD2;FBXL17;METTL5;LMBR1L;TP53;SFRP1;MLLT3;OSR1;PSMD11;EEF1AKMT4-ECE2
prerank,mRNA 3'-end processing (GO:0031124),0.40623493625757684,0.9485541017849731,0.5630165289256198,1.0,1.0,19/78,12.68%,TENT2;SRSF4;CSTF3;FIP1L1;UPF3B;SLBP;LSM11;DDX39B;SRSF7;TUT1;WDR33;LEO1;PAPOLB;PCF11;SCAF8;SRSF3;SRRM1;CPSF4;RPRD1A
prerank,regulation of myoblast fusion (GO:1901739),0.48505651895864055,0.9484208195558362,0.5305810397553516,1.0,1.0,4/11,24.32%,RIPOR2;EHD1;MAPK14;EHD2
prerank,positive regulation of developmental process (GO:0051094),0.39934582561665477,0.9483536170233792,0.6098790322580645,1.0,1.0,29/164,12.73%,CDC20;BMP1;FBXO5;PAXIP1;BMPR1A;MIEF2;AURKA;AGO2;ADGRL1;NUMA1;SRF;SOX6;FMR1;ENPP2;RIF1;MCU;CORO1B;VHL;TAPT1;DDHD1;MIEF1;GRIP1;SMURF2;BMP2;ZDHHC15;GJA1;TRPM4;SOX9;KMT5C
prerank,tRNA processing (GO:0008033),-0.23856105742515482,-0.9482257096537079,0.5806451612903226,0.7811891172029137,1.0,28/61,29.54%,TRMT9B;ANKRD16;DTWD2;CSTF2;AARS1;NSUN2;RTRAF;SARS1;CDKAL1;QTRT2;TRMT10B;TRMT1;TRUB1;TSEN15;METTL1;KARS1;PUS3;THUMPD1;QTRT1;TRMT10A;LCMT2;RTCB;DTWD1;WDR4;POP5;ELAC2;CLP1;PTCD1
prerank,cellular response to copper ion (GO:0071280),0.45656962528807316,0.9480679906688836,0.5285118219749653,1.0,1.0,2/16,5.25%,AQP1;PRNP
prerank,regulation of plasminogen activation (GO:0010755),-0.36669413126233613,-0.9478621281328335,0.5016611295681063,0.7811761529096302,1.0,6/12,24.46%,CTSZ;THBS1;PLGRKT;ENO1;CLEC3B;SERPINE2
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.3303397065132233,-0.947442706449369,0.5258620689655172,0.7811733371931858,1.0,2/17,2.43%,ADIPOR2;CAV1
prerank,neuron projection development (GO:0031175),0.39684896579912543,0.9472334990606864,0.608433734939759,1.0,1.0,39/168,17.34%,KIF20B;VASH2;STMN1;MAP4K4;ADGRV1;RB1;GSK3B;LAMB1;NEDD4;MAPT;NRK;EPHA4;ANKRD27;LRRK2;DNM2;ROCK1;MAP4;HMGB1;MARK2;SVBP;SRGAP2;SAMD14;EPB41L3;PLXNB1;FRYL;MAPK8IP3;EHD1;BLOC1S5;DOCK7;TAOK1;VAPA;HDGFL3;GDNF;DBN1;PTEN;NCKAP1;STMN2;NGF;RAB13
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.4472949409964531,0.9468532182937879,0.5093582887700535,1.0,1.0,9/20,23.20%,STOML2;MCU;MCUB;MICU1;PMPCA;MAIP1;SPG7;MICU2;LETM1
prerank,ncRNA 3'-end processing (GO:0043628),0.47635238089538146,0.9467191632861137,0.5113960113960114,1.0,1.0,3/14,10.74%,INTS7;ERI1;INTS8
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.44411697231154357,0.9465987261363339,0.5132408575031526,1.0,1.0,3/24,7.30%,DDIAS;CDKN2D;SFRP2
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.4257558341776181,0.9465046276166045,0.5049261083743842,1.0,1.0,6/28,11.14%,MMP14;DLK1;ARRB1;FBXW7;YTHDF2;ARRDC1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.44693251238772475,0.9464012793451383,0.5088607594936709,1.0,1.0,4/22,11.15%,DDX11;SMARCA4;NOL11;EIF2AK3
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.38019093884284905,-0.9462411726309933,0.5355029585798816,0.7829430998389126,1.0,7/10,38.12%,ACADM;ETFDH;ETFB;ACADS;ACADVL;GCDH;ETFA
prerank,positive regulation of blood coagulation (GO:0030194),0.46064465400452437,0.9454155342324158,0.536745406824147,1.0,1.0,4/17,14.14%,HPSE;SERPINE1;DMTN;ST3GAL4
prerank,extracellular matrix disassembly (GO:0022617),0.4070504521847457,0.9453213106922861,0.5482123510292525,1.0,1.0,10/53,17.53%,BMP1;SCUBE1;MMP14;ADAMTS5;TLL2;EXOC8;CD44;CAPG;LCP1;SH3PXD2B
prerank,negative regulation of cell communication (GO:0010648),-0.2993785937542186,-0.9451839083505003,0.5161290322580645,0.7844058605540697,1.0,5/21,13.50%,ACVR1;GLRA1;SOCS5;OPRM1;HHIP
prerank,regulation of osteoblast differentiation (GO:0045667),0.4019448209084053,0.9451825006832799,0.5708376421923474,1.0,1.0,21/82,13.65%,FBXO5;BMPR1A;TWIST2;FGFR2;BMP6;NPNT;CRIM1;CCN1;WWTR1;SMAD6;TMEM64;LIMD1;YAP1;DDR2;BMP2;ZHX3;TRPM4;SOX9;LRP5;TWIST1;PRKD1
prerank,regulation of JNK cascade (GO:0046328),-0.20547041849478054,-0.9448936761374994,0.6296296296296297,0.7841149287549956,1.0,21/101,14.06%,MECOM;PRKN;TNFRSF19;SH3RF3;HIPK2;TPD52L1;TAOK2;ZMYND11;ANKRD6;MAP3K5;DUSP3;CYLD;DUSP22;DACT1;SEMA3A;MINK1;APP;HDAC3;PINK1;SDCBP;SH3RF2
prerank,receptor catabolic process (GO:0032801),-0.2994384459455256,-0.944849992342491,0.5402843601895735,0.7833090924582741,1.0,10/24,15.62%,KIF16B;GPRASP1;BECN1;AP2A2;PIK3R4;LGMN;VLDLR;AP2M1;AP2S1;AP2A1
prerank,N-glycan processing (GO:0006491),-0.321703081022006,-0.9446659234378124,0.5224489795918368,0.7827988559311067,1.0,12/18,27.60%,ST8SIA4;MAN2A1;ST8SIA1;ST8SIA6;MAN1A2;MGAT4B;PRKCSH;GNPTAB;GANC;ST8SIA3;ST8SIA5;MAN2A2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.4353853153679449,0.9445793911051357,0.516728624535316,1.0,1.0,12/29,23.55%,FADD;WWOX;PML;HTRA2;AGT;SFRP1;PPP2R1B;TNFSF10;RIPK1;TRAF2;BID;BCL10
prerank,regulation of cellular component size (GO:0032535),0.43089908257172255,0.9443084240038735,0.5259975816203144,1.0,1.0,11/30,17.76%,HP1BP3;VAV2;RAB22A;PICALM;EZR;RAC1;RPTOR;PTEN;LARS1;MSN;LAMTOR5
prerank,regulation of cell growth (GO:0001558),0.39387189805668066,0.9441743780677988,0.6204819277108434,1.0,1.0,39/204,16.07%,KIF14;RAB33B;PSRC1;CDKN2D;CDKN2C;RB1;HYAL1;CEP43;FXN;MMP14;NET1;RBBP7;PML;DERL2;SFRP2;SMARCA4;KLHL22;CDA;AGT;TGFBR1;CRLF3;IP6K2;CCN3;NDRG3;ENPP1;GJA1;ADAM17;SMAD4;ITCH;JADE1;USP47;CDKN1B;SMAD3;STK11;RPTOR;INO80;TP53;SESN2;SFRP1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.3147749724461855,-0.9440989343995416,0.5077519379844961,0.7831156369673438,1.0,8/17,24.57%,APOE;PRKAA1;FGF1;SREBF2;ERLIN2;ABCA2;RAN;MBTPS1
prerank,protein deacetylation (GO:0006476),0.4202042555335985,0.9434507678503098,0.5446327683615819,1.0,1.0,9/41,12.63%,MIER1;TBL1XR1;MIDEAS;RCOR1;MSL3;MIER3;MTA3;HDAC1;HDAC2
prerank,Rac protein signal transduction (GO:0016601),-0.3183642695447325,-0.9432921261983115,0.5294117647058824,0.7839775573929827,1.0,3/18,3.68%,ELMO1;TIAM1;HACD3
prerank,cardiac ventricle development (GO:0003231),0.45392014674706577,0.9428101212617397,0.5203145478374837,1.0,1.0,6/20,16.75%,MDM4;MATR3;HEY2;TMEM65;HECTD1;SALL1
prerank,regulation of cholesterol transport (GO:0032374),-0.309332041478383,-0.9427777861868764,0.5315315315315315,0.7841559005663705,1.0,8/20,23.08%,OSBPL6;LRP1;ABCA5;NR1H3;ARV1;NR1H2;NUS1;ABCA2
prerank,atrioventricular valve morphogenesis (GO:0003181),0.4492586416790253,0.9426970950493301,0.5135483870967742,1.0,1.0,7/19,13.45%,BMPR1A;MDM4;EFNA1;SMAD6;BMP2;SMAD4;HEY2
prerank,response to sterol (GO:0036314),0.47820921215979717,0.942507615699722,0.5116959064327485,1.0,1.0,5/11,20.91%,PMVK;TGFBR1;RORA;SMAD2;INSIG1
prerank,regulation of cell development (GO:0060284),0.41557923886493003,0.9424317173251875,0.5357548240635641,1.0,1.0,8/36,14.61%,HMGB2;BHLHE41;ADGRA2;YAP1;YTHDF2;NOTCH2;HEY2;DOCK7
prerank,regulation of macrophage cytokine production (GO:0010935),-0.3580567784029659,-0.942310392468561,0.5488215488215489,0.7843558500096738,1.0,6/13,27.97%,TGFB2;SEMA7A;TGFB3;CD74;LAPTM5;IRAK3
prerank,regulation of lymphocyte migration (GO:2000401),0.49569114785122265,0.9423067013653238,0.5159332321699545,1.0,1.0,3/10,16.28%,STK10;MIA3;MSN
prerank,cellular response to drug (GO:0035690),-0.28943288569978454,-0.9422118749999749,0.5665024630541872,0.7836533871381621,1.0,7/25,20.45%,MEF2C;GAS6;ACER2;GPLD1;PPM1F;KCNQ1;CERS1
prerank,positive regulation of vasculogenesis (GO:2001214),-0.39346419900202173,-0.9420456849126824,0.5308988764044944,0.7830864024272394,1.0,3/10,9.30%,RAP1A;CD34;TMEM100
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.42613906053354034,0.9420439358244108,0.5195402298850574,1.0,1.0,7/35,10.44%,STMN1;ARHGAP24;MFN2;CUL3;RIPOR2;MAPKAP1;ARHGAP35
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.4003134827702399,-0.9417491260308736,0.5370370370370371,0.7828539414035779,1.0,2/10,8.23%,SLC44A1;HNMT
prerank,regulation of cellular response to heat (GO:1900034),0.39719542592781637,0.9414597713148679,0.5466804979253111,1.0,1.0,19/77,17.41%,NDC1;NUP155;NUP205;NUP160;GSK3B;RPA1;MAPT;NUP85;RPA2;TPR;BAG5;NUP214;RANBP2;NUP133;RPTOR;NUP42;NUP98;ATR;NUP210
prerank,phospholipid metabolic process (GO:0006644),-0.22369802480067819,-0.9412721605951484,0.5652173913043478,0.7828990325332809,1.0,21/71,24.76%,PLA2G4A;PLPPR1;PIP4K2A;PLAAT3;ABHD12;PIP4K2B;PLPP3;AGPAT5;GPX4;PCYT2;PIP5K1A;TNFAIP8L3;PIP4P1;PLBD2;ACP6;PLPPR4;AGPAT4;ABCA2;PLA2G15;PGP;FADS1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.4470957652576004,0.9409112426437517,0.5155666251556662,1.0,1.0,4/22,7.78%,VPS37B;NEDD4;VPS37A;STAM
prerank,cellular response to sterol (GO:0036315),0.4804532309452897,0.940885629764449,0.5557163531114327,1.0,1.0,5/13,20.91%,GRAMD1C;RORA;INSIG2;GRAMD1B;INSIG1
prerank,regulation of smoothened signaling pathway (GO:0008589),0.41451133370265913,0.9408354699780557,0.5518763796909493,1.0,1.0,10/50,13.73%,GLI3;FGFR2;TXNDC15;WDR11;TUBD1;FBXL17;GAS1;TEDC1;RORA;BTRC
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.4708484472267338,0.9408290848219204,0.5161744022503516,1.0,1.0,5/11,18.96%,ING4;FOXM1;TP53;TFAP4;SP100
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.4647829158877249,0.9404686023366859,0.530758226037196,1.0,1.0,4/13,18.35%,BMF;RHOT1;VDAC2;BAD
prerank,B cell activation involved in immune response (GO:0002312),0.4678474881806872,0.9402199138274451,0.5223463687150838,1.0,1.0,2/13,12.42%,RNF168;MSH6
prerank,blood circulation (GO:0008015),0.404799598039009,0.9400380032722723,0.5423162583518931,1.0,1.0,8/49,9.91%,F5;ROCK2;MYOF;SCPEP1;ROCK1;ELN;BDKRB2;MEOX2
prerank,endocytic recycling (GO:0032456),-0.24946225089196528,-0.939826667661177,0.5822784810126582,0.7853645304069885,1.0,10/50,8.24%,VPS35L;MICALL1;VPS53;STX6;SNX4;ANKRD50;SNX3;EHD4;CCDC93;ENTR1
prerank,anterior/posterior pattern specification (GO:0009952),0.4058897301433297,0.9396484977596902,0.5577342047930284,1.0,1.0,15/53,20.52%,HOXC5;BHLHE41;HOXC4;HOXA7;HOXB3;HOXB6;TGFBR1;BMP2;LRP5;HEY2;HOXB7;SMAD2;HOXA3;SKI;HOXA6
prerank,regulation of regulated secretory pathway (GO:1903305),-0.2635457777933049,-0.9396165366117987,0.5645161290322581,0.7848995938826603,1.0,12/34,20.57%,RIMS1;SYT1;RAB5A;SYT7;DTNBP1;SYT11;SYT12;PREPL;SYT10;SYT6;RAB27A;SYT2
prerank,positive regulation of cell development (GO:0010720),-0.27143035198633314,-0.9396134988427594,0.5394736842105263,0.7839908917829204,1.0,13/31,26.98%,PDE3A;NUMBL;NUMB;TGM2;OPRM1;FAIM;SNW1;SERPINF1;ATP6AP1;TRIM32;GPER1;NKX6-1;SOX11
prerank,protein trimerization (GO:0070206),-0.3427508419571946,-0.9393814794521945,0.5286195286195287,0.7826909920826375,1.0,2/14,3.00%,SLC1A2;SCARA5
prerank,protein homotrimerization (GO:0070207),-0.3427508419571946,-0.9393814794521945,0.5286195286195287,0.7826909920826375,1.0,2/14,3.00%,SLC1A2;SCARA5
prerank,regulation of brown fat cell differentiation (GO:0090335),0.45235972907596356,0.9392044346918134,0.5068306010928961,1.0,1.0,4/16,10.51%,FTO;ZBTB7B;PIM1;HNRNPU
prerank,response to leucine (GO:0043201),0.49377682910347004,0.9386315093091121,0.5503048780487805,1.0,1.0,5/10,16.28%,KLHL22;SESN1;RPTOR;SESN2;LARS1
prerank,cellular response to leucine (GO:0071233),0.49377682910347004,0.9386315093091121,0.5503048780487805,1.0,1.0,5/10,16.28%,KLHL22;SESN1;RPTOR;SESN2;LARS1
prerank,ventricular septum morphogenesis (GO:0060412),-0.28101198531785987,-0.9385440279138422,0.5511363636363636,0.7836225593865564,1.0,11/27,17.42%,ACVR1;SMAD7;TGFBR2;BMPR2;TGFB2;PROX1;SLIT2;SOX4;HEYL;ROBO2;CITED2
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.3557824395123281,-0.9384565209090248,0.555205047318612,0.782905354837615,1.0,9/12,42.26%,SERINC3;MTHFD1;PSAT1;CBS;SEPHS2;CTH;PSPH;GGT1;PHGDH
prerank,regulation of platelet aggregation (GO:0090330),-0.3253004646891048,-0.9381734723592224,0.5462555066079295,0.7826044418034214,1.0,4/17,8.02%,PRKG1;F11R;LYN;PRKCQ
prerank,Golgi localization (GO:0051645),0.4897893135504141,0.9380456286226679,0.5301027900146843,1.0,1.0,3/11,15.22%,ARHGAP21;TBCCD1;UVRAG
prerank,mammary gland development (GO:0030879),0.44579093900017286,0.9379953536580337,0.5297845373891001,1.0,1.0,3/21,10.44%,GLI2;ZBTB7B;ARHGAP35
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.39177540179085363,0.9379636509477992,0.6536536536536537,1.0,1.0,77/264,19.98%,RBM15;COIL;PPIL1;SYNCRIP;SNRNP25;SRSF4;HNRNPD;TRA2B;CSTF3;FIP1L1;DHX9;HNRNPA1;SRSF10;UPF3B;CCAR1;LSM3;RAVER2;DDX39B;PSPC1;PRPF40A;HNRNPH1;PRPF19;SRSF7;POLR2A;FUS;DHX8;HNRNPUL1;WDR33;PRPF3;NONO;SF3A2;PCF11;LSM2;SRSF3;SFPQ;HNRNPU;SNRNP48;RBM15B;HNRNPL;SRPK1;SRRM1;CPSF4;SNRNP35;HNRNPH2;SF3B3;SNRNP27;RBM4;LSM7;WBP4;PABPC1;AQR;UBL5;RBM19;HNRNPA2B1;PPWD1;LSM4;DDX1;ZCCHC8;RALY;METTL3;DHX38;PRPF4;RBM10;GEMIN7;CWC25;SRPK2;CWC22;PDCD7;BUD13;CDC5L;DNAJC8;HNRNPR;POLR2B;SF3A3;TGS1;SNRPB;TRA2A
prerank,positive regulation of GTPase activity (GO:0043547),0.39110319097928437,0.9376751850568891,0.6386386386386387,1.0,1.0,24/188,11.06%,ECT2;EZH2;ARHGAP22;ARHGAP11A;USP6NL;MAP4K4;GSK3B;RTN4R;EVI5L;TBC1D25;NET1;TBC1D13;AFDN;TBC1D2B;SCRIB;ARHGAP24;SYDE2;RSU1;TBC1D7;PICALM;RANGAP1;SRGAP2;LIMS1;PLXNB1
prerank,chromatin remodeling (GO:0006338),0.39651007690121703,0.9375974688517389,0.5803480040941658,1.0,1.0,37/100,23.35%,ATRX;SMARCC1;RB1;BAZ1B;CHD1L;SMARCAD1;NUDT5;RBBP4;ARID1A;SRCAP;SMARCA4;HDAC1;SOX9;HDAC2;TADA2A;ACTL6B;KDM5C;RUVBL2;BAZ1A;INO80;DR1;SUV39H2;MBD3;ZBTB1;KDM4B;MBD2;ARID1B;NPM3;HDAC4;CHD4;CBX3;DAXX;MYSM1;KAT2A;ACTL6A;SMARCC2;CECR2
prerank,actin filament depolymerization (GO:0030042),0.485730385114469,0.9367576409008951,0.5342261904761905,1.0,1.0,5/11,23.18%,MICAL3;TWF1;DSTN;CFL2;MICAL2
prerank,regulation of protein ubiquitination (GO:0031396),0.3976989113203735,0.9366272272871462,0.5938461538461538,1.0,1.0,16/108,11.41%,BRCA1;PAXIP1;FANCI;MYCBP2;ARRB1;FBXW7;UBE2N;LRRK2;CUL3;ANGPT1;TBC1D7;HDAC8;SVBP;TGFBR1;IVNS1ABP;BAG5
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.2147423026490355,-0.936515290932376,0.6666666666666666,0.7854517975161976,1.0,31/107,20.87%,SLC8A3;ATP1B1;SLC39A10;CAV1;RYR2;SLC39A13;SLC24A2;DMPK;CDH5;TPT1;HTR2C;CHRNA7;TMCO1;SLC39A7;SLC30A1;ATP2B2;ATP2B3;HTR2A;PTH1R;RMDN3;MT2A;VAPB;SLC24A4;MT1X;MT1E;MT1M;MT1H;MT1F;MT1B;MT1A;MT1G
prerank,regulation of response to cytokine stimulus (GO:0060759),0.4499211918025955,0.9361958504623423,0.5391644908616188,1.0,1.0,6/19,18.15%,CBFB;DHX9;ELF1;PARP9;MAVS;RUNX1
prerank,epidermal cell differentiation (GO:0009913),0.4131167451532683,0.9361713359777017,0.5317018909899889,1.0,1.0,8/41,13.78%,TGM1;ERCC3;HDAC1;ANXA1;HDAC2;CLIC4;MED1;ADAM9
prerank,protein import (GO:0017038),0.39548553803392184,0.9358585181089523,0.5684647302904564,1.0,1.0,28/84,22.03%,RANBP17;NUP155;RPAIN;E2F3;TNPO1;NUP85;EIF4ENIF1;CSE1L;TPR;SNX33;IPO7;APPL2;NUP214;IPO11;NXT1;NUP133;IPO5;NXT2;SLC25A17;FAM53B;IPO9;NUP188;PEX12;IPO4;HSPA4;RAB8B;PEX13;APPL1
prerank,regulation of sodium ion transport (GO:0002028),0.4215143260679857,0.9358207490369573,0.5430622009569378,1.0,1.0,10/34,17.54%,ATP2B4;RANGRF;NEDD4;WNK1;SNTA1;DLG1;NKAIN1;PER1;CNKSR3;WNK3
prerank,regulation of GTPase activity (GO:0043087),0.39198720682502963,0.9342373422779244,0.6288866599799399,1.0,1.0,26/177,11.06%,ECT2;EZH2;ARHGAP11A;USP6NL;MAP4K4;GSK3B;RTN4R;EVI5L;OCRL;NET1;AFDN;FGD4;WNK1;VAV2;EPHA4;FGD1;LRRK2;RSU1;CPEB2;TBC1D7;PICALM;SRGAP2;PLXNB2;FGD6;LIMS1;PLXNB1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.4672427539260098,0.9338594936990958,0.5246826516220028,1.0,1.0,2/14,4.54%,TICAM1;KIT
prerank,negative regulation of gluconeogenesis (GO:0045721),0.47538109831057995,0.9337590559564188,0.538235294117647,1.0,1.0,2/11,4.84%,GCK;ERFE
prerank,glucose transmembrane transport (GO:1904659),-0.322211597660597,-0.9333691301509942,0.5354330708661418,0.7917418611593292,1.0,6/18,32.84%,SLC2A1;SLC2A3;SLC2A10;SLC2A9;SLC5A3;SLC45A1
prerank,cellular metal ion homeostasis (GO:0006875),-0.2078700138247339,-0.9332878952575223,0.7,0.7910284457655592,1.0,22/102,16.64%,SLC8A3;ATP1B1;CAV1;RYR2;SLC24A2;DMPK;CDH5;TPT1;HTR2C;ATP1A1;ATP1B3;CHRNA7;ATP1A3;TMCO1;ATP1A2;SLC30A1;ATP2B2;ATP2B3;SLC12A2;HTR2A;PTH1R;RMDN3
prerank,negative regulation of locomotion (GO:0040013),-0.3579320762104724,-0.9330392602442525,0.5648148148148148,0.7907038473559729,1.0,4/12,14.34%,FRMD5;DUSP3;SPOCK3;CCDC125
prerank,base conversion or substitution editing (GO:0016553),-0.37559897375809254,-0.9327576915334654,0.5111111111111111,0.790446740434462,1.0,3/11,20.04%,ADAR;ADARB1;ADARB2
prerank,atrial septum development (GO:0003283),0.46388938159273774,0.9325467403467798,0.5273492286115007,1.0,1.0,4/13,13.45%,MDM4;NPHP3;NOTCH2;HEY2
prerank,regulation of leukocyte migration (GO:0002685),0.4602267219364722,0.9323884285142213,0.5470430107526881,1.0,1.0,4/16,14.43%,HOXA7;ANXA1;RAC1;MIA3
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.4483982575178157,0.9322693252147445,0.5317460317460317,1.0,1.0,5/19,10.56%,CBFB;ROCK2;MYO1C;ROCK1;NPHP1
prerank,organelle fission (GO:0048285),-0.2911778316813173,-0.9322675859865958,0.5969387755102041,0.7906569044641449,1.0,4/24,7.00%,DNM3;PRKN;FIS1;DNM1
prerank,T cell proliferation (GO:0042098),0.46484975664941164,0.9321040746683218,0.5326704545454546,1.0,1.0,3/13,16.28%,CTPS1;LMBR1L;MSN
prerank,endoplasmic reticulum organization (GO:0007029),0.3998516923751441,0.9318613079072428,0.5643776824034334,1.0,1.0,21/72,19.48%,RAB10;RTN3;LNPK;PRNP;ATL2;ATL3;LRRK2;TRAM2;EMD;EIF2AK3;STX18;GAK;MIA3;TOR1B;VAPA;TMCC1;CYB5A;REEP2;TRAM1;CCDC47;DNM1L
prerank,regulation of exocytosis (GO:0017157),-0.24490729054406343,-0.93181670521091,0.5779816513761468,0.7907647395731602,1.0,8/46,7.80%,STXBP5L;CADPS;SYT1;STX4;STXBP6;RAB27B;IL1RAPL1;RAB5A
prerank,mitochondrion transport along microtubule (GO:0047497),0.47690117023283435,0.9316568277250407,0.5453194650817236,1.0,1.0,3/13,9.61%,MAPT;RHOT1;UXT
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.3450725928391595,-0.9311858567843779,0.5463258785942492,0.7911990381834991,1.0,8/13,27.23%,NAMPT;PTGS2;PARP16;PARP10;NAXD;NNMT;NUDT12;NAXE
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.3899989760281581,0.9310685023631556,0.6010416666666667,1.0,1.0,22/88,18.64%,TYMS;ILF3;SYNCRIP;CNOT1;DNAJC1;EIF4ENIF1;SAMD4A;CAPRIN1;FMR1;LARP1;MRPL13;EIF2AK3;RBM4;DHFR;EPRS1;CNOT7;FXR1;NFKB1;PAIP2B;RIC1;PLAT;PUS7
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.4334337897874391,0.9300536313360873,0.5425257731958762,1.0,1.0,3/21,9.99%,GCK;GPI;TKT
prerank,membrane lipid catabolic process (GO:0046466),0.4877147651028222,0.9299673898540576,0.5363214837712519,1.0,1.0,5/10,21.95%,ENPP2;SMPD2;NAGA;PDXDC1;SMPDL3B
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.4293106412604514,0.9299343372296429,0.5211442786069652,1.0,1.0,11/27,19.33%,AGO2;AJUBA;DHX9;EIF4ENIF1;FMR1;LIMD1;PUM2;FXR1;TP53;RIPK1;TNRC6B
prerank,carboxylic acid metabolic process (GO:0019752),0.41322344122130755,0.9299247606671829,0.5376344086021505,1.0,1.0,2/33,3.54%,PON1;GSTO2
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.4814125711767675,0.9296455663845057,0.5223214285714286,1.0,1.0,1/11,1.68%,TERF1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.4799232645779715,0.9290700303796033,0.548936170212766,1.0,1.0,3/12,10.11%,ATP2B4;XDH;PIK3CB
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.4479789045903091,0.9290051745802509,0.5094339622641509,1.0,1.0,5/18,15.20%,GSK3B;POLR1A;CTNNA1;ILRUN;OTUD7B
prerank,proteasomal protein catabolic process (GO:0010498),0.38930137513437185,0.9286221271750944,0.6596596596596597,1.0,1.0,65/201,23.20%,KIF14;FEM1C;PSMC2;PSMD5;UBE2K;NEDD4;SPSB3;SIAH2;SPSB2;TBL1XR1;FAF1;ARRB1;PML;FBXW7;PRPF19;AGAP3;PSMB1;SMURF1;CUL3;PSMD14;KCTD2;KLHL22;CUL4B;PSMD1;SKP2;FBXL17;ARMC8;PPP2R5C;FBXO45;PSMB9;SMURF2;FBXW11;ITCH;CRBN;BTRC;SPOP;PSMC6;ZNRF1;RAD23B;SIAH3;UBXN2B;WWP1;PSMB2;PLAA;HECTD3;PSME4;PSMB7;CCDC47;UBE2D3;PSMD11;ZSWIM8;HECW2;PSME3;FEM1B;CLOCK;PSMD13;PCNP;GID4;SIRT2;BIRC2;RNF216;PSMB8;PSMD4;DDB1;PCBP2
prerank,aspartate family amino acid catabolic process (GO:0009068),0.4477391296872349,0.9285034574839771,0.5427461139896373,1.0,1.0,1/19,1.41%,SLC25A21
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.4569216806713575,0.9281915903585691,0.5348837209302325,1.0,1.0,6/15,19.33%,AGO2;CNOT1;PABPC1;CNOT7;TNRC6C;TNRC6B
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.4569216806713575,0.9281915903585691,0.5348837209302325,1.0,1.0,6/15,19.33%,AGO2;CNOT1;PABPC1;CNOT7;TNRC6C;TNRC6B
prerank,regulation of mRNA catabolic process (GO:0061013),0.3917930902046613,0.9276668757958264,0.6052899287894201,1.0,1.0,42/121,23.27%,XPO1;MOV10;PSMC2;ZC3HAV1;PSMD5;HNRNPD;CNOT1;TNPO1;SERBP1;SAMD4A;FMR1;RC3H2;PSMB1;PSMD14;PUM2;PSMD1;YTHDF2;PSMB9;EXOSC7;NUP214;PRKCA;RC3H1;PABPC1;PSMC6;ZC3H14;CNOT7;FXR1;PNPT1;PSMB2;PSME4;PSMB7;PRKCD;PSMD11;PSME3;MAPKAPK2;DIS3;PSMD13;ZFP36L1;PSMB8;PSMD4;YTHDF1;HSPA8
prerank,regulation of neurogenesis (GO:0050767),0.3951714247120635,0.9273537347577024,0.5639913232104121,1.0,1.0,9/55,14.61%,HMGB2;NAP1L1;PCM1;BHLHE41;YAP1;YTHDF2;APPL2;HEY2;DOCK7
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.45389838877238176,0.9271396242090183,0.5321477428180574,1.0,1.0,2/13,7.98%,LARGE1;CHST3
prerank,actin filament organization (GO:0007015),0.38639617232296536,0.9267516974301853,0.6505538771399798,1.0,1.0,34/151,17.68%,SPTA1;GAS2L3;SHROOM3;TRIOBP;RHOA;CGNL1;TPM4;MYO1C;CDC42EP2;FAT1;RFLNA;MCU;CORO1B;ABI1;SAMD14;RND2;RAC1;DMTN;DPYSL3;BAIAP2L1;SVIL;DLG1;TMOD3;DSTN;CAPG;MPRIP;RHOC;LCP1;FHOD1;DBN1;COBL;SHROOM2;TRPV4;ABI2
prerank,regulation of ruffle assembly (GO:1900027),-0.29605216965538395,-0.9267173644002394,0.5065502183406113,0.8001073275389604,1.0,12/23,32.30%,CAV1;FAM98A;PFN1;PLEKHM1;EPS8L2;NLGN1;P2RX4;ABI3;P2RY12;DEF8;EPS8;HRAS
prerank,positive regulation of mitochondrion organization (GO:0010822),0.3975281768964427,0.9265654875457571,0.5573770491803278,1.0,1.0,15/57,19.48%,MIEF2;AURKA;GSK3B;BMF;FAM162A;HTRA2;MCU;DDHD1;MIEF1;BOK;PLAUR;TP53;TNFSF10;BAD;DNM1L
prerank,membrane fusion (GO:0061025),-0.26498728261525784,-0.9265245962046335,0.5912408759124088,0.799589150584958,1.0,10/33,16.57%,DNM3;RIMS1;NAPG;DNM1;RABIF;SNAP29;NSFL1C;VPS33B;GCA;VAMP3
prerank,neurotransmitter biosynthetic process (GO:0042136),0.4667330472640675,0.9264636100082018,0.5231884057971015,1.0,1.0,6/14,26.21%,CHAT;ACHE;DAGLB;DAGLA;SLC6A4;ALDH9A1
prerank,camera-type eye development (GO:0043010),0.42045140377281,0.9264221845349279,0.535264483627204,1.0,1.0,8/25,22.60%,FBN1;CACNA1C;NES;EFEMP1;SHROOM2;SKI;ALDH1A3;CEP290
prerank,dicarboxylic acid transport (GO:0006835),-0.26854536286035313,-0.9256854577485384,0.5914634146341463,0.8005811863604494,1.0,6/28,10.33%,SLC1A2;SLC13A3;SLC25A13;SLC25A12;SLC22A6;GIPC1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.45443166179062006,0.9255447013148168,0.5283505154639175,1.0,1.0,5/19,10.11%,MYO1C;XDH;JCAD;ROBO1;PIK3CB
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.3286178166988749,-0.9255424423235674,0.5035714285714286,0.799991595968728,1.0,5/14,31.77%,ATP1B1;ATP1B3;LRRC38;ATP1B2;KCNIP2
prerank,generation of neurons (GO:0048699),0.38779659568794755,0.9254976374908097,0.6676676676676677,1.0,1.0,22/190,10.73%,EN1;RACGAP1;CIT;HMGB2;ATOH8;ARTN;MYEF2;AUTS2;BHLHE41;WNT2B;MAPT;POU3F2;OLIG2;LMX1B;SH3RF1;YAP1;WNT6;MARK2;SDCCAG8;NR4A2;YTHDF2;PLXNB2
prerank,protein K48-linked ubiquitination (GO:0070936),0.3957925862978463,0.9254612017173351,0.5560391730141458,1.0,1.0,7/54,9.62%,UBE2T;UBE2C;UBE2K;UBR5;CUL3;UBE2R2;SKP2
prerank,positive regulation of inflammatory response (GO:0050729),-0.21515763557118456,-0.924926629184933,0.65,0.8004401453390863,1.0,21/86,19.44%,SNX4;TLR4;PDCD4;GPR4;IFI35;LBP;RPS19;GRN;CD81;APP;AGTR1;OSMR;CX3CL1;NUPR1;PLA2G7;VAMP8;FEM1A;PDE2A;CCN4;KARS1;TNIP1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.2785900032210807,-0.9247511978847378,0.536144578313253,0.7998909168391367,1.0,11/28,21.40%,GRB14;PIP4K2A;GRB10;PIP4K2B;PRKCQ;INPP5K;IRS1;GSK3A;PRKCZ;PIP4K2C;SLC27A4
prerank,regulation of dendrite morphogenesis (GO:0048814),0.4132402181739292,0.9245308359704649,0.5263157894736842,1.0,1.0,6/32,6.54%,GSK3B;OBSL1;NEDD4;CUX1;RAP2A;CAPRIN1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.44449989210637836,0.9244983923806165,0.5305851063829787,1.0,1.0,3/17,11.46%,PRNP;PTPN2;EZR
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.2980457696116144,-0.9240883765500298,0.5454545454545454,0.8004491861429242,1.0,5/24,6.47%,RYR3;RYR2;ANXA6;FGF2;HTR2C
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.312514973609595,-0.923582857442417,0.5684647302904564,0.8006591812422629,1.0,11/20,19.33%,VTN;IGF1;PDGFRB;LRP1;S100A11;ACE;SLIT2;NDRG4;SORL1;CCN4;NRP1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.2527053814552021,-0.9235700922374435,0.6407185628742516,0.7997804502100121,1.0,8/37,15.59%,STAT3;APOD;TLR4;PDCD4;PLD3;CHID1;ABCD2;IL17D
prerank,regulation of protein localization (GO:0032880),0.40153518877132044,0.9232194213495797,0.5686486486486486,1.0,1.0,12/58,14.24%,BORA;TRIML2;DZIP1L;AFDN;TPR;FBXW7;WDPCP;PICALM;AAK1;TRIM6;DLG1;TRIM5
prerank,negative regulation of synaptic transmission (GO:0050805),0.4405021293439786,0.9231162691339249,0.5432098765432098,1.0,1.0,9/23,19.96%,GRIK3;LRRK2;MTMR2;ACHE;PLK2;PTEN;SHANK2;STXBP1;ARF1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.3320196112099259,-0.9229831104078949,0.55,0.8002943956061536,1.0,5/14,11.92%,PRKG1;MEF2C;LRP1;TPM1;SLIT2
prerank,regulation of gene expression (GO:0010468),0.38724270362812463,0.9227403581824035,0.788,1.0,1.0,165/903,15.57%,BRCA1;PHF19;EZH2;TCF19;ATRX;MYBL1;NSD2;ERMAP;TCFL5;RBL1;E2F1;BRCA2;ATOH8;ZC3H7A;MED26;ATP2B4;TRIML2;RB1;SP3;BMPR1A;AURKA;MOV10;TICAM1;ROCK2;FGFR4;AGO2;CTCF;GSK3B;LIN54;HNRNPD;TRA2B;NLK;DDRGK1;AJUBA;CHEK2;SETDB2;NFIA;UBAP2;NFIL3;TCF7L1;SRSF10;MAPT;CCAR1;AFF3;XDH;MBNL3;BMP6;MUSK;AFDN;GZF1;YAF2;SOX6;HP1BP3;GON4L;PML;FBXW7;PSPC1;MYBL2;HNRNPH1;SFRP2;YBX3;CIAO3;POLR2A;FUS;MATR3;ZBTB7B;MYCBP;WWTR1;PHF1;CDK2;PRRX2;UBR5;LARP1;LMX1B;BNC2;ZFP64;MSL3;ROBO1;LIMD1;DNM2;YAP1;NONO;NFYA;ANGPT1;VHL;PUM2;SLC24A3;ROCK1;SLC8A1;WNT6;PICALM;ZNHIT3;ERC1;PIK3CB;NR3C1;HINT1;PARP9;SFPQ;TGFBR1;YTHDF2;FLOT2;SLC39A8;LIMS1;POFUT1;HNRNPL;EIF2AK3;NCOA2;CRKL;CPSF4;CNTF;HDAC1;BMP2;AHR;EZR;NKX2-1;TERF2;STOX1;ATXN1;ZUP1;SPTY2D1;RBMS3;HNRNPH2;FUBP1;RBPJ;GJA1;METTL4;KMT2D;TRIM6;SOX9;TOB2;NOTCH2;ATF5;CASP8;C1QTNF1;CTSH;RORA;TWIST1;PTBP2;HEY2;LARP4;MED1;GPBP1L1;YY1;RC3H1;ADAM19;FOXK2;TRIM5;SMAD3;RAMP3;JMJD1C;SOX1;PER1;RBAK;PIN1;PRDM8;EFEMP1;CNOT7;PRKAG1;ZC3H7B;GDNF;TRRAP;MLF2;TNRC6C;ZNF507;HOXB7
prerank,positive regulation of natural killer cell activation (GO:0032816),0.4623779915763507,0.9224353836114477,0.533715925394548,1.0,1.0,4/13,18.57%,TICAM1;IL18;AXL;ZBTB1
prerank,regulation of dendrite development (GO:0050773),-0.2533678451369065,-0.922168230718514,0.6074074074074074,0.8011530074555974,1.0,12/37,16.21%,HECW1;DCC;CDKL5;TNIK;CAMSAP2;SEMA4D;VLDLR;NSMF;ADGRB3;RTN4IP1;LRP8;CSMD3
prerank,negative regulation of cell projection organization (GO:0031345),0.3967733420101706,0.9220528373110761,0.5604026845637584,1.0,1.0,17/48,18.58%,RTN4R;LPAR1;PRNP;EPHA4;RAB29;DENND5A;PTPRS;BAG5;GAK;HDAC2;DPYSL3;EFNB2;ADCY6;PTEN;STMN2;TRPV4;MYLIP
prerank,regulation of interleukin-1 production (GO:0032652),0.45162543370719943,0.9220302663748579,0.5345557122708039,1.0,1.0,6/15,20.47%,HMGB1;ANXA1;SIRPA;FOXP1;TMED10;CEACAM1
prerank,macrophage activation (GO:0042116),-0.2640130029812847,-0.9219573150508222,0.6274509803921569,0.8006568724632918,1.0,9/34,14.32%,TLR4;IFI35;CD93;LBP;APP;CRTC3;CX3CL1;IFNGR1;SBNO2
prerank,protein deneddylation (GO:0000338),-0.37675475799913394,-0.9217826479473644,0.5719063545150501,0.8001406533122956,1.0,7/10,30.61%,COPS8;COPS7A;COPS2;COPS4;TOR1A;COPS6;GPS1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.3923585876986435,0.9217473737043732,0.5830687830687831,1.0,1.0,30/73,24.78%,CBFB;PSMC2;PSMD5;PRKDC;PSMB1;PSMD14;YAP1;PSMD1;KMT2A;YTHDF2;TAL1;PSMB9;ITCH;PSMC6;METTL3;PSMB2;RUNX1;PSME4;PUS7;PSMB7;PSMD11;PSME3;EIF2AK2;LDB1;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,T cell mediated immunity (GO:0002456),-0.3531567704367997,-0.9214614919314819,0.528169014084507,0.7998759095448505,1.0,2/13,12.98%,JAG1;GNL1
prerank,regulation of Wnt signaling pathway (GO:0030111),0.39493633722381455,0.9213169193149201,0.592292089249493,1.0,1.0,33/108,19.63%,CBFB;MACF1;CDK14;DEPDC1B;WWOX;FGFR2;TRABD2B;NLK;SULF2;TCF7L1;RNF43;HMGXB4;SFRP2;SULF1;LRRK2;GNAQ;SMARCA4;EMD;BMP2;RSPO3;BTRC;FOXL1;NKD1;NOTUM;SFRP1;TMEM237;SALL1;AMER1;FAM53B;RUNX1;FRZB;SKI;TERT
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.3959444539504183,0.9212952782360038,0.5879828326180258,1.0,1.0,21/63,21.28%,FADD;PHIP;WWOX;BCL2L12;SIAH2;TCF7L2;PML;SH3RF1;TNFRSF10B;AGT;TGFBR1;CASP8;BIRC6;ITGAV;SRC;TNFSF10;RIPK1;SP100;PSME3;TRAF2;FEM1B
prerank,"transcription, DNA-templated (GO:0006351)",0.3893103180829657,0.9212334575573432,0.655310621242485,1.0,1.0,34/207,12.62%,TRIP13;TCFL5;E2F1;TTF2;NAT14;PMF1;CBFB;SETX;DEK;TFDP1;TAF3;MBD1;KLF13;ERCC3;ELOC;GLIS3;TAF12;POLR2A;ZBTB7B;FOXO3;GTF3C4;LEO1;NFYA;EPC1;NR4A2;MMS19;IVNS1ABP;DRG1;TAF15;GTF2A1;TTF1;TAF4;RNGTT;SSRP1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.2602616268640755,-0.9211183183655272,0.6047904191616766,0.7997483166392384,1.0,15/34,34.28%,STX4;EPHB2;SLC7A5;PTPN22;VAMP3;XBP1;DNAJB9;CD86;LAPTM5;PHB2;PTPRC;RBP4;SPHK2;CLCF1;NOD2
prerank,microtubule anchoring (GO:0034453),0.46400243573936184,0.920746381475544,0.53601108033241,1.0,1.0,2/12,6.64%,PCM1;BICD2
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.40699638478972017,0.9202493211200758,0.5599547511312217,1.0,1.0,13/42,16.28%,CARS2;SARS2;VARS1;DARS2;DARS1;IARS2;PPA1;TARS2;PARS2;RARS2;EPRS1;QARS1;LARS1
prerank,neuron projection extension (GO:1990138),-0.271315373779599,-0.9199765148647034,0.5470588235294118,0.8013903813362707,1.0,12/32,19.34%,NRP2;HSP90AB1;SPG11;TMEM108;MAP1B;ULK1;SEMA3A;CTNNB1;CDKL3;SEMA5B;NRP1;CYFIP1
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.26617663131302316,-0.9195573588352638,0.5345911949685535,0.8013995402125077,1.0,7/33,12.52%,PTPRG;KRIT1;APOE;ACVRL1;SYNJ2BP;SLIT2;THBS1
prerank,protein alkylation (GO:0008213),-0.2894624522289586,-0.9192673327939603,0.5747663551401869,0.8011805759573464,1.0,8/22,26.39%,PRMT3;FAM98A;PRMT2;METTL21A;PRMT8;PRMT1;METTL22;GSPT1
prerank,lipoprotein localization (GO:0044872),0.4709749337150717,0.9192106984527035,0.5433186490455213,1.0,1.0,5/11,19.45%,PRKCB;MIA3;UNC119;ZDHHC3;UNC119B
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.24350246472321002,-0.9190721531898396,0.6390977443609023,0.8006883034946869,1.0,21/45,39.60%,STAT3;MALT1;TLR4;APP;PANX1;LGALS9;TRIM16;EGR1;HSPB1;JAK2;P2RX7;TMEM106A;TYROBP;CCL19;NOD2;USP50;PYCARD;MYD88;CASP1;FZD5;AGER
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.30459724736065175,-0.9190181888446977,0.5582329317269076,0.7999236409931997,1.0,7/19,19.71%,BPNT2;TPST1;SLC35B3;ABHD14B;TPST2;SLC26A2;PAPSS1
prerank,negative regulation of cell population proliferation (GO:0008285),0.38501207782112457,0.9189850585648816,0.709,1.0,1.0,69/351,17.40%,E2F7;CDKN3;E2F1;CDKN2D;PPM1D;CDKN2C;PDS5B;CDC6;CTCF;E2F3;TFDP1;ALDH1A2;MDM4;ARID2;CTBP1;MCC;PDPN;NMI;COL18A1;PTPN2;RBBP4;TGFBR3;PML;SFRP2;CLMN;B4GALT7;SLC16A2;KDM2B;MFN2;BTG3;SMAD6;IRF1;ING4;KLF11;AXIN2;KANK2;VHL;ABI1;EMD;NOX4;PPP2R5C;PLXNB1;CCN3;BMP2;APPL2;P3H1;PLPP1;NCK2;WNT9A;SOX9;TES;ATF5;CDKN1B;ADAMTS1;MORC3;STK11;PTPRU;CNOT7;PKD2;NF2;ZBTB7C;TP53;SFRP1;PTEN;TINF2;PTPRK;NGF;SLURP1;TFAP4
prerank,Golgi to endosome transport (GO:0006895),0.4422265469329812,0.9189768863956587,0.5250338294993234,1.0,1.0,3/16,8.10%,AP4M1;GBF1;VPS13A
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.24044876883214167,-0.9185549647092546,0.6078431372549019,0.8001063351822113,1.0,10/46,12.53%,SEMA6A;TIMP3;TLR4;WNK2;EPHB2;DUSP3;LYN;LMO3;SYNJ2BP;SPRY2
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.47408198939854196,0.9180314644803134,0.5483870967741935,1.0,1.0,2/10,14.29%,PCGF5;DNMT3A
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.3828434256680772,0.9173411737176184,0.6131979695431472,1.0,1.0,28/122,16.97%,ATAD5;GLI2;FGFR4;LARP4B;GCK;HNRNPD;STN1;DNA2;DHX9;PRKDC;UPF3B;FAF1;SAMD4A;NMD3;SLC25A37;FMR1;ABCB10;PLXNB2;METTL5;PCNA;EIF3C;LARP4;FXR1;PRKD2;PASK;NFKB1;METTL3;PYM1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.3653750579839109,-0.9172778958557382,0.5643564356435643,0.8020060564767488,1.0,3/11,12.80%,NOVA2;PCBP1;IGF2BP2
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.4452713830238093,0.9169550397157245,0.5613079019073569,1.0,1.0,3/15,12.07%,LARGE1;CHST3;GNPDA2
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.335448879727428,-0.9162743549292103,0.5866666666666667,0.8033106364776907,1.0,7/14,15.86%,PPP2R2B;PPTC7;PPP2CB;PPM1F;PPP2R2C;DUSP1;PPP5C
prerank,cAMP metabolic process (GO:0046058),-0.34995185396199135,-0.91614292219237,0.5791245791245792,0.8026797408666633,1.0,7/13,29.91%,ADCY3;ADCY8;ADCY4;PDE4D;PTHLH;EPHA2;ADCY5
prerank,cilium-dependent cell motility (GO:0060285),0.423072002793224,0.9159291178835282,0.5373711340206185,1.0,1.0,3/22,10.34%,DNAH2;DNAH1;RSPH9
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.31678234687363105,-0.9156771667785794,0.582089552238806,0.8027539483635233,1.0,8/18,21.77%,PTPRZ1;TNFRSF21;NF1;TNFRSF1B;TENM4;DAAM2;IL34;SLC45A3
prerank,amino acid import across plasma membrane (GO:0089718),-0.29084242900154866,-0.9155080287555762,0.5487179487179488,0.8021991665983341,1.0,5/24,5.85%,SLC6A6;SLC1A2;SLC7A2;SLC3A2;SLC7A5
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.37375512068763483,-0.9154479331291578,0.5124555160142349,0.801457749335667,1.0,8/11,50.11%,P2RX4;CDH13;TREM2;P2RX5;P2RX3;TRAT1;CCL4;NEUROD2
prerank,bile acid metabolic process (GO:0008206),-0.27715544021995536,-0.915400363047154,0.5988372093023255,0.8006592156677591,1.0,8/27,21.61%,OSBPL6;CYP7B1;SCP2;OSBPL7;GBA2;AMACR;OSBP;OSBPL2
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.3638724507080499,-0.9151278187535179,0.5351681957186545,0.8003112008002163,1.0,3/11,20.05%,PRKN;PINK1;PARK7
prerank,triglyceride biosynthetic process (GO:0019432),0.43929617789840675,0.9151187576297467,0.5539473684210526,1.0,1.0,8/18,27.10%,LPIN2;AGMO;PCK2;GK;LPIN3;GPAM;LPGAT1;DGAT1
prerank,type I interferon signaling pathway (GO:0060337),-0.2521870674199146,-0.9144474596352902,0.6153846153846154,0.80004634367494,1.0,17/41,29.27%,IFNAR1;IFI35;IFITM3;IRF2;IRF3;IRF9;ADAR;IFIT1;BST2;IFI27;IFITM2;EGR1;RNASEL;STAT2;JAK1;SAMHD1;RSAD2
prerank,cellular response to type I interferon (GO:0071357),-0.2521870674199146,-0.9144474596352902,0.6153846153846154,0.80004634367494,1.0,17/41,29.27%,IFNAR1;IFI35;IFITM3;IRF2;IRF3;IRF9;ADAR;IFIT1;BST2;IFI27;IFITM2;EGR1;RNASEL;STAT2;JAK1;SAMHD1;RSAD2
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.28465187067088665,-0.9142808050251922,0.5682819383259912,0.7995114420795317,1.0,15/22,41.84%,AHNAK;GNB5;CACNB2;SRI;CACNB1;STAC;DRD2;CACNB3;STAC3;CBARP;HPCA;STAC2;GPR35;NOS1AP;DMD
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.3131352980382357,-0.9141033821536606,0.5198237885462555,0.798149544118296,1.0,6/20,11.05%,PSEN1;INSR;IGF1;PFKFB3;PRKAA1;APP
prerank,positive regulation of glycolytic process (GO:0045821),-0.3131352980382357,-0.9141033821536606,0.5198237885462555,0.798149544118296,1.0,6/20,11.05%,PSEN1;INSR;IGF1;PFKFB3;PRKAA1;APP
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.34454696181648753,-0.9133719194937291,0.574750830564784,0.7989238715726898,1.0,5/13,7.83%,HSP90AB1;STX4;STX3;RIC3;MAP1A
prerank,alpha-amino acid metabolic process (GO:1901605),-0.23991312458114614,-0.9132207876198111,0.6283185840707964,0.7983418290961475,1.0,16/45,23.55%,GLUL;GLS;GOT2;SLC25A13;SLC25A12;MTHFD1;KYAT1;GOT1;MTRR;GPT2;DDAH2;GLUD1;ATP7A;ASS1;RIMKLA;OAT
prerank,regulation of tube diameter (GO:0035296),0.453273340176366,0.913190209310631,0.5535211267605634,1.0,1.0,6/13,19.17%,ROCK2;SCPEP1;ROCK1;ADCY6;GCLM;GCLC
prerank,vascular process in circulatory system (GO:0003018),0.453273340176366,0.913190209310631,0.5535211267605634,1.0,1.0,6/13,19.17%,ROCK2;SCPEP1;ROCK1;ADCY6;GCLM;GCLC
prerank,regulation of cholesterol efflux (GO:0010874),0.42318890578580726,0.9129078931273885,0.5520581113801453,1.0,1.0,1/30,0.82%,PON1
prerank,myelin maintenance (GO:0043217),0.4776840299391961,0.9128283286516945,0.561377245508982,1.0,1.0,4/10,21.74%,CXCR4;EPB41L3;PTEN;SOD1
prerank,RNA interference (GO:0016246),0.44032720633526734,0.9128115915588656,0.5428571428571428,1.0,1.0,3/17,6.11%,AGO2;DHX9;NRDE2
prerank,negative regulation of interferon-beta production (GO:0032688),0.47770842805722236,0.9124108927328676,0.5596465390279823,1.0,1.0,5/10,24.07%,PTPRS;YY1;SIRPA;RELB;REL
prerank,positive regulation of catalytic activity (GO:0043085),-0.25741101279037387,-0.9124073783583191,0.583941605839416,0.799185562082555,1.0,10/37,10.85%,PSEN1;CAV1;MAPK8;STX4;NCSTN;MSH2;IGF2;NHEJ1;MAPK3;ABL1
prerank,regulation of vasoconstriction (GO:0019229),-0.268236413819801,-0.9117134647955262,0.6276595744680851,0.7998455923366607,1.0,8/27,15.76%,ECE1;CAV1;PER2;BMPR2;ACE;AGTR1;ADRA1A;CHRM3
prerank,angiogenesis involved in wound healing (GO:0060055),0.47245720479391484,0.9116861037276875,0.56,1.0,1.0,2/11,5.11%,HPSE;SRF
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.20662350166032198,-0.911504164069668,0.875,0.7994442321361785,1.0,30/91,23.32%,FTH1;SLC39A10;ATP6V0D1;SCARA5;SLC39A13;CUL1;FBXL5;FTL;HMOX2;ABCG2;APP;COX19;IREB2;SLC31A2;GLRX3;SLC39A7;SLC30A1;MT2A;ATOX1;MT1X;MT1E;MT1M;MT1H;MT1F;MT1B;MT1A;MT1G;ATP7A;NDFIP1;ISCU
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.3536622994039714,-0.9114882299634627,0.6057692307692307,0.7986153746544614,1.0,3/12,5.39%,MAP2K5;TLR4;KLF4
prerank,positive regulation of protein modification process (GO:0031401),0.3802077738087877,0.9112310925630459,0.666,1.0,1.0,38/203,15.54%,CDCA2;CEP295;DYRK1A;FNIP1;ROCK2;TRABD2B;FAM161A;LEPR;MUSK;RAP2A;ARRB1;UBE2N;EFNA1;FMR1;ATG7;TXN;CCN1;PPP1R7;LRRK2;AXIN2;ANGPT1;RB1CC1;P2RY1;CALM2;CRKL;BMP2;RAC1;ADAM17;SOX9;PLAUR;SLCO3A1;SMPD1;CAMTA1;PTPA;WDFY2;PIN1;TAOK1;FXR1
prerank,negative regulation of transport (GO:0051051),-0.23284242168473124,-0.9107786202335825,0.5882352941176471,0.7992121987738977,1.0,17/51,24.60%,PRKN;MCTP1;SNX3;CTTNBP2NL;NR1H3;CRYAB;SYT11;PPM1F;SCAMP5;BST2;WWP2;NR1H2;ITGB3;PACSIN3;RACK1;NDFIP1;ARL6IP5
prerank,cell chemotaxis (GO:0060326),0.3978186182163365,0.9103543601595115,0.587027027027027,1.0,1.0,9/60,12.39%,HMGB2;PARVA;LPAR1;KIT;CXCR4;PDGFRA;CORO1B;CCN3;NR4A1
prerank,cellular response to dsRNA (GO:0071359),0.4507733536481273,0.9095294694102338,0.5527777777777778,1.0,1.0,3/15,8.99%,COLEC12;DHX9;RIOK3
prerank,proteasome assembly (GO:0043248),0.4559016091996867,0.9093965690421634,0.522342064714946,1.0,1.0,5/11,22.99%,PSMD5;ADRM1;PSMD11;PSMD13;PSMD4
prerank,positive regulation of translational initiation (GO:0045948),0.4413200829341709,0.909381173609343,0.5483443708609271,1.0,1.0,4/18,10.57%,KHDRBS1;LARP1;CDC123;YTHDF2
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.34889635752383696,-0.9092945673810454,0.5570469798657718,0.8014801479462,1.0,4/13,9.48%,NR3C2;AR;ESR1;ABHD2
prerank,sarcomere organization (GO:0045214),0.4156007329729884,0.9092129533798469,0.5515527950310559,1.0,1.0,4/27,16.50%,MYLK3;CSRP2;CSRP3;TNNT3
prerank,mesonephros development (GO:0001823),-0.367311984043326,-0.9091916007763284,0.5744047619047619,0.8007990789872264,1.0,4/11,24.27%,FGF1;BMP7;FGF10;PAX8
prerank,positive regulation of cell differentiation (GO:0045597),0.3797897455496943,0.909178374285961,0.695,1.0,1.0,47/237,16.07%,ECT2;EZH2;CDH15;FBXO5;LOXL2;BMPR1A;RHOA;ZEB1;SPAG9;SRF;PDPN;BMP6;CTNNA1;SOX6;IL18;TCF4;NPNT;SFRP2;CCN1;WWTR1;RIPOR2;AXIN2;TMEM64;YAP1;VHL;AGT;DDR2;TGFBR1;BMP2;ZHX3;RRAS;GJA1;TRPM4;SOX9;SMAD4;LRP5;TWIST1;RBM4;PRKD1;BLOC1S5;SMAD3;MEDAG;WDFY2;GDNF;NFKB1;LPL;SFRP1
prerank,positive regulation of ion transport (GO:0043270),-0.23482210764436814,-0.9090750417831824,0.6274509803921569,0.8001381202555691,1.0,19/48,34.05%,ANO6;SNX4;MYLK;KIF5B;CACNB2;SCN1B;VAMP8;CRACR2A;ADRA2A;P2RX4;DRD2;WFS1;P2RX7;SCN4B;RAB3B;PKP2;GPD1L;SCN3B;CACNA1D
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.36115219211020233,-0.9088784920798614,0.5853658536585366,0.799709297449895,1.0,2/10,1.56%,CAMK2D;HECW1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.3939912113640656,0.9084276303141533,0.5808189655172413,1.0,1.0,10/57,14.09%,MRPL36;XPO1;RRS1;CUL4B;MRTO4;DHX37;RPS17;NOM1;SDAD1;PAK1IP1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.44876729159164586,0.9080317522983261,0.5534246575342465,1.0,1.0,3/15,9.99%,FGFR4;PDPN;DDR2
prerank,polyol metabolic process (GO:0019751),-0.2362051672913525,-0.907942505449729,0.6534653465346535,0.8008722210589077,1.0,16/46,20.67%,INPP4B;CALM1;IPPK;PPIP5K2;PLCB3;PLCG1;NUDT3;INPP1;ITPKB;INPP5D;SYNJ1;PLCE1;IMPA1;INPP4A;ITPKC;PLCH1
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.31265355700303166,-0.9077886935442836,0.5815602836879432,0.8003284353331396,1.0,6/17,10.34%,NTRK2;APOE;IGF1;BIN1;RTN1;CHRNA7
prerank,positive regulation of stress fiber assembly (GO:0051496),0.39615445400913857,0.9077144546537297,0.5712669683257918,1.0,1.0,13/44,17.31%,ROCK2;RHOA;LPAR1;SORBS3;TGFBR1;RAC1;ARHGEF10L;RHOC;NF2;FHOD1;SFRP1;CCN2;CD47
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.43275330216773633,0.9074627472229939,0.5428954423592494,1.0,1.0,2/18,9.04%,CFAP53;NPHP3
prerank,glutathione biosynthetic process (GO:0006750),0.46291168912135416,0.907303178297391,0.5626865671641791,1.0,1.0,4/11,19.93%,GSS;GCLM;GCLC;HAGH
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.3555192007932018,-0.907075576768802,0.5640243902439024,0.8010542338677379,1.0,4/11,17.94%,MEF2C;LYN;LGALS9;PIK3CD
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.46494956780501034,0.9070498739765063,0.5530973451327433,1.0,1.0,5/11,20.87%,RSPO3;NKD1;SFRP1;MLLT3;CSNK1E
prerank,negative regulation of viral genome replication (GO:0045071),0.399011169806625,0.9070123856006674,0.5777777777777777,1.0,1.0,4/40,4.07%,ILF3;FAM111A;ZC3HAV1;MPHOSPH8
prerank,cellular response to virus (GO:0098586),0.41622698938753544,0.9052254819295074,0.5526960784313726,1.0,1.0,4/30,8.99%,VWCE;GBF1;FMR1;RIOK3
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.4254534854468578,0.9049144333611562,0.5460277427490542,1.0,1.0,5/21,11.15%,TXNDC12;LRRK2;NCK1;BOK;EIF2AK3
prerank,neuromuscular process (GO:0050905),-0.31759353703895643,-0.9048835816548786,0.5775577557755776,0.8047719035442029,1.0,7/16,19.57%,UBA5;NRXN1;TPP1;SHANK1;GCH1;STRA6;DCTN1
prerank,bone morphogenesis (GO:0060349),0.4563962266690006,0.9046807677768385,0.5716332378223495,1.0,1.0,2/14,3.53%,CYP26B1;FGFR2
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.31759481217589736,-0.9045976439644161,0.5912698412698413,0.8045698295937064,1.0,7/17,19.86%,EMC2;EMC3;SGTA;EMC1;EMC9;GET4;MMGT1
prerank,apoptotic process (GO:0006915),0.37750908349178114,0.9044921183587302,0.6880641925777332,1.0,1.0,36/203,16.44%,MELK;ESPL1;CIT;FADD;MCM2;BMF;CASP7;MAGI3;IAPP;DAP;AIFM2;FAM162A;STK3;ERCC3;CXCR4;CHEK1;IRF1;ING4;BCLAF1;TNFRSF10B;PLAGL1;IKBKG;APAF1;BOK;AHR;NOTCH2;CASP8;PRKCE;JADE1;STK11;FXR1;BCL2L13;RFK;AKAP1;NCKAP1;TNFRSF25
prerank,cellular response to organonitrogen compound (GO:0071417),0.3835439061426512,0.9039629144530233,0.6142709410548087,1.0,1.0,21/99,16.85%,BRCA1;AQP1;DIAPH1;CTNNA1;LARP1;P2RY1;TRPM2;AHR;EZR;AKAP9;SOX9;DMTN;SLC38A9;GLRA2;RPTOR;PKD2;IPO5;SESN2;SFRP1;LARS1;LAMTOR3
prerank,positive regulation of reproductive process (GO:2000243),-0.26445692696635736,-0.9039334990157242,0.6012658227848101,0.8051445085114116,1.0,13/31,33.31%,PDE3A;GLRA1;CFAP69;LHFPL2;VEGFA;PGAM4;INHBA;TACR3;PRDM9;CACNA1H;PLCB1;INHBB;C1QBP
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.36519021215209135,-0.9038957863166099,0.5748502994011976,0.8043405514058998,1.0,2/10,1.56%,CAMK2D;HECW1
prerank,negative regulation of myotube differentiation (GO:0010832),0.4569376390988976,0.9036666100950964,0.5712250712250713,1.0,1.0,3/12,11.38%,BHLHE41;CCN3;HDAC1
prerank,sensory perception (GO:0007600),-0.23167828002958357,-0.9033780627814791,0.65625,0.8046117587206225,1.0,9/45,13.63%,PCDH15;GNAL;SCN9A;WHRN;BBS4;OPRM1;CHRNA7;KCNA2;TMEM150C
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.3348271069585298,-0.9030121583482615,0.5935251798561151,0.8045415390510301,1.0,1/13,0.28%,STAT3
prerank,positive regulation of stem cell proliferation (GO:2000648),0.43701002375224407,0.9028354972028717,0.5714285714285714,1.0,1.0,6/17,24.26%,CCNE1;HNRNPU;GJA1;TERT;FERMT2;KDM1A
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.36902492097807615,-0.9028316009427435,0.5749235474006116,0.8040592204282442,1.0,5/10,17.98%,ATP5F1A;ATP5PO;ATP5MC3;ATP5PD;ATP5F1D
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.4616892897203793,0.9025490104436003,0.5516265912305516,1.0,1.0,3/13,8.30%,TXN;PYCR1;LRRK2
prerank,vasodilation (GO:0042311),-0.3459157622665774,-0.9022391839509794,0.5950155763239875,0.8044511906240654,1.0,5/13,26.13%,NOS3;SOD2;KLF2;NOS1;GPER1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.42218349928994975,0.9018680223288316,0.5528031290743155,1.0,1.0,2/18,6.72%,FBN1;FBXW7
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.4223168253923113,0.901402725386431,0.5560975609756098,1.0,1.0,12/27,25.59%,CSTF3;RNASE6;PCF11;RPP30;POP1;RNASE1;KHNYN;LACTB2;TRIR;RNASEH1;TOE1;NUDT16
prerank,regulation of protein metabolic process (GO:0051246),0.39974656232327777,0.9012358139740588,0.5787671232876712,1.0,1.0,4/44,5.71%,FAM83D;ROCK2;CHEK2;FAF1
prerank,negative regulation of cell differentiation (GO:0045596),0.378643726236903,0.901012220813599,0.6840521564694082,1.0,1.0,43/181,16.15%,E2F1;ADGRV1;RB1;TWIST2;SUZ12;USF3;ANP32B;ASXL1;ANKRD26;XDH;COL5A2;EFNA1;SFRP2;CRIM1;WWTR1;SMAD6;TMEM64;NPHP3;LIMD1;LEO1;YAP1;TGFBR1;HNRNPU;YTHDF2;RUNX1T1;NKX2-1;ABCA1;ENPP1;WNT9A;TRPM4;SOX9;ADIPOR1;LRP5;RORA;TWIST1;MED1;SPRED1;SMAD3;ITGAV;EFEMP1;SFRP1;SPRED2;PTEN
prerank,spliceosomal snRNP assembly (GO:0000387),0.39490827366883646,0.900943528850401,0.5742009132420092,1.0,1.0,9/38,19.78%,COIL;SRSF10;PRPF19;PRPF3;LSM2;LSM4;GEMIN7;TGS1;SNRPB
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.36728380586575593,-0.9008315890576035,0.6037151702786377,0.8066787630916563,1.0,4/10,17.16%,FKBP1A;BIN1;ATP1A2;ADRA2A
prerank,limb development (GO:0060173),0.40281348239855647,0.8992579675595084,0.5690072639225182,1.0,1.0,3/28,6.90%,GLI3;LNPK;MAP3K20
prerank,regulation of actin nucleation (GO:0051125),0.45444991488383313,0.8989639824222865,0.5710059171597633,1.0,1.0,5/12,22.34%,ARFIP1;CORO1B;ARF1;WHAMM;ARPIN
prerank,negative regulation of macrophage activation (GO:0043031),-0.3125733440565067,-0.8986951293256559,0.5579710144927537,0.810365459414745,1.0,7/16,29.50%,NR1H3;GRN;CX3CL1;SYT11;ZC3H12A;LRFN5;PTPRC
prerank,response to interferon-beta (GO:0035456),0.4182105008180888,0.8982834194543943,0.5717981888745148,1.0,1.0,6/22,16.35%,UBE2K;HTRA2;IRF1;TRIM6;PNPT1;IFNAR2
prerank,miRNA metabolic process (GO:0010586),0.43511760559915413,0.8981845776227684,0.5660130718954248,1.0,1.0,4/20,13.47%,DGCR8;AGO2;TUT7;TUT4
prerank,positive regulation of cell motility (GO:2000147),0.3763418734232353,0.8976744751407502,0.717434869739479,1.0,1.0,23/205,7.43%,ARHGEF39;GTSE1;CCDC25;MAP4K4;SYNE2;TWIST2;TRIP6;ROCK2;CEP43;MMP14;DDRGK1;ACTN4;LAMB1;KIT;SPAG9;NTN1;CCAR1;PDPN;MYO1C;PDGFRA;PLAU;CCN1;PPP3CA
prerank,glycolytic process (GO:0006096),0.408731555767361,0.8976311987944646,0.5738705738705738,1.0,1.0,4/28,8.45%,PFKFB1;GCK;GPI;PGM1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.46070958177638177,0.8969176422874713,0.5845481049562682,1.0,1.0,2/12,4.75%,COLEC12;DHX9
prerank,protein localization to organelle (GO:0033365),0.3782907854768122,0.896736153620215,0.6723963599595552,1.0,1.0,25/133,16.30%,RAB33B;CNTLN;BBS9;WDR35;RPA1;GBF1;IFT140;OBSL1;PACSIN2;DDRGK1;DHX9;PRNP;RPA2;BICD2;LRRK2;TRAM2;EMD;XPA;GAK;EHD1;TOR1B;VAPA;CSRP3;DDX1;CYB5A
prerank,acetyl-CoA metabolic process (GO:0006084),0.44039301373695444,0.8966674212500001,0.5524475524475524,1.0,1.0,5/15,13.74%,PMVK;ACAT1;ACSS1;ACACA;MVK
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.4619008501229085,0.8963539986880281,0.5777126099706745,1.0,1.0,3/10,19.97%,TICAM1;MIA3;CD68
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.4050154952032795,0.8960450566776884,0.5762514551804424,1.0,1.0,9/38,15.16%,DHX9;NMI;BMP6;RIOK3;PUM2;POLR3D;PRKCA;AKIRIN2;SLC15A4
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.4502260384689175,0.8957864926557428,0.5536959553695955,1.0,1.0,4/12,17.26%,SMARCA4;HDAC1;SFRP1;FOXP1
prerank,negative regulation of signal transduction (GO:0009968),0.37459998282208445,0.8954239536793246,0.7164328657314629,1.0,1.0,39/249,11.80%,EZH2;GLI3;RB1;BRAP;CYP26B1;WWOX;TRABD2B;CNOT1;MMP14;NLK;NEDD4;DLK1;SULF2;NTN1;ASXL1;SIAH2;XDH;LEPROT;RNF43;PTPN2;HMGXB4;ARRB1;FBXW7;SFRP2;SULF1;LRRK2;NCK1;KANK2;MTMR2;AGT;CSNK2A2;PIK3CB;NR4A2;YTHDF2;DKK3;ARRDC1;PRKCB;BMP2;ENPP1
prerank,cellular response to superoxide (GO:0071451),-0.37201522019295324,-0.8949647124075184,0.5632183908045977,0.8174197173829338,1.0,6/10,21.97%,NOS3;SOD2;PRDX2;PRDX1;ADPRS;ATP7A
prerank,myofibril assembly (GO:0030239),0.3950726652228531,0.8946306021731719,0.5753424657534246,1.0,1.0,10/42,22.29%,OBSL1;MYLK3;CSRP2;PDGFRA;TMOD3;CSRP3;TNNT3;TMOD1;LMOD1;TMOD2
prerank,negative regulation of T cell proliferation (GO:0042130),0.3987667563142946,0.8944134508660685,0.5590452261306532,1.0,1.0,5/28,13.97%,PRNP;SCRIB;CD80;IL4I1;RC3H1
prerank,cardiac atrium morphogenesis (GO:0003209),-0.31065676705899586,-0.8935140794318296,0.5703422053231939,0.8197433819997628,1.0,3/16,4.85%,BMPR2;TGFB2;PROX1
prerank,glycogen metabolic process (GO:0005977),0.4015259554631029,0.8934320282079706,0.5586124401913876,1.0,1.0,6/27,12.44%,GSK3B;AGL;PYGB;PHKA2;PGM1;GYG1
prerank,regulation of angiogenesis (GO:0045765),0.37400102356355497,0.8929453550271792,0.6926926926926927,1.0,1.0,31/192,14.28%,BRCA1;VASH2;AQP1;ATP2B4;THBS2;ANGPT4;ROCK2;HYAL1;AGO2;ADAM12;PDE3B;ADGRA2;ANXA3;PML;SFRP2;HSPB6;SULF1;SERPINE1;ROCK1;GAB1;PRKCB;RRAS;PRKCA;PDPK1;CTSH;TWIST1;PLXND1;PRKD1;SPRED1;ADAMTS1;ITGB1
prerank,sterol metabolic process (GO:0016125),0.3864515801288815,0.892617562444284,0.6123110151187905,1.0,1.0,12/60,15.94%,LBR;CYP39A1;CYP26B1;PMVK;SOAT1;SCAP;TM7SF2;ABCA1;SOAT2;FDXR;STARD3;DHCR7
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.4138248141282369,0.8925622950212173,0.5803048065650644,1.0,1.0,15/31,22.05%,CAPRIN1;EFNA1;EPHA4;LRRK2;LZTS3;PDLIM5;ZDHHC15;DBN1;PTEN;SIPA1L1;ABI2;TANC2;CAPRIN2;CDK5;NGEF
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.3119226736556098,-0.8920243177368936,0.6162361623616236,0.822084013853641,1.0,5/16,11.68%,DDX17;AR;SAFB;ESR1;DDX5
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.2939506045158654,-0.8918498241342296,0.6431535269709544,0.8215810642933125,1.0,4/19,10.35%,APOE;RIC3;CHRNA7;CHRFAM7A
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.42976395793442235,0.891517132431115,0.5629322268326418,1.0,1.0,4/17,11.75%,MCU;RIPOR2;CAMK1D;RAC1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.41621051188152713,0.8913203601873699,0.5678524374176548,1.0,1.0,10/21,22.81%,MACF1;ROCK2;RHOA;ROCK1;PTPRA;EPHA3;CLASP1;LDB1;VCL;SLK
prerank,neuron apoptotic process (GO:0051402),0.4149927930537134,0.8910910195453672,0.5766710353866317,1.0,1.0,2/19,5.17%,CIT;FAM162A
prerank,positive regulation of MAP kinase activity (GO:0043406),0.3816584594236426,0.890905289392192,0.6319148936170212,1.0,1.0,5/66,9.16%,EZH2;KIT;LRRK2;ROBO1;MAP3K4
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.35776358264135005,-0.8905566484414627,0.6151685393258427,0.8234001736375901,1.0,2/10,3.95%,SMAD7;MALT1
prerank,ureteric bud morphogenesis (GO:0060675),0.43504963015101916,0.8904013577804102,0.5746971736204576,1.0,1.0,5/16,16.75%,NPNT;BMP2;GDNF;PKD2;SALL1
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.29061321340374024,-0.8899664545419868,0.6205533596837944,0.8237936740382862,1.0,8/19,20.05%,PRKN;USP36;SREBF2;CAMKK2;PINK1;GSK3A;FBXO7;PARK7
prerank,proteolysis (GO:0006508),0.3716123456243136,0.8899536909442659,0.736,1.0,1.0,27/252,10.46%,KEL;BMP1;VASH2;CTSE;FAM111A;MMP24;MMP25;ADGRV1;SENP1;TRABD2B;CASP7;MMP14;LVRN;NLN;CPXM1;TASP1;PLAU;CAPN15;TMPRSS5;SPPL2B;ADAMTS9;HTRA2;CPQ;VHL;LONP1;SVBP;TRHDE
prerank,regulation of microglial cell activation (GO:1903978),-0.3256748636427912,-0.8897016419585521,0.5868055555555556,0.8234962588239074,1.0,5/15,29.50%,GRN;CX3CL1;SYT11;SPHK1;PTPRC
prerank,regulation of T cell mediated immunity (GO:0002709),0.47282514016669264,0.8890473672736451,0.5685670261941448,1.0,1.0,3/10,18.57%,HMGB1;TRPM4;ZBTB1
prerank,protein acylation (GO:0043543),-0.253200233637144,-0.888772014640185,0.6643356643356644,0.8246927476010669,1.0,11/38,15.69%,FOXO1;EP300;GLUL;ZDHHC5;ZDHHC1;ZDHHC13;KAT2B;ING5;ZDHHC7;NAA80;ZDHHC8
prerank,melanocyte differentiation (GO:0030318),0.45796772675637865,0.8886248751716823,0.5899705014749262,1.0,1.0,3/11,11.80%,LRMDA;KIT;ENPP1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.32992335522819677,-0.8885025294579121,0.6170212765957447,0.8244258961694214,1.0,10/15,36.34%,PRKN;IGF1;GHITM;GPX1;BCL2L1;PRELID1;HGF;PPIF;AKT1;PSMD10
prerank,protein K48-linked deubiquitination (GO:0071108),-0.2867450107279636,-0.8882455600057331,0.6308411214953271,0.8241269423040956,1.0,9/23,24.55%,OTUD7A;ATXN3;USP8;MINDY1;YOD1;USP33;OTUB1;MINDY2;USP34
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.3210244050658273,-0.8878721205081107,0.59,0.8231723333016205,1.0,8/15,29.32%,AP3D1;DTNBP1;BLOC1S2;AP3B2;AP3M1;AP3S1;AP3M2;BLOC1S6
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.3210244050658273,-0.8878721205081107,0.59,0.8231723333016205,1.0,8/15,29.32%,AP3D1;DTNBP1;BLOC1S2;AP3B2;AP3M1;AP3S1;AP3M2;BLOC1S6
prerank,homocysteine metabolic process (GO:0050667),0.46096681755341395,0.8876752442011769,0.5712250712250713,1.0,1.0,3/11,18.10%,MTHFR;NOX4;DPEP1
prerank,maintenance of protein localization in organelle (GO:0072595),0.42599843631275447,0.8875548414919726,0.5804749340369393,1.0,1.0,5/19,14.26%,TAF3;PML;TAPT1;HNRNPU;MORC3
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.2762640152021046,-0.8871960439989954,0.5879828326180258,0.8237205584058697,1.0,7/21,19.55%,CAV1;FZD2;CTNNB1;APC;DVL1;LRP6;FZD1
prerank,regulation of fibroblast proliferation (GO:0048145),0.39274158195993003,0.8867172834360674,0.6015625,1.0,1.0,11/45,16.07%,E2F1;AQP1;DHX9;PDGFRA;B4GALT7;EMD;AGT;DDR2;MORC3;TP53;SFRP1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.4218046781366527,0.8860664163215911,0.5708446866485014,1.0,1.0,4/19,11.75%,MCU;RIPOR2;CAMK1D;RAC1
prerank,protein deacylation (GO:0035601),-0.2864332226345653,-0.8860451529860531,0.6382978723404256,0.8251857292548653,1.0,10/23,27.00%,LYPLA1;ABHD17C;HDAC5;HDAC3;SIRT5;HDAC7;PPT1;LYPLAL1;LYPLA2;ABHD17B
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.43760560911824986,0.8853078118910709,0.5807799442896936,1.0,1.0,6/16,19.68%,LEPROT;PTPN2;VHL;ADIPOR1;NF2;PARP14
prerank,ureteric bud development (GO:0001657),0.43113094642584904,0.8851966757004005,0.5842245989304813,1.0,1.0,6/17,18.17%,FGFR2;NPNT;BMP2;PKD2;SALL1;OSR1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.36673192240047625,0.8847238617870327,0.6740890688259109,1.0,1.0,51/129,24.87%,FGFR2;PSMC2;RNF220;PSMD5;TBL1XR1;ADGRA2;WNK1;SFRP2;UBR5;LRRK2;PSMB1;PSMD14;AXIN2;PSMD1;LRRK1;PSMB9;SMURF2;CSNK1G2;TRPM4;USP47;XIAP;PSMC6;PIN1;NFKB1;SFRP1;AMER1;FAM53B;PSMB2;CSNK1G1;PSME4;PSMB7;CAPRIN2;PPM1A;PSMD11;SEMA5A;LGR4;ZEB2;PSME3;CSNK1E;PSMD13;COL1A1;GPRC5B;PSMB8;PSMD4;PSMF1;GPC3;WLS;AXIN1;PSMA5;PSMC3;TGFB1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3663908978796157,0.8847115719727031,0.6978851963746223,1.0,1.0,34/158,18.74%,ECT2;FADD;TRIML2;TICAM1;MAP3K14;MIER1;RHOA;LPAR1;UBE2N;RNF31;TNFRSF10B;MAP3K3;IKBKG;CXXC5;PRKCB;GJA1;TRIM6;CASP8;BRD4;ROR1;DDX21;PRKD1;PLK2;TRIM5;VAPA;RHOC;DDX1;MAVS;TNFSF10;LAMTOR5;PLEKHG5;TERF2IP;ANKRD17;RIPK1
prerank,gastrulation (GO:0007369),0.44347480917775073,0.8842537757972525,0.5921787709497207,1.0,1.0,5/15,17.84%,MKKS;NPHP3;LRP5;UGDH;SMAD2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.4321105423753868,0.8841970213926663,0.5783633841886269,1.0,1.0,5/16,12.34%,BMPR1A;FGFR2;TGFBR3;PIM1;RBPJ
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.42329296980736925,0.8840155791930526,0.5687583444592791,1.0,1.0,5/17,13.45%,BMPR1A;BMP2;RBPJ;NOTCH2;HEY2
prerank,purine ribonucleotide catabolic process (GO:0009154),0.4238474903396711,0.8839007730851194,0.5809284818067754,1.0,1.0,5/21,13.60%,HPRT1;XDH;ACAT1;HINT1;NUDT4
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.37071316576007457,0.8838980638304542,0.7224448897795591,1.0,1.0,49/182,19.68%,RBL1;ATOH8;ATP2B4;RB1;BMPR1A;AURKA;MOV10;ROCK2;AGO2;DDRGK1;SETDB2;WDR54;MAPT;XDH;FBXW7;SFRP2;ROBO1;YAP1;VHL;MTMR2;SLC24A3;PICALM;PARP9;FLOT2;CRKL;HDAC1;BMP2;TERF2;STOX1;RBMS3;TRIM6;NOTCH2;HEY2;YY1;CNOT7;TNRC6C;NFKB1;SFRP1;ITGB8;LDLR;FOXP1;ANKRD13D;RUNX1;RBL2;WNT4;HAVCR2;TNRC6B;TERT;PARP14
prerank,eye photoreceptor cell development (GO:0042462),-0.30589101436965854,-0.8833056700738691,0.5962264150943396,0.8301953836902429,1.0,5/15,26.78%,BBS4;RORB;VEGFA;RP1;THY1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.38723564280738887,0.8832981056213153,0.5852803738317757,1.0,1.0,4/35,8.09%,PCDHGB4;CDH18;CDH24;PCDHGC3
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.4165784017158732,0.8831523762806025,0.5728770595690748,1.0,1.0,4/22,15.53%,KIT;OCIAD2;CRLF3;OCIAD1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.44683396026046174,0.8829544576641064,0.5625,1.0,1.0,3/11,13.18%,FGFR2;SOX9;LRP5
prerank,regulation of MAPK cascade (GO:0043408),0.3688642013073892,0.8820381682629479,0.6918429003021148,1.0,1.0,25/157,14.24%,FAM83D;MAP4K4;KSR1;ULK4;ROCK2;FGFR2;LPAR1;IAPP;KIT;WDR54;VRK2;STK3;NRK;TGFBR3;JCAD;CCN1;ROCK1;HMGB1;APIP;BMP2;RRAS;ROR1;ADRB2;SPRED1;TRIM5
prerank,positive regulation of transmembrane transport (GO:0034764),-0.32595740322425226,-0.8817629079067563,0.6118012422360248,0.8325956456869279,1.0,9/13,34.39%,ANO6;CLIP3;ACSL5;ACSL1;P2RX7;SLC26A6;C2CD5;NR4A3;C3
prerank,negative regulation of protein binding (GO:0032091),0.37273776418751786,0.8814978794943144,0.6415094339622641,1.0,1.0,17/71,19.70%,AURKB;DDX11;AURKA;GSK3B;LRRK2;ATP2A2;ROCK1;PSME3IP1;MITD1;NES;ADRB2;PIN1;DNAJB2;STYX;ZFPM1;PRKCD;IFIT2
prerank,iron-sulfur cluster assembly (GO:0016226),0.4124177964008847,0.8814193857100082,0.5927318295739349,1.0,1.0,9/24,22.56%,FXN;NUBP2;CIAO3;MMS19;ISCA2;NUBP1;LYRM4;CIAO2A;NFS1
prerank,skeletal muscle organ development (GO:0060538),-0.2748136283362319,-0.8808628109612738,0.6540284360189573,0.8335135515152942,1.0,8/26,21.65%,MEF2C;CAV1;IGSF8;MYL6;SIX1;STRA6;DISP1;BASP1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.3466028407906701,-0.880301892145399,0.6029850746268657,0.8329740875962314,1.0,7/11,43.26%,SHC1;PTK2B;SYK;JAK1;JAK3;IL2RA;IL2RG
prerank,cellular response to interleukin-2 (GO:0071352),-0.3466028407906701,-0.880301892145399,0.6029850746268657,0.8329740875962314,1.0,7/11,43.26%,SHC1;PTK2B;SYK;JAK1;JAK3;IL2RA;IL2RG
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3664299662392092,0.8801098059794753,0.789,1.0,1.0,62/348,15.84%,CENPE;TTK;PLK1;SPDYA;ATP2B4;BMPR1A;FNIP1;ANGPT4;ROCK2;UBE2K;DDRGK1;SH2D3C;PRNP;MRE11;LEPR;BMP6;MUSK;RAP2A;ARRB1;EFNA1;FMR1;ENPP2;TXN;SFRP2;CCN1;CD80;MRNIP;LRRK2;AXIN2;ANGPT1;AGT;DDR2;RB1CC1;P2RY1;S1PR2;TGFBR1;CALM2;CRKL;BMP2;AKAP9;RAC1;STOX1;ADAM17;TRIM6;SOX9;SMAD4;PLAUR;SLCO3A1;PRKD1;CAB39;ITGA5;RAMP3;CD44;DOCK7;RPTOR;WDFY2;PIN1;PRKAG1;SRC;FXR1;PRKD2;TP53
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.31224471305727164,-0.8797913061781456,0.6120401337792643,0.8331936893678588,1.0,2/15,10.54%,PRKN;BCL2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.44559098595172497,0.8795752244506175,0.6111111111111112,1.0,1.0,7/13,21.74%,SCAP;DKK3;BMP2;NFKB1;ERLIN1;BMP5;SOD1
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.3639378265033718,-0.8794755590986088,0.6040462427745664,0.832958946182567,1.0,3/10,8.57%,PDCD4;DNAJA1;PTPN22
prerank,cellular response to calcium ion (GO:0071277),0.37547047806657197,0.8792155255790527,0.6461211477151966,1.0,1.0,2/67,2.44%,ECT2;ADGRV1
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.30757737812203023,-0.8792123353887504,0.6016260162601627,0.8326709319214898,1.0,6/18,12.77%,SNX3;DAB2;VPS11;MAPK3;MAPK1;MAP2K1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.4131579927694433,0.8791070141211398,0.5873850197109067,1.0,1.0,4/22,9.56%,ROCK2;EFNA1;EPHA4;PICALM
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.4584811030016134,0.8789511112750382,0.5941605839416059,1.0,1.0,2/10,5.34%,UPB1;DPYD
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.4508031850093116,0.8788408311233578,0.5755287009063444,1.0,1.0,3/10,13.18%,FGFR2;SOX9;LRP5
prerank,tRNA 5'-end processing (GO:0099116),0.4320228659723622,0.8787330778277845,0.603905160390516,1.0,1.0,5/15,19.62%,RPP40;RPP30;POP1;PRORP;RPP21
prerank,glucan catabolic process (GO:0009251),0.4226928189380574,0.8784372194898344,0.5870786516853933,1.0,1.0,3/15,7.73%,AGL;PYGB;PHKA2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.41002578147217555,0.8776951259835442,0.5981794538361509,1.0,1.0,5/20,15.61%,SPDYA;PSRC1;STOX1;ADAM17;PKD2
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.40888126425077365,0.877502533195056,0.5877862595419847,1.0,1.0,3/23,4.84%,PFKFB1;GCK;ERFE
prerank,protein-containing complex disassembly (GO:0032984),-0.2243952592205828,-0.8773268087707322,0.6888888888888889,0.835754553436702,1.0,14/54,16.16%,CAV1;TECPR1;SNX14;RPL23;TSG101;FZD2;SNAP29;CTNNB1;VPS33B;APC;DVL1;LAMP2;VAMP8;LRP6
prerank,sensory perception of smell (GO:0007608),-0.3417850317542764,-0.8763589484698139,0.6432926829268293,0.8368913348569565,1.0,5/11,22.19%,BBS4;ADCY3;SYT10;SLC24A4;DRD2
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.37784427272958776,0.8760901286539675,0.6371398078975453,1.0,1.0,11/61,12.64%,MAP4K4;RTN4R;LPAR1;AUTS2;NET1;ARRB1;ROBO1;PIK3CB;CRKL;RAC1;NOTCH2
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.447866490907995,0.8760727873046767,0.5981308411214953,1.0,1.0,4/12,20.97%,ACTN4;DMTN;RCC2;FBLN1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.447866490907995,0.8760727873046767,0.5981308411214953,1.0,1.0,4/12,20.97%,ACTN4;DMTN;RCC2;FBLN1
prerank,regulation of receptor binding (GO:1900120),-0.35966400259732073,-0.8757417786449355,0.6169014084507042,0.8373718790530594,1.0,5/10,26.03%,ADAM15;B2M;ATP2A3;BDNF;PTPRF
prerank,negative regulation of potassium ion transport (GO:0043267),-0.3303054010793667,-0.8755716455884249,0.629746835443038,0.8368609475042474,1.0,5/13,23.70%,CAV1;BIN1;NOS1;NEDD4L;PTK2B
prerank,regulation of phospholipid metabolic process (GO:1903725),0.44917496708469384,0.8749817828203458,0.6129985228951256,1.0,1.0,4/10,14.96%,MTMR1;MTMR2;MTMR9;MTMR3
prerank,negative regulation of leukocyte activation (GO:0002695),-0.32451077413089136,-0.8743393816828975,0.62890625,0.8384725794067208,1.0,7/15,26.13%,NR1H3;GRN;ZC3H12A;CD84;CD300A;LRFN5;GPER1
prerank,sphingoid metabolic process (GO:0046519),-0.3238245321998652,-0.8742843194886293,0.6081504702194357,0.8377068953168716,1.0,8/12,38.52%,PLPP3;DEGS2;ASAH2;SPHK1;KDSR;SPHK2;SGPP1;PLPP2
prerank,establishment of protein localization to membrane (GO:0090150),0.37671537928822785,0.8740677127628046,0.6338028169014085,1.0,1.0,22/66,23.28%,SYNE3;VPS37B;RAB10;MYO1C;AFDN;VPS37A;ZDHHC18;CHM;ZDHHC15;GORASP2;ATG3;PRKCI;ZDHHC3;ZDHHC21;PIKFYVE;BRAF;ZDHHC24;ICMT;VPS37C;ZDHHC2;ZDHHC14;BID
prerank,apoptotic mitochondrial changes (GO:0008637),-0.2556822449734546,-0.8738273079215814,0.7083333333333334,0.8377593932463661,1.0,8/32,13.10%,FIS1;SOD2;HSPD1;ERBB4;NDUFS1;BCL2;BNIP3;CCAR2
prerank,regulation of tau-protein kinase activity (GO:1902947),0.4666912156782189,0.8737219123262565,0.6003184713375797,1.0,1.0,1/10,2.56%,RB1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.3022887822280306,-0.873629582854452,0.6571428571428571,0.8372572939433549,1.0,3/18,6.15%,POLDIP3;THOC2;DDX19B
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.3651768735744442,0.8736247472706038,0.6778797145769623,1.0,1.0,25/113,20.03%,TGM1;HMGB2;VASH2;HYAL1;FGFR2;LAMB1;BMP6;TCF7L2;YAP1;TGFBR1;BMP2;PRKCA;NR4A1;SOX9;NOTCH2;PRKD1;ARNT;PRKD2;SFRP1;NRAS;OSR1;BAD;PLXNB3;RREB1;SEMA5A
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.3063894117583529,-0.8733284997283247,0.6096654275092936,0.8370882303851906,1.0,8/16,33.00%,EP300;NAA25;KAT2B;NAA80;NAA30;CREBBP;NAA16;NAA10
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.2001759721162546,-0.8728117547857722,0.7666666666666667,0.8373380672669608,1.0,29/93,24.90%,TNFRSF19;SH3RF3;HIPK2;TPD52L1;TGFB2;TAOK2;ANKRD6;MAP3K5;MID1;DUSP22;SEMA3A;MINK1;STK25;APP;SDCBP;SH3RF2;VEGFA;ZC3H12A;PRMT1;TIRAP;GADD45B;FLT4;MAP3K11;WNT16;PTK2B;SPHK1;MAPK8IP1;ARL6IP5;MFHAS1
prerank,negative regulation of endopeptidase activity (GO:0010951),0.3827703429518077,0.8727076139028416,0.6374859708193041,1.0,1.0,4/47,9.78%,SERPINB8;SERPINA9;SERPINE1;AGT
prerank,positive regulation of epithelial cell migration (GO:0010634),0.37165274565139483,0.8726428172595023,0.6676954732510288,1.0,1.0,24/92,15.60%,ATOH8;MAP4K4;ANGPT4;ROCK2;HYAL1;GPI;ANXA3;ENPP2;ANGPT1;AGT;PIK3CB;RAC1;RRAS;PRKCA;SOX9;CTSH;PRKCE;DOCK1;PRKD1;ADAM9;INSL3;AAMP;SRC;PRKD2
prerank,carbohydrate derivative transport (GO:1901264),-0.2992635767379275,-0.8724543553046098,0.658008658008658,0.8371852157422724,1.0,4/18,10.93%,PLTP;LBP;SLC15A2;VLDLR
prerank,positive regulation of neutrophil migration (GO:1902624),0.41361991448161,0.8722109497632231,0.5774456521739131,1.0,1.0,4/18,11.75%,MCU;RIPOR2;CAMK1D;RAC1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.35419630557290105,-0.871981679604657,0.6289855072463768,0.8373760296573336,1.0,5/10,18.75%,ERLEC1;OS9;YOD1;SVIP;UBE2G2
prerank,regulation of autophagosome assembly (GO:2000785),-0.25442666419787097,-0.8716384819991645,0.6326530612244898,0.8372641194410111,1.0,10/33,13.18%,PIP4K2A;FEZ1;PIP4K2B;RALB;RAB5A;IFT20;FEZ2;RAB3GAP2;PINK1;NUPR1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.3727448296714421,0.8710490278199537,0.6380236305048335,1.0,1.0,10/65,10.89%,AURKB;AURKA;PSMC2;PSMD5;FBXL7;CHEK1;PSMB1;PSMD14;PSMD1;PSMB9
prerank,cellular response to nutrient levels (GO:0031669),-0.21051605850532656,-0.8703438089727001,0.7727272727272727,0.8391075996458425,1.0,16/62,16.81%,FOXO1;KCNB1;BMPR2;WDR45B;RALB;EIF4G1;ULK1;PRKAA1;VPS41;MTOR;SREBF2;KLF10;RRAGC;LAMP2;USP33;XBP1
prerank,negative regulation of cell cycle (GO:0045786),0.36984620659255873,0.8700017909579122,0.6334033613445378,1.0,1.0,16/73,17.40%,PLK1;RB1;SCRIB;HTRA2;BTG3;GAS1;BMP2;IPO7;NR4A1;CDKN1B;SMAD3;IPO5;PTEN;PTPRK;ANGEL2;TFAP4
prerank,endothelial cell migration (GO:0043542),0.38775100042754185,0.8699507570723403,0.6252873563218391,1.0,1.0,10/37,17.78%,LOXL2;RHOA;ADGRA2;CORO1B;LGALS12;CCN3;NR4A1;PLXND1;RAB13;PLEKHG5
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.3511064480026267,-0.8698210214790654,0.6397694524495677,0.8393805252229922,1.0,6/10,35.73%,GIPC1;ATP7A;CTNS;OPN3;CDH3;MFSD12
prerank,negative regulation of cellular process (GO:0048523),0.36477866939724674,0.8693687712971877,0.863,1.0,1.0,113/521,18.99%,E2F7;CDKN3;MYBL1;RAD18;PSRC1;CDKN2D;FBXO5;PPM1D;CDKN2C;TXNDC12;RB1;PDS5B;HYAL1;SUZ12;CDC6;CTCF;ALDH1A2;MDM4;ARID2;ANP32B;SPEF1;CASK;PDE3B;CTBP1;BLM;PDPN;NMI;COL18A1;PTPN2;RBBP4;TGFBR3;RBBP7;PML;SFRP2;CCN1;CLMN;HTRA2;BTG3;SMAD6;IRF1;ING4;SMARCA4;RIPOR2;KLF11;AXIN2;NCK1;KANK2;CDA;ANGPT1;VHL;ABI1;NOX4;SRGAP2;PIP4P2;PPP2R5C;TMEM98;PLXNB2;CRLF3;PLXNB1;IP6K2;EIF2AK3;CCN3;DSCAM;BMP2;NDRG3;ENPP1;APPL2;P3H1;PLPP1;NCK2;GJA1;NR4A1;WNT9A;TES;SMAD4;ATF5;ORC6;PLXND1;JADE1;PRKD1;CDKN1B;ADAMTS1;FOXM1;SMAD3;MIA3;STK11;PTPRU;CNOT7;PKD2;NF2;ZBTB7C;TP53;DYSF;SESN2;SFRP1;PTEN;PTPRK;CCN2;NGF;SIRPA;SLURP1;TFAP4;DNAJB2;CHMP4B;IGFBP3;DCBLD2;SIPA1;FRZB;NIBAN2;PLXNA2;ADNP2;SP100;CAPRIN2
prerank,negative regulation of signaling (GO:0023057),-0.26283494959611237,-0.8692084624622948,0.6634146341463415,0.8398467660681409,1.0,5/25,13.50%,ACVR1;GLRA1;SOCS5;OPRM1;HHIP
prerank,regulation of vasculature development (GO:1901342),0.3946376222702618,0.8690133827957011,0.5880149812734082,1.0,1.0,6/26,20.28%,VASH2;ADGRA2;PLXND1;SFRP1;SP100;EGLN1
prerank,vasculogenesis (GO:0001570),-0.25638568258169325,-0.8688366595195929,0.6709677419354839,0.8397556594880505,1.0,9/32,15.07%,CAV1;TGFBR2;PDGFRB;RAMP2;RASIP1;CUL7;VEGFA;ENG;SOX17
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.3017913412035834,-0.8684509827238802,0.6309523809523809,0.8396524282475978,1.0,5/18,17.19%,PUM1;DDX60;UFD1;RNF125;BIRC3
prerank,regulation of TOR signaling (GO:0032006),0.3698173690342841,0.8682114171860721,0.6466244725738397,1.0,1.0,13/67,17.76%,FAM83D;TNFAIP8L1;FNIP1;DEPDC5;DYRK3;TBC1D7;NPRL3;SLC38A9;ITFG2;RPTOR;LARS1;LAMTOR3;LAMTOR5
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.3663943980448886,0.8674272872508686,0.6642335766423357,1.0,1.0,15/86,13.20%,CDK5RAP2;PSRC1;RB1;MYLK3;NUMA1;MAPT;CDC42EP2;NCK1;DRG1;AKAP9;RAC1;NCK2;SYNPO2;BAIAP2L1;PRKCE
prerank,muscle cell differentiation (GO:0042692),-0.24765016450042965,-0.8672076744409266,0.6582278481012658,0.8413065020643657,1.0,6/32,13.44%,MEF2C;SYNE1;SPEG;NEBL;MRTFB;TBX1
prerank,negative regulation of neuron projection development (GO:0010977),0.3687654654179696,0.8670867948929459,0.6342794759825328,1.0,1.0,18/56,18.58%,RHOA;RTN4R;LPAR1;EFNA1;EPHA4;RAB29;DENND5A;PTPRS;BAG5;GAK;HDAC2;DPYSL3;EFNB2;ADCY6;PTEN;STMN2;TRPV4;MYLIP
prerank,phasic smooth muscle contraction (GO:0014821),-0.348345597130735,-0.8669459911174381,0.5983379501385041,0.8409877441491154,1.0,6/10,34.92%,DRD2;EDNRB;EDN1;PTGER3;EDN3;HTR2B
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.2894003919211052,-0.8668863211947071,0.6343283582089553,0.8402295161193816,1.0,3/18,11.92%,MTUS1;LYN;SLIT2
prerank,regulation of protein processing (GO:0070613),0.40887228518767926,0.8666553941821713,0.582798459563543,1.0,1.0,3/21,10.00%,PRNP;LRRK2;GAS1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3755483273937177,0.8665495287530635,0.6430834213305174,1.0,1.0,23/65,19.39%,FBN1;PEG10;PMEPA1;LEMD3;SMAD6;SMURF1;ADAMTSL2;TGFBR1;SMURF2;NKX2-1;PDPK1;ADAM17;SPRED1;HTRA3;SMAD3;PIN1;SPRED2;VEPH1;SMAD2;SKIL;LTBP1;SKI;PPM1A
prerank,negative regulation of cell activation (GO:0050866),-0.3248182033757787,-0.8665337774820734,0.6083916083916084,0.8400946920331587,1.0,3/14,5.31%,APOE;NOS3;THBD
prerank,protein palmitoylation (GO:0018345),-0.25307123481784,-0.8664329292680414,0.7244897959183674,0.8394176778769561,1.0,12/30,23.28%,GLUL;CLIP3;ZDHHC5;ZDHHC1;ZDHHC13;ZDHHC7;ZDHHC8;GOLGA7;ZDHHC16;ZDHHC20;ZDHHC4;ZDHHC17
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.289117390866189,-0.8661121963186291,0.6535433070866141,0.8391511051094399,1.0,8/17,26.13%,AR;ATP1A1;ABHD2;ATP1A3;ATP1A2;BMP7;URI1;GPER1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.3990873429563504,0.866110744423914,0.6162361623616236,1.0,1.0,6/25,12.70%,SRSF4;TRA2B;SRSF10;PRPF3;SRRM1;SF3B3
prerank,sulfation (GO:0051923),0.4293246296761236,0.8659896434733477,0.5965665236051502,1.0,1.0,11/11,57.10%,UST;SULT4A1;SULT2A1;CHST4;SULT1C2;SULT1C4;SULT6B1;SULT1A1;SULT2B1;HS3ST5;CHST5
prerank,positive regulation of cell killing (GO:0031343),-0.3179952952745374,-0.8659846370472927,0.5954692556634305,0.8385515317093937,1.0,4/13,27.32%,MAPK8;NOX1;SYK;DVL2
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.20733023936330405,-0.8659262480552216,0.7692307692307693,0.8378362997243015,1.0,23/65,26.13%,SH3KBP1;ARAP1;STAM2;DUSP3;EPN1;TSG101;TGFA;BCAR3;GRB2;SPRY2;RHBDF1;HIP1;ARHGEF7;CBL;AFAP1L2;PTPN12;DGKD;HBEGF;RHBDF2;SH3GL2;MVB12A;SHKBP1;GPER1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.33431646083972505,-0.8658277669299282,0.6349206349206349,0.8371678388712008,1.0,1/12,0.75%,IL1R1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.2817085310655256,-0.8657282193360357,0.6592920353982301,0.8365111866684827,1.0,5/20,11.05%,HSP90AB1;TXNIP;ANO6;ENTPD1;APP
prerank,lymphocyte chemotaxis (GO:0048247),-0.23688251905149343,-0.865617831619087,0.6901408450704225,0.8358750030390739,1.0,16/34,41.85%,CYP7B1;GAS6;CX3CL1;SLC12A2;PIK3CD;CCL13;CXCL16;GPR183;CCL19;ADAM8;CH25H;CCL15;HSD3B7;PIK3CG;CCL2;CXCL10
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.2591049984502248,-0.8650561481471172,0.6733668341708543,0.8360984043837331,1.0,11/27,22.47%,MAPK8;CUL1;TAOK2;MAP3K5;MAPK3;MAPK1;CHUK;MAP2K7;UBB;UBC;RPS27A
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.4240791017210683,0.8648579445155795,0.5810055865921788,1.0,1.0,8/14,26.50%,AK1;AK7;NMNAT1;NMNAT2;PNP;NMNAT3;ME1;AK8
prerank,positive regulation of vacuole organization (GO:0044090),-0.36263670976464807,-0.864242023907724,0.6467065868263473,0.8368958566723953,1.0,5/10,11.86%,PIP4K2A;PIP4K2B;RALB;GRN;RAB3GAP2
prerank,wound healing (GO:0042060),0.37276719547199805,0.863713633764237,0.6476190476190476,1.0,1.0,14/62,15.86%,HPSE;MACF1;FUT10;SRF;MYOF;PDGFRA;PPP3CA;CORO1B;TGFBR1;SYTL4;SMPD1;SMAD3;MIA3;DYSF
prerank,Rho protein signal transduction (GO:0007266),0.3794929976692561,0.8635949099862985,0.6421404682274248,1.0,1.0,10/53,10.42%,ROCK2;RHOA;NTN1;PDPN;CDC42EP2;GNA13;ROCK1;EPS8L1;MYO9B;ARHGAP6
prerank,regulation of postsynapse organization (GO:0099175),0.4013292622024168,0.8635824100938562,0.6101694915254238,1.0,1.0,9/28,18.68%,ARHGAP22;EPHA4;LRRK2;LZTS3;PDLIM5;ZDHHC15;SIPA1L1;ABI2;TANC2
prerank,keratinocyte differentiation (GO:0030216),0.39404120014989313,0.8633633746650933,0.6074429771908764,1.0,1.0,5/29,13.78%,TGM1;ANXA1;CLIC4;MED1;ADAM9
prerank,positive regulation of RNA metabolic process (GO:0051254),0.3758697583959834,0.863287139096767,0.6304591265397537,1.0,1.0,12/45,18.74%,DYRK1A;SETX;NMD3;POLR2A;DXO;NFKB1;TP53;ZC3H18;PNPT1;HNRNPLL;SLC38A2;RIPK1
prerank,response to molecule of bacterial origin (GO:0002237),-0.20391732504311538,-0.8629259776020007,0.7846153846153846,0.8386592074149393,1.0,15/69,17.68%,CYRIB;IFNAR1;TAB2;NOS3;TLR4;LIAS;GGT5;LBP;PTPN22;TNFRSF11A;C4B;GCH1;ERBIN;LGALS9;PRDX3
prerank,phospholipid biosynthetic process (GO:0008654),0.3805552621106954,0.8626583606626366,0.6077981651376146,1.0,1.0,5/36,13.25%,DHDDS;LPCAT1;SRD5A3;AGK;AGPAT3
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.40413615839183303,0.8623302701158712,0.6265508684863523,1.0,1.0,5/24,10.36%,MIEF2;PRNP;PDZK1;MYO1C;MIEF1
prerank,metal ion homeostasis (GO:0055065),-0.23773354604326513,-0.8618415860066567,0.7419354838709677,0.8399824810754593,1.0,7/40,16.25%,TMTC2;CAV1;FAM20A;SELENON;SLC12A9;GRIN1;SLC12A2
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.26477824016255685,-0.861789339515237,0.6851851851851852,0.8392404495093724,1.0,13/26,33.68%,CALM1;FKBP1A;GNB5;ATP1A2;SRI;ADRA2A;CALM3;DRD2;GSTM2;GSTO1;CBARP;CASQ2;PLN
prerank,stress-activated MAPK cascade (GO:0051403),-0.214181036916124,-0.8610531562940934,0.8311688311688312,0.8398326997024972,1.0,24/61,23.35%,MAPK10;TNFRSF19;MAPK8;TAB2;CUL1;TAOK2;MAP3K5;TAB3;MAPK9;NOD1;MINK1;MAPK3;MAPK1;CHUK;MAP2K7;LGALS9;MAP3K13;UBB;GPS2;MAP3K12;UBC;RPS27A;MAP2K4;MAP3K11
prerank,regulation of exosomal secretion (GO:1903541),-0.29093335706478163,-0.8610050730636288,0.6571428571428571,0.839083685703892,1.0,5/19,15.43%,PRKN;VPS4B;TSG101;SDCBP;ATP9A
prerank,aorta development (GO:0035904),-0.32569109036742233,-0.8600416493676645,0.6779661016949152,0.8402493712334957,1.0,7/14,18.26%,JAG1;PDGFRB;LRP1;TBX1;ROBO2;TBX2;PDE2A
prerank,hexose transmembrane transport (GO:0008645),-0.2859249997888943,-0.859682654367325,0.6559633027522935,0.8401770230525454,1.0,7/21,32.84%,SLC2A1;SLC2A3;SLC2A10;SLC45A3;SLC2A9;SLC5A3;SLC45A1
prerank,nucleoside catabolic process (GO:0009164),0.4452066206390383,0.8596690459754563,0.6095100864553314,1.0,1.0,2/11,5.34%,UPB1;DPYD
prerank,carboxylic acid transmembrane transport (GO:1905039),0.37853499932994455,0.8596263719597137,0.6261574074074074,1.0,1.0,6/40,13.12%,SLC25A21;SLC38A7;SLC38A4;SLC19A1;SLC38A9;SLC25A30
prerank,actin filament bundle assembly (GO:0051017),0.38456728129524437,0.8594398599106604,0.627039627039627,1.0,1.0,12/33,22.67%,ADD2;CORO1B;EZR;DMTN;DPYSL3;BAIAP2L1;ADD1;LCP1;SHROOM2;SHROOM1;PLS1;MYO1B
prerank,protein dephosphorylation (GO:0006470),0.3611752660897867,0.8593919720924569,0.7129909365558912,1.0,1.0,39/135,19.94%,PPM1G;PPM1D;EYA4;LHPP;TAB1;PPP2R3A;SSH2;PTPN2;PPP3CA;NCK1;DUSP12;MTMR2;EYA2;PPP2R5C;PTPN21;PTPRS;FBXW11;RPRD1A;PPP1CC;PPP2R2D;BTRC;PPP1R15B;PTPRA;STK11;PTPN13;PTPRU;MTMR3;PPP2R5B;DAPP1;PPP2R1B;PTEN;UBLCP1;PTPRK;PTPRE;RPRD1B;DUSP7;PPM1A;PTPN1;PTPN5
prerank,intracellular protein transport (GO:0006886),0.36087740144129765,0.8593290194913944,0.799,1.0,1.0,82/304,20.53%,ANKLE1;CCHCR1;RANBP17;USP6NL;NUP155;XPO1;RANGRF;STX11;RPAIN;TRAK1;E2F3;XPO4;ARFIP1;AP4M1;FUT10;EVI5L;TBC1D25;SNX1;TNPO1;MYO1C;NUP85;TBC1D13;EIF4ENIF1;CSE1L;WDR11;TPR;VPS26C;TBC1D2B;RAB22A;RAB29;STXBP2;STAM;SMURF1;STX2;SRPRA;RAB1A;SNX27;VIPAS39;COPB2;HERC2;COPZ1;AP3B1;IPO7;APPL2;NUP214;SCFD1;EHD1;STRADA;IFT27;IPO11;ARF4;NXT1;NUP133;ARL4A;MAIP1;IPO5;STX12;NUP42;ARF3;TBC1D9;STXBP1;VPS26A;TMED3;NXT2;FAM53B;ACD;RIC1;USO1;ARL5A;TMED10;EGR2;TBC1D12;STRADB;TBC1D10A;IPO9;BCS1L;NUP188;KIF13B;ARF1;EIF2D;RANBP3L;IPO4
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.3985108998133546,0.8592770076036015,0.6027568922305765,1.0,1.0,6/21,18.15%,CBFB;ELF2;ELF1;PRKCB;FOXP1;RUNX1
prerank,vasculature development (GO:0001944),-0.30505862449791765,-0.8592366282571119,0.6477272727272727,0.8402184507827535,1.0,8/16,18.25%,BMPR2;ACVRL1;PDGFRB;CDH5;ACVR2B;STRA6;NOTCH4;PIK3CA
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3592856288896927,0.8587030000587174,0.7535070140280561,1.0,1.0,50/186,18.67%,GLI3;WWOX;GSK3B;PSMC2;PSMD5;TRABD2B;BICC1;NLK;SIAH2;MCC;STK3;RNF43;TCF7L2;HMGXB4;SFRP2;WWTR1;PSMB1;CUL3;PSMD14;AXIN2;TMEM64;NPHP3;LIMD1;PSMD1;EMD;PSMB9;DKK3;HDAC1;BMP2;RBMS3;LZTS2;LMBR1L;SOX9;JADE1;RUVBL2;TLE4;PSMC6;STK11;NKD1;PTPRU;TLE3;NOTUM;SFRP1;AMER1;MLLT3;CSNK1A1;PSMB2;PSME4;FRZB;PSMB7
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.380271244125023,0.8584801596098948,0.6261904761904762,1.0,1.0,9/39,15.98%,MAP4K4;RHOA;ACTN4;CASK;HOXA7;DMTN;NF2;TBCD;RCC2
prerank,regulation of myotube differentiation (GO:0010830),0.40375256155008876,0.8579988383637571,0.6327827191867853,1.0,1.0,6/24,13.44%,MMP14;BHLHE41;CCN3;HDAC1;PIEZO1;MAML1
prerank,lipid homeostasis (GO:0055088),-0.2167358491291985,-0.8579671483827848,0.7195121951219512,0.8419057715173848,1.0,27/57,33.79%,APOE;ADCK1;ABHD5;TLCD2;IRS2;PRKAA1;PNPLA8;NR1D2;NR1H3;RCN3;TLCD3A;XBP1;USF2;USF1;ABCA2;ABHD8;PNPLA2;CLN8;ORMDL1;DDX3X;PNPLA3;TLCD1;DGAT2;MLXIPL;ANGPTL3;FITM2;PPARG
prerank,regulation of calcium-mediated signaling (GO:0050848),0.4056821501782874,0.8576997611540949,0.6034271725826194,1.0,1.0,3/25,8.30%,ITPR1;MAPT;LRRK2
prerank,cardiac muscle tissue development (GO:0048738),0.3767352331264848,0.8574711406619696,0.6477916194790487,1.0,1.0,14/50,21.19%,BMPR1A;ADAMTS9;BMP2;TBX18;GJA1;SMAD4;NOTCH2;MAML1;HEY2;CSRP3;ZFPM1;NDUFV2;CACNA1G;BMP5
prerank,entry into host (GO:0044409),-0.3249254768902953,-0.8573942588065784,0.6377245508982036,0.8421464064913472,1.0,6/13,17.57%,CTNND1;CTNNB1;GRB2;MET;CBLL1;CBL
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.4146883449934814,0.857306872537568,0.6012738853503184,1.0,1.0,2/20,3.89%,STMN1;ADA
prerank,regulation of amyloid-beta formation (GO:1902003),0.37869904108997615,0.8571021294808304,0.6282352941176471,1.0,1.0,7/34,9.56%,ROCK2;RTN3;PRNP;EFNA1;EPHA4;ROCK1;PICALM
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.2761162842518233,-0.8570973170833932,0.6682027649769585,0.841917959710079,1.0,8/23,17.57%,CAV1;TSG101;DUSP22;SOCS5;ZGPAT;SRCIN1;CBLB;CBL
prerank,regulation of cellular response to stress (GO:0080135),0.3593754774383455,0.8570180837504575,0.6799184505606524,1.0,1.0,14/115,6.59%,NDC1;NUP155;NUP205;NUP160;ROCK2;GSK3B;RPA1;AJUBA;AIFM2;DYRK3;MAPT;NUP85;RPA2;TPR
prerank,phosphate ion transmembrane transport (GO:0035435),0.43461390819986934,0.8561205622865448,0.6038863976083707,1.0,1.0,4/12,21.70%,SLC20A2;SLC25A30;SLC37A2;SLC37A3
prerank,negative regulation of cell growth (GO:0030308),0.36034355603434465,0.8558732738968808,0.7090163934426229,1.0,1.0,32/121,18.99%,PSRC1;CDKN2D;CDKN2C;RB1;HYAL1;RTN4R;RBBP7;PML;SFRP2;SMARCA4;CDA;CRLF3;IP6K2;CCN3;PTPRS;NDRG3;ENPP1;ULK2;GJA1;SMAD4;JADE1;CDKN1B;SMAD3;STK11;TP53;SESN2;SFRP1;DNAJB2;DCBLD2;SIPA1;FRZB;CAPRIN2
prerank,regulation of cell-matrix adhesion (GO:0001952),0.3650874243518543,0.8557432353611477,0.6616052060737527,1.0,1.0,10/64,10.11%,MAP4K4;MACF1;ROCK2;RHOA;GSK3B;CASK;HOXA7;PLAU;ROCK1;PIK3CB
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.40667969949387245,0.8556802322578598,0.6119205298013245,1.0,1.0,7/20,19.93%,GSS;PTDSS2;PLOD2;GCLM;MTHFS;GCLC;HAGH
prerank,mRNA processing (GO:0006397),0.3574287448181814,0.8554031387793366,0.8098098098098098,1.0,1.0,79/287,19.98%,RBM15;PPIL1;SYNCRIP;SNRNP25;SRSF4;HNRNPD;TRA2B;CSTF3;FIP1L1;DHX9;HNRNPA1;SRSF10;UPF3B;CCAR1;LSM3;RAVER2;ERCC3;DDX39B;PSPC1;PRPF40A;HNRNPH1;PRPF19;SRSF7;POLR2A;FUS;DHX8;HNRNPUL1;WDR33;PRPF3;NONO;SF3A2;PCF11;LSM2;SRSF3;SFPQ;HNRNPU;SNRNP48;RBM15B;HNRNPL;SRRM1;CPSF4;SNRNP35;HNRNPH2;RNGTT;RPRD1A;SF3B3;SNRNP27;RBM4;LSM7;WBP4;PABPC1;AQR;UBL5;KIN;RBM19;HNRNPA2B1;PPWD1;LSM4;ZCCHC8;RALY;METTL3;DHX38;PRPF4;RBM10;PRPF18;GEMIN7;CWC25;CWC22;PDCD7;BUD13;RPRD1B;CDC5L;DNAJC8;HNRNPR;POLR2B;SF3A3;SNRPB;ERCC2;TRA2A
prerank,positive regulation of viral process (GO:0048524),0.37183073320558946,0.855383006566219,0.6749460043196545,1.0,1.0,13/60,19.34%,KPNA2;DHX9;POLR2A;LARP1;TMEM39A;SRPK1;PPID;PABPC1;CNOT7;AXL;SRPK2;PKN2;POLR2B
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.27940827061689844,-0.8553391395671066,0.6633663366336634,0.8445090256968034,1.0,6/23,11.05%,PSEN1;INSR;IGF1;PFKFB3;PRKAA1;APP
prerank,regulation of cell migration (GO:0030334),0.3564053991642275,0.8550424905530051,0.845,1.0,1.0,71/382,16.15%,KIF14;ARHGEF39;GTSE1;MAP4K4;SYNE2;ULK4;MACF1;TWIST2;TRIP6;ROCK2;RHOA;CEP43;MMP14;DDRGK1;ACTN4;ARID2;LAMB1;KIT;SPAG9;CCAR1;PDPN;MYO1C;STK24;RAP2A;AFDN;ENPP2;PDGFRA;PLAU;SFRP2;CCN1;PPP3CA;PHACTR1;EPHA4;SULF1;SERPINE1;FOXO3;TMEFF2;ROBO1;ROCK1;SRGAP2;SRGAP3;TGFBR1;PLXNB2;PLXNB1;BMP2;ANXA1;NKX2-1;TBCCD1;RAC1;APPL2;PRKCA;ADAM17;CLIC4;DPYSL3;CTSH;PLXND1;ADAM9;ITGB1;MIA3;NKD1;PTPRU;SEMA3D;SRC;ELP6;RHOC;SUN2;NF2;LMO4;RCC2;SFRP1;PTEN
prerank,negative regulation of neuron death (GO:1901215),0.3605431753341402,0.8550324065239483,0.6818652849740933,1.0,1.0,12/93,15.39%,KIF14;GSK3B;HTRA2;KDM2B;LRRK2;IKBKG;CNTF;NENF;PRKCI;BTBD10;SLC30A10;GDNF
prerank,neuron projection morphogenesis (GO:0048812),0.358792068854191,0.8547517668840344,0.7243460764587525,1.0,1.0,15/137,11.06%,KIF20B;MAP4K4;ALCAM;FGFR2;RAB10;NRK;ANKRD27;LRRK2;DSCAML1;DNM2;FARP1;ROCK1;SRGAP2;EPB41L3;PLXNB1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.38709711024717586,0.8547442175787401,0.6223529411764706,1.0,1.0,10/35,15.34%,RBFOX2;NEDD4;ARID1A;PMEPA1;UBR5;YAP1;NR3C1;PLPP1;MED1;SRC
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.43874100713823955,0.854609726660765,0.6063675832127352,1.0,1.0,3/11,7.14%,ELOF1;ARID1A;CHEK1
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.276570103080793,-0.8545280430293818,0.6604651162790698,0.845299635214459,1.0,10/23,18.55%,HSP90B1;OS9;UFD1;DERL1;SURF4;SELENOS;PREB;SEC61B;AUP1;SYVN1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.4383879840628611,0.8543370610048258,0.6391752577319587,1.0,1.0,2/12,12.03%,SOAT1;SOAT2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3540429998135888,0.853360302540456,0.7447236180904523,1.0,1.0,46/161,18.67%,GLI3;GSK3B;PSMC2;PSMD5;BICC1;SIAH2;MCC;STK3;TCF7L2;SFRP2;WWTR1;PSMB1;CUL3;PSMD14;AXIN2;TMEM64;NPHP3;LIMD1;PSMD1;EMD;PSMB9;DKK3;HDAC1;BMP2;TBX18;RBMS3;LZTS2;LMBR1L;SOX9;JADE1;RUVBL2;TLE4;PSMC6;STK11;NKD1;PTPRU;TLE3;NOTUM;SFRP1;AMER1;MLLT3;CSNK1A1;PSMB2;PSME4;FRZB;PSMB7
prerank,response to purine-containing compound (GO:0014074),-0.2876231054157734,-0.8528922977111454,0.6440677966101694,0.8477109885631157,1.0,9/17,32.58%,RYR2;TRPC3;DGKQ;NDUFS4;P2RX4;P2RX7;ABCC9;P2RY6;VGF
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.40638303582754914,0.8526781858977451,0.6391184573002755,1.0,1.0,4/17,14.38%,DYRK1A;YJU2;TWIST1;CD44
prerank,cytosolic calcium ion transport (GO:0060401),0.3964218684199407,0.8525654169825052,0.620253164556962,1.0,1.0,10/28,18.19%,MCU;ATP2A2;SLC8A1;MCUB;CACNA1C;ATP2B1;MICU1;ITPR3;MAIP1;JPH1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.3823420997425542,0.8525450836709462,0.6114421930870083,1.0,1.0,5/31,15.25%,PAXIP1;GPI;RIF1;KMT5C;SHLD2
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.3156850391375441,-0.8524811156483885,0.645367412140575,0.8476334602642188,1.0,3/13,13.91%,GLUL;GOT2;GOT1
prerank,establishment of vesicle localization (GO:0051650),-0.2877389365455416,-0.8523091437188716,0.6438356164383562,0.8471000793097319,1.0,7/18,18.48%,SPG11;KIF5B;KIF5C;SYT11;SYNJ1;RAB11A;RAB27A
prerank,regulation of mitochondrion organization (GO:0010821),0.3763034592508154,0.8518883348981174,0.6504424778761062,1.0,1.0,10/47,11.85%,MIEF2;GSK3B;IAPP;MAPT;RHOT1;FBXW7;HTRA2;LRRK2;CSNK2A2;STOX1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.4426867143737166,0.8515254741262276,0.6293494704992436,1.0,1.0,4/11,15.64%,LEPROT;VHL;ADIPOR1;NF2
prerank,visual perception (GO:0007601),0.3658051610731327,0.8513005686960905,0.6861313868613139,1.0,1.0,7/84,8.42%,GPR179;ADGRV1;EYA4;CRYBA1;RDH12;COL18A1;TYR
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.38148245599324476,0.8503053246481621,0.6335697399527187,1.0,1.0,10/32,16.15%,MAP4K4;CASK;HOXA7;SERPINE1;ARHGAP6;DMTN;SRC;NF2;RCC2;PTEN
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.44513792495971094,0.8502461726438904,0.6259659969088099,1.0,1.0,1/10,2.99%,PFKFB1
prerank,negative regulation of glycolytic process (GO:0045820),0.44513792495971094,0.8502461726438904,0.6259659969088099,1.0,1.0,1/10,2.99%,PFKFB1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.3614991780161561,0.8501693666621734,0.6394335511982571,1.0,1.0,23/59,24.72%,TICAM1;MAP3K14;ROCK2;TAB1;RNF31;ROCK1;IKBKG;ERC1;PRDX4;RIPK1;RELB;TRAF6;TANK;TRAF2;IKBKB;BIRC2;TLR7;DAB2IP;NFKBIL1;BCL10;RIPK2;REL;RELA
prerank,peptidyl-proline modification (GO:0018208),0.39164766642545396,0.849993899556414,0.6240694789081885,1.0,1.0,6/25,15.58%,PPIL1;FKBP5;PPIG;PPID;PIN1;PPWD1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.34138491032340934,-0.8495261810233954,0.6601941747572816,0.8516777967079482,1.0,4/11,20.20%,NBL1;SLIT2;DUSP1;PADI2
prerank,leukotriene metabolic process (GO:0006691),0.4150030481554416,0.8491596768740093,0.6073871409028728,1.0,1.0,6/19,20.71%,PTGR1;ABCC10;MGST3;DPEP1;DPEP2;MAPKAPK2
prerank,response to peptide (GO:1901652),-0.25012981563269454,-0.8488833465786452,0.656441717791411,0.8520942512835701,1.0,7/33,12.34%,STAT3;GNAI1;STAT6;CACNA1B;CHRNA7;IRS1;MMP2
prerank,neutral amino acid transport (GO:0015804),-0.25746898807588303,-0.8485361798167073,0.6918918918918919,0.8519581728757745,1.0,9/28,24.23%,SLC6A6;SLC3A2;SLC7A5;SLC1A1;SLC38A5;SLC6A15;SLC36A1;SLC6A7;CTNS
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.42266717063514286,0.8484283208585337,0.6328571428571429,1.0,1.0,6/14,20.15%,RFLNA;TGFBR1;WNT9A;SOX9;EFEMP1;CHADL
prerank,regulation of immunoglobulin production (GO:0002637),-0.27414642821070956,-0.8484181850711517,0.7163461538461539,0.8513426582466948,1.0,10/23,33.98%,STX4;EPHB2;VAMP3;XBP1;DNAJB9;CD86;PHB2;PTPRC;RBP4;CLCF1
prerank,cellular polysaccharide catabolic process (GO:0044247),0.4072806484297582,0.8483114497584987,0.6188524590163934,1.0,1.0,3/16,7.73%,AGL;PYGB;PHKA2
prerank,glycogen biosynthetic process (GO:0005978),-0.32778694104791384,-0.8482212595168647,0.6622073578595318,0.8500185307049826,1.0,2/12,2.88%,PER2;GBE1
prerank,glucan biosynthetic process (GO:0009250),-0.32778694104791384,-0.8482212595168647,0.6622073578595318,0.8500185307049826,1.0,2/12,2.88%,PER2;GBE1
prerank,non-motile cilium assembly (GO:1905515),0.3811911848476426,0.8481618025706754,0.6268115942028986,1.0,1.0,3/30,5.29%,CEP89;PCM1;C2CD3
prerank,nucleotide-sugar metabolic process (GO:0009225),0.42807405972809937,0.8481089293847074,0.624113475177305,1.0,1.0,1/12,2.53%,GMDS
prerank,phosphate ion transport (GO:0006817),0.4085977798937614,0.8479067195980193,0.6146408839779005,1.0,1.0,4/16,21.70%,SLC20A2;SLC25A30;SLC37A2;SLC37A3
prerank,negative regulation of immune effector process (GO:0002698),0.42292544049904507,0.8478805409770312,0.610632183908046,1.0,1.0,6/13,22.03%,ENPP3;RC3H1;CD47;HAVCR2;FER;APPL1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.3651397753028615,0.8476975785622001,0.6397790055248619,1.0,1.0,14/51,17.31%,ROCK2;RHOA;LPAR1;SORBS3;TGFBR1;RAC1;SYNPO2;ARHGEF10L;RHOC;NF2;FHOD1;SFRP1;CCN2;CD47
prerank,response to retinoic acid (GO:0032526),0.367963313244975,0.8474498869596232,0.6759956942949408,1.0,1.0,9/59,13.10%,AQP1;CDKN2D;SETX;ASXL1;HTRA2;WNT6;WNT9A;SOX9;CTSH
prerank,neural crest cell differentiation (GO:0014033),-0.2959230465807984,-0.8470574081030448,0.676056338028169,0.8514267380256,1.0,2/18,1.12%,MEF2C;CDH2
prerank,mesoderm development (GO:0007498),-0.29006456645167766,-0.8468703584181686,0.7126865671641791,0.8509632949937848,1.0,6/18,14.56%,FOXC2;TBX3;TIE1;TBX1;BMX;VEGFA
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.3421763842722191,-0.8466523760510063,0.6320754716981132,0.8497584586780458,1.0,2/10,5.39%,MAP2K5;KLF4
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.3421763842722191,-0.8466523760510063,0.6320754716981132,0.8497584586780458,1.0,2/10,5.39%,MAP2K5;KLF4
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.426629084676964,0.8466382700901338,0.6323943661971831,1.0,1.0,5/13,17.79%,RRS1;RPP40;TSR1;NOL9;ABT1
prerank,regulation of endopeptidase activity (GO:0052548),0.36537585012026275,0.8464925224514496,0.6720955483170467,1.0,1.0,7/59,11.38%,SERPINB8;SERPINA9;SERPINE1;PICALM;AGT;PSMB9;HDAC1
prerank,negative regulation of growth (GO:0045926),0.35493213577473304,0.8461367254335957,0.7247706422018348,1.0,1.0,32/121,18.99%,PSRC1;CDKN2D;CDKN2C;RB1;HYAL1;RBBP7;PML;SFRP2;ING4;SMARCA4;CDA;CRLF3;IP6K2;CCN3;NDRG3;ENPP1;GJA1;SMAD4;NOTCH2;JADE1;CDKN1B;SMAD3;STK11;TP53;SESN2;SFRP1;PNPT1;DNAJB2;DCBLD2;SIPA1;FRZB;CAPRIN2
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.36124518741970624,0.84596523985779,0.6746861924686193,1.0,1.0,15/80,12.83%,ANLN;ACTR3;AUTS2;FMR1;CDC42EP2;RHOQ;RIPOR2;EPS8L1;TAPT1;ARHGAP35;CEP120;RAC1;DOCK11;WASF2;DPYSL3
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3682050171895863,0.8458872263656085,0.6426991150442478,1.0,1.0,10/48,13.45%,TRIOBP;OBSL1;CUX1;PRKDC;CAPRIN1;LIMS1;CRKL;RAC1;DMTN;DOCK1
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.2759669716663967,-0.8455699099165653,0.6113744075829384,0.8509941098478062,1.0,11/22,41.62%,APOE;CREBL2;MTOR;SORBS1;MLXIPL;ANGPTL3;AKT1;PPARG;CREB1;PPARA;EEF1A2
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.27065790522307,-0.845264110403125,0.6787330316742082,0.8507219420474699,1.0,2/20,1.56%,CAMK2D;HECW1
prerank,Notch signaling pathway (GO:0007219),0.3586237841097405,0.8451492060356123,0.6764069264069265,1.0,1.0,11/59,13.45%,DLGAP5;GMDS;POFUT1;BMP2;RBPJ;ADAM17;NOTCH2;ITCH;PLXND1;MAML1;HEY2
prerank,positive regulation of translation (GO:0045727),0.3583057845578343,0.8446933905470504,0.7116374871266735,1.0,1.0,22/94,16.97%,LARP4B;AGO2;HNRNPD;KHDRBS1;DHX9;PRKDC;UPF3B;SAMD4A;FMR1;YBX3;LARP1;USP16;CDC123;YTHDF2;PLXNB2;METTL5;EIF3C;LARP4;FXR1;PASK;METTL3;PYM1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.39570388017664926,0.8446228583301137,0.6310679611650486,1.0,1.0,7/27,12.75%,STMN1;ARHGAP28;CGNL1;TMEFF2;ARHGAP6;ARHGEF18;WASF2
prerank,response to glucocorticoid (GO:0051384),0.3886879062395532,0.8442603570534633,0.6264009962640099,1.0,1.0,7/26,22.49%,NR3C1;HNRNPU;ANXA1;ADAM9;PDCD7;UBE2L3;ZFP36L1
prerank,triglyceride catabolic process (GO:0019433),0.39817944135246985,0.8435214508843768,0.6277561608300908,1.0,1.0,2/19,15.78%,FABP12;LPL
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.37853329038004396,0.8433014153138485,0.627039627039627,1.0,1.0,15/34,26.20%,TRIOBP;LIMS1;CRKL;RAC1;DMTN;DOCK1;DOCK5;RREB1;FERMT2;FLNA;S100A10;CRK;MYADM;P4HB;CDC42
prerank,regulation of p38MAPK cascade (GO:1900744),0.3773973317601269,0.8430436243316594,0.6524317912218268,1.0,1.0,8/35,14.81%,ULK4;XDH;MAP3K4;RELL1;BMP2;EZR;DLG1;PER1
prerank,endothelial cell proliferation (GO:0001935),0.40997788801818075,0.8427574191638307,0.6256684491978609,1.0,1.0,2/17,3.05%,LOXL2;ANGPT4
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.34954684786149404,0.8426876655423345,0.7867867867867868,1.0,1.0,79/248,21.78%,GLI3;CDK14;GSK3B;FGFR2;PSMC2;RNF220;PSMD5;BICC1;SIAH2;MCC;TBL1XR1;ADGRA2;STK3;TCF7L2;WNK1;SFRP2;WWTR1;UBR5;LRRK2;PSMB1;CUL3;GNAQ;PSMD14;AXIN2;TMEM64;NPHP3;LIMD1;PSMD1;LRRK1;EMD;PSMB9;DKK3;SMURF2;HDAC1;BMP2;RBMS3;LZTS2;LMBR1L;CSNK1G2;TRPM4;SOX9;JADE1;USP47;BTRC;XIAP;RUVBL2;TLE4;PSMC6;STK11;NKD1;PTPRU;PIN1;TLE3;NFKB1;NOTUM;SFRP1;AMER1;MLLT3;FAM53B;CSNK1A1;PSMB2;CSNK1G1;PSME4;FRZB;PSMB7;CAPRIN2;TMEM131L;PPM1A;PSMD11;SEMA5A;LGR4;ZEB2;PSME3;CSNK1E;FRMD8;LATS1;PSMD13;COL1A1;STK4
prerank,positive regulation of T cell proliferation (GO:0042102),0.3653372422255181,0.8426858887377999,0.6612021857923497,1.0,1.0,7/55,12.31%,FADD;IL18;CD80;NCK1;HMGB1;ANXA1;NCK2
prerank,cation transmembrane transport (GO:0098655),0.36745811297801667,0.8422470909842522,0.6391982182628062,1.0,1.0,11/44,19.09%,RHAG;SLC6A5;TRPM2;TRPM4;PKD2;SLC36A4;SLC7A1;SLC6A9;SLC25A29;SLC25A19;TRPM6
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.421099159929775,0.8418682856353626,0.6282051282051282,1.0,1.0,3/13,7.14%,ELOF1;ARID1A;CHEK1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.3820164810404791,0.8415858224507613,0.6499416569428238,1.0,1.0,2/35,3.51%,MASTL;GSK3B
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.2772393086392686,-0.8414700498060241,0.7615384615384615,0.8569716681594105,1.0,5/18,10.73%,CTSC;APOE;DACT1;VPS11;CD81
prerank,cellular response to unfolded protein (GO:0034620),-0.24627953727848406,-0.8411711674797673,0.7164179104477612,0.8566756147009917,1.0,6/26,18.18%,PRKN;HSPD1;HSPA5;PACRG;TM7SF3;HSPB8
prerank,cellular response to interferon-gamma (GO:0071346),-0.18737598838853933,-0.8410892890573957,0.8333333333333334,0.8559964994325252,1.0,19/88,17.26%,CAMK2D;TLR4;TRIM25;MID1;VCAM1;TRIM8;B2M;IRF2;CAMK2G;IFNGR2;IRF3;IRF9;CX3CL1;IFNGR1;GBP3;GBP4;RPL13A;MT2A;LGALS9
prerank,positive regulation of cellular senescence (GO:2000774),-0.3494244949029378,-0.8409690559355067,0.6918604651162791,0.8553825989323226,1.0,4/10,28.96%,B2M;HMGA2;ABI3;EEF1E1
prerank,stem cell development (GO:0048864),-0.3005235807993596,-0.8404027665971401,0.6790540540540541,0.8557103390130024,1.0,14/16,50.10%,CDH2;NOLC1;KLHL12;SOX11;PTPRC;SOX8;KBTBD8;PDCD6;SNAI2;NRG1;SHH;WNT7A;PEF1;CYP26C1
prerank,endomembrane system organization (GO:0010256),0.35499907178925766,0.8404019419809393,0.7620481927710844,1.0,1.0,47/178,20.50%,ARHGAP21;USP6NL;NUP155;GBF1;OBSL1;LNPK;COG1;ZW10;WASHC4;ATL2;MYOF;ATL3;RAB22A;LEMD3;RAB29;VPS18;LRRK2;GOLGA8B;GOLGA5;RAB1A;SNX33;EIF2AK3;BAG5;GAK;GORASP2;EXOC8;PRKD1;MIA3;TOR1B;VAPA;SYP;SUN2;TMCC1;DYSF;TMED3;UBXN2B;CSNK1A1;COG4;CLASP1;TMED10;PI4K2B;SUN1;LYSMD3;DNM1L;ANK3;ATP8B2;TRAPPC8
prerank,regulation of B cell differentiation (GO:0045577),0.4054493973051961,0.8401665575830688,0.6187919463087248,1.0,1.0,4/17,16.07%,MMP14;BTK;IL4I1;SFRP1
prerank,regulation of cell size (GO:0008361),0.3920092639927073,0.8399583907979538,0.6206030150753769,1.0,1.0,9/23,17.76%,RHOA;VAV2;EZR;RAC1;RPTOR;PTEN;LARS1;MSN;LAMTOR5
prerank,synaptic vesicle recycling (GO:0036465),-0.25140486540810364,-0.8398311961030489,0.751412429378531,0.8560005259018056,1.0,12/31,20.57%,OPHN1;AMPH;SYT1;PLD2;RAB5A;SYT7;TBC1D24;SYNJ2;FCHO2;SYNJ1;NLGN1;SYT2
prerank,ketone body metabolic process (GO:1902224),0.4429865444981458,0.839674877059611,0.6441717791411042,1.0,1.0,3/10,18.82%,ACAT1;AACS;BDH2
prerank,regulation of T cell activation (GO:0050863),-0.22446814359303421,-0.8396443394546391,0.7387387387387387,0.8555007241028705,1.0,7/42,11.61%,CYRIB;DUSP3;PRKCQ;PTPN22;HSPD1;ABL1;TNFRSF1B
prerank,regulation of phospholipase activity (GO:0010517),0.44384658490060525,0.8394142677880253,0.6439628482972136,1.0,1.0,2/10,12.29%,FGFR2;PDPK1
prerank,positive regulation of cilium assembly (GO:0045724),0.3983752064678985,0.8389126795107643,0.6285329744279946,1.0,1.0,3/18,11.03%,TAPT1;ARHGAP35;CEP120
prerank,regulation of necroptotic process (GO:0060544),-0.2616356454127414,-0.8381565009718668,0.7194570135746606,0.8575352784862833,1.0,7/23,17.19%,OGT;CYLD;ARHGEF2;STUB1;SDCBP;SLC25A4;BIRC3
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.39000152850579944,0.838148861479885,0.6291139240506329,1.0,1.0,7/25,19.48%,BMF;FAM162A;PLAUR;TP53;TNFSF10;BAD;DNM1L
prerank,regulation of protein binding (GO:0043393),0.3499532249248793,0.8379829828371741,0.7342158859470469,1.0,1.0,13/114,9.82%,PLK1;AURKB;DDX11;AURKA;GSK3B;ADD2;STK3;TCF7L2;NMD3;LRRK2;ROCK1;PSME3IP1;MARK2
prerank,negative regulation of protein catabolic process (GO:0042177),-0.23126490178659484,-0.8379299742397655,0.7258064516129032,0.8571085542479275,1.0,5/40,4.87%,SNRNP70;CST3;TIMP3;BANP;SNX3
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.3832359959688956,0.8370953109235021,0.6220858895705521,1.0,1.0,6/29,11.16%,RPA1;CHD1L;RPA2;ERCC3;CUL4B;XPA
prerank,erythrocyte differentiation (GO:0030218),0.36884829353789994,0.8367313554750911,0.64,1.0,1.0,11/44,13.65%,KIT;TSPO2;DYRK3;IKZF1;PTPN2;TGFBR3;ABCB10;TAL1;DMTN;ATP5IF1;MED1
prerank,embryonic hemopoiesis (GO:0035162),0.42183536318630827,0.8364780219465725,0.638328530259366,1.0,1.0,3/12,10.58%,KIT;KMT2A;TAL1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.4188085959229258,0.8361395845554896,0.6512605042016807,1.0,1.0,4/13,23.14%,NEDD4;NIBAN2;PTPN1;DAB2IP
prerank,positive regulation of interleukin-2 production (GO:0032743),0.3855277251091136,0.835803142919917,0.6176470588235294,1.0,1.0,9/25,21.52%,STOML2;CD80;ANXA1;PRKD2;RUNX1;PDE4B;TRAF6;TRAF2;PNP
prerank,sensory perception of sound (GO:0007605),0.36031013146697916,0.8348958692531214,0.6983298538622129,1.0,1.0,9/88,13.19%,BIRC5;ADGRV1;KIT;MKKS;NIPBL;RIPOR2;LHFPL5;HOMER2;ROR1
prerank,regulation of store-operated calcium entry (GO:2001256),-0.3453942408919818,-0.8348111430257973,0.6869565217391305,0.8622291429360298,1.0,2/10,5.11%,SARAF;HOMER1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.36094767222402635,0.834681954765447,0.6835722160970231,1.0,1.0,22/55,24.78%,AURKA;PSMC2;PSMD5;FBXL7;PSMB1;PSMD14;PSMD1;PSMB9;ATF5;USP47;PSMC6;PSMB2;PSME4;PSMB7;PSMD11;PSME3;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,neuromuscular synaptic transmission (GO:0007274),0.40229512504386244,0.8346315019867412,0.6342780026990553,1.0,1.0,4/18,13.17%,CHAT;ERC1;CHRNB1;ERC2
prerank,regulation of dephosphorylation (GO:0035303),0.4143047439429517,0.8345955533514601,0.650523560209424,1.0,1.0,6/15,15.34%,MTMR1;MTMR2;MTMR9;SMG6;MTMR3;SRC
prerank,acute-phase response (GO:0006953),-0.3170376569093164,-0.834594021684452,0.6917808219178082,0.861796995129711,1.0,3/12,20.74%,LBP;CEBPB;IL22
prerank,mucosal immune response (GO:0002385),-0.3082222796054455,-0.8345404618022445,0.7112676056338029,0.8610754828022659,1.0,2/15,10.51%,DEFA6;RPL39
prerank,negative regulation of TOR signaling (GO:0032007),0.3746847253390986,0.8345222248232921,0.6702002355712603,1.0,1.0,9/36,16.00%,TNFAIP8L1;FNIP1;DEPDC5;TBC1D7;NPRL3;SESN1;ITFG2;STK11;SESN2
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.30002036046410335,-0.8343596266462381,0.6883561643835616,0.8605453294472231,1.0,3/15,19.19%,SAT1;MOXD1;DDC
prerank,calcium ion import across plasma membrane (GO:0098703),0.4146361649839237,0.8341871128880108,0.610719322990127,1.0,1.0,3/14,10.66%,ATP2B4;SLC8A1;TRPM2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.4089434375140264,0.8341537099610459,0.6369770580296896,1.0,1.0,7/15,25.59%,RPP40;RPP30;POP1;KHNYN;LACTB2;RNASEH1;NUDT16
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.38838932687746053,0.8338667430948552,0.6491885143570537,1.0,1.0,1/26,1.19%,SLC18A2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.3298904364119426,-0.833555931489206,0.6666666666666666,0.8603345835873591,1.0,7/11,33.21%,CALM1;FKBP1A;SRI;CALM3;GSTM2;GSTO1;CASQ2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.3298904364119426,-0.833555931489206,0.6666666666666666,0.8603345835873591,1.0,7/11,33.21%,CALM1;FKBP1A;SRI;CALM3;GSTM2;GSTO1;CASQ2
prerank,chemical homeostasis (GO:0048878),-0.210190538948457,-0.8334508493047745,0.8507462686567164,0.8596837563017211,1.0,28/61,33.79%,ADCK1;ABHD5;SLC4A7;WNK2;TLCD2;IRS2;PNPLA8;NR1D2;NR1H3;KLHL3;SLC4A8;TLCD3A;AQP11;TENT4B;USF2;USF1;NEDD4L;EIF5A2;ABHD8;PNPLA2;CLN8;DDX3X;PNPLA3;TLCD1;VGF;ANGPTL3;FITM2;PPARG
prerank,polyol biosynthetic process (GO:0046173),-0.28429260784271115,-0.8326232462595895,0.6923076923076923,0.8603885589499329,1.0,5/16,13.40%,IPPK;PPIP5K2;FGF2;ACER3;ITPKB
prerank,positive regulation of bone resorption (GO:0045780),-0.32734706465152574,-0.8319451659941239,0.707936507936508,0.8607719701830457,1.0,7/11,36.56%,TNFRSF11A;PLEKHM1;ATP6AP1;SYK;DEF8;SPP1;ADAM8
prerank,cell projection organization (GO:0030030),0.38500007425798166,0.8315534306313248,0.6506765067650676,1.0,1.0,8/30,16.38%,PARVA;PACSIN2;RHOQ;NPHP1;RAC1;ITGB1;CAPG;NCKAP1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3480108864227736,0.8314408337815588,0.7636363636363637,1.0,1.0,36/132,16.78%,TRIML2;MOV10;TICAM1;PFKFB1;GSK3B;ZC3HAV1;CNOT1;FAF1;TPCN1;SH3GLB1;FOXO3;LRRK2;SH3D19;ROCK1;ZBTB20;HMGB1;PIK3CB;SNX33;EZR;DAGLB;TRIM6;ITCH;DXO;TWIST1;PRKD1;ADAM9;PLK2;RC3H1;TRIM5;ARNT;STK11;CNOT7;ZC3H18;PNPT1;MSN;AMER1
prerank,regulation of viral genome replication (GO:0045069),0.35684793967280637,0.8314190596945646,0.6729074889867841,1.0,1.0,13/56,17.98%,ILF3;FAM111A;ZC3HAV1;LARP1;TMEM39A;SRPK1;TRIM6;PPID;PABPC1;CNOT7;MAVS;SRPK2;PKN2
prerank,copper ion homeostasis (GO:0055070),-0.290894556797888,-0.8313024717577207,0.6743295019157088,0.8611678899806189,1.0,8/17,21.97%,APP;COX19;SLC31A2;MT2A;ATOX1;CUTC;COMMD1;ATP7A
prerank,gliogenesis (GO:0042063),0.40172194330602756,0.8308170055882541,0.6463245492371706,1.0,1.0,4/15,16.36%,MMP24;NFIB;ANXA1;METTL3
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.3609386855524063,0.8307997343384727,0.6783068783068783,1.0,1.0,10/62,13.00%,DDIAS;CDKN2D;TXNDC12;RTKN2;SFRP2;YBX3;HTRA2;LRRK2;BAG5;PLAUR
prerank,lung epithelium development (GO:0060428),0.43369293095016515,0.8307976884969385,0.6322869955156951,1.0,1.0,2/10,10.56%,GRHL2;ERRFI1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.37201248672698556,0.8306348662532625,0.6573426573426573,1.0,1.0,5/33,9.91%,ATP2B4;ANGPT4;RHOA;HMGB1;MEOX2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.37512489966650703,0.8305891845927308,0.6788665879574971,1.0,1.0,6/31,12.61%,BMPR1A;FGFR2;TGFBR3;TGFBR1;RBPJ;SMAD4
prerank,autophagy of nucleus (GO:0044804),0.40807484101937114,0.8302934675835373,0.6413793103448275,1.0,1.0,5/16,14.55%,ATG7;RB1CC1;ULK2;ATG3;ATG2A
prerank,xenobiotic transport (GO:0042908),-0.2850268154967319,-0.8297097093213661,0.6987951807228916,0.8632858309697825,1.0,4/17,14.08%,SLC7A5;ABCG2;SLC15A2;ABCC5
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.37869046589719724,0.8295892835578381,0.6336154776299879,1.0,1.0,6/25,12.61%,BMPR1A;NUMA1;CCN1;SULF1;RBPJ;SMAD4
prerank,negative regulation of peptidase activity (GO:0010466),0.3660836433931656,0.8293768256588963,0.6887640449438203,1.0,1.0,4/47,9.78%,SERPINB8;SERPINA9;SERPINE1;AGT
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.4121273774123819,0.8289933649843754,0.6257396449704142,1.0,1.0,3/11,10.25%,LEPROT;PICALM;SNX33
prerank,histone H2B ubiquitination (GO:0033523),-0.3425992773608788,-0.8285818542174973,0.6687306501547987,0.8645465510360056,1.0,2/10,3.25%,CDC73;UBE2E1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.4193039123442527,0.8285075262833964,0.6375358166189111,1.0,1.0,5/14,20.35%,ACTN4;WNK1;GLRX;WNK3;ANK3
prerank,erythrocyte development (GO:0048821),0.4382522513731368,0.8284807577477189,0.6755162241887905,1.0,1.0,4/10,16.88%,ABCB10;DMTN;MED1;ALAS2
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.41216613213761216,0.8281040194085263,0.6453804347826086,1.0,1.0,6/14,23.86%,ZNHIT3;DDX18;WDR12;NOL9;URB1;RPL7
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.26149441747144225,-0.8277961913722512,0.7192118226600985,0.8651408350775736,1.0,7/23,18.36%,HSP90AB1;NR1H3;IFNGR2;IRGM;IFNGR1;NR1H2;NLRC5
prerank,acylglycerol catabolic process (GO:0046464),-0.24400978224803876,-0.8275555409399104,0.7870967741935484,0.864806592524024,1.0,4/30,9.48%,ABHD6;ABHD12;ABHD16A;ABHD2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.3611199768024886,0.8272737912837969,0.7061965811965812,1.0,1.0,24/67,18.35%,ROCK2;RHOA;VAV2;SULF1;NCK1;ABI1;ROCK1;CYBB;PIK3CB;SH2D2A;RAC1;NCK2;MAPKAPK3;WASF2;DOCK1;PRKD1;ITGAV;AAMP;SRC;PRKD2;NCKAP1;AXL;SHB;MAPK14
prerank,outflow tract septum morphogenesis (GO:0003148),0.38398529648477997,0.8271192005334804,0.6316455696202532,1.0,1.0,6/24,12.61%,BMPR1A;FGFR2;PARVA;SMAD6;ROBO1;SMAD4
prerank,reticulophagy (GO:0061709),0.4197065828150356,0.8269730803820233,0.6537313432835821,1.0,1.0,4/12,14.55%,DDRGK1;RB1CC1;ULK2;ATG2A
prerank,epidermis development (GO:0008544),0.3590879549650244,0.826760453233339,0.6829787234042554,1.0,1.0,9/56,16.94%,FGFR2;GRHL2;SVEP1;ATP2A2;FLOT2;HDAC1;HDAC2;EMP1;CCN2
prerank,snRNA 3'-end processing (GO:0034472),0.39359234296824475,0.8266158988490467,0.65,1.0,1.0,4/19,11.82%,INTS7;TUT1;INTS8;EXOSC7
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.35066719810315633,0.8265536522758858,0.7091295116772823,1.0,1.0,23/72,22.64%,FADD;CBFB;USP18;VRK2;PTPN2;ELF1;RNF31;SPPL2B;AGPAT2;IKBKG;CASP8;AGPAT1;IFNAR2;AXL;RUNX1;HIPK1;RIPK1;PTPN1;TRAF2;TAX1BP1;IKBKB;BIRC2;PIAS1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.3486614297602471,0.8263284401137311,0.7153061224489796,1.0,1.0,23/95,16.68%,HAS3;CHST15;HYAL1;B4GALT1;GPC6;CHSY1;SLC10A7;ST3GAL3;SLC35D2;B4GALT7;CHST3;ANGPT1;HAS1;UST;SDC1;HS2ST1;DSE;BGN;ST3GAL4;ST3GAL1;ST3GAL2;HSPG2;UGDH
prerank,antibacterial humoral response (GO:0019731),0.3985961735125914,0.8261638828236377,0.6431535269709544,1.0,1.0,1/16,4.50%,RNASE6
prerank,regulation of bone mineralization (GO:0030500),0.3511574132393172,0.8260346336159258,0.6608884073672806,1.0,1.0,12/55,13.30%,ADGRV1;BMPR1A;BCOR;BMP6;CCN1;SLC8A1;DDR2;ATP2B1;BMP2;ENPP1;TRPM4;TWIST1
prerank,phospholipid dephosphorylation (GO:0046839),0.3682582476925338,0.8259656091874111,0.6597222222222222,1.0,1.0,10/37,16.15%,OCRL;INPP5B;MTMR1;MTMR2;MTMR9;PIP4P2;PLPP1;PLPP5;MTMR3;PTEN
prerank,protein localization to cell surface (GO:0034394),0.37810415590660856,0.8257371978618271,0.6578282828282829,1.0,1.0,8/26,16.92%,FBLN5;SMURF1;ANGPT1;PIGU;MESD;PTPRU;UNC50;PTPRK
prerank,mesonephric tubule development (GO:0072164),0.41425520603713084,0.8256605004420714,0.6543715846994536,1.0,1.0,5/15,18.17%,FGFR2;NPNT;PKD2;SALL1;OSR1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.34874581841796526,0.8255356001199396,0.677384780278671,1.0,1.0,24/65,23.40%,AQP1;ANGPT4;MDM4;FAM162A;HP1BP3;CPEB2;NDRG1;RORA;TWIST1;NPEPPS;TP53;SFRP1;SUV39H2;BAD;PTGIS;TBL2;FMN2;TERT;EGLN1;SIRT2;EGLN3;ZFP36L1;KCND2;NOP53
prerank,calcium ion import into cytosol (GO:1902656),0.4075998963755624,0.8252812755635731,0.6283309957924264,1.0,1.0,3/15,10.66%,ATP2B4;SLC8A1;TRPM2
prerank,peptide metabolic process (GO:0006518),0.34930558009277113,0.8251347402996556,0.6890052356020943,1.0,1.0,8/75,10.46%,RHD;DNPEP;LVRN;NLN;CPXM1;HPGDS;CPQ;TRHDE
prerank,peptidyl-glutamic acid modification (GO:0018200),0.39106762713305293,0.8249479312415514,0.6560587515299877,1.0,1.0,5/24,13.22%,VKORC1L1;GGCX;TTLL4;TTLL11;TTLL3
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.3916049292625515,0.8249099365451997,0.6445859872611465,1.0,1.0,6/24,17.68%,ACTR3;AUTS2;RAC1;WASF2;NCKAP1;ABI2
prerank,regulation of translation (GO:0006417),0.34443634836886095,0.8244890477202179,0.7917505030181087,1.0,1.0,42/173,19.12%,TYMS;ILF3;SYNCRIP;LARP4B;CTIF;HNRNPD;CNOT1;DHX9;PRKDC;EIF4E;UPF3B;EIF4ENIF1;EIF4H;SAMD4A;CAPRIN1;FMR1;FOXO3;LARP1;PLXNB2;METTL5;MRPL13;EIF2AK3;EIF3C;RBM4;DHFR;LARP4;EIF4A2;MTRF1;EPRS1;CNOT7;FXR1;PASK;DDX1;METTL3;PYM1;NSUN3;EIF3H;PAIP2B;METAP1;PUS7;OGFOD1;ETF1
prerank,chondroitin sulfate metabolic process (GO:0030204),0.3785193439742984,0.8240886909941387,0.6666666666666666,1.0,1.0,8/30,17.36%,CHST15;HYAL1;CHSY1;CHST3;DSE;BGN;UGDH;ARSB
prerank,activation of protein kinase A activity (GO:0034199),-0.29289063840671126,-0.8239524180169359,0.7230769230769231,0.8705182148140674,1.0,5/16,14.87%,PRKACB;PRKAR1B;ADCY3;ADCY8;ADCY4
prerank,regulation of axon extension (GO:0030516),0.36617007634996196,0.8236626897927597,0.6473265073947668,1.0,1.0,7/37,11.39%,MACF1;GSK3B;RTN4R;NTN1;MAPT;DNM2;PTPRS
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.3931227396396078,0.8235857969588739,0.6555851063829787,1.0,1.0,7/17,22.32%,ROCK2;ROCK1;S1PR2;ADD1;ZDHHC21;IKBKB;VCL
prerank,sodium-independent organic anion transport (GO:0043252),0.43472069695594995,0.8234490961734994,0.6615853658536586,1.0,1.0,3/10,13.37%,SLCO4A1;SLC16A2;SLCO3A1
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.4162884078874515,0.8232065964993486,0.6370157819225251,1.0,1.0,3/12,14.05%,UST;DSE;BGN
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.25039979336068285,-0.8231307878218564,0.7336956521739131,0.871240071465524,1.0,4/27,8.62%,CYRIB;NFAT5;PRKCQ;HSPD1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.40954030839686,0.8229920522346451,0.6339779005524862,1.0,1.0,1/15,2.25%,DYRK1A
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.3758846273571911,0.8220157115218288,0.632183908045977,1.0,1.0,7/23,17.84%,TGFBR3L;TGFBR3;DKK3;SMURF2;SMAD4;SMAD3;SMAD2
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.32222227014816973,-0.8214588848698453,0.6875,0.8734002360005952,1.0,3/11,9.04%,PRKN;DAB2;VPS11
prerank,positive regulation of cell aging (GO:0090343),-0.33304836528317966,-0.8209010277904308,0.6867088607594937,0.8735869862866495,1.0,4/11,28.96%,B2M;HMGA2;ABI3;EEF1E1
prerank,defense response to Gram-positive bacterium (GO:0050830),0.35491123670300945,0.8208657762637015,0.6666666666666666,1.0,1.0,2/40,4.50%,HMGB2;RNASE6
prerank,response to chemokine (GO:1990868),0.41041189107046583,0.8208135616829733,0.6628242074927954,1.0,1.0,5/13,18.18%,RHOA;WNK1;RIPOR2;STK39;OXSR1
prerank,cellular response to fatty acid (GO:0071398),-0.3197586548005573,-0.8207640397426301,0.6976744186046512,0.8729801920263215,1.0,8/12,42.60%,IRS1;ZC3H12A;NR1H4;DGAT2;PDK4;PDK3;KCNK4;PID1
prerank,lipid catabolic process (GO:0016042),-0.2747087490026765,-0.8202727238599714,0.7280334728033473,0.8730587055553105,1.0,2/18,4.80%,PLAAT3;PLA1A
prerank,eye development (GO:0001654),0.35479303896528197,0.820101787327392,0.6939890710382514,1.0,1.0,12/54,19.30%,PBX4;PBX3;FBN1;COL5A2;NIPBL;CACNA1C;MAB21L2;EFEMP1;SHROOM2;SH3PXD2B;HIPK1;SKI
prerank,negative regulation of lymphocyte activation (GO:0051250),0.3780436052211718,0.8198118604416267,0.6505867014341591,1.0,1.0,3/21,13.22%,FGL1;SAMSN1;IL4I1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.4068785016254225,0.8190118929345975,0.6733870967741935,1.0,1.0,5/16,16.75%,NPNT;BMP2;GDNF;PKD2;SALL1
prerank,positive regulation of phospholipase activity (GO:0010518),0.39014924575003396,0.8189700839096888,0.6538952745849298,1.0,1.0,6/22,13.71%,FGFR2;KIT;PDGFRA;GNA13;PDPK1;ARF4
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.37184803532439326,0.8184780882486848,0.6535141800246609,1.0,1.0,9/26,23.19%,IRF1;FLOT2;APPL2;LGR4;SMPDL3B;APPL1;BIRC2;GPR108;NFKBIL1
prerank,regulation of interleukin-2 production (GO:0032663),0.3569392195192897,0.8184297414835217,0.6511363636363636,1.0,1.0,13/43,21.52%,PRNP;STOML2;CD80;EZR;ANXA1;HOMER2;PRKD2;RUNX1;HAVCR2;PDE4B;TRAF6;TRAF2;PNP
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.3518667167185399,0.8181169775276048,0.7255520504731862,1.0,1.0,4/78,4.06%,PLK1;CDC20;GSK3B;DDRGK1
prerank,positive regulation of macroautophagy (GO:0016239),-0.22027629029140386,-0.8177546052396382,0.851063829787234,0.8769216435964269,1.0,18/48,24.64%,PIP4K2A;SESN3;EPM2A;PIP4K2B;RALB;BNIP3L;BNIP3;RAB3GAP2;IRGM;PINK1;SLC25A4;TBK1;HSPB8;PIP4K2C;VPS13D;PAFAH1B2;BAG3;SMCR8
prerank,response to calcium ion (GO:0051592),0.34264510732932874,0.8172988455775656,0.7602459016393442,1.0,1.0,18/102,16.01%,ECT2;ADGRV1;NEDD4;PPP3CA;KCNMB2;KCNMB3;CARF;TRPM2;CALM2;ITPR3;DMTN;CLIC4;ADAM9;SMPD1;KCNMB4;PKD2;ADD1;STIM1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.35053566912751927,0.8170757431840397,0.7336108220603538,1.0,1.0,18/75,19.81%,PLK1;RB1;PKIG;SLC8A1;AGT;PIK3CB;IPO7;LRP5;SMPD1;CDKN1B;IPO5;PTEN;PRKAR2B;PRKAR2A;TFAP4;DUSP7;PRKCD;PTPN1
prerank,muscle cell migration (GO:0014812),0.42391350322764654,0.816873269553882,0.6435045317220544,1.0,1.0,4/10,18.52%,ROCK1;CCN3;AAMP;PLAT
prerank,bile acid biosynthetic process (GO:0006699),-0.260421335869397,-0.8164768919839522,0.7712765957446809,0.8783324131836442,1.0,7/24,21.61%,OSBPL6;CYP7B1;SCP2;OSBPL7;AMACR;OSBP;OSBPL2
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.27534144590658544,-0.81574804407211,0.7415730337078652,0.8788227324806464,1.0,8/18,25.76%,PRKN;TRAP1;SOD2;PINK1;PARK7;HSPB1;MAPK7;HIF1A
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.40105182610263473,0.815429465415821,0.6502057613168725,1.0,1.0,4/18,8.30%,GSK3B;FMR1;VPS18;LRRK2
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.4090231154406791,0.8149329532676357,0.6651718983557549,1.0,1.0,1/12,6.39%,IL18
prerank,regulation of immune response (GO:0050776),0.3431767315321676,0.814919431939346,0.7848484848484848,1.0,1.0,14/135,14.28%,ULBP1;FGL1;COLEC12;ITGB7;RAET1E;LAG3;SPPL2B;IRF1;AHR;APPL2;CASP8;IL4I1;XIAP;ITGB1
prerank,positive regulation of cation channel activity (GO:2001259),-0.21395096360454804,-0.8144871013085433,0.831858407079646,0.8801783180069009,1.0,5/40,5.30%,TMSB4X;SHANK3;CALM1;AKAP6;EPHB2
prerank,phosphatidylcholine metabolic process (GO:0046470),0.3470764323127442,0.8139373826856621,0.7025316455696202,1.0,1.0,8/70,12.26%,PON1;CHAT;LPCAT1;LPIN2;ENPP2;CSNK2A2;TMEM86B;ACHE
prerank,regulation of inclusion body assembly (GO:0090083),0.4155826391520155,0.8137618035943731,0.6617647058823529,1.0,1.0,5/11,24.11%,BAG5;DNAJB2;DNAJB6;SACS;SNCAIP
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.27115962069614735,-0.8131953880972452,0.7368421052631579,0.8816292787455225,1.0,5/21,17.59%,GRIN2B;DELE1;GRIN1;BIRC3;SOX2
prerank,prostaglandin metabolic process (GO:0006693),0.37686284747244964,0.8126811635248472,0.6525,1.0,1.0,7/26,18.40%,PTGR1;PTGR2;HPGDS;PTGS1;DAGLB;PLAA;PTGIS
prerank,lipoprotein transport (GO:0042953),0.4245948454436428,0.8125896517234473,0.6701183431952663,1.0,1.0,4/10,19.45%,PRKCB;MIA3;UNC119;UNC119B
prerank,autophagosome maturation (GO:0097352),-0.23569852769119615,-0.8125065889260394,0.7950310559006211,0.8820416390589105,1.0,18/32,34.30%,CALM1;TECPR1;SNX14;TSG101;SNAP29;VPS33B;LAMP2;VAMP8;GABARAPL2;CHMP3;MAP1LC3A;VPS33A;MAP1LC3B;CLN3;EPG5;ATG14;VCP;GABARAP
prerank,sulfur amino acid metabolic process (GO:0000096),0.38751312792925796,0.812308159299119,0.6484771573604061,1.0,1.0,3/24,9.70%,AHCY;MTHFR;NOX4
prerank,negative regulation of developmental process (GO:0051093),0.34702261305704707,0.8122604779820659,0.7127771911298838,1.0,1.0,14/69,14.34%,SFMBT1;LOXL2;ROCK2;SUZ12;ANP32B;NFIB;MAPT;ROCK1;PTPRS;BMP2;SOX9;HEY2;RC3H1;FOXM1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.32631745616294927,-0.8118829935721169,0.7103658536585366,0.8822755784062501,1.0,7/11,31.74%,TOMM70;TIMM9;TIMM13;TIMM8B;NDUFA13;ROMO1;TIMM29
prerank,Ras protein signal transduction (GO:0007265),0.34242804368673935,0.8115587135407629,0.7874493927125507,1.0,1.0,35/137,18.35%,KSR1;GPSM2;RB1;BRAP;ROCK2;RASSF1;RHOA;CCNA2;NTN1;PDPN;RAP2A;G3BP1;CDC42EP2;GNA13;CDK2;TRIM28;ROCK1;EPS8L1;MYO9B;ARHGAP6;USP28;CRKL;RAC1;RRAS;PRKD1;PLK2;TP53;NCKAP1;RRAS2;ABI2;PLEKHG5;NRAS;KRAS;ARHGAP29;MAPK14
prerank,negative regulation of axon extension (GO:0030517),-0.250623079470463,-0.8111252244480062,0.8163265306122449,0.8827223549721468,1.0,10/30,19.19%,SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;SEMA3B;SEMA3C;CDKL3;MAG;SEMA5B
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.29246944467027963,-0.8109022603480083,0.690566037735849,0.8822915615877834,1.0,5/15,11.22%,SMAD7;RPL23;RPS7;ABL1;LIMK1
prerank,negative regulation of receptor internalization (GO:0002091),0.40636380729334276,0.8094361100251034,0.6715328467153284,1.0,1.0,6/12,27.35%,WDR54;MTMR2;ANKRD13D;RIN3;LRPAP1;ATXN2
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.26998132055418234,-0.8088762125222029,0.7056277056277056,0.8850644987129374,1.0,6/21,20.03%,GUCY1A1;NPR1;ADCY3;ADCY8;ADCY4;AMPD2
prerank,regulation of cellular protein catabolic process (GO:1903362),0.3820125660991521,0.8080545123212319,0.664886515353805,1.0,1.0,9/18,25.97%,FAF1;EZR;MSN;AMER1;RIC1;VGLL4;DAB2IP;HSP90AA1;RDX
prerank,amino sugar metabolic process (GO:0006040),-0.3293209921848643,-0.8076881623712081,0.6936416184971098,0.8863044755926042,1.0,2/10,3.56%,CSGALNACT1;ST6GAL1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.35553822528873524,0.8075237556613032,0.6753407682775713,1.0,1.0,6/28,17.03%,FADD;CASP8AP2;TNFRSF10B;CASP8;ZDHHC3;NGF
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3598922951747568,0.8075230073577104,0.6813441483198146,1.0,1.0,5/36,7.43%,MOV10;AGO2;NLK;TCF7L2;PPP3CA
prerank,apical protein localization (GO:0045176),0.4153086070618444,0.8074789664592907,0.6767830045523521,1.0,1.0,1/10,1.69%,SHROOM3
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.39362940713977385,0.807341433873944,0.6639784946236559,1.0,1.0,4/16,12.83%,UPB1;DPYD;DPYSL4;DPYSL3
prerank,regulation of protein targeting to membrane (GO:0090313),0.3710822725283603,0.8073234912287706,0.6912991656734208,1.0,1.0,6/28,12.65%,MIEF2;PRNP;PDZK1;MYO1C;MIEF1;DMTN
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3402057432324386,0.8071234004313009,0.897,1.0,1.0,55/348,14.36%,BRCA1;E2F1;MED26;MOV10;TICAM1;ROCK2;FGFR4;AGO2;CTCF;GSK3B;ANXA2;DDRGK1;MPHOSPH8;SETDB2;BMP6;MUSK;AFDN;ARRB1;FMR1;SCRIB;RAB29;ZBTB7B;UBR5;ATF7IP;TRIM28;ROBO1;YAP1;ANGPT1;SLC24A3;ROCK1;WNT6;PIK3CB;TGFBR1;LIMS1;EIF2AK3;CNTF;BMP2;EZR;NKX2-1;TERF2;STOX1;RBMS3;FUBP1;RBPJ;GJA1;SOX9;ITCH;C1QTNF1;CTSH;TWIST1;HEY2;MED1;ADAM19;SMAD3;RAMP3
prerank,regulation of smooth muscle contraction (GO:0006940),0.3813609469989738,0.8071227893182289,0.6653171390013495,1.0,1.0,6/20,16.80%,SRF;SETD3;ATP2B1;ADRB2;KCNB2;ZDHHC21
prerank,hepaticobiliary system development (GO:0061008),0.38346269075557493,0.8068710629069903,0.6658097686375322,1.0,1.0,7/20,19.06%,TGFBR3;NIPBL;PHF2;GFER;PKD2;COBL;WNT4
prerank,microvillus organization (GO:0032528),0.40449930168714965,0.8068674869283406,0.6722222222222223,1.0,1.0,3/13,11.46%,MAP4K4;RAP2A;EZR
prerank,positive regulation of mRNA processing (GO:0050685),0.3781511353341627,0.8066858986189579,0.6721311475409836,1.0,1.0,8/21,23.34%,TRA2B;THRAP3;LEO1;DAZAP1;NUP98;TRA2A;RBMX;NCL
prerank,protein glycosylation (GO:0006486),0.33816289779285136,0.8049767203959627,0.790224032586558,1.0,1.0,24/125,16.85%,POMT1;TRAK1;LARGE1;B4GALT1;FUT10;GALNT1;ST8SIA2;B3GNT8;ST3GAL3;B4GALT7;MAGT1;RPN2;ST3GAL5;SLC39A8;POFUT1;STT3A;STT3B;MAN1C1;ALG8;ST3GAL4;ST3GAL1;ST3GAL2;PLOD2;B3GALT2
prerank,sensory perception of light stimulus (GO:0050953),0.3464717987395182,0.8043666284030045,0.741901776384535,1.0,1.0,7/87,8.42%,GPR179;ADGRV1;EYA4;CRYBA1;RDH12;COL18A1;TYR
prerank,ethanol metabolic process (GO:0006067),0.4133242901728661,0.8041633492162743,0.6729377713458755,1.0,1.0,2/12,9.52%,ALDH1A1;ACSS1
prerank,regulation of protein transport (GO:0051223),0.37631913509637,0.804153647335424,0.6592592592592592,1.0,1.0,7/27,15.79%,ARFIP1;DNAJC1;STXBP5;LLGL2;P3H1;SCFD1;LCP1
prerank,zinc ion transport (GO:0006829),0.3785325216671033,0.8039938799270643,0.6701570680628273,1.0,1.0,6/21,15.03%,SLC39A11;TRPM2;SLC39A8;SLC30A9;SLC39A6;SLC30A10
prerank,negative regulation of protein modification process (GO:0031400),0.3443792727664394,0.8037001979402144,0.7494802494802495,1.0,1.0,27/79,21.61%,ATP2B4;GSK3B;PRKDC;PRNP;MAPT;XDH;WWTR1;LRRK2;PPP1R8;TPPP;SNTA1;CRKL;P3H1;ENSA;PPP1R15B;PTPA;PTPN13;PTEN;TINF2;SIRPA;TERF2IP;IGFBP3;DNAJC10;XRCC1;PNKP;FBLN1;FKBP8
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.38172473615215496,0.8032626870409197,0.6680161943319838,1.0,1.0,5/16,18.53%,LEPROT;STAM;VTA1;CHMP4A;CHMP4B
prerank,regulation of steroid biosynthetic process (GO:0050810),0.42096589412148716,0.8031293244393523,0.6652236652236653,1.0,1.0,4/11,21.19%,FGFR4;BMP2;WNT4;BMP5
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.2965692298507566,-0.8025029916240063,0.6666666666666666,0.894568305353973,1.0,2/14,4.30%,CARD16;GAS6
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.28154227913428415,-0.8024480463581876,0.7042801556420234,0.8938151719989268,1.0,5/16,20.56%,MEF2C;BOC;BTG1;LRRC8A;HIF1AN
prerank,snRNA processing (GO:0016180),0.3947975968376757,0.8021842903282665,0.6662198391420912,1.0,1.0,3/16,10.74%,INTS7;TUT1;INTS8
prerank,glycoprotein metabolic process (GO:0009100),0.3476426115955246,0.8020330833676217,0.6929824561403509,1.0,1.0,12/53,15.47%,HPSE;LARGE1;ST8SIA2;B4GALT7;ADAMTS9;GANAB;STT3B;MAN1C1;FBXO27;ST3GAL4;FBXO17;ST3GAL2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3349401648425853,0.8018934471678695,0.7991967871485943,1.0,1.0,32/166,16.98%,ATAD5;GLI2;FGFR4;LARP4B;GCK;HNRNPD;STN1;DNA2;DHX9;PRKDC;UPF3B;FAF1;PTPN2;SAMD4A;NMD3;SLC25A37;FMR1;ABCB10;PLXNB2;METTL5;PCNA;EIF3C;LARP4;SMAD3;ARNT;FXR1;PRKD2;PKD2;PASK;METTL3;PYM1;LDLR
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.33731145007009544,0.8016273537516297,0.7796954314720812,1.0,1.0,42/124,24.78%,VANGL1;MOV10;RHOA;AGO2;PSMC2;PSMD5;NLK;DAAM1;TCF7L2;SFRP2;PPP3CA;PSMB1;SMURF1;PSMD14;PSMD1;PSMB9;SMURF2;RAC1;PSMC6;TNRC6C;SFRP1;PPP3R1;PSMB2;PSME4;FRZB;PSMB7;WNT4;TNRC6B;PSMD11;ARHGEF19;PSME3;PSMD13;GNB1;CELSR1;PSMB8;GNAO1;PSMD4;PSMF1;AP2B1;PPP3CB;PSMA5;PSMC3
prerank,membrane raft organization (GO:0031579),0.39290877038096717,0.8008904991135711,0.6685393258426966,1.0,1.0,5/15,25.01%,ANXA2;FLOT2;FA2H;S100A10;MYADM
prerank,positive regulation of bone mineralization (GO:0030501),0.3555831054472581,0.8003017241175975,0.69965075669383,1.0,1.0,7/35,11.42%,ADGRV1;BMPR1A;BMP6;CCN1;SLC8A1;ATP2B1;BMP2
prerank,regulation of innate immune response (GO:0045088),0.34024315659605564,0.8002930592262377,0.7038251366120218,1.0,1.0,20/57,24.22%,USP18;DHX9;NMI;IRF1;RIOK3;PARP9;POLR3D;APPL2;AKIRIN2;CASP8;XIAP;SLC15A4;IFNAR2;PTPN1;APPL1;POLR3C;BIRC2;POLR3G;ABCE1;FGR
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.2824362905644858,-0.8002436226032916,0.752895752895753,0.8967949315909819,1.0,6/17,18.03%,BIN1;PTPRZ1;TNFRSF1B;TENM4;DICER1;IL34
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.28548783097367736,-0.799993748413729,0.7403508771929824,0.8963953100144489,1.0,7/15,30.55%,SYN3;CNTNAP4;ADRA1A;NLGN1;DRD2;BAIAP3;CLN3
prerank,positive regulation of gene expression (GO:0010628),0.3369970727511575,0.7998265706749446,0.932,1.0,1.0,82/442,17.09%,BRCA1;E2F1;MED26;DYRK1A;BAZ1B;SETX;DEK;MOV10;TICAM1;ROCK2;FGFR4;LARP4B;AGO2;CTCF;GSK3B;POLR1A;HNRNPD;DDRGK1;PRKDC;UPF3B;MYO1C;BMP6;MUSK;POLR1B;AFDN;SAMD4A;TENT4A;FMR1;POLR2A;ZBTB7B;PHF2;UBR5;AGPAT2;ROBO1;YAP1;ANGPT1;SLC24A3;ROCK1;WNT6;AGT;TAF1D;PIK3CB;TGFBR1;PLXNB2;LIMS1;METTL5;EIF2AK3;CNTF;BMP2;EZR;NKX2-1;TERF2;STOX1;EIF3C;RBMS3;FUBP1;RBPJ;GJA1;SOX9;C1QTNF1;CTSH;POLR1G;TWIST1;HEY2;DDX21;LARP4;MED1;ADAM19;SMAD3;RAMP3;AGPAT1;PRKAG1;TNRC6C;FXR1;PASK;TP53;MSN;METTL3;ITGB8;PYM1;NGF;HNRNPLL
prerank,regulation of neuron apoptotic process (GO:0043523),0.33425864047094583,0.7996703465718954,0.7593360995850622,1.0,1.0,1/96,0.13%,KIF14
prerank,NIK/NF-kappaB signaling (GO:0038061),0.33892906048096244,0.7995461783270021,0.7355110642781876,1.0,1.0,29/72,24.78%,MAP3K14;PSMC2;PSMD5;PSMB1;PSMD14;TNFRSF10B;PSMD1;PSMB9;FBXW11;BTRC;PSMC6;ZFP91;PSMB2;PSME4;PSMB7;RELB;PSMD11;TRAF6;PSME3;TRAF2;PSMD13;BIRC2;PSMB8;PSMD4;PSMF1;REL;PSMA5;RELA;PSMC3
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.27743327830900844,-0.7995352510074443,0.7188755020080321,0.8963567665996973,1.0,1/17,0.17%,PLA2G4A
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.39055680078552163,0.7995155929191696,0.6754507628294036,1.0,1.0,3/16,20.28%,RHOA;ST3GAL4;TRAF6
prerank,cellular response to chemical stress (GO:0062197),0.34002315039276926,0.7994835582311222,0.7577319587628866,1.0,1.0,27/96,19.16%,VKORC1L1;SETX;SRXN1;VRK2;ATG7;PYCR1;FOXO3;HTRA2;LRRK2;SOD3;STX2;CPEB2;LONP1;NOX4;CYBB;STOX1;PRKD1;GPX8;PKD2;SESN2;PNPT1;RAD52;CCS;TRPV4;FANCC;ADNP2;PYROXD1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.2870618201795948,-0.7993661774305569,0.7153284671532847,0.8958049592699472,1.0,7/15,24.59%,SIK1;SLC27A1;GPLD1;NR1H3;NR1H2;MFSD2A;CTDNEP1
prerank,protein localization to cell junction (GO:1902414),0.3684825182884546,0.7992381601087808,0.6641509433962264,1.0,1.0,5/22,16.34%,CGNL1;MPP4;ARHGEF18;TJP2;NLGN2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.24552900850081222,-0.7990184205327715,0.7981651376146789,0.8955412621914889,1.0,11/24,25.50%,NUB1;CTSC;APOE;PINK1;RHBDF1;GPX1;UBB;PSME2;PTK2B;PSME1;UBE3A
prerank,cellular response to hypoxia (GO:0071456),0.3310198668826304,0.7984051706860975,0.7704752275025278,1.0,1.0,48/126,24.78%,AQP1;ANGPT4;PSMC2;PSMD5;MDM4;FAM162A;HP1BP3;ELOC;PSMB1;PSMD14;LIMD1;CPEB2;VHL;PSMD1;PSMB9;NDRG1;STOX1;RORA;TWIST1;PSMC6;ARNT;NPEPPS;TP53;SFRP1;SUV39H2;PSMB2;BAD;PTGIS;PSME4;PSMB7;TBL2;FMN2;TERT;PSMD11;EGLN1;PSME3;PSMD13;SIRT2;EGLN3;ZFP36L1;PSMB8;PSMD4;KCND2;NOP53;PSMF1;PSMA5;HIF3A;PSMC3
prerank,regulation of cellular localization (GO:0060341),0.3549740308688766,0.7977411024033427,0.6970720720720721,1.0,1.0,7/46,13.74%,SPAG5;NUMA1;STXBP2;LRRK2;MAD1L1;LRP5;GOSR1
prerank,protein kinase A signaling (GO:0010737),0.4049731147670682,0.7977405662871088,0.6671408250355618,1.0,1.0,5/12,25.97%,EZR;LCP1;RAB13;PRKACA;RDX
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.3831141557903724,0.7976792588984207,0.6875800256081946,1.0,1.0,5/21,16.68%,CHST15;CHSY1;CHST3;BGN;UGDH
prerank,superoxide anion generation (GO:0042554),0.40153288989007657,0.7975935717970934,0.6752136752136753,1.0,1.0,2/13,9.84%,NOX4;CYBB
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.39765957726215206,0.797361932497579,0.6703601108033241,1.0,1.0,3/14,11.69%,UPB1;DPYD;ERH
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.3862852049826462,0.7969539831081222,0.6770428015564203,1.0,1.0,5/19,16.07%,MAP4K4;ROCK1;LIMS1;RAC1;SFRP1
prerank,regulation of protein localization to centrosome (GO:1904779),0.41162040557758606,0.7968808820082722,0.6803519061583577,1.0,1.0,3/10,18.09%,GSK3B;UBXN2B;CEP250
prerank,microvillus assembly (GO:0030033),0.3949523686016995,0.7968521082688114,0.6831955922865014,1.0,1.0,3/14,11.46%,MAP4K4;RAP2A;EZR
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.3683288895243412,0.7961345290598348,0.6710875331564987,1.0,1.0,6/21,17.26%,KCNN4;RAB29;IKBKG;PRKCB;PRKD2;FOXP1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.4010308312032105,0.796087001974308,0.6947960618846695,1.0,1.0,1/13,2.15%,FADD
prerank,maturation of SSU-rRNA (GO:0030490),-0.22071259110585767,-0.7960266541967566,0.8410596026490066,0.8995606875539708,1.0,11/34,21.29%,RPS8;NOL10;RPS14;RPS28;RPS19;HEATR1;NGDN;SNU13;RIOK2;TSR2;NOB1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.3456854828449309,0.7958107354065466,0.7082405345211581,1.0,1.0,23/47,28.18%,TRIOBP;ACTN4;PDPN;LIMS1;CRKL;RAC1;DMTN;DOCK1;RCC2;DOCK5;RREB1;FERMT2;FBLN1;FLNA;S100A10;CRK;MYADM;P4HB;CDC42;CORO1C;KANK1;MYOC;CARMIL1
prerank,regulation of gastrulation (GO:0010470),-0.2906872944259141,-0.7946177757037197,0.7348484848484849,0.9011885672581852,1.0,4/14,27.77%,PHLDB2;TENM4;RACK1;DAG1
prerank,adherens junction organization (GO:0034332),0.3415573963515601,0.7943284406255169,0.7069922308546059,1.0,1.0,6/48,6.13%,CDH15;CDH18;CDH24;CDH4;AFDN;CTNNA1
prerank,spliceosomal complex assembly (GO:0000245),0.35102189551576135,0.7942581110608444,0.712707182320442,1.0,1.0,11/46,17.79%,SETX;SRSF10;DDX39B;PRPF19;CELF2;SF3A2;SRPK1;LUC7L3;DDX1;SRPK2;LUC7L2
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.35431707798773254,0.7942011371646441,0.6890173410404624,1.0,1.0,6/39,12.14%,TRAK1;ACTN4;MYO1C;NDE1;RAB1A;FBXW11
prerank,cellular response to retinoic acid (GO:0071300),0.3526035705031721,0.7939441712017228,0.7200447928331467,1.0,1.0,6/42,12.57%,AQP1;SETX;HTRA2;WNT6;WNT9A;SOX9
prerank,protein O-linked glycosylation (GO:0006493),0.33425009524187865,0.7934977126074713,0.7609805924412666,1.0,1.0,16/96,16.26%,POMT1;TRAK1;LARGE1;CRPPA;GALNT1;B3GNT8;FKRP;ST3GAL3;C1GALT1;POFUT1;RXYLT1;TMTC4;ST3GAL4;ST3GAL1;ST3GAL2;PLOD2
prerank,mitochondrial translational termination (GO:0070126),0.336343932382883,0.7932995355823773,0.7786885245901639,1.0,1.0,23/88,22.02%,MRPL36;MRPL18;MRPL13;MRPL55;DAP3;MRPL1;MRPS33;MRPS18B;MRPL46;MTRF1;GFM2;MRPS10;MRPS24;MRPL45;MRPL42;MRPL37;MRPL2;MRPL20;MRPS23;MRPS22;MRPL43;MRPL50;PTCD3
prerank,protein localization to synapse (GO:0035418),-0.30212054822089895,-0.793272345181762,0.7280966767371602,0.9026284398291424,1.0,5/12,18.42%,PCLO;NRXN1;SHANK1;DLG4;NLGN1
prerank,glutathione derivative metabolic process (GO:1901685),0.37952311862207483,0.7924530204856359,0.6779220779220779,1.0,1.0,6/20,22.12%,GSTO2;HPGDS;GSTT1;MGST3;GSTM5;GSTZ1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.37952311862207483,0.7924530204856359,0.6779220779220779,1.0,1.0,6/20,22.12%,GSTO2;HPGDS;GSTT1;MGST3;GSTM5;GSTZ1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.36334050794509876,0.7924271345746522,0.6946847960444994,1.0,1.0,3/26,6.52%,FBN1;PTPN2;HOXA7
prerank,cochlea morphogenesis (GO:0090103),0.4233196541542359,0.792295758313214,0.701095461658842,1.0,1.0,2/10,12.57%,TBX18;SOX9
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3338562866075904,0.7922758786661159,0.7673469387755102,1.0,1.0,28/108,21.09%,FADD;SENP1;DAP;ANP32B;CASP8AP2;FAM162A;MAPT;XDH;HTRA2;ROBO1;TNFRSF10B;HMGB1;APAF1;BOK;UACA;EIF2AK3;CASP8;SMAD3;BCL2L13;NGF;TNFSF10;BAD;RIPK1;DAPK1;COL4A3;PRR7;SNCA;TRAF2
prerank,response to organic cyclic compound (GO:0014070),0.3505132376790459,0.7920303010215544,0.7213290460878885,1.0,1.0,8/52,13.55%,CDKN2D;FGFR4;ABCB4;IL18;LRRK2;TRPM2;ANXA1;DHFR
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.2253338768218594,-0.7920095567424087,0.8322981366459627,0.9039675962360513,1.0,14/37,23.10%,NACC2;CAV1;FIS1;BECN1;RPS7;SIAH1;BCL2;NUPR1;BCAP31;DDIT3;UBB;BCL2L1;RACK1;RPS3
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.4001540822987323,0.7918517157626024,0.6932330827067669,1.0,1.0,1/11,2.68%,BMPR1A
prerank,glycine transport (GO:0015816),0.41952634480543416,0.7917772833323565,0.6907993966817496,1.0,1.0,3/10,17.84%,SLC6A5;SLC6A17;SLC6A9
prerank,regulation of primary metabolic process (GO:0080090),0.3319182805001331,0.7916346604675444,0.7846938775510204,1.0,1.0,32/126,20.45%,ZFP69;ROCK2;FGFR4;PSMC2;PSMD5;PMVK;TBL1XR1;PSMB1;NQO1;PSMD14;NFYA;PSMD1;PSMB9;NCOA2;TM7SF2;ACACA;PLPP1;ADIPOR1;MED1;MVK;PSMC6;AZIN1;DHCR7;LDLR;PSMB2;SREBF1;PSME4;PSMB7;TGS1;PRKAB1;PSMD11;PSME3
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.39424865815495225,0.7914788995198851,0.6874135546334716,1.0,1.0,3/13,16.02%,ADGRV1;GNAI3;GABBR2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.3801579887554121,0.7913098512810289,0.6761658031088082,1.0,1.0,7/21,19.55%,HPSE;SULF2;SULF1;HS2ST1;UGDH;XYLT1;GLCE
prerank,calcium ion transport into cytosol (GO:0060402),0.3717865199906872,0.7910877591095032,0.6850899742930592,1.0,1.0,8/21,18.19%,ATP2B4;SLC8A1;CACNA1C;TRPM2;ITPR3;GRIN2D;TRPV4;JPH1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.37781126181904906,0.7910491515578467,0.6763157894736842,1.0,1.0,5/19,15.73%,ADGRL1;PRNP;TRPM2;DMTN;STIMATE
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.37661772366508495,0.7909767074759305,0.6711229946524064,1.0,1.0,6/20,19.63%,ZC3H7A;AGO2;PUM2;ZC3H7B;SPOUT1;TERT
prerank,T cell receptor signaling pathway (GO:0050852),0.33558294534763816,0.7905545207237064,0.8150753768844221,1.0,1.0,45/138,25.00%,ERMAP;THEMIS;PSMC2;PSMD5;KHDRBS1;EIF2B1;WNK1;UBE2N;STOML2;RNF31;RC3H2;PSMB1;PSMD14;NCK1;PSMD1;IKBKG;PIK3CB;PSMB9;FBXW11;PDPK1;BTRC;RC3H1;PSMC6;PRKD2;NFKB1;PSMB2;PSME4;PSMB7;PDE4B;PSMD11;TRAF6;PSME3;IKBKB;PSMD13;EIF2B5;PSMB8;FYN;PSMD4;BCL10;RIPK2;PSMF1;PSMA5;RELA;PSMC3;SPPL3
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.3913397527992398,0.7900253400334132,0.6988636363636364,1.0,1.0,3/14,11.48%,IL18;CD80;ANXA1
prerank,sodium ion import across plasma membrane (GO:0098719),0.3775594785000952,0.7896988240077597,0.6689560439560439,1.0,1.0,3/17,12.53%,SLC9A5;SLC8A1;TRPM4
prerank,endothelial cell development (GO:0001885),0.3576741167763155,0.7895415477067358,0.69125,1.0,1.0,5/25,16.28%,COL22A1;COL18A1;EZR;COL15A1;MSN
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.3833325515573134,0.7895382035302796,0.6940104166666666,1.0,1.0,6/17,19.96%,ARFIP1;CORO1B;WASF2;NCKAP1;ABI2;ARF1
prerank,iron ion transmembrane transport (GO:0034755),0.40764144609717917,0.7895233941291936,0.6696969696969697,1.0,1.0,3/10,17.02%,SLC25A37;SLC39A8;SLC25A28
prerank,regulation of mRNA metabolic process (GO:1903311),0.4026842631963986,0.7887099379308673,0.6641566265060241,1.0,1.0,4/11,17.77%,DHX9;SRPK1;IWS1;SRPK2
prerank,regulation of RNA splicing (GO:0043484),0.33480593194446434,0.7886004527215891,0.7426160337552743,1.0,1.0,22/69,19.51%,DYRK1A;SETX;TRA2B;KHDRBS1;SRSF10;MBNL3;HNRNPH1;POLR2A;FUS;SRSF3;HNRNPL;SRPK1;HNRNPH2;METTL4;PTBP2;HNRNPLL;SRPK2;CWC22;SLC38A2;LARP7;CLK3;KHDRBS3
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.38350985892291795,0.7884820954636222,0.6763085399449036,1.0,1.0,1/16,2.15%,FADD
prerank,regulation of erythrocyte differentiation (GO:0045646),0.3513650648978599,0.7880284862264815,0.710401891252955,1.0,1.0,13/35,23.52%,HMGB2;PRKDC;FOXO3;ABCB10;TAL1;MED1;ARNT;MAPK14;ZFPM1;LDB1;ZFP36L1;STAT5B;ANKRD54
prerank,rRNA methylation (GO:0031167),0.37382516008086475,0.7880073042561311,0.6799485861182519,1.0,1.0,7/22,17.47%,MRM1;MRM3;METTL15;METTL5;TFB1M;MRM2;NSUN3
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.24611622673807138,-0.7877477602702667,0.7845303867403315,0.9101486191275046,1.0,4/24,7.53%,PECAM1;F11R;VCAM1;SEMA4D
prerank,mRNA metabolic process (GO:0016071),0.3356997252189669,0.7877060267744984,0.7604166666666666,1.0,1.0,24/90,19.78%,SRSF4;CSTF3;LSM3;SLBP;LSM11;SRSF7;PRPF3;NONO;SF3A2;PCF11;LSM2;SFPQ;YTHDF2;DXO;KIN;HNRNPA2B1;TP53;PNPT1;HIPK3;METTL3;PRPF18;HNRNPR;SF3A3;SNRPB
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.23840204290331038,-0.7874372307237529,0.8105263157894737,0.9098504882517403,1.0,10/27,22.47%,TAB2;TLR4;TAB3;HSPD1;IRAK4;TNIP1;UBB;TIRAP;UBC;RPS27A
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.3580851224751452,0.7874079890763176,0.6975308641975309,1.0,1.0,8/28,16.15%,PSMC2;DDRGK1;FBXW7;FMR1;SMURF1;ATP5IF1;PSMC6;PTEN
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.20919608720545235,-0.786953946115918,0.8805970149253731,0.909794841675953,1.0,12/41,25.08%,PLA2G4A;SCP2;GPX4;PNPLA8;DEGS1;GPX1;DECR2;ACSL1;SCD;ELOVL1;FADS1;GSTM2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.3620626932243554,0.7868464599896652,0.705955334987593,1.0,1.0,7/25,17.93%,WDR54;MTMR2;PICALM;RAC1;ITGAV;UNC119;ANKRD13D
prerank,protein O-linked glycosylation via serine (GO:0018242),0.4078475542616935,0.7866742357891323,0.6914893617021277,1.0,1.0,1/10,4.77%,GALNT1
prerank,organic cation transport (GO:0015695),0.36849372376236894,0.7862045543859706,0.6790450928381963,1.0,1.0,9/20,26.67%,PDZK1;SLC22A18;SLC25A42;SLC25A29;SLC25A19;SEC14L1;SLC22A4;SLC47A1;RALBP1
prerank,negative regulation of cyclase activity (GO:0031280),0.3903427776031472,0.785307305609967,0.691358024691358,1.0,1.0,3/14,16.02%,ADGRV1;GNAI3;GABBR2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.26973027039602093,-0.7852319685213425,0.7721518987341772,0.9117753268047043,1.0,9/17,30.21%,PODXL;TGFB2;FOXC2;NCKAP1L;RET;SYK;SKAP1;P2RY12;CIB1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.3531229048440915,0.7850873335705817,0.6884057971014492,1.0,1.0,7/30,18.30%,LBR;PMVK;TM7SF2;ACAT2;MVK;DHCR7;INSIG2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.3616211926541858,0.7849261364736205,0.6877323420074349,1.0,1.0,7/23,18.67%,MMP14;MYLK3;PIEZO1;MAML1;EFNB2;MAPK14;NIBAN2
prerank,mitochondrial translational elongation (GO:0070125),0.33219211722037173,0.7845266703997699,0.7868852459016393,1.0,1.0,22/88,22.02%,MRPL36;MRPL18;MRPL13;MRPL55;DAP3;MRPL1;MRPS33;MRPS18B;MRPL46;GFM2;MRPS10;MRPS24;MRPL45;MRPL42;MRPL37;MRPL2;MRPL20;MRPS23;MRPS22;MRPL43;MRPL50;PTCD3
prerank,protein transport (GO:0015031),0.3318693030934016,0.7845220964512634,0.925,1.0,1.0,52/332,16.67%,CENPF;NEURL1B;NDC1;USP6NL;STX11;ZG16;MACF1;STEAP3;ARFIP1;AP4M1;RAB10;EVI5L;TBC1D25;SNX1;TBC1D13;WDR11;VPS26C;TBC1D2B;RAB22A;SLC10A7;RAB29;STXBP2;STX2;DNM2;RAB1A;SVBP;SNX27;VIPAS39;COPB2;SNX33;HERC2;COPZ1;ARRDC1;PRKCB;AP3B1;ABCA1;SCFD1;EHD1;IFT27;TOM1;ARF4;ARRDC2;RAMP3;MIA3;ARL4A;UNC119;STX12;ARF3;TBC1D9;STXBP1;VPS26A;TMED3
prerank,protein localization to phagophore assembly site (GO:0034497),-0.3116459347193071,-0.7841034547153991,0.7212121212121212,0.9127942112704527,1.0,2/11,4.47%,WDR45B;PACS2
prerank,regulation of histone deacetylation (GO:0031063),0.3863927524260332,0.7839028899209238,0.6882352941176471,1.0,1.0,3/13,7.81%,CTBP1;NIPBL;ZBTB7B
prerank,cGMP biosynthetic process (GO:0006182),-0.325619035448916,-0.7836659238592358,0.7091412742382271,0.912560225004173,1.0,2/10,9.96%,GUCY1A1;NPR1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.3519420221216753,0.7835477716920709,0.6899766899766899,1.0,1.0,9/39,16.75%,GLI2;NPNT;SFRP2;BMP2;NKX2-1;LRP5;GDNF;PKD2;SALL1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.4063340355433296,0.7834691469164431,0.6791862284820032,1.0,1.0,1/10,3.49%,AGO2
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.3998363453244062,0.7834682011057992,0.6923076923076923,1.0,1.0,1/11,2.80%,TICAM1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.2774145866699922,-0.7834641969028867,0.7610921501706485,0.9120377706527667,1.0,6/15,21.15%,APOE;FURIN;GPLD1;TNFRSF1B;ADRA2A;PACSIN3
prerank,transcription by RNA polymerase III (GO:0006383),-0.22848560647924207,-0.7829930741428962,0.8624338624338624,0.9118910399345911,1.0,9/27,23.79%,RO60;SNAPC3;ICE1;POLR3K;GTF3C3;POLR3H;POLR2K;TBP;GTF3C1
prerank,regulation of chondrocyte differentiation (GO:0032330),0.36095322886917963,0.782959207899841,0.7064803049555273,1.0,1.0,6/24,15.24%,LOXL2;SOX6;TGFBR1;WNT9A;SOX9;EFEMP1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.32480346423100737,0.7825472678571771,0.8595787362086259,1.0,1.0,40/208,18.74%,ECT2;FADD;TRIML2;TICAM1;MAP3K14;MIER1;RHOA;LPAR1;TRIM59;UBE2N;RNF31;TNFRSF10B;RIOK3;MAP3K3;IKBKG;CXXC5;PRKCB;PDPK1;GJA1;TRIM6;CASP8;BRD4;ROR1;RORA;DDX21;PRKD1;PLK2;TRIM5;PER1;OTUD7B;VAPA;RHOC;DDX1;MAVS;TNFSF10;LAMTOR5;PLEKHG5;TERF2IP;ANKRD17;RIPK1
prerank,lysosome organization (GO:0007040),-0.21802312573342825,-0.7823696586410243,0.8085106382978723,0.912045694885706,1.0,16/36,26.92%,ZKSCAN3;CLVS1;TPP1;TMEM106B;ACP2;GRN;MTOR;HOOK1;HPS4;CLN5;TFEB;MBTPS1;ATP10B;GNPTAB;VPS33A;AKTIP
prerank,macrophage migration (GO:1905517),0.3993335779163811,0.7822242499686607,0.717546362339515,1.0,1.0,1/13,4.99%,CKLF
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.2666892275258738,-0.7820517936792599,0.7974683544303798,0.9117527938826421,1.0,7/16,23.15%,DDX17;SLU7;DDX5;PUF60;SRSF6;SRSF9;SCNM1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.32816254214613494,0.7819030670201961,0.842211055276382,1.0,1.0,43/173,20.80%,SPTA1;F5;RANGRF;ACTR1A;SPTB;GBF1;COG1;ZW10;ATL2;ANK1;DCTN5;ATL3;RAB29;CUL3;TRAPPC6B;RAB1A;COPB2;COPZ1;CAPZA1;F8;SCFD1;SEC24D;VTI1A;ARF4;GOSR1;NRBP1;MIA3;VAPA;BET1;BCAP29;TMED3;USO1;COG4;COG8;TMED10;BET1L;PROS1;COG5;CNIH4;DYNC1I1;ANK3;TRAPPC8;WHAMM
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.3819488585325977,0.7818963261375692,0.6818181818181818,1.0,1.0,1/17,1.64%,ATOH8
prerank,zymogen activation (GO:0031638),0.35717930621981697,0.7818960180379116,0.7131336405529954,1.0,1.0,8/39,19.11%,FADD;MMP14;PLAU;CASP8;CTSH;BAD;PLAT;TBC1D10A
prerank,regulation of cellular amine metabolic process (GO:0033238),0.3414609239047267,0.781868950325597,0.7334070796460177,1.0,1.0,20/50,24.78%,PSMC2;PSMD5;PSMB1;NQO1;PSMD14;PSMD1;PSMB9;PSMC6;AZIN1;PSMB2;PSME4;PSMB7;PSMD11;PSME3;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.30060370624254995,-0.7818351592981899,0.7777777777777778,0.9112696121678739,1.0,2/12,3.22%,RYR2;ANXA6
prerank,carbohydrate derivative catabolic process (GO:1901136),0.37973080773830786,0.7813414395681895,0.6832460732984293,1.0,1.0,7/18,26.16%,ADAMTS9;STT3B;FBXO27;FBXO17;NAGA;DERA;OGA
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.2421961600566549,-0.781282403553563,0.7960199004975125,0.9113831063911115,1.0,4/23,17.26%,LAMP1;NECTIN2;PIK3R6;LGALS9
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.38722234340742834,0.7812731346336118,0.7061224489795919,1.0,1.0,4/14,14.43%,RAB1A;SCAP;SEC24D;MIA3
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3318502636883219,0.7812298499126977,0.7627471383975026,1.0,1.0,16/79,14.12%,ATP2B4;BMPR1A;NEDD4;CASK;SULF2;CRIM1;LEMD3;SULF1;SMAD6;SMURF1;AGT;RBPMS2;SMURF2;BMP2;SMAD4;HTRA3
prerank,protein localization to cell-cell junction (GO:0150105),0.38336465958955424,0.7810835887310145,0.6794701986754967,1.0,1.0,4/15,12.76%,CGNL1;SCRIB;ARHGEF18;TJP2
prerank,membrane assembly (GO:0071709),0.35268207021132314,0.7806369395751015,0.7078916372202592,1.0,1.0,12/34,20.35%,ANXA2;NLGN3;STX2;PICALM;FLOT2;GAK;PTEN;NLGN2;UBXN2B;CHMP4B;UGCG;ANK3
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.3271831572385699,0.7805862821098601,0.801829268292683,1.0,1.0,25/124,15.61%,MNS1;STMN1;RB1;GSK3B;FAM161A;LAMB1;NEDD4;MAPT;CORO1B;WDPCP;ODF2;ROCK1;MAP4;HMGB1;SAMD14;FRYL;RAC1;EHD1;BLOC1S5;PLEKHA1;DOCK7;VAPA;HDGFL3;GDNF;PKD2
prerank,regulation of signal transduction (GO:0009966),0.32773328522406053,0.7804957622940486,0.8638638638638638,1.0,1.0,46/190,20.18%,RGS12;CBFB;NCAM1;BRAP;FGFR2;TCF7L1;GIT2;PRNP;PTPN2;WDR11;ELF1;NUCKS1;WWTR1;SULF1;NCLN;CD80;LRRK2;GRK5;NCK1;RGS3;LLGL2;RIC8B;FBXL17;GAS1;POFUT1;NCK2;GRK3;RSPO3;SIK2;RORA;PRKD1;FOXL1;TRIM5;SRC;GDNF;ZDHHC3;TMEM237;VEPH1;RUNX1;IGFBP3;ZIC1;SP100;USP20;PTPN1;SEMA5A;UGCG
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.3636547048310572,0.7802693318095328,0.7052096569250318,1.0,1.0,3/23,8.04%,FGFR2;TGFBR3;ADAMTS9
prerank,cholesterol biosynthetic process (GO:0006695),0.35014188975705846,0.7802403884413962,0.6948130277442702,1.0,1.0,7/31,18.30%,LBR;PMVK;TM7SF2;ACAT2;MVK;DHCR7;INSIG2
prerank,cellular response to growth factor stimulus (GO:0071363),0.32870481666750434,0.7802370277469969,0.8415741675075681,1.0,1.0,31/151,14.38%,KNSTRN;SETX;BMPR1A;HYAL1;WWOX;GAREM1;ACAP2;MAPT;BMP6;SOX6;HTRA2;CORO1B;EMD;GAS1;HAS1;NR3C1;TGFBR1;LIMS1;CRKL;BMP2;ANXA1;APPL2;PDPK1;NR4A1;SOX9;SMAD4;EHD1;PRKD1;MED1;SMAD3;CD44
prerank,positive regulation of nervous system process (GO:0031646),-0.2649921225113917,-0.7797408049496866,0.7489539748953975,0.9129423854600385,1.0,5/18,15.09%,UNC13B;RIMS1;TNFRSF1B;TENM4;DICER1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.37443666015179794,0.7790720988050739,0.7006451612903226,1.0,1.0,5/17,12.36%,SLC8A1;GJD3;GJC1;CACNA1C;GJA1
prerank,myotube differentiation (GO:0014902),0.3713456616335217,0.7789618710889029,0.7023319615912208,1.0,1.0,3/17,7.58%,MYEF2;ADAM12;ADAMTS5
prerank,regulation of lamellipodium assembly (GO:0010591),0.3542533797578256,0.7789281104072945,0.693127962085308,1.0,1.0,11/34,22.32%,ACTR3;AUTS2;TWF1;RAC1;DMTN;WASF2;NCKAP1;ABI2;PLXNB3;FER;ARPC2
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.35466629439390307,0.7787822915307848,0.7193627450980392,1.0,1.0,2/27,2.26%,ATP2B4;RANGRF
prerank,phospholipid translocation (GO:0045332),0.359634382976863,0.7787801449844906,0.704191616766467,1.0,1.0,3/28,4.58%,PLSCR2;ABCA4;ABCB4
prerank,regulation of cell junction assembly (GO:1901888),0.35939044741940085,0.7787304897022438,0.7064676616915423,1.0,1.0,5/27,12.33%,CBFB;ROCK2;MYO1C;ROCK1;PDLIM5
prerank,endothelial tube morphogenesis (GO:0061154),0.40117644284359866,0.7785874728805794,0.6865671641791045,1.0,1.0,3/10,15.60%,RHOA;RBPJ;PRKD2
prerank,defense response to tumor cell (GO:0002357),-0.3236102905234931,-0.7780240914966096,0.7680722891566265,0.9147461519144356,1.0,5/10,27.36%,KLF4;PRDX2;ABI3;PLK5;LAPTM5
prerank,T cell migration (GO:0072678),-0.2853194831559402,-0.7775658808063893,0.7717041800643086,0.914627963608853,1.0,9/13,49.01%,S1PR1;SLC12A2;PIK3CD;CXCL16;GPR183;PIK3CG;CXCL10;MYO1G;ZAP70
prerank,ameboidal-type cell migration (GO:0001667),-0.19577883640061355,-0.7775088733697681,0.925531914893617,0.9138578605921662,1.0,14/51,19.19%,SEMA6A;ANXA6;SEMA6D;SEMA7A;SEMA4D;SEMA3A;ERBB4;AMOT;MEGF8;TBX1;SEMA3B;SEMA3C;PDLIM1;SEMA5B
prerank,membrane depolarization during action potential (GO:0086010),-0.23752503285285215,-0.7773991805639023,0.8385416666666666,0.9131698342446862,1.0,12/26,34.05%,SCN1A;SCN9A;ATP1A2;SCN3A;SCN8A;SCN1B;SCN4B;CACNA1H;CACNA1I;YWHAH;SCN3B;CACNA1D
prerank,oligodendrocyte differentiation (GO:0048709),0.3680816625283288,0.7773048036157093,0.6828947368421052,1.0,1.0,5/19,15.19%,SOX6;EIF2B1;TPPP;SOX9;PRDM8
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.2824995684390733,-0.7769938537640371,0.7664233576642335,0.9129744361148017,1.0,4/14,17.26%,TGFBR2;PTPN22;CD81;LGALS9
prerank,negative regulation of T cell activation (GO:0050868),0.34086506935061556,0.7767354181522097,0.7137850467289719,1.0,1.0,7/35,20.47%,FGL1;CD80;RIPOR2;IL4I1;HAVCR2;SDC4;CEACAM1
prerank,cellular response to oxidative stress (GO:0034599),0.3284436849336772,0.7765043575018284,0.8059244126659857,1.0,1.0,35/118,20.94%,VKORC1L1;SETX;SRXN1;MAPT;VRK2;PDGFRA;PYCR1;FOXO3;AGAP3;HTRA2;LRRK2;SOD3;STX2;CPEB2;LONP1;NOX4;CYBB;PRKD1;ARNT;GPX8;PKD2;TP53;SESN2;PNPT1;RAD52;PTPRK;CCS;FANCC;ADNP2;PYROXD1;PRKCD;DAPK1;TXNRD1;SNCA;FER
prerank,negative regulation of receptor binding (GO:1900121),-0.30517464576613185,-0.7764243050336098,0.7611111111111111,0.9130777281626462,1.0,4/10,26.03%,ADAM15;B2M;ATP2A3;PTPRF
prerank,negative regulation of TORC1 signaling (GO:1904262),0.3889691153362362,0.7763198741940439,0.7060518731988472,1.0,1.0,5/13,16.00%,DEPDC5;SESN1;ITFG2;STK11;SESN2
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.25255513885697,-0.7761730703195034,0.7853881278538812,0.9126288784720846,1.0,9/22,19.76%,CALM1;TAOK2;ACE;RAP2C;PDGFD;NBN;VEGFA;TNKS1BP1;CALM3
prerank,regulation of macromolecule metabolic process (GO:0060255),0.32303494011460127,0.7761429386773278,0.8473895582329317,1.0,1.0,36/170,19.21%,TCF19;TRIML2;ROCK2;CTCF;HNRNPD;UBAP2;AFF3;YBX3;CIAO3;CDK2;ZFP64;MTMR1;MTMR2;SLC8A1;MTMR9;AHR;STOX1;ZUP1;FUBP1;TRIM6;TOB2;MKLN1;TRIM5;MTMR3;ZNF445;PIN1;GDNF;ZNF507;PRDM10;LDLR;SIRPA;FOXP1;MARF1;NPAT;ADNP2;ZNF462
prerank,regulation of focal adhesion assembly (GO:0051893),0.33805541640984427,0.776119322212373,0.7351648351648352,1.0,1.0,16/54,17.87%,MAP4K4;MACF1;ROCK2;RHOA;ROCK1;ARHGAP6;LIMS1;RAC1;DMTN;PTPRA;SRC;RCC2;SFRP1;PTEN;EPHA3;CLASP1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.40730794533335646,0.7756134151294267,0.700162074554295,1.0,1.0,1/10,4.54%,KIT
prerank,membrane lipid metabolic process (GO:0006643),-0.24906787530390911,-0.7752373537969169,0.8368200836820083,0.913227020802431,1.0,10/22,32.47%,ST3GAL6;SERINC1;B4GALT4;ARV1;GAL3ST1;ST6GALNAC4;SPHK1;TECR;SPHK2;CERKL
prerank,cell-cell junction organization (GO:0045216),0.32626728487784623,0.774605694676153,0.7619047619047619,1.0,1.0,14/79,14.35%,CDH15;SDK1;CDH18;CDH24;CDH4;AFDN;CTNNA1;GJC1;TLN1;LIMS1;TJP2;TLN2;PRKCI;SMAD3
prerank,global genome nucleotide-excision repair (GO:0070911),0.3602793360343557,0.7745959696477386,0.70125,1.0,1.0,11/26,23.17%,CHD1L;ERCC4;ERCC3;CUL4B;XPA;RAD23B;ERCC2;RNF111;GTF2H1;DDB2;DDB1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.39055593191377813,0.774164554350535,0.6701183431952663,1.0,1.0,4/12,20.08%,SETX;ADRB2;UVRAG;FYCO1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.32727073282497354,0.7741596671405381,0.7740585774058577,1.0,1.0,19/80,16.97%,ROCK2;LARP4B;HNRNPD;PRKDC;UPF3B;SAMD4A;EFNA1;FMR1;EPHA4;PICALM;PLXNB2;METTL5;EIF3C;LARP4;FXR1;PASK;METTL3;SMPD3;PYM1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.3260434075012982,0.7738698276766997,0.7741935483870968,1.0,1.0,11/86,12.61%,TTK;BMPR1A;NUMA1;BMP6;CCN1;SULF1;TGFBR1;BMP2;RBPJ;ADAM17;SMAD4
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.3041718202084429,-0.7738448544481233,0.7142857142857143,0.9145796265989944,1.0,4/12,20.43%,ATF6;PIK3R1;XBP1;TMEM33
prerank,negative regulation of kinase activity (GO:0033673),0.3314788015754667,0.7735633162252377,0.7352320675105485,1.0,1.0,13/62,14.59%,RB1;CEP43;TAB1;MAPT;WWTR1;GNAQ;CEP85;HNRNPU;PYDC1;PDPK1;SPRED1;CDKN1B;QARS1
prerank,neuron projection regeneration (GO:0031102),-0.31166064451382647,-0.7733824371310182,0.7551622418879056,0.9144435905062317,1.0,5/10,28.30%,GAP43;RTN4RL1;NREP;MTR;OMG
prerank,tRNA aminoacylation (GO:0043039),0.34747975193381964,0.7730693107801484,0.7050691244239631,1.0,1.0,10/37,16.28%,SARS2;VARS1;DARS2;DARS1;IARS2;PPA1;RARS2;EPRS1;QARS1;LARS1
prerank,regulation of adenylate cyclase activity (GO:0045761),0.35866025391667616,0.7728303288106806,0.7077114427860697,1.0,1.0,5/22,16.02%,ADGRV1;CACNA1C;GNAI3;STIM1;GABBR2
prerank,calcium-mediated signaling (GO:0019722),0.32628821677065367,0.7726894478328052,0.7948717948717948,1.0,1.0,19/93,16.39%,ADGRL1;PRNP;CXCR4;PPP3CA;LRRK2;MCU;ATP2A2;SLC8A1;SAMD14;CACNA1C;TRPM2;EIF2AK3;PDPK1;TRPM4;DMTN;BTK;NUDT4;STIMATE;TPCN2
prerank,cholesterol homeostasis (GO:0042632),0.335716436978509,0.7725607487986688,0.7564102564102564,1.0,1.0,12/64,16.98%,CYP39A1;FGFR4;SOAT1;IL18;ABCA1;SOAT2;EHD1;LRP5;RORA;LPL;RALY;LDLR
prerank,regulation of neuroinflammatory response (GO:0150077),-0.2727868074316286,-0.7724667077013826,0.8046875,0.9150352701621243,1.0,4/19,13.18%,IGF1;TNFRSF1B;PTGS2;NUPR1
prerank,sterol homeostasis (GO:0055092),0.3354320232956573,0.7723194507854672,0.7547974413646056,1.0,1.0,12/65,16.98%,CYP39A1;FGFR4;SOAT1;IL18;ABCA1;SOAT2;EHD1;LRP5;RORA;LPL;RALY;LDLR
prerank,response to UV-B (GO:0010224),0.38681896318389636,0.7722415677012316,0.715372907153729,1.0,1.0,2/12,14.70%,HYAL1;STK11
prerank,regulation of axonogenesis (GO:0050770),0.33734293606125704,0.7722378489419612,0.7413600891861761,1.0,1.0,18/51,19.83%,RHOA;GSK3B;RTN4R;EPHA4;ROBO1;MARK2;ARHGAP35;PLXNB2;PLXNB1;PLXND1;MAP6;PTEN;SIPA1L1;NGF;PLXNA2;AMIGO1;PLXNB3;KIF13B
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.3967992376054702,0.7719047277055023,0.7188405797101449,1.0,1.0,2/12,10.51%,RNF168;HNRNPU
prerank,mitochondrial gene expression (GO:0140053),-0.21215787908588157,-0.7718439105187156,0.8811881188118812,0.9152035979249968,1.0,26/42,34.45%,LARS2;TFB2M;MRPS18A;MRPS15;MRPS21;MRPS6;TFAM;MRPL23;MRPL51;MRPL47;MRPS14;MRPS7;NOA1;MRPL16;MRPS11;MRPS16;FASTKD2;MRPL12;TEFM;QRSL1;POLRMT;GATC;TWNK;MRPS12;MRPL57;MRPS34
prerank,regulation of phagocytosis (GO:0050764),-0.20054369255795373,-0.7716402656785512,0.9130434782608695,0.9146831266567829,1.0,23/53,38.40%,MERTK;GAS6;SNX3;TGM2;SYT7;SYT11;GATA2;RAB27A;RACK1;SPHK1;IL15;SYK;TUB;FCER1G;PTPRC;ABCA7;CALR;LYAR;HCK;PYCARD;SLC11A1;LMAN2;FCGR2B
prerank,hippo signaling (GO:0035329),0.3565205207099392,0.7714115265097135,0.7044585987261146,1.0,1.0,11/26,22.70%,TEAD1;STK3;WWTR1;YAP1;TEAD3;TJP2;TEAD4;AMOTL1;LATS1;STK4;DCHS1
prerank,ncRNA transcription (GO:0098781),-0.2828181992347975,-0.7711104966206723,0.776595744680851,0.9146618767201601,1.0,8/13,36.72%,SNAPC3;SPIN1;GTF3C1;NIFK;RPAP2;GTF3A;SIRT7;ANG
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.22925337153082562,-0.7710559208220932,0.7988165680473372,0.9138970821681686,1.0,4/30,7.70%,CACNA2D1;RYR2;SCN1A;ATP1A1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3708144946016616,0.7707485664359115,0.7107652399481194,1.0,1.0,7/20,20.62%,LHPP;HPRT1;ADSL;PFAS;GART;PPAT;ADSS2
prerank,glial cell development (GO:0021782),-0.23733001329495618,-0.7706682451763139,0.8578947368421053,0.9136717062456489,1.0,12/25,30.75%,CDK6;NF1;APP;SOX4;NRROS;PICK1;CSPG5;EIF2B2;NSUN5;SOX11;SOX10;MT3
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.3586681432360469,0.7699479416942397,0.7092288242730721,1.0,1.0,3/24,6.13%,CDH15;SPAG9;CTNNA1
prerank,necroptotic process (GO:0070266),0.36715780389781455,0.7693634405578723,0.6917613636363636,1.0,1.0,2/16,7.46%,TICAM1;IPMK
prerank,regulation of sprouting angiogenesis (GO:1903670),0.34011247424886293,0.7691920960895133,0.7154566744730679,1.0,1.0,5/33,14.23%,E2F2;ADAMTS9;PIK3CB;PDPK1;ITGA5
prerank,lipid droplet organization (GO:0034389),0.36001253522055154,0.7691006214919488,0.7001254705144291,1.0,1.0,4/22,14.93%,TSPO2;ZFYVE1;PPID;FAF2
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.3592558421196757,0.7690167931993342,0.7155388471177945,1.0,1.0,3/22,11.46%,PRNP;PTPN2;EZR
prerank,regulation of MAP kinase activity (GO:0043405),0.3303393987980289,0.7689053015672394,0.8147389969293757,1.0,1.0,7/92,10.11%,EZH2;KSR1;KIT;LRRK2;ROBO1;AGT;PIK3CB
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.3696991038397237,0.7685583093752889,0.7144772117962467,1.0,1.0,6/19,15.10%,RTN3;PRNP;ROCK1;PICALM;FLOT2;PIN1
prerank,neuromuscular junction development (GO:0007528),0.36247535353052374,0.7684495999874175,0.704630788485607,1.0,1.0,4/24,8.30%,PDZRN3;NEDD4;MUSK;LRRK2
prerank,carbohydrate catabolic process (GO:0016052),0.3452534163605304,0.7683091254192388,0.7224770642201835,1.0,1.0,4/38,8.45%,PFKFB1;GCK;GPI;PGM1
prerank,positive regulation of type 2 immune response (GO:0002830),-0.28610586751248174,-0.7680920100243305,0.801980198019802,0.916828154186656,1.0,8/14,34.28%,DENND1B;CD81;PRKCZ;CD86;CD74;RSAD2;RARA;NOD2
prerank,positive regulation of autophagy (GO:0010508),0.3246713629344165,0.7674258742637984,0.7614107883817427,1.0,1.0,19/81,14.70%,TRIML2;TICAM1;GSK3B;TPCN1;SH3GLB1;FOXO3;LARP1;LRRK2;ROCK1;HMGB1;IKBKG;SESN1;PIK3CB;TRIM6;GNAI3;PRKD1;PLK2;TRIM5;STK11
prerank,mitochondrial translation (GO:0032543),0.324297472352537,0.7674016904275981,0.8275862068965517,1.0,1.0,21/104,18.13%,MRPL36;MRPL18;IARS2;RARS2;MRPL13;MRPL55;DAP3;MRPL1;MRPS33;MRPS18B;MRPL46;MTRF1;GFM2;MRPS10;MRPS24;MRPL45;MTIF3;MRPL42;MRPL37;MRPL2;MRPL20
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.3460508962772564,0.7673485963485229,0.7396937573616019,1.0,1.0,4/36,7.11%,MACF1;RAB10;AFDN;RILPL1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3211100425373754,0.7672890058798428,0.929,1.0,1.0,47/308,15.39%,EZH2;BMP1;FBXO5;LOXL2;PAXIP1;MFAP2;BMPR1A;AGO2;NUMA1;PDPN;LEPR;CXCR4;SOX6;IL18;RIF1;ZBTB7B;WWTR1;SERPINE1;MFN2;AGPAT2;AXIN2;ALMS1;ROCK1;AGT;TAPT1;TGFBR1;SMURF2;BMP2;ABCA1;APPL2;ACHE;GJA1;TRPM4;SOX9;SMAD4;KMT5C;ADIPOR1;TWIST1;ADRB2;MED1;CPT2;ACADL;SMAD3;AGPAT1;SHLD2;RBM19;GDNF
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.3152733158547541,-0.7672857095540124,0.7598784194528876,0.9171531568515561,1.0,4/10,22.19%,CALM1;GNB5;CALM3;DRD2
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.35680152521339575,0.7669080217187235,0.6973180076628352,1.0,1.0,4/22,11.42%,XDH;MAP3K4;RELL1;BMP2
prerank,regulation of fibrinolysis (GO:0051917),-0.28872426429922393,-0.7667569080200128,0.7793594306049823,0.9170891954757613,1.0,4/13,22.72%,THBD;THBS1;FAP;USF1
prerank,action potential (GO:0001508),-0.19990816217257373,-0.7666611231428128,0.9389312977099237,0.916408265010285,1.0,18/44,32.54%,KCNB1;AKAP6;SCN1A;SCN9A;GNA14;KCNA2;SCN3A;SCN8A;SRI;KCNQ1;GPER1;CACNA1H;MYH14;CLN3;CACNA1I;YWHAH;KCNE4;SCN3B
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.34540838659333417,0.7661111739347211,0.726303317535545,1.0,1.0,9/35,18.33%,AQP1;KSR1;AHR;PDE7B;SOX9;NUDT4;IRAG1;ADCY2;PDE7A
prerank,cytoplasmic translational initiation (GO:0002183),0.36748742843556814,0.7658013048992237,0.7202216066481995,1.0,1.0,9/17,23.43%,EIF4H;RBM4;EIF4A2;MCTS1;DENR;EIF3I;EIF2D;EIF5;EIF4B
prerank,regulation of receptor internalization (GO:0002090),0.34047972923773984,0.7655117386519771,0.7262044653349001,1.0,1.0,6/35,13.02%,WDR54;ARRB1;FMR1;ANGPT1;MTMR2;MKLN1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.2885727685601721,-0.7650623192988794,0.765625,0.9180607777102883,1.0,8/13,36.41%,IGF1;RAMP1;SLC2A10;ABCA2;PLCB1;CCL19;GOLGA2;CHP1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3860924791711985,0.7644889186420196,0.6971830985915493,1.0,1.0,4/13,19.11%,FADD;CASP8;BAD;TBC1D10A
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.36336144396470627,0.7640663750999623,0.7334167709637046,1.0,1.0,4/25,10.91%,HAS3;B3GNT8;HAS1;HS2ST1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.296949060165743,-0.7638170869104882,0.7802547770700637,0.9181026136439887,1.0,2/12,3.47%,IGF1;AKAP6
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.296949060165743,-0.7638170869104882,0.7802547770700637,0.9181026136439887,1.0,2/12,3.47%,IGF1;AKAP6
prerank,skeletal muscle contraction (GO:0003009),-0.25324337389117657,-0.7635728188412085,0.7890625,0.9176188695006843,1.0,9/19,48.12%,RCSD1;STAC;MYH14;STAC3;TNNI1;STAC2;TNNC1;CCDC78;TCAP
prerank,negative regulation of viral process (GO:0048525),0.32673426280483914,0.7634596877829397,0.755750273822563,1.0,1.0,13/57,21.36%,ILF3;FAM111A;ZC3HAV1;PML;TRIM28;SRPK1;TRIM6;TRIM5;MAVS;SRPK2;LARP7;ISG15;EIF2AK2
prerank,dermatan sulfate metabolic process (GO:0030205),0.3804746588647566,0.7629032082924314,0.7172701949860725,1.0,1.0,3/13,14.05%,UST;DSE;BGN
prerank,regulation of interleukin-6 production (GO:0032675),-0.1733004836495582,-0.7626794479510519,0.9722222222222222,0.9180853511964414,1.0,21/96,20.18%,STAT3;GAS6;TLR4;LBP;PTPN22;HSPD1;SELENOS;APP;ARHGEF2;CX3CL1;SYT11;PTPN11;IL17D;C1QTNF3;IFIH1;XBP1;LGALS9;AFAP1L2;NCKAP1L;ZC3H12A;TIRAP
prerank,cellular response to estradiol stimulus (GO:0071392),0.3649476322721113,0.7624467265299292,0.7228260869565217,1.0,1.0,4/18,16.07%,LCOR;RUVBL2;RAMP3;SFRP1
prerank,negative regulation of neurogenesis (GO:0050768),0.335387493090842,0.7621308434434275,0.7213695395513577,1.0,1.0,3/34,4.44%,RHOA;RTN4R;PCM1
prerank,pinocytosis (GO:0006907),0.40157138290525884,0.7618995781079383,0.7107309486780715,1.0,1.0,3/10,20.71%,SNX33;MAPKAPK3;MAPKAPK2
prerank,cellular amino acid catabolic process (GO:0009063),0.32071049997195106,0.7615965412170732,0.7946058091286307,1.0,1.0,8/87,13.22%,ACMSD;SLC25A21;ACAT1;AMT;KMO;ABAT;HOGA1;IL4I1
prerank,cellular response to cAMP (GO:0071320),0.3424673838423652,0.7610564572558474,0.7264260768335273,1.0,1.0,6/30,15.61%,AQP1;AHR;EZR;AKAP9;DMTN;PKD2
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.31376516471973354,-0.7605332681431852,0.760932944606414,0.9204092122082788,1.0,5/10,19.86%,EMC2;EMC3;EMC1;EMC9;MMGT1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.2390854127778672,-0.7599847060342516,0.815,0.9203923117983497,1.0,4/26,6.47%,RYR3;RYR2;FGF2;HTR2C
prerank,negative regulation of cell death (GO:0060548),0.32507630318604563,0.7596363798611734,0.7993762993762994,1.0,1.0,26/88,22.81%,RAD18;TXNDC12;GSK3B;SPEF1;CCN1;HTRA2;LRRK2;NCK1;KANK2;IKBKG;SRGAP2;CCN3;NENF;PRKD1;BTBD10;CCN2;CHMP4A;CHMP4B;ADNP2;SNCA;FERMT2;INPP5A;TRAF2;CDK5;ATG5;FYN
prerank,regulation of astrocyte differentiation (GO:0048710),0.38408755311852383,0.7593081898995624,0.7094017094017094,1.0,1.0,2/12,11.42%,EPHA4;BMP2
prerank,BMP signaling pathway (GO:0030509),0.3234237256360889,0.7591807123873833,0.7486687965921193,1.0,1.0,12/62,14.35%,BMPR1A;RGMA;HIVEP1;BMP6;TGFBR3;SMAD6;SMURF1;ZFYVE16;BMP2;SMAD4;USP9X;SMAD3
prerank,neuron development (GO:0048666),0.31583526260604033,0.7591125165381669,0.8413654618473896,1.0,1.0,30/141,17.34%,PBX4;GLI2;STMN1;RB1;PBX3;GSK3B;LAMB1;NEDD4;TDP2;SRF;MAPT;WNK1;POU3F2;ROCK1;MAP4;HMGB1;SAMD14;FRYL;EHD1;ACTL6B;BLOC1S5;DOCK7;VAPA;HDGFL3;GDNF;UNK;TBCD;UGDH;STMN2;RAB13
prerank,visual system development (GO:0150063),0.3422061156411535,0.7590551508164971,0.7324913892078071,1.0,1.0,2/37,2.57%,PBX4;PBX3
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.3861704893668129,0.7589094336526881,0.7153502235469449,1.0,1.0,3/12,12.83%,ERFE;ZBTB7B;GKAP1
prerank,positive regulation of protein depolymerization (GO:1901881),0.3924969935004986,0.7581104020400077,0.7215743440233237,1.0,1.0,5/11,23.11%,NES;STMN2;TRPV4;SEMA5A;CFL2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.34622188088219225,0.7579781372798938,0.7153024911032029,1.0,1.0,2/29,5.54%,FADD;RAET1E
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.33902731481582565,0.7578948257163658,0.7411630558722919,1.0,1.0,7/38,16.15%,PHLPP2;XDH;PIK3CB;PPP2R5C;PLEKHA1;PPP2R5B;PTEN
prerank,positive regulation of axonogenesis (GO:0050772),0.3336811189998131,0.7570873891424668,0.7258601553829079,1.0,1.0,15/43,20.65%,MACF1;RHOA;NTN1;MAPT;ROBO1;PLXNB2;PLXNB1;PLXND1;MAP6;DBN1;NGF;PLXNA2;AMIGO1;PLXNB3;GOLGA4
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.3719933398109531,0.7562550871969335,0.7208672086720868,1.0,1.0,3/14,11.28%,FIP1L1;TUT1;CPSF4
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.370179115458867,0.7561253892162852,0.7022696929238985,1.0,1.0,6/16,20.62%,LHPP;ADSL;PFAS;GART;PPAT;ADSS2
prerank,intermediate filament organization (GO:0045109),-0.2584600191304113,-0.7553487591035418,0.8181818181818182,0.9263360541307747,1.0,8/17,36.71%,NEFL;GFAP;KLHL24;PKP2;BFSP1;DSP;TCHH;BFSP2
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.2616916459123957,-0.7552918174037714,0.7900763358778626,0.9255827492609029,1.0,5/17,21.58%,LARP6;RGCC;CREB3L1;TGFB3;SUCO
prerank,snRNA metabolic process (GO:0016073),0.368404770729916,0.755183252307193,0.7148703956343793,1.0,1.0,5/17,19.92%,INTS7;TUT1;INTS8;ZCCHC8;INTS4
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.34783872636651525,0.7551813114986542,0.7047970479704797,1.0,1.0,7/27,16.58%,SGF29;MSL3;RUVBL2;KAT6A;TRRAP;BRD8;PHF20
prerank,mesoderm formation (GO:0001707),-0.25488549072612987,-0.7541449075815271,0.8345323741007195,0.9264908302109793,1.0,7/17,31.32%,BMPR2;ITGB4;ITGB3;HMGA2;KDM6B;SNAI1;ITGA2
prerank,positive regulation of superoxide anion generation (GO:0032930),0.38615799628562714,0.7539125495523816,0.7179856115107913,1.0,1.0,4/13,24.87%,MAPT;PRKCD;SOD1;TGFB1
prerank,negative regulation of protein metabolic process (GO:0051248),0.3346338491121391,0.7537150295166943,0.7433628318584071,1.0,1.0,12/48,16.98%,IAPP;MDM4;PRNP;ROCK1;FLOT2;SF3B3;PFDN4;ITGAV;PIN1;AZIN1;NFKB1;LDLR
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.2649570659679841,-0.7535584736642124,0.7857142857142857,0.9264484405155456,1.0,5/16,21.58%,LARP6;RGCC;CREB3L1;TGFB3;SUCO
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.38315810307837783,0.7533001551906217,0.7263751763046544,1.0,1.0,2/13,10.51%,RNF168;HNRNPU
prerank,regulation of Rac protein signal transduction (GO:0035020),0.3679234346018506,0.7526617502703948,0.7269129287598944,1.0,1.0,3/16,10.11%,AUTS2;ARHGAP24;PIK3CB
prerank,lamellipodium assembly (GO:0030032),0.34179750081503535,0.7520656646536856,0.7177914110429447,1.0,1.0,6/26,14.28%,KIT;SPEF1;SRGAP2;RAC1;DMTN;ITGB1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.24106555066832425,-0.752002851154739,0.8651162790697674,0.9277934058988255,1.0,5/22,11.61%,TIMP3;APOE;FURIN;GPLD1;TNFRSF1B
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.3197665694544544,0.7519660504596107,0.7927736450584485,1.0,1.0,20/80,19.75%,AQP1;CDKN2D;FNIP1;SIAH2;HTRA2;ARL6IP1;SH3RF1;HMGB1;UACA;USP47;XIAP;CD44;SRC;NGF;TNFSF10;LAMTOR5;DPEP1;BAD;DNAJB6;DAPK1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.2581162113200806,-0.75158529387262,0.8308823529411765,0.9275728145691196,1.0,5/16,23.88%,PRKN;PDK1;BCKDK;SCARB2;PDK2
prerank,translational termination (GO:0006415),0.31762916484395026,0.7515821421649209,0.8348623853211009,1.0,1.0,24/95,22.02%,MRPL36;MRPL18;MRPL13;MRPL55;DAP3;MRPL1;MRPS33;MRPS18B;MRPL46;MTRF1;GFM2;MRPS10;MRPS24;MRPL45;MRPL42;MRPL37;MRPL2;MRPL20;ETF1;MRPS23;MRPS22;MRPL43;MRPL50;PTCD3
prerank,negative regulation of phosphorylation (GO:0042326),0.32104246715481655,0.7515647678906886,0.7950310559006211,1.0,1.0,20/85,18.56%,CDKN2D;CDKN2C;PFKFB1;PRKDC;PRNP;MAPT;XDH;WWTR1;LRRK2;ROCK1;HNRNPU;CRKL;PPP1R15B;CDKN1B;PTPN13;PTEN;ANKLE2;SIRPA;TERF2IP;IGFBP3
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.2940090125426394,-0.751238929537556,0.804953560371517,0.927203372302031,1.0,2/12,13.02%,TLR4;STRAP
prerank,cGMP metabolic process (GO:0046068),-0.30099091970002717,-0.7510281021442691,0.8074534161490683,0.9266824065185367,1.0,3/12,18.26%,GUCY1A1;NPR1;PDE2A
prerank,protein localization to membrane (GO:0072657),0.314182163442151,0.7507401590358661,0.8776328986960883,1.0,1.0,39/187,17.66%,NDC1;SYNE3;NUP155;TSPAN33;ROCK2;AP4M1;RAB10;ITGB7;PDZK1;DENND4C;RAP2A;ANK1;SCRIB;RAB29;SH3GLB1;SMURF1;ROCK1;P2RY1;EPB41L3;FLOT2;KCNIP3;EZR;GAK;ZDHHC15;EHD1;TSPAN5;DLG1;RAMP3;TTC7B;KCNB2;TM9SF2;ZDHHC3;NLGN2;STXBP1;DPP6;RAB13;SH3PXD2B;WNK3;TM9SF4
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3276747639875657,0.7506470465920372,0.7652947719688543,1.0,1.0,16/47,20.03%,SFRP2;ZBTB7B;TMEM64;PIM1;HNRNPU;BMP2;TRPM4;LRP5;MEDAG;WDFY2;LPL;SFRP1;AAMDC;FRZB;SYAP1;RREB1
prerank,cellular copper ion homeostasis (GO:0006878),-0.2794506319962013,-0.7506390235627971,0.8172043010752689,0.9264142613791806,1.0,6/14,21.97%,APP;COX19;SLC31A2;MT2A;ATOX1;ATP7A
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.33827910312585174,0.7503681695637181,0.7390791027154664,1.0,1.0,6/33,7.97%,ADA;PDE3B;EFNA1;PLAU;SFRP2;SERPINE1
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.3517142182311788,0.7500692507941185,0.7318652849740933,1.0,1.0,6/23,20.59%,MCU;RIPOR2;CAMK1D;RAC1;DNM1L;DPP4
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.31372867951714195,0.7497477868077157,0.8679435483870968,1.0,1.0,30/151,18.79%,RHD;SLC25A15;CERS6;CERS5;GSTO2;LARGE1;PAM;CHAT;LPCAT1;LPIN2;SLC25A2;HPGDS;CSNK2A2;ACHE;PLPP1;CSNK1G2;PRKD1;ELOVL4;ST3GAL4;SPTLC2;TYW1;VAPA;ST3GAL2;PRKD2;ALAS2;GSTT1;MGST3;FA2H;GCNT1;GSTM5
prerank,ruffle organization (GO:0031529),-0.26153973321633883,-0.7497471876283838,0.854251012145749,0.926769603459818,1.0,9/16,31.86%,PLEK;TPM1;INPP5K;PIP5K1A;CYFIP1;ARFIP2;AIF1L;ARF6;CSF1R
prerank,endosome organization (GO:0007032),-0.2020537319938453,-0.7494644475037925,0.9186991869918699,0.9263393508911125,1.0,18/41,27.78%,SNX3;SQSTM1;LAPTM4B;DNM1;USP8;VPS11;CHMP2B;ARFGEF2;HOOK1;VPS33B;RAB27A;ALS2CL;PLEKHF1;TMEM9;SNX10;PI4K2A;AKTIP;PHETA1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.295778558486777,-0.7491040354690935,0.8119122257053292,0.9261335046335243,1.0,6/11,22.71%,FAS;GSN;ST18;LGALS9;PARK7;PIH1D1
prerank,response to metal ion (GO:0010038),0.3174112560131162,0.7489836946368993,0.7832618025751072,1.0,1.0,10/67,13.78%,LOXL2;FXN;NEDD4;PAM;MAPT;PPP3CA;NDRG1;CALM2;ITPR3;ADAM9
prerank,membrane organization (GO:0061024),0.3148121514174908,0.748815301538028,0.914914914914915,1.0,1.0,39/227,17.64%,CEP55;KIF20A;NEMP1;NUP155;STX11;ACTR3;PACSIN2;OCRL;STON2;MYOF;ARRB1;LEMD3;STAM;SH3GLB1;MFN2;DNM2;PICALM;EMD;FNBP1;STX18;GAK;CHRNB1;AAK1;MITD1;ADRB2;PRKCI;PIP5K1C;TOR1B;VAPA;SYP;SUN2;SNAP23;TMCC1;DYSF;EPS15L1;UBXN2B;LDLR;EPS15;USO1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.25080335633785505,-0.7486404528091086,0.8333333333333334,0.9259632258093924,1.0,4/18,19.48%,ESR1;DDX5;MAP2K1;ZC3H12A
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.3927817008860324,0.7484416985928921,0.7361319340329835,1.0,1.0,2/11,12.61%,ATP2B4;SMAD4
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.31817701185658637,0.7481825630641824,0.8185610010427529,1.0,1.0,12/85,11.75%,VANGL1;RHOA;PSMC2;PSMD5;DAAM1;PSMB1;SMURF1;PSMD14;PSMD1;PSMB9;SMURF2;RAC1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.34713403910657403,0.7481365485242989,0.7425149700598802,1.0,1.0,10/29,15.46%,TCF7L1;TCF7L2;SMARCA4;AXIN2;LEO1;HDAC1;KMT2D;TLE4;TLE3;TRRAP
prerank,cellular response to pH (GO:0071467),0.35923506762754376,0.7478171022521061,0.7127516778523489,1.0,1.0,1/17,3.29%,HYAL1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.1733498078337823,-0.7475794847873062,0.9836065573770492,0.926605151371889,1.0,13/69,17.26%,STAT3;PSEN1;TLR4;EPHB2;LBP;APP;ARHGEF2;ARFGEF2;THBS1;PTPN11;IFNGR1;IFIH1;LGALS9
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.2691017336035681,-0.7472709939576755,0.804635761589404,0.9262086655630036,1.0,7/15,29.25%,NTRK2;GRB2;DDIT4;BCAR1;BDNF;ZFYVE27;SOS1
prerank,modified amino acid transport (GO:0072337),0.3708959383254804,0.747223480048422,0.7304116865869854,1.0,1.0,2/15,6.16%,PDPN;SLC19A1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.35364167801152424,0.7471965395752729,0.730718954248366,1.0,1.0,3/20,13.20%,TICAM1;IL18;PRKCE
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.24431804310718946,-0.7469802135637633,0.8571428571428571,0.925789994375048,1.0,8/23,27.32%,MAP3K5;PAK1;ARHGEF5;TNFRSF11A;RPS3;MAP3K11;EDN1;DVL2
prerank,negative regulation of innate immune response (GO:0045824),0.3372531555807582,0.7468193943536827,0.7484885126964933,1.0,1.0,9/34,22.40%,USP18;NMI;PTPN2;YTHDF2;CNOT7;METTL3;SUSD4;ISG15;FAM3A
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.37274565805102,0.746179731214447,0.7270194986072424,1.0,1.0,3/13,11.28%,FIP1L1;TUT1;CPSF4
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.35157776378382916,0.7459515833203088,0.7091377091377091,1.0,1.0,9/22,23.17%,CHD1L;ERCC3;CUL4B;XPA;RAD23B;ERCC2;GTF2H1;DDB2;DDB1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.39721480071602255,0.7459330204562842,0.7527047913446677,1.0,1.0,1/10,5.25%,PRNP
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.3449969708006135,0.7452464664408034,0.7408343868520859,1.0,1.0,4/23,15.53%,KIT;OCIAD2;CRLF3;OCIAD1
prerank,endodermal cell differentiation (GO:0035987),0.33963699911217893,0.7449778900212728,0.7511961722488039,1.0,1.0,7/31,15.02%,MMP14;LAMB1;SETD2;LEO1;COL12A1;ITGA5;ITGAV
prerank,icosanoid secretion (GO:0032309),-0.2871357160910626,-0.7446168890540135,0.8072289156626506,0.928304463907235,1.0,3/12,10.67%,ABCC4;PNPLA8;ACE
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.21861791217942653,-0.7443747639540337,0.8795180722891566,0.9278206812061661,1.0,6/31,15.53%,SCP2;LIAS;MOCS2;CYP51A1;MOCS1;GCH1
prerank,hexose biosynthetic process (GO:0019319),0.32958543183298955,0.7440699918616971,0.7591324200913242,1.0,1.0,5/42,8.45%,PFKFB1;CHST15;GPI;SORD;PGM1
prerank,sulfur compound biosynthetic process (GO:0044272),0.31669598421831135,0.7438577176834001,0.8386108273748724,1.0,1.0,27/104,19.93%,CHST15;GSTO2;B4GALT1;GSS;MAT2B;CHSY1;HPGDS;SLC10A7;PAPSS2;ST3GAL3;SLC35D2;CHST3;ANGPT1;UST;DSE;BGN;ST3GAL4;ST3GAL1;ST3GAL2;UGDH;GSTT1;MGST3;GCLM;GSTM5;GCLC;GLCE;HAGH
prerank,amyloid precursor protein catabolic process (GO:0042987),0.36084866204860133,0.7435050433086992,0.7322175732217573,1.0,1.0,3/14,14.08%,DYRK1A;ADAM17;ADAM19
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.19074100303082123,-0.7434282984267362,0.9108910891089109,0.9281932300766351,1.0,13/51,25.97%,STAT3;MALT1;TLR4;APP;S100A13;PANX1;LGALS9;TRIM16;EGR1;HSPB1;JAK2;P2RX7;TMEM106A
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.3257637727801612,0.7433829872294312,0.7680355160932297,1.0,1.0,10/47,16.81%,MAP4K4;ULK4;RAP2A;TGFBR3;MAPK8IP3;FOXM1;QARS1;PER1;TAOK1;KLHDC10
prerank,regulation of vesicle-mediated transport (GO:0060627),0.3082630483472339,0.7430163594980834,0.8107549120992761,1.0,1.0,10/91,10.00%,RAB33B;STON1;RAB10;PACSIN2;STXBP5;STON2;LRRK2;ZFYVE16;PICALM;GAS1
prerank,positive regulation of cytokine production (GO:0001819),0.3115273672604039,0.7427619915687733,0.945,1.0,1.0,73/292,25.00%,BRCA1;HPSE;FADD;TICAM1;ROCK2;RAB7B;DHX9;PRKDC;SULF2;MRE11;G3BP1;IL18;STOML2;SCRIB;ZBTB7B;SULF1;SERPINE1;CD80;AGPAT2;IRF1;HMGB1;AGT;RAB1A;POLR3D;EIF2AK3;ANXA1;ADAM17;TRIM6;RORA;TWIST1;POU2F2;ARNT;AGPAT1;SETD4;PRKD2;NFKB1;LPL;MAVS;FOXP1;LAMTOR5;LACC1;RUNX1;MAPK14;TMED10;RIPK1;HAVCR2;ZFPM1;PDE4B;TRAF6;IL16;TRAF2;ISG15;EIF2AK2;PNP;SOD1;APPL1;POLR3C;KAT2A;IL6R;POLR3G;TLR7;BCL10;RIPK2;IL6ST;CRCP;MBP;FGR;PAEP;F3;RELA;TGFB1;CD200;DHX33
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.23397382472653533,-0.7427499065243304,0.8762886597938144,0.9282214074833909,1.0,10/23,22.47%,RBX1;PARP1;XPC;COPS8;COPS7A;UBB;COPS2;COPS4;UBC;RPS27A
prerank,nervous system development (GO:0007399),0.3092171629435742,0.7424984565978052,0.966,1.0,1.0,68/429,17.04%,ECT2;STIL;WDR62;NAV2;CDK5RAP2;ARTN;SDK1;DYRK1A;ADGRV1;TRAK1;TEAD1;LPAR1;OBSL1;RBFOX2;ALDH1A2;FUT10;NINJ2;ST8SIA2;GSS;BTD;ADGRA2;CXCR4;SOX6;NLGN3;GRHL2;CRIM1;RAB29;POU3F2;WWTR1;WDPCP;ROBO1;DSCAML1;YAP1;FARP1;ZIC5;FBXL17;APAF1;TGFBR1;PRPS1;DPYSL4;DSCAM;ATXN1;MPZ;ACHE;ZIC4;DAGLB;NOTCH2;SH3GL3;LY6H;PLXND1;NES;ACTL6B;SMPD1;MAB21L2;CAPG;UNC119;GDNF;PKD2;PTEN;ANKLE2;NLGN2;NCKAP1;SHANK2;JRKL;ARNT2;AXL;NGF;WWP1
prerank,Golgi to lysosome transport (GO:0090160),0.3816262525837173,0.7424557271520695,0.7328358208955223,1.0,1.0,2/11,11.84%,AP4M1;GAK
prerank,canonical Wnt signaling pathway (GO:0060070),0.3237284272541062,0.7420606485746604,0.8012752391073327,1.0,1.0,17/68,19.06%,GSK3B;TCF7L1;WNT2B;TCF7L2;SFRP2;PORCN;LRRK2;WNT6;NR4A2;WNT9A;LRP5;SFRP1;PTEN;AMER1;CSNK1A1;FRZB;WNT4
prerank,regulation of chemotaxis (GO:0050920),0.32826485910101544,0.7411955881964939,0.7449822904368358,1.0,1.0,5/30,7.03%,MYCBP2;ADGRA2;PTPN2;CXCR4;PDGFRA
prerank,amino acid transport (GO:0006865),0.3239097626201685,0.7408272220178821,0.761478163493841,1.0,1.0,14/49,20.62%,SLC38A7;PDPN;SLC38A4;SLC25A47;SLC16A10;SLC38A9;SLC1A5;SLC6A17;SLC36A4;SLC7A1;SLC25A29;SLC38A2;SLC25A44;SLC7A11
prerank,MAPK cascade (GO:0000165),0.31067958431900194,0.7408081441381136,0.947,1.0,1.0,47/295,15.76%,CDK1;SPTA1;ARTN;MAP4K4;KSR1;SETX;NCAM1;BRAP;FGFR4;SPTB;FGFR2;PSMC2;PSMD5;RASA3;KIT;FRS2;NRK;IL18;MAP3K20;PDGFRA;LRRK2;PSMB1;CUL3;PSMD14;ANGPT1;MAP3K3;PSMD1;IKBKG;PIK3CB;PSMB9;FBXW11;SOX9;IL31RA;PPP1CC;CTSH;DLG1;BTRC;SPRED1;PSMC6;RGL3;PTPRA;ITGAV;TAOK1;PLVAP;RASAL3;GDNF;NFKB1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.3607821464131835,0.740586969073953,0.7248743718592965,1.0,1.0,4/21,16.07%,TXNDC15;TUBD1;TEDC1;SFRP1
prerank,regulation of execution phase of apoptosis (GO:1900117),0.38728525122180063,0.7404906489841926,0.7407407407407407,1.0,1.0,4/11,22.03%,BOK;TP53;PTGIS;SIRT2
prerank,positive regulation of growth (GO:0045927),0.3165516087024348,0.7402700464387307,0.8059701492537313,1.0,1.0,13/64,16.07%,HYAL1;CEP43;FXN;MMP14;DERL2;SFRP2;KLHL22;TGFBR1;ADAM17;USP47;RPTOR;INO80;SFRP1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.34332692958195027,0.7401449144918256,0.7334152334152334,1.0,1.0,6/25,20.28%,RB1;TRIM6;TWIST1;HEY2;NIBAN2;TRAF6
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.30196419770053334,-0.7395458335530728,0.7662337662337663,0.9315999852748038,1.0,7/10,32.74%,PDE3A;UBE2B;PDE2A;PDE4D;PDE11A;MGRN1;APLNR
prerank,protein processing (GO:0016485),0.3136827571648872,0.7390512864153075,0.8411885245901639,1.0,1.0,7/102,8.23%,KEL;FAM111A;FXN;MMP14;CPXM1;STOML2;HTRA2
prerank,muscle contraction (GO:0006936),0.30880542119929666,0.7389324837414585,0.8598790322580645,1.0,1.0,20/126,16.50%,ROCK2;TPM4;MYOF;SORBS3;ROCK1;SLC8A1;BDKRB2;EMD;GJC1;MYH2;TLN1;SNTA1;SMTN;CLCN1;CHRNB1;DES;TMOD3;DYSF;TPCN2;TNNT3
prerank,energy reserve metabolic process (GO:0006112),0.3537878002802932,0.7388381321455498,0.7477124183006536,1.0,1.0,2/19,5.85%,GSK3B;LEPR
prerank,lamellipodium organization (GO:0097581),0.334953112692447,0.7387658679335681,0.7509025270758123,1.0,1.0,6/29,14.28%,KIT;SPEF1;SNX1;RAC1;DMTN;ITGB1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.36185708188383725,0.7378987312689623,0.7437673130193906,1.0,1.0,5/17,14.43%,SRF;ROBO1;NR4A1;EFNB2;MIA3
prerank,microtubule-based transport (GO:0099111),-0.28900756920352294,-0.7377559504201813,0.794392523364486,0.9330900779271293,1.0,9/12,48.64%,DYNC1I2;CABYR;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,protein hydroxylation (GO:0018126),0.3685733089554716,0.7377322028043819,0.7447698744769874,1.0,1.0,7/15,22.18%,VIPAS39;P3H1;P3H4;PLOD2;OGFOD1;PLOD1;EGLN3
prerank,triglyceride homeostasis (GO:0070328),-0.22086875695238584,-0.7375726658883545,0.844559585492228,0.9324904348757052,1.0,11/26,33.46%,APOE;PNPLA8;NR1H3;C1QTNF3;XBP1;NR1H4;DGAT2;MTLN;MLXIPL;ANGPTL3;FITM2
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.32788645370957165,0.7375722199012926,0.7597173144876325,1.0,1.0,7/36,13.55%,ATP2B4;NOSIP;DNM2;NPR3;PIK3CB;TERF2;DHFR
prerank,regulation of pseudopodium assembly (GO:0031272),-0.3065977395135977,-0.7373618338733944,0.7821229050279329,0.9311065911449491,1.0,3/10,14.76%,CDC42EP4;CDC42EP5;APC
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.3065977395135977,-0.7373618338733944,0.7821229050279329,0.9311065911449491,1.0,3/10,14.76%,CDC42EP4;CDC42EP5;APC
prerank,regulation of ossification (GO:0030278),0.32267022430602327,0.7373134511727631,0.7474518686296716,1.0,1.0,10/36,16.07%,CHSY1;SMAD6;DDR2;BMP2;ENPP1;RBPJ;SOX9;TWIST1;NOTUM;SFRP1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.30881928570877115,0.7370346491422879,0.8479591836734693,1.0,1.0,33/118,20.82%,VASH2;PHIP;GSK3B;FGFR2;NEDD4;MAPT;ADGRA2;RAP2A;EPHA4;PDZD8;LRRK2;SH3D19;MARK2;ARHGAP35;LZTS3;PDLIM5;ZDHHC15;PLXND1;LARP4;RC3H1;GDNF;SFRP1;SIPA1L1;ABI2;CLASP1;TANC2;SP100;KIF13B;FMNL2;HECW2;EGLN1;CEACAM1;FERMT2
prerank,mesenchyme morphogenesis (GO:0072132),0.3558958791355136,0.7369428288558834,0.7386058981233244,1.0,1.0,4/17,12.57%,BMPR1A;MDM4;BMP2;SOX9
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.36963692497880163,0.7367596298194474,0.7345013477088949,1.0,1.0,4/15,12.19%,ROCK2;ROCK1;AGT;PRKCA
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.301296410125185,-0.7363378586199733,0.7971014492753623,0.9315087129216981,1.0,6/10,44.45%,LGALS9;PTPRC;ARRB2;CX3CR1;FCGR2B;LILRB1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.32033515834888243,0.7359526120158768,0.7978494623655914,1.0,1.0,22/61,24.78%,FGFR4;PSMC2;PSMD5;PSMB1;NQO1;PSMD14;PSMD1;PSMB9;PANK2;PSMC6;AZIN1;PSMB2;PSME4;PSMB7;PSMD11;PSME3;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,negative regulation of neuron differentiation (GO:0045665),0.34161255895317516,0.7355695836776469,0.7516087516087516,1.0,1.0,3/22,13.65%,GSK3B;SOX9;MED1
prerank,defense response to bacterium (GO:0042742),0.3062682493862629,0.734967213899654,0.834186284544524,1.0,1.0,7/105,9.89%,HMGB2;AQP1;COLEC12;RNASE6;ANXA3;SERPINE1;RAB1A
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.35199656751406444,0.7348709380495047,0.7363515312916112,1.0,1.0,5/19,18.57%,MMP14;PRKDC;BTK;AXL;ZBTB1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.3210306831607909,0.7346109811167515,0.7829977628635347,1.0,1.0,11/52,14.36%,ATP2B4;RANGRF;GPSM2;NUMA1;EPB41L2;PDPK1;PRKCE;PRKCI;DLG1;ITGB1;RAMP3
prerank,chemokine-mediated signaling pathway (GO:0070098),0.3305074467008501,0.734466764504922,0.7716262975778547,1.0,1.0,2/42,6.76%,RBM15;WNK1
prerank,small GTPase mediated signal transduction (GO:0007264),0.3104818369485981,0.7341087066038822,0.8471794871794872,1.0,1.0,25/103,18.35%,KSR1;RB1;BRAP;RASSF1;RRAD;CCNA2;ARHGAP18;NTN1;SIAH2;G3BP1;CDK2;TRIM28;USP28;CRKL;ARHGEF18;RAC1;RRAS;PRKD1;PLK2;TP53;TNK2;RRAS2;NRAS;KRAS;MAPK14
prerank,ventricular septum development (GO:0003281),0.3290130581264041,0.7338425534168451,0.7635524798154556,1.0,1.0,12/37,19.43%,BMPR1A;MDM4;TGFBR3;MATR3;ROBO1;TGFBR1;SMAD4;HEY2;HECTD1;SALL1;ZFPM2;ZFPM1
prerank,regulation of tissue remodeling (GO:0034103),0.3516451389735846,0.7334940282553474,0.746971736204576,1.0,1.0,3/18,9.99%,LEPR;IL18;DDR2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.3333377971822563,0.7332062133716454,0.7572815533980582,1.0,1.0,6/26,19.63%,EYA4;HTRA2;EYA2;GDNF;PPP2R1B;TERT
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.3487866795952149,0.7331626558064454,0.7548387096774194,1.0,1.0,4/19,14.95%,BMP6;AFDN;ADAM19;PTPRU
prerank,cholesterol efflux (GO:0033344),0.35480147791392425,0.7331024698747779,0.7532808398950132,1.0,1.0,4/20,15.91%,SOAT1;ABCA1;SOAT2;STX12
prerank,mitochondrial genome maintenance (GO:0000002),0.38038564494001326,0.7331024114692984,0.760342368045649,1.0,1.0,2/11,9.42%,MGME1;LONP1
prerank,sensory perception of pain (GO:0019233),-0.23577156585242418,-0.73302238060908,0.8676470588235294,0.9349556154714724,1.0,14/21,45.69%,SCN9A;OPRM1;KCNA2;NIPSNAP1;P2RX4;P2RX7;OPRK1;CHRNA4;CCR2;CCL2;KCNK4;OPRL1;CHRNB2;ALOXE3
prerank,regulation of receptor recycling (GO:0001919),0.34921542962893937,0.7328314078740067,0.75,1.0,1.0,3/16,7.69%,ANXA2;SCRIB;RAB29
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.3089584323678461,0.7328300729760909,0.8894472361809045,1.0,1.0,28/163,15.76%,ERMAP;THEMIS;PSMC2;PSMD5;KHDRBS1;EIF2B1;WNK1;UBE2N;STOML2;RNF31;RC3H2;PSMB1;PSMD14;NCK1;PSMD1;IKBKG;PIK3CB;PSMB9;PRKCB;FBXW11;PDPK1;BTK;BTRC;RC3H1;PSMC6;PLEKHA1;PRKD2;NFKB1
prerank,regulation of lipid metabolic process (GO:0019216),0.30873178465068224,0.7327736398490473,0.8177028451001054,1.0,1.0,14/88,13.74%,ZFP69;FGFR4;PMVK;TBL1XR1;NFYA;NCOA2;TM7SF2;ACACA;PLPP1;ADIPOR1;RORA;MED1;PANK2;MVK
prerank,coenzyme A metabolic process (GO:0015936),0.36381158575119754,0.7324192360392799,0.7532467532467533,1.0,1.0,5/14,19.10%,ACAT1;PPCDC;PANK4;PANK2;COASY
prerank,detection of calcium ion (GO:0005513),0.36377352872521174,0.7323920101182703,0.7496542185338866,1.0,1.0,5/13,16.01%,KCNMB2;KCNMB3;CALM2;KCNMB4;STIM1
prerank,gene expression (GO:0010467),0.30730759882979297,0.732367463864891,0.955,1.0,1.0,59/348,14.28%,MRPL36;NDC1;E2F1;NUP155;SYNCRIP;SETX;NUP205;PABPC4;TSPAN33;NUP160;AGO2;SRSF4;HNRNPD;FIP1L1;SRBD1;EIF4E;UPF3B;MRPL18;NUP85;SLBP;TPR;DDX39B;HNRNPH1;TASP1;SRSF7;POLR2A;RBMS2;DHX8;CELF2;HNRNPUL1;DARS1;WDR33;NOX4;EPC1;NR4A2;SRSF3;HNRNPU;MMS19;DRG1;MRPL13;RBM15B;HNRNPL;SRRM1;CPSF4;ATXN1;MRPL55;NUP214;ASMT;RNGTT;RPS17;RANBP2;MCM3AP;MRPS33;TSPAN5;MRPS18B;RBM4;SMG6;NXT1;RBMS1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3130537207940541,0.7323067106948717,0.8068893528183716,1.0,1.0,15/77,15.34%,RB1;PHIP;FXN;SIAH2;TCF7L2;RTKN2;SH3RF1;CSNK2A2;NR4A2;TGFBR1;PLAUR;QARS1;BIRC6;ITGAV;SRC
prerank,sterol biosynthetic process (GO:0016126),0.327399668778368,0.7322832234168913,0.747016706443914,1.0,1.0,7/33,18.30%,LBR;PMVK;TM7SF2;ACAT2;MVK;DHCR7;INSIG2
prerank,amyloid-beta metabolic process (GO:0050435),0.35321043029233207,0.732025365295101,0.764456981664316,1.0,1.0,1/16,2.25%,DYRK1A
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3090784787020994,0.7317263387287019,0.8317948717948718,1.0,1.0,41/102,24.72%,GCK;RAB10;PRKDC;PDE3B;DENND4C;LPIN2;RHOQ;CPEB2;NR4A2;ENPP1;PDPK1;NR4A1;PRKCI;EPRS1;SLC30A10;ADCY6;SRC;NFKB1;PCK2;CYSLTR2;PRKAR2B;PRKAR2A;RAB13;ADCY2;INSIG2;SLC2A4;SYAP1;PRKCD;CEACAM1;INSIG1;FER;RAB8B;VAMP2;ZFP36L1;PRKAR1A;SLC25A33;RAB8A;LPIN3;RPS6KB1;PRKACA;RELA
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.3679200448695474,0.7315101561004062,0.7381275440976933,1.0,1.0,2/14,7.88%,SULF2;SULF1
prerank,skin development (GO:0043588),0.3135844750361078,0.7314618175748119,0.7965921192758253,1.0,1.0,8/65,13.78%,TGM1;STMN1;COL5A2;ERRFI1;ANXA1;CLIC4;MED1;ADAM9
prerank,ATP transport (GO:0015867),0.37309747184604164,0.7314203906177906,0.7485029940119761,1.0,1.0,4/10,19.36%,SLC25A42;CD47;SLC25A17;SLC25A5
prerank,UV protection (GO:0009650),0.37313911030867025,0.7312011607002264,0.7705426356589147,1.0,1.0,4/10,23.77%,XPA;SDF4;ERCC2;ERCC5
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.3351207089565392,0.7311490435784596,0.7515527950310559,1.0,1.0,7/24,19.81%,NEDD4;PRKCB;ITGA5;ARNT;PRKD2;NIBAN2;PTPN1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.35783923825425773,0.7308834936145528,0.747675962815405,1.0,1.0,3/17,11.41%,HTRA2;SFPQ;BAG5
prerank,cellular response to purine-containing compound (GO:0071415),0.3795219629262661,0.730516395482157,0.7507552870090635,1.0,1.0,3/10,10.66%,SLC8A1;P2RY1;TRPM2
prerank,macrophage activation involved in immune response (GO:0002281),-0.2798626155845336,-0.7303020721940481,0.8164556962025317,0.9375296400445885,1.0,4/13,14.32%,IFI35;LBP;GRN;SBNO2
prerank,negative regulation of protein polymerization (GO:0032272),0.3346564627486679,0.7299664937426175,0.73375,1.0,1.0,3/27,5.71%,STMN1;DYRK1A;SSH2
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.3819739166431046,0.7299176615189195,0.7325408618127786,1.0,1.0,5/10,26.76%,PTPN2;NF2;PARP14;PPP2CA;PPP2R1A
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.32782927651172955,0.7297552314795781,0.7711386696730552,1.0,1.0,10/41,15.34%,PRNP;FBXW7;EFNA1;EPHA4;NOX4;AGT;DOCK3;ADAM17;UNC119;SRC
prerank,hematopoietic stem cell differentiation (GO:0060218),0.3803009961836967,0.72972628648632,0.7415384615384616,1.0,1.0,4/10,17.02%,LMBR1L;TP53;SFRP1;MLLT3
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.21781920135857985,-0.7297125779574976,0.8918918918918919,0.9374060153827249,1.0,12/25,34.86%,ARAP1;BCAR3;HIP1;CBL;AFAP1L2;DGKD;SHKBP1;GPER1;NEU3;AKT1;PDE6H;DOK1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.3484594333609742,0.7294929503854996,0.7555847568988173,1.0,1.0,4/19,16.68%,SLC35D1;UAP1;GNPDA2;UGDH
prerank,regulation of protein sumoylation (GO:0033233),0.3579568085365907,0.7292262294707169,0.7473958333333334,1.0,1.0,1/17,1.87%,SAE1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.21131734374274042,-0.7289611157078308,0.9139072847682119,0.9375162572941714,1.0,16/33,34.86%,ARAP1;TGFA;BCAR3;HIP1;ADRA2A;CBL;AFAP1L2;DGKD;HBEGF;SHKBP1;GPER1;EGF;NEU3;AKT1;PDE6H;DOK1
prerank,renal filtration (GO:0097205),0.38907702447619397,0.7286982742229112,0.7617554858934169,1.0,1.0,2/10,7.88%,SULF2;SULF1
prerank,programmed necrotic cell death (GO:0097300),0.3450684019063701,0.7286971874490161,0.7406896551724138,1.0,1.0,2/18,7.46%,TICAM1;IPMK
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.3504544755152633,0.7285673376191915,0.7439353099730458,1.0,1.0,4/18,16.18%,FXN;AGT;GDNF;RFK
prerank,peptidyl-tyrosine modification (GO:0018212),0.31582337732189597,0.7285071733215567,0.7862595419847328,1.0,1.0,13/56,17.68%,DYRK1A;FGFR4;FGFR2;KIT;PDGFRA;EPHA4;ABI1;DDR2;BTK;EFEMP1;SRC;EPHA3;ABI2
prerank,negative regulation of catalytic activity (GO:0043086),0.3344442032316758,0.7283027494271735,0.7525,1.0,1.0,6/24,19.46%,NOSIP;PARP9;ATP5IF1;NES;TP53;CAND1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.3318033454300356,0.7282027461538211,0.7647768395657418,1.0,1.0,9/29,17.42%,PATL1;LSM3;CNOT6;LSM2;EXOSC7;LSM7;CNOT7;LSM4;EDC3
prerank,renal water homeostasis (GO:0003091),0.3450345136249809,0.7281190827229316,0.7587064676616916,1.0,1.0,9/23,24.39%,AQP1;ADCY6;PRKAR2B;PRKAR2A;ADCY2;PRKAR1A;AQP4;MYO5B;PRKACA
prerank,regulation of protein secretion (GO:0050708),0.30678201324787235,0.7281009036004192,0.8575788402848423,1.0,1.0,20/119,13.78%,GCK;ARFIP1;ITPR1;FRMD4A;DNAJC1;STXBP5;MYH10;BMP6;LLGL2;CACNA1C;RAPGEF4;EZR;SYTL4;P3H1;ITPR3;PRKCA;ACHE;PPID;ENSA;ADAM9
prerank,cellular response to BMP stimulus (GO:0071773),0.3087253422585381,0.727817046265133,0.8,1.0,1.0,13/66,14.35%,BMPR1A;RGMA;HIVEP1;BMP6;TGFBR3;SMAD6;SMURF1;ZFYVE16;BMP2;SOX9;SMAD4;USP9X;SMAD3
prerank,negative regulation of phagocytosis (GO:0050765),0.35211253457701897,0.7277858689309675,0.7489878542510121,1.0,1.0,5/17,17.31%,HMGB1;PIP4P2;DYSF;SIRPA;CD47
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.29959637813751244,0.7275910634151531,0.8860887096774194,1.0,1.0,20/159,12.05%,CDH15;SDK1;MMP24;PCDHGB4;CDH18;CDH24;ALCAM;OBSL1;ADGRL1;CDH4;GPC6;PCDHGC3;ROBO1;DSCAML1;FGFRL1;PLXNB2;DSCAM;PTPRS;EMB;MPZ
prerank,prostaglandin biosynthetic process (GO:0001516),0.3484462788776367,0.7264544463421564,0.7476255088195387,1.0,1.0,4/18,12.46%,PTGES2;HPGDS;PTGS1;DAGLB
prerank,positive regulation of endopeptidase activity (GO:0010950),0.33645273073435633,0.7261429280269942,0.7556675062972292,1.0,1.0,4/26,9.56%,ROCK2;EFNA1;EPHA4;PICALM
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.3257777570205643,0.7260990397618343,0.7576832151300237,1.0,1.0,9/31,17.42%,PATL1;LSM3;CNOT6;LSM2;EXOSC7;LSM7;CNOT7;LSM4;EDC3
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.38249625582714836,0.7255424680545131,0.7674750356633381,1.0,1.0,3/11,12.76%,AFDN;RAB1A;TJP2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.3454733007129123,0.7255166820231389,0.7624671916010499,1.0,1.0,4/21,14.21%,BMPR1A;MFN2;GJA1;ADAMTS1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.3550270604198298,0.7253555628837655,0.7594594594594595,1.0,1.0,3/16,11.38%,SRF;ROCK1;HDAC1
prerank,nucleotide catabolic process (GO:0009166),0.35566958948388794,0.7252698289646788,0.7626886145404664,1.0,1.0,6/16,25.64%,XDH;ITPA;PNP;NT5E;GDA;DERA
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.35498356207915055,0.7248883025878422,0.7467248908296943,1.0,1.0,4/15,18.35%,RIPOR2;EHD1;ADAM9;MAPK14
prerank,proteoglycan metabolic process (GO:0006029),0.3355196480037607,0.724858318583589,0.7377450980392157,1.0,1.0,4/26,7.98%,HPSE;SULF2;SULF1;B4GALT7
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.3645460081608293,0.7248565466382944,0.7485207100591716,1.0,1.0,2/12,7.50%,RAB10;SCRIB
prerank,pre-miRNA processing (GO:0031054),0.35732282133864557,0.7247212913532773,0.7614285714285715,1.0,1.0,3/14,13.47%,AGO2;TUT7;TUT4
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.30297564810755523,0.7244330501401043,0.8965863453815262,1.0,1.0,35/190,16.42%,CIT;ATP2B4;TNFAIP8L1;FNIP1;CGNL1;DEPDC5;AJUBA;ITPR1;PDE3B;PHLPP2;NMI;XDH;RTKN2;TRIM59;RIOK3;LIMD1;TBC1D7;NPRL3;PIK3CB;PPP2R5C;UACA;CCN3;ADIPOR1;CASP8;PLAUR;RORA;TWIST1;SPRED1;PLEKHA1;PER1;OTUD7B;SRC;PPP2R5B;PTEN;SHANK2
prerank,regulation of epithelial cell migration (GO:0010632),0.315230585107697,0.7244174522718325,0.7940854326396495,1.0,1.0,20/51,24.09%,MACF1;HYAL1;MCC;ENPP2;SOX9;ADIPOR1;CTSH;PRKCE;DOCK1;INSL3;SRC;ARSB;CLASP1;DOCK5;RREB1;CEACAM1;DAB2IP;PTPN23;DUSP10;SASH1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.350255136652894,0.7244101109650181,0.7496617050067659,1.0,1.0,5/16,24.24%,PHIP;BMP2;IGFBP3;BMP5;IGFBP2
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.3652314325285131,0.7243252101911792,0.7230320699708455,1.0,1.0,3/13,20.28%,RHOA;ZDHHC21;TRAF6
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.362350732531702,0.7240568001670079,0.7657534246575343,1.0,1.0,4/13,13.45%,SFRP2;RBPJ;SMAD4;HEY2
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.28370098443153224,-0.7240013861731968,0.826625386996904,0.9430873487231256,1.0,3/12,9.08%,ATP1B1;WNK2;ATP1B3
prerank,heart trabecula morphogenesis (GO:0061384),0.35430273432609605,0.7237428945960885,0.7811671087533156,1.0,1.0,4/18,12.34%,BMPR1A;TGFBR3;TGFBR1;RBPJ
prerank,cytokine-mediated signaling pathway (GO:0019221),0.3023740815284023,0.7235287754398667,0.986,1.0,1.0,66/532,16.44%,TNFSF13B;LMNB1;BIRC5;IL1RL1;NCAM1;MAP3K14;PLP2;PSMC2;ANXA2;ZEB1;PSMD5;ACTN4;KIT;TAB1;LEPR;CNN2;IL18;PML;UBE2N;POU2F1;FOXO3;CD80;PSMB1;IRF1;PSMD14;SMARCA4;YAP1;MAP3K3;PIM1;PSMD1;IKBKG;EDA;PIK3CB;SDC1;LIMS1;PSMB9;IP6K2;CAPZA1;CRKL;CNTF;ANXA1;PYDC1;APPL2;FBXW11;ADAM17;SMAD4;ADIPOR1;IL31RA;RORA;TWIST1;BTRC;CDKN1B;TRIM5;ITGB1;CD44;PSMC6;HNRNPA2B1;PLVAP;SRC;IL1RL2;NFKB1;LCP1;TP53;MSN;IFNAR2;TNFRSF25
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.3440617897849566,0.7233291376200672,0.7517531556802244,1.0,1.0,4/15,16.07%,SPEF1;NPHP3;RSPO3;SFRP1
prerank,heterotypic cell-cell adhesion (GO:0034113),0.333450361902683,0.7232538452836483,0.7351077313054499,1.0,1.0,5/25,15.02%,PARVA;ITGB7;ITGA5;ITGB1;ITGAV
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.3143936024040432,0.72257381283246,0.8050383351588171,1.0,1.0,20/53,24.78%,PSMC2;PSMD5;PSMB1;NQO1;PSMD14;PSMD1;PSMB9;PSMC6;AZIN1;PSMB2;PSME4;PSMB7;PSMD11;PSME3;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,transport along microtubule (GO:0010970),0.36451421592275624,0.7220281153671323,0.7634112792297112,1.0,1.0,1/13,1.67%,ARHGAP21
prerank,translational elongation (GO:0006414),0.3029192074169379,0.7218125907994796,0.8485772357723578,1.0,1.0,24/101,22.02%,MRPL36;MRPL18;EEFSEC;MRPL13;MRPL55;DAP3;MRPL1;MRPS33;MRPS18B;MRPL46;GFM2;MRPS10;MRPS24;MRPL45;MRPL42;MRPL37;MRPL2;MRPL20;LTN1;MRPS23;MRPS22;MRPL43;MRPL50;PTCD3
prerank,microglial cell activation (GO:0001774),-0.23564924804134893,-0.7217916841916855,0.8539823008849557,0.9449348941556028,1.0,13/21,42.23%,GRN;APP;CX3CL1;IFNGR1;JAK2;C1QA;TYROBP;ITGB2;CX3CR1;ITGAM;AGER;AIF1;TREM2
prerank,regulation of interleukin-17 production (GO:0032660),0.32359592581085384,0.7216530231386409,0.7820965842167256,1.0,1.0,3/31,7.81%,PRNP;IL18;ZBTB7B
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.30743487786815277,0.72135479118976,0.8160676532769556,1.0,1.0,13/75,15.60%,HMGB2;VASH2;JCAD;HMGB1;TGFBR1;BMP2;PRKCA;PDPK1;NR4A1;ADAM17;PRKD1;ARNT;PRKD2
prerank,regulation of histone modification (GO:0031056),0.364982573755729,0.7207605062370496,0.7563739376770539,1.0,1.0,2/13,6.79%,MTHFR;UBE2N
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.261438601098855,-0.7206912526526237,0.8163265306122449,0.9454005435162561,1.0,6/13,30.55%,SHISA6;GRIK2;SHISA9;SHISA7;RAB3GAP1;CLN3
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.22613955033147995,-0.7202120288249289,0.8617511520737328,0.9451413588994831,1.0,8/23,37.85%,ATP6V0A4;SLC12A9;SLC12A2;PDK2;SLC9A1;PDK4;SLC12A5;KCNH2
prerank,positive regulation of lymphocyte migration (GO:2000403),0.36590471496481924,0.7199046740142689,0.7757142857142857,1.0,1.0,1/12,3.26%,RHOA
prerank,regulation of keratinocyte migration (GO:0051547),0.3681060742548364,0.7190800102683436,0.7528901734104047,1.0,1.0,3/12,16.15%,MAP4K4;ADAM9;PTEN
prerank,cardiac cell development (GO:0055006),-0.29215861258746345,-0.7187705516198364,0.832258064516129,0.9460997669420494,1.0,3/11,16.94%,JAG1;VEGFA;MYH11
prerank,positive regulation of ossification (GO:0045778),0.3186960945448866,0.7187196806348192,0.7902665121668598,1.0,1.0,7/39,11.42%,ADGRV1;BMPR1A;BMP6;CCN1;SLC8A1;ATP2B1;BMP2
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.3690775000550322,0.7186720638849374,0.7774436090225564,1.0,1.0,3/11,13.97%,RC3H2;ANXA1;RC3H1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.32808285475318044,0.7171918142553431,0.7644230769230769,1.0,1.0,10/30,19.68%,PTPN2;SFRP2;SAMSN1;DMTN;NF2;SFRP1;MVP;SH3BP5;PRKCD;PARP14
prerank,striated muscle cell differentiation (GO:0051146),0.35140619915978233,0.7167255059044612,0.7514204545454546,1.0,1.0,3/16,11.42%,MYEF2;SDC1;BMP2
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.3123193896507214,0.7163604646945044,0.7986798679867987,1.0,1.0,5/50,6.34%,TRIP6;RHOA;ACTN4;NMI;RTKN2
prerank,negative regulation of lyase activity (GO:0051350),0.35015084121717127,0.7159260840933289,0.766042780748663,1.0,1.0,3/16,16.02%,ADGRV1;GNAI3;GABBR2
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3110196032339313,0.7158783550044585,0.832109129066107,1.0,1.0,7/85,13.19%,BIRC5;ADGRV1;NIPBL;RIPOR2;LHFPL5;HOMER2;ROR1
prerank,atrioventricular valve development (GO:0003171),0.3545076757790377,0.7156597886009651,0.7541666666666667,1.0,1.0,3/14,11.42%,BMPR1A;MDM4;BMP2
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.3691814808949278,0.7154531469810842,0.7716417910447761,1.0,1.0,3/11,19.20%,BMPR1A;HEY2;ZFPM2
prerank,mesenchymal cell development (GO:0014031),-0.24336842935302516,-0.7150075637562447,0.8403041825095057,0.949775027576585,1.0,8/18,33.73%,CDH2;FOXC1;HEYL;NOLC1;KLHL12;SOX11;SOX8;KBTBD8
prerank,defense response to symbiont (GO:0140546),0.3009647515538864,0.7145965317647519,0.8552223371251293,1.0,1.0,15/92,17.17%,FADD;MOV10;MAP3K14;RNASE6;G3BP1;ATG7;TTC4;SETD2;IRF1;SKP2;RNASE1;TRIM5;CNOT7;IFNAR2;MAVS
prerank,negative regulation of endothelial cell migration (GO:0010596),0.31705617718443857,0.7145389024547871,0.7757225433526012,1.0,1.0,5/36,9.90%,ATP2B4;ANGPT4;ADAMTS9;HMGB1;SVBP
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.22907454395849802,-0.714437028787166,0.8828828828828829,0.9496250492087379,1.0,7/21,21.90%,SMAD7;CAV1;INPP5K;PPM1F;DDIT4;PDE4D;RACK1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.3781535949338775,0.7142851722128889,0.7566371681415929,1.0,1.0,2/10,12.40%,FBXW7;ADAM17
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.3503178200434087,0.713996851717798,0.7645390070921986,1.0,1.0,4/16,13.55%,NPR3;PIK3CB;TERF2;DHFR
prerank,regulation of TORC1 signaling (GO:1903432),0.32163221684862897,0.7131263382858531,0.7667057444314185,1.0,1.0,10/33,17.76%,DEPDC5;DYRK3;KLHL22;SESN1;ITFG2;STK11;CLEC16A;SESN2;LARS1;LAMTOR5
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.2972595424967195,-0.7130051067510857,0.8338368580060423,0.950403374320015,1.0,5/10,34.39%,ANO6;NCKAP1L;CD300A;RAB31;C3
prerank,glycerol metabolic process (GO:0006071),-0.2935172457128872,-0.7122481696785717,0.8132530120481928,0.9505881068785207,1.0,6/10,34.54%,COQ3;GOT1;TPI1;PGP;ANGPTL3;TKFC
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.2579740162114526,-0.7121559447569904,0.8740458015267175,0.9498610416789067,1.0,3/15,10.71%,PRKCH;FOXC1;SFRP4
prerank,cellular response to metal ion (GO:0071248),0.29689838000271357,0.7119661910512782,0.8717171717171717,1.0,1.0,15/123,15.62%,ECT2;AQP1;ADGRV1;PRNP;BMP6;LRRK2;CARF;TRPM2;DMTN;CLIC4;SMPD1;GLRA2;CDKN1B;PKD2;ADD1
prerank,cell projection assembly (GO:0030031),0.33647323821782726,0.7119002984023308,0.7496823379923762,1.0,1.0,5/22,16.38%,PARVA;RHOQ;RAC1;CAPG;NCKAP1
prerank,positive regulation of keratinocyte migration (GO:0051549),0.3740854362961987,0.7118426236255134,0.7591463414634146,1.0,1.0,1/10,2.18%,MAP4K4
prerank,negative regulation of lipid storage (GO:0010888),0.3450461452426188,0.7115549373488163,0.7445945945945946,1.0,1.0,4/19,15.02%,PTPN2;OSBPL8;ABCA1;ITGAV
prerank,cGMP-mediated signaling (GO:0019934),0.3584239653415445,0.7113035056509863,0.762043795620438,1.0,1.0,1/13,1.82%,AQP1
prerank,negative regulation of cartilage development (GO:0061037),0.3506870325401433,0.7111871204146545,0.7681365576102418,1.0,1.0,5/13,20.15%,TGFBR1;WNT9A;SOX9;EFEMP1;CHADL
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.30408009038650546,0.7106274902842564,0.8273684210526315,1.0,1.0,21/73,21.78%,ATP2B4;FNIP1;SH2D3C;TXN;SFRP2;AKAP9;STOX1;TRIM6;PRKD1;RAMP3;CD44;DOCK7;RPTOR;PRKD2;NGF;TERF2IP;BRAF;CAPRIN2;SNCA;LATS1;STK4
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.16279798443457522,-0.7105282834822338,1.0,0.9508819573993713,1.0,11/73,13.70%,STAT3;PSEN1;TLR4;EPHB2;LBP;APP;ARHGEF2;ARFGEF2;THBS1;PTPN11;IFNGR1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.35433009374260604,0.7104070408967296,0.7750342935528121,1.0,1.0,5/13,25.11%,FBN1;BMP2;LTBP1;DAND5;FSTL1
prerank,PERK-mediated unfolded protein response (GO:0036499),0.38395885659858897,0.7103358451477453,0.7922480620155039,1.0,1.0,2/10,11.35%,EIF2AK3;QRICH1
prerank,early endosome to Golgi transport (GO:0034498),-0.28247374287097105,-0.7097777106513524,0.8238993710691824,0.9509121520816953,1.0,6/11,25.49%,STX5;SURF4;SNX2;SNX8;RBSN;RAB6A
prerank,positive regulation of interleukin-13 production (GO:0032736),0.3652084110762111,0.7090765641335108,0.7945619335347432,1.0,1.0,1/10,6.39%,IL18
prerank,adipose tissue development (GO:0060612),0.36551931005667204,0.7087820325216275,0.7812061711079944,1.0,1.0,4/11,17.53%,PGRMC2;LRP5;SPTLC2;SH3PXD2B
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.299608012328955,0.7087252886576013,0.9031281533804238,1.0,1.0,17/142,12.85%,ATP2B4;LPAR3;LPAR1;IAPP;CXCR4;PDGFRA;SLC8A1;BDKRB2;HMGB1;P2RY1;CACNA1C;TRPC7;ATP2B1;CALB1;ITPR3;TRPM4;C1QTNF1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.32981100691988674,0.7086852063585356,0.7670384138785625,1.0,1.0,5/25,9.87%,PML;EFNA1;EPHA4;PSME3IP1;CSNK2A2
prerank,myoblast fusion (GO:0007520),0.3632402040779703,0.7086289425651465,0.7842261904761905,1.0,1.0,2/12,7.58%,ADAM12;ADAMTS5
prerank,vesicle transport along actin filament (GO:0030050),0.3412575262226105,0.708375541972995,0.7631224764468372,1.0,1.0,2/19,5.75%,ACTN4;MYO1C
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.3367609593194859,0.7082029333855056,0.7783251231527094,1.0,1.0,5/26,11.41%,TXN;PYCR1;HTRA2;LRRK2;BAG5
prerank,cellular response to leucine starvation (GO:1990253),-0.28002494520991206,-0.7081187690927413,0.8275862068965517,0.9519363301358152,1.0,3/10,10.95%,SESN3;GCN1;MTOR
prerank,monocyte differentiation (GO:0030224),-0.2885404386283801,-0.7072808347225203,0.7957317073170732,0.952035536377334,1.0,6/10,33.79%,PIR;VEGFA;MT1G;PDE1B;CSF1R;PPARG
prerank,diterpenoid metabolic process (GO:0016101),0.30949451342731926,0.7071873491079754,0.8101952277657267,1.0,1.0,6/55,10.42%,ABCA4;RDH11;GPC6;RDH12;ALDH1A1;SDC1
prerank,ERBB2 signaling pathway (GO:0038128),0.3181651788136097,0.7068274170106643,0.7744630071599046,1.0,1.0,5/31,15.34%,MATK;CUL5;GAB1;PRKCA;SRC
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.3386271710084309,0.7066261968870589,0.7780784844384303,1.0,1.0,3/17,13.95%,CASK;SULF1;XIAP
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.3139356114818057,0.7064841585322937,0.8089244851258581,1.0,1.0,6/42,12.17%,MAP4K4;GSK3B;ROCK1;LIMS1;RAC1;RRAS
prerank,TOR signaling (GO:0031929),0.3270054756461908,0.7061829817695824,0.7745098039215687,1.0,1.0,5/26,14.78%,FNIP1;LARP1;NPRL3;MAPKAP1;RPTOR
prerank,positive regulation of lyase activity (GO:0051349),0.3432406760759036,0.7059940900726888,0.7804878048780488,1.0,1.0,3/14,16.01%,FXN;CACNA1C;STIM1
prerank,pancreas development (GO:0031016),0.3590122816057402,0.7059575232205505,0.7806267806267806,1.0,1.0,2/12,9.04%,TCF7L2;NPHP3
prerank,COPII-coated vesicle budding (GO:0090114),0.30189017916353766,0.7057653922650367,0.8398727465535525,1.0,1.0,16/68,18.45%,F5;CUL3;TRAPPC6B;RAB1A;SCAP;F8;SCFD1;SEC24D;TRAPPC10;MIA3;ANKRD28;VAPA;BET1;TRAPPC9;USO1;TMED10
prerank,termination of RNA polymerase I transcription (GO:0006363),0.3231065834509763,0.7054848660455635,0.7973621103117506,1.0,1.0,6/30,13.17%,POLR1A;POLR1B;ERCC3;TAF1D;TTF1;POLR1G
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.34304048135818627,0.7050936111511075,0.7894002789400278,1.0,1.0,3/16,9.77%,LARGE1;ST8SIA2;ST3GAL5
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.3258522675902457,0.703917884835025,0.7758620689655172,1.0,1.0,9/29,22.20%,FADD;TICAM1;IKBKG;CASP8;RIPK1;UBE2D3;TANK;IKBKB;BIRC2
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.35752896385176103,0.7035933951231551,0.7543624161073825,1.0,1.0,5/15,18.89%,TSEN34;CPSF4;TSEN2;DDX1;ZBTB8OS
prerank,cAMP biosynthetic process (GO:0006171),-0.2962157480623766,-0.7035283190091652,0.828169014084507,0.9554060497707398,1.0,3/10,14.87%,ADCY3;ADCY8;ADCY4
prerank,inner ear morphogenesis (GO:0042472),0.3324429280751623,0.7032752940849446,0.7806451612903226,1.0,1.0,4/22,12.57%,FGFR2;TTC39C;TBX18;SOX9
prerank,regulation of protein localization to cell surface (GO:2000008),0.31708774435701836,0.7030875653739327,0.7863046044864227,1.0,1.0,5/33,10.25%,RANGRF;GBF1;LEPROT;PICALM;SNX33
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.22212187666259592,-0.7030043592800495,0.9083333333333333,0.9551408640305089,1.0,6/20,23.60%,NUMB;DAB2;AP2M1;PKDCC;BCL2L1;ABI3
prerank,copper ion transport (GO:0006825),0.3600751528279274,0.7029895080689944,0.7879699248120301,1.0,1.0,1/11,3.08%,STEAP3
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.34635856592819003,0.7028836042778157,0.7872044506258693,1.0,1.0,4/15,15.78%,IL18;AGT;NFKB1;LPL
prerank,striated muscle cell development (GO:0055002),0.35176570490670156,0.7026001868770567,0.7764060356652949,1.0,1.0,5/14,22.29%,SDC1;TMOD3;TMOD1;LMOD1;TMOD2
prerank,positive regulation of protein localization to membrane (GO:1905477),0.29573694820040497,0.7023110245822936,0.8544891640866873,1.0,1.0,22/98,18.35%,E2F1;ATP2B4;RANGRF;MIEF2;TFDP1;PRNP;PDZK1;MYO1C;MIEF1;PDPK1;CASP8;PRKCE;PRKCI;DLG1;ITGB1;RAMP3;TP53;PPP3R1;EPHA3;WNK3;YWHAQ;BAD
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.32375382423499094,0.7022461144135909,0.7830882352941176,1.0,1.0,5/26,12.40%,GPRC5A;FBXW7;ERRFI1;NCK2;ADAM17
prerank,negative regulation of interleukin-2 production (GO:0032703),0.33069692617133756,0.7021399130778939,0.7647058823529411,1.0,1.0,3/18,12.27%,PRNP;EZR;HOMER2
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.3121484857967001,0.7018672461332987,0.8154555940023068,1.0,1.0,3/39,5.31%,RANGRF;NEDD4;PDZK1
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.22175409239522897,-0.7015766189852293,0.8991596638655462,0.9558548370315806,1.0,12/23,33.38%,GAS6;TLR4;DDIT3;LGALS9;INHBA;ZC3H12A;CD274;LAPTM5;NR1H4;INHA;C1QBP;RARA
prerank,arachidonate transport (GO:1903963),0.363957664606355,0.7007456059862613,0.781055900621118,1.0,1.0,2/10,11.48%,BDKRB2;ANXA1
prerank,arachidonic acid secretion (GO:0050482),0.363957664606355,0.7007456059862613,0.781055900621118,1.0,1.0,2/10,11.48%,BDKRB2;ANXA1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.23991879351062897,-0.7005305869023538,0.8730769230769231,0.9561921591712745,1.0,1/17,0.29%,CACNA2D1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.29675760865007944,0.7001484580690757,0.7867247007616975,1.0,1.0,8/55,10.81%,FADD;WWOX;BMF;PML;BCLAF1;AGT;TGFBR1;BOK
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.35851917729222005,0.7000917315180469,0.7602739726027398,1.0,1.0,5/14,18.89%,TSEN34;CPSF4;TSEN2;DDX1;ZBTB8OS
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.34527707241388694,0.6999652630760085,0.776034236804565,1.0,1.0,3/13,12.36%,GJC1;CACNA1C;GJA1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.32262350332897544,0.6999409361099803,0.781973203410475,1.0,1.0,9/30,22.20%,FADD;TICAM1;IKBKG;CASP8;RIPK1;UBE2D3;TANK;IKBKB;BIRC2
prerank,regulation of cytoplasmic transport (GO:1903649),-0.28585171409112187,-0.6996793328393461,0.8389261744966443,0.9562457292203184,1.0,8/11,35.95%,MAPK3;MAPK1;MAP2K1;ATP9A;CHMP3;DENND10;DNAJC13;USP7
prerank,protein stabilization (GO:0050821),0.2919453021687891,0.6995998074487906,0.9174219536757301,1.0,1.0,28/168,16.20%,GTSE1;MCM8;PARVA;NLK;CHEK2;MDM4;WIZ;TSPAN1;STK3;FBXW7;EFNA1;EPHA4;NCLN;ATF7IP;GNAQ;VHL;MTMR9;FLOT2;BAG5;SUGT1;P3H1;AAK1;USP9X;MORC3;PIN1;STX12;PTEN;CDC37L1
prerank,epithelial structure maintenance (GO:0010669),-0.2827069509280954,-0.6995905492074498,0.8394366197183099,0.9555052503946184,1.0,6/11,49.38%,STRAP;RBP4;NOD2;MUC13;PIWIL4;MUC6
prerank,negative regulation of defense response to virus (GO:0050687),0.3706136930917482,0.6994250034098844,0.7837037037037037,1.0,1.0,2/10,12.85%,ILRUN;ITCH
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.360367042447304,0.6991815496347962,0.7654135338345864,1.0,1.0,4/10,22.14%,SMPD3;SMPD2;PRKCD;SIRT3
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.360367042447304,0.6991815496347962,0.7654135338345864,1.0,1.0,4/10,22.14%,SMPD3;SMPD2;PRKCD;SIRT3
prerank,aromatic amino acid family metabolic process (GO:0009072),0.3602902614220112,0.6989677378898249,0.7738998482549317,1.0,1.0,3/10,17.17%,ASRGL1;IL4I1;THAP4
prerank,endocardial cushion morphogenesis (GO:0003203),0.336215319792598,0.6988386873359896,0.773209549071618,1.0,1.0,4/18,12.57%,BMPR1A;MDM4;BMP2;SOX9
prerank,regulation of endothelial cell proliferation (GO:0001936),0.2967050340756351,0.6987559126074038,0.8692946058091287,1.0,1.0,14/88,15.60%,HMGB2;VASH2;ATOH8;XDH;SULF1;ANGPT1;TGFBR1;BMP2;PRKCA;NR4A1;ATP5IF1;PRKD1;ARNT;PRKD2
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.29715782109061345,0.6985368757002909,0.8369098712446352,1.0,1.0,24/67,24.78%,PSMC2;PSMD5;PSMB1;PSMD14;PSMD1;IKBKG;CYBB;PSMB9;PSMC6;ITGAV;SNAP23;PSMB2;PSME4;PSMB7;PSMD11;PSME3;SEC22B;IKBKB;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,regulation of pH (GO:0006885),-0.27469296463784887,-0.6984765690609018,0.8304597701149425,0.9559455969744662,1.0,5/11,34.90%,ATP6V0A4;PDK2;ATP6AP1;SLC9A1;PDK4
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.34503651914267747,0.6984751134109717,0.7777777777777778,1.0,1.0,3/13,10.51%,ZBTB7B;PIM1;HNRNPU
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.2942015684069345,0.6982254047977658,0.8756371049949032,1.0,1.0,26/112,17.84%,TGFBR3L;BMPR1A;RHOA;WWOX;NLK;SOX6;TGFBR3;SMAD6;SMURF1;NR3C1;TGFBR1;LIMS1;CRKL;ARHGEF18;APPL2;SOX9;SMAD4;USP9X;ADAM9;ITGB1;SMAD3;SRC;SFRP1;PTPRK;ZFYVE9;SMAD2
prerank,presynapse organization (GO:0099172),-0.28910998206525323,-0.6981232191097492,0.8236994219653179,0.9555023994479219,1.0,4/10,19.55%,LRRTM3;DVL1;NLGN1;FZD1
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.3349281770922882,0.6975476307290899,0.7841634738186463,1.0,1.0,8/23,24.76%,BMF;AGK;MAIP1;BAD;HSPA4;TIMM10B;HSP90AA1;BAX
prerank,regulation of membrane depolarization (GO:0003254),0.33666173953291667,0.6973029762773882,0.8108465608465608,1.0,1.0,2/18,8.30%,RANGRF;LRRK2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3318237127512025,0.6965691229859315,0.7844611528822055,1.0,1.0,6/22,15.59%,ROCK2;ROCK1;AGT;PRKCA;SMAD4;LMCD1
prerank,neuron fate commitment (GO:0048663),0.34663556333224876,0.6963533070993538,0.7863247863247863,1.0,1.0,2/14,10.49%,POU3F2;TGFBR1
prerank,regulation of cell aging (GO:0090342),-0.28100813972096605,-0.6961910271882116,0.8250825082508251,0.9567841143392535,1.0,2/11,10.42%,NEK6;RSL1D1
prerank,7-methylguanosine RNA capping (GO:0009452),-0.2042651007187481,-0.6957970005701192,0.9030303030303031,0.955585895979744,1.0,15/31,31.55%,CCNH;GTF2H5;CMTR1;POLR2K;POLR2H;NCBP1;POLR2F;GTF2H2;POLR2C;RAMAC;CDK7;POLR2E;POLR2J;GTF2H4;POLR2D
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.2042651007187481,-0.6957970005701192,0.9030303030303031,0.955585895979744,1.0,15/31,31.55%,CCNH;GTF2H5;CMTR1;POLR2K;POLR2H;NCBP1;POLR2F;GTF2H2;POLR2C;RAMAC;CDK7;POLR2E;POLR2J;GTF2H4;POLR2D
prerank,negative regulation of nervous system development (GO:0051961),0.32975583859265206,0.6956858510443531,0.8018867924528302,1.0,1.0,2/17,11.99%,PCM1;APPL2
prerank,positive regulation of MAPK cascade (GO:0043410),0.2906851248412516,0.6954718180019321,0.956,1.0,1.0,32/245,15.60%,EZH2;KSR1;ROCK2;FGFR4;FGFR2;LPAR1;GAREM1;IAPP;KIT;ARRB1;FBXW7;JCAD;PDGFRA;NPNT;LRRK2;ROBO1;ANGPT1;ROCK1;HMGB1;P2RY1;CRKL;BMP2;PRKCA;NOTCH2;ROR1;ADRB2;TRIM5;RAMP3;CD44;SLC30A10;TAOK1;PRKD2
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.29574555606059233,0.6954027492329755,0.8119565217391305,1.0,1.0,15/59,20.63%,SDK1;OBSL1;CDH4;ROBO1;DSCAML1;PLXNB2;DSCAM;EMB;ITGB1;AMIGO1;PLXNB3;DSG2;KIRREL3;CEACAM1;MPZL2
prerank,negative regulation of blood coagulation (GO:0030195),0.30836349117001177,0.6948857007649294,0.7995444191343963,1.0,1.0,6/38,13.00%,PDGFRA;PLAU;SERPINE1;F8;C1QTNF1;PLAUR
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.25183813263023386,-0.6938198433075312,0.8704318936877077,0.9568303285549167,1.0,2/14,4.59%,TMSB4X;SUFU
prerank,ear morphogenesis (GO:0042471),0.32698086575764,0.693618845204165,0.7804232804232805,1.0,1.0,5/20,18.84%,FGFR2;NIPBL;TWIST1;OSR1;ZIC1
prerank,fat cell differentiation (GO:0045444),0.30373777887900877,0.6933957905767744,0.8262757871878393,1.0,1.0,10/57,13.65%,BBS9;CTBP1;MKKS;TCF7L2;SMAD6;OSBPL8;NR4A2;NR4A1;ATF5;MED1
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.2720796203976173,-0.6914434239491882,0.8595890410958904,0.9585349248089988,1.0,1/12,0.38%,DOCK10
prerank,negative regulation of cell migration (GO:0030336),0.2870379676346361,0.6911190419218508,0.893037336024218,1.0,1.0,33/137,18.56%,BMPR1A;ARID2;MCC;STK24;RAP2A;AFDN;HOXA7;SFRP2;EPHA4;SULF1;SERPINE1;FOXO3;TMEFF2;ROBO1;SRGAP2;SRGAP3;HAS1;NKX2-1;RAC1;GJA1;CLIC4;ADIPOR1;DPYSL3;MIA3;PTPRU;NF2;SFRP1;PTEN;PTPRK;SLURP1;CLASP1;DPEP1;IGFBP3
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.26876065380517117,-0.6911028591165695,0.8417508417508418,0.9580535400403728,1.0,9/12,33.43%,GRN;PPT1;ATP6AP2;TMEM9;CLN5;VPS33A;TMEM199;CLN3;CLN6
prerank,negative regulation of endocytosis (GO:0045806),0.32015656394557407,0.6909204474736858,0.8002450980392157,1.0,1.0,7/24,17.07%,MTMR2;PICALM;SNX33;RAC1;PRKD1;UNC119;EPHA3
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.36315678544399976,0.6903374891959313,0.798219584569733,1.0,1.0,2/10,9.21%,FTO;MGMT
prerank,DNA dealkylation (GO:0035510),0.36315678544399976,0.6903374891959313,0.798219584569733,1.0,1.0,2/10,9.21%,FTO;MGMT
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.3176467666815071,0.690285903899398,0.8009313154831199,1.0,1.0,7/33,22.49%,FADD;PRKCA;CASP8;RUNX1;RIPK1;TRAF6;ZFP36L1
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.2318413007772988,-0.690218344118278,0.8769230769230769,0.9582402677241235,1.0,7/18,24.56%,RPS13;ESR1;KAT2B;ZC3H12A;PTBP1;RPS26;PTBP3
prerank,pharyngeal system development (GO:0060037),0.3380678608522062,0.6900985944095208,0.7968970380818053,1.0,1.0,2/15,10.49%,BMPR1A;TGFBR1
prerank,regulation of viral release from host cell (GO:1902186),0.32248528355645567,0.6896690376812018,0.7923566878980892,1.0,1.0,3/21,8.19%,VPS37B;PML;TRIM28
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.3346732650271701,0.6887834800755751,0.8110344827586207,1.0,1.0,5/16,19.12%,TBC1D25;MTRF1;CLEC16A;OGFOD1;ETF1
prerank,miRNA mediated inhibition of translation (GO:0035278),0.3511674777130017,0.6886278388915045,0.7866868381240545,1.0,1.0,3/11,15.51%,AGO2;RBM4;TNRC6C
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.3511674777130017,0.6886278388915045,0.7866868381240545,1.0,1.0,3/11,15.51%,AGO2;RBM4;TNRC6C
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.32459000054577214,0.6883740427397158,0.8110539845758354,1.0,1.0,3/24,7.09%,LEPR;COX10;COQ10B
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.2979409039642746,0.688230631726494,0.8254665203073546,1.0,1.0,11/51,14.12%,BMPR1A;FBN1;CRIM1;LEMD3;SMAD6;SMURF1;RBPMS2;SMURF2;BMP2;SMAD4;HTRA3
prerank,protein maturation (GO:0051604),0.2925394320077281,0.688038711157047,0.8725388601036269,1.0,1.0,6/95,7.13%,KEL;TSPAN33;MMP14;CPXM1;NDUFAB1;TASP1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.3108576492628164,0.6879284875575308,0.7894088669950738,1.0,1.0,7/30,14.35%,TGFBR3L;TGFBR3;DKK3;SMURF2;SMAD4;XIAP;SMAD3
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.34313706091788776,0.6879226889634865,0.7816411682892906,1.0,1.0,2/14,8.30%,TXNDC12;LRRK2
prerank,regulation of protein phosphorylation (GO:0001932),0.28787201525217876,0.6877533773760126,0.96,1.0,1.0,42/256,16.15%,ECT2;PHIP;FNIP1;ROCK2;PRKDC;PRNP;XDH;LEPR;MUSK;RAP2A;ARRB1;PML;EFNA1;FMR1;CCN1;WWTR1;LRRK2;AXIN2;ANGPT1;RB1CC1;P2RY1;PPP2R5C;PLXNB2;EIF2AK3;TWF1;CRKL;BMP2;RAC1;ADAM17;SOX9;BRD4;PLAUR;SLCO3A1;PPP1R15B;WDFY2;PTPN13;PIN1;FXR1;PPP2R5B;PPIL4;SESN2;PTEN
prerank,water-soluble vitamin metabolic process (GO:0006767),0.290400853629852,0.6875792645379796,0.8462354188759279,1.0,1.0,15/68,19.04%,MTHFD1L;GSTO2;BTD;MTHFR;PDXK;SLC19A1;ENPP1;DHFR;PANK2;SLC19A2;RFK;CYB5A;MMAB;SLC25A19;MTHFS
prerank,response to interleukin-6 (GO:0070741),-0.28225837727913683,-0.6873998046974632,0.8739255014326648,0.9603093227687983,1.0,3/10,20.16%,ST3GAL6;SBNO2;PTPRT
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.29223531222539156,0.6871065100228348,0.855026455026455,1.0,1.0,28/74,24.78%,PSMC2;PSMD5;ELOC;PSMB1;PSMD14;LIMD1;VHL;PSMD1;PSMB9;STOX1;RBPJ;PSMC6;ARNT;PSMB2;PSME4;PSMB7;PSMD11;EGLN1;PSME3;PSMD13;SIRT2;EGLN3;PSMB8;PSMD4;PSMF1;PSMA5;HIF3A;PSMC3
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.19726434696690753,-0.6870889076772508,0.9404761904761905,0.9598027108158448,1.0,10/30,27.64%,SELENOF;ST13;HSPA5;CCT2;DNAJC18;DNAJB12;SDF2;CHCHD4;ENTPD5;HSPA9
prerank,negative regulation of autophagy (GO:0010507),0.3039628846272625,0.6869998781325307,0.8469945355191257,1.0,1.0,9/54,9.58%,BMF;DAP;EIF4E;LEPR;ATG7;QSOX1;LRRK2;KLHL22;MTMR9
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.26162489250856413,-0.6868503859360423,0.8646864686468647,0.9592192703985905,1.0,4/12,20.57%,ABCA5;NR1H3;NR1H2;ITGB3
prerank,negative regulation by host of viral transcription (GO:0043922),-0.26051517546590797,-0.6865372559374439,0.8703071672354948,0.9587203212693834,1.0,4/12,21.06%,INPP5K;JUN;HMGA2;TARDBP
prerank,negative regulation of cell junction assembly (GO:1901889),0.3190366766748912,0.6865318675334174,0.8168316831683168,1.0,1.0,7/25,16.15%,ROCK2;ROCK1;ARHGAP6;DMTN;SRC;RCC2;PTEN
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.1742088544581858,-0.6863042665086988,1.0,0.9581212463549084,1.0,11/57,14.10%,GRIN2A;FIS1;GRIN2B;MALT1;MAP3K5;LGMN;NOD1;CTSD;PPM1F;BCAP31;GRIN1
prerank,negative regulation of cellular component movement (GO:0051271),-0.2503079727014807,-0.6857228401606873,0.8472727272727273,0.957856587531139,1.0,4/15,17.87%,FRMD5;SPOCK3;CCDC125;ACTN1
prerank,regulation of acute inflammatory response (GO:0002673),-0.23629513343799058,-0.6855426300978071,0.9115384615384615,0.9571862270571346,1.0,18/18,76.40%,OSMR;ADAM8;KLKB1;NLRP3;IL4;GSTP1;CREB3L3;IL6;OSM;FFAR2;DNASE1;PLA2G2D;C2CD4B;DNASE1L3;F12;C2CD4A;PTGES;IL6ST
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.348774157583142,0.6849963771108427,0.815406976744186,1.0,1.0,3/12,15.39%,AGT;SOX9;GDNF
prerank,positive regulation of protein secretion (GO:0050714),0.2977139277163919,0.6848227957227295,0.8613756613756614,1.0,1.0,16/69,19.48%,GCK;FRMD4A;MYH10;BMP6;TCF7L2;MCU;EZR;SYTL4;ACHE;PPID;ADAM9;AACS;NLGN2;BAD;TMED10;DNM1L
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.2448618051885634,-0.6847023607580394,0.9227799227799228,0.9571855727346559,1.0,9/16,41.75%,GSK3A;GPER1;MRAP2;CHGA;PDE6H;C3;ACP3;GRP;NECAB2
prerank,negative regulation of viral release from host cell (GO:1902187),0.3388555809810206,0.6841498152952052,0.772027972027972,1.0,1.0,3/13,14.24%,PML;TRIM28;TRIM5
prerank,cell-cell junction assembly (GO:0007043),0.2957843917128052,0.6841460486073009,0.8432432432432433,1.0,1.0,17/63,18.63%,CDH18;CDH24;RHOA;CTNNA1;GJD3;GJC1;TLN1;EPB41L3;PRKCA;GJA1;TLN2;PIP5K1C;RHOC;TBCD;TRPV4;PKN2;CDH11
prerank,intracellular cholesterol transport (GO:0032367),0.341240025441203,0.6841297503380792,0.8082191780821918,1.0,1.0,4/15,16.98%,TSPO2;ABCA1;RELCH;LDLR
prerank,negative regulation of response to stimulus (GO:0048585),0.3007405407943293,0.6839358036946617,0.8516129032258064,1.0,1.0,9/60,15.03%,RBL1;FBXO5;BRAP;CASK;MAP3K3;TERF2;APPL2;TWIST1;SLC30A10
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.3101209369185166,0.6839251732847629,0.8090154211150652,1.0,1.0,5/32,12.26%,CHAT;LPCAT1;LPIN2;CSNK2A2;ACHE
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.286921371926069,0.683519673080918,0.987,1.0,1.0,67/390,17.07%,SHCBP1;CEP57;STMN1;STYK1;SETX;PHIP;ROCK2;FGFR4;ACTR3;RHOA;COL4A6;GSK3B;FGFR2;RBFOX2;KIT;SULF2;HNRNPA1;FRS2;MUSK;PTPN2;EFNA1;PDGFRA;VAV2;HNRNPH1;POLR2A;EPHA4;SULF1;RHOQ;NCK1;ANGPT1;ABI1;ROCK1;FGFRL1;BDKRB2;CYBB;DDR2;PIK3CB;CLNK;SH2D2A;GAB1;EIF2AK3;EFNB1;RAC1;ANKS1B;NCK2;MAPKAPK3;WASF2;IL31RA;POLR1G;ROR1;DOCK1;ADRB2;PRKD1;SPRED1;EFNB2;ITGAV;AAMP;ARPC1B;SRC;PRKD2;SPRED2;NCKAP1;TNK2;AXL;SIPA1L1;NGF;EPHA3
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.31853492125567384,0.6833590729641088,0.8192918192918193,1.0,1.0,6/27,18.26%,CHST15;CHSY1;CHST3;BGN;UGDH;XYLT1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.2831643833675596,0.6833071459917357,0.9133064516129032,1.0,1.0,26/149,15.76%,TRIM37;TRIML2;TICAM1;DDRGK1;RAB7B;DHX9;TAB1;RTKN2;IL18;UBE2N;RNF31;AGT;IKBKG;ERC1;EDA;FLOT2;PRKCB;TRIM6;BTK;ROR1;SLCO3A1;PRKD1;PRKCI;TRIM5;PRKD2;NFKB1
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.26083753827243955,-0.6826931552982892,0.9034267912772586,0.9583881753741613,1.0,6/13,28.37%,SUFU;GOPC;GET4;MDFI;YWHAB;KEAP1
prerank,positive regulation of receptor internalization (GO:0002092),0.32252591556560883,0.682335261869076,0.7979539641943734,1.0,1.0,3/22,9.25%,ARRB1;FMR1;ANGPT1
prerank,respiratory chain complex IV assembly (GO:0008535),-0.21849722398307977,-0.6823316882321189,0.9439252336448598,0.9579318353995913,1.0,9/21,23.46%,COX16;OXA1L;COX19;PET100;COX20;SMIM20;COX17;COX14;COA8
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.22704724271702298,-0.6822095958339218,0.9024390243902439,0.9572389446571506,1.0,5/19,21.58%,LARP6;RGCC;CREB3L1;TGFB3;SUCO
prerank,negative regulation of autophagosome assembly (GO:1902902),0.3520470372263156,0.6820590510449117,0.7991202346041055,1.0,1.0,6/13,21.43%,LRRK2;TMEM39A;SCFD1;CHMP4A;CHMP4B;SEC22B
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.3107975792146325,0.6818593138145647,0.8098159509202454,1.0,1.0,6/26,15.61%,NEDD4;AKAP9;DLG1;CAB39;ITGB1;STK39
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.3415756891786148,0.6818359094006025,0.806966618287373,1.0,1.0,2/12,8.54%,STX11;STX2
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.31902125930762576,0.6816069184798901,0.796895213454075,1.0,1.0,1/23,1.27%,GLI3
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.2249872754779584,-0.6806549345668331,0.907563025210084,0.9578594322941093,1.0,6/19,21.57%,TLR4;LBP;RAB11FIP2;LGALS9;TIRAP;PIK3AP1
prerank,intracellular sterol transport (GO:0032366),0.3453120780090417,0.6805386123140362,0.7983074753173484,1.0,1.0,3/13,15.91%,TSPO2;ABCA1;RELCH
prerank,endoderm formation (GO:0001706),0.3069402930605436,0.6805209384095977,0.7838150289017342,1.0,1.0,6/35,15.02%,MMP14;LAMB1;SETD2;COL12A1;ITGA5;ITGAV
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.2980454382070306,0.6802887211253794,0.8020247469066367,1.0,1.0,9/43,12.83%,ERFE;PTPN2;NUCKS1;ZBTB7B;NCK1;PRKCB;ENPP1;SIK2;GKAP1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.2891987520003361,0.6802803732004548,0.8779731127197518,1.0,1.0,23/93,18.99%,ATP2B4;FNIP1;SH2D3C;TXN;SFRP2;NCK1;AKAP9;STOX1;NCK2;TRIM6;DMTN;PRKD1;RAMP3;CD44;DOCK7;RPTOR;PRKD2;PTEN;CNKSR3;NGF;TERF2IP;BRAF;CAPRIN2
prerank,positive regulation of axon extension (GO:0045773),0.3220063059225075,0.6795571577687897,0.8091603053435115,1.0,1.0,4/22,11.33%,MACF1;NTN1;MAPT;DSCAM
prerank,COPII vesicle coating (GO:0048208),0.2933846636892171,0.679466963428274,0.8458244111349036,1.0,1.0,13/61,18.45%,F5;CUL3;TRAPPC6B;RAB1A;F8;SCFD1;SEC24D;TRAPPC10;ANKRD28;BET1;TRAPPC9;USO1;TMED10
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.2933846636892171,0.679466963428274,0.8458244111349036,1.0,1.0,13/61,18.45%,F5;CUL3;TRAPPC6B;RAB1A;F8;SCFD1;SEC24D;TRAPPC10;ANKRD28;BET1;TRAPPC9;USO1;TMED10
prerank,vesicle coating (GO:0006901),0.2933846636892171,0.679466963428274,0.8458244111349036,1.0,1.0,13/61,18.45%,F5;CUL3;TRAPPC6B;RAB1A;F8;SCFD1;SEC24D;TRAPPC10;ANKRD28;BET1;TRAPPC9;USO1;TMED10
prerank,positive regulation of exosomal secretion (GO:1903543),0.3419633670699787,0.6794368360421049,0.7988748241912799,1.0,1.0,5/15,21.89%,STAM;SDC1;SMPD3;SDC4;PDCD6IP
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.2882305159738274,0.6793569986637605,0.8770833333333333,1.0,1.0,7/85,8.30%,PLK1;GSK3B;PSMC2;DDRGK1;FBXW7;FMR1;LRRK2
prerank,cell junction maintenance (GO:0034331),-0.2460287810765621,-0.6788770161048127,0.8659420289855072,0.9586591011117619,1.0,8/14,41.67%,DCTN1;CLDN1;CHCHD10;CSF1R;CBLN2;F2R;CBLN1;PRTN3
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.32071593929588393,0.6785854852592795,0.801980198019802,1.0,1.0,5/20,13.45%,TGFBR3;TGFBR1;BMP2;RBPJ;HEY2
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.34064461323790374,0.6781249202067328,0.8051420838971584,1.0,1.0,6/15,23.25%,PIK3CB;AAK1;UNC119;TNK2;SNAP91;SCYL2
prerank,muscle tissue morphogenesis (GO:0060415),0.3285198844824288,0.677594764899074,0.800275482093664,1.0,1.0,4/16,19.43%,TGFBR3;BMP2;HEY2;ZFPM1
prerank,regulation of gluconeogenesis (GO:0006111),0.31256787483446813,0.6771985578398282,0.8245398773006135,1.0,1.0,3/27,6.20%,GCK;ERFE;PTPN2
prerank,urogenital system development (GO:0001655),0.34614762444507524,0.6770043086175812,0.7900874635568513,1.0,1.0,3/11,18.17%,ANXA1;SOX9;OSR1
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.21264111997092028,-0.6768123968605079,0.9263157894736842,0.9598059597551948,1.0,4/24,12.91%,TRAF3IP2;PTPN22;ZDHHC1;TOMM70
prerank,regulation of fibroblast migration (GO:0010762),0.31851462188976404,0.6765326638055663,0.7975871313672922,1.0,1.0,7/20,14.28%,DDR2;HAS1;RAC1;APPL2;DMTN;PRKCE;ITGB1
prerank,ceramide biosynthetic process (GO:0046513),0.3020645270081772,0.6762868759103241,0.810244470314319,1.0,1.0,9/40,18.69%,CERS6;CERS5;ST8SIA2;ST3GAL5;AGK;SMPD1;SPTLC2;SMPD2;FA2H
prerank,regulation of calcium ion import (GO:0090279),-0.22066161728975253,-0.6762763338215282,0.9439655172413793,0.9594403193106046,1.0,6/21,18.20%,PDGFRB;CTNNB1;TRIM27;SLC30A1;PLPP4;PSEN2
prerank,SNARE complex assembly (GO:0035493),-0.27905941035313886,-0.6760411085876727,0.8465909090909091,0.9588433276201632,1.0,4/10,20.69%,STXBP6;VAMP8;VAMP3;VAMP1
prerank,lipoprotein biosynthetic process (GO:0042158),0.3485559165556205,0.6758888146734017,0.8110944527736131,1.0,1.0,2/11,7.99%,ATG7;PORCN
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.3301010613933812,0.6757875323575302,0.8147100424328148,1.0,1.0,1/15,2.67%,AK1
prerank,negative regulation of DNA binding (GO:0043392),0.3063546468269116,0.6757384084497721,0.8077830188679245,1.0,1.0,5/28,18.96%,E2F1;ILRUN;HEY2;TFAP4;SP100
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.3053818593895713,0.6753575985658058,0.8257211538461539,1.0,1.0,10/30,22.74%,MAGT1;RPN2;STT3A;STT3B;ALG8;UBE2J1;OSTC;FUT8;DPM3;MCFD2
prerank,positive regulation of endothelial cell migration (GO:0010595),0.28593212911615834,0.6749764057236848,0.8833333333333333,1.0,1.0,17/84,15.60%,ATOH8;ANGPT4;ROCK2;GPI;ANXA3;ANGPT1;HMGB1;AGT;PIK3CB;RAC1;RRAS;PRKCA;PDPK1;ADAM17;PRKD1;AAMP;PRKD2
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.2517761468098922,-0.6748665849883823,0.911864406779661,0.9591454778265208,1.0,4/13,17.76%,ISCA1;GLRX3;CIAO1;LTO1
prerank,regulation of osteoclast differentiation (GO:0045670),-0.19215880114604045,-0.674465912498603,0.9440559440559441,0.9587075109468056,1.0,5/33,13.80%,TLR4;CAMK4;MTOR;CEBPB;PRXL2A
prerank,regulation of transferase activity (GO:0051338),-0.23434353957688026,-0.6741268527650788,0.9027237354085603,0.9582109939210963,1.0,8/17,30.34%,PINX1;ATM;NABP2;FEM1A;NLRC5;SPTSSB;HMBOX1;JMJD8
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2910069917794704,0.6738335733182286,0.84,1.0,1.0,9/54,12.76%,FADD;UBE2K;PTPN2;RNF31;SPPL2B;IKBKG;PYDC1;ADAM17;CASP8
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.36092899418538615,0.6736073554108509,0.8078602620087336,1.0,1.0,2/10,10.11%,XDH;PIK3CB
prerank,regulation of interferon-beta production (GO:0032648),0.29386365554959,0.6735151039960194,0.8233333333333334,1.0,1.0,17/46,24.07%,DHX9;IRF1;RIOK3;POLR3D;PTPRS;YY1;MAVS;SIRPA;RELB;ISG15;POLR3C;RNF216;POLR3G;TLR7;RIPK2;HSP90AA1;REL
prerank,regulation of cell death (GO:0010941),0.28665189764132193,0.6732819775901467,0.8774459320288363,1.0,1.0,15/94,14.36%,RAD18;TXNDC12;SPEF1;FAF1;RILPL1;CCN1;RAB29;LRRK2;AXIN2;NCK1;SRGAP2;CCN3;PRKD1;CDKN1B;RAMP3
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.31057824917235793,0.6731294256212578,0.8119551681195517,1.0,1.0,2/30,4.03%,MACF1;RAB10
prerank,regulation of actin filament-based movement (GO:1903115),0.3514157522999035,0.6730017058041093,0.797037037037037,1.0,1.0,1/10,5.72%,PDPN
prerank,phagosome-lysosome fusion (GO:0090385),0.3469861339984723,0.6729329749034165,0.8243243243243243,1.0,1.0,1/10,4.46%,RAB7B
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.1954437844055856,-0.6728702184052171,0.9515151515151515,0.9586010522664737,1.0,9/31,26.98%,TNFRSF21;LYN;ATM;CEBPB;CD274;DLG5;CD300A;CD86;SOX11
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.32347448973089193,0.6723722511661424,0.7941952506596306,1.0,1.0,3/19,6.54%,OBSL1;CUX1;CAPRIN1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.28607229769391695,0.6722893676116566,0.8658410732714138,1.0,1.0,18/86,16.58%,ANGPT4;PRNP;BMP6;EFNA1;ENPP2;SFRP2;CD80;ANGPT1;AGT;SAMSN1;DMTN;ITGA5;CD44;CNOT7;SRC;TP53;SFRP1;TNK2
prerank,histone H3-K4 methylation (GO:0051568),0.3172136547610841,0.6722217417255762,0.8242574257425742,1.0,1.0,4/26,15.59%,PAXIP1;KMT2A;KMT2D;SETD4
prerank,positive regulation of immune response (GO:0050778),0.2893130358585402,0.6720156877876363,0.8493003229278795,1.0,1.0,7/64,15.16%,FADD;DHX9;NMI;RIOK3;POLR3D;AKIRIN2;SLC15A4
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.3488591129138976,0.6714326117263923,0.8120300751879699,1.0,1.0,2/10,9.29%,NCK1;VHL
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.2841281089337837,0.6711600223140319,0.8709677419354839,1.0,1.0,12/76,13.69%,TRIP6;RHOA;ACTN4;NMI;RTKN2;LIMS1;UACA;CCN3;EZR;TRIM6;ADIPOR1;DLG1
prerank,postsynaptic membrane organization (GO:0001941),0.32664267478176495,0.6710625134323002,0.8029689608636977,1.0,1.0,5/17,19.56%,MUSK;NLGN3;CHRNB1;NLGN2;GPHN
prerank,regulation of cell-substrate adhesion (GO:0010810),0.30054523249972837,0.6708845508143554,0.8413948256467941,1.0,1.0,8/42,12.65%,RHOA;PDPN;NPNT;RSU1;PIK3CB;LIMS1;RAC1;DMTN
prerank,protein localization to plasma membrane (GO:0072659),0.2811486047658884,0.6700830220014788,0.9146341463414634,1.0,1.0,40/129,23.60%,TSPAN33;ROCK2;RAB10;PDZK1;DENND4C;RAP2A;AFDN;ANK1;SMURF1;ROCK1;P2RY1;EPB41L3;FLOT2;KCNIP3;EZR;GAK;GORASP2;EHD1;TSPAN5;DLG1;RAMP3;TTC7B;KCNB2;ZDHHC3;STXBP1;DPP6;RAB13;WNK3;ASB3;RAB3A;MAP7;ANK3;RAB8B;IKBKB;FLNA;RAPGEF6;ZDHHC2;PACS1;S100A10;RAB8A
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.23747537742923364,-0.6696535363841697,0.9063670411985019,0.9608253905990424,1.0,5/16,19.33%,PDGFRB;ABL1;PDGFD;BCAR1;NRP1
prerank,neuron projection fasciculation (GO:0106030),0.34975884994995377,0.6690179786319284,0.8258859784283513,1.0,1.0,4/10,20.03%,EPHA4;ARHGAP35;AMIGO1;SEMA5A
prerank,response to UV-A (GO:0070141),-0.24253804297420115,-0.6685187502859334,0.8932384341637011,0.9609933252877935,1.0,6/14,33.90%,MMP2;CERS1;CCND1;AKT1;MMP1;OPN3
prerank,response to interleukin-1 (GO:0070555),0.28179412427813766,0.6679977695268245,0.8691099476439791,1.0,1.0,20/73,23.25%,HYAL1;MYLK3;ANXA1;PRKCA;SOX9;RC3H1;SMPD1;SRC;NFKB1;SFRP1;SIRPA;CD47;PTGIS;TRAF6;SNCA;TANK;RBMX;HDAC4;DAB2IP;CCL14
prerank,nucleic acid-templated transcription (GO:0097659),0.2972687582032055,0.6673667196741931,0.8299319727891157,1.0,1.0,6/42,10.91%,E2F1;POLR2A;EPC1;NR4A2;MMS19;DRG1
prerank,defense response to virus (GO:0051607),0.2809335469310217,0.6666334057725016,0.8997933884297521,1.0,1.0,16/100,17.17%,FADD;MOV10;MAP3K14;RNASE6;G3BP1;ATG7;TTC4;SETD2;IRF1;SKP2;RNASE1;TRIM5;CNOT7;AKAP1;IFNAR2;MAVS
prerank,regulation of cellular protein localization (GO:1903827),0.2998326527539101,0.6666306754037932,0.8420454545454545,1.0,1.0,15/45,24.26%,GBF1;MAPT;GPC6;SPIDR;SETD2;PIN1;LCP1;PTPN1;CSNK1E;GPC4;PRKAA2;CCDC66;GPC3;HSP90AA1;KDM1A
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.27063086076906917,-0.6664749957917376,0.8844086021505376,0.9619594350280726,1.0,2/10,6.08%,ST6GAL1;RENBP
prerank,protein localization to cell periphery (GO:1990778),0.2783657624559212,0.6661085821555567,0.9148936170212766,1.0,1.0,28/133,17.54%,TSPAN33;ROCK2;AP4M1;RAB10;PDZK1;DENND4C;RAP2A;ANK1;RAB29;SMURF1;ROCK1;P2RY1;EPB41L3;FLOT2;KCNIP3;EZR;GAK;EHD1;TSPAN5;DLG1;RAMP3;TTC7B;KCNB2;ZDHHC3;STXBP1;DPP6;RAB13;WNK3
prerank,inositol phosphate biosynthetic process (GO:0032958),0.348269620222351,0.6660421602280725,0.8096632503660323,1.0,1.0,3/11,11.11%,IPMK;PPIP5K1;IP6K2
prerank,dephosphorylation (GO:0016311),0.28129809447917975,0.6659305194491586,0.9164989939637826,1.0,1.0,35/147,20.72%,PPM1G;PPM1D;LHPP;TAB1;PPP2R3A;SSH2;PPP3CA;DUSP12;MTMR2;PPP2R5C;PTPN21;PTPRS;FBXW11;PLPP1;PLPP5;PPP1CC;BTRC;PTPRA;STK11;PTPN13;PTPRU;MTMR3;PPP2R5B;DAPP1;PPP2R1B;PTEN;UBLCP1;PTPRK;PTPRE;DUSP7;PPM1A;PTPN1;PTPN5;PNKP;PPP4R1
prerank,regulation of secretion by cell (GO:1903530),0.2820363547957006,0.6657820249780204,0.8717948717948718,1.0,1.0,17/54,24.11%,ARFIP1;RAB10;DNAJC1;STXBP5;FMR1;LLGL2;ANXA1;P3H1;KCNMB4;RAB13;RIC1;RAB3A;RAB8B;VAMP2;CPLANE2;RAB8A;SNCAIP
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.28483277551461045,0.6657141472123308,0.8629550321199143,1.0,1.0,12/67,12.89%,USP6NL;IFT140;TBC1D13;FMR1;TBC1D2B;SDCCAG8;TRPM2;TBC1D19;TWF1;RAC1;DMTN;ATG3
prerank,cellular response to glucose starvation (GO:0042149),0.2916289395038635,0.6654643319051113,0.8405466970387244,1.0,1.0,11/41,16.00%,HNRNPA1;SH3GLB1;FOXO3;SESN1;EIF2AK3;SIK2;ITFG2;MTMR3;PRKAG1;TP53;SESN2
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.3466229021269511,0.6654639120827394,0.808095952023988,1.0,1.0,3/10,11.99%,PRKCB;ENPP1;APPL2
prerank,regulation of endocytic recycling (GO:2001135),-0.2583306289536438,-0.6653518998813414,0.8691860465116279,0.9621549312406484,1.0,5/11,30.57%,ATP9A;ARHGAP1;SORL1;EIPR1;PLA2G4E
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.3321997744634173,0.665269407254923,0.8191632928475033,1.0,1.0,2/14,9.91%,RHOA;MEOX2
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.27779425908802446,0.6643972452275062,0.993,1.0,1.0,75/509,15.90%,ECT2;HPSE;FADD;KSR1;ADGRV1;TRIML2;TICAM1;TRIP6;FNIP1;MAP3K14;ROCK2;MIER1;FGFR4;RHOA;FGFR2;BMF;LPAR1;IAPP;ACTN4;NEDD4;KIT;NMI;FRS2;TCF7L2;RTKN2;IL18;UBE2N;JCAD;PDGFRA;TXN;RNF31;CD80;BCLAF1;TNFRSF10B;ANGPT1;MAP3K3;PUM2;ROCK1;HMGB1;AGT;IKBKG;OSBPL8;PIK3CB;CXXC5;TGFBR1;LIMS1;BOK;GAB1;PLXNB1;PRKCB;BMP2;RAC1;PDPK1;GJA1;TRIM6;SOX9;CASP8;SLC38A9;BRD4;ROR1;ADRB2;DDX21;PRKD1;PLK2;TRIM5;ITGB1;RAMP3;RPTOR;ITGAV;VAPA;SRC;RHOC;PRKD2;TP53;DDX1
prerank,cell differentiation in spinal cord (GO:0021515),-0.2734859244551226,-0.6641631125647995,0.8635014836795252,0.9624508163254185,1.0,4/10,22.17%,MDGA2;SOX4;SOX13;ZC4H2
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.3297993497658303,0.6640424783406785,0.8257261410788381,1.0,1.0,3/15,15.39%,AGT;SOX9;GDNF
prerank,mitochondrial RNA metabolic process (GO:0000959),0.33880260340083707,0.6640422647946451,0.8157894736842105,1.0,1.0,4/14,16.13%,FOXO3;FASTKD5;TFB1M;PNPT1
prerank,plasma membrane repair (GO:0001778),0.3334390854096421,0.6640303783395803,0.8167388167388168,1.0,1.0,6/13,22.89%,MYOF;SYTL4;SMPD1;DYSF;RAB3A;MYH9
prerank,cellular response to cytokine stimulus (GO:0071345),0.27677838569974733,0.6631814913111118,0.991,1.0,1.0,52/416,16.35%,BRCA1;BIRC5;SYNCRIP;RHOA;HYAL1;PLP2;GSK3B;ZEB1;UBE2K;MYLK3;KIT;DHX9;LEPR;PTPN2;CXCR4;IL18;TPR;WNK1;NPNT;YBX3;POU2F1;FOXO3;CD80;HTRA2;IRF1;RIPOR2;PIM1;PIK3CB;SDC1;HNRNPU;CRKL;CNTF;ANXA1;TRIM6;SOX9;IL31RA;DPYSL3;RORA;TWIST1;RC3H1;CDKN1B;ITGB1;SMAD3;EPRS1;PTPN13;STK39;IL1RL2;NFKB1;TP53;SFRP1;PNPT1;IFNAR2
prerank,mitochondrial protein processing (GO:0034982),0.3354280146665877,0.6631744855086825,0.8229954614220878,1.0,1.0,5/11,20.48%,STOML2;PMPCA;ATP23;MIPEP;SPG7
prerank,I-kappaB phosphorylation (GO:0007252),0.3369712779011788,0.6631133293514427,0.791476407914764,1.0,1.0,4/10,23.14%,ERC1;PRDX4;TLR7;DAB2IP
prerank,cholesterol metabolic process (GO:0008203),0.2823474948667917,0.6630422087828328,0.8679446219382322,1.0,1.0,11/68,15.94%,LBR;PMVK;SOAT1;SCAP;TM7SF2;ABCA1;SOAT2;ACAT2;MVK;STARD3;DHCR7
prerank,positive regulation of cell death (GO:0010942),0.29236139407327993,0.6627109057976297,0.8594594594594595,1.0,1.0,10/59,14.36%,GSK3B;PRNP;MAPT;FAF1;LRRK2;AXIN2;PICALM;CDKN1B;EFNB2;RAMP3
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.28489330507397903,0.6627028647085441,0.8696109358569927,1.0,1.0,8/75,9.40%,ATP2B4;THBS2;ANGPT4;ROCK2;PDE3B;PML;SULF1;ROCK1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.3250346577817055,0.6621486783452536,0.8204022988505747,1.0,1.0,1/15,2.80%,TICAM1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.28541471340623065,0.6620550541806499,0.8403083700440529,1.0,1.0,7/53,9.53%,XPO1;PSMC2;DDRGK1;FBXW7;FMR1;PSMD14;PSME3IP1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.28036301241869394,0.6616361728035823,0.8801261829652997,1.0,1.0,14/75,19.03%,RGS12;ROCK2;GIT2;GRK5;RGS3;ROCK1;RIC8B;NMT2;RAMP3;SYP;ZDHHC3;METAP1;FNTB;USP20
prerank,protein localization to lysosome (GO:0061462),0.2946715144579497,0.661473053770977,0.8280487804878048,1.0,1.0,4/28,12.21%,AP4M1;NEDD4;ZFYVE16;NAGPA
prerank,regulation of BMP signaling pathway (GO:0030510),0.27960466161154707,0.6605814377981021,0.869198312236287,1.0,1.0,15/73,14.12%,BMPR1A;NUMA1;CRIM1;CCN1;LEMD3;SULF1;SMAD6;SMURF1;RBPMS2;SMURF2;BMP2;RBPJ;SMAD4;XIAP;HTRA3
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.33198320157940847,0.6604641902714087,0.8150887573964497,1.0,1.0,3/13,12.40%,HMGB1;PDPK1;ADAM17
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.2760760279806442,0.6604353372670434,0.963,1.0,1.0,35/214,17.25%,FAM83D;FGFR4;FGFR2;GAREM1;PTPN2;TGFBR3;ARRB1;FBXW7;PDGFRA;NPNT;CCN1;ANGPT1;HMGB1;APIP;P2RY1;CRKL;BMP2;EZR;RRAS;PRKCA;SMAD4;NOTCH2;ROR1;DLG1;SPRED1;RAMP3;CD44;SLC30A10;PIN1;PRKD2;SPRED2;PTEN;CNKSR3;CCN2;SIRPA
prerank,negative regulation of protein phosphorylation (GO:0001933),0.2796376104685205,0.6600774957823806,0.932527693856999,1.0,1.0,43/150,21.15%,RB1;CEP43;PRKDC;PRNP;TAB1;XDH;PMEPA1;SFRP2;WWTR1;LRRK2;SMAD6;GNAQ;NCK1;CEP85;ERRFI1;CALM2;SAMSN1;CRKL;PYDC1;ENPP1;PDPK1;NCK2;DMTN;TWIST1;SPRED1;PPP1R15B;QARS1;PTPN13;SFRP1;SPRED2;PTEN;CNKSR3;SIRPA;MVP;TERF2IP;IGFBP3;PRKCD;DNAJC10;TRIB1;CEACAM1;SNCA;FBLN1;UBASH3B
prerank,pentose-phosphate shunt (GO:0006098),-0.2622268066690958,-0.6599883260193276,0.8867313915857605,0.9652016603938497,1.0,4/11,21.09%,PGD;RPE;RPIA;SHPK
prerank,axonal fasciculation (GO:0007413),0.3412165507372793,0.6598343752706743,0.8298507462686567,1.0,1.0,5/12,20.03%,EPHA4;ARHGAP35;EPHA3;AMIGO1;SEMA5A
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.28393338347495367,0.6586806573588871,0.869198312236287,1.0,1.0,9/67,13.45%,TRIOBP;GSK3B;NPNT;RSU1;LIMS1;CRKL;RAC1;DMTN;DOCK1
prerank,regulation of protein autophosphorylation (GO:0031952),0.29190661457143785,0.6586662663708676,0.8415492957746479,1.0,1.0,11/36,22.27%,MRE11;RAP2A;PPP2R5C;ERRFI1;CALM2;ENPP1;PPP2R5B;MVP;RAD50;TOM1L1;PDGFA
prerank,cellular response to gamma radiation (GO:0071480),0.32367909311839566,0.658395895751333,0.8285714285714286,1.0,1.0,4/17,17.21%,MAP3K20;YAP1;TP53;ATR
prerank,regulation of mRNA processing (GO:0050684),0.29564949303468735,0.6583573534658662,0.8479809976247031,1.0,1.0,11/32,19.51%,KHDRBS1;DHX9;SRSF10;SRSF3;SRPK1;CPSF4;IWS1;SRPK2;CWC22;LARP7;KHDRBS3
prerank,cellular protein localization (GO:0034613),0.2777110600100848,0.6583098379984786,0.978,1.0,1.0,66/285,18.45%,USP6NL;CNTLN;STX11;ARFIP1;AP4M1;EVI5L;TBC1D25;SNX1;RAP2A;TBC1D13;WDR11;BICD2;VPS26C;PRPF19;TBC1D2B;RAB22A;NIPBL;RAB29;STXBP2;FBLN5;LRRK2;MFN2;SMURF1;STX2;CORO1B;AXIN2;ANGPT1;RAB1A;SNX27;VIPAS39;COPB2;HERC2;NPHP1;EPB41L3;COPZ1;PIGU;AP3B1;SCFD1;ZDHHC15;GJA1;EHD1;IFT27;HEY2;ARF4;MESD;PTPRU;ARL4A;TM9SF2;CSRP3;STX12;ARF3;TBC1D9;STXBP1;VPS26A;TMED3;UNC50;LAMTOR3;PTPRK;SH3PXD2B;ACD;RIC1;USO1;TM9SF4;CEP250;ARL5A;TMED10
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.25587411504545643,-0.6581844783775439,0.908256880733945,0.96578320418792,1.0,3/12,14.73%,NBL1;SLIT2;DUSP1
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.34104147274997954,0.6579448593895116,0.8290854572713643,1.0,1.0,3/10,17.58%,ERRFI1;ENPP1;MVP
prerank,positive regulation of signaling receptor activity (GO:2000273),0.2994338344680245,0.6578953639290844,0.8208092485549133,1.0,1.0,7/36,14.28%,NLGN3;FBXW7;HDAC1;ADAM17;HDAC2;ADRB2;ITGB1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.2748853493796054,-0.6578205152717749,0.90625,0.9652844963722865,1.0,4/10,22.25%,CSGALNACT1;B3GAT2;XYLT2;B3GAT1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.284794798491648,0.6577949493597197,0.8680318543799772,1.0,1.0,11/48,15.60%,ANGPT4;JCAD;ANGPT1;MAP3K3;HMGB1;ANXA1;PRKCA;PDPK1;ADAM17;PRKD1;PRKD2
prerank,response to cAMP (GO:0051591),0.2928291951687402,0.6574948262031687,0.8642533936651584,1.0,1.0,6/37,15.61%,AQP1;AHR;EZR;AKAP9;DMTN;PKD2
prerank,myeloid cell activation involved in immune response (GO:0002275),0.3124120590625932,0.6574827869591768,0.8172043010752689,1.0,1.0,3/18,15.86%,NMI;ENPP3;DYSF
prerank,endocardial cushion development (GO:0003197),0.3123840148429275,0.6573510349523604,0.8174807197943444,1.0,1.0,4/21,12.57%,BMPR1A;MDM4;BMP2;SOX9
prerank,cellular response to interleukin-6 (GO:0071354),-0.20311564029443735,-0.6573324323415738,0.9476439790575916,0.9648009660177467,1.0,8/26,22.91%,STAT3;ST3GAL6;PTPN11;SBNO2;ST18;CBL;PTPRT;JAK2
prerank,inositol phosphate dephosphorylation (GO:0046855),0.34360855370217575,0.6572371420739768,0.8461538461538461,1.0,1.0,4/11,20.92%,OCRL;INPP5B;PTEN;INPP5A
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.34360855370217575,0.6572371420739768,0.8461538461538461,1.0,1.0,4/11,20.92%,OCRL;INPP5B;PTEN;INPP5A
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.33494596260423243,0.6569444679900983,0.8381240544629349,1.0,1.0,4/11,22.20%,YBX3;CASP8;RIPK1;BIRC2
prerank,regulation of monocyte differentiation (GO:0045655),-0.23344984507786193,-0.656836066105846,0.9372822299651568,0.9643755588367258,1.0,2/14,5.29%,CDK6;ACIN1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.3334341176026859,0.6565284381742661,0.8288543140028288,1.0,1.0,2/12,14.43%,WNK1;MIA3
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.26165889174315965,-0.6563323044779438,0.9203539823008849,0.964010991860729,1.0,4/11,25.97%,XBP1;JAK2;TAF7;TMEM106A
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.29915820592409675,0.6562747878075882,0.817258883248731,1.0,1.0,3/24,8.09%,PRNP;FBXW7;FOXO3
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.3414516409828534,0.6551555780818672,0.8455538221528861,1.0,1.0,4/10,15.60%,PRKCB;ITGA5;ARNT;PRKD2
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.2206802540877157,-0.6551455039948946,0.9401408450704225,0.9641333705396894,1.0,4/18,16.81%,ATXN3;PIK3R1;DDIT3;XBP1
prerank,C-terminal protein amino acid modification (GO:0018410),0.3289772967017633,0.6537847397594788,0.8280542986425339,1.0,1.0,7/11,27.74%,ATG7;AGTPBP1;ICMT;ATG5;FOLH1;TTL;LCMT1
prerank,aminoglycan biosynthetic process (GO:0006023),0.28596602506506014,0.6535738793373352,0.8585526315789473,1.0,1.0,16/49,23.80%,B3GNT8;GPC6;SLC35D2;B4GALT7;HAS1;SDC1;HS2ST1;HSPG2;UGDH;B3GALT2;XYLT1;SDC4;GPC4;GCNT2;EXT1;GPC3
prerank,myelin assembly (GO:0032288),0.339719081551542,0.6527260501675068,0.8152011922503726,1.0,1.0,2/10,10.59%,TPPP;EPB41L3
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.25724417630258223,-0.6525220087247879,0.8842975206611571,0.965407479636617,1.0,3/11,19.55%,CTNNB1;LRP6;FZD1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.31280878043839677,0.6520103528966666,0.8579017264276229,1.0,1.0,8/21,23.20%,PDZD8;MCU;MCUB;MICU1;MAIP1;RAP1GDS1;MICU2;LETM1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.28808170536705885,0.651201856519206,0.8525943396226415,1.0,1.0,5/35,12.93%,IQGAP2;PDGFRA;TRPM2;NOTCH2;BAIAP2L1
prerank,Notch signaling involved in heart development (GO:0061314),0.3296854567633026,0.6511460991295439,0.8577777777777778,1.0,1.0,3/11,13.45%,RBPJ;NOTCH2;HEY2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.29815678874931867,0.6507455007209139,0.8337468982630273,1.0,1.0,7/27,15.84%,PML;FBXL8;FBXL17;PPP1CC;RBM4;PER1;TP53
prerank,regulation of myeloid cell differentiation (GO:0045637),0.2812337362775408,0.6505797435225512,0.8654266958424508,1.0,1.0,9/62,12.47%,RBM15;CBFB;MOV10;NFE2;LEO1;KMT2A;PRKCB;HDAC1;KMT2D
prerank,positive regulation of cell growth (GO:0030307),0.27596090368437953,0.6503585761843333,0.8984455958549222,1.0,1.0,19/96,17.03%,MACF1;HYAL1;CEP43;FXN;MMP14;NTN1;MAPT;DERL2;SFRP2;SMURF1;KLHL22;TGFBR1;ADAM17;USP47;RPTOR;INO80;DBN1;SFRP1;NGF
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.3234080220538918,0.6502058480439615,0.8370786516853933,1.0,1.0,4/13,16.98%,ABCA1;ITGB1;LPL;LDLR
prerank,dicarboxylic acid metabolic process (GO:0043648),0.27984674432225337,0.6501915394601502,0.867178924259056,1.0,1.0,20/52,26.06%,MTHFD1L;MTHFR;SLC19A1;HOGA1;DGLUCY;DHFR;GCLM;MTHFS;GCLC;ME3;L2HGDH;ACOT8;ME2;SLC25A32;IDH2;SDHA;ALDH18A1;FPGS;ME1;MTHFD2
prerank,mRNA catabolic process (GO:0006402),0.28757682845611265,0.6497019207453191,0.8728908886389202,1.0,1.0,12/44,18.77%,THRAP3;TUT7;MRTO4;LSM2;YTHDF2;DXO;TUT4;RC3H1;PNPT1;METTL3;EXOSC10;XRN2
prerank,body fluid secretion (GO:0007589),-0.23229749018213489,-0.6490260250782142,0.9273356401384083,0.9672192440294411,1.0,3/15,14.56%,ERBB4;NPR1;VEGFA
prerank,presynaptic endocytosis (GO:0140238),0.3076271512204165,0.6489320288790004,0.8431876606683805,1.0,1.0,8/24,21.90%,STON1;STON2;NLGN3;PIP5K1C;NLGN2;SNCA;VAMP2;CDK5
prerank,serine family amino acid catabolic process (GO:0009071),0.3431506113338667,0.6488607014202958,0.8260233918128655,1.0,1.0,1/10,6.77%,AMT
prerank,cell junction assembly (GO:0034329),0.27027335170382605,0.6488259313439567,0.9071207430340558,1.0,1.0,20/100,16.42%,SDK1;CDH18;CDH24;RHOA;OBSL1;NLGN3;GRHL2;RAB29;FARP1;GJC1;TLN1;LIMS1;CAPZA1;DSCAM;ACHE;PLXND1;TLN2;PTEN;NLGN2;SHANK2
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.2662335488943213,-0.6483018425873285,0.9005847953216374,0.9669919204167406,1.0,4/10,26.98%,LRP6;BMP7;ARHGAP12;SOX11
prerank,histone lysine demethylation (GO:0070076),0.3021500966301799,0.6480640941509854,0.8293601003764115,1.0,1.0,9/25,25.24%,PHF2;KDM2B;KDM5C;JMJD1C;KDM4B;KDM2A;HR;KDM1A;KDM5A
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.2767986256381772,0.647886964078538,0.8935721812434141,1.0,1.0,6/76,8.40%,PLK1;GSK3B;DDRGK1;FBXW7;LRRK2;SMURF1
prerank,magnesium ion transport (GO:0015693),-0.24713264159056683,-0.6477685990824954,0.8989547038327527,0.9666053067483423,1.0,2/12,5.21%,NIPA1;NIPA2
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.2552136946037331,-0.647585173053836,0.9056047197640118,0.9659358759913388,1.0,2/11,12.77%,DDX5;MAP2K1
prerank,phospholipid homeostasis (GO:0055091),-0.25437499537248087,-0.6474359371335346,0.9069767441860465,0.9652291333360681,1.0,5/11,35.14%,TLCD2;RCN3;TLCD1;ANGPTL3;ABCG1
prerank,regulation of vacuole organization (GO:0044088),0.30658650488086303,0.6469832791418498,0.847457627118644,1.0,1.0,5/20,18.96%,ANXA2;NPRL3;MTMR3;PIKFYVE;TBC1D12
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.26869611291911016,-0.6457434432737847,0.8803418803418803,0.9656626376598763,1.0,1/10,5.18%,PLEK
prerank,peripheral nervous system development (GO:0007422),0.29981158554957704,0.6451211484874405,0.8627450980392157,1.0,1.0,1/23,1.71%,ARTN
prerank,regulation of response to stress (GO:0080134),0.3378077783608767,0.6449777792048519,0.8511904761904762,1.0,1.0,3/10,18.43%,DYRK3;STOX1;SLC38A2
prerank,positive regulation of signal transduction (GO:0009967),0.271232087781464,0.6444566949703152,0.968,1.0,1.0,49/238,16.90%,LOXL3;MACF1;PHIP;DEPDC1B;FGFR2;ERFE;SULF2;ASXL1;MYO1C;TXNDC15;BMP6;NLGN3;JCAD;ZBTB7B;SULF1;TUBD1;CD80;LRRK2;AGPAT2;SMARCA4;ROBO1;YAP1;TGFBR1;LIMS1;TEDC1;CCN3;PRKCB;BMP2;PRKCA;RBPJ;RSPO3;AAK1;DMTN;GKAP1;TSPAN5;MAML1;PRKCI;ITGA5;ARNT;AGPAT1;ITGAV;SRC;PRKD2;PKD2;SFRP1;PTEN;NLGN2;SALL1;AXL
prerank,potassium ion transport (GO:0006813),0.27035249155583446,0.6442702270421727,0.908997955010225,1.0,1.0,16/120,15.61%,AQP1;CCDC51;KCNN4;KCNK2;KCNH4;KCNH8;SLC9A5;KCNJ13;SLC24A3;KCNMB2;KCNMB3;KCNK12;KCNK6;KCNMB4;KCNB2;PKD2
prerank,lipid droplet formation (GO:0140042),-0.25811979842471866,-0.6439487397445609,0.9285714285714286,0.9662261413549331,1.0,3/10,17.84%,CDS2;CDS1;AUP1
prerank,peptidyl-asparagine modification (GO:0018196),0.28918900430229694,0.6436377300165806,0.8522050059594756,1.0,1.0,10/31,22.74%,MAGT1;RPN2;STT3A;STT3B;ALG8;UBE2J1;OSTC;FUT8;DPM3;MCFD2
prerank,cholesterol transport (GO:0030301),0.2867621471814335,0.643541570780663,0.8737541528239202,1.0,1.0,8/45,16.98%,TSPO2;SOAT1;ABCA1;SOAT2;STARD3;RELCH;STX12;LDLR
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.29940135643074783,0.6432405080277688,0.8464373464373465,1.0,1.0,2/25,4.00%,GCK;GPI
prerank,positive regulation of phospholipase C activity (GO:0010863),0.2792357598062805,0.64300994138947,0.8660508083140878,1.0,1.0,5/40,10.42%,LPAR1;KIT;PDGFRA;GNAQ;ARHGAP6
prerank,tRNA metabolic process (GO:0006399),0.30906920387116105,0.642960046609891,0.851006711409396,1.0,1.0,7/17,24.79%,DARS2;RPP30;POP1;RPP21;FARS2;DTD1;SSB
prerank,cellular response to lipid (GO:0071396),0.269157924803094,0.6428973661671374,0.9619238476953907,1.0,1.0,37/191,20.28%,HMGB2;AQP1;SETX;TICAM1;ROCK2;RHOA;ABCB4;LCOR;SERPINE1;CD80;HTRA2;WNT6;HMGB1;NR3C1;AHR;WNT9A;SOX9;RORA;MED1;ADAM9;RUVBL2;RAMP3;ADCY6;NFKB1;LPL;SFRP1;MSN;AXL;EPHA3;SIRPA;ADCY2;MAPK14;PLAA;ADNP2;PDE4B;CD68;TRAF6
prerank,glucose catabolic process to pyruvate (GO:0061718),0.30084157821987356,0.6428203698926995,0.8576779026217228,1.0,1.0,2/24,4.00%,GCK;GPI
prerank,canonical glycolysis (GO:0061621),0.30084157821987356,0.6428203698926995,0.8576779026217228,1.0,1.0,2/24,4.00%,GCK;GPI
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.27730849248421763,0.6423841722723042,0.8776824034334764,1.0,1.0,13/67,17.68%,DYRK1A;FGFR4;FGFR2;KIT;PDGFRA;EPHA4;ABI1;DDR2;BTK;EFEMP1;SRC;EPHA3;ABI2
prerank,lipid translocation (GO:0034204),0.3094111585151596,0.6423435828040045,0.8660714285714286,1.0,1.0,3/21,11.79%,ABCA4;ABCB4;ABCA1
prerank,homeostasis of number of cells (GO:0048872),0.32638138040495274,0.6422951742575405,0.8663729809104258,1.0,1.0,3/12,15.53%,OCIAD2;CCN3;OCIAD1
prerank,cellular lipid catabolic process (GO:0044242),0.3024390739670414,0.6420731876695762,0.8404522613065326,1.0,1.0,7/27,24.10%,LPIN2;ENPP2;ACADL;ACOT8;SMPDL3B;SIRT2;LPIN3
prerank,myeloid leukocyte differentiation (GO:0002573),0.2728668726942145,0.6415440231736275,0.8711063372717508,1.0,1.0,7/65,12.77%,E2F1;DEK;KIT;PML;CDK2;CASP8;IL31RA
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.28458769070737805,0.6414932544846823,0.8546099290780141,1.0,1.0,5/36,10.49%,RB1;BCL2L12;CSNK2A2;NR4A2;TGFBR1
prerank,regulation of cytokine production (GO:0001817),0.2685733497656288,0.6413519956029528,0.9320486815415822,1.0,1.0,20/126,21.74%,POLA1;ERMAP;MAST2;AGPAT2;AGT;ATP2B1;ANXA1;CASP8;AGPAT1;PER1;SIRPA;FOXP1;CD47;MAPK14;NLRP4;LGR4;MAPKAPK2;ISG15;EIF2AK2;SOD1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.28834817964765463,0.6411390512715767,0.8696172248803827,1.0,1.0,12/34,27.35%,TICAM1;RAB7B;PTPRS;LGR4;SMPDL3B;GPR108;DAB2IP;NFKBIL1;ACOD1;NLRP2B;LY96;TLR3
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.20918617892316602,-0.640902580347256,0.935361216730038,0.9676859559678561,1.0,4/18,20.98%,BCL2;BNIP3;SLC25A4;BCL2L1
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.3357724191208811,0.640862554950017,0.8300561797752809,1.0,1.0,3/12,16.98%,IAPP;PFDN4;LDLR
prerank,regulation of lymphocyte differentiation (GO:0045619),0.3063105931548406,0.6406579000549382,0.8335517693315858,1.0,1.0,3/18,16.36%,PRKDC;IL4I1;METTL3
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.2730100060208634,0.640333502980796,0.9179487179487179,1.0,1.0,26/95,19.39%,TGFBR3L;PEG10;TGFBR3;PMEPA1;LEMD3;SMAD6;SMURF1;ADAMTSL2;TGFBR1;DKK3;SMURF2;NKX2-1;PDPK1;ADAM17;SMAD4;SPRED1;HTRA3;SMAD3;STK11;PIN1;SPRED2;VEPH1;SMAD2;SKIL;SKI;PPM1A
prerank,negative regulation of B cell activation (GO:0050869),-0.20930582444999823,-0.6400448349233142,0.9357798165137615,0.9675361662689596,1.0,13/21,42.66%,TNFRSF21;LYN;ATM;INHBA;CD300A;LAPTM5;TNFAIP3;TYROBP;INHA;FCGR2B;ID2;BANK1;FOXJ1
prerank,androgen receptor signaling pathway (GO:0030521),0.33516734479527444,0.6391112383992422,0.8478915662650602,1.0,1.0,3/11,12.29%,ARID1A;PMEPA1;PLPP1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.2665635821685383,0.6387596396685263,0.8975155279503105,1.0,1.0,29/86,24.78%,PSMC2;PSMD5;ELOC;CHEK1;PSMB1;PSMD14;LIMD1;VHL;PSMD1;PSMB9;STOX1;PSMC6;ARNT;INO80;TP53;PSMB2;PSME4;PSMB7;PSMD11;EGLN1;PSME3;PSMD13;EGLN3;PSMB8;PSMD4;PSMF1;PSMA5;HIF3A;PSMC3
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.2701765031721325,0.6381920462577515,0.886411889596603,1.0,1.0,24/70,24.78%,PSMC2;PSMD5;PSMB1;PSMD14;PSMD1;IKBKG;CYBB;PSMB9;PSMC6;ITGAV;SNAP23;PSMB2;PSME4;PSMB7;PSMD11;PSME3;SEC22B;IKBKB;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,transcription by RNA polymerase I (GO:0006360),0.2875743569113878,0.637935627071053,0.8725602755453502,1.0,1.0,6/34,13.17%,POLR1A;POLR1B;ERCC3;TAF1D;TTF1;POLR1G
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.21628294234598922,-0.6377365956382702,0.9728506787330317,0.9683773454684372,1.0,1/21,0.29%,CACNA2D1
prerank,positive regulation of actin nucleation (GO:0051127),0.3257796468642078,0.6373776788357072,0.861671469740634,1.0,1.0,5/11,23.40%,WASF2;NCKAP1;ABI2;WHAMM;WASF1
prerank,glycine metabolic process (GO:0006544),0.3274662767761237,0.6372326184923967,0.8328571428571429,1.0,1.0,1/12,6.77%,AMT
prerank,synaptic membrane adhesion (GO:0099560),-0.2382613554751029,-0.6370607908999945,0.9241379310344827,0.9681068569265725,1.0,4/14,15.67%,PTPRD;SLITRK1;NTNG1;LRRC4B
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.29398310021856483,0.6367865146593286,0.8594527363184079,1.0,1.0,8/25,20.35%,PDZK1;WNK1;AKAP9;STK39;GLRX;WNK3;SLC6A9;ANK3
prerank,cation transport (GO:0006812),0.2656358268885725,0.6367102313740949,0.9576612903225806,1.0,1.0,26/167,19.09%,RHAG;SLC18A2;AQP1;KCNN4;SLC38A7;KCNH4;KCNJ13;SLC8A1;KCNMB2;KCNMB3;TRPM2;PIEZO1;CHRNB1;TRPM4;KCNK6;KCNMB4;SLC22A18;KCNB2;KCNA1;SLC6A17;SLC36A4;SLC7A1;SLC6A9;SLC25A29;KCNQ4;TRPM6
prerank,regulation of sequestering of triglyceride (GO:0010889),0.31886995405323637,0.636588962508167,0.8451268357810414,1.0,1.0,3/15,15.78%,OSBPL8;PLIN2;LPL
prerank,glycolipid biosynthetic process (GO:0009247),0.28372348629928307,0.6364732773946131,0.8612059158134243,1.0,1.0,12/38,22.30%,LARGE1;PIGN;PIGA;ST3GAL5;PIGU;ST3GAL4;ST3GAL2;PIGM;DPM3;PIGG;A4GALT;PIGH
prerank,regulation of lipase activity (GO:0060191),0.3159096915185455,0.636014557391899,0.8490028490028491,1.0,1.0,4/13,20.67%,RHOA;RHOC;LPL;SNCA
prerank,androgen metabolic process (GO:0008209),0.2981987411546261,0.6359074286354391,0.8510911424903723,1.0,1.0,2/18,13.65%,SRD5A3;MED1
prerank,intestinal absorption (GO:0050892),-0.23942686442644232,-0.635729687771586,0.9111842105263158,0.9682372590177831,1.0,3/13,19.39%,F11R;ADRA2A;KCNQ1
prerank,actin filament network formation (GO:0051639),-0.24779541964000773,-0.6354552712385642,0.9017341040462428,0.9676082240968104,1.0,1/11,0.95%,PLS3
prerank,oligosaccharide metabolic process (GO:0009311),0.28186556746007596,0.6349092719461789,0.878021978021978,1.0,1.0,10/46,20.77%,B4GALT1;ST8SIA2;MPDU1;ST3GAL3;ST3GAL4;ST3GAL2;B3GALT2;MAN1B1;NAGA;FUT8
prerank,extracellular transport (GO:0006858),-0.24826546070547728,-0.6348690916538859,0.90625,0.9672076664400205,1.0,10/12,48.64%,TSG101;WWP2;CABYR;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.33478911635011444,0.6348079524771205,0.8511278195488722,1.0,1.0,2/11,12.07%,UAP1;GNPDA2
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.28339424318611395,0.6346303314827836,0.8761261261261262,1.0,1.0,3/44,4.82%,LBR;CYP39A1;PMVK
prerank,calcium ion transmembrane transport (GO:0070588),0.2705880933349064,0.6343288025930958,0.9112734864300627,1.0,1.0,24/86,20.73%,ATP2B4;TRPA1;STOML2;MCU;ATP2A2;SLC24A3;SLC8A1;MCUB;CACNA1C;TRPM2;TRPC7;ATP2B1;MICU1;TRPM4;PMPCA;ITGAV;MAIP1;PKD2;GRIN2D;TRPV4;TRPM6;CACNA1G;SPG7;MICU2
prerank,methylguanosine-cap decapping (GO:0110156),0.33118085837236017,0.6337212064998239,0.8353474320241692,1.0,1.0,1/10,4.27%,PATL1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.29434951128493114,0.6336730880192736,0.848180677540778,1.0,1.0,6/26,15.86%,ROCK2;ALMS1;ROCK1;RAC1;SYNPO2;FHOD1
prerank,heterocycle biosynthetic process (GO:0018130),-0.24211404723530455,-0.6333307348373692,0.9326599326599326,0.9674711677256177,1.0,4/14,15.53%,LIAS;MOCS2;MOCS1;GCH1
prerank,regulation of myoblast differentiation (GO:0045661),-0.1776900294984155,-0.6330248619701898,0.96875,0.9669021467206101,1.0,7/32,20.56%,MEF2C;BOC;TBX3;BTG1;LRRC8A;SRA1;HIF1AN
prerank,embryonic appendage morphogenesis (GO:0035113),0.319034217316444,0.6328063071805607,0.8488372093023255,1.0,1.0,1/12,3.24%,CYP26B1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.27327047797247955,0.632686409150677,0.9030883919062833,1.0,1.0,9/63,9.58%,BMF;DAP;EIF4E;LEPR;NRDE2;KLHL22;MTMR2;ROCK1;MTMR9
prerank,positive regulation of interleukin-17 production (GO:0032740),0.2950734705270742,0.6321367882183349,0.8544061302681992,1.0,1.0,2/22,7.81%,IL18;ZBTB7B
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.302457740185353,0.631983989672681,0.8741721854304636,1.0,1.0,2/18,10.81%,GSK3B;BOK
prerank,iron ion homeostasis (GO:0055072),0.2712694858682849,0.631910802412666,0.8977149075081611,1.0,1.0,16/58,22.01%,FXN;ERFE;CYB561A3;BMP6;PICALM;SMAD4;CCDC115;ACO1;ALAS2;BDH2;CAND1;NUBP1;FRRS1;ATP6V0A2;SOD1;NEDD8
prerank,epithelial cell development (GO:0002064),0.3071133297987855,0.6316908083194754,0.8496732026143791,1.0,1.0,2/20,7.11%,GRHL2;RILPL1
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.22155762206151752,-0.6315869553576267,0.9514925373134329,0.9671161448917588,1.0,3/17,10.54%,FIS1;SOD2;BCL2
prerank,modulation by host of symbiont process (GO:0051851),0.2819001893122479,0.6312655741603217,0.8539976825028969,1.0,1.0,6/31,17.40%,AQP1;NUCKS1;SMARCA4;HDAC1;CHD1;TFAP4
prerank,zinc ion transmembrane transport (GO:0071577),0.29309638378495867,0.631150030811903,0.8562340966921119,1.0,1.0,5/22,15.03%,SLC39A11;TRPM2;SLC39A8;SLC39A6;SLC30A10
prerank,protein secretion (GO:0009306),0.27307347599310045,0.6310923227816883,0.8631465517241379,1.0,1.0,14/56,21.51%,STEAP3;RAB10;PORCN;SVBP;ANXA1;ABCA1;NAGPA;MIA3;SNX19;RAB13;TMEM167A;RAB3A;RAB8B;PPY
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.23397963266409383,-0.6310235549588121,0.9405940594059405,0.9667074578462304,1.0,7/13,36.10%,PTPRT;JAK2;EGF;MGAT5;PTPRC;CRLF2;JAK3
prerank,defense response to fungus (GO:0050832),-0.22416174808489264,-0.6309695300485412,0.9302325581395349,0.9659336677696274,1.0,17/17,77.61%,GAPDH;CX3CR1;HRG;S100A9;CARD9;CLEC4D;S100A8;CLEC6A;LTF;RARRES2;CLEC4E;DEFB119;NLRP10;RNASE7;PLCG2;BCL10;FAM3A
prerank,response to insulin (GO:0032868),0.2684358839054954,0.6301355600017767,0.9036269430051813,1.0,1.0,28/80,24.34%,GCK;RAB10;PRKDC;PDE3B;DENND4C;LPIN2;ZBTB7B;RHOQ;CPEB2;ENPP1;PDPK1;PRKCI;EPRS1;PCK2;RAB13;INSIG2;SLC2A4;SYAP1;CEACAM1;INSIG1;FER;RAB8B;VAMP2;ZFP36L1;SLC25A33;RAB8A;LPIN3;RPS6KB1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.31358634717724543,0.6300574330118716,0.8607038123167156,1.0,1.0,3/13,13.94%,DDRGK1;NCK1;PPP1R15B
prerank,ERBB signaling pathway (GO:0038127),0.26742158530479054,0.6298593922251623,0.9122055674518201,1.0,1.0,13/64,15.34%,MATK;GAREM1;CUL5;GAB1;PRKCA;PDPK1;NCK2;ADAM17;SOX9;SLC30A10;AAMP;EFEMP1;SRC
prerank,focal adhesion assembly (GO:0048041),0.2986940354927326,0.6293587550878402,0.8737373737373737,1.0,1.0,7/21,20.82%,TRIP6;SRC;RCC2;PTPRK;TESK2;WHAMM;FERMT2
prerank,Wnt signaling pathway (GO:0016055),0.2712447809928001,0.6292377456083527,0.9209445585215605,1.0,1.0,29/92,24.27%,GSK3B;TCF7L1;WNT2B;TCF7L2;SFRP2;PORCN;LRRK2;WNT6;NR4A2;WNT9A;CSNK1G2;LRP5;BTRC;SFRP1;PTEN;VPS26A;AMER1;CSNK1A1;CSNK1G1;FRZB;WNT4;FERMT2;CSNK1E;NXN;ZRANB1;GPC4;TCF7;WLS;AXIN1
prerank,photoperiodism (GO:0009648),0.28713473062930417,0.6292034759288585,0.8601226993865031,1.0,1.0,7/28,15.84%,PML;FBXL8;FBXL17;PPP1CC;RBM4;PER1;TP53
prerank,autophagosome assembly (GO:0000045),0.2761409274530346,0.6290993020558319,0.8886438809261301,1.0,1.0,16/52,22.42%,ATG7;MFN2;SMURF1;ATP2A2;RAB1A;RB1CC1;ULK2;ATG3;ATG2A;STX12;UBXN2B;TRAPPC8;TP53INP2;AMBRA1;ATG13;ATG5
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.31145423388473215,0.628328578179734,0.8486562942008486,1.0,1.0,2/13,10.56%,GPRC5A;ERRFI1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.28251010780027663,0.6282483749844251,0.8579881656804734,1.0,1.0,2/32,6.20%,RNASE6;HMGN2
prerank,cellular glucan metabolic process (GO:0006073),0.32225650474622813,0.6274328760966434,0.8602941176470589,1.0,1.0,1/11,3.51%,GSK3B
prerank,positive regulation of wound healing (GO:0090303),0.27802713793263245,0.6264892364991221,0.8838268792710706,1.0,1.0,8/36,14.28%,HPSE;SERPINE1;ANXA1;DMTN;PRKCE;INSL3;ST3GAL4;ITGB1
prerank,aminoglycan catabolic process (GO:0006026),0.2930448865955971,0.6263716301904553,0.87468671679198,1.0,1.0,3/28,10.42%,HPSE;GPC6;SDC1
prerank,positive regulation of cell adhesion (GO:0045785),0.27155754054091086,0.626023239859821,0.9099476439790576,1.0,1.0,13/74,15.60%,HYAL1;AFDN;NPNT;SFRP2;PPP3CA;EPHA4;RSU1;LIMS1;RAC1;PRKCA;ADAM9;ITGAV;PRKD2
prerank,regulation of mitochondrial depolarization (GO:0051900),0.3306776295270899,0.6259900933327811,0.8577777777777778,1.0,1.0,2/10,15.34%,LRRK2;SRC
prerank,sensory organ development (GO:0007423),0.2743550047464848,0.6258900078315743,0.8995633187772926,1.0,1.0,2/51,2.57%,PBX4;PBX3
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.24147127438129917,-0.6258397608221292,0.9314641744548287,0.9684658912725137,1.0,7/12,39.87%,BCL2;TAF9B;CD74;MIF;RPL26;TAF9;TRIAP1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.26846225035415383,0.6258224083100821,0.9137577002053389,1.0,1.0,30/88,23.38%,AP4M1;GBF1;RAB10;EXOC4;ACBD3;ARRB1;VPS13A;SH3D19;DNM2;CLVS2;SCFD1;TXNDC5;EXOC8;CLINT1;AP1B1;SNAP23;AP1M1;EPS15;CLTA;MON2;SCAMP2;ARF1;DNAJC6;EXOC2;VAMP2;MYO1B;SCAMP3;NAPA;HSPA8;GOLGB1
prerank,toll-like receptor signaling pathway (GO:0002224),0.2669552221074628,0.625744835882584,0.9106957424714434,1.0,1.0,11/84,13.10%,FADD;TICAM1;COLEC12;TAB1;NMI;MAP3K1;HMGB1;IKBKG;MAPKAPK3;CASP8;BTK
prerank,regulation of T cell migration (GO:2000404),0.3003777492294861,0.6252709665109286,0.8794701986754967,1.0,1.0,2/18,8.81%,RHOA;RIPOR2
prerank,regulation of cholesterol esterification (GO:0010872),-0.25630652031263396,-0.6251205321559147,0.9149560117302052,0.9681146877557145,1.0,2/10,12.21%,APOE;AGTR1
prerank,Fc receptor signaling pathway (GO:0038093),0.2616744388638416,0.6249916881673321,0.9381965552178319,1.0,1.0,40/110,24.78%,PSMC2;PSMD5;KIT;TAB1;MAP3K1;VAV2;PPP3CA;PSMB1;PSMD14;PSMD1;IKBKG;PIK3CB;PSMB9;RAC1;FBXW11;PDPK1;BTK;BTRC;PSMC6;NFKB1;PPP3R1;PSMB2;PSME4;PSMB7;NFATC3;PSMD11;TRAF6;PSME3;FER;IKBKB;PSMD13;PSMB8;GAB2;PSMD4;BCL10;PSMF1;PPP3CB;PSMA5;RELA;PSMC3
prerank,cellular response to estrogen stimulus (GO:0071391),-0.2331451295688951,-0.624964422147373,0.9264214046822743,0.9674244473006854,1.0,5/14,20.55%,AR;SFR1;SERPINB9;SRA1;WBP2
prerank,muscle cell development (GO:0055001),0.28189327333681796,0.6249429388905833,0.881437125748503,1.0,1.0,6/30,15.86%,MYOF;SLC8A1;SDC1;CHRNB1;HEY2;DYSF
prerank,synaptic vesicle endocytosis (GO:0048488),0.2855722593797627,0.6246968879451608,0.8747016706443914,1.0,1.0,13/33,21.90%,STON1;STON2;NLGN3;DNM2;PICALM;GAK;PIP5K1C;NLGN2;SNCA;DNAJC6;SNAP91;VAMP2;CDK5
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.28640196829678466,0.624626093856406,0.8350125944584383,1.0,1.0,4/25,9.92%,KLHL15;CUL3;LONP1;FBXL17
prerank,heart process (GO:0003015),0.3083326845470442,0.6244074224544925,0.8536231884057971,1.0,1.0,4/14,22.81%,NOX4;RAMP3;SOD1;FYN
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.3045066154174907,0.6242739598845686,0.8582995951417004,1.0,1.0,3/15,14.05%,UST;DSE;BGN
prerank,positive regulation of embryonic development (GO:0040019),-0.21421003115574747,-0.6237759869188315,0.9464285714285714,0.967373346644579,1.0,6/19,28.88%,B4GALT5;NR2C2;TENM4;RACK1;ZBED3;PLCB1
prerank,substantia nigra development (GO:0021762),0.2757080836073384,0.6237142160995308,0.8761574074074074,1.0,1.0,5/37,10.94%,RHOA;RAD1;CCDC14;MAPKAP1;CALM2
prerank,positive regulation of metabolic process (GO:0009893),0.2598632513114253,0.6229664205965083,0.9274770173646578,1.0,1.0,18/103,14.69%,MFAP2;LEPR;PIGA;CXCR4;IL18;ZBTB7B;MFN2;ALMS1;CAMK1D;ACACA;APPL2;ACHE;GJA1;ADIPOR1;ADRB2;CPT2;ACADL;AGPAT1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.321192823240088,0.622907562191918,0.865606936416185,1.0,1.0,7/13,28.19%,UAP1;GNPDA2;SLC35A3;AMDHD2;GFPT1;GFPT2;PGM3
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.29025925958571147,0.6220265620675777,0.8696774193548387,1.0,1.0,4/21,19.63%,EYA4;EYA2;GDNF;TERT
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.29025925958571147,0.6220265620675777,0.8696774193548387,1.0,1.0,4/21,19.63%,EYA4;EYA2;GDNF;TERT
prerank,O-glycan processing (GO:0016266),0.26698742747009574,0.6218050881186186,0.8961038961038961,1.0,1.0,8/54,15.47%,GALNT1;B3GNT8;ST3GAL3;C1GALT1;POFUT1;ST3GAL4;ST3GAL1;ST3GAL2
prerank,positive regulation of monooxygenase activity (GO:0032770),0.2901228353361691,0.6214361356858348,0.8589420654911839,1.0,1.0,6/26,19.63%,NPR3;PIK3CB;TERF2;DHFR;GDNF;TERT
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.26244801249252975,0.621286553505436,0.9244126659856997,1.0,1.0,28/104,19.74%,BMPR1A;PEG10;PMEPA1;CRIM1;LEMD3;SMAD6;SMURF1;ADAMTSL2;TGFBR1;RBPMS2;SMURF2;CCN3;BMP2;NKX2-1;PDPK1;ADAM17;SMAD4;SPRED1;HTRA3;SMAD3;PIN1;SPRED2;VEPH1;SMAD2;SKIL;SKI;PPM1A;UBE2D3
prerank,negative regulation of cell motility (GO:2000146),0.2590961310385621,0.6209182108521663,0.9276248725790011,1.0,1.0,25/108,18.10%,ARID2;STK24;RAP2A;AFDN;SFRP2;EPHA4;SULF1;SERPINE1;FOXO3;TMEFF2;ROBO1;SRGAP2;SRGAP3;NKX2-1;CLIC4;DPYSL3;MIA3;PTPRU;PIN1;NF2;SFRP1;PTEN;PTPRK;SLURP1;DPEP1
prerank,synaptic vesicle membrane organization (GO:0048499),0.29845246151050314,0.6204837559298846,0.8582781456953642,1.0,1.0,4/17,15.69%,STX11;STX2;SYP;SNAP23
prerank,negative regulation of stem cell differentiation (GO:2000737),0.3100372530509044,0.6202129308701158,0.8507890961262554,1.0,1.0,2/12,10.57%,HNRNPU;YTHDF2
prerank,phagolysosome assembly (GO:0001845),0.3108596909908255,0.6200781100455626,0.8725212464589235,1.0,1.0,1/12,4.46%,RAB7B
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.2880190566721092,0.6195390569202537,0.8664921465968587,1.0,1.0,1/21,2.15%,NAP1L1
prerank,platelet aggregation (GO:0070527),0.2804797644407753,0.6194883228516235,0.8757396449704142,1.0,1.0,11/33,22.89%,PDGFRA;PIK3CB;TLN1;CLIC1;STXBP1;FERMT3;METAP1;UBASH3B;FLNA;VCL;MYH9
prerank,inflammatory response (GO:0006954),0.2582575568616248,0.6191014992177166,0.9819458375125376,1.0,1.0,17/195,12.85%,LOXL3;MMP25;SCUBE1;HYAL1;KIT;CXCR4;IL18;BDKRB2;NOX4;HMGB1;IKBKG;CYBB;PXK;BMP2;ANXA1;RAC1;ITCH
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.2577826731563198,0.6180903648119175,0.985,1.0,1.0,35/234,14.35%,TRIM37;TRIML2;TICAM1;TFDP1;DDRGK1;RAB7B;KIT;DHX9;SRF;TAB1;STK3;ANXA3;RTKN2;IL18;UBE2N;TAF12;RNF31;SMARCA4;AGT;IKBKG;ERC1;EDA;DDR2;CAMK1D;FLOT2;PRKCB;TRIM6;BTK;ROR1;SLCO3A1;PPRC1;PRKD1;PRKCI;TRIM5;SMAD3
prerank,mitochondrial membrane organization (GO:0007006),0.27780602767950446,0.6174108768250177,0.8849347568208779,1.0,1.0,11/32,22.02%,TMEM11;MFN2;CHCHD3;APOO;MAIP1;MFN1;MICOS10;BAD;SLC25A5;SPG7;IMMT
prerank,protein insertion into membrane (GO:0051205),0.28074660932696927,0.6171899682499759,0.8834720570749108,1.0,1.0,9/32,21.75%,PRNP;TRAM2;EMD;MAIP1;VAPA;CYB5A;TRAM1;CCDC47;VAMP2
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.2591284380633914,0.6169904939124995,0.9495459132189707,1.0,1.0,21/128,14.35%,TGFBR3L;BMPR1A;RHOA;NLK;RGMA;HIVEP1;BMP6;TGFBR3;SMAD6;SMURF1;ZFYVE16;TGFBR1;SMURF2;ARHGEF18;BMP2;APPL2;SMAD4;USP9X;ADAM9;ITGB1;SMAD3
prerank,acyl-CoA biosynthetic process (GO:0071616),0.30285431521457873,0.6163099651562729,0.8777173913043478,1.0,1.0,3/16,11.74%,ACAT1;ACSS1;ACACA
prerank,aerobic respiration (GO:0009060),0.2905120067645043,0.6159215658484082,0.8728179551122195,1.0,1.0,1/20,2.45%,MTFR2
prerank,regulation of RNA metabolic process (GO:0051252),0.2644503538075613,0.6157010386353649,0.9020452099031216,1.0,1.0,12/59,13.97%,TRA2B;MBNL3;HNRNPH1;FUS;RC3H2;YTHDF2;HNRNPL;HNRNPH2;METTL4;PTBP2;MED1;RC3H1
prerank,Golgi ribbon formation (GO:0090161),-0.22758725382996767,-0.6156541032027676,0.9516129032258065,0.9715815569998343,1.0,2/13,9.91%,STX6;MYO18A
prerank,amino sugar biosynthetic process (GO:0046349),0.3193966836043348,0.6152368068872822,0.8831360946745562,1.0,1.0,2/12,12.07%,UAP1;GNPDA2
prerank,modulation by host of viral genome replication (GO:0044827),0.3018898362197786,0.6152315997899805,0.8631875881523272,1.0,1.0,3/13,15.29%,FMR1;NUCKS1;VAPA
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.2595927202913022,0.6145103637328,0.9202127659574468,1.0,1.0,22/70,24.98%,FADD;GSK3B;CASP8AP2;TNFRSF10B;BOK;PDPK1;CASP8;SMAD3;ITGAV;NGF;BAD;HIPK1;RIPK1;TRAF2;APPL1;DAXX;IL6R;DAB2IP;BID;BAX;TGFB1;MCL1
prerank,negative regulation of leukocyte migration (GO:0002686),0.3226416561528122,0.6143697685791831,0.8748091603053435,1.0,1.0,1/10,6.52%,HOXA7
prerank,regulation of protein polymerization (GO:0032271),0.2808027201317504,0.6142900429769359,0.8655660377358491,1.0,1.0,4/35,9.20%,ARHGAP28;ARHGAP18;MAPT;TPPP
prerank,response to interferon-gamma (GO:0034341),-0.14474385246838475,-0.6140307824493805,1.0,0.9717245204036502,1.0,13/67,20.22%,NUB1;TLR4;IFITM3;CX3CL1;GBP3;GBP4;GCH1;BST2;IFITM2;RPL13A;LGALS9;GAPDH;GBP6
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.2761483430034682,0.6139852987189417,0.9030786773090079,1.0,1.0,8/38,18.40%,ATP2B4;ROCK2;RAC1;SMAD3;PKD2;SIRPA;CD47;PTGIS
prerank,steroid biosynthetic process (GO:0006694),0.2657485923629043,0.6134743104990156,0.9048648648648648,1.0,1.0,3/56,4.82%,LBR;CYP39A1;PMVK
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.25878301958103017,0.6130510276949928,0.93125,1.0,1.0,17/80,19.38%,GBF1;RAB7B;SPAG9;SNX1;DENND2A;RAB29;ERC1;DENND5A;VTI1A;GOSR1;SNX32;TRAPPC10;VPS26A;RIC1;PIKFYVE;TBC1D10A;BET1L
prerank,cellular response to lectin (GO:1990858),0.26033936561581117,0.6129280368487401,0.9470468431771895,1.0,1.0,35/104,24.78%,PSMC2;PSMD5;TAB1;PSMB1;PSMD14;PSMD1;IKBKG;PSMB9;FBXW11;PDPK1;BTRC;PSMC6;SRC;NFKB1;PSMB2;NRAS;KRAS;PSME4;PSMB7;RELB;PRKCD;PSMD11;TRAF6;PSME3;IKBKB;PSMD13;PSMB8;FYN;PSMD4;BCL10;PSMF1;PRKACA;PSMA5;RELA;PSMC3
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.26033936561581117,0.6129280368487401,0.9470468431771895,1.0,1.0,35/104,24.78%,PSMC2;PSMD5;TAB1;PSMB1;PSMD14;PSMD1;IKBKG;PSMB9;FBXW11;PDPK1;BTRC;PSMC6;SRC;NFKB1;PSMB2;NRAS;KRAS;PSME4;PSMB7;RELB;PRKCD;PSMD11;TRAF6;PSME3;IKBKB;PSMD13;PSMB8;FYN;PSMD4;BCL10;PSMF1;PRKACA;PSMA5;RELA;PSMC3
prerank,regulation of lipid catabolic process (GO:0050994),0.3002969567776449,0.6123721410405328,0.8709256844850065,1.0,1.0,1/19,4.92%,PDE3B
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.2590271468448178,0.6123289727816568,0.9237199582027168,1.0,1.0,19/87,17.84%,TGFBR3L;BMPR1A;RHOA;NLK;TGFBR3;SMAD6;SMURF1;TGFBR1;ARHGEF18;APPL2;SMAD4;USP9X;ADAM9;ITGB1;SMAD3;SRC;PTPRK;ZFYVE9;SMAD2
prerank,regulation of programmed cell death (GO:0043067),0.25746364002964034,0.6119368604974075,0.9586693548387096,1.0,1.0,18/161,12.57%,BIRC5;STEAP3;ACTN4;ANP32B;AIFM2;RBM25;TMEM219;LRRK2;TNFRSF10B;KANK2;SKP2;AGT;GAS1;APAF1;NDRG1;ANP32E;CHM;SOX9
prerank,plasma membrane organization (GO:0007009),0.2626155011460572,0.6119256966632295,0.915948275862069,1.0,1.0,19/61,22.89%,PLSCR2;PACSIN2;CXCR4;MYOF;STX2;SNX33;EPB41L3;SYTL4;SMPD1;DYSF;CHMP4A;FA2H;RAB3A;UGCG;ANK3;WHAMM;A4GALT;SNX9;MYH9
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.2569064864836666,0.6118983559088469,0.9658634538152611,1.0,1.0,18/150,12.29%,HPSE;FGFR4;FGFR2;IAPP;KIT;FRS2;TCF7L2;IL18;PDGFRA;TXN;CD80;ANGPT1;OSBPL8;PIK3CB;TGFBR1;GAB1;RAC1;PDPK1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.31790320760260316,0.6118894748922352,0.8760932944606414,1.0,1.0,4/10,24.18%,PPP3CA;PPP3R1;NFATC3;PPP3CB
prerank,calcineurin-mediated signaling (GO:0097720),0.31790320760260316,0.6118894748922352,0.8760932944606414,1.0,1.0,4/10,24.18%,PPP3CA;PPP3R1;NFATC3;PPP3CB
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.25960612673706107,0.6118254961242966,0.9471007121057986,1.0,1.0,35/105,24.78%,PSMC2;PSMD5;TAB1;PSMB1;PSMD14;PSMD1;IKBKG;PSMB9;FBXW11;PDPK1;BTRC;PSMC6;SRC;NFKB1;PSMB2;NRAS;KRAS;PSME4;PSMB7;RELB;PRKCD;PSMD11;TRAF6;PSME3;IKBKB;PSMD13;PSMB8;FYN;PSMD4;BCL10;PSMF1;PRKACA;PSMA5;RELA;PSMC3
prerank,glycoprotein catabolic process (GO:0006516),0.2911657586727118,0.6108503949289492,0.8858695652173914,1.0,1.0,4/17,14.94%,ADAMTS9;STT3B;FBXO27;FBXO17
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.30279381305289105,0.6108239294324952,0.8785425101214575,1.0,1.0,1/16,5.54%,RAET1E
prerank,activation of phospholipase C activity (GO:0007202),0.2710873622331549,0.6106213478800436,0.8802469135802469,1.0,1.0,3/29,10.42%,LPAR1;GNAQ;ARHGAP6
prerank,detection of mechanical stimulus (GO:0050982),0.29185312170001676,0.610356244500736,0.8575233022636485,1.0,1.0,7/19,22.37%,PKD2L2;PIEZO1;LHFPL5;PKD2;CSRP3;PIEZO2;PKD1L2
prerank,cellular iron ion homeostasis (GO:0006879),0.26394878239729064,0.6099895361532554,0.9116022099447514,1.0,1.0,14/55,22.01%,FXN;ERFE;CYB561A3;BMP6;SMAD4;CCDC115;ACO1;ALAS2;CAND1;NUBP1;FRRS1;ATP6V0A2;SOD1;NEDD8
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.23783042218083206,-0.6098997676638689,0.9201183431952663,0.9732716113279759,1.0,4/12,33.79%,ESR1;ZC3H12A;ZC3H10;PPARG
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2860505657120774,0.6097104272223637,0.8805970149253731,1.0,1.0,4/25,12.86%,RNF168;LEO1;HNRNPU;BRD4
prerank,positive regulation of filopodium assembly (GO:0051491),0.28372825335054946,0.6090328650348975,0.8788265306122449,1.0,1.0,5/24,12.83%,FMR1;RHOQ;RIPOR2;DOCK11;DPYSL3
prerank,regulation of cardiac conduction (GO:1903779),0.26034509257540384,0.6089077209167566,0.9002169197396963,1.0,1.0,9/54,16.01%,ATP2B4;ITPR1;ATP2A2;SLC8A1;AGT;ATP2B1;ITPR3;TMEM65;STIM1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.29473637985775897,0.6087053085505048,0.8793103448275862,1.0,1.0,2/16,6.07%,PIGN;PIGA
prerank,positive regulation of neuron death (GO:1901216),0.26569279982382266,0.6080017336946297,0.9033333333333333,1.0,1.0,5/46,9.56%,GSK3B;PRNP;MAPT;FOXO3;PICALM
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.2102785039470617,-0.6075196728313808,0.9401709401709402,0.9737889180371586,1.0,10/18,40.86%,HEATR1;WDR75;ERBB2;POLR2K;MAF1;LYAR;SIRT7;POLR2L;WDR43;RASL11A
prerank,negative regulation of inflammatory response (GO:0050728),-0.13649497389978554,-0.6075084749891912,1.0,0.9729982742580706,1.0,22/182,11.67%,TEK;CALCRL;APOE;IGF1;KLF4;CDH5;PLCG1;RAMP1;LYN;RAMP2;GGT5;FURIN;OTULIN;PRKACB;SELENOS;NR1H3;RPS19;GRN;TNFAIP6;PRKAR1B;TNFRSF1B;HTR4
prerank,regulation of Notch signaling pathway (GO:0008593),0.2585179435619919,0.6074405921874773,0.9348739495798319,1.0,1.0,17/76,16.36%,MMP14;DLK1;ARRB1;FBXW7;YAP1;LLGL2;YTHDF2;POFUT1;ARRDC1;CCN3;RBPJ;AAK1;TSPAN5;MAML1;PRKCI;SRC;METTL3
prerank,B cell differentiation (GO:0030183),0.265359977938067,0.6071748555165156,0.9021372328458943,1.0,1.0,6/46,15.44%,FNIP1;KIT;PTPN2;ADAM17;ITGB1;DCAF1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.2839413859844589,0.6070862062580192,0.8772378516624041,1.0,1.0,6/24,15.10%,TAB1;UBE2N;IKBKG;CASP8;ITCH;AAMP
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.27950581389893125,0.6069484534230372,0.8677184466019418,1.0,1.0,6/27,15.78%,IL18;AGT;ABCA1;ITGAV;NFKB1;LPL
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.2583156137777506,0.6062767650268298,0.9010638297872341,1.0,1.0,5/76,6.68%,SETD6;TRIM37;DAP;FAF1;ARRB1
prerank,T-helper cell differentiation (GO:0042093),0.3047171236799294,0.6062433343181995,0.8646723646723646,1.0,1.0,4/14,19.43%,HMGB1;TMEM98;FOXP1;ZFPM1
prerank,ubiquinone metabolic process (GO:0006743),0.29791175751920085,0.6058761919051243,0.8690140845070422,1.0,1.0,2/15,7.09%,AIFM2;COQ10B
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.31213944009392847,0.6057908853690286,0.8547655068078669,1.0,1.0,2/10,13.82%,ACTN4;RARB
prerank,blood vessel endothelial cell migration (GO:0043534),0.28773617020685677,0.6055811433024296,0.8804204993429697,1.0,1.0,5/22,14.43%,SRF;ROBO1;NR4A1;EFNB2;MIA3
prerank,negative regulation of response to external stimulus (GO:0032102),0.25783109644513985,0.6052633297734774,0.95097037793667,1.0,1.0,14/105,13.74%,RB1;RTN4R;CASK;NMI;PTPN2;EPHA4;ENPP3;SERPINE1;CCN3;PTPRS;ILRUN;ITCH;RORA;MVK
prerank,regulation of lymphocyte activation (GO:0051249),0.3011110413658904,0.6043847625188979,0.8690476190476191,1.0,1.0,12/12,69.91%,KAT2A;SIT1;CD4;CD19;LCK;CRTAM;CCL5;THEMIS2;IKZF3;LAT;DCAF15;PAG1
prerank,negative regulation of ATPase activity (GO:0032780),0.2882199572222729,0.6036409388293982,0.8917112299465241,1.0,1.0,3/16,15.84%,PXK;ATP5IF1;TP53
prerank,regulation of neurotransmitter secretion (GO:0046928),0.27161819366593987,0.6035949269209767,0.8896713615023474,1.0,1.0,4/32,8.30%,GSK3B;FMR1;VPS18;LRRK2
prerank,secondary alcohol metabolic process (GO:1902652),0.26965866127681637,0.6034626397814686,0.9056818181818181,1.0,1.0,6/42,15.52%,IDH3A;SOAT1;SCAP;ABCA1;SOAT2;STARD3
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.20915038900813387,-0.603460098899312,0.916058394160584,0.9743479759618405,1.0,7/16,41.00%,PTPN22;TNFRSF1B;FGF10;SOX11;TNFSF8;IL27;LST1
prerank,regulation of endothelial cell migration (GO:0010594),0.25555352539561715,0.6032957009445192,0.9256965944272446,1.0,1.0,16/85,15.60%,ATOH8;ANGPT4;ROCK2;GPI;ANXA3;ADAMTS9;ANGPT1;AGT;SVBP;PIK3CB;RAC1;RRAS;PRKCA;PRKD1;AAMP;PRKD2
prerank,activation of adenylate cyclase activity (GO:0007190),-0.174558407978827,-0.6032337940062872,0.9798657718120806,0.9736934039809467,1.0,5/35,14.87%,CAP1;LGR5;ADCY3;ADCY8;ADCY4
prerank,peptide catabolic process (GO:0043171),0.28412764661486845,0.6031643667102413,0.8657894736842106,1.0,1.0,6/23,18.10%,LVRN;CPQ;TRHDE;CTSH;NPEPPS;DPEP1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.2614353940674179,0.6024780151782884,0.9118303571428571,1.0,1.0,6/46,10.83%,PRKDC;TCF7L2;IL18;MFN2;ELN;RBPMS2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.2969567667648018,0.6018654088252019,0.8758344459279038,1.0,1.0,1/17,5.54%,RAET1E
prerank,axon extension (GO:0048675),0.29196675370093994,0.6017987062929451,0.879746835443038,1.0,1.0,5/23,13.54%,ALCAM;AUTS2;NLGN3;ULK2;USP9X
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.2512478981445131,0.6016384964633819,0.9521871820956256,1.0,1.0,14/136,13.73%,SETD6;TRIM37;PAXIP1;RB1;DAP;TAF3;PRNP;TCF7L2;ARRB1;PIM1;PYDC1;HDAC2;ITCH;BTRC
prerank,adrenergic receptor signaling pathway (GO:0071875),0.2905734903438529,0.6010865828852701,0.8981481481481481,1.0,1.0,3/20,16.80%,LMBRD2;ADRB2;ZDHHC21
prerank,plasma membrane tubulation (GO:0097320),0.30292348660309687,0.6009781039577607,0.8933333333333333,1.0,1.0,6/13,24.32%,PACSIN2;SNX33;CHMP4A;WHAMM;SNX9;EHD2
prerank,homotypic cell-cell adhesion (GO:0034109),0.26640763067581574,0.6007362360257885,0.8986332574031891,1.0,1.0,12/39,22.89%,PDGFRA;PIK3CB;TLN1;TJP2;CLIC1;STXBP1;FERMT3;METAP1;UBASH3B;FLNA;VCL;MYH9
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.2807802298387719,0.6007321140387312,0.8910648714810282,1.0,1.0,4/24,11.75%,MAP4K4;ROCK1;LIMS1;RAC1
prerank,positive regulation of calcium ion import (GO:0090280),-0.231852414051158,-0.6001301627897888,0.946031746031746,0.9745527651857536,1.0,1/12,4.17%,PDGFRB
prerank,modulation by symbiont of entry into host (GO:0052372),0.28880042664840755,0.5998675473820234,0.8867403314917127,1.0,1.0,3/16,14.24%,TRIML2;TRIM6;TRIM5
prerank,positive regulation of phospholipid transport (GO:2001140),0.31649996577832246,0.5997810272489115,0.8826979472140762,1.0,1.0,1/10,4.58%,ABCB4
prerank,regulation of autophagy (GO:0010506),0.2526807797768481,0.5995486486686243,0.9869608826479438,1.0,1.0,43/216,16.85%,TRIML2;TICAM1;GSK3B;BMF;DEPDC5;DAP;ITPR1;EXOC4;NEDD4;EIF4E;MAPT;LEPR;TPCN1;FBXW7;SH3GLB1;FOXO3;HTRA2;LRRK2;KLHL22;ROCK1;MTMR9;HMGB1;CSNK2A2;PIK3CB;RB1CC1;BOK;DCAF12;TRIM6;SLC38A9;EXOC8;PRKD1;SNX32;PLK2;FOXK2;TRIM5;STK11;RPTOR;MTMR3;PRKAG1;CISD2;TPCN2;VPS26A;LAMTOR3
prerank,inorganic cation transmembrane transport (GO:0098662),0.2516188050008592,0.5992998297257873,0.987,1.0,1.0,21/268,10.75%,RHD;RHAG;ATP2B4;CCDC51;KCNN4;KCNK2;SLC6A2;SLC6A5;TRPA1;SLC39A11;KCNH4;KCNH8;SLC9A5;ATP2A2;SLC24A3;SLC8A1;CACNA1C;KCNK12;TRPM2;TRPC7;SLC39A8
prerank,positive regulation of defense response (GO:0031349),0.25532392779026325,0.5992083827563158,0.9347368421052632,1.0,1.0,20/89,23.00%,DHX9;NMI;IL18;SERPINE1;RIOK3;AGT;POLR3D;AKIRIN2;SLC15A4;SETD4;LPL;CD47;RIPK1;IL16;SNCA;POLR3C;OPTN;GPRC5B;POLR3G;TLR7
prerank,regulation of response to external stimulus (GO:0032101),0.24792917323973246,0.598330506793047,0.9540816326530612,1.0,1.0,24/121,18.47%,SETD6;USP18;ADGRA2;STK24;CXCR4;AKNA;PDGFRA;IRF1;NMT2;NLRP6;ANXA1;APPL2;DAGLB;CASP8;BRD4;XIAP;TRIM5;EFNB2;IL1RL2;FOXP1;LACC1;METAP1;USP14;FNTB
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.2671874514144869,0.5977384807769117,0.8940316686967114,1.0,1.0,3/29,11.42%,FGFR2;TGFBR3;BMP2
prerank,response to glucose (GO:0009749),0.26324419042650343,0.5974731175460213,0.9151047409040793,1.0,1.0,5/46,9.60%,GCK;TRA2B;TCF7L2;EIF2B1;ZBTB20
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.228061458139226,-0.5959955451214489,0.9292604501607717,0.9757656669456872,1.0,1/12,8.02%,PRKCQ
prerank,positive regulation of vascular permeability (GO:0043117),0.3032769918987801,0.5954330875101498,0.878698224852071,1.0,1.0,4/12,17.61%,BMP6;ANGPT1;TJP2;TRPV4
prerank,positive regulation of stem cell differentiation (GO:2000738),0.2854633679368381,0.5951484939477716,0.8813096862210096,1.0,1.0,2/16,12.57%,SOX6;SOX9
prerank,NAD biosynthetic process (GO:0009435),0.2821447930951251,0.5949633678427181,0.8736842105263158,1.0,1.0,8/20,25.16%,NADSYN1;PARP9;NAPRT;NMNAT1;PTGIS;NMNAT2;QPRT;NMNAT3
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.2510866845748273,0.5948730023860653,0.9483805668016194,1.0,1.0,21/121,16.58%,ANGPT4;KIT;PRNP;BMP6;IL18;EFNA1;ENPP2;EPHA4;CD80;ANGPT1;NOX4;AGT;PARP9;CNTF;IL31RA;ITGA5;CD44;UNC119;SRC;TP53;TNK2
prerank,histone H3-K4 trimethylation (GO:0080182),0.3094507310838521,0.5947153438231839,0.8788321167883212,1.0,1.0,2/11,12.47%,KMT2A;KMT2D
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.2630136842099289,0.5936538104761738,0.9055555555555556,1.0,1.0,12/48,21.85%,ACAT1;PAPSS2;PPCDC;ADSL;GUCY2C;PANK4;PANK2;ADCY6;ADCY2;COASY;ADSS2;GUCY2D
prerank,inositol phosphate catabolic process (GO:0071545),0.3036015977384249,0.5934831318765854,0.8932038834951457,1.0,1.0,4/12,20.92%,OCRL;INPP5B;PTEN;INPP5A
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.17542605264568636,-0.593297996112067,1.0,0.9763006677989883,1.0,10/31,35.43%,TLR4;HSPD1;LGALS9;TIRAP;SYK;LAPTM5;PLCB1;CD40;CCL19;IRF5
prerank,cellular response to interleukin-1 (GO:0071347),0.24611720048138247,0.5931971070654833,0.9686234817813765,1.0,1.0,42/143,24.78%,HYAL1;PSMC2;PSMD5;MYLK3;TAB1;UBE2N;PSMB1;PSMD14;MAP3K3;PSMD1;IKBKG;PSMB9;FBXW11;SOX9;BTRC;RC3H1;PSMC6;NFKB1;SFRP1;SIRPA;CD47;PSMB2;MAP3K8;PTGIS;PSME4;PSMB7;PSMD11;TRAF6;PSME3;TANK;RBMX;IKBKB;PSMD13;PSMB8;PSMD4;DAB2IP;CCL14;RIPK2;PSMF1;PSMA5;RELA;PSMC3
prerank,negative regulation of mitochondrion organization (GO:0010823),0.2694055826374977,0.592792843543336,0.8914819136522754,1.0,1.0,3/33,5.54%,FXN;IAPP;MAPT
prerank,regulation of response to biotic stimulus (GO:0002831),0.26467958453375146,0.5925674569122306,0.9062119366626066,1.0,1.0,10/28,24.22%,IRF1;APPL2;CASP8;XIAP;TRIM5;FOXP1;APPL1;BIRC2;ELMOD2;FGR
prerank,axon guidance (GO:0007411),0.24688081461381392,0.5922904400211707,0.973973973973974,1.0,1.0,35/201,15.49%,SPTA1;GLI2;ARTN;NCAM1;ALCAM;SPTB;NTN1;NFIB;FRS2;CXCR4;NTN3;EFNA1;EPHA4;DOK2;ROBO1;DSCAML1;PIK3CB;ARHGAP35;PLXNB2;GAB1;PLXNB1;EFNB1;DSCAM;EZR;RAC1;EMB;PRKCA;NOTCH2;PLXND1;EFNB2;PTPRA;SEMA3D;SRC;GDNF;NTN4
prerank,establishment of protein localization to extracellular region (GO:0035592),0.2649325080535483,0.5915985038015519,0.8861788617886179,1.0,1.0,10/39,21.51%,STEAP3;RAB10;SVBP;ABCA1;MIA3;RAB13;TMEM167A;RAB3A;RAB8B;PPY
prerank,regulation of protein kinase B signaling (GO:0051896),0.2482559672572904,0.5915821271653792,0.980980980980981,1.0,1.0,28/193,16.15%,HPSE;FGFR4;FGFR2;IAPP;KIT;PHLPP2;FRS2;XDH;TCF7L2;IL18;PDGFRA;TXN;CD80;ANGPT1;OSBPL8;PIK3CB;PPP2R5C;TGFBR1;GAB1;RAC1;RRAS;PDPK1;ITGB1;RAMP3;PLEKHA1;SRC;PPP2R5B;PTEN
prerank,gonad development (GO:0008406),0.2614605389244035,0.5911340310205314,0.9186440677966101,1.0,1.0,3/41,6.05%,KIT;WNT2B;MKKS
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.30546664156153897,0.5909130680672634,0.8870481927710844,1.0,1.0,10/10,69.47%,CEP250;TULP1;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;CACNA2D4
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.30546664156153897,0.5909130680672634,0.8870481927710844,1.0,1.0,10/10,69.47%,CEP250;TULP1;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;CACNA2D4
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.2064425196658457,-0.5906594212903402,0.966789667896679,0.9768139531010253,1.0,4/17,24.73%,ADRA1A;ADRA2A;DRD2;ADRA1B
prerank,regulation of protein modification process (GO:0031399),0.26074143754933254,0.5905963880185972,0.911504424778761,1.0,1.0,9/50,16.10%,PHIP;FNIP1;PML;ATG7;PLXNB2;SPRED1;PIN1;SESN2;SPRED2
prerank,regulation of endocytosis (GO:0030100),0.251821846465237,0.590539761523337,0.921978021978022,1.0,1.0,12/61,17.07%,STON1;PACSIN2;STON2;ZFYVE16;MTMR2;ROCK1;PICALM;SNX33;PRKD1;SMPD1;SRC;EPHA3
prerank,brain morphogenesis (GO:0048854),0.30141468838197777,0.5904435831393088,0.877521613832853,1.0,1.0,3/12,16.15%,MKKS;FBXW11;PTEN
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.2580679091521359,0.590354188775204,0.9026047565118913,1.0,1.0,6/43,14.21%,BMPR1A;IL18;MFN2;RBPMS2;GJA1;ADAMTS1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.25620089674789676,0.5902084532866201,0.9067245119305857,1.0,1.0,7/54,10.91%,HPSE;GPC6;SLC35D2;B4GALT7;HAS1;SDC1;HS2ST1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.2665719387198073,0.5901396790585625,0.9127272727272727,1.0,1.0,6/33,13.18%,TCF7L2;SERPINE1;YAP1;ANGPT1;PDPK1;CAST
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.2584024418369864,0.5899422224270382,0.9159192825112108,1.0,1.0,9/46,15.28%,RB1;ADAMTS5;ALDH1A1;NPR3;RBPJ;ADAM17;DOCK7;STK11;TLE3
prerank,regulation of ATP biosynthetic process (GO:2001169),0.2892603735838566,0.5898921305778833,0.8776595744680851,1.0,1.0,1/16,2.85%,ATPSCKMT
prerank,monocarboxylic acid metabolic process (GO:0032787),0.24779725848382506,0.5887347716470022,0.9470468431771895,1.0,1.0,13/117,13.66%,ALDH8A1;ECHDC3;PTGR1;CYP26B1;MTHFD1L;ALDH1A2;BTD;SCPEP1;AGXT;ABAT;HOGA1;ACOT2;PANK2
prerank,protein targeting to membrane (GO:0006612),0.2483004028349568,0.5882584781636029,0.9340314136125655,1.0,1.0,25/83,22.94%,VPS37B;MYO1C;VPS37A;ARL6IP1;SRPRA;ZDHHC18;CHM;ZDHHC15;ATG3;PRKCI;ZDHHC3;ZDHHC21;SLC25A17;PIKFYVE;CHMP4A;CHMP4B;TRAM1;PEX12;ZDHHC24;ICMT;RAB8B;PEX13;VPS37C;ZDHHC2;ZDHHC14
prerank,response to peptide hormone (GO:0043434),0.25552709766174725,0.588243381181572,0.923337091319053,1.0,1.0,6/43,11.48%,ROCK2;EIF2B1;TGFBR3;ZBTB7B;ROCK1;ANXA1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.2732426923135024,0.5882001332289187,0.9089790897908979,1.0,1.0,3/28,10.44%,ARHGAP28;ARHGAP18;ARHGAP35
prerank,cAMP-mediated signaling (GO:0019933),0.2737050154383817,0.5879391052576325,0.8944099378881988,1.0,1.0,6/24,18.33%,KSR1;AHR;PDE7B;SOX9;ADCY2;PDE7A
prerank,mononuclear cell differentiation (GO:1903131),0.27820178256999595,0.5876585373444833,0.8963414634146342,1.0,1.0,8/24,23.37%,IKZF1;TRPM2;IL31RA;AXL;RELB;THOC5;MYH9;IRF8
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.2718025103291602,0.587347895633864,0.9029374201787995,1.0,1.0,6/26,15.10%,TAB1;UBE2N;IKBKG;CASP8;ITCH;AAMP
prerank,nitric oxide biosynthetic process (GO:0006809),0.29355568418650824,0.5872661923215976,0.8902077151335311,1.0,1.0,2/13,10.03%,NQO1;CYB5B
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.28999619766908374,0.5870057119114896,0.8832630098452883,1.0,1.0,1/16,2.77%,MOV10
prerank,myeloid cell differentiation (GO:0030099),0.259246199056098,0.586799931031845,0.8994413407821229,1.0,1.0,11/47,19.43%,KIT;DYRK3;IKZF1;PTPN2;TAL1;ATP5IF1;KAT6A;ALAS2;RUNX1;SLC25A5;ZFPM1
prerank,nitric oxide metabolic process (GO:0046209),0.2898448663546081,0.5865578019044622,0.8892128279883382,1.0,1.0,2/14,10.03%,NQO1;CYB5B
prerank,regulation of vasculogenesis (GO:2001212),0.29298922548111583,0.5858865524136423,0.891213389121339,1.0,1.0,3/14,13.45%,XDH;RRAS;HEY2
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.28191288987995927,0.5854216217058855,0.8948069241011984,1.0,1.0,7/18,20.22%,B4GALT7;EMD;MORC3;TP53;SFRP1;SKI;MED25
prerank,multivesicular body assembly (GO:0036258),0.2649061385868515,0.5847577421441066,0.9172661870503597,1.0,1.0,4/30,10.90%,VPS37B;VPS37A;STAM;VTA1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.2719821622655902,0.584689077039982,0.8953488372093024,1.0,1.0,4/22,12.86%,DDX39B;LEO1;SCAF8;BRD4
prerank,lymphocyte differentiation (GO:0030098),0.24798247667011736,0.5844035377620043,0.9198717948717948,1.0,1.0,12/68,19.36%,KIT;NFIL3;IKZF1;LEPR;PTPN2;LMBR1L;ADAM17;ITGB1;DCAF1;AXL;RELB;SLC25A5
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.24459405435972456,0.5843914872488598,0.9573604060913705,1.0,1.0,39/109,24.78%,PSMC2;PSMD5;TAB1;MAP3K1;VAV2;PPP3CA;PSMB1;PSMD14;PSMD1;IKBKG;PIK3CB;PSMB9;RAC1;FBXW11;PDPK1;BTK;BTRC;PSMC6;NFKB1;PPP3R1;PSMB2;PSME4;PSMB7;NFATC3;PSMD11;TRAF6;PSME3;FER;IKBKB;PSMD13;PSMB8;GAB2;PSMD4;BCL10;PSMF1;PPP3CB;PSMA5;RELA;PSMC3
prerank,positive regulation of cell projection organization (GO:0031346),0.24272174703398022,0.5827184213528385,0.9561224489795919,1.0,1.0,28/115,19.68%,SETX;RHOA;OBSL1;CUX1;CAPRIN1;ROBO1;MARK2;CAMK1D;ARHGAP35;PLXNB2;PLXNB1;GRIP1;TWF1;P3H1;DPYSL3;ROR1;PLXND1;PRKD1;PRKCI;MAP6;STMN2;NGF;EPHA3;ARSB;PLXNA2;CAPRIN2;AMIGO1;PLXNB3
prerank,positive regulation of insulin secretion (GO:0032024),0.26225721991274226,0.5825733257061342,0.9080459770114943,1.0,1.0,8/36,18.35%,GCK;TCF7L2;MCU;TRPM4;AACS;C2CD2L;NLGN2;BAD
prerank,chondroitin sulfate catabolic process (GO:0030207),0.2961166797074205,0.5824857674784056,0.9005847953216374,1.0,1.0,3/13,17.36%,HYAL1;BGN;ARSB
prerank,negative regulation of ion transport (GO:0043271),0.2676321299443519,0.582166955205337,0.9178743961352657,1.0,1.0,3/24,10.05%,NEDD4;WNK1;PXK
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.2863463265432836,0.582032682617095,0.9185082872928176,1.0,1.0,5/14,24.83%,YBX3;ANGEL2;MAPK14;MAPKAPK2;HNRNPC
prerank,negative regulation of ATP metabolic process (GO:1903579),0.28721123260666725,0.5819749462854917,0.8983739837398373,1.0,1.0,1/17,2.99%,PFKFB1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.26769035492965304,0.5816745983254652,0.9159763313609467,1.0,1.0,7/32,19.54%,EIF4E;FOXO3;ROCK1;PICALM;METAP1;TMED10;PRKCD
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.19041269603479846,-0.5811278993244324,0.9615384615384616,0.9804561543584833,1.0,13/20,38.46%,HSP90AB1;HSPD1;CCT2;PSMG2;PSMG1;NDUFAF1;BBS12;HOPX;TMEM35A;PFDN6;HSPA1A;PTGES3L;PTGES3
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.25725487087700083,0.5810566259966113,0.9066059225512528,1.0,1.0,10/38,19.81%,PRNP;EFNA1;EPHA4;NOX4;AGT;NCK2;UNC119;MVP;SH3BP5;PTPN1
prerank,circulatory system development (GO:0072359),0.24370602653769013,0.5808197549108793,0.9560776302349336,1.0,1.0,26/118,19.43%,GLI2;FBN1;BCOR;SRF;PDLIM4;MKKS;WDR11;FBXW7;TGFBR1;CACNA1C;BMP2;PDLIM5;SOX9;CASP8;HEY2;FOXL1;CDKN1B;STK11;PKD2;PTEN;HSPG2;SALL1;SH3PXD2B;OSR1;ZFPM2;ZFPM1
prerank,regulation of interferon-alpha production (GO:0032647),0.2753192098748636,0.5803119453643517,0.9160401002506265,1.0,1.0,7/23,23.58%,DHX9;SETD2;PTPRS;MAVS;HAVCR2;TLR7;RIPK2
prerank,regulation of transforming growth factor beta production (GO:0071634),0.2747010108962236,0.5800739094009936,0.9087248322147651,1.0,1.0,5/18,18.61%,SMAD4;SMAD3;ITGAV;ITGB8;LTBP1
prerank,melanosome transport (GO:0032402),0.27979162015965625,0.5800590475840128,0.9094437257438551,1.0,1.0,3/18,13.83%,MKKS;MLPH;BLOC1S5
prerank,pigment granule transport (GO:0051904),0.27979162015965625,0.5800590475840128,0.9094437257438551,1.0,1.0,3/18,13.83%,MKKS;MLPH;BLOC1S5
prerank,regulation of fatty acid oxidation (GO:0046320),0.28523764343593866,0.5799489359598071,0.8828337874659401,1.0,1.0,3/16,14.32%,APPL2;SOX9;ACADL
prerank,oxoacid metabolic process (GO:0043436),0.2637908637011668,0.5798562006039726,0.8948655256723717,1.0,1.0,6/27,20.69%,PPA1;AGXT;ENPP1;THAP4;BPNT1;DDO
prerank,manganese ion transport (GO:0006828),0.2850257672604589,0.5791735562252106,0.8907563025210085,1.0,1.0,5/14,23.21%,TRPC7;SLC39A8;SLC30A10;TMEM165;SLC11A2
prerank,receptor clustering (GO:0043113),0.2733384415515681,0.5789986235394843,0.9156171284634761,1.0,1.0,3/27,7.50%,ITGB7;MUSK;SCRIB
prerank,regulation of mast cell degranulation (GO:0043304),-0.21007529444342557,-0.5788614651867809,0.9508771929824561,0.9806738752345882,1.0,7/14,31.57%,LYN;LGALS9;CD84;CD300A;SYK;FES;SPHK2
prerank,cellular amide metabolic process (GO:0043603),0.2411835436294777,0.5773848171804168,0.9446153846153846,1.0,1.0,21/102,21.54%,MTHFD1L;DNPEP;NLN;BTD;MTHFR;CPXM1;SLC19A1;PLPP1;DHFR;ACOT2;PANK2;SMPD1;ST3GAL1;ABHD4;SMPD3;SMPD2;MTHFS;MIPEP;ACOT8;ORMDL2;NAAA
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.255829564293317,0.5771117206339943,0.937070938215103,1.0,1.0,8/40,19.48%,BMF;FXN;FAM162A;PLAUR;TP53;TNFSF10;BAD;DNM1L
prerank,positive regulation of immune system process (GO:0002684),0.28030963379455326,0.5760943781629984,0.9092122830440588,1.0,1.0,3/16,14.43%,PIK3CB;ANXA1;MIA3
prerank,positive regulation of exocytosis (GO:0045921),0.26328114052169166,0.5758598271660478,0.9344262295081968,1.0,1.0,10/35,21.89%,STXBP5;STAM;SDC1;SYTL4;SMPD3;CLASP1;RAB3A;SDC4;SNCA;PDCD6IP
prerank,regulation of neutrophil migration (GO:1902622),0.29845450544634206,0.574794274813235,0.9065281899109793,1.0,1.0,2/10,22.91%,RAC1;RHOH
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.29166705902937484,0.5745172454689533,0.8997005988023952,1.0,1.0,3/11,20.47%,AHR;IL4I1;CEACAM1
prerank,negative regulation of developmental growth (GO:0048640),0.26162893138514076,0.5739630171991441,0.9009779951100244,1.0,1.0,11/30,25.94%,RTN4R;PTPRS;ULK2;CDKN1B;NKD1;PTEN;DIP2B;WWC2;DUSP10;SLC6A4;RTN4
prerank,mitochondrion morphogenesis (GO:0070584),-0.22623893464357683,-0.5738756389907543,0.9566563467492261,0.9820848277162119,1.0,7/11,42.60%,FIS1;SUPV3L1;SLIRP;MYH14;NUBPL;MFF;PID1
prerank,muscle filament sliding (GO:0030049),0.25821366700597453,0.5735676189249704,0.9269729093050648,1.0,1.0,4/38,16.50%,TPM4;MYH2;DES;TNNT3
prerank,actin-myosin filament sliding (GO:0033275),0.25821366700597453,0.5735676189249704,0.9269729093050648,1.0,1.0,4/38,16.50%,TPM4;MYH2;DES;TNNT3
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.2410627147375173,0.5733412926208825,0.9511434511434511,1.0,1.0,14/90,14.32%,MFAP2;LEPR;CXCR4;IL18;ZBTB7B;MFN2;ALMS1;APPL2;ACHE;GJA1;ADIPOR1;ADRB2;CPT2;ACADL
prerank,response to lipid (GO:0033993),0.23827878847164985,0.5729078693803794,0.9468302658486708,1.0,1.0,12/105,13.10%,HMGB2;CDKN2D;FGFR4;ASXL1;FOXO3;SMAD6;ANXA1;ADAM17;TRIM6;SOX9;MAPKAPK3;CTSH
prerank,protein insertion into ER membrane (GO:0045048),0.2573292216200169,0.572426410412834,0.9177288528389339,1.0,1.0,11/37,21.75%,PRNP;EMC7;TRAM2;EMD;VAPA;CYB5A;EMC8;TRAM1;CCDC47;EMC4;VAMP2
prerank,establishment of melanosome localization (GO:0032401),0.27604054988509497,0.5721212194841114,0.917312661498708,1.0,1.0,4/19,17.51%,MKKS;MLPH;BLOC1S5;SHROOM2
prerank,steroid hormone biosynthetic process (GO:0120178),0.2630871718765112,0.5717332792366201,0.8996372430471584,1.0,1.0,5/29,15.94%,SRD5A3;MED1;FDXR;STARD3;DHCR7
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.2971191865938616,0.5714906830919088,0.8836140888208269,1.0,1.0,10/10,70.31%,GNB1;GRK1;CNGA1;GNAT1;RHO;PDE6B;PDE6G;CNGB1;PDE6A;SAG
prerank,histone H3-K36 demethylation (GO:0070544),0.2950053201419108,0.5713891743025531,0.8945783132530121,1.0,1.0,3/10,21.65%,KDM2B;KDM4B;KDM2A
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.2491303960867568,0.5711658304925561,0.9334049409237379,1.0,1.0,8/57,15.64%,KIT;PTPN2;IL18;PARP9;CNTF;IL31RA;CNOT7;NF2
prerank,positive regulation of interferon-beta production (GO:0032728),0.25684547901484345,0.5706471062433164,0.9201934703748489,1.0,1.0,11/33,23.89%,DHX9;IRF1;RIOK3;POLR3D;MAVS;ISG15;POLR3C;POLR3G;TLR7;RIPK2;HSP90AA1
prerank,JNK cascade (GO:0007254),0.25160479531085966,0.5697961007778731,0.9214123006833713,1.0,1.0,6/40,11.27%,MAP4K2;SH2D3C;TAB1;UBE2N;IKBKG;CRKL
prerank,regulation of axon guidance (GO:1902667),0.2921544763526311,0.5695956558565973,0.9122541603630863,1.0,1.0,1/10,4.60%,MYCBP2
prerank,carbohydrate homeostasis (GO:0033500),0.24578161531783402,0.5692425527084293,0.9278131634819533,1.0,1.0,12/67,18.54%,FGFR4;GCK;LEPR;PTPN2;TCF7L2;MCU;APPL2;ADIPOR1;STK11;BAD;SLC2A4;HECTD4
prerank,positive regulation of dendrite development (GO:1900006),0.3059783212322143,0.5692343242525508,0.924812030075188,1.0,1.0,4/10,23.14%,ZDHHC15;COBL;BMP5;DAB2IP
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.19010774872567887,-0.5689136293817488,0.9787234042553191,0.9834256190351696,1.0,2/20,9.30%,AKR1B1;FDX1
prerank,regulation of cell communication (GO:0010646),0.2510807952143489,0.5679236584774889,0.9242603550295858,1.0,1.0,12/35,23.75%,NCLN;GRK5;SLC8A1;ANXA1;TBX18;GRK3;VEPH1;PTPN1;UGCG;CDC42SE2;CXADR;CRK
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.2578331416785059,0.567845784493593,0.9370629370629371,1.0,1.0,5/32,13.17%,POLR1A;POLR1B;ERCC3;TAF1D;POLR1G
prerank,regulation of actin filament polymerization (GO:0030833),0.24140884441734833,0.5674515955162145,0.941747572815534,1.0,1.0,17/69,22.51%,ARHGAP28;ARHGAP18;SSH2;CDC42EP2;NCK1;TWF1;NCK2;BAIAP2L1;PRKCE;DBN1;NCKAP1;PRKCD;FER;LATS1;VASP;LMOD1;SNX9
prerank,regulation of hormone secretion (GO:0046883),-0.2024447637934034,-0.5671345338718929,0.9494163424124513,0.9833815904661839,1.0,6/15,33.26%,VAMP3;SCG5;EDN1;SOX11;EDN3;SNX6
prerank,regulation of macroautophagy (GO:0016241),0.2397172134942583,0.5667694235094936,0.9559877175025588,1.0,1.0,21/105,17.76%,EXOC4;NEDD4;TBC1D25;QSOX1;SH3GLB1;LARP1;LRRK2;IKBKG;SESN1;RB1CC1;GNAI3;SLC38A9;EXOC8;SNX32;RPTOR;PRKAG1;CLEC16A;SESN2;VPS26A;LAMTOR3;LAMTOR5
prerank,dendrite self-avoidance (GO:0070593),0.2744685613322885,0.566273652746472,0.9132867132867133,1.0,1.0,3/16,11.82%,DSCAML1;DSCAM;EMB
prerank,regulation of neuron projection development (GO:0010975),0.23448327684214254,0.5656645474834967,0.9778894472361809,1.0,1.0,38/163,18.68%,ULK4;SETX;GSK3B;RTN4R;LPAR1;EPHA4;RAB29;LRRK2;MARK2;DENND5A;CAMK1D;ARHGAP35;LZTS3;PLXNB2;TWF1;PTPRS;BAG5;GAK;P3H1;PDLIM5;ZDHHC15;HDAC2;DPYSL3;ROR1;PRKD1;PRKCI;EFNB2;ADCY6;DBN1;PTEN;STMN2;SIPA1L1;EPHA3;ARSB;TRPV4;ABI2;MYLIP;TANC2
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.2543402769410758,0.5654043119226465,0.9324942791762014,1.0,1.0,6/39,18.35%,GCK;TCF7L2;MCU;AACS;NLGN2;BAD
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.2706915443009092,0.5651770883785169,0.8984168865435356,1.0,1.0,5/21,18.55%,CGNL1;MFN2;MAPKAP1;RASAL3;LZTR1
prerank,transcription preinitiation complex assembly (GO:0070897),0.28349033921087763,0.564216002280839,0.9205882352941176,1.0,1.0,4/12,21.66%,TAF12;DR1;GTF2B;GTF2A2
prerank,positive regulation of neurogenesis (GO:0050769),0.24066585294701,0.56413868755886,0.9376321353065539,1.0,1.0,15/68,19.68%,NAP1L1;RHOA;OBSL1;CUX1;CAPRIN1;ROBO1;PLXNB2;PLXNB1;PLXND1;MAP6;NGF;PLXNA2;CAPRIN2;AMIGO1;PLXNB3
prerank,multivesicular body organization (GO:0036257),0.2546191710178818,0.5640991859776371,0.9244391971664699,1.0,1.0,4/31,10.90%,VPS37B;VPS37A;STAM;VTA1
prerank,positive regulation of interleukin-8 production (GO:0032757),0.24435364390930817,0.5639808236634264,0.9303370786516854,1.0,1.0,8/49,18.74%,FADD;SERPINE1;HMGB1;RAB1A;PRKD2;MAVS;LAMTOR5;RIPK1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.2781039674886938,0.5638498659452297,0.9084967320261438,1.0,1.0,2/20,7.88%,SULF2;SULF1
prerank,metal ion export (GO:0070839),0.2577594434866888,0.5633577427535371,0.9266589057043073,1.0,1.0,1/31,2.09%,ATP2B4
prerank,protein kinase B signaling (GO:0043491),0.2640328663690107,0.5632343041961784,0.9021879021879022,1.0,1.0,1/23,2.65%,SETX
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.26017927072952324,0.5630912678340219,0.92875,1.0,1.0,4/23,12.73%,NMI;UACA;CCN3;ADIPOR1
prerank,metanephric mesenchyme development (GO:0072075),0.29622041497346957,0.5629008521894392,0.9156626506024096,1.0,1.0,3/10,19.06%,PKD2;OSR1;WNT4
prerank,Rap protein signal transduction (GO:0032486),0.2923109889022971,0.562569933351467,0.9311377245508982,1.0,1.0,2/10,13.87%,RAP2A;PLK2
prerank,organophosphate biosynthetic process (GO:0090407),0.2529307414249154,0.5619877732345827,0.9243986254295533,1.0,1.0,10/37,20.47%,LPCAT1;IPMK;PPIP5K1;TKT;IP6K2;AGPAT3;GK5;GK;GPHN;MOCOS
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.26129991594859514,0.5619692793740033,0.9221938775510204,1.0,1.0,3/22,14.38%,WNK1;FLOT2;CD44
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.27680951645214563,0.5616225339105069,0.9050991501416431,1.0,1.0,2/15,9.52%,RAB10;SRPRA
prerank,regulation of histone methylation (GO:0031060),0.2783079401156436,0.56126808285683,0.9126074498567335,1.0,1.0,1/13,5.68%,MTHFR
prerank,cellular response to oxygen-containing compound (GO:1901701),0.2356444190075615,0.561002098934209,0.997,1.0,1.0,51/291,18.36%,HMGB2;AQP1;ATP2B4;SETX;TICAM1;ROCK2;RHOA;ABCB4;MAPT;LCOR;PDGFRA;CDK2;SERPINE1;CD80;AGAP3;HTRA2;WNT6;HMGB1;P2RY1;IP6K2;AHR;EZR;AKAP9;WNT9A;SOX9;DMTN;SLC38A9;RORA;PRKD1;ADAM9;GLRA2;RUVBL2;RAMP3;RPTOR;ADCY6;PKD2;NFKB1;IPO5;LPL;SESN2;SFRP1;LARS1;LAMTOR3;AXL;PTPRK;EPHA3;SIRPA;LAMTOR5;DPEP1;MAPK14;PLAA
prerank,negative regulation of axonogenesis (GO:0050771),0.258491156470666,0.5609877187237169,0.9227895392278954,1.0,1.0,4/27,12.25%,RHOA;RTN4R;PTPRS;ULK2
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.2448489563124636,0.5609720866009373,0.9372294372294372,1.0,1.0,11/54,16.95%,KCNN4;NEDD4;KCNMB2;KCNMB3;KCNIP3;DLG1;CAB39;KCNMB4;STK39;GABBR2;DPP6
prerank,adenine nucleotide transport (GO:0051503),0.26897990642376124,0.5608782657918985,0.9138627187079408,1.0,1.0,5/17,19.36%,SLC19A1;SLC25A42;LRRC8C;SLC25A17;SLC25A5
prerank,negative regulation of catabolic process (GO:0009895),0.2524811502863012,0.5608061497412803,0.925,1.0,1.0,10/47,22.10%,PFKFB1;MDM4;PDE3B;SF3B3;PIN1;AZIN1;FMN2;HDAC4;SIRT2;FLNA
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.25190701768711915,0.5607748826048905,0.9459798994974874,1.0,1.0,10/28,27.19%,ITPR1;TNFRSF10B;QRICH1;TMEM117;DNAJC10;TRAF2;DAB2IP;BAX;TRIB3;BAG6
prerank,protein lipidation (GO:0006497),0.24197314445407625,0.5603696931403949,0.9325481798715204,1.0,1.0,18/59,22.94%,PIGN;PIGA;ATG7;PORCN;ZDHHC18;PIGU;ZDHHC15;HHAT;PIGM;ZDHHC3;ZDHHC21;UGCG;DPM3;PIGG;PIGH;ATG5;ZDHHC2;ZDHHC14
prerank,regulation of cellular pH (GO:0030641),0.25186015965730263,0.5602787888713459,0.9087546239210851,1.0,1.0,5/29,17.81%,SLC4A2;SLC9A5;CA2;TM9SF4;LACC1
prerank,sphingolipid catabolic process (GO:0030149),0.27753444439027275,0.5600777756145191,0.9124293785310734,1.0,1.0,5/15,21.11%,ENPP2;SMPDL3A;SMPD1;SMPD2;PDXDC1
prerank,oligodendrocyte development (GO:0014003),0.2751681075404031,0.5587270634714434,0.925414364640884,1.0,1.0,3/15,15.19%,EIF2B1;TPPP;PRDM8
prerank,positive regulation of myelination (GO:0031643),-0.22797181164867153,-0.5585506854385827,0.9655172413793104,0.9856498589935415,1.0,3/11,15.09%,TNFRSF1B;TENM4;DICER1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.24098083342348214,0.557961821871945,0.9474835886214442,1.0,1.0,9/54,15.60%,ATP2B4;ANGPT4;ANGPT1;HMGB1;PRKCA;PDPK1;ADAM17;PRKD1;PRKD2
prerank,triglyceride metabolic process (GO:0006641),0.24226203293541865,0.5579119413629943,0.9484649122807017,1.0,1.0,6/48,17.80%,FABP12;LPIN2;AGMO;LPL;GK5;GK
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.2543455215444741,0.5577608849887769,0.9290161892901619,1.0,1.0,8/28,20.28%,TAB1;UBE2N;IKBKG;CASP8;ITCH;AAMP;LACC1;TRAF6
prerank,protein polyglutamylation (GO:0018095),0.2904670949181534,0.5571621413417308,0.9121813031161473,1.0,1.0,2/11,12.27%,TTLL4;TTLL11
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.24856127209317092,0.5568163370031992,0.9405714285714286,1.0,1.0,10/41,22.10%,KCNN4;PDZK1;KCNMB2;KCNMB3;KCNMB4;GABBR2;AMIGO1;ANK3;GNB1;FLNA
prerank,ovarian follicle development (GO:0001541),0.2756838009611967,0.5564990305360259,0.9104895104895104,1.0,1.0,1/13,4.54%,KIT
prerank,cellular response to lipopolysaccharide (GO:0071222),0.233169304973992,0.5559397335457935,0.9597938144329897,1.0,1.0,17/101,20.28%,HMGB2;TICAM1;RHOA;IL18;SERPINE1;CD80;HMGB1;PRKCE;ADAM9;NFKB1;AXL;SIRPA;MAPK14;PLAA;PDE4B;CD68;TRAF6
prerank,regulation of cell differentiation (GO:0045595),0.23215664737611755,0.5558668856261672,0.9767911200807265,1.0,1.0,12/148,11.28%,CDK5RAP2;TCFL5;CBFB;SUZ12;FGFR2;ANP32B;SRF;VHL;ROCK1;TGFBR1;FLOT2;PRKCB
prerank,smooth muscle cell differentiation (GO:0051145),0.27775504553942076,0.5558129931269435,0.9201741654571843,1.0,1.0,3/12,13.45%,TBX18;MRTFA;HEY2
prerank,purine ribonucleotide metabolic process (GO:0009150),0.2404531151720968,0.5556793289852375,0.9456289978678039,1.0,1.0,14/68,20.64%,HPRT1;ACAT1;EFL1;LRRK2;RHOQ;HINT1;ENPP1;GNAI3;ACOT2;MFN1;BPNT1;BAD;ADSS2;ACOT8
prerank,cell part morphogenesis (GO:0032990),0.2746854315382937,0.555437701440256,0.9194915254237288,1.0,1.0,4/13,23.40%,PACSIN2;PNPT1;DNM1L;WASF1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.26614641855370896,0.5553685474232823,0.934228187919463,1.0,1.0,8/17,26.95%,BMP6;PRKCA;TRIM5;TRIB1;NFKBIL1;SASH1;CD55;LY96
prerank,pyruvate metabolic process (GO:0006090),0.23990884062852913,0.5546491167174306,0.9438325991189427,1.0,1.0,5/52,11.78%,PFKFB1;GCK;GPI;PGM1;HOGA1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.27929861938886225,0.5543190261156042,0.9283625730994152,1.0,1.0,4/12,16.06%,KLF9;CTSH;MED1;BRD8
prerank,positive regulation of lipid transport (GO:0032370),0.2829100111245906,0.5542558772502266,0.9167862266857962,1.0,1.0,1/12,4.58%,ABCB4
prerank,fatty acid metabolic process (GO:0006631),0.23325443971901996,0.554158497679608,0.965412004069176,1.0,1.0,11/115,15.78%,PON1;ECHDC3;LPIN2;NDUFAB1;ACACA;ADIPOR1;ACOT2;ELOVL4;CPT2;PON2;LPL
prerank,regulation of urine volume (GO:0035809),0.2915540109898949,0.5539838168435286,0.8950617283950617,1.0,1.0,2/10,15.12%,NPR3;ADCY6
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.24057000479059784,0.5536848581453577,0.934878587196468,1.0,1.0,4/52,10.44%,DDX11;HDGF;SRPRA;TLN1
prerank,positive regulation of signaling (GO:0023056),0.24207792799023153,0.5534483598706936,0.9502890173410404,1.0,1.0,4/37,8.15%,ANXA2;SCRIB;RAB29;CD80
prerank,positive regulation of chemokine production (GO:0032722),0.24074968023955215,0.55321942115199,0.9421768707482994,1.0,1.0,13/44,27.35%,IL18;HMGB1;ADAM17;TWIST1;LPL;MAVS;EIF2AK2;IL6R;TLR7;MBP;IL33;WNT5A;TLR3
prerank,neutrophil degranulation (GO:0043312),0.23238328441846104,0.5528433131064111,0.998,1.0,1.0,69/425,18.00%,IQGAP2;HPSE;DSN1;MMP25;RHOA;PSMC2;ANXA2;PTGES2;B4GALT1;STK10;GPI;RAB10;DIAPH1;UBR4;LPCAT1;ANXA3;PDXK;CNN2;AGL;PYGB;ATG7;PLAU;QSOX1;STXBP2;PSMB1;AGPAT2;PGM1;MAGT1;PSMD14;CDA;ROCK1;PSMD1;HMGB1;CYBB;ARMC8;APAF1;TRPM2;PLEKHO2;RAC1;GYG1;ILF2;TXNDC5;NAPRT;PLAUR;CTSH;TOM1;CAB39;PRDX4;CD44;CYSTM1;GSDMD;FAF2;ITGAV;SLC15A4;VAPA;CKAP4;SNAP23;NFKB1;COMMD3;GGH;LAMTOR3;AP1M1;SIRPA;CD47;ARSB;MVP;DNAJC5;CFP;NRAS
prerank,positive regulation of interferon-gamma production (GO:0032729),0.24176242955716443,0.5516686553294547,0.9484083424807903,1.0,1.0,3/48,7.50%,FADD;IL18;SCRIB
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.2231618505189893,-0.5516634566791442,0.9829059829059829,0.987176580626538,1.0,3/10,19.78%,GAP43;PICK1;DGKD
prerank,positive regulation of actin filament polymerization (GO:0030838),0.2388195361845447,0.5516307435334851,0.9276693455797933,1.0,1.0,12/44,23.99%,CDC42EP2;NCK1;NCK2;BAIAP2L1;PRKCE;NCKAP1;WHAMM;FER;VASP;LMOD1;SNX9;CDC42EP1
prerank,acylglycerol homeostasis (GO:0055090),0.25989722493920786,0.5516029216002898,0.9233817701453104,1.0,1.0,3/20,15.78%,IL18;RORA;LPL
prerank,positive regulation of phosphorylation (GO:0042327),0.2318361819698782,0.5511642822882676,0.994,1.0,1.0,39/240,15.72%,FNIP1;PFKFB1;ROCK2;FGFR4;FGFR2;KIT;MRE11;LEPR;MUSK;RAP2A;ARRB1;EFNA1;FMR1;PDGFRA;CCN1;EPHA4;LRRK2;AXIN2;ANGPT1;ZBTB20;DDR2;RB1CC1;P2RY1;CRKL;DSCAM;BMP2;RAC1;KCTD20;ADAM17;SOX9;PLAUR;ROR1;SLCO3A1;ARNT;BTBD10;WDFY2;PIN1;FXR1;LMO4
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.2695142685223493,0.5508937610053445,0.9369747899159664,1.0,1.0,6/15,25.18%,SMPD3;SMPD2;PRKCD;ORMDL2;SIRT3;ORMDL3
prerank,neutrophil activation involved in immune response (GO:0002283),0.23153545994949573,0.5506397695875612,0.998,1.0,1.0,69/428,18.00%,IQGAP2;HPSE;DSN1;MMP25;RHOA;PSMC2;ANXA2;PTGES2;B4GALT1;STK10;GPI;RAB10;DIAPH1;UBR4;LPCAT1;ANXA3;PDXK;CNN2;AGL;PYGB;ATG7;PLAU;QSOX1;STXBP2;PSMB1;AGPAT2;PGM1;MAGT1;PSMD14;CDA;ROCK1;PSMD1;HMGB1;CYBB;ARMC8;APAF1;TRPM2;PLEKHO2;RAC1;GYG1;ILF2;TXNDC5;NAPRT;PLAUR;CTSH;TOM1;CAB39;PRDX4;CD44;CYSTM1;GSDMD;FAF2;ITGAV;SLC15A4;VAPA;CKAP4;SNAP23;NFKB1;COMMD3;GGH;LAMTOR3;AP1M1;SIRPA;CD47;ARSB;MVP;DNAJC5;CFP;NRAS
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.21626638458679714,-0.5500716466983872,0.9651162790697675,0.9869170026961396,1.0,8/11,48.19%,BCL2;TAF9B;CD74;MIF;TAF9;TRIAP1;MUC1;SIRT1
prerank,alcohol catabolic process (GO:0046164),0.27962687520179486,0.54971248818124,0.9292307692307692,1.0,1.0,1/10,6.77%,SRD5A3
prerank,cranial nerve development (GO:0021545),0.27667587245794634,0.5492032486432157,0.9161849710982659,1.0,1.0,11/11,72.35%,SALL1;PAX2;ATOH7;ISL1;TIFAB;POU4F1;TFAP2A;CHRNB2;TMEM126A;ERBB3;CHD7
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.22946907376322967,0.5489500602040758,0.9709844559585492,1.0,1.0,30/94,24.78%,PSMC2;PSMD5;TAB1;UBE2N;PSMB1;PSMD14;MAP3K3;PSMD1;IKBKG;PSMB9;FBXW11;BTRC;PSMC6;NFKB1;PSMB2;MAP3K8;PSME4;PSMB7;PSMD11;TRAF6;PSME3;IKBKB;PSMD13;PSMB8;PSMD4;RIPK2;PSMF1;PSMA5;RELA;PSMC3
prerank,regulation of cellular biosynthetic process (GO:0031326),0.2557254431053836,0.5482905187998014,0.9354066985645934,1.0,1.0,6/28,17.31%,FGFR4;RAC1;ADIPOR1;MED1;SIRPA;CD47
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.26044969999666645,0.5481507068102536,0.9226804123711341,1.0,1.0,5/22,17.03%,ACAP2;MAPT;EHD1;STMN2;NGF
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.2585912171318229,0.5477935349123039,0.928843710292249,1.0,1.0,4/22,17.81%,TRPM4;TRIM6;BTK;LACC1
prerank,negative regulation of macroautophagy (GO:0016242),0.2563293486938629,0.5477079506577494,0.9061728395061729,1.0,1.0,7/26,18.53%,QSOX1;LRRK2;TMEM39A;SCFD1;CLEC16A;CHMP4A;CHMP4B
prerank,cell junction organization (GO:0034330),0.23066589850280728,0.5474998539920868,0.960167714884696,1.0,1.0,13/71,16.34%,SDK1;RHOA;MAPT;NLGN3;GRHL2;LIMS1;CAPZA1;TJP2;PPFIA4;PRKCI;SMAD3;PIN1;NLGN2
prerank,neutrophil mediated immunity (GO:0002446),0.22992579023257942,0.5471309730595398,0.999,1.0,1.0,70/432,18.00%,IQGAP2;HPSE;DSN1;MMP25;RHOA;PSMC2;ANXA2;PTGES2;B4GALT1;STK10;GPI;RAB10;DIAPH1;UBR4;LPCAT1;ANXA3;PDXK;CNN2;AGL;PYGB;ATG7;PLAU;QSOX1;STXBP2;PSMB1;AGPAT2;PGM1;MAGT1;PSMD14;CDA;ROCK1;PSMD1;HMGB1;CYBB;ARMC8;APAF1;TRPM2;PLEKHO2;RAC1;ADAM17;GYG1;ILF2;TXNDC5;NAPRT;PLAUR;CTSH;TOM1;CAB39;PRDX4;CD44;CYSTM1;GSDMD;FAF2;ITGAV;SLC15A4;VAPA;CKAP4;SNAP23;NFKB1;COMMD3;GGH;LAMTOR3;AP1M1;SIRPA;CD47;ARSB;MVP;DNAJC5;CFP;NRAS
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.246734810438647,0.5467356682675115,0.9389830508474576,1.0,1.0,6/40,12.97%,MAPT;STOML2;PYCR1;LRRK2;STOX1;ATP5IF1
prerank,positive chemotaxis (GO:0050918),0.25943565205113167,0.5467090941021657,0.9216216216216216,1.0,1.0,4/17,20.03%,SCRIB;ANGPT1;PLXNB3;SEMA5A
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.2427326421866393,0.5441239745993646,0.9537037037037037,1.0,1.0,11/38,23.14%,TRIM59;RIOK3;CASP8;RORA;PER1;OTUD7B;RIPK1;PPM1A;TANK;RHOH;DAB2IP
prerank,amino acid transmembrane transport (GO:0003333),0.24258591169808372,0.5438771854231986,0.948512585812357,1.0,1.0,11/45,21.73%,SLC38A7;TSPO2;SLC38A4;SLC16A2;SLC38A9;SLC25A22;SLC36A4;SLC7A1;SLC38A2;SLC7A11;SLC6A13
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.21261034241059912,-0.543732646580953,0.9638157894736842,0.9880815490134783,1.0,2/12,9.30%,AKR1B1;FDX1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.2704996685836717,0.5435137034231462,0.9154727793696275,1.0,1.0,4/14,21.09%,TNFRSF10B;ZFP91;TRAF6;TRAF2
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.26701846938677365,0.543096635620988,0.9360544217687075,1.0,1.0,2/17,9.75%,SERPINE1;HMGB1
prerank,lipid biosynthetic process (GO:0008610),0.2307399782409511,0.5426002366843667,0.9515789473684211,1.0,1.0,10/77,15.78%,PAM;LPCAT1;NDUFAB1;AGPS;ACACA;AGPAT3;MVK;ELOVL4;FDXR;LPL
prerank,positive regulation of interferon-alpha production (GO:0032727),0.2618474455513894,0.5415541302750575,0.9378306878306878,1.0,1.0,2/19,7.50%,DHX9;SETD2
prerank,aminoglycan metabolic process (GO:0006022),-0.22493027713390995,-0.5414540000673891,0.9517045454545454,0.9880380756462893,1.0,7/10,36.31%,CHST9;B3GAT2;XYLT2;B3GAT1;CLN6;B3GAT3;B3GALT6
prerank,response to thyroid hormone (GO:0097066),0.27005005852866576,0.5410385174757727,0.932761087267525,1.0,1.0,4/13,16.06%,KLF9;CTSH;MED1;BRD8
prerank,vitamin transport (GO:0051180),0.2455349148412009,0.5403652595445391,0.9549878345498783,1.0,1.0,2/29,6.16%,PDPN;SLC19A1
prerank,camera-type eye morphogenesis (GO:0048593),0.27969356230500697,0.5402346692879361,0.934984520123839,1.0,1.0,3/10,19.30%,KDM2B;SHROOM2;SKI
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.16926651774349022,-0.5400046152629947,0.9910714285714286,0.9876833949329109,1.0,2/23,8.44%,CALM1;NMT1
prerank,regulation of cholesterol storage (GO:0010885),0.2717903772199091,0.539174675699116,0.9284731774415406,1.0,1.0,3/15,15.78%,ABCA1;EHD1;LPL
prerank,AMP metabolic process (GO:0046033),0.2743807599482275,0.5391715681538507,0.9225449515905948,1.0,1.0,2/13,11.45%,XDH;ADSL
prerank,integrated stress response signaling (GO:0140467),0.27455968923502877,0.5389128522782796,0.9333333333333333,1.0,1.0,2/14,11.35%,EIF2AK3;QRICH1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.27867650182444037,0.5388305626216616,0.9417040358744395,1.0,1.0,2/10,13.65%,NUMA1;MED1
prerank,T cell activation involved in immune response (GO:0002286),0.27185989580064024,0.538794803664191,0.9260355029585798,1.0,1.0,12/12,72.83%,LCP1;TNFSF18;IFNK;F2RL1;ITGAL;ICAM1;LILRB1;MDK;EIF2AK4;SLC11A1;FCER1G;CD74
prerank,regulation of ion transmembrane transport (GO:0034765),0.24308474065503471,0.5384294970196333,0.9376470588235294,1.0,1.0,4/33,11.56%,NEDD4;WNK1;KCNJ13;AKAP9
prerank,positive regulation of sodium ion transport (GO:0010765),-0.21256846445030098,-0.5383027253516731,0.975609756097561,0.9873925921307904,1.0,6/12,32.54%,SCN1B;NOS1;SCN4B;PKP2;GPD1L;SCN3B
prerank,osteoclast differentiation (GO:0030316),0.24885920162496059,0.5380295019413815,0.9330759330759331,1.0,1.0,4/22,18.35%,ANXA2;SRC;FOXP1;MAPK14
prerank,sphingolipid biosynthetic process (GO:0030148),0.22921454688469228,0.5375629106952365,0.9659574468085106,1.0,1.0,13/71,15.60%,CERS6;CERS5;LARGE1;ST3GAL5;PLPP1;CSNK1G2;AGK;PRKD1;ELOVL4;SMPD1;SPTLC2;VAPA;PRKD2
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.27814713363319293,0.53720821009736,0.9293078055964654,1.0,1.0,1/12,5.14%,B3GNT8
prerank,negative regulation of cholesterol transport (GO:0032375),-0.2223371396955765,-0.5370902729320468,0.9623188405797102,0.9869661211276586,1.0,2/10,23.08%,SREBF2;ABCA2
prerank,ribonucleoprotein complex assembly (GO:0022618),0.22603531267047036,0.5365254601486557,0.9847870182555781,1.0,1.0,24/132,18.13%,COIL;SETX;DHX9;PRKDC;SRSF10;EIF4H;DDX39B;RRS1;PRPF19;CELF2;SF3A2;SRPK1;PPAN;LUC7L3;LSM4;DDX1;MCTS1;DENR;PRPF18;GEMIN7;SRPK2;LUC7L2;ABT1;MRPL20
prerank,hexose metabolic process (GO:0019318),0.23980797248315117,0.5363687263361344,0.958904109589041,1.0,1.0,3/39,8.45%,CHST15;SORD;PGM1
prerank,cellular protein metabolic process (GO:0044267),0.22557426305834563,0.5362671266218071,1.0,1.0,1.0,50/396,16.26%,MRPL36;TGM1;MATN3;F5;UBE2S;LOXL2;LOX;PABPC4;AGO2;GGCX;FBN1;CHEK2;LAMB1;PRKDC;SRBD1;ST8SIA2;SIAH2;MRPL18;STOML2;CCN1;PHKA2;QSOX1;B4GALT7;HTRA2;DARS1;DUSP12;RPN2;MRPL13;TTF1;MRPL55;APLP2;SEPHS1;NAGPA;ASMT;ADAM17;RPS17;ATG3;CTSH;MRPS33;MRPS18B;MIA3;ST3GAL1;UBL5;FDXR;CKAP4;LMCD1;PRSS23;ATP23;NOTUM;PLOD2
prerank,cellular response to heat (GO:0034605),0.24237784191427825,0.5360171515376363,0.9444444444444444,1.0,1.0,4/35,8.23%,MAPT;RBBP7;TPR;HTRA2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.271482178581924,0.5349854701190861,0.9491525423728814,1.0,1.0,5/13,19.68%,PLXNB2;PLXNB1;PLXND1;PLXNA2;PLXNB3
prerank,protein K63-linked deubiquitination (GO:0070536),0.24265604238889815,0.5348345998699839,0.9498207885304659,1.0,1.0,11/31,24.53%,UIMC1;PSMD14;USP16;BRCC3;OTUD1;OTUD7B;USP20;ZRANB1;USP25;BABAM2;USP13
prerank,macroautophagy (GO:0016236),0.2262146369509229,0.5346978022150564,0.9776422764227642,1.0,1.0,36/118,23.33%,VPS37B;MTMR14;ATG7;VPS37A;STAM;MFN2;LIX1L;ZFYVE1;CSNK2A2;VIPAS39;RB1CC1;VTA1;ILRUN;ATG3;MTMR3;UVRAG;PRKAG1;SRC;MFN1;VPS16;PLAA;CHMP4A;CHMP4B;VPS39;PRKAB1;TOMM40;LIX1;PGAM5;AMBRA1;ATG13;ATG5;VPS37C;PRKAG3;TOMM20;ATG4B;PRKAA2
prerank,response to hexose (GO:0009746),0.24742842374972907,0.5344277114985142,0.9469240048250904,1.0,1.0,2/25,6.45%,TCF7L2;EIF2B1
prerank,macrophage differentiation (GO:0030225),0.27019376987510363,0.5342961021471265,0.9237170596393898,1.0,1.0,2/13,12.77%,CASP8;IL31RA
prerank,peptide hormone secretion (GO:0030072),0.24733703284004016,0.5335604834712084,0.9464068209500609,1.0,1.0,3/26,14.73%,RAB1A;ANXA1;SNX19
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.2334441303440561,0.532892550950489,0.952054794520548,1.0,1.0,10/52,17.54%,ATP2B4;RANGRF;PDPK1;PRKCE;PRKCI;DLG1;ITGB1;RAMP3;EPHA3;WNK3
prerank,positive regulation of lipid storage (GO:0010884),0.2530155457153819,0.5326299497848748,0.9289340101522843,1.0,1.0,4/21,15.78%,PLIN2;EHD1;NFKB1;LPL
prerank,GPI anchor biosynthetic process (GO:0006506),0.2441139336540219,0.5324122978908211,0.9383155397390273,1.0,1.0,9/30,22.30%,PIGN;PIGA;PIGU;PIGT;PIGM;DPM3;PIGG;GPAA1;PIGH
prerank,integrin-mediated signaling pathway (GO:0007229),0.2250444512579381,0.5316891383308611,0.961456102783726,1.0,1.0,21/73,21.50%,ITGB7;CUL3;DOCK1;PRKD1;ADAM9;ADAMTS1;ITGA5;ITGB1;PTPRA;ITGAV;SRC;RCC2;ITGB8;FERMT3;CD47;CEACAM1;FERMT2;FBLN1;ISG15;ITGBL1;ITGA11
prerank,regulation of response to interferon-gamma (GO:0060330),0.27095979133655657,0.5311301008335698,0.9490806223479491,1.0,1.0,2/14,10.40%,PTPN2;PARP9
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.247985104826222,0.5303531244074291,0.9546027742749055,1.0,1.0,4/23,15.39%,AGT;GJA1;SOX9;GDNF
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.23477755278881596,0.5302003455622646,0.9359550561797753,1.0,1.0,7/48,16.36%,USP18;PTPN2;ROBO1;YTHDF2;PYDC1;CNOT7;METTL3
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.26195151255362165,0.5301637775665134,0.9300699300699301,1.0,1.0,1/14,5.76%,NUDT5
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.24516882790799144,0.5300252047931869,0.945054945054945,1.0,1.0,5/25,21.09%,KIT;TRIM6;LACC1;TRAF6;TRAF2
prerank,muscle organ development (GO:0007517),0.22856639220136882,0.5295481827664541,0.9576365663322185,1.0,1.0,6/54,11.33%,LARGE1;SOX6;SGCE;EMD;SMTN;CHD2
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.22388018891224504,0.5287534359040332,0.9777777777777777,1.0,1.0,13/140,12.85%,LPAR3;LPAR1;IAPP;CXCR4;PDGFRA;SLC8A1;BDKRB2;HMGB1;P2RY1;CACNA1C;ITPR3;TRPM4;C1QTNF1
prerank,regulation of ERBB signaling pathway (GO:1901184),0.25886925492847956,0.5283778633666877,0.9509116409537167,1.0,1.0,4/15,20.94%,WDR54;RBPJ;CEACAM1;FER
prerank,cellular response to amino acid stimulus (GO:0071230),0.2392919940914707,0.5282894445350318,0.949648711943794,1.0,1.0,10/33,17.76%,KLHL22;SESN1;SLC38A9;GLRA2;RPTOR;IPO5;SESN2;LARS1;LAMTOR3;LAMTOR5
prerank,Golgi to plasma membrane transport (GO:0006893),0.23577912775904064,0.5282760374272688,0.9495412844036697,1.0,1.0,3/47,4.29%,MACF1;RAB10;EXOC4
prerank,neuronal action potential (GO:0019228),0.25412759414277797,0.5281864064371392,0.9426336375488917,1.0,1.0,6/22,20.35%,KCNMB2;KCNMB3;KCNMB4;KCNA1;CACNA1G;ANK3
prerank,glycoprotein biosynthetic process (GO:0009101),0.22299349521491912,0.5273791891084167,0.9727177334732424,1.0,1.0,14/79,18.78%,LARGE1;FUT10;ST8SIA2;B3GNT8;ST3GAL3;B4GALT7;ST3GAL5;FOXL1;ST3GAL4;ST3GAL2;B3GALT2;CHST10;XYLT1;GCNT1
prerank,purine ribonucleotide transport (GO:0015868),0.25585222994587276,0.5271741806533837,0.9328767123287671,1.0,1.0,4/16,17.44%,SLC19A1;SLC25A42;LRRC8C;SLC25A17
prerank,cellular response to glucagon stimulus (GO:0071377),0.25830673629530077,0.5270922799781591,0.9460916442048517,1.0,1.0,7/17,24.39%,ADCY6;CYSLTR2;PRKAR2B;PRKAR2A;ADCY2;PRKAR1A;PRKACA
prerank,cellular response to catecholamine stimulus (GO:0071870),0.24938872761856146,0.5267780672034604,0.9484924623115578,1.0,1.0,7/23,22.05%,ATP2B4;LRRK2;ADCY6;PDE4B;SNCA;SIRT2;GNB1
prerank,protein catabolic process (GO:0030163),0.22862204442491682,0.5258707509747514,0.9741935483870968,1.0,1.0,9/59,14.94%,CHEK2;SIAH2;PRPF19;ADAMTS9;HTRA2;CUL4B;STT3B;FBXO27;FBXO17
prerank,regulation of type I interferon production (GO:0032479),0.2218016579460288,0.5257081227246738,0.9626943005181348,1.0,1.0,25/84,25.36%,POLA1;DHX9;PRKDC;MRE11;G3BP1;IRF1;POLR3D;ILRUN;ITCH;PIN1;NFKB1;MAVS;NLRP4;ISG15;TAX1BP1;POLR3C;RNF216;POLR3G;PCBP2;IRF8;CRCP;GPATCH3;RELA;DHX33;ACOD1
prerank,peptidyl-amino acid modification (GO:0018193),0.2719450602876165,0.5231493725733056,0.9299552906110283,1.0,1.0,2/10,18.01%,TTLL4;METAP1
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.26787151241582585,0.5229991437381106,0.9356223175965666,1.0,1.0,1/13,5.14%,B3GNT8
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.22072025802092088,0.5229006138127731,0.9857433808553971,1.0,1.0,13/110,16.33%,LPAR3;LPAR1;IAPP;ADGRL1;GNA13;GNAQ;S1PR2;ABCA1;ADGRG2;ADRB2;RAMP3;ADCY6;ADGRD1
prerank,arachidonic acid metabolic process (GO:0019369),0.2332481331176809,0.5225161241757649,0.9415971394517283,1.0,1.0,4/35,12.46%,PTGES2;HPGDS;PTGS1;DAGLB
prerank,regulation of defense response (GO:0031347),0.22042835258362678,0.5224489753608462,0.9641350210970464,1.0,1.0,14/76,17.81%,SETD6;USP18;AKNA;IRF1;NLRP6;ANXA1;APPL2;DAGLB;CASP8;BRD4;XIAP;IL1RL2;FOXP1;LACC1
prerank,amyloid fibril formation (GO:1990000),0.22768741991187166,0.5223456491971742,0.9540983606557377,1.0,1.0,7/51,13.54%,TSPAN33;IAPP;SIAH2;MAPT;CALB1;TSPAN5;USP9X
prerank,male gonad development (GO:0008584),0.23266070619308715,0.5219121577461332,0.9534342258440046,1.0,1.0,2/34,5.17%,KIT;WNT2B
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.2695815125342057,0.5218353900451199,0.9540581929555896,1.0,1.0,2/10,14.31%,ZNHIT3;RUVBL2
prerank,glucose homeostasis (GO:0042593),0.2229150323239596,0.5216811307323983,0.9695697796432319,1.0,1.0,11/83,14.70%,FGFR4;GCK;LEPR;PTPN2;TCF7L2;NUCKS1;MCU;APPL2;ADIPOR1;FOXK2;STK11
prerank,regulation of superoxide anion generation (GO:0032928),0.261830842118568,0.5212606894014503,0.9311797752808989,1.0,1.0,4/14,24.87%,MAPT;PRKCD;SOD1;TGFB1
prerank,membrane protein proteolysis (GO:0033619),0.23101379156515353,0.5207186978342536,0.9669421487603306,1.0,1.0,13/37,25.00%,SPPL2B;ADAM17;CTSH;ADAM9;ADAM19;NFKB1;TRAF6;RBMX;MYH9;NAPSA;RELA;TGFB1;SPPL3
prerank,negative regulation of GTPase activity (GO:0034260),0.24426518721414242,0.5207123373320726,0.9474327628361858,1.0,1.0,3/22,9.15%,WNK1;LRRK2;CPEB2
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.25592231588065595,0.5203649469180359,0.9349269588313412,1.0,1.0,4/16,17.75%,PSIP1;WBP4;PRPF39;SFSWAP
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.2279264152002113,0.5201388144346298,0.9591373439273553,1.0,1.0,11/41,23.78%,AFDN;PIEZO1;PLAUR;ADAM19;CD44;PTPRU;CD47;ANK3;DENND6A;GCNT2;PTPN23
prerank,glutathione metabolic process (GO:0006749),0.23097409744089792,0.5198500571906216,0.9555302166476625,1.0,1.0,10/38,22.12%,GSS;HPGDS;GSTT1;DPEP1;GCLM;GSTM5;GCLC;HAGH;SOD1;GSTZ1
prerank,acute inflammatory response (GO:0002526),0.24554114030526064,0.5191425265221745,0.9479553903345725,1.0,1.0,1/23,4.22%,MYLK3
prerank,negative regulation of defense response (GO:0031348),0.22430658007376597,0.5177070459743911,0.9770354906054279,1.0,1.0,9/77,13.74%,RB1;NMI;PTPN2;ENPP3;CCN3;ILRUN;ITCH;RORA;MVK
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.25619938476991655,0.5170796645099263,0.9664335664335665,1.0,1.0,14/14,74.40%,TRAF6;IFNG;POU4F2;IL12B;IL23R;TNF;IL23A;OCSTAMP;TNFSF11;CCR1;POU4F1;CSF1;TYROBP;ATP6AP1
prerank,negative regulation of reproductive process (GO:2000242),0.2559529792974957,0.5161945285935755,0.9429312581063554,1.0,1.0,2/17,12.36%,SULF1;GJA1
prerank,melanosome organization (GO:0032438),0.23745188447653148,0.515680826172779,0.9460122699386503,1.0,1.0,6/26,17.78%,RAB29;AP3B1;BLOC1S5;AP1M1;SHROOM2;PIKFYVE
prerank,negative regulation of hormone secretion (GO:0046888),0.2665515442711495,0.5156262113748482,0.9602272727272727,1.0,1.0,1/10,12.36%,GJA1
prerank,positive regulation of viral transcription (GO:0050434),0.24349154990096314,0.5155167429868683,0.9486552567237164,1.0,1.0,2/25,7.48%,DHX9;POLR2A
prerank,regulation of interferon-gamma production (GO:0032649),0.22034579585167996,0.5151877609751997,0.9727748691099476,1.0,1.0,12/71,21.11%,FADD;PRNP;IL18;SCRIB;HMGB1;AXL;SIRPA;CD47;HAVCR2;ZFPM1;PDE4B;ISG15
prerank,regulation of biosynthetic process (GO:0009889),0.26454049509201405,0.5150927642644603,0.9334341906202723,1.0,1.0,3/11,23.38%,PIKFYVE;SNCA;SLC25A33
prerank,positive regulation of neuron projection development (GO:0010976),0.21879353161270562,0.5142217407496373,0.9748953974895398,1.0,1.0,18/85,17.36%,SETX;CAPRIN1;MARK2;CAMK1D;ARHGAP35;PLXNB2;TWF1;P3H1;ZDHHC15;DPYSL3;ROR1;PRKD1;PRKCI;DBN1;COBL;STMN2;EPHA3;ARSB
prerank,glial cell differentiation (GO:0010001),0.23705746613490639,0.5142065203659707,0.9625151148730351,1.0,1.0,4/28,12.57%,MMP24;NFIB;TPPP;SOX9
prerank,negative regulation of lipid catabolic process (GO:0050995),0.25755575145246423,0.5134834052700109,0.9465020576131687,1.0,1.0,1/17,4.92%,PDE3B
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.24286998610814978,0.5129827960649246,0.9516778523489933,1.0,1.0,5/20,16.00%,CARF;BMP2;RBPJ;SMAD4;SESN2
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.26110684454699074,0.5129560436254423,0.9546120058565154,1.0,1.0,2/12,12.63%,TMEFF2;HDAC2
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.22385663128450173,0.512363672193647,0.9796791443850268,1.0,1.0,20/69,24.95%,INTS7;PHAX;POLR2A;POU2F1;INTS8;GTF2A1;RPRD1A;POU2F2;ZC3H8;RPRD1B;POLR2B;INTS4;GTF2B;ELL2;INTS13;GTF2A2;SNAPC4;SP1;INTS6;SNAPC1
prerank,lysosome localization (GO:0032418),0.23114563951041414,0.5121819302621754,0.956964892412231,1.0,1.0,7/37,19.56%,KIT;SPAG9;BORCS6;SYTL4;MAP6;KLC2;RAB3A
prerank,GPI anchor metabolic process (GO:0006505),0.23836171633130174,0.5120802163062975,0.959902794653706,1.0,1.0,7/26,22.30%,PIGN;PIGA;PIGU;PIGM;DPM3;PIGG;PIGH
prerank,positive regulation of leukocyte migration (GO:0002687),0.22708328183020532,0.5119983073165165,0.9587378640776699,1.0,1.0,3/27,15.32%,ADAM17;MIA3;PLVAP
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.2450030108688343,0.5116047537229574,0.939106901217862,1.0,1.0,3/20,13.35%,LYPD1;GNAQ;LY6H
prerank,positive regulation of secretion by cell (GO:1903532),0.2204845706711787,0.511603293373401,0.9714587737843552,1.0,1.0,15/70,20.67%,FRMD4A;STXBP5;MYH10;BMP6;BMP2;EZR;SYTL4;ACHE;PPID;ADAM9;CLASP1;TMED10;DNM1L;RAB3A;SNCA
prerank,regulation of defense response to virus by host (GO:0050691),0.23209566748944965,0.5112068610952643,0.963985594237695,1.0,1.0,4/30,17.17%,DHX9;PARP9;TRIM6;MAVS
prerank,regulation of interleukin-8 production (GO:0032677),0.21725643894719998,0.5100017990190063,0.967982924226254,1.0,1.0,11/69,18.74%,FADD;ARRB1;SERPINE1;HMGB1;RAB1A;ANXA1;OTUD7B;PRKD2;MAVS;LAMTOR5;RIPK1
prerank,acylglycerol biosynthetic process (GO:0046463),0.2365690801942979,0.5090308525386632,0.951530612244898,1.0,1.0,2/23,7.15%,LPIN2;AGMO
prerank,central nervous system development (GO:0007417),0.21142935614476635,0.5076681113661429,0.998998998998999,1.0,1.0,39/250,17.90%,PBX4;CDK5RAP2;LOXL3;PBX3;NFIB;BTD;ADGRA2;CXCR4;SOX6;GRHL2;NIPBL;DSCAML1;UTP3;TPPP;ZIC5;NR4A2;PLXNB2;DHX37;NKX2-1;ATXN1;ZIC4;SOX9;SH3GL3;TMX2;NES;QARS1;CAPG;PKD2;PTEN;ANKLE2;NCKAP1;JRKL;HSPG2;ARNT2;WWP1;SLC6A17;GRIN2D;SHROOM2;MAST1
prerank,snRNA transcription (GO:0009301),0.2223421607961667,0.5074677810186997,0.9817792068595927,1.0,1.0,20/70,24.95%,INTS7;PHAX;POLR2A;POU2F1;INTS8;GTF2A1;RPRD1A;POU2F2;ZC3H8;RPRD1B;POLR2B;INTS4;GTF2B;ELL2;INTS13;GTF2A2;SNAPC4;SP1;INTS6;SNAPC1
prerank,ceramide metabolic process (GO:0006672),0.22066942694434116,0.5073120694782304,0.9706546275395034,1.0,1.0,8/49,18.69%,CERS6;CERS5;PLPP1;AGK;SMPD1;SPTLC2;SMPD2;FA2H
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.21414580709696832,0.5066076480233799,0.9889224572004028,1.0,1.0,23/138,17.07%,STYK1;FGFR4;FGFR2;KIT;FRS2;MUSK;PDGFRA;EPHA4;ABI1;BDKRB2;DDR2;PIK3CB;CLNK;GUCY2C;IL31RA;POLR1G;ROR1;PTPRU;SRC;TNK2;AXL;NGF;EPHA3
prerank,melanosome localization (GO:0032400),0.2385444557804533,0.5063519259543381,0.9542645241038319,1.0,1.0,4/21,17.51%,MKKS;MLPH;BLOC1S5;SHROOM2
prerank,cytosolic transport (GO:0016482),0.21291357315929713,0.5059818786536299,0.9938587512794268,1.0,1.0,21/108,19.82%,AP4M1;GBF1;SPAG9;SNX1;DENND2A;RAB29;VPS13A;ANKRD27;ERC1;DENND5A;GAK;VTI1A;GOSR1;SNX32;VPS26A;EPS15;RIC1;PIKFYVE;TBC1D10A;BET1L;MON2
prerank,cellular response to chemokine (GO:1990869),0.22421348228372873,0.5057877854337182,0.9765625,1.0,1.0,3/46,8.81%,RHOA;WNK1;RIPOR2
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.2385339041818082,0.5042915162952964,0.9712418300653595,1.0,1.0,3/20,15.02%,GSK3B;BOK;ITGAV
prerank,cellular respiration (GO:0045333),0.2250434172810782,0.5041855947633589,0.9610538373424972,1.0,1.0,3/41,7.09%,MTFR2;COX10;COQ10B
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.2199216177937434,0.5021253428243648,0.9697986577181208,1.0,1.0,10/49,19.48%,BMF;RTKN2;BCLAF1;BOK;EIF2AK3;PLAUR;SRC;TP53;BAD;DNM1L
prerank,maturation of LSU-rRNA (GO:0000470),0.2332171654155235,0.501772595110622,0.9467162329615861,1.0,1.0,5/26,15.71%,ZNHIT3;DDX18;MRPL1;MAK16;WDR12
prerank,regulation of B cell activation (GO:0050864),0.23127759676348092,0.50169147202825,0.9700520833333334,1.0,1.0,3/25,13.22%,SAMSN1;AHR;IL4I1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.21048197109115177,0.4990649583306653,0.998998998998999,1.0,1.0,32/198,16.61%,PFKFB1;GCK;GPI;LHPP;OCRL;NUDT5;PPP3CA;IPMK;ENPP3;INPP5B;LRRK2;AGPAT2;LIMD1;DUSP12;PPA1;PPIP5K1;PIK3CB;ACYP2;IP6K2;ENPP1;PLPP1;AGK;NUDT4;PANK2;AGPAT1;PLCB4;TAOK1;LPL;PTEN;GK5;TNK2;GDE1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.23341186215901324,0.4983484915902268,0.9488559892328399,1.0,1.0,8/20,26.58%,SPPL2B;ADAM17;ADAM9;NFKB1;TRAF6;RELA;TGFB1;RHBDD1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.22483301297920846,0.4979248975432417,0.9715346534653465,1.0,1.0,4/25,17.84%,GPRC5A;ERRFI1;RAMP3;SLC6A9
prerank,regulation of inflammatory response (GO:0050727),0.20846488659100582,0.49712908061706507,0.9939819458375125,1.0,1.0,30/190,19.54%,SETD6;RB1;USP18;DHX9;NMI;PTPN2;IL18;AKNA;ENPP3;SERPINE1;AGT;NLRP6;CCN3;ANXA1;DAGLB;BRD4;RORA;MVK;XIAP;SETD4;IL1RL2;LPL;SIRPA;FOXP1;CD47;LACC1;PTGIS;RIPK1;DAGLA;PRKCD
prerank,negative regulation of complement activation (GO:0045916),0.2548798092010293,0.4963624563781805,0.9683257918552036,1.0,1.0,10/10,74.53%,SUSD4;CD55;C4BPB;C4BPA;CD46;VSIG4;A2M;SERPING1;CR2;CR1L
prerank,negative regulation of protein localization to membrane (GO:1905476),0.23150799131376737,0.49544135053927,0.9632911392405064,1.0,1.0,4/24,15.27%,RHOQ;PICALM;DMTN;LZTFL1
prerank,ion transport (GO:0006811),0.20766392154643304,0.494896882457754,0.9897854954034729,1.0,1.0,11/111,12.04%,KCNN4;PLP2;SLC20A2;TRPA1;WNK1;SLC4A2;SLC9A5;SLC24A3;SLC8A1;PIEZO1;CHRNB1
prerank,positive regulation of type I interferon production (GO:0032481),0.20867693047607894,0.4944643378545004,0.9771547248182763,1.0,1.0,8/73,10.55%,DHX9;PRKDC;MRE11;G3BP1;SETD2;IRF1;RIOK3;POLR3D
prerank,cellular response to starvation (GO:0009267),0.20847723815051755,0.4940402256394073,0.9919436052366566,1.0,1.0,28/147,18.10%,FNIP1;DEPDC5;DAP;HNRNPA1;STK24;ATG7;SH3GLB1;FOXO3;LRRK2;ZFYVE1;NPRL3;SESN1;EIF2AK3;SIK2;SLC38A9;PRKD1;ITFG2;RPTOR;MTMR3;PRKAG1;TP53;CLEC16A;SESN2;SFRP1;LARS1;LAMTOR3;LAMTOR5;SREBF1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.20574856502837405,0.4939111835150602,0.9949596774193549,1.0,1.0,19/151,15.60%,FGFR4;FGFR2;GAREM1;ARRB1;FBXW7;PDGFRA;NPNT;ANGPT1;HMGB1;P2RY1;CRKL;BMP2;PRKCA;NOTCH2;ROR1;RAMP3;CD44;SLC30A10;PRKD2
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.25265195057297873,0.49383768928408267,0.9642857142857143,1.0,1.0,1/11,9.78%,AGT
prerank,metanephros development (GO:0001656),0.22879182815412358,0.49334430752476743,0.969437652811736,1.0,1.0,5/26,18.17%,NIPBL;CTSH;GDNF;PKD2;OSR1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.24262011370746742,0.492442151369773,0.9666203059805285,1.0,1.0,1/14,4.06%,DDRGK1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.22672139877976474,0.49122612167789564,0.964329643296433,1.0,1.0,7/26,23.20%,NMI;ILRUN;ITCH;TRIB1;SIRT2;NFKBIL1;PCBP2
prerank,development of primary male sexual characteristics (GO:0046546),0.21938781233356264,0.49090300478560966,0.9742086752637749,1.0,1.0,2/34,5.17%,KIT;WNT2B
prerank,positive regulation of potassium ion transport (GO:0043268),0.2225639175139561,0.48994539467223003,0.9758064516129032,1.0,1.0,9/38,22.10%,KCNN4;KCNMB2;KCNMB3;DLG1;KCNMB4;GABBR2;AMIGO1;GNB1;FLNA
prerank,negative regulation of protein kinase activity (GO:0006469),0.20526352293048017,0.48870003424553266,0.984472049689441,1.0,1.0,20/88,21.15%,RB1;CEP43;TAB1;WWTR1;GNAQ;SLC8A1;CEP85;PYDC1;PDPK1;LRP5;SPRED1;CDKN1B;QARS1;MVP;SH3BP5;PTPN1;TRIB1;CEACAM1;SNCA;UBASH3B
prerank,second-messenger-mediated signaling (GO:0019932),0.20720984623324148,0.48784338744046923,0.9842602308499475,1.0,1.0,10/82,13.60%,CXCR4;LRRK2;MCU;AGT;SAMD14;EIF2AK3;PDPK1;TRPM4;BTK;NUDT4
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.21971564046899064,0.48716248853580724,0.967479674796748,1.0,1.0,4/35,14.02%,PAM;ACAT1;ACACA;AACS
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.2575532147395602,0.48689315785796317,0.9542682926829268,1.0,1.0,4/10,22.01%,TUT7;TUT4;ISG15;NEDD8
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.2335436732528779,0.4868478591459835,0.9699453551912568,1.0,1.0,3/17,12.53%,SLC8A1;CACNA1C;TRPM4
prerank,response to glucagon (GO:0033762),0.23534372801202852,0.48646285634211445,0.9695364238410596,1.0,1.0,7/19,24.39%,ADCY6;CYSLTR2;PRKAR2B;PRKAR2A;ADCY2;PRKAR1A;PRKACA
prerank,female gonad development (GO:0008585),0.23185637443173818,0.4864598375551561,0.9817470664928292,1.0,1.0,1/19,4.54%,KIT
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.22648936358434807,0.4858858514297627,0.9619771863117871,1.0,1.0,3/25,11.64%,DDX39B;SCAF8;HTATSF1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.20328780717052758,0.48500096203751814,0.9939577039274925,1.0,1.0,17/152,15.12%,LPAR3;LPAR1;IAPP;ADGRL1;GNA13;GRK5;GNAQ;S1PR2;ABCA1;GLP2R;WASF2;GNAI3;ADGRG2;ADRB2;INSL3;RAMP3;ADCY6
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.22839583184594844,0.4848244233287168,0.9748344370860927,1.0,1.0,7/22,22.94%,ZDHHC18;ZDHHC15;ZDHHC3;ZDHHC21;ZDHHC24;ZDHHC2;ZDHHC14
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.22839583184594844,0.4848244233287168,0.9748344370860927,1.0,1.0,7/22,22.94%,ZDHHC18;ZDHHC15;ZDHHC3;ZDHHC21;ZDHHC24;ZDHHC2;ZDHHC14
prerank,protein targeting (GO:0006605),0.20294626086372242,0.4847491463077025,0.9949135300101729,1.0,1.0,30/118,23.89%,VPS37B;TRAK1;AP4M1;FUT10;MYO1C;VPS37A;MFN2;SRPRA;ZDHHC18;CHM;ZDHHC15;ATG3;PRKCI;ZDHHC3;ZDHHC21;PIKFYVE;KIF13B;PEX12;ZDHHC24;TSPO;ICMT;TIMM23;TOMM40;SPCS3;VPS37C;ZDHHC2;ZDHHC14;TOMM20;PITRM1;TIMM10B
prerank,autophagosome organization (GO:1905037),0.2129793876247237,0.48447393914876585,0.9790286975717439,1.0,1.0,13/50,22.42%,ATG7;ATP2A2;RAB1A;RB1CC1;ULK2;ATG3;ATG2A;STX12;UBXN2B;TP53INP2;AMBRA1;ATG13;ATG5
prerank,inositol phosphate-mediated signaling (GO:0048016),0.23264742480413808,0.484112831374937,0.953125,1.0,1.0,6/19,24.18%,PPP3CA;PPP3R1;NFATC3;INPP5A;HRH1;PPP3CB
prerank,positive regulation of response to external stimulus (GO:0032103),0.2038161558494847,0.4836363243679372,0.9929006085192698,0.9998534714038717,1.0,25/128,23.00%,DHX9;NMI;BMP6;IL18;SERPINE1;RIOK3;PUM2;AGT;POLR3D;CNTF;PRKCA;AKIRIN2;SLC15A4;SETD4;LPL;CD47;ANKRD17;RIPK1;IL16;SNCA;POLR3C;OPTN;GPRC5B;POLR3G;TLR7
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.22701532856947815,0.4827749699835548,0.9703225806451613,0.9997884456782451,1.0,7/22,24.50%,PSMB1;PSMB9;PSMB2;PSME4;PSMB7;PSMB8;PSMA5
prerank,negative regulation of bone remodeling (GO:0046851),0.2513808686919409,0.48264041916430545,0.9782608695652174,0.9994393071600737,1.0,11/11,74.88%,SFRP1;UBASH3B;GPR137B;IL6;TMEM119;CARTPT;CALCA;GREM1;TNFAIP3;GPR137;P2RX7
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.2234119340388624,0.4819678752237806,0.9635220125786164,0.999296296832356,1.0,4/21,14.08%,SPPL2B;ADAM17;ADAM9;ADAM19
prerank,response to cytokine (GO:0034097),0.20236147287083278,0.48131199114504225,0.9949647532729103,0.9991466348581093,1.0,30/141,21.37%,RHOA;ALDH1A2;SRF;AFF3;PTPN2;CXCR4;PML;SETD2;ANXA1;PRKCA;MAPKAPK3;CASP8;DPYSL3;ADAM9;SMPD1;SMAD3;PTPN13;SRC;IL1RL2;IFNAR2;RIPK1;SP100;RELB;PTPN5;TRAF6;SNCA;MAPKAPK2;ISG15;EIF2AK2;HDAC4
prerank,regulation of interleukin-12 production (GO:0032655),0.20800125118787932,0.48073867857736075,0.9742441209406495,0.9989608988963339,1.0,6/47,20.33%,MAST2;HMGB1;FOXP1;CD47;MAPK14;IL16
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.20139995525300558,0.4780290652260856,0.9927909371781668,0.9996341987879743,1.0,15/95,20.28%,HMGB2;TICAM1;RHOA;SERPINE1;CD80;HMGB1;ADAM9;NFKB1;AXL;SIRPA;MAPK14;PLAA;PDE4B;CD68;TRAF6
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.20743789094188558,0.4756804386000764,0.9871794871794872,1.0,1.0,8/62,12.62%,ERCC3;ELOF1;ELOC;POLR2A;SETD2;LEO1;ADRM1;SSRP1
prerank,ncRNA catabolic process (GO:0034661),0.21421087708387931,0.4751663236697435,0.9805352798053528,0.9999216259542215,1.0,7/28,21.23%,POP1;EXOSC7;TUT4;ZCCHC8;EXOSC10;DIS3;TRIR
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.23476241290565583,0.47446637686931026,0.9763313609467456,0.9997804573298986,1.0,12/12,76.54%,CD44;GCNT2;FLOT1;FGG;IL10;IL1B;TNF;LCK;AGER;SKAP1;THY1;BMP7
prerank,carnitine shuttle (GO:0006853),0.244527220968227,0.47361069704091696,0.9748520710059172,0.9996829531252609,1.0,2/11,14.04%,ACACA;CPT2
prerank,tricarboxylic acid metabolic process (GO:0072350),0.24514526772031336,0.4734572892488301,0.9721407624633431,0.999327037510482,1.0,1/12,4.72%,IDH3A
prerank,histone H3-K9 demethylation (GO:0033169),-0.18474388512832796,-0.47307667390646874,0.990625,0.9990877928721196,1.0,5/11,32.70%,KDM4C;KDM4D;KDM4A;KDM3B;KDM7A
prerank,positive regulation of TORC1 signaling (GO:1904263),0.23420327915674255,0.4718714964436528,0.9620253164556962,0.999481436363901,1.0,6/16,25.21%,KLHL22;CLEC16A;LARS1;LAMTOR5;GPR137B;SEH1L
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.24110565334028872,0.4715798215818884,0.9605839416058394,0.9991670282445922,1.0,3/11,20.35%,PRKCA;PLAUR;ANK3
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.1894300778307808,-0.4708763527640352,0.9932203389830508,0.9985468925274871,1.0,11/11,81.08%,P3H2;P4HA1;EGLN2;P4HA3;P4HTM;P4HA2;CRTAP;P4HB;EGLN3;EGLN1;OGFOD1
prerank,superoxide metabolic process (GO:0006801),0.21380562509271928,0.46917469539921275,0.9781553398058253,0.9996051574892137,1.0,5/29,17.53%,SOD3;NOX4;CYBB;CCS;SH3PXD2B
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.20580034807859668,0.46873087554285997,0.9868852459016394,0.9993556407229163,1.0,5/49,12.77%,KIT;IL18;PARP9;CNTF;IL31RA
prerank,regulation of peptide hormone secretion (GO:0090276),0.19876186480691754,0.46796589838274855,0.987220447284345,0.9992329521698471,1.0,8/67,15.62%,GCK;ITPR1;CACNA1C;RAPGEF4;ITPR3;PRKCA;ENSA;PASK
prerank,mammary gland epithelium development (GO:0061180),-0.17071287376818545,-0.4674205475535037,0.9964539007092199,0.9982126314669187,1.0,2/14,8.69%,AKT2;ERBB4
prerank,lytic vacuole organization (GO:0080171),0.21356250468933807,0.4673948772034837,0.9763872491145218,0.9990258682924734,1.0,7/32,17.36%,VPS18;LRRK2;CLVS2;ABCA1;NAGPA;TPCN2;ARSB
prerank,positive regulation of integrin activation (GO:0033625),0.23892189484449503,0.4671363795614196,0.9632352941176471,0.9987048801401095,1.0,3/11,20.82%,PIEZO1;SRC;FERMT2
prerank,cellular response to UV-A (GO:0071492),-0.18364575306458247,-0.4656797695270981,0.9840764331210191,0.997634922076224,1.0,6/11,44.82%,MMP2;CERS1;MMP1;OPN3;TIMP1;MMP3
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.20272271147024692,0.4654014704090291,0.9903743315508021,0.9988749018612063,1.0,8/64,12.62%,ERCC3;ELOF1;ELOC;POLR2A;SETD2;LEO1;ADRM1;SSRP1
prerank,B cell activation (GO:0042113),0.19640829363715842,0.4647134758931155,0.988272921108742,0.998706880835083,1.0,9/68,15.44%,KIT;PTPN2;CTPS1;PRKCB;ADAM17;CASP8;BTK;ITGB1;DCAF1
prerank,mitochondrial transcription (GO:0006390),0.24398161251241596,0.4642867016243616,0.9703588143525741,0.9984455637134614,1.0,2/10,14.98%,FOXO3;TFB1M
prerank,positive regulation of TOR signaling (GO:0032008),0.2052570787459564,0.4603696577199808,0.9875141884222475,0.9993465137964995,1.0,8/40,17.76%,FNIP1;KLHL22;SLC38A9;RPTOR;CLEC16A;LARS1;LAMTOR3;LAMTOR5
prerank,response to lipopolysaccharide (GO:0032496),0.1911814836061748,0.460255286221959,0.9969481180061037,0.9989736586408879,1.0,24/138,20.94%,HMGB2;TICAM1;RHOA;SERPINE1;CD80;SMAD6;HMGB1;ADAM17;TRIM6;MAPKAPK3;ADAM9;NFKB1;AXL;SIRPA;FOXP1;MAPK14;PLAA;PDE4B;TRIB1;CD68;TRAF6;SNCA;MAPKAPK2;FER
prerank,negative chemotaxis (GO:0050919),0.2094630869483195,0.4601098786505282,0.9736526946107784,0.9986138612035547,1.0,5/33,15.24%,RHOA;NTN1;ROBO1;ITGAV;SEMA3D
prerank,protein localization to mitochondrion (GO:0070585),0.24140108087755102,0.45801189701218264,0.972463768115942,0.9988902097184831,1.0,5/11,26.98%,LRRK2;MAIP1;ISG15;RALA;COX18
prerank,negative regulation of immune response (GO:0050777),0.19444839568092115,0.4579893603918574,0.9959718026183283,0.9984948485175639,1.0,31/154,23.20%,IAPP;NMI;ENPP3;SAMSN1;ILRUN;GLP2R;ADAM17;ITCH;ADRB2;PLK2;RC3H1;INSL3;RAMP3;ADCY6;SRC;CYSLTR2;PRKAR2B;PRKAR2A;ADCY2;DPEP1;MAPK14;HAVCR2;YES1;FER;HTR7;SIRT2;GNB1;PRKAR1A;FYN;MYH9;PCBP2
prerank,negative regulation of inclusion body assembly (GO:0090084),0.23698962777291704,0.45597663109386455,0.9875389408099688,0.9987016203543768,1.0,3/10,19.67%,DNAJB2;DNAJB6;SACS
prerank,regulation of T cell proliferation (GO:0042129),0.1928405858778506,0.45503234048358043,0.9892241379310345,0.9985787858432669,1.0,8/61,21.52%,CD80;NCK1;ANXA1;NCK2;IL4I1;SLC7A1;SDC4;PNP
prerank,neutrophil chemotaxis (GO:0030593),0.19804610396552336,0.4548530776123515,0.9902491874322861,0.9982228898239447,1.0,2/53,4.99%,GBF1;CKLF
prerank,negative regulation of type I interferon production (GO:0032480),0.20002923456111937,0.45316341510946245,0.9863945578231292,0.9982935654506494,1.0,16/40,25.36%,PTPRS;ILRUN;ITCH;YY1;PIN1;MAVS;SIRPA;HAVCR2;RELB;ISG15;TAX1BP1;RNF216;PCBP2;REL;GPATCH3;ACOD1
prerank,steroid metabolic process (GO:0008202),0.1931741099251771,0.4496385337218949,0.9936034115138592,0.998858581129719,1.0,2/72,3.24%,CYP39A1;CYP26B1
prerank,positive regulation of peptidase activity (GO:0010952),0.2102643677053441,0.4482353228112732,0.9806701030927835,0.9988392715768918,1.0,4/20,21.09%,DDRGK1;CTSH;PSME3;TANK
prerank,regulation of actin filament depolymerization (GO:0030834),-0.17062137990758877,-0.4480797683433165,0.9967741935483871,0.9986468778983769,1.0,1/12,5.18%,PLEK
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.19452851472397503,0.4469297026156422,0.9934569247546347,0.9987942241393125,1.0,3/53,11.48%,LPAR3;AGT;ANXA1
prerank,response to fatty acid (GO:0070542),0.21841560786250758,0.44496786468413063,0.9777158774373259,0.9989060117829579,1.0,3/17,15.78%,FOXO3;SOX9;LPL
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.22966438318063825,0.4429574318704035,0.9785714285714285,0.9990160383568933,1.0,3/13,17.21%,SPRED1;SPRED2;ATR
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.2011591350861187,0.44249474161426583,0.9855595667870036,0.9987368006836259,1.0,5/30,17.02%,KIT;LMBR1L;TP53;SFRP1;MLLT3
prerank,innate immune response (GO:0045087),0.18347560779152997,0.4410885888741099,0.998997995991984,0.9986748370745946,1.0,35/217,21.70%,STYK1;TRIML2;COLEC12;RNASE6;TRIM59;PML;TTC4;SETD2;TRIM28;SKP2;HMGB1;IKBKG;CYBB;SRPK1;CAPZA1;PYDC1;TRIM6;BTK;SMPD1;TRIM5;SRC;AKAP1;TNK2;MAVS;SRPK2;CFP;ANKRD17;SP100;RELB;YES1;SNCA;FER;ISG15;CLPB;IKBKB
prerank,DNA catabolic process (GO:0006308),0.2295380366557871,0.44046414351634844,0.9771341463414634,0.9984326781964997,1.0,11/11,77.06%,XRN2;DFFB;DNASE1L1;DNASE1L3;DNASE1;ISG20;FBH1;DNASE1L2;MUS81;SETMAR;REXO4
prerank,regulation of intracellular pH (GO:0051453),0.2001946845732252,0.43704986346376223,0.9902794653705954,0.9988596885021067,1.0,5/34,17.66%,SLC4A2;LRRK2;SLC9A5;CA2;TM9SF4
prerank,lymphocyte migration (GO:0072676),0.19902349645224127,0.43358377057124536,0.9904761904761905,0.9992313246739727,1.0,1/32,4.99%,CKLF
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.19750673368701036,0.43077966593651057,0.9888059701492538,0.9994516387166933,1.0,1/27,3.90%,LPAR1
prerank,regulation of chemokine production (GO:0032642),0.1901450294200447,0.42946512091300204,0.9953216374269006,0.9993345259533786,1.0,10/36,27.35%,IL18;ADAM17;LPL;FOXP1;EIF2AK2;IL6R;TLR7;IL33;WNT5A;TLR3
prerank,RNA methylation (GO:0001510),0.1820338622314714,0.4291134286394981,0.9967982924226254,0.9990009813698048,1.0,10/60,19.76%,RBM15;METTL5;RBM15B;METTL8;TFB1M;MRM2;METTL3;NSUN3;VIRMA;TGS1
prerank,granulocyte chemotaxis (GO:0071621),0.18542519962124795,0.42799275118152813,0.9924324324324324,0.9988285354946582,1.0,8/55,23.25%,GBF1;CKLF;ANXA1;PIP5K1C;PIKFYVE;PDE4B;CXADR;CCL14
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.1563950452560144,-0.42770689829239816,1.0,0.9992028683861662,1.0,9/15,44.95%,TLR4;NLRC3;DDX3X;USP50;MYD88;TREM2;CPTP;CD36;TLR6
prerank,regulation of phosphatase activity (GO:0010921),0.19938554302604103,0.42073788728799216,0.9859514687100894,0.9998311862825457,1.0,4/24,17.47%,MTMR9;BMP2;PTPA;PPP6R2
prerank,peptidyl-methionine modification (GO:0018206),0.2123062338133132,0.4126206591250735,0.9811046511627907,1.0,1.0,3/12,18.01%,NAA20;NAA60;METAP1
prerank,rRNA transcription (GO:0009303),0.19675826774299285,0.4105839882259623,0.9854689564068693,1.0,1.0,5/17,24.74%,GTF3C4;POLR1G;GTF3C5;BRF1;CAVIN1
prerank,rRNA modification (GO:0000154),0.19528820675071681,0.40878126894815986,0.9885931558935361,1.0,1.0,4/21,17.47%,METTL5;TFB1M;MRM2;NSUN3
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.15167513339655425,-0.4070379147941083,0.9968553459119497,0.9992698035033023,1.0,9/13,51.55%,TBX3;SRA1;SOX8;DLL1;EID2B;SOSTDC1;ANKRD2;PRICKLE1;NOTCH1
prerank,negative regulation of dephosphorylation (GO:0035305),0.19896919981349254,0.40657955385388905,0.9896373056994818,1.0,1.0,3/18,14.66%,PPP1R8;ENSA;PTPA
prerank,positive regulation of interleukin-6 production (GO:0032755),0.17315104267349163,0.4051197044418458,0.9978401727861771,1.0,1.0,8/68,17.17%,RAB7B;DHX9;HMGB1;TWIST1;POU2F2;SETD4;LPL;MAVS
prerank,mesenchymal to epithelial transition (GO:0060231),0.21653172660515918,0.404858740577057,0.9772382397572079,0.9999612503988412,1.0,10/10,78.36%,SALL1;BMP4;FZD7;SIX2;PAX2;CITED1;WT1;GATA3;PAX8;BASP1
prerank,N-terminal protein amino acid modification (GO:0031365),0.19771774593790464,0.4023509338231706,0.9871611982881597,0.9998892111983141,1.0,6/14,28.34%,NAA60;METAP1;NAA40;NAA50;NAA35;METAP2
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.17608003449746495,0.3988814546305595,0.9955506117908788,0.9999525974452771,1.0,8/47,19.54%,MAPT;XDH;AGT;TP53;MAPK14;RIPK1;DHRS4;PRKCD
prerank,rRNA catabolic process (GO:0016075),0.1888005231679206,0.39797283910689996,0.9918588873812755,0.999675327310715,1.0,5/16,24.55%,EXOSC7;EXOSC10;DIS3;TRIR;EXOSC8
prerank,neutrophil migration (GO:1990266),0.17022299029419757,0.39185069575896636,0.9989258861439313,0.9999704798097528,1.0,2/58,4.99%,GBF1;CKLF
prerank,monosaccharide transmembrane transport (GO:0015749),0.1867897281346141,0.3876039839549986,0.9931412894375857,1.0,1.0,16/16,81.34%,SLC50A1;SLC2A8;SLC2A7;SLC2A12;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC2A6;SLC23A2;SLC23A1;SLC2A2;SLC5A3;SLC2A9;SLC45A3;SLC2A10
prerank,potassium ion export across plasma membrane (GO:0097623),0.19397363465160072,0.38755996672033527,0.9958333333333333,0.9996279296922223,1.0,13/13,80.62%,KCNT2;KCNK5;KCND3;KCNA5;KCNK18;KCNE1;KCNE3;KCNE2;KCNE5;KCNH2;KCNE4;KCNIP2;KCNQ1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.18691156706347256,0.38483737169972204,0.9986807387862797,0.9995018923318603,1.0,6/18,23.61%,YAP1;SMAD4;SRC;FER;IL6R;IL6ST
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.19527599539596546,0.38207031944472725,0.9909228441754917,0.9993610610899639,1.0,1/10,8.99%,RIOK3
prerank,negative regulation of hydrolase activity (GO:0051346),0.1675782310887727,0.38069799070499155,0.9967105263157895,0.9990886611429329,1.0,8/49,20.28%,WNK1;LRRK2;CPEB2;TERF2;ATP5IF1;RCC2;PLXNB3;EGLN1
prerank,positive regulation of T cell activation (GO:0050870),0.1621611600894534,0.38051262392173707,0.9978632478632479,0.9987053548862732,1.0,9/62,18.57%,CD80;NCK1;FLOT2;ANXA1;NCK2;SIRPA;CD47;SLC7A1;ZBTB1
prerank,cell-cell junction maintenance (GO:0045217),0.17732000404236498,0.35154383115634696,0.9985590778097982,1.0,1.0,3/11,25.01%,NLGN2;FERMT2;MYADM
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.1602395507790584,0.34664713693674754,1.0,1.0,1.0,5/25,23.27%,DNAJB5;GAK;HSPA14;BAG1;HSPA8
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.1362207348428249,0.31628425628769585,1.0,1.0,1.0,21/116,22.89%,IAPP;GLP2R;ADAM17;ADRB2;PLK2;INSL3;RAMP3;ADCY6;SRC;CYSLTR2;PRKAR2B;PRKAR2A;ADCY2;DPEP1;MAPK14;YES1;HTR7;GNB1;PRKAR1A;FYN;MYH9
prerank,insulin secretion (GO:0030073),0.15281497121395005,0.3159831491315517,1.0,1.0,1.0,2/19,14.73%,ANXA1;SNX19
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.13383108219979906,0.31160535717808474,1.0,0.9997300053800884,1.0,21/117,22.89%,IAPP;GLP2R;ADAM17;ADRB2;PLK2;INSL3;RAMP3;ADCY6;SRC;CYSLTR2;PRKAR2B;PRKAR2A;ADCY2;DPEP1;MAPK14;YES1;HTR7;GNB1;PRKAR1A;FYN;MYH9
